cell_line_id,drug_id,response,predictions
DMS 273,9952709,2.373087309160908,2.303606540612021
NCI-H522,613000,2.2856040748624347,2.3550892465796167
YAPC,16038120,1.926562361021756,0.9809224849591964
NCI-H292,9935249,3.8808310590786,3.3341197425608824
SNU-449,navitoclax-gemcitabine (1-1 mol-mol),5.117951975418846,-1.1396214981429325
NCI-H522,9908783,5.043768225694569,4.615345452312918
JM-1,11175137,0.9157477453434189,1.628539553646145
NCI-H522,5287620,-2.19230412457559,-2.046074169713938
MDA-MB-453,4917,2.8920757434762203,3.0727904980184633
DMS 273,135421197,2.3407622077730035,1.7099427680538306
SNU-449,BRD-K55473186,5.1406225681359174,4.174522873601452
SNU-61,4521392,3.90812104829802,4.020878101499802
G-401,9549297,1.736191202159007,2.0267560597558756
NCI-H146,89183176,1.451528120959232,3.4887569211796987
LOU-NH91,5287620,-1.52867963951729,-1.8890642451925368
FTC-133,123631,3.8044847524269865,2.3780270991620522
KMRC-1,5291,3.811670367299954,3.5658833325639887
A-673,9823820,4.6435125645675095,3.443443812762344
FU-OV-1,168313047,2.3973799381416208,2.52984992124979
Panc 04.03,44462760,4.978463894781355,4.265403953692525
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272,2.9828237442450116
OPM-2,445091,3.996829176942573,3.9365835502348068
ONS-76,5746,1.4703359849180313,1.2630912760386201
NCI-H661,3025944,3.908905198351104,4.342853765264483
A4/Fukuda,107970,1.5574682195612295,1.97206601459127
CAL-51,49850262,3.6300011952383584,3.999450428006808
NCI-H460,2858523,3.1665522277325575,2.8438105244922425
G-401,6184667,2.5094508901292487,2.761826847436313
NCI-H661,44607531,1.139733733680255,1.5636244053376394
SNU-81,6917907,-6.2756065511253185,-4.900655571169968
MSTO-211H,54678924,1.5146991125566602,2.2481661161521282
FTC-133,10127622,5.496386107928154,3.5555758393841335
EFO-27,11977753,-1.8189065225127747,-1.0812259718403912
SNU-61,selumetinib-decitabine (4-1 mol-mol),0.7791363138333649,2.0028859800934287
MSTO-211H,19582717,3.17062921236116,4.168002994533835
KMRC-1,53392493,3.2185750963739026,2.6367416365322613
OPM-2,2749,1.7313419667612246,1.144799862005955
NCI-H460,5351362,3.0809857123464037,1.7536508855878568
SNU-449,56949517,4.374997906660537,4.717665566321556
NCI-H146,1716436,1.8968095332546364,2.7623651268906717
MSTO-211H,9884685,-1.5007126123703023,1.0834217864506304
CA46,46926350,-5.311040218420036,-4.5553874349366
BxPC-3,72193861,-0.2425633398981322,1.8121201460688676
NCI-H522,24180719,4.104291025168841,2.886282227431235
NCI-H292,16038120,0.8772093711483475,1.271148191975527
NCI-H2171,11364421,-5.769988570724398,-3.7217289152714033
LOU-NH91,71304818,3.9209078908272703,2.6247880434664568
NCI-H2009,71466380,3.950405172838994,4.69529296648865
EFO-27,44607530,2.237032971856772,1.908649819935374
CAL-51,3136844,4.799885860604426,4.410804480800866
MSTO-211H,9936388,-4.464575449065994,-0.39522614065849576
A2780,66577038,2.715796351675557,2.881307110114465
G-401,24779724,6.361263224396382,3.4856867780742804
OPM-2,5470400,-0.1217933569770787,0.41772178476120486
HCC1143,36314,1.6197332159913502,-1.3720213388399765
SW1463,54143018,1.6932952952144893,0.2560614162034708
JM-1,1317464,3.8125649173872938,2.988581032524115
DMS 273,46907787,0.4735517334159472,0.7155573382524234
MDA-MB-453,46843906,1.4379824902109608,3.2302668730881403
YAPC,6252,1.451992868069142,1.584419083382694
MDA-MB-157,navitoclax-sorafenib (1-1 mol-mol),-1.4384143120917083,1.823204468289401
CA46,46943432,1.2105530921386296,1.2503279752293697
NCI-H292,24785538,2.1095024536235374,1.7983920717643722
NCI-H292,3038522,3.811290582208577,3.1601532744133145
NCI-H460,54454,2.7807551042334935,2.4921611365926375
NCI-H661,9911463,3.595935737335879,3.93865253813295
BT-549,4261,1.9217340769001163,1.9273779338124053
FTC-133,16013152,4.199465293191842,4.140325549780622
MDA-MB-453,54618305,5.448966988850886,4.24530526797335
LOU-NH91,56946209,-2.032751224257796,-4.152743466013572
KMRC-1,16659841,4.161446951047465,3.6651118251229873
LXF 289,66577038,2.7615792990535937,3.031821515636659
A-673,2871966,-2.1375369153988597,0.07514933266046009
EFO-27,4788,6.204062284318603,5.715065287335095
FTC-133,5281321,-2.4880366458953196,-0.9518472948155491
JM-1,613753,2.4959303189076376,2.813880811459427
CAL-51,168312962,1.4117577594763937,1.6878304735575134
OPM-2,6450551,0.7106995413225735,1.4388832898284685
ONS-76,selumetinib-decitabine (4-1 mol-mol),-0.8020302824426914,2.790623726600659
EFO-27,26596,4.577324640946523,-0.9909018187940358
LoVo,656346,0.766025679375412,0.8892782348152345
NCI-H522,4477,0.4448521837298123,0.48330772101335695
NCI-H727,9936388,1.6432072244848812,-1.6161618099696315
FTC-133,104842,-5.8581546696404,-2.420993282822962
EFO-27,7326481,5.957065585898912,3.1370296288815975
NCI-H460,11222830,2.8861636193629323,1.7342167646600135
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245,2.9754276533960966
NCI-H460,54618771,1.6853262233131374,1.271345892016082
JM-1,52947716,1.780956269613054,-2.719032799565179
OPM-2,9444,2.5095115053941557,3.6678993646125724
NCI-H146,60700,-4.723399126949256,-0.8279898953873454
BxPC-3,9911830,2.611582201474507,2.5850431029946193
NCI-H146,16038120,1.7989248875403512,0.7009648236929558
LXF 289,51037431,5.679407317259089,3.210039771550592
HCC1143,44589607,1.260451666530297,3.025354827885593
CA46,5281321,-3.5082232289526663,-2.558812141714794
BxPC-3,3815108,3.682439325637505,2.9599081534504283
BT-549,ISOX-bortezomib (250-1 mol-mol),0.1826356805695565,0.7578265890809067
BxPC-3,3552672,2.73628551508051,2.773309949495271
SCC-9,3081361,1.719146178558617,2.468180288898863
SCC-9,135875424,4.9754653396039314,3.9911398594783134
LoVo,1716436,2.86184708699294,3.089615060811778
MDA-MB-157,9884685,1.398372779004129,1.029238648912954
NCI-H292,9911463,4.207043029649759,3.9886843851553526
G-401,54626689,4.421186382617726,4.246056574350483
NCI-H460,6917907,-4.956095121428261,-4.543525426602117
CA46,25062766,1.483751377697603,1.6734074614120389
LXF 289,44241473,4.688676931788039,4.832135485672973
EFO-27,71680916,4.9682795090816185,4.76101030922215
SW1463,11152667,-0.1903484351781526,-0.5726522559336843
NCI-H292,73707398,0.96137499748578,1.5382581811280778
NCI-H2009,16725315,3.943728055015544,4.201825399692416
SNU-61,135440466,2.760100648324382,2.259319573545274
A2780,451668,4.676838081876032,1.5417508532113613
JM-1,46191454,-0.7072965876905944,0.14382160455081291
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.515412170291972
SNU-449,2733526,4.280379959685792,3.886631715661191
JM-1,10302451,3.097435274235228,2.3827770007261653
DMS 273,tanespimycin-gemcitabine (1-1 mol-mol),-1.669434491650497,-1.4462300871489726
EFO-27,vorinostat-carboplatin (1-1 mol-mol),2.7861871023454077,3.3485749539212124
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.505258823255376
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.3844191054413684
OPM-2,52912189,-3.1407059889083424,0.19639169779208646
SCC-9,9549297,5.273243325738832,2.5533593290707572
A-673,375860,-0.5094320760358009,-0.3902944169302332
SNU-449,15983966,0.8926749279922188,-0.4893954275305369
SNU-449,135440466,2.7536019754154375,2.2493704755345347
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956,1.2364333026027297
NCI-H522,73707398,0.7434005611154502,0.9163457617607507
NCI-H1623,72376,-0.6301176586270604,-1.5378255298502481
SCC-9,24901704,4.548877009949327,3.389109820237437
HSC-4,448949,2.25928901468022,2.160530218253129
SCC-9,25102847,2.571358625043281,2.571397974815809
FTC-133,135411,0.6572104898559208,1.0351162084065857
DMS 273,445643,4.452334519038606,3.7702661710652694
HSC-4,24771867,2.9499855440491243,2.708639728289919
BxPC-3,2841722,6.186043735824486,4.268997706089689
MDA-MB-157,52947716,2.709287320485668,-0.35945350497825146
HSC-4,46224516,3.389129888163455,2.5796462787483256
NCI-H146,400769,-1.4971487301951925,-0.7579741863441544
LOU-NH91,387447,-3.4249375140388247,-4.221667955233862
CA46,6610216,4.017162804005507,3.9637813440519754
LoVo,375860,-0.1162329718395109,-0.10304974594992944
FU-OV-1,9911830,2.8434321082933773,2.331539532747601
LoVo,9840324,5.061772266378942,5.784350390347213
MSTO-211H,56649450,2.845391743702004,3.3902520330581227
HSC-4,9935249,3.700870290975298,3.0722923681706735
BT-549,44486219,4.179253703467884,4.413458992806869
SNU-449,24901704,3.9093934632949616,3.4400403913736284
FTC-133,44589607,3.1305768616958085,2.9331197950132624
LOU-NH91,42642645,0.5799169530603235,1.2237198382274537
KYSE-70,51037431,6.2873914521382765,3.0696790030941092
KMRC-1,1566236,3.0378094444517645,2.6256258010190026
Panc 04.03,42642645,1.6619965718360328,0.936476446976714
CAL-51,3689413,0.5709426612715743,-0.01466212853259396
NCI-H522,44487872,5.4176039717063915,4.370804473355355
NCI-H2009,16722836,0.9347693241342916,1.8682729953787154
NCI-H522,11222830,1.4433136379668847,1.4888552305638936
CA46,72193861,0.1338517787347367,0.3292601913588168
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403,-0.30289748611069117
LoVo,119607,4.4096130331744865,5.278250185619995
MDA-MB-453,1566236,2.5975650319928434,1.9803971412326344
ONS-76,11152667,-0.1692604119623072,-0.5460342349892369
G-401,24748573,1.6686206591324024,1.869422936641941
A2780,176870,3.0464675702719655,2.7729384469933365
NCI-H727,vorinostat-navitoclax (4-1 mol-mol),3.0192408076128823,1.2970374806006544
OPM-2,3385,3.5898560550490837,2.8731984669384185
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-1.0517154462438434
NOMO-1,53495165,-0.0338576092201104,-1.7695246697764466
LoVo,46191454,2.275591949439888,1.61359369787874
A4/Fukuda,4096211,1.2598455852625392,1.2420207031588344
NCI-H522,25126798,3.91575296607237,3.505622146405022
FU-OV-1,135411,0.8541212220651947,0.9489771645262317
KYSE-70,10113978,1.960067513789881,3.303769095811095
FU-OV-1,24856436,0.8416503079264269,0.7384339479360504
A-498,10026128,4.231838396167064,3.6773703911975373
JM-1,11626560,-0.1801568688824005,0.46816505061512204
NCI-H460,9911830,3.1326305509826824,2.621530945551009
A-673,9911830,1.9751375507094395,2.3560204884968674
Panc 04.03,71751553,4.683117627568525,4.5156854233952615
LXF 289,6450551,1.9915066986525345,3.1229058559816103
NCI-H522,156414,0.937566519659893,1.1799900376036416
MDA-MB-453,6610355,3.820285868995436,4.524664918072476
FU-OV-1,46843906,0.6915308493256752,3.1745015393357177
NCI-H522,42642645,1.4297074042386375,0.3249533463930829
SCC-9,4917,3.683292695011318,3.145187734058271
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,0.9078721497613829
SBC-5,54649381,4.189343649803657,3.717560692122412
NCI-H1623,6918837,-3.3974396350468674,-2.975153423712149
KMRC-1,10184653,1.755388017214173,0.5648391840049062
LXF 289,9967941,3.6599941581067057,3.986035782666661
FTC-133,57519531,1.7209799050566308,2.741004126985574
NCI-H661,19582717,3.3132894226769056,4.292462372180411
MSTO-211H,selumetinib-PLX-4032 (8-1 mol-mol),2.4533429181840307,3.4865920410179796
LoVo,71466578,1.8530080227063717,4.556561862312339
NCI-H2009,46907787,0.5680124512944033,2.5298970860841825
DMS 273,49793307,-3.720971975288363,-3.6789654209782894
NCI-H522,135659046,3.4944475458884012,3.148542858091785
FTC-133,5351362,2.946320615286136,1.6909273686795427
JM-1,208908,1.8689748302954872,1.9881140961173531
Panc 04.03,216239,3.3806837686851923,2.445737940700831
NOMO-1,71466445,1.8310961714544176,2.3054079694961054
NCI-H522,71680916,3.6078643166976896,4.20361510827023
EFO-27,2126,5.846579140474247,4.626977140405881
ONS-76,5284616,3.539643222518188,2.5673669055624093
SCC-9,16736978,3.1048488109971664,1.9362076670766384
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485,-4.011305223973148
A4/Fukuda,23582824,-0.7377224087572002,0.7569259999742007
NCI-H661,53325874,4.390083123893945,4.438518094250894
SNU-61,4096211,1.05462843518756,1.4119844984593568
CAL-51,675434,4.354107922133551,4.416893103279984
NOMO-1,11175137,1.3676050257567425,1.6751828235070332
NCI-H2171,5335621,4.282845813975702,4.178118526222286
SNU-449,11647372,1.9881649315547345,1.5997348683911943
NCI-H522,3503,2.0960599148243557,2.0520753348108602
NCI-H2171,52947716,1.4567314464455066,-1.0974925801539457
NOMO-1,5291,3.5817896511091862,3.18191287490212
NCI-H522,46843906,2.3044802452603967,2.3220261253170187
OPM-2,11494412,0.3054873199299708,0.21432030492441373
A-673,53495165,-1.305348317827654,-1.0586436528286602
KYSE-70,54618771,1.1170424016733127,1.3097788019988044
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.0734156996597246
SCC-9,3062316,1.318086870144001,0.7081009028993015
LoVo,387447,-3.727342469020989,-4.31830338482881
MSTO-211H,73707386,2.8647689708389943,3.0084198189264
FTC-133,54613361,1.5430217136639572,0.3820000800789356
SNU-61,12001922,2.043150446887516,1.6319813302273074
DMS 273,374536,2.442253811681885,1.463884152175048
LXF 289,10302451,1.735451917587997,3.1042365600018176
CAL-51,2858523,3.1959449804225524,3.070095020437817
Panc 04.03,23582824,1.118403221753994,0.9341884070651383
KMRC-1,6505803,1.455434702084088,-0.5125833781416272
CAL-51,4261,2.4552246887350417,1.8852728091325432
SCC-9,5746,1.774962232755205,1.3425016291958694
NCI-H661,71466578,3.739107690689307,4.63906099364748
ONS-76,54619267,4.0364090976663,4.172262583534642
NCI-H522,100016,6.692385014202011,5.664009057416628
G-401,11719255,3.853695059500007,2.8059880003356934
HSC-4,3815108,3.178044313970192,3.0951196448888725
NCI-H2171,5287620,-0.0573950216422359,-2.185333195815934
A4/Fukuda,5311,-0.1264358008137528,0.8385721288476469
NCI-H292,387447,-4.003442188855186,-4.1037878864405775
OPM-2,148124,-6.3849256320012575,-2.8818299424154974
MDA-MB-453,alisertib-navitoclax (2-1 mol-mol),3.3277558601146215,-0.1700646009184934
DMS 273,salermide-PLX-4032 (12-1 mol-mol),5.306834954267239,4.73419239616685
CA46,9967941,3.699441503938977,3.221702837263763
SNU-61,JQ-1-navitoclax (2-1 mol-mol),0.8164075639499123,0.291294576112145
LXF 289,387447,-4.093727880786265,-4.151259085057081
CAL-51,5113032,4.55807021159329,4.798833398049893
NCI-H727,serdemetan-SCH-529074 (1-1 mol-mol),2.331809225876462,1.9601067293703058
OPM-2,241158,1.7102591321182437,2.554060134361573
ONS-76,16741245,1.9308546797770672,3.8487999674401947
Panc 04.03,322968,5.075488138121087,4.030636114362069
BT-549,135875424,3.804392758634582,4.2304298495823
A-673,54626689,4.6393725921997415,4.285799676124532
SNU-449,navitoclax-birinapant (1-1 mol-mol),3.571225842715355,1.8265310023128756
HCC1143,3543504,4.280043771428645,4.568369831848659
BxPC-3,107970,2.2592769610294448,2.2838911729609963
ONS-76,51037431,1.0002101292366832,2.953231437314692
G-401,24785538,-1.0602782345595374,0.8594201587408373
MDA-MB-453,SNX-2112-bortezomib (250-1 mol-mol),-2.8558068979293383,-1.20556495602648
FTC-133,676352,3.9949531967924297,1.9331240165367551
NOMO-1,53232,3.2414615649348772,2.22225426838915
LoVo,11625818,2.0848313295223844,4.479872156482774
A4/Fukuda,702558,5.147225783500614,4.408570876061648
NOMO-1,11455910,0.2303469505827257,0.5181377017428059
SNU-81,4096211,1.97800800333133,1.5866819923803213
NCI-H522,676352,1.6559488811299496,1.831274709497405
YAPC,60750,-4.781219880342373,-1.6453313995230356
Panc 04.03,11612883,3.751429287253437,2.96371778965195
NCI-H661,67156097,-3.370555704228358,-0.649015004263602
SNU-449,4705,3.898593282840832,3.167084541661435
MDA-MB-157,9952709,2.6586157499418444,3.0105921078194116
NCI-H522,16038120,0.9671280612186928,0.7309984636617066
A4/Fukuda,4259181,-0.5702867723998835,-0.051602272853874157
LoVo,135398744,6.330186357549225,6.414353301288916
OPM-2,637858,0.8070227403937857,0.929120365378923
SCC-9,3038522,1.9571402343301385,3.1842930979490207
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498,-0.42741504608373987
A4/Fukuda,10127622,0.8035335483112384,3.068025087695437
Panc 04.03,4378219,5.53220646065493,2.5693701161752664
EFO-27,JQ-1-vorinostat (2-1 mol-mol),1.2489296683546294,1.307565485559808
LOU-NH91,navitoclax-piperlongumine (1-1 mol-mol),-1.482580438049138,2.12622379431866
EFO-27,11396600,3.826824277303455,3.7914765448690484
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283,1.666503119937646
NCI-H2171,7251185,0.8673768610035957,2.033180053903134
NCI-H1623,5311281,4.903104817913162,2.3814836452451913
OPM-2,11317348,2.0151792351474755,0.8498453792337314
OPM-2,100016,3.804278037815123,4.890526455830061
LoVo,46224516,4.94892102130723,2.4748794901212734
A4/Fukuda,9826308,-1.4955537783248567,-0.027465154394120297
LoVo,15547703,1.4569683263207862,3.2532847913911613
LoVo,227681,3.064150517180394,3.53401633999527
NCI-H727,5460769,4.510942150258337,2.7842988705891076
NCI-H292,6918837,-2.538558148903755,-2.29375898725368
A2780,132971,2.947129832610188,2.5983650580675897
FTC-133,4788,5.605324981437421,5.663617337069875
A-498,selumetinib-decitabine (4-1 mol-mol),2.586259947527723,3.692041529302969
A-498,23582824,2.0595934555669886,0.9426640324930624
SNU-61,8515,5.6731171982359365,3.4448646709602624
MDA-MB-453,23582824,0.0198148722876335,0.6114317430043635
DMS 273,5329102,2.038563375095403,1.6247756625716219
NCI-H460,72193861,2.1658883750752844,1.8080016467896594
MDA-MB-157,6610355,3.680589360872168,4.514509421375248
Panc 04.03,56649450,4.182465283011193,3.7195358649062022
NCI-H727,124202324,2.79148434895864,2.221966320851007
MSTO-211H,24772860,-3.3585393605141824,-1.8610933312980884
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776,1.3346908338983348
CAL-51,20959075,-3.1196535578382987,-2.771683573666116
OPM-2,322968,0.7466819505545055,2.1271068043634362
CA46,984333,-2.431082434536014,-0.3720881934632219
JM-1,1242560,2.356943306915098,2.9285410772000353
NOMO-1,25126798,3.9519848152055848,3.264778122164746
MDA-MB-453,5738263,2.9414099779046934,3.566050466017824
OVISE,10074640,3.3556303567674064,3.2592876406191964
SNU-81,JQ-1-MK-0752 (1-1 mol-mol),4.555770786077887,1.4307715554798954
MSTO-211H,159324,-0.971759723426381,3.375455160156014
Panc 04.03,46191454,2.0071895522726377,1.8970211898928417
SBC-5,9826308,0.1778598819423294,0.5548165085962026
BxPC-3,1641662,3.0109567862503654,3.6799160310526844
NCI-H460,2708,4.613368759945332,4.7852329830405695
MDA-MB-453,2746,1.6853152695376463,2.6864957933623965
NCI-H292,2858523,3.0406792249868633,3.082880465381436
LoVo,52912189,0.3784309245329977,1.9146738384690778
BxPC-3,navitoclax-gemcitabine (1-1 mol-mol),-2.057283602704844,-0.5536216760192224
NCI-H460,9936388,2.3098343611543415,-0.8907536708626577
A4/Fukuda,176870,1.9874765150136215,2.8919013258858293
LOU-NH91,49793307,0.2442451207819767,-2.1057623136974577
MDA-MB-453,2945648,2.145365576847094,3.0371233056280467
SNU-449,54596490,5.440438718305218,4.819713349372688
NCI-H2171,9927531,3.1501077196413783,4.120197413656637
CAL-51,25150857,2.2346870378683934,2.624015292478792
YAPC,navitoclax-sorafenib (1-1 mol-mol),5.55182899322967,1.976120391910526
NCI-H727,9444,4.415864627267573,3.9640980356489615
CA46,71466578,1.7711352492213497,2.5574588496879658
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.3431438807461045
G-401,11507802,0.4930201538787991,1.0297064961986397
OVISE,11214940,-0.1911189695405239,2.1837948914260483
MDA-MB-453,135999136,4.2113637134750395,3.5765810358698844
CA46,445455,4.357290874085763,3.9470636674084822
KMRC-1,5335621,6.052276706579308,4.410603245497115
Panc 04.03,36462,3.526332093717117,2.5205991242644803
SBC-5,56963564,-0.838635946263744,0.38344685485292035
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997,2.4117647167181593
NCI-H727,46224516,2.477743379244975,2.3563239308809627
NCI-H292,11222830,1.205012148013641,1.7555748621582432
MDA-MB-453,24771867,4.091824937074987,3.001712215674415
NCI-H460,72376,-0.5460239014371263,-1.478952268890332
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023,0.7317698320741088
LXF 289,9911830,2.045852319971143,2.467992603216517
LoVo,1242560,3.2639930925900305,3.5128933341486794
NCI-H292,6918736,3.734181331597608,-1.5202282546906698
G-401,11717001,3.7897150646045863,4.004201190964656
ONS-76,46398810,2.9642978938134004,2.415502856974517
NCI-H522,1242560,4.210520049105227,3.4953353624674053
EFO-27,3081361,2.362036241237279,2.622652721305956
SBC-5,11222830,1.4112085967579189,1.515105742455085
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.10561661456686
CA46,11213558,2.4131379110887496,1.1524822896515368
FU-OV-1,6918837,-4.1157354170673495,-2.3837147912693744
A4/Fukuda,56946209,-6.395954164738885,-4.509926518029221
NCI-H2171,tanespimycin-gemcitabine (1-1 mol-mol),-2.6967474652224745,-1.5850886007983231
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492,1.1004475778676794
OVISE,vorinostat-navitoclax (4-1 mol-mol),1.48951856204489,1.2195774898100638
MDA-MB-453,navitoclax-birinapant (1-1 mol-mol),3.002333269444996,1.2445889581234766
A4/Fukuda,216239,1.5760740052804734,1.9105207243632396
FTC-133,4578,5.173307644971936,4.3894238067112745
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304,1.1833996830101146
NCI-H460,54618164,4.49670945938676,4.052139408921185
CAL-51,42642645,0.4324607401831485,0.8256202146416954
BxPC-3,24771867,1.9124988819938955,2.9944371980644395
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335,1.8893988883157717
NCI-H460,15953870,5.00315267734786,3.5526561266541523
A2780,24964624,-0.4628922796959323,2.0322243558466053
CAL-51,654092,0.82886283906252,-0.17873002955414619
G-401,5281321,-2.57337969869382,-1.7267587248173746
MDA-MB-157,3634881,2.7842407118999852,3.332021236159841
MDA-MB-453,42642645,1.5292302084545462,1.1295777698715543
BT-549,54618164,4.423974096662665,4.218325937595949
A4/Fukuda,16741245,4.963846947143099,3.6066999209397426
BxPC-3,44632017,0.4026385498906549,1.3422118026041314
ONS-76,9911830,2.941904202808556,2.101397300717597
NCI-H146,navitoclax-birinapant (1-1 mol-mol),-2.693365824422348,0.9675190741048396
ONS-76,4477,-0.2351585842599584,0.7385018410817135
JM-1,44493528,3.997956862382446,4.099233829199006
NCI-H146,5702613,3.149923076768629,3.3197352979986094
NOMO-1,25150857,2.063048355345986,1.7133394215750137
LoVo,24856436,-0.7244956111709783,0.1827854491680897
OPM-2,53481919,3.0492738202957206,3.1674039551283903
BxPC-3,44507138,1.658490789748868,2.560560879483646
FU-OV-1,2113511,4.466585490981426,5.542988863655674
NCI-H661,2749,0.7713739826565964,1.9715031086347852
NCI-H1623,53495165,-0.5563852526996439,0.7409409939975565
NCI-H522,6610216,4.154510920860766,4.135055027541626
BxPC-3,148198,-2.171424706341701,-3.4283866118476722
MSTO-211H,4788,5.119342350142264,5.671389527025321
A-498,1750826,-1.7479882416802337,-1.5771769789140486
HSC-4,136227924,4.2199200707906845,2.8746435443587592
Panc 04.03,selumetinib-UNC0638 (4-1 mol-mol),4.963542223842957,2.923491378796106
LoVo,54618771,0.7060685526757626,1.2596020249453972
DMS 273,10322450,3.6367733537116167,3.562071923176745
ONS-76,1750826,-1.6505794475434372,-1.8830468687752282
MDA-MB-157,135440466,3.174924928897617,2.245677753135381
NCI-H727,241158,6.115461447477091,3.8726450999938526
HCC1143,46398810,2.1694021244377333,2.4849824347143623
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416,0.9138388312156871
SNU-449,3062316,-1.3612378425924234,1.3194486443535127
SNU-449,11977753,-2.005546044599541,-1.20546330245401
JM-1,24771867,-4.48997165682624,-1.264502377383879
NCI-H2009,11507802,1.1556617167312242,1.8412736153901605
HSC-4,11964036,1.64347500999081,1.4033317453262328
Panc 04.03,5479543,4.112837907412102,3.7727168662750477
ONS-76,439501,-2.2755976390662163,-2.0735291297247542
JM-1,54639126,4.392955654749798,2.0191411022311323
CA46,11167602,1.6890466560929325,1.7546086175320286
CA46,135411,0.0331424760277949,-0.19627913601852376
MDA-MB-453,tretinoin-navitoclax (4-1 mol-mol),3.844804044479517,2.119322219915338
Panc 04.03,11625818,5.081289492721679,4.5051376569484765
NCI-H292,12001922,1.805770236255338,2.0015554002763696
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,2.0396567757018627
MDA-MB-453,5278396,3.602107220771141,3.135933281687759
NCI-H522,6438330,2.681865372615506,1.7163900480714986
A-673,71466445,2.638210082463498,3.2472883032938595
MDA-MB-453,25105715,3.2581724710849778,3.3689450466156763
A2780,17759555,2.3500586644289165,3.4355391853525963
YAPC,124202324,3.68667481758741,2.714282054941458
NCI-H522,25227462,-0.4562280137645088,0.08035455695945942
KYSE-70,10074640,3.109810551584267,3.0400438814460653
HCC1143,5278396,2.995823973274505,3.478373557752212
HSC-4,5479543,4.052409111099337,3.8231394648896857
NCI-H661,446155,0.1985182541705634,2.597065023164346
YAPC,53495165,-1.0203233667221312,0.6072336201656999
FU-OV-1,11719255,3.4823701199113097,3.543766781443089
NCI-H2171,5278396,3.2627520221828115,3.2995862154232007
MDA-MB-157,9911830,0.0801478348660684,2.462875382403675
OPM-2,9911463,3.091122447781221,3.010731265973549
LoVo,25126798,3.7423562181337338,3.893190872121896
EFO-27,9911463,4.361076045114702,3.9318764536699775
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148,-2.6895043113636037
A2780,5280436,2.9198027340920434,3.0511788134174695
SCC-9,5311037,3.6943722712183007,3.694457144736136
ONS-76,5978,-2.168221630618191,-1.2423629928141626
A-673,44819697,-3.745571155852308,-0.9541657437014268
CA46,24785538,1.2011715151517115,0.3762382059248508
HSC-4,9936388,2.361545024779824,-1.085546295090606
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.3712238596799438
NCI-H460,49793307,0.4479933662320887,-2.4740922254705113
A2780,64971,1.607646338152048,2.5618349610418005
JM-1,72193861,0.5763432020354632,-0.018211846012228847
NOMO-1,11625818,1.7683333213472852,3.159695124653315
NCI-H522,navitoclax-PLX-4032 (1-1 mol-mol),3.539669986895116,1.605629236088245
MSTO-211H,11507802,-2.113337212450165,1.9320101938442271
NCI-H661,53232,0.4849867031297817,2.4951668221644723
YAPC,16720766,-1.1916244870670316,0.9335620519762928
NCI-H522,208908,1.8410391152152548,2.1342071948640386
MDA-MB-157,5284616,2.798393493195082,2.4153120160256196
MSTO-211H,6505803,-0.0669493563910609,-0.3943013445177235
NOMO-1,56649450,3.0749194455734012,2.643370133034229
NCI-H727,9967941,3.73486297967426,3.5067808319554774
SW1463,15547703,3.1824451623977312,2.7834429692881795
FTC-133,24951314,1.987520160616717,1.5968002329505464
MDA-MB-157,24772860,-2.2599749907314175,-1.5100224539514824
G-401,2749,1.3663456978729704,1.1629208751719842
BT-549,16065773,1.5788570773866877,2.5726457385792014
OPM-2,11955716,-2.9191891869850015,-2.41411699065624
NCI-H661,176870,2.3474624932942207,3.3569558011414533
NCI-H292,66577038,2.9683700205355765,3.1097319334662763
MSTO-211H,54143018,-0.309857947329572,0.530324697833112
OPM-2,3634881,2.0291765129520467,2.6640447862527736
LOU-NH91,navitoclax-birinapant (1-1 mol-mol),-1.5910791983061243,2.091858480006228
A-498,44607531,1.7098722083353044,1.7980360798816215
KMRC-1,2749,2.412459730094544,2.201859731808964
NCI-H292,57519531,1.7489075965122454,2.511484228925277
NCI-H727,11404337,0.8145711342672778,-0.020118653440766344
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379,4.832622532872409
SNU-81,107985,-4.076050447844214,-3.52372529990256
SNU-61,24785538,1.5668080683488936,0.6257051823947478
SNU-449,56946209,-2.472995255165521,-3.670186379741898
KYSE-70,452548,2.3575041584151637,0.3697280342629685
BxPC-3,5280436,3.644569175052812,3.574722009518813
JM-1,409805,3.649428990507172,3.97975894119125
SNU-81,17755052,-1.02795410661762,1.47325189429205
DMS 273,SNX-2112-bortezomib (250-1 mol-mol),0.148208176798338,-1.715855507968996
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906,2.2592996303600406
G-401,54618771,0.8582285882331511,1.07590559054769
LoVo,4788,4.577300245187766,5.770567242436851
A2780,24771867,-2.9740519428749055,0.24293995296030743
NCI-H292,4261,1.3935441456482582,2.0386127897009696
SCC-9,vorinostat-navitoclax (4-1 mol-mol),1.1894462341904075,1.3087958979509546
NCI-H522,2729026,3.0595997973682043,2.2318830397587788
MSTO-211H,448949,1.6774063902575909,2.0142724804609564
BxPC-3,9825149,2.348819386499172,2.4115911656343387
NCI-H522,44607531,1.4505766804532754,1.563871875276801
NCI-H292,ISOX-bortezomib (250-1 mol-mol),0.5542499080925709,0.8444430413127029
A-498,1285940,4.242355519484504,3.674052291441126
BT-549,selumetinib-BRD-A02303741 (4-1 mol-mol),5.411757040622344,4.529881581640971
NCI-H661,44543605,4.030509034099432,3.756855742316089
CAL-51,12003241,-1.2189714227076325,-1.2235689846401934
A4/Fukuda,135411,0.1560078623072997,0.2969592504495006
HCC1143,675434,4.285446752444937,4.634796551193009
CA46,11719255,3.04595311036835,2.223356498647785
BxPC-3,654092,-0.3546902897816355,-0.42723889176064256
NCI-H292,11238147,1.7384499640365698,2.858305804924965
LoVo,285033,-2.045623665035502,-1.6103842076161345
NCI-H1623,136227924,2.959018127447204,3.115082586890604
OPM-2,5329102,0.9197947820907424,0.9535108245338122
OPM-2,208908,1.37961789198716,2.2489509561240713
MSTO-211H,124202324,2.766151060695559,2.748333964517179
LOU-NH91,piperlongumine-MST-312 (1-1 mol-mol),1.9465172211690425,2.062586355047351
SBC-5,selumetinib-piperlongumine (8-1 mol-mol),5.086049517752745,3.1076193474191673
SNU-81,55508,3.0035688840672767,3.105875923538295
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.6637536715176889
A-498,24821094,3.8657770123239574,2.9864394496547897
DMS 273,6918736,-3.620580414510608,-2.1683891144620135
JM-1,3062316,-0.5573937765637444,0.40031593316286157
JM-1,56649450,3.7062904943567263,2.4869556199240437
SBC-5,24856436,0.2896075356546521,0.5235807214065852
BT-549,285033,-1.3520552126123144,-1.5962070055470816
OPM-2,5746,0.8583790934138843,-0.0405821315585632
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449,4.4307410580155535
G-401,6914657,-5.660532663542792,-4.743647545472206
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-0.9432613110867962
HSC-4,2858523,3.1192513569149245,3.046185099980188
NCI-H522,675434,4.236381328267226,4.320306022340886
CAL-51,25183872,-0.1080661998677032,-0.7846609326652235
BT-549,4259181,2.4625999028961743,0.40527968390337565
NCI-H522,11455910,0.4156799864056491,0.7060528781113493
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893,0.26351193583423815
EFO-27,JQ-1-UNC0638 (2-1 mol-mol),3.1988831496339536,1.9340765390810881
NCI-H460,3543504,4.388423548450019,4.307837804961424
LOU-NH91,11626560,1.802766880846386,2.0525107437856724
NCI-H522,2871966,1.782445654343025,0.2923400304674379
G-401,135440466,1.822823734742602,2.16561278376745
A-673,10172275,4.325815901444083,2.651524383113599
LoVo,3385,1.4948122184820352,3.9114205754544393
OVISE,BRD-K27188169-navitoclax (2-1 mol-mol),1.3102218056663513,2.301919320454266
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259,-1.081438693452283
A-673,637858,0.7164978632133837,1.3829283747164185
OPM-2,4915,5.457147549775398,2.667669997176769
CAL-51,11626560,0.7349282975065881,2.076845256873993
NCI-H661,2729026,2.3445725854556696,2.832433043614655
KMRC-1,25126798,3.86147373401716,3.705585361073052
KMRC-1,107970,3.035071998795665,2.408736653528274
MDA-MB-157,16219061,1.3123257474603047,3.3997346589761963
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121,2.3882080674952935
NCI-H292,erlotinib-PLX-4032 (2-1 mol-mol),3.1994790670479,3.080035838156905
NCI-H2009,24964624,2.271229049936602,2.9139506775676067
NCI-H522,7251185,1.2190943442977031,1.8922381808374908
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.3151522255566954
G-401,52912189,0.0594470173160698,1.0703059774378763
OPM-2,vorinostat-carboplatin (1-1 mol-mol),1.8335119611994213,2.09717175916807
OVISE,702558,5.699669356311473,5.254196572582851
BxPC-3,selumetinib-navitoclax (8-1 mol-mol),-0.6113329982147029,1.8201749829806
EFO-27,54678924,2.818156902929417,2.475335726332642
LOU-NH91,44607530,2.1348137775706646,1.8325678216370094
EFO-27,24180125,3.663788732934096,3.2639947279356436
NCI-H661,135421197,1.0600684669241136,2.103698206105974
MDA-MB-157,56963564,-0.5852778857487072,0.7170663936767129
OVISE,navitoclax-pluripotin (1-1 mol-mol),-0.9390281108513666,-0.7010747796028397
LXF 289,6505803,-2.367756082461904,-0.23434622765663046
SCC-9,navitoclax-gemcitabine (1-1 mol-mol),1.7873613384947808,-1.3137311563018976
A-673,5278396,3.572368012209165,3.3570041131146025
MDA-MB-453,135421197,0.8806711164351635,1.8763287706614882
NCI-H661,11396600,4.301216087095742,3.545505267308763
G-401,148124,-6.018913106580182,-3.9357314697374615
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884,2.6016051074981066
SNU-61,208908,2.000237947522829,1.8296474356821184
NCI-H661,5329102,2.676948448482624,1.9881914662479572
NCI-H146,148124,-0.9007997951548676,-2.1698733746722194
HSC-4,446155,4.1145986724492865,2.779891232961178
NCI-H661,3825829,3.711058317012711,4.136323435578215
OPM-2,135411,1.0006691045824918,-0.23463062130251583
CAL-51,3815108,3.0623029951861396,3.249415196527276
NCI-H522,2858523,2.9817407099898676,2.9783326305243323
YAPC,2708,5.2324194580289065,4.7998871171218065
Panc 04.03,4917,3.7974030923782274,3.188406161182606
KMRC-1,51039095,3.0507646213845008,2.6463283813612253
MDA-MB-157,44632017,-0.0621812067979977,1.25809012044616
KYSE-70,613753,3.646356391333843,3.2776619443932526
OPM-2,11364421,-7.162542415885671,-4.234255569273617
KYSE-70,11964036,0.6479741930424838,1.454805965342386
EFO-27,9915743,1.432055126276498,1.4311116453780994
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258,2.7949766268255054
A2780,9935249,1.4583070792637778,2.168009686741665
NCI-H292,25105715,3.507158893285561,3.4386602201643104
JM-1,5566,2.903571956440186,2.7557177707776077
NCI-H460,16722836,2.818869820371906,1.9004657953831108
MDA-MB-453,71466380,3.4268898477848784,4.376541849188995
MSTO-211H,24753719,3.2448003358152286,4.398232664271736
JM-1,637858,0.5231851777275447,0.7624261710113126
MDA-MB-453,11152667,-1.4808178636693017,0.5418645764880506
HCC1143,44185566,2.5224843451498273,2.6775534467556934
SBC-5,53481919,4.872311947173971,3.809504036457732
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834,2.144270674582545
LoVo,3038522,4.270533501697307,3.136390025114206
OPM-2,5280436,1.5288125622159816,2.7229496507144377
A-673,71680916,4.0499723530429295,4.35284801823871
LOU-NH91,6610355,5.077923698507978,4.610781776912706
SW1463,10127622,-0.1211197806374188,3.1886215317156945
ONS-76,2126,3.999900921085769,4.414017713594513
NCI-H522,53301938,4.938312106360689,1.0857430944740596
NCI-H2171,3552672,1.63504499488054,2.5955448865838857
SNU-449,375860,2.655390537146391,-0.1070198605199963
MDA-MB-157,54626689,4.568687551235484,4.5496391990213
KMRC-1,5746,2.0919022066371484,1.0216909118220674
CAL-51,24964624,1.6704816041215405,2.641758388607209
EFO-27,46199207,3.7203826311454096,3.2096747362617974
A2780,439501,-2.4090624878410316,-2.494988390267503
LoVo,89183176,4.107889784939482,4.493715624609936
NCI-H661,24772860,-4.399665014096174,-1.2745074227276976
NOMO-1,46224516,2.27353152393119,2.1222609833735895
NCI-H460,5281672,4.99885948312363,4.751264311402818
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935,1.5635289948706648
OVISE,navitoclax-birinapant (1-1 mol-mol),0.2692297316447783,1.8168500197557034
NCI-H460,9967941,4.030885542149613,3.4305452794509304
NCI-H292,44819697,-0.5623825720804246,-0.04368372894092078
OPM-2,216468,0.7655721379939343,1.104975267422507
ONS-76,60700,0.0915142349819345,-0.03582231594434627
YAPC,17755052,3.2330221121257874,1.8505444732946046
EFO-27,444795,5.488221670965637,4.856476580032357
YAPC,24797083,1.6153709299916277,1.5608604971740296
NCI-H661,51039095,3.3700376717556315,2.643228314705466
MDA-MB-453,25154868,3.2796937080857296,4.06619169833188
A2780,decitabine-navitoclax (2-1 mol-mol),1.762746087507787,0.9522427506939205
KMRC-1,9911463,4.4126092990485395,3.7685734804040165
NCI-H727,JQ-1-vorinostat (2-1 mol-mol),2.062672486797119,0.9131743426602508
G-401,107970,2.0352708529532824,2.05700276158416
FU-OV-1,25195348,3.3767609447508846,3.249468638069022
NCI-H1623,11234052,4.315313421055944,4.038179650474666
MDA-MB-157,151289,0.3130009139891556,1.1478141679429108
EFO-27,56973724,4.318199286965652,3.225775324038929
NCI-H460,5328940,3.322075361136407,1.7451529748512595
NCI-H2171,11964036,0.8555185627034467,0.9857293933886822
Panc 04.03,24821094,4.144896314615952,3.2580737199298615
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.252198614746458
Panc 04.03,selumetinib-MK-2206 (8-1 mol-mol),2.306008489562984,2.258722717128777
FTC-133,5280436,3.005172717589714,3.4145584396001163
NCI-H292,49766530,5.348764781206105,-0.4342478698851426
NCI-H661,selumetinib-decitabine (4-1 mol-mol),5.0553831746033815,3.9842124995682155
FTC-133,219104,4.114698267906641,3.955135577445942
A-498,BRD-A02303741-navitoclax (2-1 mol-mol),1.0685247130671895,2.856750690913499
ONS-76,6918736,-1.0728340962982743,-1.340582075630879
A4/Fukuda,16065773,1.900447949816596,1.9853900582286041
FU-OV-1,25126798,3.715640842708804,3.8390709224456443
NCI-H460,6505803,-0.4074860596498978,-0.8580604477010086
ONS-76,44491742,4.314760532803232,4.3542620819701545
MSTO-211H,6914657,-1.9341273237470331,-3.793064464830362
G-401,136227924,2.3105932180874365,2.734002159217515
Panc 04.03,148198,-3.912302089259141,-2.9578832150394647
CAL-51,23725625,3.781531245600544,5.061974336523889
NCI-H1623,7251185,3.63742147878688,2.703445005268987
A2780,44589607,1.4452328541597397,2.268340592768689
A-673,675434,3.949120496105267,4.348265075662986
KMRC-1,25227462,1.6145893273286742,-0.17167898793821504
BxPC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),1.732263513385207,3.431342191456304
HSC-4,2749,1.8453067540575636,1.9193300254695052
DMS 273,6438330,2.6669951536881182,1.8382374964109949
KMRC-1,44491742,6.09620831621162,4.3730998642108325
MDA-MB-453,3465537,1.8912554302439897,2.229332310194425
SNU-61,156414,1.6812768260110038,0.7409179023642423
YAPC,11625818,4.8006567630911094,4.363152292038193
CAL-51,9911463,4.251278022142156,3.9302355020552677
MSTO-211H,68056272,2.8034566103574825,3.608841520630301
OVISE,9911830,4.830872688345326,2.451976712755132
MDA-MB-453,6917907,3.1299164846836796,-4.7679406853964315
SNU-449,9444,4.238096768887569,4.11826611882958
SNU-61,3062316,1.255261088163193,1.453358770085383
A2780,11178236,-3.658526043242797,-3.438070897867764
MSTO-211H,219104,2.9811404214526136,3.7424652041894535
CA46,11364421,-6.636542851208846,-4.248430982904794
NCI-H1623,3689413,0.664737487618683,-0.045926156844972116
YAPC,9907093,4.959151627500645,4.1905256747359765
ONS-76,19582717,4.438276624405871,4.003392647404088
LoVo,446155,3.732759169917468,2.8037654087612367
G-401,5566,2.967754959970698,2.8415907192142
JM-1,navitoclax-PLX-4032 (1-1 mol-mol),0.5328133860295355,-0.026801056238582092
HSC-4,9884685,0.6492053944574516,0.8721413380683775
CA46,4788,4.772802977698259,4.86187663198378
SBC-5,selumetinib-PLX-4032 (8-1 mol-mol),4.703781138829708,3.339492108705504
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,2.1513533306041808
Panc 04.03,6918837,-2.8853122799888085,-2.1487183209826015
NCI-H460,71466380,4.4879606530616725,4.496939296175106
CA46,25183872,-1.226882585953409,-2.2711838754438394
NCI-H146,12001922,1.0892970499924846,1.6894273732310359
SBC-5,11625818,4.225517908096314,4.1176121409712545
JM-1,vorinostat-navitoclax (4-1 mol-mol),-0.3924776625427159,-0.3088247476424099
LoVo,2708,4.2308362163689415,4.8809298553848555
OVISE,72193861,4.281646205908775,2.093975204888923
NCI-H460,16720766,0.8258921674033131,0.7743314788171005
LoVo,4378219,2.040258922351895,2.4181227305189914
MSTO-211H,24901704,1.657456360567008,3.381764116554132
A4/Fukuda,4477,0.5783674149898913,0.5937284424568976
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026,3.3018804641838506
CA46,107985,-3.181693098398671,-3.792436214899949
DMS 273,JQ-1-MK-0752 (1-1 mol-mol),0.7328961203568959,0.899358810049808
EFO-27,19582717,3.374407024388894,4.314252120768248
NCI-H1623,15953870,1.9962949386047493,3.4921304521316587
FU-OV-1,46199207,3.737847668041784,3.180797798133646
A2780,11213558,0.737897067491707,1.5768756186947104
NCI-H460,9926054,2.081701465030928,2.0746399756780236
NCI-H460,11404337,1.7201854837770862,-0.40170705767556647
NCI-H2171,2749,1.9442537074322577,1.3493628517212841
HSC-4,49846579,1.975916395804951,1.2333964939106359
NCI-H2009,56963564,-0.2763231945711286,0.6558966077403601
Panc 04.03,3825829,5.002168928220905,4.187610231372239
HSC-4,5738263,3.918173826320675,3.6578659328215006
MDA-MB-157,9926054,2.0716850398098368,2.187024752593655
OPM-2,50905018,4.056598853615348,3.179477089538724
BxPC-3,9915743,0.4274244099837221,0.8053583951732364
HSC-4,16725315,4.164866459292326,4.381468682716573
SCC-9,11175137,3.431057653368815,2.577742107879015
A-673,BRD-A02303741-carboplatin (1-1 mol-mol),5.048794854025553,4.429826746205373
NCI-H146,107985,-3.379993708562796,-3.613979227818271
SNU-61,3689413,-2.128463404187725,-0.47227281130040966
KMRC-1,9903786,4.024109374851969,2.6006776956936064
JM-1,BRD-A02303741-navitoclax (2-1 mol-mol),0.7492754152668983,0.6434649246448074
SNU-61,73707386,3.625444775073466,2.7399563989152678
ONS-76,11238147,3.0900457426442864,2.674067527564954
KMRC-1,selumetinib-UNC0638 (4-1 mol-mol),3.730844045001738,2.745669743669923
SBC-5,JQ-1-vorinostat (2-1 mol-mol),1.350348201689009,1.0286014099968306
MDA-MB-157,piperlongumine-MST-312 (1-1 mol-mol),0.2909221181293618,1.5910716172487103
OPM-2,44607531,0.9426576866563848,1.1626662440614957
BT-549,409805,3.826135579342285,4.911719627557399
G-401,6505803,-2.085126737120111,-0.588894522148796
ONS-76,9866186,2.0020907987509657,0.9956494192316208
BT-549,1641662,3.5282995747020514,3.54803723428217
MSTO-211H,3384730,2.0695323326007387,3.1962961411559734
NCI-H292,439501,-2.469830491210978,-1.9225886264371843
NCI-H2009,11964036,0.3874991337590915,1.5343926414870106
Panc 04.03,9840324,5.85151623174837,5.861409067396969
NCI-H522,5311,1.356899837189567,1.1293626027809684
ONS-76,5311,1.4287655491580966,1.332559173046459
NCI-H146,JQ-1-navitoclax (2-1 mol-mol),-2.878043275810858,0.3128738971768674
EFO-27,24775005,4.127014722833266,3.7972901291842924
NCI-H460,5278396,3.885794996406102,3.5091303028741634
NCI-H2009,23725625,3.8804106674125713,5.08455255016874
NCI-H146,25102847,3.053262776547781,2.508520346263885
JM-1,11396600,1.6173586604508372,2.3320780296653627
SBC-5,168312962,-2.5718885882949896,1.5153185563079012
DMS 273,46215462,1.755765775691153,1.4024746474548087
YAPC,107985,-3.02393363080246,-3.3777946236919987
KYSE-70,5566,3.0340425256076813,2.641166710900411
G-401,BRD-A02303741-carboplatin (1-1 mol-mol),4.945197636740216,4.14376335795555
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984,1.6787944783124766
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704,0.31049065632395345
CAL-51,11404337,-1.4033364127444676,-0.252991256381949
A4/Fukuda,25183872,-2.565081518812491,-1.916785286115354
SNU-61,3815108,2.973673139417603,2.593136983860193
KYSE-70,11507802,1.463595053056406,2.091068806433734
A2780,10296883,3.5268945611299927,3.549799444703542
FTC-133,24797083,1.5806228477994335,1.3984560893996574
MDA-MB-157,122327,5.563359607134461,4.82712795940229
NCI-H2009,ISOX-bortezomib (250-1 mol-mol),0.5557935848602048,0.8118091168267205
NCI-H146,4378219,1.8118272794434884,1.984319935451899
SNU-81,54143018,-0.9079963072010888,0.2742749718825838
NCI-H2009,49850262,3.4451640543988233,3.757512501883475
KMRC-1,54143018,1.481383467839363,0.5832942619838328
NCI-H522,11507802,0.900021964921284,0.8905497793627013
A2780,6438330,0.9178294762259074,1.7438839720835224
A-673,selumetinib-piperlongumine (8-1 mol-mol),2.5365769801397,2.653035838559713
SW1463,82146,3.98984472956996,3.1748036714594763
BxPC-3,135984461,1.8776729747018608,3.903394704256208
NCI-H2171,56946209,-6.55665845628197,-4.46842183329192
KMRC-1,selumetinib-MK-2206 (8-1 mol-mol),2.4382383240498244,2.336232930220313
HCC1143,54619267,5.25191473393144,4.304451478663361
NCI-H2171,46907787,0.7633638606493435,1.0177858237513768
NCI-H1623,216468,3.833399887526913,3.1595090419928384
MDA-MB-453,9803433,3.6839578739817935,4.3728085266115375
SCC-9,11955716,-2.333323067647372,-1.0217297904430775
A4/Fukuda,54619267,3.184419267966046,3.8678756035710777
KYSE-70,387447,-2.8804562370412765,-3.939935000309965
FTC-133,135398744,6.510037604259866,6.3673990542440775
CA46,2842253,3.7037662444842696,3.4590892953072454
BT-549,12001922,2.460799936977109,2.0195782681656884
LoVo,107970,2.0597080136849795,2.206745728918605
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.271504344652566
CAL-51,3385,3.064238699960593,4.359404803950294
CAL-51,375860,-0.3577134594482877,0.052607665587384576
OPM-2,3025944,3.8735985412418943,3.6809447250310376
NCI-H522,53325874,4.347038439567835,3.661811127837246
MSTO-211H,216239,0.7405720543436254,2.534273361811412
CAL-51,9868037,3.5441777448678615,3.364417073599759
A-673,49836020,4.096681472773702,3.1962435648749374
SNU-61,erlotinib-PLX-4032 (2-1 mol-mol),3.033607579022277,2.9286794419499524
LoVo,49836020,1.6927786584323,2.9664690398029245
OPM-2,5291,3.3293230980723254,3.0570148546814435
LOU-NH91,9884685,4.047485572984955,0.6132199726866645
HSC-4,36462,0.7755986988683452,2.1057863071826413
SNU-61,46907787,2.0753699666277936,0.7789127409840231
NCI-H522,5951923,5.621144710124551,3.6135631028751387
SBC-5,445091,4.3721050746953845,4.432184566327609
MSTO-211H,6252,0.7966303392140095,1.5453958010910316
MSTO-211H,6610355,3.5448971464264507,4.353272497753673
DMS 273,selumetinib-MK-2206 (8-1 mol-mol),1.7350778472906083,2.143964507151461
CAL-51,15953870,3.220977372988981,3.5018506971465895
NCI-H460,25150857,3.536831166282903,2.4734589496008828
DMS 273,3854666,0.530051590236263,0.8321801790375843
LXF 289,9825149,1.6285560242869113,2.2350871549960747
NCI-H522,67156097,-2.1513446238308656,-1.3226143259083387
MSTO-211H,3062316,0.3213577633457804,1.1263214034225024
LXF 289,11485656,2.2610473771175847,2.6401338838119552
BT-549,4477,0.6326595549350394,0.5245159087762211
NCI-H2009,54454,1.843451372115344,2.5943207271025828
SNU-449,16013152,4.866412327860677,4.126896421030181
SBC-5,16115403,-4.662279180425711,-3.8259761092253743
A2780,2842253,3.957240977141399,4.266259085918147
MSTO-211H,135398516,-0.6247457561994184,2.104868384670621
NCI-H146,navitoclax-pluripotin (1-1 mol-mol),-2.9432727760472326,-1.0230245115060215
YAPC,702558,5.05880400043124,5.262491252275732
MDA-MB-453,409805,5.496183153122164,4.876033443118638
G-401,25161177,2.410029759496817,3.6332742317335387
A4/Fukuda,3025944,3.254701794903189,3.939752621288642
NOMO-1,126941,-2.339513844414448,-3.2820032061823263
FU-OV-1,159324,3.7929038817112746,3.0704186396525093
MSTO-211H,2113511,3.4014041807223228,5.628111259659228
A4/Fukuda,1242560,1.4412010240031818,2.9045242771498487
OPM-2,327653,2.4944005218311984,2.5110592924990063
HCC1143,navitoclax-pluripotin (1-1 mol-mol),0.3469367515592647,-0.7422941986353575
KYSE-70,46398810,2.5990171625416916,2.562819900799336
MSTO-211H,44486219,3.5621328730435216,4.205776117714535
MDA-MB-453,6450551,2.407686053683273,2.764441737490999
A4/Fukuda,24180719,2.900503133545593,2.980275425258572
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416,1.6810362070143388
A4/Fukuda,11234052,3.83864189929063,3.1069380166407443
ONS-76,10231331,-2.145918525616272,1.8813158851613432
JM-1,11656518,1.5501827619920003,0.36069668383994513
SNU-61,ISOX-bortezomib (250-1 mol-mol),1.4968983788663748,0.6121452037518945
EFO-27,16741245,5.191473652546265,4.092143868782428
DMS 273,216468,1.1199955960897896,1.516561391990931
MSTO-211H,3689413,-2.1873545800685865,-0.08846692843850108
NCI-H727,10074640,3.0722260002613697,3.199342332662368
BxPC-3,66577038,2.7392816080167117,3.1212296288920247
OPM-2,44489675,4.196628172603179,3.443909094903338
A-673,1239801,2.654695998337671,3.50855518721888
G-401,9444,5.739332402240228,3.914934043697946
NCI-H661,SNX-2112-bortezomib (250-1 mol-mol),0.017075608398325,-0.9825935794023042
KYSE-70,71466380,5.08916461895765,4.443789611647566
NCI-H460,3025944,5.476008686130055,4.289511316472741
OPM-2,375860,-0.7230228450862618,-0.3917937496923552
G-401,262093,2.911602765721858,2.172072683059015
OPM-2,12001922,1.1641343868089369,1.4973483586393812
SCC-9,9903786,2.6448761987997917,3.0887446997810826
YAPC,1750826,2.252131937951327,-0.665476210903316
JM-1,9840324,5.823306366003189,5.330817581764352
SNU-61,4705,2.600761934037586,2.795750482595936
HCC1143,24821094,3.095995819095247,2.8127170259761827
A-673,JQ-1-vorinostat (2-1 mol-mol),0.4793000681263289,0.6394127175426738
HSC-4,15983966,0.1445652725334258,-0.8859317387720701
MDA-MB-157,9887053,3.277628039368057,3.7862211436176545
KYSE-70,969516,2.5944329315988552,3.0883602647257247
CAL-51,135421197,1.6266864976107616,1.8565825016184152
LOU-NH91,11175137,1.9157928307161511,2.7879170469022525
NCI-H661,168313047,3.0111797961595523,2.5125528054985984
Panc 04.03,16659841,4.736684370351261,4.122333021372211
KYSE-70,16720766,1.38091635176305,0.8064446143226449
SNU-449,BRD-A02303741-navitoclax (2-1 mol-mol),3.897294679895557,2.3655628934058615
NCI-H2009,9911463,4.220122302208283,4.0499893759028
HCC1143,selumetinib-navitoclax (8-1 mol-mol),3.081871684463836,2.2885703802273683
MDA-MB-157,44491742,3.772080854170876,4.276267043717499
A-673,216239,1.7434495050319987,1.9598018123648406
MSTO-211H,9967941,1.8027522151796112,3.7657964775680415
YAPC,3815108,3.3369752363492315,3.0645443935490646
MSTO-211H,73707398,0.6990065379334892,1.6183622911444377
NCI-H727,4788,5.448581481072406,5.599588376582184
A2780,9911830,1.8386970616579583,2.4346902868243347
JM-1,3038522,1.6953465924304043,2.3748757574740966
FTC-133,107985,-2.14591043360211,-3.488200068380619
NCI-H727,3503,3.7902677592538265,2.38775584271235
ONS-76,selumetinib-navitoclax (8-1 mol-mol),-1.4029292063040089,2.3833809250321507
KMRC-1,24771867,5.5206603877823275,2.2098213245787575
KYSE-70,3634881,3.4536977245329363,3.473182192572645
SBC-5,119607,3.910029744126627,5.164123998770463
NCI-H292,serdemetan-SCH-529074 (1-1 mol-mol),2.3213297405207083,2.1616766450638805
Panc 04.03,5329102,2.9853977590279075,2.1869158709000875
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457,1.6019789946698113
A2780,9826308,-0.0101157672837292,-0.032673398635356274
HSC-4,135440466,2.2202939224472655,2.2359227354841904
NCI-H727,6917907,-5.56846167215282,-4.421840929004392
MDA-MB-157,123631,3.9412563374531864,2.411986989860435
MSTO-211H,11640390,2.078497045728262,3.6398512323250203
OVISE,54649381,4.33420809644373,3.732836122014998
MDA-MB-157,9868037,3.2071579521245823,3.6666649621449854
A4/Fukuda,67291369,-0.3870993856905487,0.8277612540608864
A4/Fukuda,10113978,1.900139268592958,2.529589935479685
KMRC-1,doxorubicin-navitoclax (2-1 mol-mol),-0.3990728174038296,-0.9352585180894115
A2780,46199207,2.4758344041689093,3.1318526497378643
NCI-H2009,151289,0.8401149520435854,1.3309656441120095
DMS 273,4477,0.2378478748071137,0.4596466170603176
HCC1143,6852167,2.667487538311212,2.9798289226305044
NCI-H460,5335621,5.645903220513178,4.699147396038891
NCI-H460,54613361,2.8642714411834502,0.04229998307161015
A2780,6852167,1.374383856311773,2.1581403947492843
SCC-9,11707110,2.5707994933885736,0.08362039041077933
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831,2.0141923503988783
MDA-MB-453,BRD9876-MK-1775 (4-1 mol-mol),0.1986827293321165,0.6829234914384668
EFO-27,6610355,3.735872349212987,4.533673873865762
ONS-76,navitoclax-piperlongumine (1-1 mol-mol),2.7557969357291476,1.7699449782426717
OPM-2,16038120,-1.581922980476964,0.11657024459496315
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622,2.056278434409079
HCC1143,10410894,4.771687149558392,3.254258696283984
YAPC,54454,3.200830039856186,3.099183221522428
DMS 273,6252,1.7538621935564394,-0.6247527065974575
SCC-9,doxorubicin-navitoclax (2-1 mol-mol),-1.5026968555435367,-1.1020065050765568
G-401,44491742,3.951665256591854,4.030745999237221
DMS 273,11625818,4.382645377089847,3.7417865368116683
LOU-NH91,3503,2.9647844947930397,2.5459475011773134
G-401,446155,3.2535633304842144,2.453226708388464
DMS 273,675434,4.24768091674901,4.355967794367254
Panc 04.03,erlotinib-PLX-4032 (2-1 mol-mol),4.205995552769646,3.1958604501109313
YAPC,ISOX-bortezomib (250-1 mol-mol),1.2420544087730638,0.7930607733236189
Panc 04.03,168313016,6.087789512449841,4.936980939216504
NCI-H1623,24856436,0.944997546799197,0.6932235688550122
ONS-76,ISOX-bortezomib (250-1 mol-mol),0.2723721998746015,0.7583305899150807
LoVo,3025986,-0.1762115912359206,-0.9173103615951012
A-673,10184653,1.446453264453446,1.1355198636501724
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633,1.978896977206412
LoVo,66577038,2.852951614414874,3.1100917834847324
NCI-H522,3136844,3.3827652175643577,3.8978913913878612
A-673,3676137,4.749608800479587,4.259492021619054
SCC-9,409805,5.497565328609373,4.765394924213653
DMS 273,6918328,-1.955094157059326,-0.35992197630413053
LXF 289,4259181,0.8555931132792622,0.19985390623380742
OVISE,448949,2.233154508177948,2.1265548461209924
JM-1,675434,3.7844228868956296,4.186163014942602
NCI-H292,5566,3.044146869319611,3.0302061211200533
EFO-27,227681,1.958013080406725,3.468390194255673
EFO-27,65064,5.385038331959097,4.9682624964086815
A-498,9907093,3.786767310891997,4.25958412287376
SNU-61,676352,2.4274144006766893,1.8964340482520925
MDA-MB-157,135421197,1.265960780615991,2.1471045939670166
NCI-H460,10074640,3.83137833519258,3.0373539078437957
BxPC-3,46199207,2.8626203608628416,3.222177043178521
CAL-51,387447,-3.720200693098244,-4.403045035439966
NCI-H146,56946209,-6.937271673290349,-4.315763555540306
EFO-27,46907787,4.067144836646944,2.5074426861274266
NCI-H292,2729026,2.9142630754738037,2.8626873258254575
LOU-NH91,1716436,1.3649900096390022,3.1400193366038667
KMRC-1,8515,4.713762602344707,3.745653002218467
MDA-MB-453,crizotinib-PLX-4032 (2-1 mol-mol),2.6505270517489596,1.9436606962219591
SNU-449,448949,1.5810053045793695,2.178261345234302
SBC-5,4096211,1.588189246491771,2.052523504119471
NCI-H661,26596,-0.5563822784391794,-0.9491719576582274
A4/Fukuda,51037431,0.9928208538339424,2.8206754907475835
HCC1143,doxorubicin-navitoclax (2-1 mol-mol),-0.0488581620418106,-0.9444562031726396
OVISE,5311,2.608797421965248,1.5599312814308368
A2780,11238147,1.47132390494783,2.486519228240468
NCI-H1623,676352,1.987229853680802,2.1136699638400334
Panc 04.03,126941,-1.1535511280443094,-1.9239563510497861
NCI-H727,9926054,2.0492739470784445,2.0003567144134373
LoVo,65064,4.389937632551182,4.937408705837057
SNU-449,52947716,1.9936156354056855,-0.11477629642183798
Panc 04.03,5351362,1.307383541492636,1.6388827443351688
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355,1.3497362698438864
NOMO-1,44493952,3.580250185381126,3.3589113441659504
A-498,676352,1.77005199556574,2.186655267182081
Panc 04.03,5280436,1.6844699655115762,3.4932628080181645
CAL-51,16736978,0.375988055286384,1.6601424446249862
MDA-MB-157,54618771,3.1146330047846877,1.2035691087792315
NOMO-1,6450551,1.2307950565416117,1.3925727021481356
MDA-MB-157,tretinoin-carboplatin (2-1 mol-mol),3.238516076449109,4.806592318154943
G-401,25105715,3.9034348367564258,3.333937926378573
BxPC-3,151289,0.5689607060021993,1.273038698566208
NCI-H727,44543605,4.300237824274415,4.021550237344939
SNU-81,2907,6.641268536629272,2.139830576799806
SNU-81,613753,2.2388707005796507,2.8463994944790123
JM-1,168312962,1.22629450044224,0.8079686027137886
LOU-NH91,168313200,3.810508485111527,3.0239077100012666
NCI-H146,3854666,1.3221451848305394,1.4822183793773425
KYSE-70,322968,3.381611542483835,3.626270251730633
ONS-76,241158,4.846225597872182,3.5867545089871005
SNU-61,selumetinib-PLX-4032 (8-1 mol-mol),1.220990708913243,2.981405073999245
KMRC-1,JQ-1-vorinostat (2-1 mol-mol),1.4567711420543266,0.9898421349750705
CAL-51,5291,4.8235616489491635,3.64208640278259
SNU-61,SNX-2112-bortezomib (250-1 mol-mol),-2.113975984395572,-1.481682755885845
MDA-MB-453,168313016,4.163913885489913,4.376980012918248
A-498,60700,2.2087582051541257,0.24429798946908002
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609,5.045218017918004
HSC-4,6918878,5.2813290465493505,3.180320157820791
MDA-MB-453,9884685,-1.4419247946131482,0.8347578965544474
A2780,2746,1.939184711313242,2.4446088973058564
NCI-H661,148198,-4.235070372495308,-3.778238094531165
HSC-4,54678924,3.092091974621669,2.166451042727901
A-673,2113511,4.0082027727586,5.325427811676812
A4/Fukuda,5287620,-3.30087759062066,-1.8735127576871826
SNU-449,selumetinib-MK-2206 (8-1 mol-mol),3.758556004242712,2.1141980160268043
LOU-NH91,6918328,0.1478473020386815,0.3712867278090378
BxPC-3,3385,3.820290029267426,4.402292727984835
MDA-MB-453,44185566,2.487729821066063,2.4327058516365345
LXF 289,46907787,-0.1426698074457199,2.4298142630019037
EFO-27,piperlongumine-MST-312 (1-1 mol-mol),1.300459178940563,1.859889310832228
EFO-27,9887053,4.025142225668377,4.174226565572482
BxPC-3,4259181,0.1397018777458316,0.4770730289427141
SCC-9,10184653,-0.319006591471168,0.8011662625022372
SNU-449,53232,1.6560937312011326,2.4032298872932816
BxPC-3,53232,2.859321527409702,2.7987493944081416
NCI-H460,71304818,2.359856693071434,2.4478471327011375
NCI-H2009,11178236,-2.605718631753464,-3.232979113489215
FU-OV-1,400769,0.1189863997269066,-0.4822008714243523
NCI-H292,vorinostat-carboplatin (1-1 mol-mol),3.668554918362719,3.4010168421468125
FTC-133,72376,-0.3430893294901544,-1.5339638039511019
LOU-NH91,2858523,2.98680776080117,3.0778254109187797
LoVo,6918837,-3.586713596901602,-2.9921627800322277
SNU-449,erlotinib-PLX-4032 (2-1 mol-mol),3.286095103916852,2.765577569729298
CAL-51,6918837,-3.0563476396929703,-2.474520246935824
NCI-H292,676352,2.616071543582294,2.1224852050668
NCI-H522,11626560,2.464867345362881,1.241215829085772
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526,-1.1393627315844566
A-673,11167602,2.442600782118551,2.09057864424075
OPM-2,11222830,0.0961911151739945,1.1622878459497203
A4/Fukuda,7251185,1.076285820033946,1.7186623254474978
OPM-2,24978538,1.9225155298388676,-0.3772030853319673
CAL-51,135411,0.595745817277345,0.48766673296465707
NCI-H2009,selumetinib-tretinoin (2-1 mol-mol),-1.112372565869968,3.2102568857037808
HSC-4,3025986,-1.9523671858491285,-1.3440155190543623
BT-549,54618771,1.4883156908959423,1.4884708254106398
DMS 273,1239801,5.369367906855259,3.440830934373078
SNU-449,374536,4.370390285639732,2.262611637620312
MDA-MB-157,168313016,4.249309770188466,4.852165203555867
NCI-H522,446155,3.2752737209903504,2.4748192522649957
BxPC-3,9935249,3.9268263105803727,3.2513438923765166
A2780,16725315,3.2354385253964253,3.884756083012581
NCI-H522,11647372,2.460433695225771,1.0125764128189254
MDA-MB-157,3689413,-1.567220624306923,-0.15222507801277207
NOMO-1,36314,1.6795260413615891,-2.11785257839958
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.08090900748620251
ONS-76,46199207,3.062888044588984,3.2000365822823507
HSC-4,2746,3.845189406581069,3.2013071686741164
A-673,126941,-4.88778992999732,-2.7465232644615902
A4/Fukuda,2874250,4.0164309105299685,4.328199743172788
DMS 273,navitoclax-piperlongumine (1-1 mol-mol),2.7902567268334786,0.8450603497854385
Panc 04.03,3136844,4.698465140769799,4.535537353540342
KYSE-70,53232,3.7067207893488017,2.7679083334725196
CAL-51,24180125,2.8082301472193203,3.1406580295884563
Panc 04.03,9884685,1.6842032304446288,1.1147733399917676
NCI-H460,11626560,2.497647926194901,2.0441230907607046
SNU-449,168312962,3.745202246753347,1.864824659563178
HCC1143,9935249,3.8757786370374303,3.1203288554637374
SNU-449,613753,3.229445182846538,3.0597243389179223
OPM-2,44491742,3.727542800888903,3.7552671419097554
KYSE-70,9936388,-4.915846401119174,-1.5018615792289964
CAL-51,654092,0.82886283906252,-0.17873002955414619
SBC-5,448949,2.9920694717704204,2.0043743779238956
OPM-2,46843906,-0.5330027912440064,1.1672137357982098
CAL-51,5566,3.271951139375183,3.0771143497127604
KMRC-1,53232,3.79650380515527,2.4298070484854772
CAL-51,11228183,3.6770505489909007,2.4676606194452777
SW1463,24785538,0.6322996420886741,0.9281157112013493
A4/Fukuda,119182,-4.160589878424858,-1.936236355596251
A-498,107970,3.0044685679861054,2.5106304160455317
CAL-51,11612883,1.9359641259018452,2.992459405464823
A-498,11317348,4.2355090436144875,3.5110011014292457
LoVo,67291369,1.4516021942624118,3.010302500826685
A2780,11222830,0.6433638933511314,1.3869524528850128
BxPC-3,241158,3.755569293331497,4.083429985440086
SCC-9,6610216,4.4695629784882795,4.216041058179521
CAL-51,374536,3.1977545561189347,2.512818275497109
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296,2.2276868156144722
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942,-0.5367764221980658
SNU-449,72376,1.1438392823146497,-1.1814244543392207
A-673,4259181,-0.6373852614685119,0.0072786823639642015
DMS 273,168313200,2.725135044490621,2.6820174290283343
NCI-H460,9911463,4.421747687015995,3.912292936447608
JM-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.988694058348957,3.728173083039035
YAPC,119182,-1.6155541294016968,-0.5639121270224161
SBC-5,6184667,2.5027552360756946,3.3627027247064065
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326,1.757425098100443
G-401,2858523,3.0226653633513,2.891904354158532
MDA-MB-157,10184653,0.5581112583171038,1.3868418298439833
A4/Fukuda,19582717,0.7629696429231957,2.853844285243475
NCI-H460,53392493,4.733063337287369,2.727641283181815
OPM-2,72193861,0.7906161175639799,0.22588658324327107
NCI-H146,44491742,2.6808030102351323,4.136487695726863
NOMO-1,46398810,2.1682472320454504,1.9758890905692654
DMS 273,16736978,0.9096800466601204,1.5720974174100704
NCI-H292,navitoclax-piperlongumine (1-1 mol-mol),2.359221869060842,1.9110602294563994
CAL-51,16741245,4.222373420591208,4.206463052882181
MDA-MB-157,10074640,3.629475203970288,3.0869896129877774
SNU-449,2828334,6.138780539354761,6.261652429103652
HSC-4,9823820,4.434899642824078,4.15275108790273
A-673,11238147,1.6374380314183412,2.502937742120885
EFO-27,selumetinib-PLX-4032 (8-1 mol-mol),5.056777545277596,3.56103631601744
A4/Fukuda,4915,4.811112690158961,2.8065332156955356
JM-1,42642645,-0.9084434189288264,-0.005555403998786792
MDA-MB-157,3854666,0.668628762558335,2.0898130139403035
SBC-5,2841722,4.592516057239796,4.466499529367936
BxPC-3,2742550,6.208235416241253,3.8495917721975412
NCI-H2171,168313200,1.615164123973231,2.823486044490042
LOU-NH91,46843906,2.60442098689998,3.157677302283886
DMS 273,54619267,3.628421853226673,3.844306101280772
CAL-51,16725315,3.2794500362302,4.335690990709463
MDA-MB-157,10127622,3.2546864424502076,3.678121552426236
NCI-H2171,16725315,3.053630151756443,3.645688433942512
SCC-9,9935249,4.690276947265519,3.223368177605684
NCI-H460,44507138,4.578042897326484,2.5479268436823412
NCI-H1623,5282054,3.865413044747809,3.8243108690540373
HCC1143,984333,-0.0539665216618622,0.582050704158562
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309,3.6911811693920886
MDA-MB-453,9840324,6.873328025428986,5.773742272817283
Panc 04.03,176870,4.897846724128431,3.5565675964435832
NOMO-1,11640390,1.5691640408186416,2.5304581098762564
Panc 04.03,409805,5.536204895331733,5.259512903130984
MSTO-211H,71466445,2.2675767772231024,4.319702156997728
NCI-H2171,9915743,0.832341910278816,0.6957188627953659
A4/Fukuda,5281672,3.917758560865086,4.199696551479835
LXF 289,11427553,2.4541082171467368,2.8950389080427557
Panc 04.03,7251185,3.2944683029692237,2.8725248729516015
NCI-H522,9933475,1.020852520604034,1.9013294672468062
JM-1,24180719,3.5833576580940005,3.0307077702401086
SCC-9,15953870,4.1491811794097995,3.6304318399378923
Panc 04.03,56946209,-4.443392589569815,-3.9454360217402025
BT-549,6918837,-1.3661230802503712,-2.422886898598794
ONS-76,56946209,-3.559106939272703,-3.774075331235561
OVISE,44507138,4.185704551553473,2.334221557208949
NCI-H292,441298,3.4530013870499037,2.392995961160375
EFO-27,374536,3.468329704237433,2.3961705655051357
NCI-H292,568763,1.0095796953036382,0.5998578633587887
NCI-H522,122327,3.7548997428021904,4.310898852126086
FTC-133,409805,6.0297974484260655,4.988115158084662
KMRC-1,3384730,3.706671423221143,2.717955938336114
HSC-4,5351362,1.6988999536887646,1.6363805334193626
BT-549,448949,1.6914375683866394,1.8831743503815
JM-1,753704,3.307600856766594,4.080511488545315
CAL-51,25195348,5.6667768045179905,3.407651104188434
CAL-51,3025986,-1.0834382414923172,-0.9395000347388109
HCC1143,15547703,3.062266000318877,3.270553445837747
EFO-27,navitoclax-PLX-4032 (1-1 mol-mol),3.1574015935029083,2.2517659120057227
CAL-51,135999136,4.2132345103647015,4.159996706354538
ONS-76,55283,0.3588409196586273,2.404387084134756
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.3077664161930427
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485,2.0664162268274864
SW1463,25262965,-1.5690747748042335,-1.1701757716002337
FTC-133,241158,4.091507154193835,3.8481279757298807
KMRC-1,23582824,0.9449566223543509,0.8917073184549826
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086,0.9600315534314596
FU-OV-1,16013152,4.2048953133679765,4.148749400608723
MDA-MB-453,613000,0.0740651651217389,2.429765315929733
MDA-MB-157,24797083,0.6098010922803769,1.5087708934097426
NCI-H460,10074640,3.83137833519258,3.0373539078437957
CAL-51,16722836,0.8083581946159574,1.6163573908605335
NCI-H146,tretinoin-navitoclax (4-1 mol-mol),-1.851053903762128,1.3398215159971516
G-401,BRD-A02303741-navitoclax (2-1 mol-mol),3.4869097822802915,1.7132704312336802
G-401,10322450,4.220475308231234,3.612676814847482
G-401,15983966,-4.354524639754001,-3.1716283545632167
CA46,9887053,1.048475441216289,2.248521375504981
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035,4.5693886394291425
NCI-H1623,11152667,-0.7587975819891684,-0.35351258128628965
HSC-4,11609586,5.018303752842559,2.820590068028709
OPM-2,67156097,-3.031514601372161,-2.1728825009890467
G-401,984333,0.0612358592539302,0.2260556310319987
LXF 289,9908783,5.689655754809611,5.053302322130009
SCC-9,5329102,2.2394800798474677,2.1823368113964396
NCI-H661,17759555,2.3282310316349935,3.459600143778604
LXF 289,24856436,0.8419130403195528,0.40420733549707527
SBC-5,159324,3.4028835437957112,2.994776680579576
JM-1,6184667,1.7187669889057045,2.2436171946765993
MDA-MB-157,11396600,3.7386973485738424,3.728578248641489
BxPC-3,216239,2.4917493719892274,2.5627743826138363
MDA-MB-453,72193861,1.6700607918257404,1.6074678493673797
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049,2.8772698250539945
KMRC-1,9915743,1.4003501061845525,0.9243766115439266
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863,1.5763116672788502
A-673,12001922,0.9671300191794728,1.7685500237675773
A-673,1323703,5.495685082034704,1.6809174055507414
SCC-9,2729026,3.0647326637868573,2.7464000177373253
HCC1143,navitoclax-piperlongumine (1-1 mol-mol),1.8457079169425925,1.6184312594978618
NCI-H2171,3503,1.152076889590999,2.1901713755302072
JM-1,252682,6.042634536055517,6.387229250990122
CA46,44137675,2.206940954689562,2.7525799744233153
CAL-51,11152667,-1.203722258692511,-0.361945823921262
LXF 289,135984461,4.539632657840611,3.848441761751736
EFO-27,docetaxel-tanespimycin (2-1 mol-mol),2.492630012164076,-2.838042697635322
SW1463,11507802,1.438199099446833,1.49586214888527
BxPC-3,25062766,1.590701824067561,2.2074733239449604
EFO-27,45279963,4.232301991437958,3.960101235835725
G-401,selumetinib-MK-2206 (8-1 mol-mol),1.699600486285741,2.104707360959337
NCI-H2009,42642645,0.1491359953679814,0.9407933182687881
FTC-133,53495165,1.6157050027500164,0.6084169829266591
NCI-H292,11640390,3.2514062698758015,3.694658424788122
A-673,135423438,2.29660224903782,1.799546499947541
SBC-5,9911830,3.21689826570876,2.3883764233187375
MDA-MB-157,36314,-4.695989096441824,-0.7243623258300167
NCI-H1623,5328940,1.639592653942716,1.6968780398351027
SNU-61,135999136,5.618921387112628,3.3521726316689833
CAL-51,25102847,1.94226811064499,2.1410557251739006
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037,2.584719067717389
A2780,68056272,2.2410901197134923,3.518329174527348
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814,1.5947261425645252
KYSE-70,24856436,0.5719980221753466,0.7309730603579492
CAL-51,46398810,2.084696284876613,2.6443894390139273
NCI-H661,16720766,3.873672796747104,0.7603916091436035
LXF 289,11234052,4.719623128458786,4.2276830199095174
NCI-H146,selumetinib-PLX-4032 (8-1 mol-mol),4.7955071162055,3.0146889644550465
MSTO-211H,107970,1.929708493397844,2.2041711014878995
MDA-MB-453,9929138,5.862527790185705,5.245545591929888
G-401,285033,-4.902412101243927,-2.6752805417508774
OPM-2,6852167,1.7172653102666242,1.474439059146058
EFO-27,11228183,3.371245966973651,2.443622786775447
CAL-51,17759555,3.5733302595078182,3.556190267677088
SCC-9,24785538,2.4612574042553432,1.9781248469878676
KMRC-1,11364421,1.724167601186248,-1.757872840331149
MDA-MB-453,24748573,1.9919110400088051,2.2650522464296885
EFO-27,5460769,4.47484627366887,2.7993234626705576
HCC1143,49850262,3.2153342375189533,3.6757526124823956
Panc 04.03,66577038,3.1738099516277667,3.0394310175522774
NCI-H661,11238147,3.129195095759777,3.2211122331601785
SNU-61,6623618,1.73773822434396,2.1678340963272675
EFO-27,16720766,3.656433318818957,0.744575036995108
BxPC-3,969516,1.4378873066513898,2.8852416003055787
JM-1,54596558,3.768195826371459,4.008277102770467
LOU-NH91,5738263,3.7277759973822726,3.64173019739619
JM-1,25183872,-4.29494207596009,-2.255559139362559
NCI-H292,89928392,1.456532385863884,1.7997337627587655
NCI-H460,119607,4.735621464768821,5.050381388374807
NCI-H460,322968,5.369771337760045,4.046650570295466
MSTO-211H,navitoclax-sorafenib (1-1 mol-mol),-1.757065878159517,1.781857817124333
CAL-51,9907093,3.7886359098281783,4.082683288168919
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,5.073538758870023
LoVo,123631,1.2882244486240189,2.374159970647504
NCI-H661,crizotinib-PLX-4032 (2-1 mol-mol),2.1767708357401188,2.027679284214225
MDA-MB-453,15983966,1.8434310309669164,-0.7579049626123061
A-673,selumetinib-PLX-4032 (8-1 mol-mol),5.680938960321501,3.8212706314111826
HCC1143,135440466,2.588436572703006,2.4729262915827497
NCI-H146,9926054,1.7480459470636802,1.8750847199679848
KMRC-1,5278396,3.6212610119500783,3.570964144237617
A2780,46191454,-1.192769752942619,1.1563193353884709
A4/Fukuda,25062766,1.3929374396347198,1.7147911649040213
NCI-H292,53232,1.814131755875953,2.7990112918039114
ONS-76,24771867,4.286887453999452,2.2831386880256175
FU-OV-1,31703,-1.7023718917237094,-0.3632198729096872
A4/Fukuda,66577038,2.118562328013949,2.6244971719721746
NOMO-1,445455,4.303833401854377,3.5752157691777806
NCI-H2009,12003241,-1.6852069192913937,-0.9902887965972039
LXF 289,42642645,0.485507292149712,0.8586049105256194
NOMO-1,46199207,2.5514936314753434,2.8344906349483887
NCI-H460,322968,5.369771337760045,4.046650570295466
Panc 04.03,5328940,2.517395347800957,1.7647684636481182
SNU-61,9936388,-6.308071034865157,-2.4714511486836837
LoVo,4261,-0.8211989197292223,1.6237685316526227
A2780,136227924,2.141563547945887,2.7942887863612667
DMS 273,11175137,1.5448586489611442,2.0292080798001266
LoVo,44202524,1.5416570481285088,2.0388543433864275
HCC1143,9907093,3.794716934303189,4.142681521606512
NCI-H292,6610216,4.846288432835765,4.296624228363698
BxPC-3,11178236,-3.5754762678880567,-2.9709190396167724
MDA-MB-453,5978,-2.563797038396111,-1.4982543417784253
NCI-H146,5460769,1.8747395178404,2.835924250516905
CA46,11238147,1.5462987380530164,1.9911269464056045
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063,2.143407627341456
LoVo,2828334,5.515630519838643,6.180594285382788
KMRC-1,5287969,-1.8174868244268352,-1.9185712641025348
NCI-H460,676352,2.985829219207002,2.115826604466647
SNU-61,23635314,-2.2430318809352556,-1.864388571963069
NCI-H460,11612883,2.88158995470921,2.8706165057485333
HCC1143,24951314,0.9489239510798212,1.363532108245276
OVISE,387447,-4.037756707187744,-3.720344035610751
JM-1,568763,-0.4685251193741573,-0.2681695702484764
SNU-449,9907093,4.078651849005814,4.137901605908926
BT-549,53392493,1.9491955503491856,2.7427896400150833
MSTO-211H,24180719,1.9210037149309027,3.3713307590833916
NCI-H1623,23635314,-3.504391783968502,-1.0793506282393148
MDA-MB-157,135875424,2.7117106005077276,4.071572410152389
NCI-H661,54678924,1.9600004323573317,2.2424746249389655
DMS 273,25105715,3.6490952941772496,3.245761578879639
NCI-H1623,216345,4.517328735854535,4.028706881741256
SNU-61,5282054,3.0015154117441996,3.3168552404517464
SNU-61,10302451,2.848073588995495,2.6819665074913126
CAL-51,16720766,0.5416929462446769,0.4456278478371695
ONS-76,BRD-A02303741-navitoclax (2-1 mol-mol),3.993242759783489,2.480432196505954
OPM-2,selumetinib-decitabine (4-1 mol-mol),0.7585781361547917,0.6722920486356664
NCI-H522,46398810,2.2314734558486053,2.2228936912862527
JM-1,67156097,-2.627968736143573,-2.3839289925250475
LXF 289,60700,2.2902498510351528,0.33715204025767187
BxPC-3,2945648,3.219283504871713,2.9559989110151874
A4/Fukuda,65064,3.1077716650538707,3.9648837197627547
NCI-H292,tanespimycin-gemcitabine (1-1 mol-mol),0.0441766051027791,-0.7862163865252471
BxPC-3,10077130,4.243605425717339,3.0930638314438257
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815,0.8501091563662212
NCI-H2171,tretinoin-navitoclax (4-1 mol-mol),-0.4442650177645615,1.3547236972617145
NCI-H292,carboplatin-UNC0638 (2-1 mol-mol),3.385304428653225,3.3975917422239656
LoVo,168312962,0.7059894109575258,1.9596203821673115
G-401,65064,5.209946412003188,4.500572591395606
NCI-H146,148198,-5.323171419653744,-3.6138111964690016
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739,-0.8509184878865856
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094,0.5480361670687399
HCC1143,2746,1.9419289545652112,3.1680134924626553
NCI-H2009,erlotinib-PLX-4032 (2-1 mol-mol),3.949302222933775,2.949611043073441
JM-1,decitabine-navitoclax (2-1 mol-mol),-3.5626840909623234,-0.6892672988140377
NCI-H2009,10385095,0.2451756361843044,1.4926941377157332
OPM-2,11167602,1.1745103577473592,1.6986405106460263
CAL-51,26596,-1.4638590943230956,-0.780090665735863
NCI-H460,1716436,4.318712917611328,3.1318871729789497
ONS-76,71304818,2.469307822454373,2.4409094124431756
BxPC-3,11626560,1.2674200020854305,2.0113749524304056
CAL-51,104842,-3.020036586723177,-2.7448032806930613
NCI-H460,49793307,0.4479933662320887,-2.4740922254705113
FTC-133,5284373,3.681008384459256,2.7885757720465945
SBC-5,11455910,0.8715920005264659,1.0436042586007872
MSTO-211H,49850262,3.597717946429448,3.82921156264918
DMS 273,2871966,0.6484564569530932,0.1966930723881285
OPM-2,2729026,2.502425703285658,2.2331150661630317
KMRC-1,JQ-1-navitoclax (2-1 mol-mol),1.5220385393532236,0.9366205644596461
NCI-H292,9840324,5.8141064790381884,5.784211545901872
NCI-H661,375860,0.2037463104187888,0.08514454300441139
NOMO-1,6918328,-2.206625897840938,-1.138735159363927
NCI-H522,54143018,0.2801073306793095,0.25362604309552783
OPM-2,23635314,-4.85335222903722,-2.8557983764693846
NCI-H1623,1716436,2.729344651836522,2.965141691126332
CA46,60700,-1.6899904219212585,-2.0969296801221393
SNU-81,10077130,-1.1742608263747976,2.8606792948209305
MSTO-211H,9907093,3.5779290533064856,4.237720565292463
CA46,2126,3.4622152695614767,3.6790336037698643
CAL-51,49766530,0.4609697007955676,-0.379450854519653
CAL-51,6438330,3.884194225982375,2.3254899494760624
KYSE-70,68056272,3.571583007543391,3.725639298362754
LOU-NH91,vorinostat-navitoclax (4-1 mol-mol),-1.0050592172430175,1.2791636607987575
EFO-27,68056272,3.9995237189063784,3.5245327911140816
SCC-9,241158,3.962823581088113,3.9463606396708606
NOMO-1,5746,1.3002002606442051,0.009593778017539899
MSTO-211H,44202524,1.4972222665959742,2.110603578138853
NCI-H727,49793307,-2.322611372156632,-2.6481978924559626
NCI-H146,4578,4.154543455900732,4.017622607926324
NCI-H522,JQ-1-vorinostat (2-1 mol-mol),-0.7689256810946783,0.6437506360875817
LoVo,107985,-3.583734032756361,-3.4267442352479547
YAPC,984333,0.9591784056691972,0.8870250750752504
SW1463,1750826,-6.63000221324875,-1.6746607470851564
NCI-H1623,crizotinib-PLX-4032 (2-1 mol-mol),2.4308697458394652,2.0226777522099537
HSC-4,9866186,0.7177643600632182,0.8867499238524483
G-401,navitoclax-pluripotin (1-1 mol-mol),-1.0942323522272883,-1.4048505541341518
ONS-76,135398516,1.9151603507117831,2.0185632005965592
LoVo,11964036,-0.4950100771581299,1.0144478939139312
KMRC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.7808089870084007,1.575066371015867
CAL-51,11964036,0.7531640395115359,1.2805270261430868
SBC-5,5328940,3.016318294707136,1.7349341277847705
SNU-61,9444,4.091366887299019,3.906322720768647
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149,2.4634839655289067
A2780,676352,1.788840905955693,1.8819197864528783
FTC-133,JQ-1-vorinostat (2-1 mol-mol),2.666931641938378,0.9055813357031564
JM-1,7251185,0.7253388444333596,1.2680408588672558
Panc 04.03,JQ-1-navitoclax (2-1 mol-mol),4.611253227928805,0.9971806632489656
NCI-H460,52947716,-4.997624319891589,-0.542933799399524
NCI-H2009,6505803,-0.1719772058921901,-0.4909823721395538
OVISE,25126798,4.262747569123806,3.7285084779651605
G-401,54678924,1.6253720221899297,1.5894062333781716
Panc 04.03,tretinoin-navitoclax (4-1 mol-mol),4.366288248143094,2.747356487419836
A2780,135421197,1.3895584306244824,1.6042081688619947
EFO-27,25126798,3.692256603979053,3.877244519176038
DMS 273,73707398,1.2764695344106731,0.8188186994893439
MSTO-211H,10296883,3.6762481855456985,3.9915298025124817
LOU-NH91,60700,-0.2604526525302556,-0.029820891066277833
Panc 04.03,8515,4.900392472396633,4.2066072737083
A4/Fukuda,216345,2.739557201577506,3.0540059339689414
A-673,24978538,2.0217931845087596,0.4545670384616014
SBC-5,11152667,-0.3838978082878119,-0.535756075440825
NCI-H460,15983966,-0.5601417251503862,-0.8666078282251581
EFO-27,400769,-0.0834796845468066,-0.5492389513052619
YAPC,2858523,3.168058012530131,3.1357660892497847
LOU-NH91,navitoclax-sorafenib (1-1 mol-mol),-0.9074262006529596,1.9643586580500305
NCI-H2171,227681,1.8296199533038344,2.482167174389372
NCI-H460,11455910,1.4134750909778395,1.221949503110057
G-401,44566777,-0.9568944013200004,0.4630461998860518
NCI-H292,5328940,1.2067364026743148,1.7795226012934933
G-401,navitoclax-sorafenib (1-1 mol-mol),1.5806960178530294,1.4013374319598837
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.1936233832486773
JM-1,25154868,2.919888649987432,3.901921138005926
LoVo,44185566,1.1715497148164364,2.3961238591952836
ONS-76,54618164,4.167815792355048,4.151650372931688
NOMO-1,151289,1.0922355572005962,0.5013386449562937
G-401,44493528,4.310857122389352,4.274737414024412
KYSE-70,89928392,5.113782206339635,1.5613488118219274
NCI-H661,89928392,1.5970967591597882,1.853101672226675
SCC-9,docetaxel-tanespimycin (2-1 mol-mol),-3.608220129301709,-2.7048492543943605
KMRC-1,3503,2.6706031423305845,2.215332726941769
G-401,11455910,1.3171347053017213,0.6116938513320512
SNU-449,208908,2.01293579360495,1.8670697356882302
G-401,57519531,1.5783303012871783,1.8915626691574758
MDA-MB-453,11427553,2.8599395215861567,3.0334296231943103
LOU-NH91,241158,4.097895358021133,4.078324849336851
G-401,24951314,0.7541386929645643,0.7456371167691591
MDA-MB-453,208908,1.869724740513474,2.0505080683905383
YAPC,46398810,3.0625661294812216,2.7093841287414704
LOU-NH91,1750826,-0.8784962447018205,-1.6244628022578629
FTC-133,ISOX-bortezomib (250-1 mol-mol),0.3351331605659957,0.6723766496870095
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209,2.7085896022601252
MDA-MB-157,100016,3.517936084480814,6.226095708260852
HCC1143,60750,-4.413462787403808,-1.4052448312957895
NCI-H661,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5299727991020555,3.8790426832912175
HCC1143,159324,3.533344711636858,3.1203288554637374
JM-1,1750826,-4.271139507623605,-3.136965322583953
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205,-0.23929301000864173
A-673,11396600,2.723776149104898,3.082165619264933
NCI-H1623,24964624,2.070631930148384,2.2104420142594194
MDA-MB-453,104842,-3.389911854354977,-2.9595551408528022
SNU-81,49793307,-4.215972202332142,-3.5271005866723386
A4/Fukuda,54618164,3.3817410387547575,3.8878546017690976
NCI-H2171,26596,-1.7584148860978708,-2.358648848796999
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155,1.348108883201857
ONS-76,676352,2.5309673509494535,2.2686481107169083
SCC-9,4378219,1.9931327421657885,2.667326536890095
CAL-51,613753,3.3238399640193177,3.201709455171779
Panc 04.03,49867926,4.237506736984018,4.469528963453648
NCI-H292,salermide-PLX-4032 (12-1 mol-mol),5.437042614590839,5.022049989384804
NCI-H727,selumetinib-navitoclax (8-1 mol-mol),-2.0021206675207885,1.850552428303004
MSTO-211H,3543504,4.118160915221066,4.649349282082054
NCI-H460,6252,1.4342703041264255,0.9401687463658157
OVISE,navitoclax-gemcitabine (1-1 mol-mol),-0.8912301406187855,-1.034751483018063
NCI-H727,3825829,4.725008182252989,3.943548346446168
OPM-2,119182,-0.8289962289267476,-1.9973052594011693
LoVo,54613361,-1.4267659732177436,-0.25527504297663817
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023,2.479284465893384
A4/Fukuda,126941,-4.18863393868508,-2.7852175502400285
NCI-H2171,SNX-2112-bortezomib (250-1 mol-mol),-3.076194221484089,-1.7694700217491754
NCI-H460,136227924,3.925006850615035,3.075706201310735
NCI-H727,3136844,6.195563862298742,4.3924802700623005
MDA-MB-453,136227924,2.410345496671846,2.972287053465158
SNU-61,51037431,3.7250627983577513,3.0052247491905684
SNU-61,3384730,2.3184170398790154,1.9204362390700456
Panc 04.03,24753719,4.39873379823384,4.45816183750992
SNU-81,5978,-4.726956734092058,-2.0342836596658342
SNU-61,9967941,2.1294940171884043,3.322619682430672
SNU-81,selumetinib-piperlongumine (8-1 mol-mol),-0.9226947877098262,2.221898051718689
ONS-76,5470400,1.68546701619173,0.07013271253712938
JM-1,52912189,-1.1165299764243126,0.10018918866067217
NOMO-1,52947716,-3.339302012338735,-2.482240558458734
JM-1,26596,-2.491901301923365,-2.621052516224125
NCI-H661,445455,5.2176896422295025,4.590629175931341
SBC-5,216468,3.330480208625043,2.8722991612558797
NCI-H292,5311,1.7806932533505695,1.743818885624678
Panc 04.03,9935249,3.3873751996630177,3.350913886973812
NCI-H2009,doxorubicin-navitoclax (2-1 mol-mol),-0.756296183538871,-1.0528977195816358
CA46,25262965,-5.196703638661911,-2.146668671481613
NCI-H460,11626560,2.497647926194901,2.0441230907607046
CAL-51,54686904,4.850424917483252,3.4851816167004377
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994,0.7543017138148875
NCI-H2171,6918328,-2.9240080597430813,-0.8063387006552264
CAL-51,3825829,3.9510679995615257,3.9906537817350864
SNU-61,65064,4.771880102821997,4.802880185982453
CAL-51,124202324,2.033990287468598,2.5088995918763723
NCI-H1623,11494412,1.2552972437851018,1.9688667604138943
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415,-0.3266382987848459
JM-1,135398516,1.8505892369708832,1.4216725274069804
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708,3.88262714639835
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327,2.0973163494556006
LoVo,1641662,3.111662868893329,3.464500833197649
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142,1.1724728486692428
HCC1143,24856436,0.4052757500096688,0.8917709519290163
YAPC,73707398,1.1307339717786768,1.345532019419513
FU-OV-1,24771867,2.3744516407985485,2.864208699281806
NCI-H727,piperlongumine-MST-312 (1-1 mol-mol),1.950169428347768,2.0488265258317178
SNU-61,2749,1.958913212534665,1.8299681122132399
CAL-51,20959075,-3.1196535578382987,-2.771683573666116
A-673,6918878,1.2344260030899934,1.7010145053355297
LOU-NH91,73707398,1.1540810865513749,1.4790765640914996
NCI-H2171,107985,-3.896160678794096,-3.3794085117070205
KYSE-70,12003241,-1.4257688129039825,-0.8153958086800074
MDA-MB-453,10296883,4.2989687155614735,3.7980867017241122
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266,2.361699817877494
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858,1.2304592986836462
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186,1.523034179773934
NCI-H661,4259181,-1.4326329693308524,0.12354320401984616
JM-1,salermide-PLX-4032 (12-1 mol-mol),5.264877641383212,4.308169271986125
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086,0.6156331543055463
SCC-9,25183872,-1.5689686359020558,-0.702206678117224
NCI-H727,6438394,3.7246032061112553,1.4640193651007443
NCI-H1623,selumetinib-navitoclax (8-1 mol-mol),2.5972184822142004,1.824410435016984
Panc 04.03,9911463,4.4327726522455855,3.9358465839179657
ONS-76,2733487,6.718347537986806,5.650728956678625
MDA-MB-453,25062766,1.9156877669914651,2.273798911948051
NCI-H1623,36314,1.7259264714185265,-0.9516814508663818
SCC-9,selumetinib-piperlongumine (8-1 mol-mol),4.590174164336879,3.27104100703298
MDA-MB-453,11234052,3.3366002038414493,4.022577615668315
NCI-H661,54143018,-0.94518686271758,0.6676557232803094
NOMO-1,72376,-3.881755374018637,-3.5627732564092036
NCI-H1623,104842,-3.8091356035642434,-2.228394018280179
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.505258823255376
JM-1,71466445,1.831003524042788,2.3118337489402907
EFO-27,49766530,-2.657964166176686,-0.6835058851628557
NCI-H661,753704,5.093119647973415,4.938604695202275
OPM-2,11175137,1.4890519960627426,1.878838851278858
G-401,carboplatin-etoposide (40-17 mol-mol),0.9786260223785996,1.514547092764507
A4/Fukuda,5746,-1.1009867615741116,0.17431186352211425
SNU-449,44489675,3.6193477306301927,4.143628940035576
NCI-H661,12001922,2.629031416850278,1.9402696199866736
DMS 273,11640390,3.3173332454053717,2.8038483875338414
SNU-449,4259181,0.6587440570439733,0.2739631269840334
EFO-27,24964624,2.939505532014586,2.7460013063959408
LoVo,4096211,0.5868958804653562,2.093445610855077
A2780,2841722,4.258280317113099,3.877663020856568
CAL-51,24771867,-0.5018492111736887,2.8635940465078096
G-401,46907787,-0.0293884143124787,0.9572002049178632
JM-1,24772860,-4.004711239665373,-2.846165321042299
MDA-MB-453,71680916,4.8348560692055695,4.599832808386809
JM-1,11507802,0.223918960474334,0.5200680786691608
A-673,462382,-0.040658639847304,0.5189961192113626
NCI-H661,216345,4.176204855685743,3.90138848219777
BxPC-3,9907093,4.5613416209155755,4.459739540807582
HSC-4,216468,2.5769925673594227,3.318950005667398
NOMO-1,60700,-1.0021705320646457,-1.6266276710290826
YAPC,11455910,1.8317787914833017,1.4663437854994605
SNU-449,11175137,3.183352091664916,2.712452466112527
A2780,2113511,4.588817591987419,5.144134050285047
NCI-H146,613753,2.6314812615131222,3.0015812174251972
SNU-81,10231331,-2.370371712203436,1.7815372771371052
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109,-3.713440275321789
NCI-H661,168313016,5.326553105852446,4.60777324568713
CAL-51,25126798,3.926975819986009,3.8653002122471865
Panc 04.03,1716436,3.048029385411991,3.0532537351613844
EFO-27,11625818,4.615590718074381,4.460497217590023
A-498,44495899,4.223152889477574,3.292432780394205
A2780,3825829,2.5427924978442467,3.558056569346787
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021,4.575082153078366
NCI-H1623,2858523,3.2758661507497115,3.004952744069407
A-673,49793307,-5.444897343264971,-3.921828462111573
MDA-MB-453,9935249,2.561550169446695,3.146138288891456
MSTO-211H,navitoclax-gemcitabine (1-1 mol-mol),0.5051490037024954,-1.4261768046405014
LXF 289,3062316,-3.851151802003845,0.9375371966447829
MDA-MB-157,2874250,4.29768331905581,4.30866069582222
HSC-4,4521392,4.744801099229743,4.337119518427542
EFO-27,23725625,5.484413053531449,5.290881120449044
MDA-MB-157,navitoclax-MST-312 (1-1 mol-mol),-3.237142139083902,0.7842357726631071
NCI-H2009,5460769,1.3316086312624285,2.851023082520961
LOU-NH91,654092,0.641619390442256,-0.2433816071564077
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,3.8270386364686266
SNU-449,9887053,4.621717664819675,3.962759746789532
LOU-NH91,54618164,4.244208934703923,4.244100328324122
MDA-MB-157,24951314,0.2652102931153908,1.4615599684103313
SCC-9,4261,1.568262163612179,1.784786975955478
CAL-51,262093,2.862241975448649,3.1053600091899587
DMS 273,100016,5.677769516399485,5.246227414141219
A2780,44137675,1.3252793631369038,3.0501447878725294
DMS 273,71466578,4.37241227128359,2.9774263169309774
A4/Fukuda,1566236,1.4071330472860828,1.7566092088361736
SNU-61,navitoclax-gemcitabine (1-1 mol-mol),2.2784859242088062,-1.2795650048010088
NCI-H2171,25102847,1.8897460049958847,2.3042625175314844
MDA-MB-453,60700,-1.6006047446684224,-1.127177652677207
A-498,11404337,2.25955984981305,0.1688007979279598
NCI-H2171,10302451,3.986494326049399,3.194246386120272
YAPC,10184653,0.1561987566095487,1.2490050237072026
NCI-H661,9967941,4.170813203069281,3.571288555837755
BT-549,24901704,3.7794480452342,3.34318480081175
A2780,3038522,3.0311112283818864,3.040123989403548
NCI-H522,67291369,2.1338291538877514,1.8665818681920205
HSC-4,753704,4.983094182740762,4.854949274425819
G-401,44607530,1.0217800111575093,1.577437202476914
OPM-2,19582717,1.9960397366001383,3.045285424396168
NCI-H2009,104741,-5.941055510927969,3.6312939340447663
OVISE,9936388,2.6758567859836826,-0.8217891310952801
NCI-H1623,11178236,-2.2917099582879144,-2.912139563429304
CAL-51,5746,-0.6872762444946757,0.9738797137572732
JM-1,3503,1.2397121319894746,1.8515453553411894
LoVo,26596,-4.043483931746528,-1.2287653131130563
ONS-76,44486219,4.293725912166159,4.432097711999111
SNU-81,vorinostat-navitoclax (4-1 mol-mol),1.2655278546702862,0.5207771717664903
NCI-H460,24964624,3.5490884182562565,2.4633403750508935
A2780,448949,1.9574027813966313,1.7995132053055147
G-401,6918878,1.5849207586223315,1.539631628496836
EFO-27,123631,3.2705036111065957,2.6854575486252306
NCI-H460,71466380,4.4879606530616725,4.496939296175106
NCI-H146,126941,0.4535750644224253,-2.744305952291126
SCC-9,JQ-1-vorinostat (2-1 mol-mol),0.3641375851810363,1.1275060096997287
JM-1,25062766,0.7257031347370316,1.8720637396423165
BxPC-3,44819697,-0.5900667288519075,0.19888635472574645
DMS 273,49766530,-1.3487399530522592,-1.5342199023551575
G-401,6918837,-4.518653911968971,-3.8153254075997967
FTC-133,25195348,4.144583358862902,3.464643095716872
BT-549,5281321,-3.0037540013163433,-1.2952891367522978
Panc 04.03,44241473,4.425072929332434,4.7762589226064085
YAPC,5278396,4.010893890545004,3.7104996005990216
ONS-76,5287620,-2.6985711183159573,-1.8828965951380028
SBC-5,11612883,3.4240653421197877,2.7318362761107484
SNU-81,doxorubicin-navitoclax (2-1 mol-mol),-2.5154002454653277,-1.1637216135205453
A-673,tretinoin-navitoclax (4-1 mol-mol),2.75284038442573,1.4051161237085048
SBC-5,219104,3.745930190487188,3.8812072154091544
SNU-61,176870,2.732721688120773,2.5276106779129486
CAL-51,36314,1.3238047725901672,-2.368566717837414
SNU-81,carboplatin-UNC0638 (2-1 mol-mol),2.7350455316868416,3.3132643200998317
DMS 273,71751553,4.31191978803821,4.173404990986719
NCI-H2171,400769,-1.2297634018381476,-0.6280954198098064
MSTO-211H,salermide-PLX-4032 (12-1 mol-mol),5.150950565200891,4.919516059405391
NCI-H727,71304818,2.536891878991305,2.450251741489759
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567,1.1314930272290338
CA46,135398516,0.7680931483587626,1.2848207954995963
MSTO-211H,100016,4.243846732059744,6.122411791310726
NCI-H522,selumetinib-MK-2206 (8-1 mol-mol),3.9815155524182337,2.166472465916898
NCI-H2171,carboplatin-UNC0638 (2-1 mol-mol),3.641096967492651,3.2300836353860842
SW1463,25183872,-1.2446986167158185,-0.7299430936654276
EFO-27,122327,4.8281000238128,4.634785953335644
MDA-MB-157,11222830,0.6776847499576403,1.6092464985276445
NCI-H2009,25150857,2.992056775880064,2.6908431597262408
NOMO-1,216468,1.212023833941809,0.9962317199607178
JM-1,11152667,-1.617053586455527,-2.467094120102247
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.9040519635519622
A-673,25126798,3.569829443135804,3.78976739793695
DMS 273,148198,-4.27913692458833,-3.9138720626176253
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203,3.6556249364325937
LXF 289,5329102,1.6667075021580833,2.0023076328772293
HSC-4,53495165,1.6708694504220498,0.4207671470201064
CAL-51,969516,2.948027689121256,2.7804330713134933
NCI-H661,5746,2.052034109930783,0.9114123787003359
A4/Fukuda,9967941,2.4411204768161983,3.4173065468450425
MDA-MB-157,89928392,-0.9485630303355488,1.7374195331032607
NCI-H460,12001922,2.3574763109101253,1.986123465003331
SNU-81,327653,3.5323829695882267,2.90381490958132
NCI-H661,124202324,2.0891928025286943,2.609739416889495
BxPC-3,42642645,0.6313588777440967,0.8177054639616993
NCI-H2009,24772860,-3.0306018162615342,-1.4257645072642762
A-673,6610355,3.502413574243847,4.316372827386303
SNU-61,57330099,3.603690788773508,4.177251195533258
NCI-H522,2749,2.969505400884835,1.549968899836746
NCI-H661,57519531,4.09429699672183,2.360679599732042
MSTO-211H,2126,4.496176254172968,4.5625511113694905
KMRC-1,10410894,3.4812991400934585,3.4479758785670938
EFO-27,44237094,3.2066908421034332,2.7969769298677445
LoVo,16725315,3.2447595903434627,4.3721573889108996
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552,3.6577589856823196
MDA-MB-453,2842253,6.29942483998937,5.342776285864434
A-498,135875424,4.978423270774445,4.279145420906552
Panc 04.03,9903786,4.611047286699123,3.039532652388411
SCC-9,54639665,4.512228528266098,3.178741076124206
JM-1,24856436,-2.211637583066154,-0.447844997539369
A4/Fukuda,5311037,4.577970147235868,3.1188964439196205
NCI-H522,66577038,3.0388231599187017,2.7257103928382582
BT-549,25154868,5.818557590138654,4.4997014175929575
KYSE-70,6505803,-1.025033993677824,-0.3663062462598861
LXF 289,11396600,4.152956454399736,3.915932593461175
SNU-61,navitoclax-MST-312 (1-1 mol-mol),3.0006796747399394,0.8277561608168376
SBC-5,126941,-0.8684780314881991,-2.435719155537793
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667,-0.4712160995489992
OPM-2,9933475,-1.3895511853659537,1.477710884730236
YAPC,11214940,1.707662344700129,2.064613922866082
EFO-27,4259181,1.8274060730963064,0.40239030824823224
NCI-H460,446155,3.79922347841428,2.768442104361936
NCI-H1623,carboplatin-etoposide (40-17 mol-mol),1.5186330340389391,2.796990424285675
A4/Fukuda,3634881,2.7004024711225596,2.6583476715758767
NCI-H661,1566236,3.2299922345410006,2.4739307814234626
MDA-MB-157,6450551,1.4635370045174534,2.722959699134725
NCI-H146,vorinostat-carboplatin (1-1 mol-mol),1.5707903367584717,2.534852008958852
BT-549,6918328,0.6487197523295809,0.40018601279857136
NCI-H727,11175137,3.085433657363398,2.666043620518066
NCI-H460,3854666,3.1385110084048065,2.207544147423278
LoVo,44241473,4.10673515965005,4.78444739900282
G-401,10074640,2.6430496317806957,2.951701107633858
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264,0.8351322243653583
SBC-5,2126,4.14698296213378,4.667900307567702
ONS-76,3503,2.5109588721491938,2.341691756002007
SNU-61,5470400,-1.745187092277687,-0.46423529152076404
NCI-H661,36314,-4.592945905020296,-1.386221694025968
JM-1,451668,-4.255879556837535,-1.1374391864040654
NCI-H1623,5978,-1.0298747552622975,-1.2307887750320479
DMS 273,136227924,2.538513279360657,2.6724473264242943
SBC-5,selumetinib-navitoclax (8-1 mol-mol),4.706526584593769,1.9620453187887086
A4/Fukuda,6918638,-1.9449982869755031,-0.1808796750944999
HCC1143,16038120,0.5509172721588973,1.0734723105508863
BxPC-3,44185566,1.4327209520395616,2.754355594437053
ONS-76,2858523,2.9452513130208975,3.124478972090937
NOMO-1,46191454,0.6880471005756411,0.021610148660730272
NCI-H292,216239,2.858200088172953,2.3920588815235875
DMS 273,11178236,-4.200581603954177,-3.1451754849821714
OPM-2,10074640,2.1693178922200813,2.7250364856098934
ONS-76,5566,3.1751487050742804,3.0120335416529604
BxPC-3,10385095,1.8732992891777025,1.4252390858890316
A-673,crizotinib-PLX-4032 (2-1 mol-mol),0.1365223010669094,1.3147536559402917
MDA-MB-453,675434,4.221225816741011,4.482499045517708
SCC-9,navitoclax-pluripotin (1-1 mol-mol),-0.0123473768643266,-0.9591007132350717
CA46,9825149,2.310107059064329,1.52702336875816
MDA-MB-453,12003241,-0.9610578830621354,-0.7789933102869426
A-673,613753,2.7839803669097134,2.9850264953645542
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113,2.611747851901622
NCI-H460,3062316,3.704520183651484,0.7681165848246109
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364,0.12086521661480171
A2780,11427553,1.40474333506403,1.9026104443654166
CAL-51,5287620,-2.338247824560234,-1.9804267323332343
KMRC-1,11640390,3.901360175468555,3.1689636970586452
EFO-27,16219061,3.8100949831762296,3.5046022324758868
A2780,31703,-4.480868228272363,-1.6531060841906509
Panc 04.03,135440466,2.8713092707831116,2.3374494584941097
SCC-9,16065773,3.2014379284662864,2.657694245765183
SNU-449,148198,-4.785889264279132,-3.573526374473295
OPM-2,2949965,2.476405976050771,2.49451063858915
ONS-76,44489367,4.840464292002439,4.604111081090245
NCI-H146,navitoclax-piperlongumine (1-1 mol-mol),-3.055255187933708,0.5045107368624903
NCI-H522,vorinostat-navitoclax (4-1 mol-mol),1.5182214624562833,0.9133768491987572
MDA-MB-453,135411,0.2962177293375728,0.7163536364486005
DMS 273,123631,3.074313122611396,2.086747194595667
CA46,19582717,2.2741322004032716,2.7333137192246513
A2780,3676137,3.624330330130062,4.307380918884453
BxPC-3,11964036,0.7144816609502266,1.263513338047897
G-401,71466445,3.182548969694367,3.0970547809645073
YAPC,navitoclax-piperlongumine (1-1 mol-mol),3.667001325655349,1.928019301167022
A-673,49766530,-3.0139632371957705,-1.115131569293322
JM-1,JQ-1-UNC0638 (2-1 mol-mol),-2.068621419812743,0.015389814370933137
SNU-449,11609586,3.2368097564340546,2.9506606354288563
G-401,46199207,3.084348249789013,3.1742298739419126
A2780,11612883,1.284093973133662,2.385906289140335
KMRC-1,2708,5.927603665606935,4.597895904469397
EFO-27,SNX-2112-bortezomib (250-1 mol-mol),1.0533662240531856,-1.219831391371991
DMS 273,135875424,3.231864587804135,3.2790919104471827
Panc 04.03,2749,3.2242301239764184,2.2668698816303605
G-401,675434,4.2282934242266235,4.28349215961955
G-401,72734382,4.843742106159305,4.137549727018267
SNU-81,72376,-4.141271855112041,-2.5920910063484137
LXF 289,208908,1.975389940693236,1.8488438078954343
EFO-27,11175137,3.0704812268942296,2.7600426243767635
HCC1143,16736978,2.2332113551174415,1.9347788648872066
LoVo,24821094,2.523288695365458,2.9670051443686596
A4/Fukuda,10322450,2.3588003127389277,3.358756168637104
EFO-27,11152667,1.7712187839859168,-0.3563419542701275
A2780,6918736,-1.942572837589071,-2.0447085534398943
FU-OV-1,285033,0.0377877938075082,-1.646076906589276
KYSE-70,11626560,2.028097573065789,1.7527789542167869
CAL-51,400769,-0.1641693790968544,-0.6078790972513791
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323,1.3106242996965451
CA46,11507802,0.4399982092061076,0.7102421736958802
SBC-5,tretinoin-navitoclax (4-1 mol-mol),3.0928632602038575,2.718368065986647
SNU-61,44607531,1.8838139804325664,1.4226822756375808
MDA-MB-157,135984461,1.8807242402896556,3.769110993654061
YAPC,68056272,3.685228443179594,3.7177586667220934
KMRC-1,3025986,0.2913922358554936,-0.7435893140095193
G-401,11656518,0.9589948119457968,1.1331359672512782
CAL-51,25262965,-2.904292987251918,-1.7791919820417765
NCI-H727,31703,0.5895859224805655,-0.5032393666647393
FTC-133,3025986,2.6500554516402515,-0.9556271792248883
OPM-2,11404337,-1.9830798838769188,-0.9093774558674224
NOMO-1,54649381,4.1030759428324455,3.3339790738687465
OPM-2,45279963,2.6394525890823335,2.844423743908264
G-401,54619267,3.6389956680017495,3.868720867091428
SCC-9,613753,3.4469207135602904,3.3199588065898
FTC-133,3825829,4.910712910753543,4.082750733062872
NCI-H727,6918328,2.020699769993763,0.03830058174460446
JM-1,3384730,1.783412153965406,1.4062932825546222
OPM-2,5335621,3.731372916139424,4.053683899481887
NCI-H727,46199207,3.049846279584177,3.1548149336385336
NCI-H2009,100016,6.24887408197215,6.212983659535972
OPM-2,2742550,2.8639715022070713,2.9883589908236403
A-673,56649450,2.339222019664337,3.0869054945220076
LoVo,135928012,4.12079355273469,4.163070608726472
SNU-449,46215462,1.6240369462021291,1.831732397520822
EFO-27,10385095,0.896347771716858,1.4386666823284964
BT-549,6917907,-5.828237871920148,-4.939772169114773
A-673,262093,2.1198375376891705,2.119509171219638
SCC-9,crizotinib-PLX-4032 (2-1 mol-mol),2.600413424515517,1.7607883594238474
G-401,2871966,-1.4998546935779766,0.21801133631062417
NCI-H460,6610355,4.949206869720499,4.466085009198871
NCI-H292,56946209,-3.439063202171596,-4.015749608948009
MDA-MB-453,46907787,-0.524764523127372,2.5128056236469125
NCI-H661,9935249,3.279757521015836,3.071884266127335
Panc 04.03,5311281,5.064761813982229,2.580389348054549
EFO-27,54765302,4.904683382842226,4.205016521207818
OVISE,24964624,2.347879134584806,2.5162062174245277
MSTO-211H,6918878,2.3677965777112653,3.1519736126060223
KMRC-1,1641662,3.91383049133015,3.4639710517874325
NOMO-1,3025944,3.969971169930392,3.9917054735857453
MDA-MB-453,10322450,5.853812101119735,3.6401824939062353
A-498,675434,6.195396019607132,4.69469296846663
JM-1,16736978,2.465148690257062,0.7466588238552131
HCC1143,400769,-0.895432113907658,-0.5694558536977573
JM-1,5328940,0.4457439228433418,0.8020064824564307
NCI-H522,156422,4.012108454967305,3.3048806325704674
DMS 273,135999136,4.8097980755766505,2.7900589891146943
A2780,44607530,1.3884091000724437,1.4550259939482304
KMRC-1,10302451,2.629362111325239,2.9952691483193714
SNU-61,6918736,-1.624439463390885,-1.4152090958460324
BT-549,135999136,1.9798336492119424,3.8485670898804667
NCI-H1623,9926054,1.7409203229588674,2.0745462871180944
JM-1,16722836,0.523497579231149,0.637495595916674
MSTO-211H,613753,2.697490548990984,3.3198878890315644
NOMO-1,16725315,4.952538276899841,3.717594972675615
KMRC-1,16736978,2.1404631421072975,1.9710835636193236
A-498,123631,3.2458168084526564,2.610154400516562
MDA-MB-157,decitabine-carboplatin (1-1 mol-mol),3.837030982901149,3.9810811844099687
NCI-H1623,24951314,1.0133274480783143,1.4939268614652819
NCI-H661,11228183,4.275001578251326,2.19884985876601
FTC-133,5479543,4.4305420476204205,3.4274134646646655
NCI-H292,136227924,3.1886204590132654,3.192506297839893
A2780,6184667,2.4201329833494705,2.7723212555687127
SCC-9,5278396,3.934746070394729,3.6336597491860347
OPM-2,5743,-3.6176009576451142,-0.6546503684584078
DMS 273,66577038,3.0260629384717443,2.668411853036668
SBC-5,151289,0.3068057764327633,1.4705639503881718
A4/Fukuda,44491742,3.3943913096556444,4.055664749970796
MDA-MB-453,135928012,3.1518499848728534,3.931844766982299
A-673,2828334,5.945698490544337,5.899561514340357
OVISE,44185566,3.1371413376940724,2.658067414742977
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849,-0.2759803623493546
KYSE-70,5460769,2.831605222646697,2.655153988683918
EFO-27,60700,0.0275300045157078,-0.2499719721683353
SNU-449,2871966,0.0642629453363792,0.5009291223056809
A-498,135411,0.9450284346401692,0.9292172393932077
CAL-51,151289,0.6583498849401344,1.100730161785548
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.713755369178617
NCI-H292,54454,1.5363763322568371,2.7302590948359096
MDA-MB-453,984333,1.2010378495759917,0.5678662646993718
A2780,1242560,2.8030380184252346,3.213838241189236
G-401,11625818,3.256149300060542,3.6344907778035167
EFO-27,2729026,3.178460421270277,2.915357280094863
CAL-51,54454,2.240351559744082,2.849967138502031
SNU-81,5470400,-5.232383325772668,-0.49553821748442034
JM-1,selumetinib-tretinoin (2-1 mol-mol),2.58796154707147,2.6885321246234413
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821,-0.7435780007310787
LoVo,51037431,2.9518330914759043,2.9816687058874773
NCI-H1623,57519531,2.253772853853667,2.5536523728907867
BxPC-3,6918837,-2.8801990347910045,-2.713585533115701
SNU-81,452548,-0.1759999006209261,-0.5070531366447836
BT-549,327653,2.9888914918454854,3.31663584541601
CA46,46199207,1.8825158344658808,2.59106226497268
MDA-MB-157,10410894,1.6628456414259642,3.2662061023709557
SCC-9,66577038,2.999012470787333,3.0447107605454318
NOMO-1,6918878,0.4522523514749809,0.45327075801167616
SNU-61,5281321,-1.743716860572046,-1.2929713309513402
SBC-5,decitabine-navitoclax (2-1 mol-mol),2.675632395894592,1.915882433439129
HCC1143,9840324,5.44269474449066,5.776100724974683
CA46,11234052,2.4794836109026077,2.760704131016762
CA46,11609586,1.0102139081655188,1.4143488348792752
NCI-H460,10385095,2.2920897819597896,1.4771306184633852
BT-549,11625818,5.0921701677816875,4.510129657443103
SW1463,400769,-0.5224692496950973,-0.6789604531987148
Panc 04.03,10113978,5.097338218314276,3.4379227540939543
JM-1,9907093,3.962832886035932,3.284851817685029
CAL-51,23582824,1.0413279539794644,0.6830192590816844
Panc 04.03,135398738,4.347297256699442,4.555050017066801
G-401,3038522,2.1905688095022215,2.847918694319591
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648,2.4361136152371934
NCI-H146,4261,-1.8051480987265105,0.9897079219929666
DMS 273,2729026,2.67706862921606,2.4633665511942495
SNU-81,1750826,0.9975547695410114,-1.8014891794161338
CA46,168313200,1.9493207867170304,2.4964128223614943
OVISE,vorinostat-carboplatin (1-1 mol-mol),3.460247929578718,3.239029037323014
A2780,57519531,1.3251208810116586,1.9773928458834817
OPM-2,navitoclax-sorafenib (1-1 mol-mol),1.274845961219173,0.3282862040868564
A4/Fukuda,11717001,3.8123333180630103,3.769400864885212
LOU-NH91,3634881,3.4323223488487593,3.3985071479818423
JM-1,11485656,1.6613246077420758,1.616350772718563
SNU-61,107985,-3.1587785808489297,-3.41902695505868
FTC-133,2729026,3.353273516564875,2.801744124683643
ONS-76,159324,2.5690437216419677,3.0113789993395743
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,2.0959107131871093
G-401,9927531,4.9703255494446035,4.470313242239792
LOU-NH91,25105715,3.511519280721543,3.3983032869620216
SNU-61,15953870,3.2687219409332657,3.2791481380517293
NCI-H2009,navitoclax-gemcitabine (1-1 mol-mol),0.4354090663504973,-0.38157120740236833
EFO-27,24951314,0.9989426715403756,1.641322268043647
MSTO-211H,5311,0.950405781568164,1.6006008966557956
A-673,9444,4.054770941664931,3.9623339749357114
MDA-MB-453,6852167,1.219966928776707,2.8311251303386427
DMS 273,3384730,2.794672653243152,1.7221503971467995
NCI-H522,24964624,3.0091798278143003,2.1122711674591463
DMS 273,6918878,0.6913807013381441,1.279556304443336
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,4.212905111578933
CAL-51,5311,1.4183219405835503,1.372214032085589
SNU-449,3136844,4.333259755823753,4.590964800639116
SNU-61,10074640,3.0465009012673923,3.0291326289622047
NCI-H292,5738263,3.605646843776872,3.5875765865061124
NCI-H2009,135440466,0.1778924686528867,2.5092924168471353
SBC-5,387447,-4.42204631831661,-4.193524954513737
HSC-4,60700,-2.3901041148359,-0.275219217989645
Panc 04.03,navitoclax-PLX-4032 (1-1 mol-mol),3.364460655624257,2.2404679190773025
BxPC-3,322968,4.585795478380971,4.028390815881791
CA46,24821094,1.9467424475066963,2.5668139270522916
SNU-449,5282054,4.57557530009064,3.9960974667342026
CAL-51,11625818,4.1129054868405905,4.288128764099777
A2780,16038120,0.4203115446628392,0.7948048876790778
MDA-MB-453,44484893,4.218904183145372,3.798842386099701
YAPC,969516,2.7207948170212894,2.8419031285844603
SCC-9,6914657,-2.6898440352771704,-3.6777953255672635
BT-549,156414,4.402880659642667,1.7731871852819103
A2780,10410894,2.69442494781606,3.0829264666272724
HSC-4,1566236,1.9723291328750472,2.640036877202247
CAL-51,53232,2.8018516258833395,2.825336234151342
NCI-H522,73707371,4.918377506073214,4.1387522095033225
FTC-133,2858523,3.137647378022636,2.9465529577211287
NCI-H146,2949965,2.1998257096859235,2.3803313120093974
A2780,5291,3.6974106280730767,3.5014494281195514
A-673,11317348,1.5484644948233677,2.023816864559773
CA46,5284616,-8.167802056045408,0.24151838489375912
FU-OV-1,9840324,7.491199941931371,5.7356865994659145
NCI-H292,17759555,3.476208496969499,3.581216107986695
NCI-H2009,6918837,-3.78935135271195,-2.1106934623647557
NCI-H460,216345,3.827300936034388,4.075262535339399
BxPC-3,54143018,-0.804639103071218,0.23762510286051516
SNU-449,11612883,3.957753067546404,2.939611692212048
DMS 273,49867930,4.404291499076759,3.7267374322378966
FTC-133,15953870,4.441911294632587,3.5458807201047313
NCI-H522,11612883,3.3366707819202666,2.139429837391414
A2780,9444,3.815396075990075,3.7136007021834856
NCI-H460,54619267,4.901891634717457,4.105556880664962
SNU-449,salermide-PLX-4032 (12-1 mol-mol),5.474676464487576,4.753808784676892
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108,-1.139537257891505
A4/Fukuda,4521392,3.820585335578038,3.9089214221270794
CA46,5328940,1.1838617633473132,0.8815036692594694
NCI-H460,452548,0.6919333948360032,0.4907494707733464
YAPC,25126798,3.983335704988987,3.7790728018125788
SNU-449,322968,4.603056923598163,3.760055043391326
SNU-61,54618164,4.021673833793196,4.007261478977585
NCI-H661,400769,-1.492892337104586,-0.5129509811452816
G-401,24964624,1.4880998129973728,1.895320049994474
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023,5.370923844777807
OVISE,2945648,2.8352179600513367,2.9691879712716474
FU-OV-1,JQ-1-UNC0638 (2-1 mol-mol),1.6948403130228156,1.742622037894905
BxPC-3,984333,0.8836461068661873,0.8302305880935531
NCI-H1623,42642645,0.9313727170286358,0.7100374239917574
BxPC-3,71466445,4.819923879864087,4.372554618752811
MSTO-211H,126941,-2.2791548116201987,-2.695382538376243
MSTO-211H,20959075,-3.222615813929693,-2.2716515573382283
BxPC-3,16741245,5.048799679028713,3.8240255437080197
OVISE,12001922,2.261742632923514,1.9501194431487476
NCI-H2171,135440466,1.9220793929810305,2.147393729089681
BT-549,119182,-0.6766164524597643,-0.6404182131836581
KMRC-1,65064,5.386842832596526,4.913932583588151
ONS-76,16725315,4.104726960292652,4.071608898110424
ONS-76,6505803,1.3937943977095182,-0.2318641087527315
MDA-MB-453,JQ-1-navitoclax (2-1 mol-mol),-0.5308919352690735,0.6104911577048883
FU-OV-1,25062766,2.359728819743937,1.9903268385872566
KMRC-1,5566,3.18269246163038,3.1451699801192654
NCI-H460,6438330,3.783082395235063,2.1092700313205857
CAL-51,135440466,2.9511327404143755,2.2837308694868117
DMS 273,23582824,1.3511796414129456,0.8277972908985995
CAL-51,56946209,-4.496983035262223,-4.125643869123667
OVISE,176870,4.342841287056181,2.999357575615254
KMRC-1,11494412,2.978505743964039,1.511574333323055
A4/Fukuda,54454,2.014078017992857,2.2671159528044864
MDA-MB-453,2733526,2.894784526555574,3.8032787628019475
HSC-4,11625818,4.485436042124793,4.45710338362636
NCI-H727,2733487,6.440431233061491,5.974450033247352
HSC-4,54618771,2.9865797342969564,1.333695561447029
CAL-51,12003241,-1.2189714227076325,-1.2235689846401934
A4/Fukuda,52912189,-0.8285591911559074,0.628429132971358
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.4284877108347667
CAL-51,6610355,4.388066889778601,4.47725491731101
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448,0.16616005613977397
NCI-H1623,56649450,-0.2540238687607088,2.9697781554330014
A4/Fukuda,9444,3.1818692272898423,3.716777078840426
NCI-H2171,55508,1.786136919471965,3.0201490932764803
NCI-H522,9840324,6.2981118504366735,5.5961571993286
DMS 273,409805,3.6932334728164826,4.2260586002542935
SNU-81,selumetinib-UNC0638 (4-1 mol-mol),-1.1313432157917445,2.9844093774664278
NCI-H727,16722836,1.5817712487099789,1.4950881349141576
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275,3.6329723710045894
G-401,5281672,4.259815588040996,4.307959038401732
FTC-133,4917,3.819256860929221,3.132781564832818
YAPC,selumetinib-UNC0638 (4-1 mol-mol),2.613021216315863,3.262672607045263
JM-1,10113978,2.290370569955518,2.05637623057133
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946,-4.6450758283527165
EFO-27,675434,4.38679148408465,4.559210384864778
SNU-81,5460769,-2.0941921209529575,2.4266579307443505
BxPC-3,5282054,3.885649252328735,3.9319277740689853
OVISE,6184667,4.390472676016808,3.2940583362065907
G-401,16659841,2.2879294183156396,2.9503812132650094
HSC-4,19582717,4.479728463380205,4.245833136602705
KYSE-70,1750826,1.0050628158627442,-1.3319705972521592
LOU-NH91,135659046,3.4412725013745336,3.8509843452707333
HSC-4,11396600,3.0766488056466104,3.601571169834603
KMRC-1,11964036,1.816670768699429,1.44023290249968
MDA-MB-157,decitabine-navitoclax (2-1 mol-mol),-2.3403643839095607,2.1004887071034135
HCC1143,54618771,1.714955024233068,1.447345746571132
A2780,8515,1.754639935244518,3.660374008363253
FU-OV-1,36462,2.321134275550796,2.1746602168052998
OVISE,selumetinib-UNC0638 (4-1 mol-mol),4.700379518419309,2.764100139345932
YAPC,216345,4.822006863531136,3.9553818250914055
ONS-76,tretinoin-navitoclax (4-1 mol-mol),3.585528237924169,2.3633990083949485
LOU-NH91,72193861,1.0473212139197163,1.983377605865208
NCI-H2009,piperlongumine-MST-312 (1-1 mol-mol),1.2420237661253426,1.87107561583763
CA46,54618164,3.845436645537388,3.6348967817104376
NCI-H292,446155,1.4424758906582096,2.7369648716837087
HCC1143,9936388,-6.988875343339418,-1.6839291224535264
NCI-H727,9907093,4.262034183201205,4.160596516362055
ONS-76,126941,-2.856353430413947,-2.3558632599537095
A2780,11455910,-0.8495199814745813,0.5442538907143983
A2780,73707398,0.6651600447827565,0.9542708141291761
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561,-0.3924213477445682
MDA-MB-157,24856436,-0.6830375019554852,0.7740523500615175
LoVo,1750826,-1.736017877496402,-0.7562958641168571
NCI-H146,49766530,4.81095512251176,-0.6789807865312804
HCC1143,409805,4.31745443409651,5.084003003108782
OVISE,159324,4.206537691518507,2.9940949509541754
SNU-81,10302451,3.60256279960024,2.6486342586894023
EFO-27,5282054,3.999430083075576,3.840920669440826
LOU-NH91,4917,3.4124252266322297,3.170084053557631
SCC-9,5328940,1.568072217369216,1.6587945848176233
OVISE,637858,1.8122421616924396,2.01116406477546
NCI-H2171,44607531,0.7654225162387793,1.4118602933753408
SBC-5,7326481,1.449700392659346,2.8732767044736844
LXF 289,9907093,2.975231625485398,4.333492896061204
G-401,SNX-2112-bortezomib (250-1 mol-mol),-1.620175957239239,-2.030320562695664
NCI-H522,navitoclax-MST-312 (1-1 mol-mol),0.9315063640095164,0.7553371428308076
KYSE-70,159324,1.7590392520862297,3.163507498401432
NCI-H2009,3025944,4.548991530576528,4.414574170406326
SNU-81,135398516,1.5373988209241822,1.7649991285941735
A-673,9911463,3.7053308577681583,3.6026190686462147
CAL-51,9826308,0.5677925602140103,0.9368123287918217
SNU-449,10074640,3.65403010435808,3.1018990410349416
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273,2.9264848121504388
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687,-2.2445615492872824
JM-1,11213558,1.11781575024048,0.735041346545989
FTC-133,navitoclax-MST-312 (1-1 mol-mol),0.3680672721218185,0.7978359482767198
DMS 273,11396600,2.9821670224503025,3.0926797377990956
CAL-51,2742550,4.689941422286605,3.93674317506784
SCC-9,salermide-PLX-4032 (12-1 mol-mol),5.953204050581384,4.834761049577092
NOMO-1,24856436,-0.4465471145990737,-0.13672001860955138
BxPC-3,54454,2.2110977916594945,2.5798624778602197
NCI-H2009,selumetinib-decitabine (4-1 mol-mol),-0.75536294855302,3.5060205770824964
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838,3.6477202501739368
LoVo,54678924,0.9602640778132784,2.326628880661385
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853,2.4415519979388334
NCI-H460,9911463,4.421747687015995,3.912292936447608
CAL-51,3062316,-2.5625958708444205,1.6133825845338314
G-401,11404337,0.5096427987118028,-0.8874865972607623
A4/Fukuda,107985,-4.34456564276242,-3.8034373887508854
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323,-1.225729407398451
SNU-61,9956119,3.7156714580567063,3.5243391335947662
FU-OV-1,navitoclax-gemcitabine (1-1 mol-mol),3.0788972572820597,-1.1643297508424373
EFO-27,53301938,6.290465616373669,2.9139431217038223
NCI-H727,17759555,3.180616959518291,3.4911044322452613
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224,2.3359147289844535
SNU-61,44819697,3.53302657640718,-0.463483905170654
FTC-133,16065773,0.3113531910395277,2.6970412729172675
G-401,tretinoin-navitoclax (4-1 mol-mol),3.928321185847307,1.6503793041636114
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345,-0.6134826088396494
NCI-H2009,107985,-3.3237358160703843,-3.3207260974679293
NCI-H146,3676137,4.978597159303883,4.133499962596854
NCI-H146,16065773,1.505871551892472,2.2223904610413587
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.801266092932226
NCI-H661,60700,0.4833445990508663,0.15104963719972506
A-673,selumetinib-tretinoin (2-1 mol-mol),4.294042915691989,3.262615589195278
MDA-MB-453,44491742,4.088527945953042,4.281642001494029
NCI-H661,2945648,2.4705894827529984,2.8914135390974938
FU-OV-1,12001922,2.2107336164209586,2.0381275935966947
SNU-81,serdemetan-SCH-529074 (1-1 mol-mol),1.2075198291977594,1.7015999543232285
FTC-133,168312962,3.97521401805193,2.396123641585488
NCI-H2009,24951314,0.5822698862930126,1.6974745153136248
Panc 04.03,3552672,4.635312487107652,2.769489739582129
HCC1143,16725315,4.684699585721338,4.1915343613937885
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208,1.8375863664467307
A4/Fukuda,67156097,-3.3575882698535526,-2.154747155441864
NCI-H460,44507138,4.578042897326484,2.5479268436823412
BT-549,262093,3.1295246575488354,2.930028130486915
A-673,BRD-A02303741-navitoclax (2-1 mol-mol),2.626339202884455,1.19399803153106
LOU-NH91,23635314,-2.2216361010230545,-1.6890479348251133
HSC-4,11485656,2.41592786996926,2.4920848433581715
Panc 04.03,2858523,3.1704472292667245,3.051558476191488
CAL-51,31703,-2.726607914110417,-1.156254292542859
SCC-9,11485656,3.6663619913543446,2.344959480419298
EFO-27,11234052,4.354926990140025,4.2415294470137495
NOMO-1,11977753,-1.9426292333262003,-2.1757019604884977
NCI-H146,5280436,1.6778415991784894,3.0924901114094836
SCC-9,44589607,3.476138487776652,2.9941790733217744
YAPC,1716436,3.308380745751715,3.0240281131401123
MSTO-211H,72376,-3.945669301292739,-1.7076670435640258
CA46,6438330,0.8057128440407828,1.0181766264656171
SNU-81,46907787,-1.0582449369350613,1.0758616929281617
ONS-76,53232,1.9476307600046912,2.6932032483466326
SCC-9,51037431,5.108150298111964,3.242024067188227
SNU-61,11719255,3.5581483316812275,2.8415707290850714
BxPC-3,serdemetan-SCH-529074 (1-1 mol-mol),1.9726746361730008,1.9941957246816948
NCI-H522,8515,4.67214972936148,3.3063021815955813
A2780,104842,-8.58016789938804,-3.6108399886256852
KYSE-70,56946209,-4.444419695204879,-3.7778784027803995
NCI-H2171,46191454,1.782184086758524,1.0044217376217264
NCI-H292,54618305,4.4370648491662195,4.387403800691549
A-498,16725315,5.296109915632034,4.370990541005653
A-498,11494412,3.741733086313002,1.9784350422043855
JM-1,36314,-7.745176622378906,-3.486086390410274
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082,1.3672633807218906
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158,1.8110160557184856
A-673,erlotinib-PLX-4032 (2-1 mol-mol),2.801712278221697,2.928971523073524
BxPC-3,72734382,5.457836982387995,4.693084079137431
NCI-H2009,72734382,3.739945681050146,4.652776513652388
CAL-51,65064,3.306239750209062,4.825129121442364
A4/Fukuda,6252,-3.645065834912594,-1.3843099870525741
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394,-3.5249052053174244
A-673,36462,-0.225010248526114,1.0796197194253994
BT-549,25195348,2.629764497852918,3.2855610320010866
ONS-76,3385,3.2517912405561784,3.7692005750772397
A-498,73707398,1.745059470984177,1.6553634245714663
A-673,56963564,0.0212663307031236,-0.10443242683164698
NCI-H522,984333,-0.7488997443424653,0.20066734082740748
NCI-H292,452548,1.0483210578903834,0.5036557684453343
NCI-H661,57330099,4.147264508988866,4.276535246176767
KMRC-1,11167602,5.704956856257104,2.3627488811935096
YAPC,25150857,2.3485140693919178,2.5033970369907825
LoVo,6918878,0.5506920931363443,2.9224213157671772
LoVo,5282054,3.3404837473565077,3.8066253647011656
G-401,445643,3.8388087856424,3.80924195353737
Panc 04.03,31703,0.9238663549391216,-0.3969858020319333
KMRC-1,25150857,2.932634990579502,2.2701990294075647
LXF 289,9903786,1.8485652979864533,3.0648115386684167
MDA-MB-157,navitoclax-pluripotin (1-1 mol-mol),-3.540221681232844,-0.7798792614576991
Panc 04.03,25227462,1.6849134644206611,0.6078542062256015
LoVo,5328940,0.1711764774474706,1.6591286202561342
SNU-81,49850262,-1.5447601433950633,3.226552384747087
CA46,46215462,1.3062506059575565,1.3848901771917426
MDA-MB-157,219104,2.454471278072077,3.7550281651625936
MSTO-211H,168313047,1.6297190097298295,2.264763228335666
NCI-H522,16722836,1.5816295407965617,1.453533506617812
OPM-2,54626689,3.88605573030338,3.954547793634974
DMS 273,60700,-0.3389173956036069,-0.861294596109722
OPM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.9302198277032876,1.059332563145553
SNU-81,9826308,-1.744878476856413,0.030420602792794297
NCI-H661,selumetinib-PLX-4032 (8-1 mol-mol),2.9532845148669495,3.65682949713597
NCI-H292,72734382,4.432039940054941,4.662980707419478
NCI-H661,11507802,0.3336368123539006,1.7099803353487304
Panc 04.03,676352,2.180457258433582,2.3192758276615457
FTC-133,322968,4.798855030018761,3.7300297292196523
G-401,16720766,1.0481135004094,0.04073769215557746
G-401,462382,0.38796721763981,0.6773168184979695
MSTO-211H,25062766,2.0532887481804605,1.9426386377895537
A2780,16736978,-0.7643928517553599,1.280314685830105
NCI-H727,2729026,3.015864992302643,2.7757849128297867
CAL-51,135440466,2.9511327404143755,2.2837308694868117
A-498,selumetinib-MK-2206 (8-1 mol-mol),1.8815723158535835,2.2631491053907817
BT-549,72376,-0.6560931555152002,-1.3188201409039888
A-673,9933475,1.583729012108943,1.8339248212554082
ONS-76,navitoclax-gemcitabine (1-1 mol-mol),0.9931716655175384,-1.2880699891119085
EFO-27,135875424,4.6207788215281465,3.8736016004281844
A-673,24785538,-1.1944412082957694,0.6036209392338194
CA46,135659046,2.986085914123542,3.4382579053787357
CA46,3038522,1.2076902647573031,2.6536822437109375
MSTO-211H,54626689,2.3486455994654767,4.527011331746049
SNU-61,44241473,4.262106100814371,4.436875811452707
MDA-MB-157,25126798,2.9199314308838327,3.7727355416221746
SNU-449,10410894,3.985550363358928,3.295782539927263
LXF 289,53232,1.5859701947912777,2.6104718076594637
ONS-76,JQ-1-vorinostat (2-1 mol-mol),1.13707340055611,0.9223384420628389
DMS 273,11234052,4.3748762471871725,3.308718084619818
A2780,107985,-4.859396565896689,-3.5399310542280227
Panc 04.03,44202524,4.489701680422056,2.2300660460133157
LOU-NH91,44185566,3.062522771292805,2.623090761067177
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144,2.270661351676071
EFO-27,36462,3.079082429258617,2.18462546898349
JM-1,24821094,1.723225199642946,2.2617659003643675
KMRC-1,216345,4.164305633353381,3.7921599616355035
NOMO-1,168313047,1.7455342513633885,1.99631006986683
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822,3.351780343423862
NCI-H522,5282054,2.516149277526254,2.879722842656613
SNU-81,26596,-2.2143193215677925,-1.5978187460039084
LOU-NH91,135875424,2.9424536382603215,4.115895723448027
HCC1143,446155,3.993343592958968,2.722154217642086
NCI-H1623,selumetinib-piperlongumine (8-1 mol-mol),4.451549095180413,2.7209410451965512
LXF 289,3081361,2.235375481166719,2.5078532256504413
Panc 04.03,6918638,0.956445062850862,0.8185565515038964
ONS-76,46907787,2.0367347893242247,1.5512120200084891
FTC-133,5470400,2.075616738071143,-0.0016864437514414346
SNU-449,9884685,0.40134732620175,0.5956358219707417
FTC-133,44566777,0.1715240988601806,0.7002625983170903
KMRC-1,9911830,2.7576147713752532,2.1808238912572078
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767,-0.6468812912278703
SNU-61,119607,4.552023022199627,5.0102453444658055
FU-OV-1,2945648,2.6612648927829348,2.82804643066922
CAL-51,5282054,3.552468823116285,3.8402080126257796
A-673,1750826,-4.326827801164573,-1.8933063483926134
NCI-H661,23582824,0.4459994130921247,0.6782179653985563
A4/Fukuda,208908,1.6750686900112284,2.1930716358536286
LXF 289,24180719,2.719444673565486,3.5648344580884457
MDA-MB-453,11647372,0.3935032395331521,1.4293344885833779
NOMO-1,54454,3.4949720971193083,2.0798811031299933
SBC-5,1750826,-0.5333690682178334,-1.3115734408712285
SNU-449,11234052,5.346874708028275,4.121754488393233
LXF 289,159324,2.685439807189008,3.205242507672606
A-498,11964036,1.806054574855834,1.713960324577319
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507,-2.8017379149704738
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.874549072416564
NOMO-1,11178236,-2.492998231075174,-3.8648926206372454
BxPC-3,3503,1.5238678808710824,2.2795584808386913
A2780,5281672,4.494440141018236,4.359925266724911
NCI-H460,57519531,1.7606196796007008,2.666942343231388
NCI-H146,3038522,1.5824622735127496,2.8103117548361864
NCI-H146,alisertib-navitoclax (2-1 mol-mol),-3.5747410805145425,-0.5583746833584416
A2780,7251185,3.0282253021168835,1.9072958804576297
NCI-H2009,54143018,-0.2798924220132643,0.7137782429706445
NCI-H661,navitoclax-pluripotin (1-1 mol-mol),-0.6328260588885871,-0.4361256230545814
A-673,50905018,4.224820228350104,3.93856352121354
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557,0.3760367021549485
A2780,11640390,3.511086163886132,2.90948923174911
NOMO-1,984333,-1.7512214516120577,-0.3023131992831895
NCI-H292,3062316,0.0480521305272509,0.7136460103081516
NCI-H1623,25183872,0.2518729007636168,-0.41964962933122996
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623,2.2932424553317747
DMS 273,11647372,0.2469617170644157,0.6898988805060821
KMRC-1,12001922,2.9414276180440884,1.7880977955927173
A2780,54143018,-1.3409986451592475,0.16191290841412687
YAPC,49793307,-4.348408449857898,-2.7011781551498704
CA46,1716436,3.005257864158129,2.542680899877721
HSC-4,676352,2.328446260179327,1.9657413128940948
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621,2.7573987821979062
YAPC,12001922,1.7591466639310227,1.9856352829277604
MSTO-211H,5460769,-2.0887143253822615,2.9059523034933505
CA46,3384730,2.283076300956678,1.1320263616108701
JM-1,9911830,1.0886367976495992,1.6221195491153173
BxPC-3,1242560,2.823718248478356,3.6762873287288738
G-401,44237094,3.2290132612915325,2.702557991540987
BxPC-3,16736978,1.696086021540879,1.5038424983017606
SNU-61,46191454,1.739312628335972,1.175181126796148
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763,1.9834631392477848
NCI-H460,5329102,3.240160570329804,2.0470887087915846
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.013793137080991
LXF 289,216468,2.2889797638929683,3.4163421639274514
SCC-9,44819697,0.1293575980749295,0.2815944208161356
Panc 04.03,675434,5.243078667682196,4.4837955019614455
HCC1143,135398516,2.188515967576281,2.3272051670340805
ONS-76,25262965,-0.7369683376858831,-1.423451281262354
A4/Fukuda,53392493,1.8640822641046917,2.0109659739592183
A-673,2130404,3.217416760546526,2.2270664835087133
NCI-H661,72193861,0.3965882674238952,1.804312100232298
CA46,119607,3.9558807366301374,4.465778007676638
CAL-51,24856436,-0.3083697359271743,0.39375921930090546
NCI-H2009,2828334,6.796615650463657,6.247905820164143
JM-1,135398738,1.1596934849395544,2.3855091304436895
CAL-51,49793307,-3.2015156477281193,-2.647697647931364
HSC-4,10410894,2.7401570440851155,3.0251763850672635
KYSE-70,46843906,3.5210263801871498,3.4686654593721173
KYSE-70,11178236,-1.2639965798928303,-3.205326229622052
EFO-27,6610216,4.772563131438148,4.331122629437399
JM-1,135659046,3.550517545140938,3.178094677448456
A4/Fukuda,3136844,3.333855932915555,3.6873038384139636
KYSE-70,53495165,0.5494520653774981,0.4415553749783132
EFO-27,9926054,1.857839666788878,2.0073274549208553
NCI-H460,16741245,2.175171044948558,3.647119174733295
NCI-H727,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2513080779268564,3.402630481658585
MSTO-211H,SNX-2112-bortezomib (250-1 mol-mol),-1.2312117350271496,-1.1421098491157142
NCI-H661,107970,2.2398777867932473,2.328291482424007
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149,2.628648190071445
SNU-61,51039095,2.128467827492616,2.6894742884083
YAPC,104842,-2.4249346234244302,-2.3923089466040626
EFO-27,11364421,0.0539420857608272,-1.4996928458758922
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485,2.440390233876935
HSC-4,5284616,2.67117659303102,2.703102353327207
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351,0.7622673387031753
KMRC-1,100016,6.458679548763862,6.004766648330513
A2780,JQ-1-MK-0752 (1-1 mol-mol),0.9266829250462012,1.1789916557490965
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735,1.1388535884459134
LXF 289,10184653,0.2846387514020494,1.4281758382145264
G-401,docetaxel-tanespimycin (2-1 mol-mol),-6.677172451643826,-4.253935063526567
ONS-76,73707438,3.6763163562039103,4.019333095056521
CA46,10113978,2.0547387812543425,2.327752656125846
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923,4.082392768852125
MDA-MB-453,9444,3.890114397090033,3.9843597660408943
DMS 273,462382,0.1050500144131629,0.637561745547817
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872,1.9555540229318655
SNU-449,327653,3.836895463512291,3.3057960888942
JM-1,4917,2.618606210388543,2.600529144885972
A-673,7326481,2.3948672158707027,2.730071850283185
LoVo,3543504,4.109477120593384,4.337472984803228
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837,-1.8047517695970898
FU-OV-1,322968,2.943455676205593,3.9243217132838986
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,4.113008775855528
NCI-H522,10172275,5.332939953657848,2.5461175105657046
FU-OV-1,11175137,4.687876560675478,2.7515219281212966
NCI-H292,702558,5.809534673466565,5.352593997681127
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805,0.04331390271557087
FTC-133,4378219,2.0024564120700874,2.7157561776026733
A-673,322968,2.685664332943325,2.8382156513055916
A4/Fukuda,11175137,1.0544671313881684,2.001206391757174
NCI-H522,9907093,4.234502914187168,4.036023426309495
NCI-H460,73707398,3.251551904382877,1.4706085779460125
NCI-H1623,11625818,3.770410958253076,4.462995470319169
NCI-H2171,3384730,2.17478810564445,1.7827834465145767
EFO-27,navitoclax-gemcitabine (1-1 mol-mol),2.157503731341055,-0.9219670577880871
BxPC-3,135398516,1.0474106677719497,2.2245054685061807
YAPC,6852167,3.757016833172803,2.80318542790701
HCC1143,11178236,-3.0622306456236728,-3.284434630419556
LoVo,168313047,1.791039731088859,2.3256648731091722
CA46,9915743,0.7447060154867644,0.09195788343591196
CA46,16065773,1.8844207098737984,2.118838540507569
DMS 273,2749,1.7681499736943271,1.3496522945649443
OPM-2,9549297,1.1861201303789202,1.777242237626045
MDA-MB-157,selumetinib-PLX-4032 (8-1 mol-mol),5.042710602125305,3.62480891571211
G-401,3136844,3.887156631896907,3.9649076319091456
NCI-H727,24901704,2.771852034083143,3.1615996779574744
LOU-NH91,serdemetan-SCH-529074 (1-1 mol-mol),2.4104201077494913,2.1168994429661963
ONS-76,36314,-4.67770988102335,-1.3216227813935697
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356,0.4904689173411104
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401,-1.1783123240210678
NCI-H146,54618771,0.1782763900918093,1.0519748330021816
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514,-0.7865593028040785
BT-549,1750826,-1.15792790160721,-1.7127422091265427
A-673,4521392,3.83212246390289,4.169759914833199
A-498,10127622,2.6897842830613934,3.945374970990873
NCI-H146,24951314,0.0243539025761212,0.9873452490085364
LXF 289,11404337,0.1273620702572638,-0.23813779060711787
CAL-51,72376,-2.938334648898351,-1.7238021737529277
HSC-4,56946209,-4.10163917558625,-3.7870439212122813
OPM-2,11719255,1.0053781432887028,2.2666970621997633
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276,2.7710257559810105
OPM-2,54765302,3.66991118627716,3.7471828974336137
YAPC,107970,2.510985201601563,2.369039583281215
A4/Fukuda,6505803,0.0348674492980193,-0.6657079083741227
NCI-H146,421610,3.280213272702812,3.037886430078793
CA46,10427712,3.800630662833656,3.6131201166504696
Panc 04.03,42611257,4.903884607697216,3.605444228867766
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254,1.6914091407968246
SBC-5,54618771,0.9612938071948806,1.1759984933803864
NOMO-1,44819697,-3.3724853213010895,-1.6689762615787351
SNU-449,46843906,3.9850337221839074,3.1912012608726785
A-673,2733526,4.173930306540303,3.591046279268591
Panc 04.03,387447,-4.060832381569581,-4.040403285635623
ONS-76,16038120,1.944596111088229,0.744615003948692
Panc 04.03,12001922,2.0215480430072588,2.0447227030243895
EFO-27,56946209,-4.24663912291577,-3.994822929669785
A4/Fukuda,15983966,4.102938700353478,-3.3701472527150376
NCI-H522,10322450,3.5945001970925787,3.4691619029881133
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.4497794285021033
BT-549,16038120,1.0292862217749383,1.281805342118598
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292,-0.09182030011394801
FU-OV-1,selumetinib-navitoclax (8-1 mol-mol),1.6329291252143736,2.3466057573561825
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912,-1.1576192718835094
OPM-2,10302451,3.176323712036339,2.606024238787151
BT-549,5291,3.9626748190842167,3.6168466568022835
A4/Fukuda,54143018,0.5698360241890451,-0.16778946976258433
CAL-51,5113032,4.55807021159329,4.798833398049893
A-673,navitoclax-sorafenib (1-1 mol-mol),1.9636796155178384,0.8114129580301658
KMRC-1,15983966,1.4470823508624893,-1.3496553084051064
SBC-5,409805,5.881004535625117,5.200400852485809
MSTO-211H,11717001,4.186640197436745,4.113024889227023
MSTO-211H,5351362,0.1292531164344693,1.5897350925067024
BxPC-3,navitoclax-MST-312 (1-1 mol-mol),1.414454953268366,1.1363366898786014
A-673,135398738,4.1394757023123505,3.229067532191898
NCI-H2009,navitoclax-pluripotin (1-1 mol-mol),-1.5280134971991166,-0.5803674898851799
NCI-H2009,12001922,2.0619007134450524,2.0246833256465093
CAL-51,3634881,3.319714226315486,3.315842515590009
SCC-9,5282054,4.577178009511458,3.9318092751410245
SNU-449,6610355,5.42598000328545,4.5245961161802795
JM-1,100016,5.094244415703564,4.8611912309186565
DMS 273,16720766,1.3424969772091375,-0.20569268003440655
MDA-MB-453,82146,5.197355724890258,3.8045536308477406
NCI-H727,219104,4.385991256377306,3.577842834955065
G-401,387447,-4.890417311710873,-4.701677103003411
SNU-61,445643,4.910443238015828,3.91314173607989
G-401,445091,4.490925944707375,3.8996465809331546
Panc 04.03,10074640,3.644812120140466,3.2054653004943803
KYSE-70,3038522,4.319477989558539,3.017175754477462
NCI-H727,5311281,4.417954223041409,2.493087694306009
OPM-2,24889392,2.046562304125139,3.205708265181791
OPM-2,9866186,1.7779199456036283,0.15820918997243388
NCI-H292,65628,4.3235700442832625,4.609818916068006
JM-1,5284329,3.614100674193798,2.5685672834295916
LoVo,49850262,2.4887252685350227,3.8675208530785907
BxPC-3,24785538,1.143761767664292,1.7337163539548734
LoVo,176870,1.1282563754131285,3.053357223372868
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163,1.5471384700525455
EFO-27,73707398,1.1269975883077623,1.4734605164247403
CAL-51,49850262,3.6300011952383584,3.999450428006808
NCI-H2009,1750826,0.0733322198534379,-0.9322503685894051
LOU-NH91,9903786,3.184012464559237,3.010411649424224
NOMO-1,9911463,3.1879476164010243,3.024374110441027
A2780,16722836,0.6661441985838381,1.4046036269866744
MDA-MB-453,11238147,2.2482376857817856,2.863152461315674
NCI-H2009,11626560,0.9059448501577204,1.9032315452935964
LoVo,2746,2.3133613771451524,3.258326510774655
NCI-H661,9840324,5.7754199175322825,5.797090287337356
SNU-61,10385095,2.7560205308704044,1.304489533337137
A4/Fukuda,24771867,-3.7385177445932585,-0.6523654219878157
NCI-H727,654092,0.4388886539996767,-0.06685650805221609
NCI-H661,44507138,1.7319125686737762,2.4242276048188454
EFO-27,16013152,4.523705738143722,4.173931812957358
CAL-51,4259181,-0.5132501801478601,0.4299235305017807
A4/Fukuda,2746,1.0000278581130588,2.1026046182203233
NOMO-1,10184653,1.080224838410231,0.6892390812827414
Panc 04.03,135398516,3.776050709281408,2.126212995188885
YAPC,3038522,4.3203914817087234,3.12903859909335
NCI-H292,9926054,1.8794077191249725,1.845794964798267
NCI-H661,5278396,2.727600530538007,3.5749549280039155
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654,2.3112754751221316
A2780,9803433,4.475774001896097,4.65119514038217
MDA-MB-157,11178236,-4.597953573249134,-3.3935919123698146
ONS-76,44137675,3.612845962454732,3.600091246265303
LoVo,51039095,1.8047028032602028,2.8625604773188202
NCI-H522,tanespimycin-gemcitabine (1-1 mol-mol),-2.467840431866496,-1.1938871666835429
SNU-61,25183872,0.0265852822027559,-0.7158939102471027
NCI-H661,10410894,2.079430431888453,3.078488836180103
NCI-H1623,11497983,5.112351206162292,3.7302056566030832
FTC-133,navitoclax-gemcitabine (1-1 mol-mol),-2.9541403252647744,-1.1475320000444538
NCI-H522,6184667,2.532079714436212,2.891290662464267
MDA-MB-157,selumetinib-navitoclax (8-1 mol-mol),-0.2333098537360622,2.004246284648834
NCI-H2009,44589607,3.679148722712513,3.1440301524020295
EFO-27,44137675,3.925812188621705,3.6778054607997404
FTC-133,5328940,3.204514542529291,1.9149018834040523
FTC-133,2708,3.4116435244290773,4.692331903377851
NCI-H661,24901704,2.3315866691701395,2.8818166340850815
MSTO-211H,11719255,2.56955632094912,3.633189519910552
OVISE,11626560,2.348997135596899,1.9844050644748583
OPM-2,ISOX-bortezomib (250-1 mol-mol),-0.1945134958657626,0.3153010503185007
CAL-51,9868037,3.5441777448678615,3.364417073599759
MDA-MB-157,5328940,1.5742504795877947,1.8021589873309503
BxPC-3,19582717,4.685369750995796,4.501878428282814
MSTO-211H,6852167,2.890925130180435,3.077958266792548
CAL-51,5746,-0.6872762444946757,0.9738797137572732
OVISE,17759555,4.197708618199663,3.53328805531627
EFO-27,6918638,-0.5643283195590469,0.5755350573394731
JM-1,439501,-5.872076466297635,-2.440312482026144
NCI-H522,44486219,4.336787525166091,4.372346023589998
SNU-449,11167602,2.762483283064935,2.562182963983937
NCI-H661,11640390,3.9877189690607993,3.3428292570195794
SNU-449,216239,2.7953722371364473,2.45070311407205
NOMO-1,17755052,-0.2814114025249274,0.6820014360473554
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414,2.047058236561399
A-498,54618771,1.1394352833671273,1.5309280430430794
CAL-51,176870,2.9999818119422175,3.3412549548245045
NCI-H292,11404337,-1.5117614396305947,-0.09492249207878302
HSC-4,9911463,3.832706037448295,3.951836264272349
DMS 273,5470400,-1.1243568241206934,0.2562783896190544
OPM-2,25183872,-4.3499490255982085,-2.354045853150823
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894,-0.31387009953784956
LOU-NH91,31703,0.5806868540812907,-0.5647385941435021
NCI-H661,44493528,5.823125515558819,4.477696673578746
SCC-9,10074640,3.673307032160535,3.2393549770081673
A4/Fukuda,11427553,0.0702382308883879,1.3584951143203472
SBC-5,568763,0.2965266090010964,0.6478114464164956
BT-549,25126798,3.990115132251306,3.85639755291582
SNU-449,9933475,1.8242814161965168,1.7956835678337109
BT-549,2113511,7.745487386721322,5.515930170761887
SCC-9,969516,2.533129063350548,2.7039512437939326
A-498,11178236,-0.0767055613398424,-2.7779577863117497
YAPC,1242560,3.336355906074855,3.5841302332728553
YAPC,54626689,5.597039319211252,4.635183805367787
SBC-5,BRD-A02303741-navitoclax (2-1 mol-mol),3.4496626470660807,2.574464773525338
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776,1.4189004628038777
HSC-4,6918837,-1.8301723200742368,-2.5093873220483296
YAPC,656346,3.528875898488543,1.0325750848065254
LXF 289,5470400,3.745756378340341,-0.1657982827277043
NCI-H2171,168312962,2.801787293375821,1.106095315724029
MDA-MB-453,6918638,-1.2403270134347248,0.43746106045053096
NCI-H522,1566236,1.6835491869847783,2.1326242780802467
NCI-H661,24964624,2.8216778680067836,2.550070270207278
NCI-H2009,5281672,4.642324044569225,4.733455051370527
Panc 04.03,navitoclax-gemcitabine (1-1 mol-mol),1.3720951008161577,-0.6909183302329154
NCI-H1623,16065773,2.4078381094703456,2.496760622388466
CAL-51,46398810,2.084696284876613,2.6443894390139273
OPM-2,54143018,-0.7196855693728514,-0.049481753512448164
SCC-9,15547703,2.91115041464476,3.1026414312005484
DMS 273,6914657,-3.971712341208325,-4.419462374006797
OPM-2,3676137,3.169610101166173,4.315716809447034
OVISE,3025944,5.5857056433387235,4.270920266729891
Panc 04.03,4259181,1.0934261994249337,0.5595865211624134
A2780,11683005,3.0394905793504963,3.2719139568004403
HCC1143,5328940,1.7305674649682683,1.5265970503745836
NCI-H2009,72193861,0.2482611586799762,1.8983606185604094
NCI-H292,6914657,-3.659053204598075,-3.851363002701987
NCI-H522,46199207,1.8719788650663136,3.0637136360697785
CA46,53481919,3.755788894439918,3.1659060888873602
LoVo,444795,4.8141558651213145,4.833883079734735
FTC-133,9823820,4.816748988305079,3.872789308939677
KMRC-1,6918837,-1.4377118656295438,-2.4989425682583875
HSC-4,44486219,5.375029781512573,4.4132743955707205
NCI-H292,54613361,2.8419740491204957,0.241673187650473
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727,-0.4827739980941798
CAL-51,11234052,5.18044926966805,4.133857917812538
SNU-449,387447,-3.8386512960067862,-3.7410277041900213
SNU-61,53232,3.65751057839411,2.8008397349785663
LoVo,16038120,0.8839921956645777,1.0654317576969925
BxPC-3,219104,3.7528053800812615,4.051966517877532
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148,0.7801922359086193
SNU-81,24748573,1.8214275246808207,2.161105528320941
MSTO-211H,16725315,3.290115596802182,3.968358120147132
SNU-61,25154868,4.341936394973705,4.319742965243998
MDA-MB-453,1716436,1.6727209102312437,2.788713989516966
G-401,5329102,1.4807949874052762,1.6574753741286836
BxPC-3,6610216,4.298723179439111,4.447335045018959
ONS-76,5738263,4.146346761655981,3.4512501418073134
A2780,51037431,1.9184867581168112,2.8495385132384246
CA46,46398810,1.9636985074186508,1.9698441096928736
BxPC-3,9936388,-5.112429278661846,-0.9794723509045444
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544,1.3467491474867679
MSTO-211H,637858,1.3984482263345202,1.9749129898294975
A-673,5284373,2.9730764803314496,2.599785044618074
JM-1,5284616,2.861882362083186,0.4254194281188116
A-673,64971,3.704564654457452,2.5309721734207726
ONS-76,6918289,2.669224964930956,2.656016273842973
HSC-4,11167602,1.6360881716966182,2.383710181119668
NCI-H661,3689413,0.5447440822016135,-0.32970319753977434
A4/Fukuda,12003241,-4.192136354440014,-1.2141006870726547
LoVo,10231331,-0.6826574775964468,1.9105980977593118
NCI-H292,219104,4.068792108053485,3.954384289934153
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.5179742491403688
NCI-H460,216468,4.763843832635099,3.199025959855309
SBC-5,322968,4.849411960208385,3.916735434252045
MDA-MB-157,135411,-1.5273896245850724,0.8701507713097594
A-498,6918837,-1.461997313484149,-2.384874554273705
MSTO-211H,decitabine-navitoclax (2-1 mol-mol),0.593652289859318,2.426958056461332
MDA-MB-157,doxorubicin-navitoclax (2-1 mol-mol),-3.2378494218759637,-1.1819096633346735
FTC-133,36314,-6.239918298117373,-0.9150304941089652
CAL-51,23635314,-2.261837237964324,-1.5818265907419178
NCI-H292,126941,-3.055153146808903,-2.197377461702824
A4/Fukuda,23725625,4.971593284778653,3.717821660870029
A2780,25105715,3.052833826388835,3.3394850002860625
JM-1,9903786,1.587415218469425,2.0599077614603876
NCI-H460,5566,3.3663694984335533,3.0876625942736164
OVISE,262093,2.7343448368987597,2.925147675338178
CAL-51,25262965,-2.904292987251918,-1.7791919820417765
SNU-61,448949,2.574317813231787,1.7957611163319576
SCC-9,24180125,3.671852734769843,2.8530215684747127
HSC-4,42611257,3.4394582921614933,3.2212896343687634
EFO-27,46174525,4.9061854461465435,4.499230992186653
G-401,3384730,2.1525913455039474,2.0854718315347602
G-401,3825829,3.962498358217521,3.537038883054947
A2780,53232,-0.3956468617212337,2.640381454738441
YAPC,54618164,4.31457100114165,4.2460497650229145
SNU-449,54765302,4.743565917095417,4.328630634434121
NCI-H460,24951314,1.96669984187411,1.719579318620598
FTC-133,11364421,1.174405518858428,-1.5636883586656123
MDA-MB-453,carboplatin-etoposide (40-17 mol-mol),3.9287174119504225,1.851826190939968
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657,1.0161568376522747
NCI-H2171,24771867,-2.6220866978549444,-0.3417394792459498
A-498,11427553,3.7697046176741185,2.9592394712154726
MDA-MB-157,5394,4.303334925677516,3.8323692359558312
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134,2.991370290195146
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372,1.0303382302063968
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477,-0.4445666481082843
SNU-61,15983966,-2.103596771317332,-1.5925739541959893
A2780,9927531,3.2712332494904226,4.418054958313546
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275,1.6040079769375586
NCI-H661,168312962,0.9705864877614524,1.979866462526232
OPM-2,135440466,0.016624870652288,1.4863984883211916
NCI-H727,44486219,4.75896405378265,4.408035899957734
NOMO-1,637858,1.0893367728071195,1.1082794698663228
NCI-H727,23725625,5.500914308976136,4.916663301163624
NCI-H661,444795,4.831383676329662,4.686203419851686
NCI-H1623,10427712,4.824592613381889,4.259402099236592
CAL-51,11507802,1.2528060552922216,1.3522741246962937
SNU-81,tanespimycin-gemcitabine (1-1 mol-mol),-5.141011099555512,-0.866535119874154
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944,1.6239762470013008
A-673,2949965,2.43157797191215,2.6574157408663717
FTC-133,46907787,3.491897677971775,2.2112300438713657
BxPC-3,JQ-1-MK-0752 (1-1 mol-mol),0.0240612102256537,1.8311039387115944
JM-1,12003241,0.2073989775302392,-1.9988093048725732
DMS 273,72376,-2.307681046282287,-3.151438966885312
A-673,3025986,-4.4852998426095985,-1.1854149907065399
A2780,9823820,2.6289512031423836,3.2435664226694394
HCC1143,11152667,-1.9901975183751028,-0.6789300262746003
A2780,119607,4.019563194528792,4.761549612086129
MSTO-211H,136227924,2.717505566177341,2.983765458964214
A-673,3025944,3.970835118137527,3.9517655368784097
NCI-H146,11222830,0.9953145616857674,1.5148297309930154
NCI-H146,1750826,0.7822669653178473,-1.782139623210089
JM-1,selumetinib-PLX-4032 (8-1 mol-mol),4.727165716436182,3.1923549386670813
BxPC-3,1750826,-1.1292189334445044,-0.366277678544165
CA46,6450551,1.1375422858810305,1.2472992617413972
NCI-H1623,46191454,1.8980276717062192,1.6838193532977934
CAL-51,24797083,1.5666479073716466,1.1912872404841863
CA46,448949,1.4123991312197492,1.3333294649508158
OVISE,135999136,4.426271635938179,4.233968055904226
HSC-4,2742550,4.46855499399167,3.951579444084613
NCI-H460,168313200,3.91056508525232,2.9830412028159
NCI-H292,1750826,1.4118366921158176,-1.173806707371952
HCC1143,452548,1.7974899966046338,0.2663009638415665
SCC-9,53325874,4.533787552290022,4.441650193790888
CA46,24771867,-0.8036362931877258,-1.1432744898688678
A2780,72199292,-0.0351373222218005,0.3782892819039163
MDA-MB-157,216468,1.0474678727125786,3.4098733477043424
SNU-449,65064,5.2463646910054536,4.926557612806521
NCI-H292,9952709,2.799114874088216,3.167118371236139
LOU-NH91,24964624,2.935669445800335,2.817795061398128
MSTO-211H,5566,3.048712391825719,2.9636794755408924
MDA-MB-157,3384730,2.532514051685687,3.0891064016006533
BxPC-3,753704,5.46289082133378,5.171693887025196
A2780,SNX-2112-bortezomib (250-1 mol-mol),-3.4792243011702957,-2.0894643551718923
SCC-9,12003241,-1.125345709331217,-0.7586499814234088
HCC1143,285033,-0.1452813325821209,-1.723709158636727
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.58698731840708
FTC-133,9956119,4.526890245155382,3.629477719428312
SNU-61,3854666,2.8565665342705735,1.6131909915145248
G-401,16065773,1.1067048318222386,2.146000518521188
G-401,11214940,0.8244141998238856,1.720154482806054
HCC1143,54618164,3.885707225557291,4.319823049268193
MDA-MB-453,16013152,4.031304285322853,4.074454151669082
SBC-5,24951314,1.1707148737631825,1.4679283266936358
FTC-133,135398516,3.4482633492568913,2.0741652950445078
KYSE-70,11625818,4.1356453826336965,4.195681010692599
BT-549,16722836,2.2023880033470893,1.8969424185817783
MDA-MB-157,54678924,0.1283777680712135,2.390394449098542
SNU-81,10410894,4.450607476297739,3.099367473799293
KYSE-70,9926054,2.326174845830733,1.8156874955371065
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071,-1.1417900840365802
EFO-27,25102847,3.020723568572887,2.625068348619424
MDA-MB-453,5351362,1.2969167061447922,1.475909700940215
LoVo,9926054,1.9069881185353632,2.057217070163757
NCI-H1623,46926350,-4.300601402935136,-3.979234014013297
SNU-61,16065773,0.792903808301444,2.279446687294806
A-673,5287620,-2.2582011832849824,-2.1540260302846397
NCI-H727,9903786,3.725485605999375,2.8589987585024996
KMRC-1,72376,-0.8386976675707333,-1.9386875639349808
JM-1,11640390,2.558073354039076,2.188559795793926
A-498,104842,-1.4921326822698753,-2.023762874806786
LoVo,10127622,2.21220618035224,3.0145567616140276
LoVo,11364421,-3.7348040522268624,-1.8909288779184144
FU-OV-1,57519531,3.042184872303348,2.8243720135798935
MDA-MB-453,serdemetan-SCH-529074 (1-1 mol-mol),1.825240779322759,2.1057167281614926
DMS 273,6917907,-5.615473283892677,-5.175469760861838
MDA-MB-453,2828334,5.6655606940020755,6.20087570267425
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905,1.7268061712283984
A2780,3025944,3.330273751246369,4.061308264692368
MSTO-211H,vorinostat-navitoclax (4-1 mol-mol),-1.2418766725750991,1.1340510151856165
Panc 04.03,11152667,-0.1106415062306802,-0.5085579295434794
SNU-449,selumetinib-decitabine (4-1 mol-mol),5.489476406274314,3.7520897226399956
SBC-5,374536,0.1871414147839566,2.100695104484469
NCI-H661,11222830,1.6760341955617937,1.6571291674018531
BxPC-3,89183176,5.843393871566337,4.586499670008052
JM-1,135999136,3.9281924738089016,2.2986914160271525
BxPC-3,selumetinib-UNC0638 (4-1 mol-mol),1.3922516322535516,3.5069893119231406
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.4143399707846047
SBC-5,navitoclax-MST-312 (1-1 mol-mol),1.562622268083127,0.9423054030884183
SBC-5,56946209,0.800516243447007,-3.8550482434566002
NCI-H2009,5328940,1.7426808664178373,1.8811800798838094
NCI-H2171,navitoclax-pluripotin (1-1 mol-mol),-1.0064664066659004,-1.25230534031265
LOU-NH91,decitabine-navitoclax (2-1 mol-mol),-0.8280147922678951,2.239530176745178
SNU-449,9911463,3.778924364931394,3.9595070108477097
HCC1143,3025944,4.170847171640537,4.263337358288385
JM-1,969516,2.095061675415332,2.1672430661990063
NCI-H460,3384730,3.247736649900264,3.163640665695291
LOU-NH91,135411,2.1671070624345674,0.7576331075240854
FTC-133,44607531,1.7603587928522244,1.5171514064951694
NCI-H146,decitabine-navitoclax (2-1 mol-mol),-2.2755638944126644,0.9227746348852489
MDA-MB-157,445091,2.3343110617588785,4.686276663374191
HSC-4,16013152,3.4985623845199956,4.210752480101124
Panc 04.03,11427553,3.7212087866143433,3.1967080528799086
KMRC-1,10113978,4.2388531684480615,3.154416666804899
A2780,10127622,1.5174517910950884,3.9442565063933843
JM-1,navitoclax-gemcitabine (1-1 mol-mol),-5.563041913768145,-2.344273867760965
NCI-H2171,89183176,2.3651641452605747,2.823797256296987
Panc 04.03,54618771,1.7180394725494992,1.2198399610731296
NCI-H292,11485656,2.2579953762585725,2.3850929916275567
LXF 289,322968,3.971478433961818,3.843682137036542
SBC-5,vorinostat-carboplatin (1-1 mol-mol),1.8980945585311684,3.128426883778302
YAPC,10385095,1.3302689043535871,1.5047919320568053
LOU-NH91,5329102,1.7122787452562382,2.2476178411163747
SNU-61,19582717,4.214212535444011,3.629060625397043
HSC-4,49850262,4.158516161733518,3.6493718660875825
FU-OV-1,selumetinib-UNC0638 (4-1 mol-mol),1.7956327688699871,3.1293658504510034
NCI-H661,123631,1.2265867761007856,2.494082532755467
KMRC-1,3062316,-0.7612421720697753,0.4915881006877656
BT-549,9936388,-4.888200161073446,0.03011984779941332
HSC-4,24951314,1.4348411807415282,1.363493521243103
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.5179742491403688
A2780,navitoclax-pluripotin (1-1 mol-mol),-1.8595742905962285,-1.1705209561812098
SCC-9,9933475,1.8547363245124415,1.9536973774199222
CAL-51,9936388,-5.638746232401389,-1.5784178952126433
KMRC-1,ISOX-bortezomib (250-1 mol-mol),0.316621545277449,0.7454826486002553
CA46,72734382,3.577472012209052,3.3832085617318115
NCI-H661,16741245,3.244500107466936,3.8799088586784647
SNU-81,docetaxel-tanespimycin (2-1 mol-mol),-6.596466940190321,-3.3593914219650873
HCC1143,11964036,1.1986784595252613,1.499189655647357
NCI-H661,selumetinib-UNC0638 (4-1 mol-mol),3.9317627584077695,3.3536769577912096
A2780,126941,-2.3178428604154746,-3.0753784100794803
A2780,navitoclax-PLX-4032 (1-1 mol-mol),1.492192553915411,2.029537001917804
NCI-H661,24753719,3.905315348750775,4.211867987671977
SBC-5,25126798,4.2020115243555285,3.8057144288542504
NCI-H146,6917907,-6.190181636892531,-4.6436035977964085
NCI-H661,1750826,-0.2904028146963975,-1.0456151388733046
Panc 04.03,navitoclax-birinapant (1-1 mol-mol),3.2417464009141845,1.6257615111413808
ONS-76,613753,4.08215787211526,3.201205218041334
SBC-5,3689413,-0.1482568941323282,-0.28189570714201345
FU-OV-1,446155,2.635089718837861,2.858023106338276
SNU-449,216345,4.054978999003172,4.07208040066943
CA46,6918328,-3.721989268042841,-1.6574239286272077
CAL-51,5978,-2.6819752982341463,-2.515505828964661
MDA-MB-157,57519531,1.1252399396652772,2.8802575243423347
NCI-H1623,51037431,4.287686451446288,3.4209205575567974
A4/Fukuda,5394,2.6676913787283305,3.4867605059048508
MSTO-211H,151289,1.1545674452198869,1.344959826776116
HCC1143,3825829,3.893715702367038,4.089803972178424
MSTO-211H,374536,3.2477584475462904,2.09832511377796
NCI-H460,6610216,4.838717363885395,4.193111875328614
CAL-51,54618771,0.0049145289548569,1.4934921198206808
CA46,1239801,3.4142476342729817,2.8726155480310225
A-673,9956119,3.229119212963112,3.3905986081478012
NCI-H460,73707438,4.549718141383013,3.9311519964909074
YAPC,9936388,2.1810367621372095,-1.251580641983857
LXF 289,4705,5.10311909598278,3.4407134197089406
CAL-51,54454,2.240351559744082,2.849967138502031
JM-1,4788,5.493172342149484,4.903917680321365
SNU-449,262093,3.0394524195162766,3.06442635781805
EFO-27,46926350,-4.056205960361391,-3.9595724031669626
SNU-61,5566,2.945300560810773,2.925837583126109
Panc 04.03,6610355,5.365295116093154,4.3792846738246105
NCI-H727,navitoclax-piperlongumine (1-1 mol-mol),2.3472848325526448,1.4919297374227753
NCI-H1623,56963564,0.7315466561739135,0.5525288594877582
HCC1143,10113978,4.851592729588868,3.345468625821224
NCI-H2009,navitoclax-piperlongumine (1-1 mol-mol),2.538490249667484,2.111703963367128
LOU-NH91,5311281,1.0411900413843744,2.3331365890314175
KMRC-1,24856436,1.3740575733249207,0.5999292415860402
SBC-5,400769,-0.0932857286492618,-0.27730392984918706
OVISE,11964036,1.5054845636014844,1.550650775623884
JM-1,1716436,2.291915875842717,2.5380950236491246
SW1463,6505803,0.5252870082270547,-0.8374506000384756
A-673,navitoclax-pluripotin (1-1 mol-mol),-1.5806846608606773,-1.2596666429105545
CAL-51,119182,-1.323881847361974,-0.8089971627141775
A4/Fukuda,4788,3.9402862208503753,5.1617609527006865
SBC-5,9926054,3.0567796435466628,2.083958924006447
EFO-27,vorinostat-navitoclax (4-1 mol-mol),0.8763520950927793,1.406517772369434
G-401,3634881,2.5006119442923938,2.9232605696463447
NCI-H727,9911830,2.860892848593743,2.382840088958283
G-401,9911463,2.712760379614347,3.412769687846532
NCI-H460,15983966,-0.5601417251503862,-0.8666078282251581
BT-549,serdemetan-SCH-529074 (1-1 mol-mol),2.72716237465292,2.214181563144461
NCI-H292,31703,-1.868725819699569,-0.8519454332487952
NCI-H292,11175137,3.5103695935197328,2.7012425988628506
NCI-H2009,3543504,4.270240870629309,4.711187036892014
EFO-27,702558,4.734643042503988,5.342286914873349
NCI-H292,107985,-2.5053359043606043,-3.3914527557887975
HSC-4,25154868,3.1331848354363063,4.5080953475985766
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545,-1.740291588527981
SBC-5,doxorubicin-navitoclax (2-1 mol-mol),-2.1214883367160113,-1.249522645772147
MSTO-211H,11364421,-5.484172518994792,-1.6834066445975155
NCI-H460,11238147,4.460003386993959,2.824835565557674
NCI-H2171,60700,-0.3771090207819011,-0.8276951602104857
LXF 289,1641662,3.640483694902119,3.642459996581739
MDA-MB-157,49793307,-3.250396628323611,-2.46985409003357
A-673,3503,1.5343061624145853,2.010300054220737
LoVo,10296883,3.831816674357036,3.999685618743184
HCC1143,6917907,-6.676374133945339,-4.359057652958491
NCI-H661,44185566,2.810411867420033,2.6427500035996503
NCI-H522,23725625,7.287275637495971,4.384580602931571
BT-549,11175137,0.9532540120968724,2.626593866438335
BT-549,9840324,5.7680719211185005,5.903499748139119
DMS 273,42642645,-0.2214891751848421,0.23410587190921073
LXF 289,24797083,1.462636821965973,1.520133723179305
A2780,9887053,0.4462184617201571,3.17545540019777
G-401,3689413,-2.428789331956376,-0.8569021867885822
NCI-H460,65064,5.803776096144955,4.89808964934621
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666,2.4638187655912502
CAL-51,452548,-0.9080095532304931,0.5733615601450832
NCI-H460,54613361,2.8642714411834502,0.04229998307161015
YAPC,675434,4.582728256156342,4.6390703804220355
KMRC-1,4578,4.295676817145532,4.233849318330411
BT-549,387447,-4.9509675804959,-4.070281741093851
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652,1.3933431842118114
EFO-27,11719255,3.4932821683662865,3.615907690162422
OPM-2,219104,1.446566622432128,2.438081985394056
NCI-H1623,6610216,4.306736710776884,4.289755585033043
NOMO-1,23582824,0.0799476906959343,0.4699130235763723
NCI-H292,6610355,4.982353204264952,4.6281389593191715
NCI-H2009,46191454,2.1369399253900347,2.059432465597932
NOMO-1,3062316,2.517026306117631,0.7257082738889464
NOMO-1,119182,-3.695250738066314,-2.8846394771314134
SNU-61,decitabine-carboplatin (1-1 mol-mol),5.043967029141517,2.6722569069930775
FU-OV-1,11364421,-3.956792545928709,-1.6295186717698442
OPM-2,17755052,0.9533058757913144,0.40685895321170906
SNU-449,doxorubicin-navitoclax (2-1 mol-mol),1.3165597718985669,-0.7977708094321869
DMS 273,46199207,3.605640907411319,2.9342725391876936
NCI-H522,55508,2.4640988254574356,3.0464991441621594
NCI-H292,10385095,1.2562128411100733,1.3584285637722027
SNU-61,piperlongumine-MST-312 (1-1 mol-mol),2.3794490551959107,1.8687498839600911
CA46,107970,1.651382626144423,2.093809994579407
EFO-27,5746,1.7615281276545924,1.435078438743186
OPM-2,24856436,-0.767009816479034,-0.24216737907420643
CA46,25126798,3.582571225160254,3.2227536835710087
YAPC,89928392,2.607647468641453,1.5384940812173966
MDA-MB-453,3062316,2.3886014193927285,1.5300236359780575
MDA-MB-453,387447,-4.667010811634082,-4.587895714701594
G-401,107985,-4.394015959361378,-3.507299922956578
A2780,decitabine-carboplatin (1-1 mol-mol),3.747400322321459,1.9497721858851196
SBC-5,135875424,3.947045576812926,3.988615853098257
KYSE-70,24785538,1.5800117539652696,1.5859823792468188
BT-549,25262965,-2.559107571112332,-1.441814532101295
G-401,selumetinib-PLX-4032 (8-1 mol-mol),2.777074550060763,3.9206838373251656
BxPC-3,2828334,6.44946379786602,6.306387417707284
NCI-H460,3025986,0.3909368316008428,-0.9208577226688266
DMS 273,11656518,1.6608448179793895,1.263794533996584
EFO-27,3825829,4.213579429540561,4.178264968050189
NCI-H146,44493528,1.3818057906729433,4.338852322897369
CAL-51,73707398,0.7053044464230985,1.0464112165387973
NCI-H292,148198,-2.0841293800573446,-3.067252989916148
NCI-H460,2828334,6.134119597935603,6.200357476585984
CAL-51,439501,-2.444412450902406,-2.027341025710113
SNU-449,73707398,1.8238531786702632,1.4052145961935159
A-673,10322450,2.1969870036583323,3.5841357756926313
NCI-H2171,71466380,3.3392440967630797,4.010008390515538
HSC-4,53392493,2.986961827224748,2.750426270679834
OPM-2,1239801,3.3443313732590543,3.1808616483437095
LoVo,9935249,1.1872155844887071,2.9903283146754864
G-401,1566236,1.5621622205700352,1.9576822391962714
HSC-4,9907093,5.592562690426939,4.3128973906636645
MDA-MB-453,445091,4.203535883394564,4.141485852690192
EFO-27,24821094,3.745327872256005,3.1840836267050205
KMRC-1,3038522,2.3225128068669676,2.9698399657783905
NCI-H2009,11427553,1.9586555200212517,2.914659038970421
SNU-449,25227462,3.4571199035251565,0.6145052504093316
CAL-51,136227924,2.079284078064279,3.092930467594591
ONS-76,452548,1.1046001555889895,-0.16971927012134572
SNU-449,25105715,3.5056666677867625,3.487236767110367
CA46,156414,1.2808873732328336,0.6401911064210847
SNU-449,400769,-0.6000208096132458,-0.4982462030723343
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076,2.691522325723633
NCI-H146,462382,-0.5302162316770459,0.4420176785592476
NCI-H460,613753,5.368273372553464,3.2115652690583363
MDA-MB-453,3136844,3.6967063162994114,4.082266094401079
A-673,5281672,3.4533278359325323,3.9718013282070963
A2780,salermide-PLX-4032 (12-1 mol-mol),4.80403055299543,4.814847292867384
EFO-27,1716436,3.5844471141038823,3.007268439817709
SNU-449,3825829,4.613153689576251,4.282097001266584
NOMO-1,73707398,0.2786764614411772,0.5086429190789727
A2780,568763,-1.431759576680003,-0.07064991090666405
HCC1143,6918878,5.533567107436573,3.1581138511693148
LoVo,11455910,2.8170443999319574,0.938489073993619
EFO-27,23582824,2.0177544133250187,0.6782005661706217
DMS 273,crizotinib-PLX-4032 (2-1 mol-mol),1.107090848194829,1.3294730025027024
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711,2.269105610801525
MDA-MB-453,44819697,-2.6195477020037696,-0.24351653356966416
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.4077885273394284
A4/Fukuda,7326481,2.3355820774301206,2.9324003316980947
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935,-0.10899063558164286
DMS 273,5566,3.001039957404815,2.932785368718675
MDA-MB-157,148124,-6.016678597172854,-1.5429755261301765
LoVo,11507802,0.9778049572121082,1.5394640781373798
NCI-H522,9444,4.166279980928258,3.8635897326962563
SNU-61,crizotinib-PLX-4032 (2-1 mol-mol),2.112541337520524,1.5112715032743127
MDA-MB-157,9549297,2.7932032986762008,2.3444933440840736
YAPC,3689413,3.09003195173071,0.2528279502630649
KYSE-70,10385095,0.9665013844498838,1.6221594771193013
ONS-76,11222830,1.7336224967240552,1.6414949453623606
JM-1,11625818,3.7613008305210727,3.3255251539553017
LoVo,16736978,-0.2277330125842315,1.6701372543360418
NCI-H2009,10074640,3.329342225437922,3.258887230304459
MDA-MB-157,selumetinib-piperlongumine (8-1 mol-mol),2.303505265933228,3.2993279793213754
NCI-H460,9866186,0.4176494313944011,1.1146032743061982
DMS 273,piperlongumine-MST-312 (1-1 mol-mol),1.0735064497414797,1.3414083573439004
A2780,60750,-0.3844759756013921,-2.5420774275537754
MSTO-211H,5329102,1.1990183253858175,2.0729028510020884
NCI-H292,60700,-1.1983388185725197,-0.15471948907969174
OPM-2,16659841,1.643311806599576,2.7593639682636786
NCI-H661,11427553,3.4193847918785782,2.568265450063708
DMS 273,445455,4.9732665628078045,4.13320298046431
NCI-H460,9967941,4.030885542149613,3.4305452794509304
NCI-H460,5281321,2.142807178276493,-0.8396750367842067
HSC-4,44137675,2.9134227764609735,3.709707838469635
HCC1143,2729026,2.66692124656069,2.680520240696828
LoVo,1566236,1.5203890875485482,2.16827357523163
NCI-H146,2842253,3.419228107779433,4.615302354037952
BxPC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.1893497843020568,1.9325913457009036
G-401,navitoclax-birinapant (1-1 mol-mol),1.830641570341204,0.7673170239072086
NCI-H522,5311281,2.6748920868920125,2.1208404593343277
NCI-H2171,2945648,2.4840683519833835,2.305794833150169
OVISE,9840324,5.37005208850368,5.822425166302498
NCI-H522,11485656,1.866098793785005,2.0345315368721235
LoVo,5280436,3.7935840263164984,3.5300976668979773
SNU-61,11152667,-1.0116802565381595,-0.7878405375678674
NCI-H460,2708,4.613368759945332,4.7852329830405695
JM-1,6918328,-3.1408711543116854,-1.8062501211691375
ONS-76,1716436,4.404636467874722,3.045994996741016
A-673,vorinostat-carboplatin (1-1 mol-mol),1.8302271851347216,2.4664937285657165
EFO-27,241158,4.165561573655071,4.042210508290995
A2780,7326481,2.2466116261364215,2.8864837822992837
SNU-61,11507802,1.2021022137126776,1.1919219404191854
MDA-MB-157,11404337,0.0143481506183785,-0.39721585315116914
CA46,71466445,1.6737757590775906,2.477889673961312
NCI-H727,5329102,2.005304296489746,2.114144423350211
HSC-4,51039095,3.5449735354798,2.8673447139611685
SNU-61,135411,1.4786327368897634,0.6510257686058581
KYSE-70,23635314,-2.258343718513796,-0.6371706698640992
LoVo,54619267,3.1603381625719,4.032836358799083
A4/Fukuda,71751553,4.0599050322296995,3.9773212711329107
MSTO-211H,156414,0.8242215144670997,1.4497144965966902
OPM-2,salermide-PLX-4032 (12-1 mol-mol),5.221268337510566,4.663822566901892
FTC-133,44185566,3.3632936032593403,2.579469967919633
DMS 273,448949,2.08082767357287,1.6932285548746306
NCI-H2009,71466578,3.1093531088855797,4.86287432188682
G-401,44632017,0.8985354611426208,1.0664748747522899
BT-549,selumetinib-MK-2206 (8-1 mol-mol),3.7435094380917793,2.54147075286113
HCC1143,107970,2.31840177997234,2.375662366212103
NCI-H661,156414,0.2928474479064595,1.6199973436827215
OVISE,216345,4.54917324344274,3.8843133117683353
SCC-9,25227462,0.3695734481821194,0.5610143859971299
FTC-133,46199207,4.2182762440826576,3.160713077996243
Panc 04.03,9926054,1.9560696374821285,2.315840777017289
G-401,6918736,-2.2327850291733577,-2.1098254022185365
SCC-9,44607531,1.3853072214617428,1.4704100675182936
NCI-H146,serdemetan-SCH-529074 (1-1 mol-mol),0.832618254010713,1.7912551072006937
HSC-4,171352865,4.360447231593142,2.9515979384888635
OVISE,613753,2.681502253258482,3.180534639556236
A-673,5282054,2.3452018577417166,2.8597756654594453
CAL-51,5328940,1.595278406971918,1.7433279974699396
G-401,426756,4.944025345893246,4.338329188517755
BxPC-3,selumetinib-PLX-4032 (8-1 mol-mol),0.9505923867338788,3.138053827020495
FTC-133,73707398,1.7335394908123083,1.6764946044623534
LoVo,20959075,-3.964629838563966,-2.8765017436235367
LoVo,46907787,0.5340804086119918,2.022277427315185
FU-OV-1,9907093,3.428205270837273,4.222646475014203
NCI-H146,5470400,-3.389889619220011,-0.10191886930816818
FTC-133,60750,-2.331663889988264,-2.4115295545335043
NCI-H661,637858,2.3544841299222927,2.0944449841170116
NCI-H460,24772860,-0.596461213785507,-1.674030807778256
FTC-133,135999136,5.800253145127344,3.917924625607818
SNU-61,2945648,3.4316222719918903,2.6889606528719345
SBC-5,52947716,-5.148190181120178,-1.4570319676349284
G-401,5311,0.6627378317361174,1.0154429562201006
SNU-449,25183872,-0.2769192593247403,-0.7089090224889921
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.1823273100460088
A2780,444795,1.1255727490438436,3.975391958336487
HCC1143,11404337,-0.7051632820466462,-0.3512065444180594
LOU-NH91,23582824,0.7266398713670753,0.730949922759249
JM-1,24964624,1.3785887120991174,1.1619848610532568
SCC-9,6918328,0.8244293983868239,0.3146618216021567
SBC-5,44507138,1.9527307391432291,2.390390059126462
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084,-0.37409792586779667
HSC-4,3081361,1.976322212956416,2.310466902018729
MDA-MB-453,navitoclax-piperlongumine (1-1 mol-mol),1.490500263606314,1.5631403272644409
A4/Fukuda,73707398,-0.4328093310020208,0.5462120453664788
NCI-H146,2130404,3.7873290414593983,3.0228636480243396
NCI-H522,11656518,2.6059049947054533,1.09360692827739
A-498,11626560,2.3564203123568648,2.1604295425115296
A2780,17755052,-1.4995675278651837,1.3427839218106201
HSC-4,2841722,4.578140166849417,4.151664008991785
JM-1,44462760,2.3346005220819785,2.566990735635157
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372,1.3134148164698987
FTC-133,4261,1.6400921135700228,1.7716123798672174
LOU-NH91,54618771,2.8270991446030593,1.6544490290465526
NCI-H1623,16720766,0.9555863303424396,1.0504416989915104
BT-549,44632017,1.021144372127497,1.6708073441082403
NCI-H292,107970,2.31632347859771,2.389056333837483
SCC-9,24753719,4.411411644196846,4.412719249614043
KMRC-1,4917,3.6746853329943248,3.105605862265765
NCI-H661,72734382,5.266471995298585,4.688901379706589
SNU-449,4578,4.5704959764236675,4.611374068718204
KYSE-70,9887053,4.5630363901990565,3.8104881620981272
NCI-H460,81146,4.483282466350705,4.885174743258955
G-401,637858,0.5800115670130345,1.4846035212838455
BT-549,5280436,2.325988989460079,3.3809516619444278
HSC-4,107970,2.304506496588027,2.272656310866031
NCI-H292,421610,4.310067764922952,3.2038493150662877
MSTO-211H,11175137,1.4320314455831638,2.579016754096009
BxPC-3,11175137,2.81920931641519,2.6501584205350412
G-401,vorinostat-navitoclax (4-1 mol-mol),0.632092146955943,0.7679197309577505
NCI-H292,11625818,5.668815438823822,4.559175292688995
BxPC-3,3025986,-1.3024282207469429,-1.1202807084474231
NCI-H460,11364421,0.3566052665939138,-1.9617802095818087
MDA-MB-157,3385,-0.6145392702282009,4.174935919095937
DMS 273,44589607,2.105355871894398,2.213944653231353
SCC-9,107970,3.0149180037966095,2.306088027166103
Panc 04.03,17755052,3.2992451395509503,1.7146068590143306
LoVo,10427712,4.119455144779727,4.297351388292088
MDA-MB-453,ISOX-bortezomib (250-1 mol-mol),-0.3200221310037367,0.6233596483978624
OVISE,9825149,2.776616936788869,2.205518124653128
DMS 273,44185566,2.401025824688418,1.8993744288969663
SBC-5,selumetinib-MK-2206 (8-1 mol-mol),4.137952563186265,1.818653988060419
EFO-27,5329102,3.2209933806874926,2.0571532240435264
NCI-H2009,3503,2.6223022737526085,2.5156987765586147
SNU-449,66577038,3.1506640300230075,3.089916884251817
SNU-449,135999136,4.264029635041134,4.228715164250507
MDA-MB-453,16725315,3.1590887754383847,4.246999973529385
SNU-61,6505803,-0.8091898598550518,-1.0143586714167976
Panc 04.03,6438330,3.1739512088269968,2.5048766015678425
SNU-81,124202324,-1.5604837877349913,1.9343287623601544
Panc 04.03,navitoclax-piperlongumine (1-1 mol-mol),2.817487895898936,1.9400287393379532
FU-OV-1,49850262,3.0107305406398206,3.7520262059926974
FU-OV-1,selumetinib-MK-2206 (8-1 mol-mol),-0.4869777969309855,2.0017959657253415
ONS-76,54618771,0.5276024038238057,1.2274281785145345
SNU-61,5311,1.5459052759872411,1.084661624429367
CA46,11612883,1.866301185217262,1.6391077550563948
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009,1.9463950850982292
A-673,11960529,3.1772019850221054,3.676557681021957
YAPC,400769,-0.4056066486406303,-0.3295205164690335
KYSE-70,107970,2.5727619321994353,2.2349251702931903
JM-1,5291,3.241129374385646,2.8601194155892835
KMRC-1,9444,4.31479767249553,4.102743017512652
NCI-H727,44819697,-0.26094531007839,-0.3444102656150311
NCI-H2009,5351362,1.2372754831617516,1.542239705418653
LXF 289,53495165,1.0389398894889437,0.4971867522139196
ONS-76,vorinostat-carboplatin (1-1 mol-mol),3.120131426487973,2.9875087728477303
NCI-H727,123631,2.758434269009812,2.202135488349323
NCI-H2009,5311,0.3641463076187463,1.6673789819681295
MDA-MB-157,241158,1.407364121620741,3.7884713489815187
LXF 289,24785538,0.6202102990423739,1.7484468406929576
BxPC-3,10074640,2.675443562621253,3.1604089364273342
G-401,4378219,4.593157039926137,2.2198528940657827
CAL-51,445643,4.334473435217703,4.043992124214366
OPM-2,2858523,3.124441680057984,2.836332228523724
NCI-H522,tretinoin-navitoclax (4-1 mol-mol),4.26592131531013,1.6309472906856133
HSC-4,11175137,3.5997845208099797,2.573760564537384
MDA-MB-453,25126798,3.9955340419002057,3.8781545056004343
SNU-81,159324,-2.5700546068481502,2.0247343544467102
SNU-61,3552672,2.025857953798933,2.8037763374014038
FTC-133,246676,4.92384525208296,4.564874468852066
MDA-MB-453,11364421,-1.677319267600166,-1.0333317265025586
CA46,122327,3.963727711050333,3.93496921047439
LXF 289,262093,3.4150141342974605,3.049173457395975
NCI-H292,6918289,2.42392533304279,2.976577437120949
NCI-H661,25154868,3.681430006213129,4.464021994019534
NCI-H522,327653,3.011425661783578,2.8403929300377615
KYSE-70,44202524,1.884457998669868,2.582914680993719
A-673,8515,3.2253171108003023,3.514438685413
SNU-449,6505803,1.2866498789511422,-0.15478688755167672
FTC-133,10074640,3.79174067417729,3.1000999955002753
NCI-H522,72734382,6.037966635177564,4.027623411404393
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-0.9432613110867962
NOMO-1,46943432,0.592792127892358,0.9823806899920525
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056,6.187189782907216
MSTO-211H,15953870,2.3250629767102273,3.6442465863490288
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373,-1.0866908802751967
NOMO-1,24951314,-0.0494287054100275,0.06927323577721642
NCI-H292,6918328,0.4467511585294103,0.3695841011707376
SNU-81,72193861,-0.4444993909438327,0.9090579764115725
SCC-9,9956119,4.352516606884389,3.687666534177333
CAL-51,66577038,4.134711160885491,3.1577646362410703
MSTO-211H,44489675,3.600660518296678,4.026021497016774
SNU-449,11494412,2.814472666417892,2.002437592101394
OPM-2,navitoclax-MST-312 (1-1 mol-mol),0.8084377370546902,0.3356670827222217
NCI-H522,11364421,-6.31463288554187,-2.751810946048427
OVISE,11222830,0.6942836946088363,1.6925650259031806
LoVo,135398516,0.8347424818537327,2.0292219160959486
MSTO-211H,409805,4.793476239157615,4.914101673528345
SNU-449,selumetinib-piperlongumine (8-1 mol-mol),4.611443902148163,3.2291644246974505
MSTO-211H,9926054,1.9546831701161536,1.7196359388809241
NCI-H292,2749,1.484796478537434,2.1306541827451864
OPM-2,702558,4.8466631372101725,4.0654255037308475
LoVo,71466445,2.646256567071358,4.1324937599374145
BT-549,16659841,4.205377629414311,3.885734290872617
KYSE-70,3025986,-0.3454993097331295,-0.8620785829397323
NCI-H2171,15953870,3.344319567560605,3.1942881042980567
Panc 04.03,11640390,3.824707626147026,3.7344132392708853
NCI-H292,5278396,3.8202006656128735,3.571953460759195
NCI-H460,5311,2.161812802665503,1.762412122115434
CA46,54596558,4.227379600712383,3.957189996012781
NCI-H522,50905018,5.2003053075185734,3.7914561232056307
JM-1,54596490,4.858476490911798,4.022428639650721
KMRC-1,5281672,4.43646792139098,4.590286596009403
SBC-5,46199207,3.436092011920994,3.094335534024491
NCI-H661,46907787,3.1119891404607083,2.734245719227319
NCI-H1623,11222830,2.056201659978474,1.6241640864588325
SBC-5,3038522,3.9213361824350024,2.9910965693952107
NCI-H661,9926054,1.7811448977738318,2.197302637362229
LOU-NH91,969516,2.9922565120136944,2.8932570021121227
MDA-MB-157,5329102,3.39801486229995,1.8411207037500157
SNU-449,445643,4.11461116511151,4.009869619079464
NCI-H522,9887053,3.177768808520637,2.9891749420824847
NOMO-1,16065773,2.6012917178973405,1.8739143082672363
G-401,67291369,1.7656191364648908,1.7128153984552685
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076,1.9132268398525747
MSTO-211H,11609586,2.648073114002603,3.092275777101037
A4/Fukuda,25195348,0.8993846970771071,2.616324869332436
NCI-H2009,54649381,3.659944396907473,3.9689072758961292
CAL-51,3025986,-1.0834382414923172,-0.9395000347388109
EFO-27,52912189,5.780518526906142,2.145641624309967
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942,-2.257424600808544
A-673,123631,1.860693828866879,2.2354834374710806
A2780,44632017,0.0856486258730489,1.0157269836722835
A-673,24901704,3.0162186042420966,2.6927409651020673
OPM-2,168312962,0.8773607091058507,0.7353799597019937
NCI-H292,46398810,2.6001901820453166,2.6449782587424284
SNU-449,53495165,1.8844225218094013,0.6034642387846912
YAPC,2749,2.2394739682848512,2.0540618449475643
NCI-H460,4788,5.894567383019075,5.711543439534466
LOU-NH91,637858,2.168731257760998,2.328605364485906
NCI-H727,11427553,2.8726920198872397,2.7825143147434823
NCI-H2171,5978,-3.1305615418900468,-3.251066921862535
EFO-27,969516,2.57565712333896,2.946597000971083
SNU-81,11152667,-1.3658791794225291,-0.7880506636929827
LoVo,2858523,2.923658201852042,3.005654871926183
FU-OV-1,56946209,-4.492733112758285,-3.828489357690767
CA46,9549297,1.0960598621603344,1.6003407203021718
ONS-76,6917907,-5.751164378556486,-4.461732190395743
NCI-H460,51037431,2.104101453867928,3.300801537880431
CA46,68056272,3.136594245199668,2.9773214223167623
CAL-51,54143018,-0.6388505972102335,0.5551089251792372
SNU-449,5284329,2.300938885216567,3.236089298519268
A4/Fukuda,11609586,0.4485915276425587,2.106153234425156
NCI-H146,9933475,1.6402256772331771,1.7341119461926982
NOMO-1,9927531,5.049638663441057,4.399934742391837
A-673,148198,-7.755828732328633,-3.9727093738304906
SNU-449,2113511,6.338115821615388,5.733621364418877
NCI-H522,49793307,-5.2014711504438,-3.3561280055163247
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332,6.41887832661074
FU-OV-1,44493952,2.9850522959236883,3.8502379772790816
NCI-H661,5328940,0.9675290055268168,1.648521344792195
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693,4.048339721124679
NCI-H727,60700,1.7894131654495464,-0.41699188872649023
MDA-MB-157,10385095,0.7848337329764868,1.3854838689721776
DMS 273,46224516,2.6849968878024297,2.348022791509018
G-401,1641662,3.2482177517563766,3.3011443196900148
NCI-H292,448949,2.3471350598248795,2.1032461905189437
ONS-76,3038522,3.87205505246704,3.1322867916079953
G-401,216468,0.7704979015554879,1.6215644929870343
NCI-H727,10127622,-2.4732053445147333,3.304150167687718
JM-1,erlotinib-PLX-4032 (2-1 mol-mol),3.366484807659052,2.729298074892898
LXF 289,16722836,0.8079280065417594,1.7749036309467767
FTC-133,11167602,2.051836472120041,2.701771889602879
LXF 289,3825829,3.6707575370566534,4.19455860951726
CA46,25150857,1.719157108492683,1.534063187838287
NCI-H727,3025986,0.1020219293656271,-0.9972723241766707
MDA-MB-453,107985,-4.386344018126506,-3.4641353989152135
NCI-H1623,72193861,2.1993190803521423,2.073065536273752
MDA-MB-453,decitabine-navitoclax (2-1 mol-mol),3.3987025983008468,1.7093375923731347
ONS-76,12001922,1.7268373273866384,1.9318843324679162
LXF 289,5460769,3.06478422280727,2.889926379393377
MDA-MB-453,doxorubicin-navitoclax (2-1 mol-mol),-1.00600213948852,-1.5350769820334191
LoVo,9967941,3.621110602900207,3.5377799866768926
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849,1.1572825779253029
NCI-H727,5113032,6.018394893069797,4.744206884177044
MDA-MB-157,5351362,0.7984725267524495,1.6385127924823184
JM-1,1641662,2.861679408031504,2.6039201065705257
A-673,JQ-1-navitoclax (2-1 mol-mol),0.2328293171340499,0.01906875824553067
MSTO-211H,445091,2.4700472101717312,4.40907046526031
NCI-H146,11404337,-1.5914515878545687,-0.669530347053849
CAL-51,11364421,-3.809863778172731,-2.0305676168484106
A2780,4096211,0.5297517602102724,1.6218452373485668
SW1463,23635314,0.7077124425294024,-1.633844289349562
EFO-27,9933475,2.2279721994416364,2.0098637941924737
CAL-51,135875424,4.33643967165441,3.830671239708084
NCI-H1623,15983966,2.013058792543676,-0.34355577355085154
SNU-449,3038522,2.1807259662851735,3.1671029705690317
SNU-81,969516,2.098687325749346,2.4647198014054026
SNU-449,9935249,2.650976699885872,3.1973828156317547
LoVo,10385095,1.3603816893768768,1.2148303090620218
ONS-76,322968,4.979501026393853,3.7131500463593685
DMS 273,9933475,2.0005654751864865,1.692679706411478
CAL-51,71466578,5.340961831553399,4.600268853405211
Panc 04.03,selumetinib-PLX-4032 (8-1 mol-mol),4.2289817394660805,3.7193480723251917
MDA-MB-157,1750826,-3.091616753079083,-1.2668257461340824
G-401,salermide-PLX-4032 (12-1 mol-mol),5.25337589730296,4.526177591866018
NOMO-1,702558,2.777027807122979,4.047282524024217
YAPC,60700,-0.2763967023007928,-0.22785121446664114
CA46,5287969,-2.5448622649608925,-2.2057771226235148
CA46,15953870,3.0438117584706164,2.839908262084867
A2780,selumetinib-UNC0638 (4-1 mol-mol),2.0119949051388493,3.115942672977301
YAPC,6610355,5.243598963135711,4.7821034840522385
SNU-449,4477,0.3396527753410003,0.5190002345553805
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152,2.0507607893926125
SCC-9,168312962,1.0708744032070256,1.8397033893451098
SNU-449,119607,5.345576432951938,5.271854872480689
LoVo,135999136,5.7154474843469565,4.029433958365091
NCI-H146,984333,-0.904410626141992,0.4295791088229177
KMRC-1,54619267,4.117989845600413,3.9506024159587083
A4/Fukuda,11485656,1.5130746228374388,1.516999241102116
BxPC-3,5311,1.3160685062040935,1.5839053470636377
NCI-H522,3038522,2.4524519125835473,2.9269989839968042
SNU-61,89928392,1.2163192063780537,1.28440282515927
FTC-133,5287969,-0.5047683720981219,-1.5501613500857798
ONS-76,25062766,2.430053801867403,1.8665462479526065
NCI-H2009,44486219,4.368704582532332,4.230494130806413
NCI-H522,637858,0.9732265340904396,1.4566473993759228
NCI-H522,44632017,0.530418286591973,1.3880504761612555
SW1463,11485656,1.9271812519349985,2.0559886581126205
SCC-9,46843906,3.309522412048413,3.2541103030452674
A4/Fukuda,6914657,-5.308594861321554,-4.728855749604399
LOU-NH91,36462,3.2256365983613677,2.388836608114704
NCI-H1623,3825829,4.488518875119825,4.064784710454501
MSTO-211H,56946209,-4.75779739938848,-3.766960760521915
YAPC,11427553,3.397606686380644,2.854978100608048
JM-1,426756,3.661156723786521,3.7039040879689726
JM-1,10184653,1.3269176228991806,0.5080193577034349
NOMO-1,11497983,-3.443590431300748,-0.8807321628780238
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926,-0.06006297952913027
A2780,9952709,2.339079626269582,2.7286049920869146
MDA-MB-157,9866186,-1.7048510464532898,1.2105740277242756
CA46,216239,1.3191761483145148,1.7467398003440573
MSTO-211H,176870,1.3974668510804569,3.208765469045872
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631,1.141214335939403
OPM-2,135928012,2.8826672527394956,3.773282825384767
BT-549,9915743,2.34179420613382,1.4512875161368313
LXF 289,71304818,2.1201305139291033,2.6631832246868536
HCC1143,11214940,2.1301365232114144,2.002782649635367
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668,0.35616865385356056
KYSE-70,11404337,0.2060464556058333,0.0675748447301211
NCI-H2171,11152667,-0.915095731247344,-1.2810831976160486
HCC1143,46191454,1.52291312584366,1.7164361190156003
SNU-449,71680916,5.959793136995753,4.790946914248655
YAPC,219104,4.027438046449075,3.850674206389609
JM-1,446155,2.7706022090916793,2.2390242021922844
BxPC-3,46398810,2.2883583084835126,2.697291546840516
OPM-2,2828334,5.82639787583413,5.607179699031105
A-673,44137675,3.4578104481213905,3.2732810711346185
FTC-133,7251185,3.0292037228467628,2.571622432984866
KMRC-1,676352,1.883475825529446,1.9924223867013806
EFO-27,1641662,3.8267974599371417,3.6014491170330665
G-401,168312962,3.2015141434031547,1.5397711795839906
CAL-51,2945648,2.7250935788350064,3.0621405896485845
CAL-51,71466445,4.7818956768695715,4.2507420846295085
JM-1,5113032,4.766616079684312,4.285200681266669
SCC-9,24821094,2.906183993814488,2.76931935367702
NCI-H661,piperlongumine-MST-312 (1-1 mol-mol),1.6507934598054954,1.924174622970992
NCI-H292,216345,3.474677020151061,4.027293896720355
MSTO-211H,JQ-1-MK-0752 (1-1 mol-mol),2.3232645118005015,1.5756310230201283
SBC-5,9549297,3.510799485826288,2.122489173405542
CA46,156422,3.7635879578153126,3.0173827949957963
MDA-MB-453,71466445,1.9167870178623896,4.168336749385745
A-673,54596558,3.847043372257958,4.280190612291217
OPM-2,10231331,0.6444733525039235,1.0086322924146918
HSC-4,5335621,5.235604448739508,4.460665236685732
CAL-51,11719255,2.5837610433465588,3.512973678122563
Panc 04.03,44493528,4.362737332857046,4.434379501301164
SBC-5,carboplatin-etoposide (40-17 mol-mol),1.335045540127449,2.2698467436290453
NCI-H522,24821094,2.425713290484283,2.9203264366521284
CAL-51,6610355,4.388066889778601,4.47725491731101
MDA-MB-453,6438330,2.0150251794967655,1.8588186720919209
Panc 04.03,46199207,3.759856924739056,3.173147353219909
SNU-61,9866186,1.5207851909017442,0.9191248323389022
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137,4.438470193887971
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645,1.6761225552487165
Panc 04.03,71466578,5.726073349824824,4.8878801080367325
NCI-H727,107970,3.133468251114326,2.2920621873920304
BT-549,60700,-0.4810674620852896,-0.16217819328547428
OPM-2,51037431,4.229346700902662,2.9339263250365972
MDA-MB-453,56946209,-4.730570165381635,-4.122617063272547
NCI-H460,72376,-0.5460239014371263,-1.478952268890332
BT-549,44241473,4.976602861760902,4.870442946572533
A2780,24748573,1.2286507677110594,1.8910507845055913
NOMO-1,5311,-0.031303965270056,0.47795749556499983
A-673,9927531,4.216692000672551,4.421045347332151
NCI-H1623,46199207,3.747077477678168,3.089181405912557
NCI-H292,71304818,2.830949431838268,2.595703152695685
NCI-H1623,9911463,3.95788841498078,3.811949519263674
SBC-5,9825149,2.9056064620320896,2.3548329449641483
NCI-H460,11612883,2.88158995470921,2.8706165057485333
OVISE,6918878,5.066606594706477,3.028198658847787
FTC-133,5278396,3.726623182659884,3.597724225654714
Panc 04.03,24775005,4.54660450697204,3.6256199163747103
CA46,1641662,3.144498035259472,2.743615499328255
MDA-MB-453,16722836,1.2443221263797826,1.8434266615350396
CA46,54618771,1.203400154931592,-0.19394423210728776
HCC1143,613753,3.4353326628352714,3.291462826162729
A-673,60750,-4.61356677624384,-2.3534597630647727
A4/Fukuda,1641662,2.3667755294261297,2.793769956626317
OVISE,navitoclax-piperlongumine (1-1 mol-mol),0.5165659112827317,1.4964482351079158
MSTO-211H,375860,0.0606650448750636,-0.15693806848060926
BxPC-3,6184667,3.26727461265582,3.061372880511534
CA46,227681,1.829365253324193,2.624407809762094
SW1463,11964036,0.627645429671571,1.0442096690194251
NCI-H2009,vorinostat-navitoclax (4-1 mol-mol),0.5355412888346941,1.3278870754863386
FTC-133,49766530,-1.1381086002707512,-0.2992635471933237
SNU-449,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2718140952083585,3.8572169995500336
NCI-H292,11364421,1.76762986564817,-1.1274868337277189
KMRC-1,44819697,1.235264283084374,-0.13852761272610511
NCI-H661,9907093,3.834837743900246,4.050716722901912
DMS 273,17755052,0.9609599247674856,1.6230194039191297
SCC-9,11364421,-0.952029021799848,-1.413575955453994
FTC-133,135984461,4.350998124633342,3.85694215000806
JM-1,11497983,-3.7280544169699192,-0.467160154724163
MDA-MB-453,24753719,4.38597739181452,4.100148323058112
ONS-76,168313047,2.901208476511606,2.5179254764261834
NCI-H460,67156097,3.7191617083219097,0.1318347329057082
SNU-81,selumetinib-decitabine (4-1 mol-mol),-2.7455044109926168,2.016013066868634
A2780,9866186,0.3046354439957303,0.5095153500390974
HSC-4,219104,4.150323587810277,4.022826775046758
SBC-5,168313047,3.954131669958023,2.402055717160561
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333,4.192610629399312
NCI-H292,15953870,3.631273190289841,3.591074138612085
SNU-449,5281321,-2.557888043471457,-0.9552148007226652
HCC1143,702558,5.703077608026742,5.337194323346426
EFO-27,644241,3.241988529302909,2.507263503387045
Panc 04.03,9911830,2.4999304852863404,2.675988838646727
NCI-H522,9967941,3.44539283334302,3.308162263258707
BT-549,44607531,1.5480457992975702,1.6157513154030851
BxPC-3,44607531,1.3275313586220698,1.4348854874680486
KMRC-1,24951314,2.7376925539969927,1.5127813771096439
JM-1,10231331,5.343116821873739,0.6101600759579915
A-673,25262965,-3.9892118887375303,-1.8440205080317715
FTC-133,1716436,3.3698315146098015,3.0734483020650782
OPM-2,2733526,4.066729211955922,3.363820366514943
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345,1.827928741682037
DMS 273,3825829,3.788583241717048,3.4802144550880274
KYSE-70,3825829,3.6022414485207452,4.112964696638651
BxPC-3,5351362,0.9304368738373464,1.6291778283490006
NOMO-1,6918736,-3.755126975181922,-2.543339107034873
A4/Fukuda,11977753,-3.131569873612884,-2.2154058596490898
SBC-5,navitoclax-pluripotin (1-1 mol-mol),2.5594903061856744,-0.7157018971387863
MDA-MB-157,navitoclax-piperlongumine (1-1 mol-mol),-2.7470196870152894,1.919609630638231
A2780,73707386,2.710080958425795,2.6112626017948224
SW1463,44819697,-0.8614164905769626,-0.6307531749775516
YAPC,24180125,3.806846010722946,3.1886504828267
NCI-H727,54649381,3.660865770056845,3.587521312626149
SNU-449,2708,5.735631765174737,4.792420589311423
CAL-51,54143018,-0.6388505972102335,0.5551089251792372
LXF 289,753704,4.962227230589067,5.160689889704347
NCI-H2009,9907093,4.391694288558607,4.441887859015175
EFO-27,387447,-3.111228692284437,-4.241380173515475
NCI-H661,65064,3.46809117241053,4.786238868531046
SNU-61,5278396,3.627128978826316,3.2729846361820414
NCI-H727,452548,3.7056139041011034,0.2999430186517384
NCI-H292,16720766,0.3451831901206211,0.7198209644776205
SBC-5,serdemetan-SCH-529074 (1-1 mol-mol),2.482890846632963,2.2038507417923783
A4/Fukuda,100016,4.8831896191852096,5.034438530562778
G-401,25126798,3.708942608188802,3.6826592719189177
SNU-61,24951314,1.416243399270427,0.9059515886456321
CA46,89183176,2.547561715641907,2.8134712876418053
Panc 04.03,2746,3.3610494767062513,3.5078667535457955
FTC-133,107970,3.2744864550719126,2.287602119629447
NCI-H661,6918878,1.4921814323330362,2.8250309322848968
YAPC,24951314,2.2257819926279243,1.513209448505436
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925,2.4812601358199022
LXF 289,216345,3.67485776854348,3.92810135411053
G-401,5287969,-2.352936827953192,-1.8833622168701376
LXF 289,5566,2.9960878643930218,2.977133307281946
JM-1,71680916,3.747509118270568,3.8799167651970974
LoVo,16741245,3.141864677583783,4.011139757212597
NCI-H661,54649381,3.920223147571483,4.038895305428283
EFO-27,25154868,5.200143123549252,4.384616542425877
SCC-9,25126798,4.663845786250664,4.006541244407662
A4/Fukuda,24964624,-0.76967256635286,1.520605702565922
A-673,11178236,-6.344930978772708,-3.3683630682109107
SNU-81,3825829,3.873341985908314,3.733118871533437
KMRC-1,36462,3.0698954920529324,2.2448117826558542
NCI-H661,262093,3.4983141095274126,2.796909980051683
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743,1.104550730839987
G-401,676352,1.5550652369933835,1.8391774844769904
SNU-81,11228183,0.0397441918833689,0.8358410808082526
MDA-MB-453,10385095,0.8735195901829151,1.3746229107698926
KMRC-1,16065773,3.457331493974802,2.5491621998546536
CAL-51,5328940,1.595278406971918,1.7433279974699396
CAL-51,56946209,-4.496983035262223,-4.125643869123667
FU-OV-1,5329102,1.609553320034118,2.0349535302684485
YAPC,3062316,1.4892918633711576,0.9753765264206664
NCI-H661,11609586,3.2377833862635206,2.885083428116129
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985,2.0141228324570393
NCI-H661,serdemetan-SCH-529074 (1-1 mol-mol),2.3260585064542014,2.1615259657142256
JM-1,36462,-2.702351282209385,0.28204822501788873
EFO-27,55508,5.431657737658487,3.593048870711649
CAL-51,10296883,4.0377332681132305,4.021489355808091
CAL-51,123631,2.4616591372530605,2.6752896450107397
A-673,53481919,3.7180877845578073,3.6685541290809542
JM-1,107970,1.4704012549786991,1.8266515590677428
CAL-51,5278396,3.885366261927898,3.6219885519865893
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475,0.05896164477819006
KYSE-70,4096211,2.254549645630953,2.149699135941477
DMS 273,11609586,1.9163652577621844,2.3876755254274684
EFO-27,9903786,4.039986452778869,2.8000332231311997
CAL-51,6917907,-8.395782425589301,-5.245120909846442
A-498,54454,2.893611310147977,2.507110804834793
A4/Fukuda,49793307,-5.572580515048152,-3.8651483462294185
NOMO-1,4259181,0.2459758371125145,-0.577097465865163
SNU-449,107985,-3.1392486992039235,-3.256284249203954
FU-OV-1,5278396,3.713343254157872,3.463331594671702
SCC-9,selumetinib-decitabine (4-1 mol-mol),6.773727258865908,3.634786923910645
A-673,5460769,1.3883868162718005,2.5249218984526554
SCC-9,568763,0.9120329628896908,0.6464491462234824
CAL-51,72199292,1.0008292341873897,0.3982282302383227
MDA-MB-157,8515,2.4995790404865983,4.042515184495561
NCI-H661,374536,3.546483103952357,2.3695397982651523
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077,1.9042186422341414
FTC-133,53392493,3.195209876090235,2.6904843656067383
SBC-5,selumetinib-tretinoin (2-1 mol-mol),5.430491518611957,3.280850558168281
SNU-61,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6699368728217061,3.313009109857093
BxPC-3,selumetinib-MK-2206 (8-1 mol-mol),0.2275715298784707,1.9584438370188786
NCI-H2009,3825829,4.333180881174198,4.174358896713716
A-673,6610216,4.190818336865809,4.05036069473352
LXF 289,1750826,-0.5305094201812034,-1.1689110375183591
MDA-MB-453,44543605,3.7347256504274418,3.9704157703030507
BT-549,24964624,2.3327253679943696,2.6750254838133936
DMS 273,24797083,1.0969779553781829,1.2314440228994405
NCI-H2009,24856436,-1.037334288977755,0.8392889388911304
ONS-76,73707440,4.1934861569389845,4.037250327480822
NCI-H2009,1242560,3.090706196906407,3.7247121756346537
NCI-H2009,6610355,3.511475006316147,4.610057687506998
CAL-51,51039095,2.1842093640891416,2.914658380678918
CA46,11404337,-2.4021967063511434,-1.166071620525043
A-673,decitabine-navitoclax (2-1 mol-mol),0.9419890820834614,0.3456354592056284
NCI-H292,11152667,0.5464898224488388,-0.3305595905702312
CAL-51,25154868,4.656760297450745,4.2372390180057735
NCI-H727,doxorubicin-navitoclax (2-1 mol-mol),0.353164953880874,-1.0505677089669887
HSC-4,66577038,3.591157601556467,3.052519754040789
LoVo,11175137,1.7419612548831422,2.4261687965292005
Panc 04.03,46215462,2.9027075063139804,1.9549027799857361
G-401,1750826,-3.031444880989549,-2.286736662953804
SCC-9,462382,0.912003027061621,0.6000099078124029
NCI-H2171,71304818,1.9125624841179896,1.9320521056363549
NCI-H2171,6252,2.1051572182795,-1.068196375988089
G-401,51037431,3.9974576184013726,2.860870751237207
SNU-61,219104,3.1068483513637033,3.0656244833868556
SBC-5,60750,-3.858196401702703,-1.793561683995859
JM-1,72734382,2.7239851923699443,3.4288408642767623
EFO-27,2733526,4.707486415914075,3.848246198537781
A4/Fukuda,71466445,1.4546499284121797,2.30159911321911
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355,2.9112168971496546
NCI-H460,24797083,0.9153025805785596,1.3426817093368104
A4/Fukuda,54596558,4.022693113590735,4.209278591194046
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405,-0.7963546795141275
NCI-H2009,serdemetan-SCH-529074 (1-1 mol-mol),2.304731385362492,2.148204520395677
HSC-4,44202524,5.184990397771561,1.9654929832418935
MSTO-211H,erlotinib-PLX-4032 (2-1 mol-mol),1.1572104860425592,3.105333811553805
SNU-61,selumetinib-piperlongumine (8-1 mol-mol),1.4116770683714617,2.574699144016192
OPM-2,9915743,0.7579871544404475,0.16737192548514485
CA46,56949517,4.303265452215328,3.5061184844423825
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361,-1.0216048350674762
CAL-51,24785538,0.7720267524795773,1.7843345171589005
EFO-27,navitoclax-piperlongumine (1-1 mol-mol),2.507192070148125,1.9117509550953375
CAL-51,10322450,3.881825194853649,3.9684901387647504
A2780,241158,1.61479428578643,3.2783943924446777
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928,0.006985701408998901
LXF 289,10074640,2.806214579062189,3.1111902374686475
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928,-1.0710526957176723
NCI-H522,119607,5.115168095819997,4.798568397003964
A-498,6918638,1.620608219340894,0.7305095459682994
CA46,10302451,0.2515382956842912,2.381500151861328
NCI-H727,11152667,-1.354343634557878,-0.6931448206212407
NCI-H292,135999136,4.360218039072087,4.170776464244248
NCI-H292,322968,4.489137987914782,4.067268857187666
KMRC-1,11238147,2.6910045327617422,2.729334828929356
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264,1.012081450127607
NCI-H522,9911463,3.273817127322074,3.455038733642285
A4/Fukuda,26596,-3.7061252239164553,-2.4709071054136285
CAL-51,2945648,2.7250935788350064,3.0621405896485845
FTC-133,10113978,5.149340897630058,3.143427612938686
G-401,25227462,-4.354739504605027,-0.0995006883237558
CAL-51,3634881,3.319714226315486,3.315842515590009
NCI-H522,5280436,1.9285860105900432,2.9223448149119418
LOU-NH91,JQ-1-MK-0752 (1-1 mol-mol),2.239144963977278,1.862055824850039
A-673,285033,-3.783680268063714,-2.7453719512110673
KYSE-70,11497983,4.3699696445826035,3.742675038341547
EFO-27,135423438,3.7049046399150134,2.405515938852038
CA46,26596,-3.5845712744961324,-2.5605452319030273
A2780,24785538,0.5365701421591345,0.7675293202557181
NCI-H2009,8515,4.894015987740437,3.921672155700486
DMS 273,carboplatin-etoposide (40-17 mol-mol),3.245479848916456,1.86034655704659
JM-1,387447,-6.033292615187937,-5.294519468345856
DMS 273,9956119,4.190734481617164,3.331690660791908
A2780,navitoclax-birinapant (1-1 mol-mol),-1.2503932555480053,1.1916609938444023
NCI-H146,36462,-0.9223549938225544,1.2521349728492226
NCI-H1623,11485656,1.644044907667622,2.4408682882116666
NCI-H1623,24821094,-0.2323488781711246,2.9738434140702354
HSC-4,53301938,4.738168418112686,3.0269361153000096
LOU-NH91,676352,2.464978676736505,2.013613117489254
NCI-H146,46926350,-6.324766796143129,-4.388127876688375
ONS-76,16722836,1.7132123007700326,1.7126111214377473
YAPC,327653,3.117178905090827,3.273914050892967
OVISE,24901704,4.2849421736627615,3.517708311634576
JM-1,54618164,3.458143614246244,3.5419861574709843
A-673,445091,4.1466370846962075,4.0348231904522045
OVISE,5329102,2.956482132219437,2.059779017667331
HCC1143,5470400,2.3870928447001867,-0.413615907823651
BxPC-3,salermide-PLX-4032 (12-1 mol-mol),4.912455807166081,4.984585255306108
SNU-61,3503,2.986460298481687,2.3139128913620493
DMS 273,11455910,0.4737958394902512,0.5743900777007559
NCI-H460,46907787,4.3372157131836255,2.54252701204051
CAL-51,216345,2.9520334452605637,4.05355683752008
A2780,6450551,0.1349302943593443,1.8466566258914185
LoVo,46398810,1.578557668618055,2.553671095819516
SNU-81,15953870,1.3050219745867302,3.4052166094494396
A-673,54613361,-0.6759826855411176,-0.26035924585226927
SBC-5,11234052,4.136817608168693,4.00536579491711
NCI-H460,36462,3.103581216464206,2.0671324690509754
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963,1.5033102854091902
A-673,168313200,1.7801049656035806,2.7680890938162808
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645,2.234075527416422
A2780,100016,4.757543521992015,5.422426796004779
NCI-H727,selumetinib-tretinoin (2-1 mol-mol),0.6638203077807998,3.0473330090277773
CA46,25105715,3.628482142858773,3.194890597528942
HCC1143,9911463,3.749174224015704,3.781071018577269
LOU-NH91,4477,1.3512747052000795,0.5023981939729252
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108,1.319005931961555
FU-OV-1,25154868,3.6525772823030502,4.530863199101533
A2780,168313016,3.896841135664639,4.228610713343429
MDA-MB-453,JQ-1-UNC0638 (2-1 mol-mol),-0.1830175507337199,0.9759643683336169
FU-OV-1,selumetinib-piperlongumine (8-1 mol-mol),2.8006116127321463,3.2042746578140355
NCI-H292,15547703,3.23498204624142,3.2737145217352803
JM-1,5329102,1.4301495534996294,0.8095417341266817
NCI-H522,3384730,2.8239588226941104,2.131550353378762
A2780,9911463,2.7303797257759235,3.5845230037193567
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744,1.285232495132997
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642,3.2311791820778377
YAPC,9887053,4.707664045043398,3.8719179759762543
HCC1143,10074640,2.8253679093766104,3.0366852918552762
LXF 289,11178236,-2.9660816129263297,-3.1560872450777295
A2780,ISOX-bortezomib (250-1 mol-mol),0.49630436037141,0.5549017587918933
KYSE-70,135398516,2.3739819683449697,2.1588229840002224
A-498,57519531,4.461574036812888,3.0001807338686546
NOMO-1,9840324,6.741383080584752,5.430138979753946
BxPC-3,10427712,4.346184062898943,4.511828767506003
NCI-H292,selumetinib-decitabine (4-1 mol-mol),4.672876887029793,3.673155362165097
LoVo,25062766,1.8850615394111836,2.1668543167692844
FTC-133,262093,3.024825063724614,2.7324923961757075
HCC1143,44819697,-2.8669414823386115,-0.423574598369122
BT-549,5351362,2.1022372489581227,1.663222674454348
FTC-133,selumetinib-navitoclax (8-1 mol-mol),3.0170288782836163,1.8943912009775679
MSTO-211H,53325874,5.432400358349695,4.710761001366743
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.013793137080991
DMS 273,7326481,3.48743847164077,2.842356406302221
JM-1,11955716,-2.692308040243548,-2.037228310286615
SNU-61,JQ-1-vorinostat (2-1 mol-mol),1.221813874955551,0.37914156477288474
MDA-MB-157,2842253,6.170125707570699,5.4296402157141435
SNU-61,54454,3.789888893365768,2.7893028736642993
NOMO-1,5460769,4.769752092364765,2.0837292295521093
A2780,285033,-3.502152061737446,-2.892167675849348
HCC1143,44495899,4.517503920361928,3.001170221477559
NCI-H661,31703,-1.814857416200904,-1.0229481877064843
A-498,piperlongumine-MST-312 (1-1 mol-mol),3.2083615282552853,2.150656959947694
YAPC,navitoclax-pluripotin (1-1 mol-mol),-0.110540489139909,-0.7368707257982778
A2780,2729026,1.9590477988732768,2.4102847364633537
JM-1,89928392,-1.0810313065311572,0.33844269862655557
JM-1,10410894,1.2527004533251185,2.563370230913585
NCI-H661,16038120,1.553795977052523,0.8302473221881037
LoVo,135421197,2.0078610802467307,1.8233629522431125
HSC-4,24901704,4.088081803824046,3.358558648890397
HSC-4,135411,-0.261300177061483,0.8915081466662484
NCI-H522,4917,2.9130794248329392,2.8508316549246375
JM-1,11364421,-7.32386861469755,-4.329776885136066
NCI-H2009,10127622,-1.471627480680591,3.7667195944339356
DMS 273,4917,3.103248515982538,2.8707564569610997
OPM-2,44462760,2.3304413416808463,2.8588381661355644
YAPC,9956119,3.92905072911681,3.6000095932577305
A4/Fukuda,5113032,4.450145517718883,4.51277319041584
NCI-H1623,49793307,-1.4788317062169576,-2.4900827593284576
BxPC-3,637858,2.219072546092823,2.1743069547428724
NCI-H1623,1566236,4.077529389730835,2.4432435406508306
G-401,23725625,4.115882586635449,4.263985154130615
SNU-81,crizotinib-PLX-4032 (2-1 mol-mol),1.4380831221683867,1.3917272949412327
DMS 273,252682,6.321322886147215,6.409668131598871
KYSE-70,135411,1.9014599224142343,1.102265818098964
NCI-H2171,49867930,3.814749813399888,3.4384814502308543
SW1463,10302451,2.197754569420114,2.9331598934881082
Panc 04.03,salermide-PLX-4032 (12-1 mol-mol),5.297407479315669,4.9616617879452765
NCI-H522,71466445,4.480637973076106,3.2558240595500716
NCI-H727,6610355,5.167779637611195,4.598052397441163
A4/Fukuda,613753,2.966875582154842,2.841855513932413
ONS-76,4261,2.2909626551681757,1.5890963469630597
YAPC,serdemetan-SCH-529074 (1-1 mol-mol),2.033605312871709,2.0555501828063454
KMRC-1,31703,0.3325905755235477,-0.9792681007917288
SNU-449,445455,4.484776409201516,4.709665561270566
A-498,6918878,4.306638073301365,3.049475669258412
SCC-9,selumetinib-tretinoin (2-1 mol-mol),3.7791942672746974,3.356167622653052
OPM-2,1750826,-5.079410714013139,-2.4838145947458146
NCI-H1623,9915743,-1.6977137550638366,0.8158953533653911
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,2.0959107131871093
SNU-449,7251185,2.777592648573664,2.7101743250702284
NCI-H522,2733526,4.089503686239825,3.756611636129546
LoVo,24180719,2.381979820549913,3.5492059480112186
A-498,49793307,2.582548635431232,-1.9108382951325884
FU-OV-1,selumetinib-PLX-4032 (8-1 mol-mol),1.0793153404708502,3.590732661132275
NCI-H522,4788,5.8756804910396925,5.191428768215767
G-401,374536,1.448879337840406,1.617904937531972
SBC-5,135440466,3.787084066930897,2.3301622126701633
BxPC-3,36314,4.043064497836865,-1.474683868099013
SBC-5,11626560,2.9533832336239985,1.7576752338190877
OPM-2,613753,2.6904302784099845,2.990315630932697
G-401,71466380,4.3225707153388,4.2291155424375795
G-401,45279963,3.527434868311602,3.103643734940832
MDA-MB-453,1239801,4.069717893467032,4.127819220362195
A2780,11719255,1.8256962189728296,2.9496110953427293
KMRC-1,navitoclax-gemcitabine (1-1 mol-mol),-4.218093403904549,-0.9483990014299998
HSC-4,11404337,-0.2351979780524762,-0.1626859275340699
A2780,crizotinib-PLX-4032 (2-1 mol-mol),0.8552062968209889,1.5676923439883572
JM-1,5978,-5.097158196512326,-3.640797741088962
BxPC-3,6917907,-5.822397614063261,-4.441414160785057
NCI-H2009,52912189,1.2519346625881922,2.442857211734749
KMRC-1,6917907,2.5901706443444477,-4.780933944738388
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592,1.146281094011651
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367,3.987446817652099
KYSE-70,2746,2.8005709054024224,3.3027146499301008
BxPC-3,638278,3.0042450495358923,3.1019799286135155
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.6805565842272989
HSC-4,31703,-2.446577735650292,-0.7698805740601329
NCI-H661,11152667,-1.7022631730770723,-0.17992234813530864
SCC-9,73707398,1.5896934234406246,1.6244369157198575
FU-OV-1,148198,-3.302287500778492,-3.602784281232621
MDA-MB-157,5287969,-2.775456728988527,-1.587324768304293
OVISE,6918289,3.317561176891493,2.9324284882955918
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.6637536715176889
HCC1143,10296883,4.463772522749199,3.731487325630566
FU-OV-1,25150857,2.264135178575504,2.6150849790863533
LOU-NH91,ISOX-bortezomib (250-1 mol-mol),1.5845315088477396,0.6483670613639784
BxPC-3,16725315,4.1100247270568815,4.478224396910715
EFO-27,11707110,4.483747329636401,0.6512620900261468
A-673,2858523,3.068752318729834,2.960139393392318
OVISE,5280436,4.204860612632051,3.569272685040425
NCI-H727,122327,5.896927010318378,4.463603045141626
CAL-51,448949,2.479839067238928,2.0564200204496546
NCI-H2171,serdemetan-SCH-529074 (1-1 mol-mol),1.0572285020282108,1.7185172046165684
HSC-4,72199292,2.0552941548988506,0.5432380989897069
NCI-H2009,36462,0.0033291412741449,2.4472806929697084
Panc 04.03,JQ-1-vorinostat (2-1 mol-mol),1.3014737329174946,1.3413506278999503
JM-1,71466578,1.9829041072742877,2.6238833577888867
A2780,JQ-1-vorinostat (2-1 mol-mol),0.2041997396935529,0.7412712591378187
LXF 289,67291369,3.4412292386368746,3.0448047294090355
NOMO-1,5281321,-2.1390969134868656,-2.252089300030717
NCI-H661,387447,-3.746079371333459,-3.853754029316986
NCI-H460,10385095,2.2920897819597896,1.4771306184633852
EFO-27,3543504,5.270070957864149,4.4825038647223225
NCI-H2009,11497983,-2.437134563400756,4.094526385679472
NCI-H2171,4917,1.7834364774656617,2.8236490560070475
MDA-MB-157,4578,4.4846224734546025,4.5667918463268755
A-673,9935249,0.595201632659186,1.8125535001659805
NCI-H146,4096211,2.4692816884948856,1.9488506256504454
NOMO-1,60750,-2.6028640292275567,-3.3179017375415185
NOMO-1,676352,2.3647709516043336,1.800472923742416
SNU-81,168312962,1.078666024421789,1.7776802710777206
A-673,3081361,1.7117642477526505,2.2627538741541167
NCI-H460,46398810,3.30325787352206,2.5689622614881564
FTC-133,24771867,3.849205905915908,2.581594589530253
KMRC-1,409805,5.852991634240623,4.662494885662482
LXF 289,2708,6.094251503540483,4.90255585788806
A4/Fukuda,11647372,-0.68075141177871,0.34690200424895545
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735,3.360441210058363
NCI-H522,3025944,4.039653719751215,4.1415878039511735
HSC-4,6918289,2.856015155241233,2.7462148039829795
MDA-MB-453,erlotinib-PLX-4032 (2-1 mol-mol),2.999832239704596,2.8421025198046617
MDA-MB-453,67291369,1.3466484853812946,2.7324735181570032
A4/Fukuda,11178236,-5.149024442366163,-3.9086070408584637
NCI-H661,168313200,3.81404568417466,2.8055561010601098
EFO-27,219104,4.121088157278177,4.086043439159622
KYSE-70,46191454,2.1451937437577575,1.6412623288896209
SCC-9,9927531,5.254709651648818,4.784980637246008
A-673,navitoclax-piperlongumine (1-1 mol-mol),0.5796855962539734,0.7978700232036973
CAL-51,16038120,-0.248771562775031,1.113947108999001
JM-1,3634881,1.559410928505107,2.5746507662880207
SCC-9,5113032,4.570528604758655,4.820093894450358
CAL-51,68056272,3.9955701948507247,3.5777424610942092
CAL-51,4521392,4.667802355757324,4.346082461762578
BxPC-3,navitoclax-piperlongumine (1-1 mol-mol),1.3224342280969303,1.6289584497471075
Panc 04.03,BRD-A02303741-navitoclax (2-1 mol-mol),3.819752111817625,2.8372391236883896
A-673,serdemetan-SCH-529074 (1-1 mol-mol),0.8484968738221454,1.7240575936358373
SNU-61,9887053,4.377899885829067,3.3353811050561495
NCI-H2009,25102847,2.121570289721804,2.544035943264506
NCI-H661,54454,0.5886754914082402,2.6312602286836357
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603,3.4306408522961633
MDA-MB-157,46174525,4.215722898807237,4.533984593707944
LoVo,5978,-0.9838296745754056,-1.525899070279829
NOMO-1,44137675,1.7607667559168472,2.8781749172091917
JM-1,ISOX-bortezomib (250-1 mol-mol),-0.4363685688396392,0.10750837564369005
FTC-133,216468,3.7386330008080018,3.7000811152400694
NCI-H522,5284616,3.1429047752915036,1.9115651247986662
A-673,6450551,1.2504532759531255,1.6804109507965697
MDA-MB-453,2126,4.599537631708682,4.5639112175719365
FTC-133,12001922,3.1425787892022656,1.7900611185745496
BxPC-3,6610355,3.939463034432562,4.602924234186979
Panc 04.03,72193861,4.339971647759762,2.1712028114916806
DMS 273,984333,0.9143511576606916,0.10581670172509895
NCI-H460,126941,-2.220790788147435,-2.636107506031586
SBC-5,11178236,-5.106449128542812,-3.369173257658781
A2780,11497983,-3.587231584220661,1.3530523399229506
EFO-27,5278396,3.98166727080577,3.693841614020382
NCI-H460,40482356,5.06381124686115,3.670883450901277
OVISE,51039095,3.497583622307714,2.824056971790025
HCC1143,56946209,-4.25120546555742,-3.6374587059583616
NCI-H2009,3025986,-0.6988289053859157,-0.8985215812237476
DMS 273,44543605,5.15097132829554,4.0435738558515375
HSC-4,23635314,4.118860430098142,-1.6729642290245144
FU-OV-1,107970,2.0514231206369686,2.334855049909372
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744,1.3688975938534833
A-498,5284329,4.906845392884974,3.3921645912203195
NCI-H522,selumetinib-piperlongumine (8-1 mol-mol),2.5567872657123307,2.781086453093602
A-673,11612883,1.6900414301434703,2.1883974446955463
DMS 273,11507802,0.7884214749573938,0.7300097316476719
NCI-H661,44486219,4.876697308801278,4.369588151450271
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178,3.375144362639934
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123,3.9066223068946893
LOU-NH91,JQ-1-navitoclax (2-1 mol-mol),-0.9494893938719444,1.0344952533604483
SNU-449,135875424,4.841371934548395,3.896771314035182
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157,2.654590784732452
NCI-H292,72376,-2.1951743702669573,-1.751069911383557
CA46,36462,0.0715644321871689,-0.29160381023141035
A2780,54678924,1.3135335490837166,1.7101878819161687
JM-1,9926054,1.6867956204893688,1.4947909492244655
LOU-NH91,4788,5.956614254075031,5.7809228443403695
G-401,navitoclax-piperlongumine (1-1 mol-mol),0.8522562027001119,0.9564791688528824
YAPC,9929138,5.651296587688524,5.568470332288885
CA46,613753,2.777360120502711,2.696688284532568
BxPC-3,159324,1.5239234886257875,3.2513438923765166
DMS 273,9911830,2.0619640796568848,1.9884432630633069
LOU-NH91,selumetinib-navitoclax (8-1 mol-mol),0.0322992078492161,2.2973882964445433
ONS-76,17755052,2.9613727126940126,1.6767445212834307
Panc 04.03,navitoclax-MST-312 (1-1 mol-mol),2.2985193388482177,1.0375238586041111
DMS 273,serdemetan-SCH-529074 (1-1 mol-mol),2.0860866366199584,1.5225703108128343
BT-549,56963564,0.7590937126260752,0.603615258200506
A4/Fukuda,135398738,0.2588260022635366,2.7665537984190145
FU-OV-1,6918328,-0.3184221939986219,0.4410484603643393
NCI-H2171,119182,5.854927706564024,-1.8004725616301787
LXF 289,46224516,3.632609368126253,2.596486976666609
BT-549,66577038,3.347380186099457,3.1359458160673426
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528,1.0299288955031354
NCI-H460,25183872,2.110783783288614,-0.7808403377704921
CAL-51,17759555,3.5733302595078182,3.556190267677088
HCC1143,4788,5.8180322078124265,5.579387686458749
NCI-H727,selumetinib-PLX-4032 (8-1 mol-mol),-1.7195859584086806,3.1772895957330194
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103,2.0621952979056184
A-673,11656518,-0.6930464248114873,0.8610941949966253
NCI-H522,12003241,-1.5672925136718587,-1.159010475073728
NCI-H2009,19582717,2.816304614086765,4.354694255475397
LXF 289,9911463,2.935801973679381,4.103438633475263
NCI-H1623,44202524,1.6623127043604982,2.2160787657173846
NCI-H522,9952709,3.5153076410238477,2.582429284182197
EFO-27,4378219,5.419366677908557,2.939471041108875
FU-OV-1,11404337,-0.2130364442314083,-0.30805218368678644
FU-OV-1,119607,4.651010364988691,5.1641451096734095
NCI-H146,135875424,2.9115600315347057,3.6601589002752903
LOU-NH91,11152667,-0.304989451834292,-0.39760635749920875
SW1463,439501,-0.3046644173954531,-1.8198393015962047
LoVo,25022340,4.929882293123705,2.847935566067512
NCI-H1623,23725625,5.633484297207613,5.278520018489969
KMRC-1,439501,-2.7889227637684773,-2.1126870121388936
A4/Fukuda,9907093,3.513986602103764,3.56769608712171
A2780,969516,2.2684147801302155,2.35687219335187
HCC1143,24753719,5.247680835091332,4.272896429300921
DMS 273,25183872,-1.4455230978287994,-1.376806640401191
SNU-81,3854666,0.9917295007006844,1.7323660723505452
NCI-H522,57330099,4.380671698756577,4.0545929885754
A-673,135421197,0.3124298336996849,1.5845092754287404
NCI-H460,46398810,3.30325787352206,2.5689622614881564
NCI-H661,52947716,-6.022145864838143,-0.7587768500478816
CAL-51,9907093,3.7886359098281783,4.082683288168919
FTC-133,erlotinib-PLX-4032 (2-1 mol-mol),4.762605584233989,2.8817540711913354
SCC-9,11640390,4.170413196512925,3.6237023081906754
SW1463,56973724,0.8689023909239705,2.5528172200462858
HCC1143,24180719,4.266131781804432,3.4843473538209953
KMRC-1,135398738,5.381791034510906,4.086123389007368
BxPC-3,36462,3.4182720226712457,2.264512303363443
MDA-MB-157,4261,1.9483424687424111,1.6824631940155863
NOMO-1,2708,4.2098167660909525,3.2075222790493148
A4/Fukuda,10410894,1.64506751408979,2.7755668948034344
A2780,3384730,1.1479192192658911,2.2352139737946386
SNU-449,439501,-4.772752939359215,-1.8906795859162457
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288,-1.0596179206378848
DMS 273,51037431,4.4079331684726775,3.149407064185244
A2780,16741245,2.3123767413084786,3.7666245978718695
SNU-81,42642645,1.3921275935464503,0.46556558665232656
CA46,44632017,0.5480853683486498,0.6333984534132695
A-673,71304818,1.350808371963784,1.9681155383293558
SNU-449,6914657,-4.967870149056919,-3.560013108880452
MSTO-211H,25150857,2.632878402859221,2.2729178794398424
MDA-MB-157,26596,-2.8480155125253623,-0.990269871318657
LXF 289,9929138,7.38651684018349,5.549432238463367
G-401,25183872,-1.5190566583165497,-1.2851235116869657
A-673,241158,1.6738540084680422,3.024769951694866
SNU-61,25195348,2.878615726844662,3.453272249234025
MDA-MB-157,53392493,1.7008245883035995,2.6375239118855154
LoVo,68056272,4.365145786196869,3.567031774777608
NCI-H2171,6918837,-5.273009588122425,-4.047864907151144
NCI-H460,168312962,-1.8333752522095308,1.8719892537761536
CAL-51,44259,0.1826439745217317,1.080518919685819
HSC-4,285033,-0.8602386046724618,-1.5988863576417025
EFO-27,25105715,3.778793980481446,3.4580026616181367
A-673,1641662,3.2069303925294625,3.2467176179624904
KMRC-1,3854666,2.659759078644905,2.0636422441005475
DMS 273,375860,-0.4468381354972334,-0.3389858623229891
NCI-H661,10231331,4.850159308010921,2.070516397976499
DMS 273,16725315,5.248612259787856,3.8625226822418073
NCI-H292,crizotinib-PLX-4032 (2-1 mol-mol),2.353099722482166,1.9936491997838257
NCI-H661,73707398,1.1965083244926786,1.5388651923190253
OPM-2,JQ-1-vorinostat (2-1 mol-mol),-2.42287599285764,-0.4104759314057816
NCI-H1623,135421197,3.7764453326534855,2.127556053073736
BxPC-3,24951314,1.2340413323146109,1.6205353921857406
MSTO-211H,navitoclax-birinapant (1-1 mol-mol),-0.9866972359238844,1.4571574594185983
NCI-H146,119182,2.1823445512420308,-0.8460005166796501
G-401,4578,4.054730999265937,4.083165960966983
MDA-MB-157,6918837,-2.759774975538005,-2.2897338934375613
EFO-27,9907093,4.474758252228614,4.325040354373187
HCC1143,navitoclax-gemcitabine (1-1 mol-mol),1.7090792961792267,-1.0951221697099347
NCI-H727,navitoclax-MST-312 (1-1 mol-mol),1.3064491848942938,0.9231772990323865
FU-OV-1,carboplatin-etoposide (40-17 mol-mol),3.4615233575458992,2.929745703176505
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023,-0.5120681660914022
NCI-H460,3025944,5.476008686130055,4.289511316472741
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122,1.5117445010867283
NCI-H292,9915743,-0.4817131806939655,1.1234686858058187
LXF 289,44202524,1.498501439362416,2.161459739422792
OVISE,135411,0.7729741022965545,0.8061952207647698
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445,4.624514519849923
NCI-H2009,5746,1.7505534195957702,1.4019088310689267
A4/Fukuda,10184653,1.3612642262853822,0.8240086558962316
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382,1.5055365592909535
BxPC-3,ISOX-bortezomib (250-1 mol-mol),0.0666490306431122,0.8036228870119017
JM-1,375860,-0.4977027167273706,-0.7604668094430858
SNU-61,46943432,3.2717403410494397,1.7598116682389504
NCI-H146,168313200,1.5894074456272884,2.8588781538410495
HCC1143,piperlongumine-MST-312 (1-1 mol-mol),2.011691576039941,1.7678277615201998
NCI-H2171,6184667,1.4164127707768046,2.59493004927375
DMS 273,10184653,1.3805891581139824,1.043914390106441
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025,1.1103390936339421
SNU-81,24856436,-0.0712468901893707,0.2547551904681944
LXF 289,71680916,5.339150924844951,4.721632538592842
CA46,5291,2.960224941202677,2.8321729960737794
NCI-H2009,5329102,2.1297157842750756,2.174183311237717
HCC1143,49793307,-2.279288310815399,-2.401705535000974
HCC1143,15953870,6.0969880807250085,3.4104401899753483
BxPC-3,2749,2.8971498792709784,2.1772607446217576
SNU-449,12003241,0.2005365129445947,-0.8562773142422219
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393,2.164837759623231
MDA-MB-157,2733487,0.3711294020076626,6.187659478034983
NCI-H292,3025944,4.3344233170115185,4.283839078970476
FTC-133,637858,3.731185140297224,2.1958009791627795
NCI-H1623,387447,-3.670338978810225,-3.6959855011438725
JM-1,5394,4.3191880254190425,3.2312132295720524
NCI-H292,alisertib-navitoclax (2-1 mol-mol),2.7354640490460724,1.0999190727657118
MDA-MB-453,24964624,0.7400526464517642,2.320849163062382
SBC-5,637858,3.033148612268187,2.0207005957254465
HSC-4,3825829,4.330540788358233,3.9996165520291047
LOU-NH91,26596,-0.8372049149458933,-0.9638959110009823
Panc 04.03,24180719,4.502790622897018,3.591320409408992
MDA-MB-453,44486219,3.97168660448306,4.23317397560234
ONS-76,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0736426571342059,3.4515118157580913
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566,0.7335686786231976
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609,1.3135387014926614
MDA-MB-453,carboplatin-UNC0638 (2-1 mol-mol),3.2412925949460223,3.0339187974460433
A2780,46398810,1.6945681809511193,2.2318452058302016
ONS-76,44493528,4.396938069944904,4.486215155936081
HSC-4,3854666,2.969420021692798,2.0905205016870863
SNU-449,5291,3.951163668523845,3.5782421891969833
MDA-MB-453,216345,3.4613524333124337,3.6330581948071745
NCI-H727,71680916,5.541731669631066,4.784308513349032
NCI-H460,4261,3.676509117184606,1.733073408036625
NCI-H2171,10184653,0.99528741531969,0.9231057499247473
FTC-133,54626689,4.834884112239084,4.516043227596936
A2780,55283,0.78738067747292,2.738902778591564
OPM-2,753704,3.6202062566191984,4.05849365097041
NCI-H522,53392493,1.8355339375888644,2.2648346113407722
DMS 273,10127622,5.766745520319409,3.674158067925603
ONS-76,BRD-K58730230,4.314454311755605,3.8115179845828475
MDA-MB-453,49766530,3.3081056054922064,0.09720129913452837
A2780,16065773,0.67384212990199,2.059559739617604
JM-1,241158,1.7269305863155773,2.3764192679558933
A4/Fukuda,71466380,2.851115718652883,3.9852708909946557
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322,3.3854477183569474
MDA-MB-157,16722836,1.792866712111087,1.7267326673158585
NCI-H460,6852167,4.590065962834362,3.247586918418879
SCC-9,375860,0.1694000381305893,-0.2542362257795046
CAL-51,54649381,3.902782783768603,4.042539487846979
EFO-27,2708,5.128228617584202,5.146355654788575
G-401,6450551,1.2745400494425214,1.92939776364808
SNU-449,168313016,5.914877518762689,4.626302383638649
NCI-H661,654092,0.3537062860674825,-0.11221834596223282
SNU-61,5284616,3.808934677012338,2.394542742952952
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113,1.2561953202892244
KYSE-70,25195348,5.534160735777195,3.0780068018528657
NCI-H2171,135421197,2.0026019926205185,1.5368668129454752
NCI-H460,4261,3.676509117184606,1.733073408036625
DMS 273,1641662,3.247845954250749,2.857016447072488
BxPC-3,6914657,-4.023901786471393,-3.7624143952628772
CAL-51,9936388,-5.638746232401389,-1.5784178952126433
A4/Fukuda,25161177,3.5710974046751804,3.4887926584416813
NOMO-1,24821094,3.1222382635594967,2.378393301795769
A4/Fukuda,53232,1.4709221708336295,2.515901956606823
A-673,9840324,5.96119566119886,5.596897601729783
LoVo,613753,3.444351424595812,3.2293120951460903
FTC-133,4477,0.2258553638980791,0.6458908613967747
MDA-MB-453,11214940,4.455338804672604,2.362405046999761
A2780,56649450,-0.3009304069219352,2.9789482086655017
HCC1143,89928392,0.2924123173203115,1.6057400122092194
BT-549,6852167,2.654575121453327,3.2290029734151218
G-401,375860,-0.2910974790080222,-0.4393123425849826
NCI-H661,613753,3.3170674343428708,3.3407627806748685
YAPC,71304818,2.728620236586343,2.568457381234452
NCI-H292,3503,2.756562172316919,2.4292315036947443
OPM-2,44819697,-1.6539436611429392,-1.540390380117605
HCC1143,60700,1.3373007617879429,-0.34995479398936413
MSTO-211H,446155,-0.2868964860821164,2.8448180294581613
A4/Fukuda,2708,3.0461577581065007,3.509051504035276
SNU-61,126941,2.173772773827979,-2.2776610221192586
DMS 273,selumetinib-piperlongumine (8-1 mol-mol),4.661418163963333,2.375989677719009
HCC1143,444795,4.803024181226615,4.6091084487645055
JM-1,441298,2.4952150007247393,2.259320915275197
DMS 273,44507138,4.08877163590395,2.082549234145684
Panc 04.03,5291,3.9842309161066063,3.763467852492101
BxPC-3,3062316,-1.891072672499,0.6769246821590655
KYSE-70,15983966,-0.1847866067827735,-0.07611696874326611
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932,-1.1296076698454722
DMS 273,44607531,1.5313743675110545,1.2566906858021047
NCI-H292,5746,0.9253562515034884,1.296087681092599
NCI-H146,6914657,-5.6838858588772245,-4.284617722775982
EFO-27,25150857,3.1416161415552173,2.4763306764752917
SNU-61,54618771,-0.470226071786205,1.3118706051250724
BT-549,1716436,2.964006130486385,2.9576905451436004
BxPC-3,4521392,4.6952932183187,4.482162342795315
BxPC-3,5328940,0.9544734009845622,1.540076198686871
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014,3.2280978389799575
Panc 04.03,16013152,4.359497957481629,4.219776491620681
A4/Fukuda,3062316,0.4248767517614322,1.227973968351642
A-673,11609586,1.032418246609784,2.059777124086746
SW1463,322968,1.9625017896764745,3.16012372763781
JM-1,11427553,0.2949480151387566,1.045161783367057
CAL-51,11497983,2.6322425573174213,4.229495844639286
Panc 04.03,12003241,0.3752932920389255,-0.9789030213484438
FU-OV-1,216345,4.02478525181321,4.0715235852081175
NCI-H522,89928392,1.1479343378844449,1.1165661978806867
NCI-H460,11485656,2.6212830818798065,2.5777793650220207
LOU-NH91,6438330,3.480541802748286,2.4691617399804127
MDA-MB-157,11228183,0.9797898244038654,2.141943519045285
A4/Fukuda,10385095,0.4549399411675465,0.9735935951507573
G-401,241158,1.9889661714459972,3.3260794990887605
MDA-MB-157,5282054,1.4096594950320644,3.6465105843221943
NCI-H522,11404337,-1.4542746262182442,-0.5036385785096205
NCI-H661,322968,4.732962604670861,3.7764893783511404
NOMO-1,65064,5.083490310509571,4.207437550949762
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284,-0.19615181577024804
BxPC-3,1716436,3.6064873492654943,3.166985636967462
NCI-H2009,24753719,4.192950544032197,4.259745026953979
BxPC-3,136227924,2.62858882862477,3.0346628906524273
OPM-2,alisertib-navitoclax (2-1 mol-mol),-2.0231135401510967,-0.8663772088818343
SBC-5,3854666,0.5257720708282073,1.8890683605757954
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876,0.3570575433918269
NCI-H460,1750826,3.3189287492303197,-1.1504534453175022
A4/Fukuda,4705,2.104501352907832,3.055788733801354
BT-549,24821094,3.680768028115557,3.2358016593735033
NCI-H727,vorinostat-carboplatin (1-1 mol-mol),4.5535915499208,2.9710573845253965
A4/Fukuda,46398810,1.5683404384737003,1.9741377826907662
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702,0.9511451576491545
MDA-MB-157,3062316,3.257879214731084,1.0447103773099142
NCI-H727,71466380,5.170266193783112,4.588750687522552
OPM-2,selumetinib-tretinoin (2-1 mol-mol),2.843446228896377,2.4045161926403686
HSC-4,16038120,1.7232268235274473,0.9803710713359913
FU-OV-1,53392493,2.412509849766808,2.801175584746167
NCI-H2171,3634881,2.317126021520602,2.6006361602685013
DMS 273,54618305,4.272082763698834,4.239828281942101
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701,-3.6692351482933634
SNU-61,9926054,1.8929452670989917,1.779555150768422
MDA-MB-453,216239,1.9202357593604051,2.6008211394633185
A4/Fukuda,252682,6.117343290485243,6.359277657278892
Panc 04.03,11455910,2.454958233695195,1.4106566116827322
MSTO-211H,24951314,-1.1401244239295247,1.3404046736180373
A2780,navitoclax-sorafenib (1-1 mol-mol),1.0762822607268765,1.6116733878222183
NCI-H146,67156097,-2.3396756899377595,-1.0102642455694966
NCI-H727,alisertib-navitoclax (2-1 mol-mol),5.700791179880255,0.24385717978960542
FTC-133,25150857,3.5794152247995004,2.505457870192145
KMRC-1,24797083,0.8876318381449373,1.5000943577032797
KMRC-1,5282054,4.624285853166485,3.6699002268102743
MDA-MB-157,36462,0.1516360669313773,1.9587899327600546
SNU-61,11609586,2.423992088951442,2.1820876817427965
MDA-MB-157,4378219,2.6716514190617104,2.6182871453977494
NCI-H2171,navitoclax-PLX-4032 (1-1 mol-mol),-0.7537972454626107,0.7581439132089449
A4/Fukuda,57519531,1.5811593813701257,1.795728171561844
EFO-27,136227331,4.702115323060179,4.052410355825307
MDA-MB-453,9952709,3.2945084007394616,2.9389088531681824
G-401,54143018,0.971383874427432,0.21473548733932998
EFO-27,9927531,5.387402639259967,4.843529112577983
DMS 273,3025986,-1.574939205922683,-1.2101411075071002
NCI-H522,26596,-2.5500947066960276,-1.4489909703021018
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373,2.0559327533250955
CAL-51,5280436,3.749440064194485,3.3699255900025604
SNU-449,25150857,3.008716268425874,2.59545727299543
KYSE-70,23582824,2.6933165956875964,0.798994956136262
OVISE,54454,2.25285494204451,2.7220221712302415
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569,2.867418927811589
MSTO-211H,5282054,2.057664237493602,3.696676283530891
CAL-51,16720766,0.5416929462446769,0.4456278478371695
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253,1.54984839562796
EFO-27,navitoclax-pluripotin (1-1 mol-mol),-0.1072190892754552,-0.6598906978007116
SNU-449,446155,0.8119451390236352,2.7777453807334735
NCI-H146,375860,0.4213004900992469,-0.26001949558952864
CAL-51,5281321,-0.4656602142962174,-1.2177221930587205
SNU-449,navitoclax-piperlongumine (1-1 mol-mol),2.97767132898613,1.8366251043654562
NCI-H2171,44462760,3.915746717375186,2.801435782772266
SNU-61,151289,1.0402759766313254,0.8908605698638665
DMS 273,24856436,0.3584417497554937,0.30152890547844274
CAL-51,71466578,5.340961831553399,4.600268853405211
HCC1143,44607530,2.3193328073886628,1.826248657212855
SCC-9,3136844,4.895725881728452,4.36226970386352
CAL-51,148198,-3.728190383000159,-3.691139199473469
DMS 273,25126798,4.049346019168164,3.599922054848073
A2780,JQ-1-navitoclax (2-1 mol-mol),-0.0889318851591051,0.47345321936209034
A2780,9825149,2.396834344892177,2.044620438494439
CAL-51,104842,-3.020036586723177,-2.7448032806930613
A-673,676352,1.522059533133182,1.8422942887811717
FTC-133,9967941,5.123707260677636,3.631602753904786
NCI-H2171,56963564,-0.0417490265139498,-0.3236352008108906
DMS 273,753704,5.000496745911757,4.2968916241620825
JM-1,6918837,-6.173851145057706,-4.672907026777656
KMRC-1,285033,-1.948983558292048,-1.6982202471929475
FU-OV-1,54454,4.96368280899624,2.74927921208026
LoVo,11152667,-3.1828514843907967,-0.4827252707501121
A2780,3081361,2.3669572433114663,2.2376222591082517
CA46,11497983,3.715862022418827,-0.42723004133111336
EFO-27,9952709,3.7128554087131658,2.9835872961496603
SCC-9,3503,2.580691900576731,2.475629104851962
CAL-51,42642645,0.4324607401831485,0.8256202146416954
NCI-H522,462382,-0.0152056919239,0.7753885512787255
NCI-H661,44632017,0.8459474985730225,1.626447371831344
LXF 289,44137675,2.0502885463252665,3.636861497069008
SNU-61,11404337,-0.7844361329588494,-0.42492991210580505
FTC-133,15983966,2.5675405254421113,-1.1939456606703451
KMRC-1,56946209,-5.003023698532595,-3.9581659515904395
CA46,9866186,-0.3275085520058725,0.17909254631165894
DMS 273,23635314,-4.293922540672693,-2.8359747454255473
LOU-NH91,4259181,1.0248896787271708,0.445979237361477
SCC-9,46224516,2.803045033456012,2.663141261250626
SCC-9,6918837,-2.658799999554452,-2.3400847266889544
FU-OV-1,tanespimycin-gemcitabine (1-1 mol-mol),2.043943445508653,-0.7761141681494662
LOU-NH91,15983966,2.104720476479653,-0.6253255538733509
NCI-H661,285033,-2.1039671806681985,-2.0369904615266985
G-401,16722836,1.0452487365316014,1.2990301639290343
SNU-61,11964036,1.5202881054490238,0.8344564788744256
MDA-MB-157,374536,-0.5698586384338129,2.402935119856706
OVISE,168313047,2.139797955827927,2.3743237463204
LXF 289,400769,-1.8947060859446272,-0.4668746186343106
BxPC-3,10302451,2.105262518783424,2.8798056008147546
KMRC-1,446155,2.327207673229407,2.6694561664895406
KMRC-1,selumetinib-decitabine (4-1 mol-mol),7.0489920004822855,3.033145889829228
MDA-MB-453,421610,2.7771188964172664,3.2071719014660016
SBC-5,navitoclax-gemcitabine (1-1 mol-mol),-2.8520173060125296,-1.6607148933169558
OPM-2,2113511,3.5660346238413565,4.870081480924794
ONS-76,31703,-1.5971524717515937,-0.6776677509762626
CA46,100016,3.773189878640827,4.87234820585984
MSTO-211H,tretinoin-navitoclax (4-1 mol-mol),1.3222230725566817,2.8246390191336945
EFO-27,11167602,3.5204241483481686,2.515719378174137
SNU-81,6505803,-0.5044882096333503,-0.6150923022060124
NCI-H727,1716436,2.7605133955676178,3.011157835451513
OVISE,10302451,2.747913318530857,2.8705629645976747
NCI-H292,24772860,-1.7688616980402292,-1.8507541206577038
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279,1.98405340756549
Panc 04.03,702558,5.6133476434957,5.4403528272171915
NCI-H727,24964624,2.2819429425827984,2.5770217560721496
MDA-MB-157,2828334,5.757584300180036,6.186421470140882
NCI-H2009,67291369,0.975633217461442,3.2647829894485945
EFO-27,421610,3.836140121936173,3.1436298406696643
G-401,vorinostat-carboplatin (1-1 mol-mol),1.81058220615163,2.549038929935346
LXF 289,11626560,1.452143156792952,2.00207015714287
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614,3.050536035663987
NOMO-1,9444,3.521396869825756,3.979397141701278
KYSE-70,24821094,5.190593902676824,2.964843863707401
NCI-H292,104842,-3.713576042756873,-2.113952608967864
CAL-51,23725625,3.781531245600544,5.061974336523889
MDA-MB-453,11175137,2.676203543730399,2.710919817900378
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982,-0.8526353404479703
OPM-2,3038522,1.4393753112244685,2.75969528235565
KMRC-1,107985,-3.501321688193531,-3.704772041581703
G-401,selumetinib-piperlongumine (8-1 mol-mol),2.3292817687818768,2.8267802869286927
FTC-133,9549297,5.410509835078823,2.406372196538966
HCC1143,66577038,3.1905565845946993,3.0326376398077253
A-673,73707438,5.240927680887528,3.928370154486748
LoVo,44137675,-1.419079349485425,3.5797936961942645
SNU-449,3503,2.7484718807665396,2.527162268184827
JM-1,11960529,4.3881984442046384,3.2845806781297324
FTC-133,5460769,4.281031552964228,2.888971291467188
LoVo,3025944,2.9449078290251256,4.251856932811938
A2780,613753,3.052273906836147,3.057777859461881
NCI-H661,navitoclax-MST-312 (1-1 mol-mol),1.292744867259036,1.0705431140203272
NCI-H2171,navitoclax-piperlongumine (1-1 mol-mol),-0.1756857272470243,0.44435503268124826
NCI-H727,119607,4.980733327072692,5.278282243018018
A2780,15983966,-5.363621110890126,-2.698611213543726
LOU-NH91,52912189,2.021653283813576,2.5095127300573097
NCI-H2171,46926350,-4.867098709680934,-4.08453378563846
JM-1,11222830,1.159649219525665,0.9620819086529444
Panc 04.03,9887053,4.247469701197239,4.075717617985214
MDA-MB-157,6918878,0.7604288199483474,3.2582169258338296
DMS 273,25150857,2.151062266440261,1.9181888860622989
NCI-H2009,637858,2.463099291034241,2.1412489714787823
A-673,89928392,0.0772153864579325,0.9368082919217852
OPM-2,56646779,4.429673228200906,2.236962473029724
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117,1.4862101086980362
MDA-MB-157,104842,-7.463907387011825,-2.711358928579025
ONS-76,tanespimycin-gemcitabine (1-1 mol-mol),1.9345282385200928,-0.481724460117688
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.9040519635519622
SBC-5,23725625,4.5493880465204235,4.844209164493273
CA46,16736978,0.453820731366511,0.755297754985182
SNU-81,5287620,-3.371703836172312,-1.8921648590440014
OPM-2,9929138,4.40255967212205,4.377948923556645
CAL-51,107985,-4.126908547019261,-3.615512752860047
SNU-61,4261,1.9153687598051303,1.2429687052832705
KYSE-70,5311,1.3049127753558711,1.6345716228633236
A2780,2874250,4.6617329815359545,4.714517815852004
A2780,46843906,2.4977538844634637,2.1472574079181586
FTC-133,11234052,5.0298463189452445,4.174545860920255
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448,2.090088815120444
OVISE,5282054,4.4060399380094415,3.792337196960185
HCC1143,4096211,1.556998125169598,2.1600438219974456
NCI-H661,11364421,-5.690348879388773,-1.7825228315510815
MDA-MB-453,docetaxel-tanespimycin (2-1 mol-mol),-3.838890117483947,-2.5403066075726617
A-673,11427553,0.6536689467636717,1.7387975905959911
JM-1,6917907,-6.147483124234289,-5.381482840730542
A4/Fukuda,9926054,1.7963505717751411,1.6827130592319548
Panc 04.03,65064,5.203402541242721,5.09690740465878
MDA-MB-157,25154868,5.338832763625219,4.244646966820501
A2780,3689413,0.5219259729031659,-0.9674748975500426
NOMO-1,2828334,5.727397129817869,5.706399205950869
NCI-H292,selumetinib-PLX-4032 (8-1 mol-mol),2.9334189816499476,3.4840017279560374
JM-1,carboplatin-etoposide (40-17 mol-mol),-1.4071886446096369,0.5329769392070702
A-498,10385095,3.0502652475567347,1.7043529491146863
NCI-H460,5280436,4.847067650781305,3.476062910364028
NCI-H146,71304818,1.6140243095299662,2.349505537495655
SNU-61,135398516,5.118120351018792,1.9223446273291516
HCC1143,9967941,5.23006520077408,3.741071147660453
SBC-5,51039095,3.807088636542375,2.4164965536881384
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.1936233832486773
NCI-H1623,vorinostat-navitoclax (4-1 mol-mol),1.3203635672750993,1.007710924322278
HCC1143,44137675,2.963488174732173,3.5765972741195795
EFO-27,15983966,2.453959425588555,-0.753977104987893
NCI-H1623,10184653,-1.536462891864862,1.2514720316261398
JM-1,216468,0.5768131010636649,0.9154639620192367
KYSE-70,5278396,3.1929088159597656,3.5211249108610865
SW1463,216345,4.078496637973622,3.7050763869745627
MDA-MB-157,54619267,4.18775168816921,4.08022252007753
LXF 289,16065773,1.584092119185821,2.538186303013956
Panc 04.03,107985,-4.416167995938274,-3.334486366288861
SNU-449,11238147,4.105269625362408,2.824725335189448
ONS-76,66577038,3.2799369572038977,2.8933240475010393
NCI-H1623,156414,-2.396664487331107,1.2869720280002996
DMS 273,4578,4.680938801431088,4.108715432748621
NCI-H2009,selumetinib-piperlongumine (8-1 mol-mol),-1.1472655544324035,3.290427805003569
OVISE,73707398,1.6715872061037895,1.5155171179070563
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818,2.384091764554119
MSTO-211H,navitoclax-PLX-4032 (1-1 mol-mol),-0.7263097826113902,2.002227080071536
G-401,2945648,2.835527608429738,2.397097008579893
BT-549,89928392,1.2423762488932544,1.6975289259105164
NCI-H146,107970,1.621489555747201,2.0184318772378345
OPM-2,71466380,2.758760560312852,3.793719661288677
HSC-4,15547703,3.6362413258054063,3.3272480378756604
JM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.7552309582979843,0.6769967958355402
EFO-27,navitoclax-sorafenib (1-1 mol-mol),3.3507850442139024,1.7634792977079672
MDA-MB-453,navitoclax-MST-312 (1-1 mol-mol),1.1594914654574615,0.7948426807311643
HSC-4,17759555,2.4253306074953978,3.5005090339137195
FTC-133,2945648,3.116487231281591,2.9536350707722403
BxPC-3,3825829,3.4267099071969738,4.256410981450274
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699,3.801640971754935
NCI-H1623,3025986,-1.391492623029173,-1.0734939086539066
BT-549,3025986,-1.1986125704978905,-0.607753130560564
JM-1,25227462,-4.63830716322272,-1.3941524032397288
EFO-27,4477,1.1283660363220671,0.7288375974139395
LOU-NH91,52947716,2.984350097195249,0.6963288289816351
CAL-51,44489367,4.725330666921359,4.633922355459026
DMS 273,2949965,2.5486766063035056,2.6449378190051713
MSTO-211H,36462,1.134601353001676,2.1249769034192103
BxPC-3,4917,2.980696163243889,3.207470632269687
CA46,9903786,1.650432742323398,1.9046498360451078
CAL-51,156414,1.13799157004995,1.4645388731848612
OPM-2,6610355,3.590135914900994,3.814034272048025
FTC-133,doxorubicin-navitoclax (2-1 mol-mol),-1.6634242865770594,-1.0285060046266894
NCI-H661,439501,-2.903837615768139,-2.0286874436556888
Panc 04.03,9952709,3.610885547265169,3.4080533208681203
BT-549,navitoclax-birinapant (1-1 mol-mol),-2.097754918128948,1.4843753876810462
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.801266092932226
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.7632742882800363
OPM-2,2708,4.148168261065231,3.4335500789411877
NCI-H661,10385095,0.8549868667974337,1.4502195998912168
JM-1,24785538,-0.4888535449792195,0.7173194562161557
FTC-133,6610216,5.488595178062795,4.122557458193306
MSTO-211H,216468,0.7149646325927866,3.1959590045282495
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864,1.6412909364596902
NOMO-1,5978,-2.430694050184869,-3.0592501050945815
DMS 273,216345,4.389361768667068,3.4404804472497097
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883,2.682351714799079
LoVo,676352,2.5317553470156646,2.097618069508832
Panc 04.03,107970,2.70125557955606,2.4147766125105603
HCC1143,11427553,3.376761154443363,2.7473948170688307
BxPC-3,piperlongumine-MST-312 (1-1 mol-mol),2.334096835358741,1.9446036433701608
FTC-133,salermide-PLX-4032 (12-1 mol-mol),5.419117653198884,4.771050032593787
NCI-H2171,vorinostat-navitoclax (4-1 mol-mol),-0.1406498808904326,0.00567581671725279
NCI-H292,11626560,1.446983052748098,1.8678822450082375
EFO-27,3062316,-1.351094232476051,1.2939604397357742
MDA-MB-157,2746,2.873003215594031,3.4062201210906466
LOU-NH91,24180125,2.532676427085935,3.040614421225844
JM-1,135411,-1.048960589681706,-0.2865827317135395
NCI-H146,644241,1.2089846023639548,2.0593594116508482
A4/Fukuda,72199292,-0.4044306818473915,0.6042177252116191
SBC-5,135421197,2.079587314097717,2.03704621589502
SNU-81,6918837,-2.735310336273069,-3.419590756587636
JM-1,7326481,2.606242200480973,2.603467218453121
LXF 289,67156097,-1.7104573080698593,-0.3718540430630689
CAL-51,89928392,1.068329558331595,1.232793040346623
A-673,6505803,0.2745970276233078,-0.6043704594456131
FTC-133,carboplatin-etoposide (40-17 mol-mol),1.440649023013039,2.866545589565214
SNU-61,15547703,3.101064478021952,2.8073990583987705
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585,1.9939906670253855
SNU-449,16065773,2.84526561612217,2.371477895950984
MDA-MB-453,53392493,1.7017875748321412,2.5921514856836296
SW1463,11317348,3.510696959395443,2.006787984845323
MDA-MB-157,11214940,-0.245291289631715,1.9083668899099129
ONS-76,navitoclax-pluripotin (1-1 mol-mol),-0.9678858040482444,-1.0978773953233496
OVISE,44202524,4.183655897410181,2.392609637852849
A-673,11964036,0.9382905451812168,0.9330903908322208
LXF 289,3503,2.5386473527097837,2.064432503490462
MDA-MB-453,54678924,1.5140521677167769,2.402324821536389
SCC-9,2749,3.600343159035071,1.831628356519723
CA46,9840324,5.575806842573594,5.429599633782043
DMS 273,54143018,0.522600880214995,-0.12590808262720532
KMRC-1,selumetinib-PLX-4032 (8-1 mol-mol),3.77714123562175,3.18194679536125
FU-OV-1,25102847,2.696211974787464,2.353131846757884
KMRC-1,73707398,1.5458693028147192,1.443573239110866
A2780,5287620,-3.13264442622338,-2.204996122109781
NCI-H460,54619267,4.901891634717457,4.105556880664962
EFO-27,2945648,3.241602940948522,3.091696042373525
NCI-H522,25105715,3.4847863866008755,3.0580184774676207
SBC-5,638278,3.4285441526954687,3.118991070262642
KMRC-1,piperlongumine-MST-312 (1-1 mol-mol),2.0343376342805906,1.7642245750463115
CAL-51,6918328,0.3807555589851347,0.1956222362179533
NCI-H727,11497983,4.370504456176288,4.188807740867378
NCI-H460,4259181,-0.2054535095090753,0.28551161081215454
FU-OV-1,16741245,4.362196150231273,4.022320416084039
SNU-449,9911830,2.1326623866395487,2.4292040489640194
NCI-H727,5278396,3.8599732465447247,3.5430036209419495
MDA-MB-157,44566777,-1.1276584651283623,0.8084304761804597
LXF 289,656346,1.157307128170796,0.9260623735357114
CAL-51,176870,2.9999818119422175,3.3412549548245045
NCI-H661,JQ-1-vorinostat (2-1 mol-mol),1.2466897580827978,1.2638871952831237
SNU-61,10184653,-0.5580603125211917,0.939994247285363
OPM-2,25126798,3.830489811395835,3.3655554937053718
SNU-449,49793307,-2.0136733678876335,-2.006928739135985
NCI-H2009,60750,0.952457111724262,-1.4353838184004153
MDA-MB-157,60750,-2.031758614917575,-1.7367147502976903
Panc 04.03,selumetinib-tretinoin (2-1 mol-mol),5.031160903281955,3.4769751652715577
MDA-MB-453,44137675,2.41330993625909,3.346744252877895
DMS 273,5287969,-2.213452126148289,-2.001869718804557
LOU-NH91,11609586,3.3390226168587716,3.132287980036777
NCI-H661,24951314,0.8780582238506052,1.6317674787358794
A4/Fukuda,6852167,0.513003696591474,1.922144847819922
CA46,5311281,1.0891225881142432,1.7587963537769291
A2780,11625818,1.819164792403796,3.9071134612096534
LOU-NH91,51039095,2.9779244840652295,2.836927251306494
NCI-H661,4096211,1.4698398043308702,2.0812393346079285
LoVo,4705,1.5085236639058903,3.1481925778054523
MDA-MB-453,46926350,-4.337117227146235,-3.932429840036207
SCC-9,5738263,4.330654025732234,3.467261230703997
YAPC,46199207,3.321634350680955,3.2648465014488237
A-673,71466578,4.1904953682389,3.506418156936694
G-401,10127622,3.1466102465201793,3.958443986100039
A-673,5311281,0.6354511881397967,2.2065810166699293
Panc 04.03,6917907,-5.49357619863333,-4.638007391457504
OPM-2,216239,1.2934585013066655,1.822726843296865
KYSE-70,1716436,3.404085131889099,2.9164957341824818
NCI-H727,9887053,6.41036176282966,3.7540358966917404
NCI-H460,11404337,1.7201854837770862,-0.40170705767556647
CA46,24901704,2.114836921018661,2.1957019889064524
NCI-H292,9903786,2.498172259524573,2.9536938103838875
A4/Fukuda,9927531,3.7257201794253776,4.351994109137587
CAL-51,2113511,6.39897875596168,5.449724757055208
OVISE,409805,6.403340651497087,5.138725744046772
HCC1143,11626560,1.5863706836040057,2.1117197852138303
CAL-51,26596,-1.4638590943230956,-0.780090665735863
A-673,23725625,2.0065405091728272,4.237393218308886
DMS 273,6610355,5.006954006570411,4.3000807044601705
A2780,24901704,1.9524214470888757,2.861688048218032
SCC-9,11494412,1.4365999648395638,1.7999489968251488
DMS 273,4788,5.897035505528926,5.497802324629694
NOMO-1,46907787,-1.215006340822028,-0.20328543615268274
EFO-27,676352,2.5978940444924703,2.2026658730006115
A-673,44607530,1.766367479354274,1.2788391807092068
SW1463,9887053,1.032433665952219,3.471453551479432
EFO-27,54619267,4.322845534804342,4.182678673899436
G-401,9907093,3.2734126555601506,3.6883368213613386
NCI-H460,24772860,-0.596461213785507,-1.674030807778256
NCI-H292,JQ-1-vorinostat (2-1 mol-mol),-1.255345642631911,1.3706712603265485
FTC-133,119607,5.542629368531396,5.448280932631847
SBC-5,11364421,-4.061592659681506,-1.6169333417774072
Panc 04.03,5566,3.3462548914340204,3.1279840576291775
NOMO-1,6505803,0.1224616163714439,-0.7073316475948985
NCI-H146,24772860,-4.237473750878659,-2.033023543256438
NCI-H1623,11609586,3.053283731487635,3.004361193515469
CA46,208908,1.4900061271350116,1.908765549727162
BxPC-3,9956119,3.6276214672042975,3.731368347525356
SBC-5,BRD-K27188169-navitoclax (2-1 mol-mol),2.901601885739978,2.0278159100467747
CAL-51,10410894,3.3356149928792513,3.027533860963785
JM-1,9927531,4.0230036766634125,3.995799759103755
FTC-133,9866186,-0.0573555179634338,1.069573524536004
OPM-2,3136844,3.3377711403827783,3.5475899553742147
FU-OV-1,3815108,2.287889788505342,2.8365268123062832
CAL-51,10410894,3.3356149928792513,3.027533860963785
FTC-133,selumetinib-piperlongumine (8-1 mol-mol),4.667559315189104,3.1158818403158057
LoVo,5329102,1.3429054297502294,2.089010272755739
A2780,168313047,2.060680306449853,2.1653994181793292
HCC1143,104842,-3.076711821193911,-2.588720826103572
NCI-H2171,JQ-1-MK-0752 (1-1 mol-mol),0.9706610774505884,0.950096326937848
LOU-NH91,6918736,-0.749268328982244,-1.6178040617730909
LXF 289,11625818,3.3628594045115805,4.42911935892877
LXF 289,5311281,0.8902308213691446,2.356764047336803
SNU-449,5351362,1.2849200933546208,1.6792132164282305
NCI-H522,135875424,3.5456342124976445,3.279865822375242
MSTO-211H,44185566,1.3875680654995235,2.6373945137264143
BxPC-3,24964624,2.317613094015834,2.5080094804617064
HSC-4,6852167,2.6632521076475446,2.7473994072117307
NCI-H661,409805,4.01937565581764,4.920591110774368
NCI-H2009,16038120,-1.1539994385349277,1.1681429400325007
NCI-H2009,5978,-2.257242885332271,-1.4140484255750851
EFO-27,56649450,4.209581770525167,3.3766324434399086
DMS 273,5287620,-2.166812480100597,-1.949504480085693
LOU-NH91,613753,3.2819891552194327,3.406194558665677
NCI-H460,73707438,4.549718141383013,3.9311519964909074
LOU-NH91,24785538,0.7950573935003075,2.025735178563828
KMRC-1,71304818,3.217910603872335,2.2644085581205613
MDA-MB-157,carboplatin-etoposide (40-17 mol-mol),-0.0660482957905645,2.573451449091267
LOU-NH91,15953870,3.547895487506012,3.7456216156830124
SNU-81,3384730,-0.4505726212948157,2.3003718376198647
SNU-61,1750826,-4.373387519590766,-1.8562973134043748
MDA-MB-453,753704,5.23059705064669,4.887169723390966
A-673,119607,5.020937738944074,4.78213544639411
KMRC-1,9907093,4.272059047954712,4.172673834501259
CA46,11640390,3.3312213559791397,2.175371617546614
SCC-9,24771867,5.065268858490301,3.020124390089789
ONS-76,5280436,3.697781558026248,3.381105407758203
JM-1,10427712,3.737784417116883,3.6419792551906767
FTC-133,3081361,3.8958462184451697,2.4922482609633105
KMRC-1,56649450,3.8757723452520136,3.336499610089914
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073,-1.7940647564728156
LoVo,159324,-0.9516179858777442,2.9903283146754864
ONS-76,2841722,4.548555296080543,3.990499722231454
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152,-3.378274922836114
SNU-449,5460769,0.9117409452183444,3.0400980597347402
NCI-H460,6852167,4.590065962834362,3.247586918418879
OPM-2,tanespimycin-gemcitabine (1-1 mol-mol),-0.8527630037012235,-2.105414318859425
KYSE-70,176870,5.518340217914711,3.4069669933246547
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388,0.6300678104810703
JM-1,vorinostat-carboplatin (1-1 mol-mol),1.5414150367145687,1.9471211299822428
FU-OV-1,15953870,3.743404981829692,3.6555378487209107
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,0.7969234105149292
SCC-9,navitoclax-MST-312 (1-1 mol-mol),0.9061907565004998,1.112387540205331
LXF 289,654092,-0.8888310934038361,-0.164498913987392
BxPC-3,9826308,0.5055656835854033,0.7111523129411148
LOU-NH91,25150857,3.1116403082593096,2.539050149901227
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218,1.0068709780501226
A2780,375860,-0.912616297645574,-0.19117965023142097
LOU-NH91,6852167,3.2671273023515934,2.9904572441499657
CA46,24753719,4.040239779097469,2.9570709186484545
HCC1143,135999136,4.602247958833588,3.9372876796472207
SNU-61,selumetinib-MK-2206 (8-1 mol-mol),0.3339128925553656,1.6541173951319428
CAL-51,11960529,3.662834723962616,3.889260813414178
SNU-81,20959075,-6.025577396301825,-2.563785544704714
NCI-H522,57519531,3.3673050119485555,2.0450229936285105
HCC1143,135421197,0.8918606552263807,2.0723459414415517
SW1463,24978538,1.1634359901262634,0.9617654162372962
HSC-4,445091,4.370395830414555,4.404617883914867
SNU-61,5329102,2.445912447276521,1.8202285321403615
G-401,23582824,-0.1091259215243222,0.7434909732645822
MDA-MB-157,11485656,1.3019788320898549,2.358128478174898
NCI-H1623,11964036,0.5644570453188236,1.4395672337076524
MSTO-211H,1242560,2.686361074048806,3.7210006035356624
A-673,65064,3.1048319417370775,4.271259108713905
KYSE-70,208908,2.5295165235288004,1.7130619816042096
SBC-5,2733526,3.427490731511537,3.8023729048555106
ONS-76,6184667,3.7303112000686256,2.8795608978375644
A2780,23939,3.9158411595028046,3.731687375171603
JM-1,1566236,0.6280103536338946,1.394120129429205
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.5583108057373318
NCI-H727,ISOX-bortezomib (250-1 mol-mol),1.608281700069038,0.5352415039494187
CA46,11396600,2.515122226404857,2.7326409169781316
BxPC-3,262093,3.443903516481154,3.0987045905528845
CAL-51,1566236,2.769525954778687,2.1238507460572134
JM-1,3025944,3.553601432401545,3.913195823620232
CA46,31703,-2.2435350155349023,-2.7596272260902275
FTC-133,25105715,3.757366730830659,3.3236062455864714
LOU-NH91,54649381,2.7277802519486514,3.9452128277924867
A4/Fukuda,11364421,-5.769651092108399,-3.7870428422031805
A4/Fukuda,5978,-3.163562671527086,-3.103624643125666
NCI-H1623,969516,3.836806795163693,2.897781261903121
NCI-H2009,5113032,6.328717344861362,4.828443893068662
HSC-4,7326481,1.9301811465772087,2.998612643035309
DMS 273,54639665,4.46621146803559,3.2966925858121714
YAPC,9926054,1.8358643335634888,1.9698416096967437
NCI-H460,11238147,4.460003386993959,2.824835565557674
OPM-2,9887053,1.8393709016316329,2.635449144996943
JM-1,168313016,3.8541200519849017,3.8206932866063665
NCI-H1623,285033,-2.516722374910668,-1.7650725029810277
KYSE-70,5351362,2.601126509135012,1.9167801016487231
NOMO-1,10113978,3.435868796737405,2.273472765785111
HCC1143,17759555,3.749709067386792,3.4762707278763143
NCI-H292,11964036,1.1514824488888922,1.514592529092557
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039,4.165861527421128
FU-OV-1,46943432,0.7627718951481175,2.829283109066905
NCI-H292,4917,3.248446822462735,3.1125155134405817
FU-OV-1,452548,0.3745426606957432,0.2714610673884499
A2780,24180125,2.723679145549484,2.6241673669973977
SNU-61,9911830,2.7749851076050187,2.494525469826637
DMS 273,6918837,-4.776469138555483,-3.73609021833912
NCI-H460,54454,2.7807551042334935,2.4921611365926375
SNU-61,5978,-3.491631614089224,-1.1931393279561735
G-401,5287620,-2.7219963273379766,-2.0463114292860807
ONS-76,9884685,2.079600161824297,0.3120072090526016
NCI-H460,6610216,4.838717363885395,4.193111875328614
CAL-51,51039095,2.1842093640891416,2.914658380678918
MDA-MB-157,2871966,-0.7905554969861216,0.7919533589253401
G-401,46926350,-4.213486210672068,-4.545423056401586
LOU-NH91,navitoclax-PLX-4032 (1-1 mol-mol),-1.9251020200365585,2.3540872430273945
OVISE,10184653,1.818458167845024,1.0871648794252604
A-498,6918328,1.134294475717993,0.6159318266437582
A-498,10302451,3.720340150939392,2.9077559631273995
CAL-51,9935249,3.84795648434564,3.155916600554625
NCI-H292,24856436,1.0729923244387796,0.5088146012097949
A-498,409805,6.12415200666612,5.279705835826254
EFO-27,24889392,4.405449300162506,4.190435186069083
NCI-H1623,navitoclax-piperlongumine (1-1 mol-mol),2.7839098581302366,1.5271082465569885
NCI-H460,159324,4.0462841352482855,3.073419817592809
LXF 289,16720766,0.4842655504206017,0.8148887283353582
LXF 289,54649381,3.6309892426510406,4.0698477156256185
G-401,decitabine-navitoclax (2-1 mol-mol),2.109547843543789,0.7493811021963532
JM-1,71751553,4.311473922741218,3.6186444674949576
MDA-MB-157,2945648,2.730573332542116,3.0291546506266447
SCC-9,navitoclax-birinapant (1-1 mol-mol),1.9538462590257963,1.444930548687847
SNU-449,67156097,3.7845495552330024,0.038207108790352405
NCI-H2171,24951314,0.4758147687646419,0.576647055583728
A2780,24180719,2.9021439553303026,3.5364264039279054
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175,-0.6209939773767055
A2780,54454,-0.2144211598876236,2.6335886072039343
A4/Fukuda,16659841,2.2699989015311437,2.8053844922596713
Panc 04.03,44137675,4.02019355498934,3.6617247615106527
HCC1143,25150857,2.69660437037969,2.422994768129182
BT-549,104842,-3.414515083122074,-2.5881271606860605
NCI-H146,11960529,3.5646000180725146,3.550910817514897
MDA-MB-157,11238147,1.748896698587814,2.8598976109286207
SCC-9,72376,-1.0275629780171365,-1.3052364978699882
MSTO-211H,57330099,2.804758704858228,4.309372811774263
MSTO-211H,135999136,4.2061059176098645,3.592695473831593
LOU-NH91,46907787,1.567116016960845,2.6684224415235467
G-401,navitoclax-MST-312 (1-1 mol-mol),0.8926313701991264,0.43248444087564736
NCI-H2009,71466445,2.5164920571758036,4.41561602878995
OPM-2,54618771,0.7318105179081044,0.4831320985415087
A-673,1716436,1.8403672814357532,2.8102596354439617
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022,1.824027510961932
SNU-449,selumetinib-tretinoin (2-1 mol-mol),6.057400941930893,3.57974585872912
FU-OV-1,327653,2.5930307991109784,3.158411647414998
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247,1.1074789886066267
NCI-H522,56973724,3.7409361942384183,2.351508478119402
NCI-H146,25262965,-1.0264838155868825,-1.7743824817675584
CAL-51,2749,1.4482754145936665,1.934949461371302
MSTO-211H,4477,1.290064962685197,0.5477214497777365
NCI-H292,637858,2.5198155256882813,2.2582283484210697
DMS 273,3136844,4.133948633698644,3.73915055177175
HCC1143,654092,-0.1725481204081408,-0.1877047530365611
NCI-H727,72734382,4.575159301501077,4.4126543302119385
NCI-H1623,ISOX-bortezomib (250-1 mol-mol),0.4701818373659249,0.7134400417637368
NCI-H522,6918837,-4.666914399076351,-3.293966959262146
HSC-4,11228183,2.0585180361700313,2.3549922348768884
NCI-H1623,107970,2.966658693868389,2.214591332759812
A4/Fukuda,5278396,2.678829799859676,3.111987486861716
SNU-61,25062766,2.174077685737065,1.9942193826235146
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864,1.141002071681733
ONS-76,5460769,1.8809234095271896,2.854965492620382
BxPC-3,448949,1.967823553768285,2.108203885259507
FTC-133,42642645,4.559192948180462,1.0249004713344305
MDA-MB-453,4705,2.8938913201458583,2.95915438517399
NCI-H727,54454,4.237398664855094,2.717021573996042
SCC-9,selumetinib-MK-2206 (8-1 mol-mol),2.3963375706124967,2.1201953314087483
MDA-MB-453,tanespimycin-gemcitabine (1-1 mol-mol),-3.3001321684488825,-1.584874320453178
NOMO-1,19582717,2.563142509513499,2.8648714049176176
A2780,445643,3.2119323974162786,3.8785172741654645
MDA-MB-453,6918837,-5.413037386455184,-3.4394128288335337
BT-549,72193861,1.0619418160757952,1.6394902643194014
HSC-4,44607530,1.7156299328297433,1.5694702623057974
A-673,11455910,-0.0977898825280259,0.7400738923368428
SCC-9,262093,3.396257832039873,3.1638300816830203
JM-1,148198,-6.864264453079388,-4.320105979546352
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576,1.0258288333431538
CAL-51,8515,3.5852991976047863,4.131953909587546
NCI-H292,49793307,-2.523289852336332,-2.2243171990514004
NCI-H1623,2708,5.67986318014104,5.024749463629365
SCC-9,3025944,4.376039606027409,4.303837276990191
LXF 289,24772860,-1.828128181459349,-1.5329021943967667
NCI-H1623,5287969,-1.6741359655835943,-1.7046323196511322
A-673,54454,2.1191092291244877,2.698840325342204
HCC1143,10302451,1.8641137803790455,3.110607122855545
NCI-H292,54649381,3.811841265663476,4.140863416097867
FU-OV-1,44607530,1.1358438423183184,1.7494246125263269
OPM-2,5702613,2.283159730657738,2.601121905829398
LOU-NH91,11612883,2.793800542696417,2.842111205047013
DMS 273,11214940,1.0513565801549722,1.3464705300278133
FU-OV-1,65064,4.9743661807936235,4.852093260039828
A4/Fukuda,23635314,-5.004930640559638,-2.7306121806315184
NCI-H146,44137675,3.928890295501361,3.412157515176493
NCI-H727,carboplatin-UNC0638 (2-1 mol-mol),3.50410186086625,3.1634178200649314
YAPC,navitoclax-gemcitabine (1-1 mol-mol),-2.531110642636913,-0.7283375845878198
SCC-9,25105715,3.642638215460893,3.3271654422710104
HCC1143,219104,3.69834662828724,3.6215346535063726
CAL-51,46215462,0.9657515518660452,1.7609367324936502
FU-OV-1,9936388,1.7648084748519457,-0.5332780905847672
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725,4.115884277570494
A2780,65628,0.1843862993724733,3.8992945127677414
SNU-81,11647372,-4.046967337474091,0.5565008001785343
NCI-H460,44589607,4.73035444754351,3.1765512778797795
SNU-449,9549297,4.8793656902716345,2.571614892154019
SCC-9,11625818,5.698343618019975,4.371076153909792
LOU-NH91,54619267,4.2625648850210665,4.201362221399219
SNU-81,676352,1.7899908822518449,1.9284704796120373
CA46,4096211,0.9281979530192106,0.7754394949660167
FTC-133,6918638,0.7173410835371117,0.7043449168828562
A-673,10074640,2.0498537136670696,2.7634662348228147
FTC-133,9907093,5.562055210260789,4.244827715990069
HSC-4,24775005,4.677905847548428,3.6276951671933513
A-498,selumetinib-PLX-4032 (8-1 mol-mol),2.57044020856199,3.224117720412093
CAL-51,11964036,0.7531640395115359,1.2805270261430868
NCI-H146,16736978,0.7510083752799234,1.3750850087549695
YAPC,15547703,3.1542356669454055,3.1932410480408935
NCI-H1623,25195348,2.589072393428722,3.2928612840614577
JM-1,5311281,0.5908340552261697,1.8939195994001687
SNU-61,9840324,5.730394861191507,5.626715946579565
CAL-51,322968,3.332930006684798,3.732829380524933
BxPC-3,613753,3.1887459622848935,3.3330946755098734
A4/Fukuda,9887053,3.945623871756388,2.904878983732181
ONS-76,119607,5.207716304164231,4.910630331470973
G-401,11955716,-2.313708507563708,-1.8980841898673182
EFO-27,9840324,6.098788849131883,5.873765532210885
Panc 04.03,219104,4.644038290885272,3.9636589209206106
HCC1143,25262965,-0.487374364701845,-1.1948234150424448
EFO-27,25227462,1.7048102531951876,0.6731615090803423
HSC-4,10074640,3.187745953835862,3.140836293776013
SNU-449,5287969,-1.7501228923890362,-1.506892906410666
BT-549,49836020,-1.94641857460656,2.964168145439598
BT-549,36462,2.0708174288882075,2.278964112999015
SNU-449,135421197,1.7191553190938056,2.03614954598536
EFO-27,49867926,4.359647239344765,4.276328356502647
NCI-H727,568763,0.1873556014231215,0.5130588522440335
SCC-9,5287620,-3.0509576220001953,-1.639122879599031
SNU-449,3543504,4.913571994290616,4.315900183670277
BxPC-3,12001922,2.0478076671218317,1.897470758042795
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333,2.4012524823165666
NCI-H661,54618164,4.023349318575714,4.167005783204396
ONS-76,JQ-1-UNC0638 (2-1 mol-mol),1.9548647661287404,1.5611107599331362
OPM-2,5287620,-2.918074250075414,-2.010939654885766
SBC-5,71304818,1.011143162310159,2.289053363859107
NCI-H522,navitoclax-sorafenib (1-1 mol-mol),2.7725846762531856,1.6481665837043138
CAL-51,216468,1.370586512271769,3.1154463670146915
MDA-MB-157,25150857,3.068531629493821,2.524083613117993
ONS-76,10074640,3.173150149140259,3.2947395888316118
NCI-H2009,5470400,0.3791383114910072,-0.39350864630270727
CAL-51,54619267,4.1828818787298765,4.049343404319918
A4/Fukuda,5738263,2.3624425097256676,2.5848026864625253
SCC-9,1239801,5.7667211168431205,4.398364880229903
CA46,11152667,-1.1506421067609531,-2.150189886974229
LXF 289,9444,4.020808033871241,4.165481928153959
Panc 04.03,25062766,2.3535958479396166,2.1744727830267028
MDA-MB-157,71466445,-0.8161407888171323,4.100233921325307
NCI-H661,10302451,1.6315200392387812,3.1432851064966747
NCI-H522,10385095,0.7404415633977295,1.1596682256259208
LoVo,53495165,-1.2075385636979648,0.6239758691422216
NCI-H1623,613753,3.253043904005535,3.2465748279149533
SNU-81,49836020,-3.195484765979539,3.100343821181998
A-673,73707371,5.345141037142936,3.8416744513873846
JM-1,71466380,3.0146886034862885,3.689592893558863
MDA-MB-453,135659046,3.699316020945489,3.7974511546630283
LXF 289,72193861,1.9781400147016948,2.1242615993001017
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165,2.6770864066664553
Panc 04.03,46843906,4.199928797005276,3.30053993722573
NCI-H460,16725315,5.407057101640495,4.394570852156005
SNU-61,375860,-0.3575080218905608,-0.023247912503502145
SNU-61,216345,4.373705885149758,3.6955768497535617
CAL-51,25154868,4.656760297450745,4.2372390180057735
NCI-H146,10172275,4.247153556222009,3.138374977063036
SBC-5,122327,4.539216274618647,4.6515300885081405
A4/Fukuda,24785538,-4.18833617701787,0.45890817569430564
NCI-H727,54618305,5.896457883643312,4.674608890509992
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698,1.4146868236537224
NCI-H727,6918736,5.488213607701973,-1.7134126911682805
NCI-H522,168313200,1.7984937800694238,2.704020923694715
OVISE,11396600,4.241731433198166,3.789794302643004
ONS-76,25154868,3.0856348617246048,4.363977246312869
LXF 289,135398516,1.6034740470130215,2.377380622016009
G-401,9967941,2.755238424074781,3.1986001519336305
NCI-H2171,44493528,3.677120674941258,4.206441604688598
DMS 273,135398516,0.9081791710880508,2.0622450369278353
CAL-51,219104,3.260140555917495,3.8677984530141614
SNU-449,9927531,4.924705078398161,4.6349313789643185
A4/Fukuda,9840324,5.782088483619631,5.39105031592278
DMS 273,11404337,-1.7233190830375906,-0.487996119050671
MDA-MB-157,24964624,3.531877357122639,2.555496501484794
CAL-51,44486219,4.943814728636009,4.259606985440432
LOU-NH91,216345,4.715464564049095,4.2865727919954795
LXF 289,124202324,2.1762748500922657,2.634251317818576
HSC-4,23582824,-0.585849233367442,0.7750151664435043
LXF 289,25126798,3.2757893610597923,3.903103155434074
SBC-5,4788,5.245695847909484,5.4503447900376925
ONS-76,24856436,1.9295271968291927,0.5574866325743933
SNU-61,24753719,3.71513491278392,3.772345826861614
MDA-MB-157,vorinostat-carboplatin (1-1 mol-mol),2.089611871642824,3.185514289278649
LXF 289,54618305,4.64176895308047,4.345100407750145
CAL-51,9926054,2.2227862000004577,1.9601731445579986
DMS 273,11427553,3.72076353850383,1.5874620533559858
NCI-H460,25126798,4.092385726400508,3.783593214419332
SNU-81,1716436,3.163180638308135,3.0756729429515883
SW1463,426756,2.2352578961733967,4.276041622323588
NCI-H1623,6918638,-0.0742651507067239,0.43074944766598094
NCI-H522,46191454,1.7170402718959707,0.9502692247151588
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885,1.5018891760906794
MSTO-211H,49766530,-4.866552298919663,-0.2539941125705617
NCI-H2171,11228183,-0.0614644470988351,0.8022656014222396
HCC1143,5311281,1.3434544130633397,2.525086668017052
ONS-76,10410894,3.505250871213463,3.137168882522251
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411,1.6977353944476568
SCC-9,46398810,2.8303032541075455,2.649295024936188
OVISE,5351362,2.5456705040985708,1.780557781155271
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992,0.28812313036772036
NCI-H522,5287969,-0.7039868347543177,-1.664278095282107
KYSE-70,9840324,6.215387239369238,5.624176376788199
G-401,2708,4.061322582720861,3.9818880929296854
MDA-MB-453,selumetinib-PLX-4032 (8-1 mol-mol),5.5493324312500825,3.5551146073263915
SNU-81,selumetinib-MK-2206 (8-1 mol-mol),-1.5641952931996328,2.0078308898455313
A2780,9868037,1.6123332444026346,2.74706879331403
EFO-27,selumetinib-MK-2206 (8-1 mol-mol),3.7293539227770824,2.3776374084911414
NCI-H292,2708,4.789540620747355,5.2119661478679715
HSC-4,11238147,3.6589845000918504,2.9820534039478583
NCI-H2009,168313047,3.1000323585702083,2.396164357248164
OVISE,3689413,-2.3316050545360136,-0.0853282256445288
NCI-H522,71751553,5.137300136027492,4.198614164414753
NCI-H661,9444,4.500292949687679,4.2960497280354675
BxPC-3,54649381,3.6406106092590007,3.8694504045897444
KMRC-1,selumetinib-piperlongumine (8-1 mol-mol),4.604012019572112,2.9767131502829334
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247,0.8736415069605475
KMRC-1,10427712,4.418169957842134,4.249526779494312
FTC-133,9935249,4.194644265855045,3.389858729212649
LOU-NH91,alisertib-navitoclax (2-1 mol-mol),-1.2312433531350488,0.7370630470190352
SBC-5,5280436,3.662085558148715,3.252354781441253
JM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.97629163512536,0.31992685949249433
BT-549,462382,0.0307570083617302,0.713415315192098
Panc 04.03,445091,5.978315194185719,4.4870129409542
A4/Fukuda,3011155,4.269088750580724,2.0227336739136934
G-401,selumetinib-tretinoin (2-1 mol-mol),2.678729484296938,3.3429346219929177
A-673,57519531,1.198988142705803,1.9242819751017044
SNU-61,3025944,3.777150750907422,4.211044833943074
CAL-51,11497983,2.6322425573174213,4.229495844639286
JM-1,12001922,1.1772658700026328,1.7206790005378094
A4/Fukuda,375860,-1.1918610484687095,-0.5696538256236137
LXF 289,5978,0.6093029371771528,-1.6383742179529874
FTC-133,5329102,4.217502606235289,1.903707517746851
LOU-NH91,erlotinib-PLX-4032 (2-1 mol-mol),3.00809922416846,3.282482772233069
OPM-2,10296883,2.7550650350156474,2.992163854723422
FU-OV-1,4259181,1.2776952629591818,-0.12177899426788948
BxPC-3,100016,6.453363473458683,6.176211110944222
YAPC,168313047,2.3481335437424957,2.4451690269396873
NCI-H460,10184653,3.574651577310896,1.3419132601331425
OPM-2,3062316,1.3077504545650411,0.6189634063603222
NCI-H460,9956119,4.485375019847723,3.6712830941430843
ONS-76,3815108,3.0019527232257555,2.8590066696901983
NCI-H2009,6918878,-0.4863456687538305,3.213303304836322
NCI-H727,10302451,3.178772538514987,3.3136125730459827
NCI-H727,2945648,2.622160220955332,2.972627169931678
SCC-9,71751553,4.89059631642312,4.582770243969055
SBC-5,36462,0.3494520767872783,1.7296997146658524
G-401,4477,0.236688812816839,0.5228070249367669
DMS 273,9926054,1.8030373867492464,1.5928279067642206
MSTO-211H,2828334,5.714930690846282,6.184563077780831
A2780,24797083,0.8113195258872324,1.3888151567601275
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546,1.0724822245668022
FTC-133,44486219,4.933137185021197,4.172889227917552
CAL-51,6918736,-2.0480142356294637,-1.5309398741535574
NCI-H522,72193861,-0.7243330419144597,0.8328995910209934
BxPC-3,JQ-1-navitoclax (2-1 mol-mol),-0.3389644558379706,1.0035003999468644
ONS-76,25102847,3.483061373005376,2.1224004158896177
NCI-H727,168313016,5.705554517808247,4.416678287168808
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484,2.012275526992427
OPM-2,25161177,3.2493247866394497,3.1735792215274956
NCI-H292,374536,1.098561227965989,2.48067748885139
NCI-H522,54618771,1.252244709003548,1.2226349438952986
KYSE-70,44486219,3.9722791166403657,4.352845605186253
FU-OV-1,72193861,4.196952295232924,1.6560473504273094
CA46,56973724,2.349278499068081,1.6786040626537555
A4/Fukuda,2729026,2.569130626356953,2.3513016688816726
YAPC,148198,-3.117185181322903,-3.4542058399865674
A-673,24753719,3.397650756866718,3.78454604487588
NCI-H1623,16659841,4.138965758514941,3.8686152477760483
NCI-H727,637858,2.2360670355510086,1.9673627193589383
NOMO-1,31703,-1.8429032714500968,-2.819174815645578
LoVo,65628,4.171555925906434,4.3633571638100985
EFO-27,322968,2.5694057659070264,3.9532941051107446
NCI-H2009,216345,4.438201480917741,4.0819310029432705
BT-549,5282054,2.5925054001589976,3.667320493373294
FTC-133,6918837,-2.2077574090678307,-2.1399768921731424
DMS 273,54626689,4.997985813086497,4.436457182210933
HSC-4,16741245,1.7716610997683242,3.843531505085973
SNU-61,6438330,3.4216884605560085,2.0576317427578577
FTC-133,9936388,3.0046059879710363,-0.3806727623523117
OVISE,3815108,2.0996140723315913,2.8618149907423174
NCI-H522,navitoclax-piperlongumine (1-1 mol-mol),1.629477440849753,1.0154253700161258
NCI-H292,5281321,-0.9498489394799606,-1.1733375946649711
BxPC-3,25126798,3.172026591671247,3.85418972102376
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968,4.105426461389482
BxPC-3,11213558,1.5061777503093252,1.8037643672346177
BT-549,3503,1.5652779265398058,2.4208894739680726
FU-OV-1,1716436,3.524722071533676,2.708266298317518
MSTO-211H,15547703,3.049193057044517,3.2688513828274988
KMRC-1,11427553,3.2258060185151343,2.622560576735505
NCI-H292,46191454,0.9903655583180804,1.6145970173875475
CAL-51,135928012,4.192641653546412,4.025098534408302
NCI-H2009,44202524,1.444691297679544,2.5458406742448925
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324,2.535681326633266
SCC-9,2858523,3.190510944053216,3.054557363726138
BxPC-3,15953870,2.831569416015373,3.5832908760353104
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291,-2.5267285375732564
SNU-449,135398516,1.5851782119809552,2.3612663851451994
SNU-81,9843750,-0.6437789188002867,3.6871062011448004
SNU-449,11427553,2.8197595076352564,2.829571921446069
OPM-2,11656518,2.629079922396914,0.3365428873126827
BT-549,135398516,2.1186047788766085,2.1895068916101668
OPM-2,176870,3.9257377377060383,2.8315848044889025
OPM-2,46926350,-5.934740852723627,-4.530466147383395
HSC-4,2729026,2.4603123985812276,2.5867596738275176
KYSE-70,9444,4.1582482593031145,4.076742485111484
FTC-133,9933475,4.176811369298493,1.992821857439258
MDA-MB-157,51037431,2.1321019948022046,3.1470533287909204
NCI-H522,carboplatin-UNC0638 (2-1 mol-mol),3.513501660159428,3.262869650776151
FTC-133,44493528,6.31419839504633,4.437762386590858
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882,-0.35428390544721694
KMRC-1,11507802,3.5140789318254426,1.769363199604808
KMRC-1,25183872,-1.331773303463366,-0.9543443688095423
OPM-2,16219061,1.6139038412518538,2.2445900812171127
LoVo,25183872,-1.0423877479811554,-0.6105166155922715
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.7632742882800363
FU-OV-1,6623618,4.441105176868704,2.5380561176668737
DMS 273,4259181,0.4383145170351891,0.028856609782381047
A-673,docetaxel-tanespimycin (2-1 mol-mol),-8.62633538117336,-4.163809685785583
KMRC-1,89183176,5.996613867274686,3.7945790894328475
MDA-MB-453,9825149,2.3540085594050204,2.14415324369535
Panc 04.03,decitabine-navitoclax (2-1 mol-mol),3.786860225423862,2.2281633961515985
G-401,4788,4.978954455161412,5.1748835590449005
MDA-MB-453,52947716,-7.0217551266009375,-1.714198092936546
SBC-5,6918328,-0.0891350348900322,0.18490519998610874
HCC1143,49836020,2.702530837822698,2.852885324585563
MDA-MB-453,9956119,4.182542041452956,3.8649196384966564
A-673,136227924,1.815433973878695,2.688473431294326
HCC1143,9956119,3.9159046092458785,3.7244147286754288
OVISE,ISOX-bortezomib (250-1 mol-mol),-0.1243058727191033,0.6712467995008841
BxPC-3,11234052,5.706263551465742,4.244923387458367
NCI-H727,44259,1.5490626006331412,1.060850379183008
SNU-449,24964624,2.993830455857875,2.5403172503047653
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919,0.9578124817675626
LXF 289,3025944,3.4981276099044134,4.3729778252651235
A-498,24964624,2.395732501339878,2.4896831513595203
DMS 273,4096211,1.7794100041919845,1.456924206353197
NCI-H146,SNX-2112-bortezomib (250-1 mol-mol),-4.105126294975654,-1.567827013972788
SCC-9,16722836,2.261290441734353,1.8455007925658728
LOU-NH91,452548,2.191181432305291,0.3098673088088308
KYSE-70,2828334,5.886367586734188,6.239128030005719
EFO-27,6450551,4.042476340029328,3.1032507736109367
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542,2.9734726078335076
SCC-9,1716436,3.7585685406918783,3.2357210398298277
NCI-H2009,409805,3.859994247591149,4.999792928820734
Panc 04.03,SNX-2112-bortezomib (250-1 mol-mol),-2.269720015649412,-1.055968369409652
SCC-9,54618164,4.4493976732458576,4.194563256594724
OVISE,5470400,-1.924229347102114,-0.5750046735668909
EFO-27,44607531,1.7985046151445,1.61856905105154
KYSE-70,439501,-1.7979650249976522,-1.9372437183780908
FU-OV-1,JQ-1-navitoclax (2-1 mol-mol),0.4181206302825215,0.7481964289243825
NCI-H460,11175137,3.7005840280640374,2.694045135835053
ONS-76,71680916,4.956248935312428,4.65462220764935
NCI-H1623,10410894,1.736668634267143,3.363656975478024
KMRC-1,6918736,4.048742051120841,-1.8723706282987838
CA46,25161177,3.91788686206549,3.3067915114002324
MDA-MB-157,6852167,3.8998726158787007,2.925467561544299
HSC-4,11364421,-0.0916399418549534,-1.5110941790025079
CAL-51,2746,3.539110169106334,3.0467269807139736
SNU-449,24748573,1.9316038598597545,2.344549900413434
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188,1.7660110425753865
KMRC-1,9926054,1.768451409600443,2.0784488398544805
SNU-61,4917,3.0491510397841015,2.8468614222293973
FU-OV-1,5335621,4.183078950789895,4.2231502343704586
LXF 289,44607531,1.6515112206427849,1.601239854816387
A-673,11640390,1.6795118149646189,2.686694000871043
DMS 273,51039095,3.4577395537233526,2.4891419119193463
NCI-H460,126941,-2.220790788147435,-2.636107506031586
NOMO-1,5281672,5.39154363605107,4.190357414922039
SW1463,11214940,-1.9875595606860448,1.8619821729220203
SW1463,72376,-4.419423024557842,-2.3549537960300397
OPM-2,613000,1.2483941007528057,2.6088976266066233
NCI-H292,445091,4.263425815338472,4.558830059529766
MDA-MB-157,46926350,-4.132103643787292,-4.093285748396934
Panc 04.03,10296883,4.422301293811254,4.081751271892139
SCC-9,11964036,1.807051006133268,1.4213072799770594
YAPC,11626560,1.7222365359336271,1.9603879474138526
LOU-NH91,375860,-0.2088041582630222,-0.2800278316274331
MSTO-211H,JQ-1-vorinostat (2-1 mol-mol),0.928346567061831,1.4005420227380592
A2780,374536,0.6453837370733745,1.3938563687202576
LoVo,5351362,1.2957137522113673,1.262028759650803
DMS 273,navitoclax-PLX-4032 (1-1 mol-mol),3.5987731605667284,1.399699591205837
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277,-1.2734606371004111
LOU-NH91,322968,3.304915281144932,4.248556373176299
OPM-2,54596558,4.064764759335406,4.21335627510774
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448,1.9324656344800308
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112,2.0373410038580717
MSTO-211H,44137675,1.9879298255329003,3.55694554602811
NCI-H2171,42642645,-0.8345775302937554,0.35736427826619704
A-673,5287969,-3.109107778120567,-1.9991137687416978
HSC-4,5566,3.1631957469062684,2.968833396009812
NCI-H146,5284616,1.616711114994892,1.1681650662656302
FTC-133,10184653,4.443025626482117,1.0467230087532164
BT-549,241158,3.5488750117076484,3.9557808623902786
CA46,25195348,1.4184238486273535,2.568763381443895
BxPC-3,11497983,5.307904838671978,3.9021280450587534
MSTO-211H,4096211,1.4030307395810702,2.3330318074733745
CA46,11175137,1.918070959510412,1.5735577895632205
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-1.0517154462438434
NCI-H1623,5566,3.3003894636357565,3.043947040503381
SNU-449,25262965,-2.560427276701697,-1.4844331154161328
FU-OV-1,16038120,1.1817724128349547,0.928680035960727
NCI-H460,6438330,3.783082395235063,2.1092700313205857
SNU-449,selumetinib-navitoclax (8-1 mol-mol),4.616443457041138,1.5032730083072736
LOU-NH91,12003241,-1.4006618643370652,-0.8567612589124662
NCI-H2009,89928392,1.462956527326012,1.7815477280958922
OPM-2,selumetinib-MK-2206 (8-1 mol-mol),1.6316326577463918,1.37120460847
NCI-H661,53495165,0.322884771008066,0.33115823926731186
FTC-133,16659841,4.779782303247626,3.9277892671623804
FU-OV-1,176870,2.993075468358777,3.3153124368456086
MDA-MB-157,24771867,-2.9284017086321197,2.4924492278168224
MSTO-211H,5328940,-0.7344582610548551,1.767723224806598
A-498,25126798,4.108305960475203,3.781723940729165
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637,1.8642134534779218
HSC-4,5460769,1.9290612526481368,2.0848028256651854
JM-1,9826308,-1.254578223347674,-0.3300327216167973
ONS-76,124202324,3.376244033970937,2.278200666511669
YAPC,135984461,4.395865755985396,3.9644499181699393
DMS 273,5746,-0.0149388723107023,0.4941711786535926
FU-OV-1,4917,3.642085139957623,3.168358588922268
LXF 289,49793307,-1.960491877422628,-2.221033459708535
OVISE,107970,3.0608588072726444,2.3449271352788603
BxPC-3,446155,2.3080345350315015,2.5510078311625435
OPM-2,65064,2.528451354351822,3.87565921116454
SNU-81,5278396,1.9031243607798085,3.4415098763918395
NOMO-1,5351362,2.08054014163225,1.037960913267975
A4/Fukuda,675434,3.712142385749843,4.278782116202321
ONS-76,44241473,4.684511997660941,4.666786581542844
NCI-H292,54619267,4.1033140795833445,4.135540157733102
NOMO-1,5470400,0.2862684612003833,0.13856365248655345
LXF 289,1716436,2.59582131383783,3.124746148671789
OPM-2,71680916,3.9051822114426025,3.960210880025904
YAPC,72193861,3.178335780336401,1.882331097257341
HSC-4,148198,-2.795908666323494,-3.342902486964359
Panc 04.03,piperlongumine-MST-312 (1-1 mol-mol),2.325884658046027,2.0517920400902883
A-673,25161177,3.4603475867806788,3.728609200893999
NCI-H522,9866186,0.2313673592680447,0.5296645795142527
CAL-51,24772860,-2.425084956958233,-2.082736412225212
KYSE-70,72734382,4.428008981499565,4.588126296134919
EFO-27,44491742,4.311239061696844,4.259193336336657
CAL-51,322968,3.332930006684798,3.732829380524933
OPM-2,68056272,3.036834126647856,2.922663619693269
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417,3.2065530374778466
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226,2.839325817712824
LoVo,11485656,1.8604760547282393,2.2857605421249483
LOU-NH91,selumetinib-MK-2206 (8-1 mol-mol),3.1932369628338195,2.5208330257929723
CAL-51,10074640,3.192334769578339,3.1768596217845144
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718,1.1699898957450228
SNU-61,452548,0.6134547199912214,-0.13847369723694442
MDA-MB-453,5311,-0.5257883568365231,1.3881563865994686
HCC1143,23582824,-0.3689859010226292,0.9497381578043878
SBC-5,7251185,3.120445126947185,2.6566946982619704
NCI-H292,24901704,3.391496569820259,3.3951005459029386
NCI-H522,10410894,2.9293088965189553,3.0665056540334468
SNU-61,23582824,2.5643180100002225,0.8618395806505993
HCC1143,16065773,2.712611567173667,2.340318297857649
MSTO-211H,46191454,1.2859626841233986,1.4428763213226585
DMS 273,72199292,5.337691921623293,0.632633186451131
LOU-NH91,46398810,3.045211454343731,2.614414154133594
HSC-4,135928012,4.241462346184107,4.39654523292694
NCI-H727,3384730,3.6794289647639737,3.1342037496985387
SNU-61,4788,5.909414847709577,5.701476351716292
A2780,5329102,1.3737092942346336,1.6069995773801256
MDA-MB-453,444795,4.759998515464953,4.574907036411519
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.271504344652566
BxPC-3,11507802,0.9945684314547258,1.9244629951816261
Panc 04.03,24889392,4.270107644861146,4.073312973469428
MSTO-211H,46215462,0.9168806818627014,2.027598916311902
MDA-MB-453,11167602,2.244240898320102,2.734413985990044
A2780,400769,-2.1774855243121425,-0.7814928629436325
ONS-76,52912189,4.881284158574923,1.9196057921046208
BxPC-3,44137675,2.990010873447489,3.616008971827136
HCC1143,753704,4.831564496260181,5.231288269446813
SNU-61,9915743,-0.5579526190142376,0.5523719033170985
OVISE,1242560,3.5076159129293956,3.5685673913888207
CAL-51,6914657,-5.067352950634086,-4.517346516737985
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057,2.742632971035477
NCI-H292,9907093,4.58058164849987,4.300735376661476
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032,0.6292484246829948
Panc 04.03,vorinostat-navitoclax (4-1 mol-mol),1.7756869415630383,1.295575065599464
EFO-27,6852167,4.289895730200754,2.9211052124171446
A4/Fukuda,148124,-6.6912736941139865,-2.473782123015426
MSTO-211H,24785538,0.8010437121318222,1.5447136594744157
NCI-H661,49850262,3.557667726590132,3.8780570319272227
BxPC-3,navitoclax-PLX-4032 (1-1 mol-mol),1.642487970123168,1.9982333436551338
EFO-27,4521392,4.521895501485345,4.33191926444653
A-673,65628,3.827084992759042,3.8649657893321274
SCC-9,11427553,3.060791645335887,2.915809945003202
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954,1.288629000504445
NCI-H661,36462,2.012090600363037,2.260627766494983
CAL-51,11625818,4.1129054868405905,4.288128764099777
SNU-449,252682,6.455952915446744,6.521469953969797
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202,1.7624477368383762
HSC-4,2828334,6.111197262680893,6.252834877491779
MSTO-211H,selumetinib-navitoclax (8-1 mol-mol),0.5648552965523568,2.5437462285464845
A-673,753704,3.1138845387287657,4.484472442722212
NCI-H292,409805,3.708436738901026,5.154053314453348
NCI-H2009,72376,-1.9106633783650309,-1.0541128484798525
OPM-2,24753719,4.370940438199297,3.6239537490537326
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098,3.219781489135147
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073,3.361722955933634
LoVo,9915743,-0.8819018227786422,0.8061070301522665
BT-549,4788,5.920199401047736,5.609647969985071
CAL-51,2858523,3.1959449804225524,3.070095020437817
OVISE,2742550,5.280611289386831,3.8541548919657083
HSC-4,5470400,-1.775367561967962,-0.19012372380879583
FTC-133,3503,1.9089172693495084,2.445060208991652
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951,0.8217254785163844
MDA-MB-453,4578,4.4862028800041545,4.188124375308474
EFO-27,16038120,2.346094356536249,1.296640067448966
SNU-61,66577038,2.989851386241242,2.874050034876085
CAL-51,4259181,-0.5132501801478601,0.4299235305017807
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043,-0.5826896790081467
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786,-1.4265163971656936
SNU-449,3552672,3.5064135830435563,2.7967320050105364
SNU-61,44589607,2.748444545219875,2.3749614541024293
ONS-76,2945648,2.901632251679741,2.7798867413937485
ONS-76,44607531,1.762572438348297,1.6170351370921958
DMS 273,2874250,4.3291006423311025,4.4972463705706796
SNU-449,9840324,5.822936489993131,5.758930212621082
NCI-H460,6610355,4.949206869720499,4.466085009198871
HSC-4,11612883,3.5946567658341197,2.6640928573506955
NCI-H522,11175137,2.853962760117135,2.0773094481735135
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345,2.8287521087273344
A-498,5281321,-0.4472251536664238,-0.9838471186932027
OVISE,25154868,4.508600245054991,4.288717260521664
Panc 04.03,44185566,3.115745823738928,2.76748523578006
SNU-61,49793307,-2.3504304765085573,-2.965412743935855
CA46,44607530,1.320133740199814,1.3689098903197479
SCC-9,10385095,1.4052834583911455,1.4696123711711941
HSC-4,675434,4.235689784331333,4.576296101676877
NCI-H522,16725315,3.2253372097194752,3.56422063167612
FU-OV-1,1750826,-4.024957616345245,-1.6872273224697025
HSC-4,57519531,1.2769425534379089,2.799965853552666
NCI-H292,9868037,4.01216306257403,3.478225430187953
G-401,52947716,-7.497954818853376,-0.7654154983584222
EFO-27,5280436,2.3763113561475997,3.439857174991334
SNU-449,11625818,4.573588862325648,4.215293668949616
CAL-51,135999136,4.2132345103647015,4.159996706354538
NCI-H146,19582717,2.457603508665216,3.885464300680488
HCC1143,1716436,2.8430583337953284,3.0346645508220593
DMS 273,9911463,3.7655644930376257,3.3067791876708243
NCI-H460,54649381,4.173104904963283,3.859825437088546
NCI-H727,6918837,-1.02939028052569,-3.1026140028418485
BxPC-3,6852167,2.5268139587107754,2.906540261537824
MSTO-211H,168312962,-1.9489367550084584,1.9170392535163976
CA46,17755052,1.7120394846678155,0.8205948344117766
ONS-76,3676137,5.654292431942107,4.552997660856066
A2780,11175137,0.1901581111291173,2.2414802469647355
NCI-H727,10427712,4.338841626329874,4.295992602737026
LoVo,241158,4.012317425862525,3.8768073572466513
Panc 04.03,3062316,3.5966054915380647,1.230435569240557
SNU-81,54454,2.7601348658589,2.8190267760726493
SBC-5,3136844,4.085952663076754,4.383599646067612
BxPC-3,4261,1.8613797726144792,1.7678659613530103
YAPC,11364421,2.3126725462898508,-1.2005563096956826
NCI-H727,387447,-3.6268426938273457,-3.9726011967433528
A-673,11955716,-2.8120675934907107,-1.7590238997759886
Panc 04.03,selumetinib-decitabine (4-1 mol-mol),4.200719534788661,3.97214409868504
FU-OV-1,135440466,0.9480137026796296,2.179120977164986
NCI-H146,25150857,0.3973439930915976,1.9422943511933983
SNU-449,46926350,-1.1609870247475182,-3.939453534916577
MSTO-211H,9840324,5.369584805162093,5.809434476297667
G-401,5460769,-1.872739736028161,2.544045296705176
CAL-51,568763,0.0917223714484538,0.4584265822684436
MDA-MB-453,5951923,4.303369563038856,4.474426369582268
KYSE-70,66577038,3.0162273972396005,2.6085061551592887
LOU-NH91,16722836,1.148829534310261,1.7003118005690905
FU-OV-1,613753,3.071481920375854,3.1747705380376137
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454,-1.0966337399258976
CA46,49766530,-5.499020578204802,-2.1003971286225025
SNU-61,11175137,3.4257878627613505,2.331825868111977
HSC-4,969516,2.6364274978390703,2.781037267670408
A2780,10074640,2.580771204793581,3.0408687521410314
EFO-27,10410894,3.5790791622635907,3.2851176543524936
SNU-81,8515,4.116210915577815,3.3827051701391624
KMRC-1,322968,4.639571189041566,3.8164052876024743
EFO-27,54626689,4.866384531477491,4.652111639539472
LOU-NH91,9911830,2.650870613913377,2.5250817779336465
OPM-2,135659046,2.7260896342727396,3.065223488685269
OPM-2,6917907,-6.048813777211379,-5.4639722306018745
SCC-9,151289,2.789872420286255,1.3020367247541993
NCI-H661,4705,2.5155315968978127,3.2909055422337317
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904,3.484264155449713
LOU-NH91,25154868,5.6992218929630205,4.508267447928311
NCI-H522,54619267,4.072629967998864,3.905061870693988
BT-549,11222830,1.721965279957128,1.7670828716228868
NCI-H146,53301938,3.7804038583893504,2.2502731148775066
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434,2.135855534158777
NCI-H727,selumetinib-MK-2206 (8-1 mol-mol),-1.8356480928534216,2.0577562702033716
MDA-MB-453,7326481,2.376694251985227,2.8408988508851625
HSC-4,6914657,-3.070952064512468,-4.030527278634253
MDA-MB-453,72376,-2.4391350280385033,-1.728284638192613
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548,1.322909764440725
CA46,2130404,5.640885888744477,2.4283418957852967
G-401,216345,1.83916726924219,3.3761195562989075
LXF 289,54143018,0.7636513295056184,0.5978293127921956
MDA-MB-453,246676,1.942789144720036,4.113832241807582
A-498,19582717,5.689025629434131,4.407003997546865
MSTO-211H,11964036,1.836732040985672,1.6034861798035334
A-673,3552672,1.3462933778606576,2.6805422674564108
CAL-51,11152667,-1.203722258692511,-0.361945823921262
CAL-51,67156097,-2.385254348530768,-1.1344918125193404
CAL-51,65064,3.306239750209062,4.825129121442364
A-673,piperlongumine-MST-312 (1-1 mol-mol),1.0809583866306374,1.5535401698215756
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967,-0.8812379180971758
MDA-MB-157,6917907,-6.62909111977728,-4.439326937065004
HSC-4,64971,1.7199562834608897,2.5699760208649667
NCI-H460,135440466,3.295247648571462,2.185396740452174
MSTO-211H,57519531,1.3086690033484818,2.4285283731740144
G-401,9926054,1.744192331951833,1.8265315235234485
OPM-2,24821094,1.5161257655930716,2.4415912415545553
NCI-H727,1641662,3.969866081416476,3.439975889919582
YAPC,66577038,3.3954554117120224,3.054320509212362
A4/Fukuda,36462,-0.7730347482869518,0.8624588643162161
DMS 273,135440466,3.3485559592244214,2.1491098146605037
FTC-133,445455,5.178470647326205,4.507408023011061
Panc 04.03,72376,-2.048199615123948,-1.3587654936331652
CAL-51,10302451,1.350542324147247,3.109192109813114
JM-1,11214940,0.7147440273172748,1.1751723651929835
A-498,25183872,-0.6220750954527926,-0.1731076966863531
OVISE,44607531,3.0758971794813093,1.4761641964558103
A-673,53392493,1.8369213613876785,2.0421638078095543
LoVo,11719255,3.552916809155198,3.5692299222680917
SNU-61,439501,-1.3808373898758073,-1.9100829404159783
NCI-H460,104842,-2.7771726159534773,-2.4355694396469527
CAL-51,11364421,-3.809863778172731,-2.0305676168484106
BxPC-3,71466578,5.509660254732227,4.557110823414459
NCI-H522,12001922,1.5621076115514363,1.7733546190379081
KMRC-1,11626560,2.283484204530191,1.6818104058316903
MDA-MB-453,5329102,2.150481946774112,2.276390405604298
DMS 273,navitoclax-gemcitabine (1-1 mol-mol),-2.068576653592491,-1.1830663401815946
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.9567096019988512
ONS-76,16720766,0.8880370259188662,0.3493296439640959
EFO-27,56949517,4.565823410262603,4.4560096395413336
DMS 273,11222830,1.4389641717758948,1.1993989481012686
LoVo,36462,0.97058855741136,2.0426749839628533
OVISE,SNX-2112-bortezomib (250-1 mol-mol),-0.8591608441303084,-0.9921915935252278
Panc 04.03,16038120,1.7157321990683845,1.3360573652359706
LOU-NH91,3062316,-1.7568876367320156,1.3082463133041216
A2780,9903786,1.372407357095215,2.543261159484786
OVISE,49766530,-2.0570642495309004,-0.8515328816356962
G-401,doxorubicin-navitoclax (2-1 mol-mol),-2.722419727945218,-1.9022432913771399
SNU-61,11427553,3.286064968901604,2.4750868189794963
A-673,72193861,0.2228627716233472,0.7349176866611948
Panc 04.03,tanespimycin-gemcitabine (1-1 mol-mol),-1.7855747696836677,-0.9638427313274961
NCI-H2009,3815108,3.061482559784255,3.128570576015047
A-673,2126,5.190382873813306,4.187953759942442
ONS-76,10302451,3.399700001459874,3.146481097597635
G-401,9825149,1.4427851681991832,2.1901846371390303
NCI-H522,44202524,1.1337498661514331,2.0393164120719613
SNU-61,52947716,-2.831948664567002,-1.0537073663389054
A4/Fukuda,2945648,2.3216808345706035,2.316075503168056
A-673,25105715,3.2161270828318207,3.401927517198176
NCI-H522,11178236,-5.864645603629742,-3.1998136543295868
JM-1,216239,1.5816975151035817,1.55207574231705
CAL-51,9903786,2.1849161121493847,2.7296906526614966
SNU-449,9936388,0.4589950900054629,-0.2103570376527712
NCI-H292,9927531,4.942242070848643,4.9931089768587
NCI-H2171,25262965,-0.9052216234257174,-1.772707078050381
OVISE,selumetinib-MK-2206 (8-1 mol-mol),3.824616242676661,1.9978343516565404
JM-1,24901704,1.786623485766962,1.9119883907788486
SBC-5,656346,0.6270929807498155,0.8422185823538898
KMRC-1,89928392,3.173061856078121,1.6602000244992896
NCI-H292,156414,1.4083938325335852,1.4121964095266635
LXF 289,135875424,3.2815298243266553,4.206252168644949
A-673,11494412,0.2373053627626316,0.8759168703105111
A-673,5746,-2.085801833901771,0.28045192065571745
DMS 273,9935249,1.448801275140577,1.7363286574151493
FTC-133,11404337,1.1811341910019733,-0.1580288102430306
MDA-MB-453,57519531,4.708696705883037,2.809888242956392
FU-OV-1,11152667,-0.9879051128837576,-0.3566648811184099
A-673,44493528,4.641329710074662,4.242051625122354
NCI-H460,2828334,6.134119597935603,6.200357476585984
NCI-H2171,16659841,2.989016667138281,2.8622573068540738
FU-OV-1,73707386,2.8924737769549633,2.7716262103080185
FU-OV-1,24901704,3.02942514713799,3.4066885975064656
NCI-H727,4259181,-0.7375001764594127,0.09540943399428586
LOU-NH91,tretinoin-navitoclax (4-1 mol-mol),-1.081702007915755,3.28667012013434
KMRC-1,navitoclax-PLX-4032 (1-1 mol-mol),3.702338136233157,1.556313549081683
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574,0.09368071142520297
MDA-MB-453,17755052,-0.3952702915340721,1.1614107509658367
DMS 273,46398810,2.5474695176149527,2.165381451727819
G-401,5278396,3.0023073980849424,3.3454288459181254
NCI-H661,24821094,2.278259467148376,2.8877592696111973
NCI-H146,11364421,-6.559818289293388,-2.2944142705488932
JM-1,24797083,0.8026470280931975,1.1703103456218882
NCI-H522,168312962,3.69802370811012,1.3341873277342657
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764,0.7493088277625539
BT-549,16736978,2.673955173636492,1.6806769007257918
A4/Fukuda,46907787,-1.6446005772830188,-0.04414143868827709
ONS-76,654092,-0.1261556450149646,-0.22838901987584648
NCI-H661,6610355,4.759868911507443,4.606539724385262
Panc 04.03,JQ-1-UNC0638 (2-1 mol-mol),2.939045539650312,1.6840044147838815
G-401,25154868,3.6071608181606063,4.141144165880867
MDA-MB-453,4788,3.7423511350995255,5.347042378175194
MDA-MB-157,11960529,3.789984251684095,3.978080691795299
SCC-9,16720766,1.7269628893506093,0.9905602300623498
NOMO-1,753704,4.4431191000277375,4.129580592990676
A4/Fukuda,6450551,1.0528971846899622,1.5433280732535295
YAPC,24964624,2.625771283300636,2.6900318181163967
A2780,82146,3.1377115486631273,3.362752093350988
MDA-MB-157,1566236,1.4232096904008935,2.2873219113819334
LXF 289,25183872,-1.882522005728347,-0.6934539754440557
KMRC-1,24753719,4.192591897270876,4.147038143750649
LoVo,44607530,0.9946707755477716,1.6924919101870015
SBC-5,44632017,0.6241642112624288,1.3692408596354755
SBC-5,23635314,-2.6646956028329223,-1.6322014354701162
LXF 289,54619267,4.7435335143288935,4.2527675091947295
BT-549,46199207,3.7007120058669623,3.2059427626548653
KYSE-70,6914657,-2.943523310206574,-3.5708193209181913
A2780,89928392,-0.8241966309638568,0.9467868389818274
MDA-MB-453,54618164,4.967166731196573,3.8896275813668377
SNU-81,selumetinib-tretinoin (2-1 mol-mol),-2.852334261178199,2.411339418348747
NCI-H460,4788,5.894567383019075,5.711543439534466
DMS 273,24951314,0.5391494064850418,0.7766469267459916
NCI-H460,1750826,3.3189287492303197,-1.1504534453175022
CAL-51,2749,1.4482754145936665,1.934949461371302
OPM-2,1566236,0.7571858740606694,1.4767141453886654
A-673,selumetinib-decitabine (4-1 mol-mol),3.170233971616513,2.087449504738905
EFO-27,11626560,3.0674086659258646,2.1638796557679725
BT-549,216345,4.357029009920563,4.098981610157075
KYSE-70,3081361,2.4267899196210982,2.129775399850707
NCI-H146,156414,1.153076826996135,1.1141625231997494
NCI-H522,135411,0.5669945497970937,0.4696979775419454
BxPC-3,6438330,1.9774707221451924,2.4788257000558853
MDA-MB-453,9903786,4.505035222499518,2.6873267907782865
YAPC,5281321,0.2366473375234088,-0.9544595167786126
MDA-MB-157,71304818,1.9463509570918949,2.5096953687070824
BxPC-3,56946209,-3.950691768305054,-3.76980713189813
LOU-NH91,6450551,3.4853298595759687,3.062730337840266
G-401,1242560,3.581659075050411,3.2267536019724257
MSTO-211H,3854666,2.1662920246080963,1.9788508119600012
NCI-H522,25062766,2.616535601519866,2.1635829582965513
Panc 04.03,3038522,3.0958365698912154,3.179256257987749
NCI-H460,25183872,2.110783783288614,-0.7808403377704921
SCC-9,71304818,2.8421374335972653,2.58284842040397
SCC-9,65064,5.356580923551092,4.967249302763771
NCI-H727,25183872,0.4102957812787974,-0.5869496924598622
NCI-H460,81146,4.483282466350705,4.885174743258955
OPM-2,navitoclax-piperlongumine (1-1 mol-mol),0.7945063119799598,0.17683586751813163
MDA-MB-453,54765302,2.0573663082868405,3.9919142610954452
KYSE-70,10302451,3.1884398798129525,2.5749934514347523
LoVo,49793307,-4.412709808216002,-3.0397108941594215
SNU-81,36314,-5.848392982376778,-1.5336905758571293
A-673,navitoclax-birinapant (1-1 mol-mol),1.618517186072499,0.7030130695705757
Panc 04.03,2733526,4.292486036611722,3.8272509212930133
CA46,9926054,1.6892727173627182,1.543942700993213
NCI-H522,2746,2.8917767436803414,2.242361933236482
LOU-NH91,67156097,-3.1227398262817587,-1.0759663906857324
NCI-H146,5284329,3.6277290639514455,3.1001495422515593
KMRC-1,644241,4.9037113640465035,1.4411010855922155
A4/Fukuda,60700,-1.3381290141173086,-1.1015763868359216
NOMO-1,24753719,4.496099764979975,3.3946699078933373
NOMO-1,9903786,1.612481289648159,1.7658179482680134
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182,2.5412487036921694
JM-1,54618771,-0.5043757930015165,0.09637566505321601
G-401,3854666,0.6606077023561356,1.3312637842384547
EFO-27,24978538,3.143555245211511,1.693550694405111
OVISE,322968,2.654176014952692,3.902964810250243
EFO-27,alisertib-navitoclax (2-1 mol-mol),2.9537662820479693,0.7493086582860323
FU-OV-1,637858,1.762395691671764,1.9713700550112412
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.7665940812125964
ONS-76,11626560,1.9844806011562912,1.4418475799949
LoVo,216345,1.1599721320761718,3.8502157667830703
SNU-449,9926054,1.9385314164963827,2.215251078386751
HCC1143,568763,-0.6390257750571487,0.5842352333895073
MDA-MB-157,JQ-1-MK-0752 (1-1 mol-mol),3.739596804581883,1.7876273813118702
NCI-H292,72193870,4.439424680926146,1.93551945414325
NCI-H522,11228183,3.862798460505377,1.0910380951714467
CAL-51,4788,6.061217822513647,5.592329283539857
LoVo,4521392,4.145025799048703,4.1997932820645305
HSC-4,11626560,2.5873766751252436,1.9145817693431078
NCI-H460,60750,-0.8382921927225392,-2.096160229957378
JM-1,44137675,3.718094845766921,2.4428144190651953
HSC-4,71304818,1.898043557267106,2.4497803584854236
CAL-51,25150857,2.2346870378683934,2.624015292478792
CA46,2871966,-1.7971239931694716,-0.03774568712727646
DMS 273,54454,3.225049529812471,2.4595473440121047
ONS-76,25183872,-0.170903852827654,-0.6569941083362232
SNU-61,984333,6.216581141210495,0.636031093007627
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.0264947141904193
A2780,71466578,2.665399831677294,3.352653439577217
HCC1143,docetaxel-tanespimycin (2-1 mol-mol),-1.7966403961348645,-2.637447857382189
CA46,24797083,-0.1839530161688024,0.853301871573664
CAL-51,135875424,4.33643967165441,3.830671239708084
NCI-H2171,3689413,-2.7117222930063867,-1.221358789684948
A2780,11396600,2.9320615716687564,3.299795652858602
SNU-449,navitoclax-PLX-4032 (1-1 mol-mol),3.4557412405701258,2.1297988934523495
G-401,56963564,0.504836775176006,-0.14477559547094127
LOU-NH91,44632017,2.871860814691948,1.6871243225071038
CA46,11214940,-0.2735426892992921,1.1747050455491175
NOMO-1,67156097,-2.629595584457773,-2.2289142637169963
NOMO-1,26596,-2.074766602044621,-2.719150160760011
JM-1,50905018,4.16446369685189,3.2881769680466504
NCI-H2171,445455,3.811797523558628,3.7125407822429266
EFO-27,16736978,1.8793599511128067,2.025923875931391
JM-1,54678924,1.2599632015511184,1.316552975089686
NCI-H460,5281321,2.142807178276493,-0.8396750367842067
SNU-449,5738263,4.026622535351311,3.457093700922901
SCC-9,216239,3.331867398285969,2.565938975318945
G-401,10410894,3.279247022117546,3.1066177563846096
SNU-61,11222830,1.6415416447740467,1.4370304073093
CA46,2113511,3.5674790523720317,4.2721560573790756
NCI-H146,72734382,2.9399655016804114,4.127824624246219
NCI-H522,613753,2.504960527289346,3.002992320564671
G-401,156414,1.0662464633968871,1.137194812254763
BxPC-3,5470400,-0.5134005920596514,-0.5939847381123544
KMRC-1,1242560,3.860865345198952,3.623406060090543
BT-549,1242560,4.319126066576065,3.759320018640378
OPM-2,66577038,2.8274271292709536,2.5468388357243494
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531,3.214907716727994
DMS 273,16013152,3.9042510131977353,3.4308351976858233
NCI-H522,448949,1.6947060599097594,1.9864952423316806
MDA-MB-157,5566,3.489209385839125,3.0243991213247075
Panc 04.03,53392493,3.71782736184095,2.830807062299526
BxPC-3,55508,4.124435576281598,3.5071109779786678
EFO-27,carboplatin-UNC0638 (2-1 mol-mol),4.02907602487195,3.6541626887042917
NCI-H661,4521392,4.344795346058825,4.343951277905423
JM-1,119607,3.9456515069078,4.441610406765373
NCI-H292,SNX-2112-bortezomib (250-1 mol-mol),-1.594180190580018,-1.1625235369683842
NCI-H460,3385,3.2657114863965573,3.930136193394881
A2780,327653,2.026169684275287,2.915609255042589
SBC-5,vorinostat-navitoclax (4-1 mol-mol),1.5319499176143987,1.231156455636071
MSTO-211H,crizotinib-PLX-4032 (2-1 mol-mol),1.678384538966045,1.9207460528685951
JM-1,4261,-0.3533034531676731,0.2348331151983738
HSC-4,135875424,3.4627713632233537,4.0355305384136395
A2780,44491742,3.4077888459991774,4.178329877411828
Panc 04.03,135999136,5.549073334475873,4.263147137482829
SCC-9,57519531,3.918058558817349,2.972824013608624
LoVo,3815108,2.2685826541267615,2.9342530856040123
DMS 273,71466445,2.157471967137961,2.6873167141175016
NCI-H661,44241473,4.80522256986357,4.957466093805778
ONS-76,6438330,3.0471678199579206,2.4882609128271307
Panc 04.03,2949965,2.626604824548014,3.05965835569617
OPM-2,676352,1.691725548140899,2.025104326874005
SNU-449,16722836,2.5551835494173325,1.669257745181348
A-673,11152667,-2.304412849002376,-0.8437645562488251
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262,3.00888295449104
G-401,151289,0.7906130786084481,0.8233315136264969
OPM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.0013874340560274,1.3119573051821272
LoVo,25195348,3.880726101323461,3.16081063364914
NCI-H1623,11404337,1.3417738865788873,-0.13788084738309306
BT-549,3062316,0.532185160328145,0.9276336208638034
NCI-H146,doxorubicin-navitoclax (2-1 mol-mol),-3.7183112313857216,-1.3358227240932081
EFO-27,44185566,3.1194970070950276,2.614985783713105
A4/Fukuda,16725315,3.095723533871789,3.7785655217778045
LOU-NH91,3854666,2.9087049696787544,2.518171437628732
NCI-H460,676352,2.985829219207002,2.115826604466647
MSTO-211H,23725625,2.234746785874409,5.117227657445787
SCC-9,5351362,1.6846115382104403,1.668812665606161
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699,-0.3968934437472299
NCI-H522,241158,3.3210308536521156,3.3564625891481965
A-673,10127622,5.418104152685571,3.6335536598979563
MDA-MB-157,serdemetan-SCH-529074 (1-1 mol-mol),2.3164799956967665,2.16250169822771
G-401,53232,3.5991410971239866,2.7750341863106263
OPM-2,5287969,-2.4106191892149185,-2.342259143891339
SCC-9,637858,3.7694424070181127,2.0882963596976665
NCI-H2171,5282054,2.409902559914623,2.833670407902324
NCI-H292,1242560,3.487131794973456,3.7401168927859825
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974,1.1492789355961954
CAL-51,3503,3.2899889427654245,2.2262384032733467
DMS 273,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1319495853751045,3.4967741992342236
Panc 04.03,51039095,3.732934843851844,2.9045574830905387
NOMO-1,5329102,1.5937414073922636,0.8481788183117961
ONS-76,1242560,3.484199229378892,3.5231104947578693
G-401,24180719,3.4290114124184568,3.263225513727341
A-673,11485656,1.6006257465541904,2.0271017840276615
NCI-H460,5278396,3.885794996406102,3.5091303028741634
ONS-76,4788,5.851184911612036,5.662361042354664
NCI-H661,11234052,4.193192571907383,4.17265855411299
LoVo,46174525,4.300656487428364,4.356675459871159
CA46,135875424,2.985562686352135,3.1717577885294888
SNU-81,6610355,3.7225360861185592,4.364864756095704
MDA-MB-453,JQ-1-MK-0752 (1-1 mol-mol),0.5621675718726626,1.6048487927040602
A-673,1566236,1.6605846703776754,1.809906821251112
LXF 289,55283,4.7983814176360715,2.8806874474924875
DMS 273,1566236,1.8001113918747356,2.137940354225778
SCC-9,4477,0.0462068475019735,0.652525896334149
BxPC-3,439501,-2.27553783948146,-2.129407703807942
G-401,3503,1.5245243202568906,1.9577312660354174
SNU-449,5280436,2.098309971831213,3.4991745830285788
LOU-NH91,119607,5.561970464467383,5.531978794684415
MSTO-211H,6918328,-0.4462053694736546,0.03556962769378958
A2780,10231331,0.3686619766312378,1.6295204689520773
SNU-449,44137675,3.6126407514409378,3.702399034233777
Panc 04.03,9866186,0.4755964236535121,0.9874559951483682
JM-1,40482356,5.622716652052393,2.913634685616755
CAL-51,49766530,0.4609697007955676,-0.379450854519653
G-401,11960529,4.93979495553103,3.3703291949405667
HCC1143,6505803,-0.5233928936461414,-0.3642592542063099
KYSE-70,676352,2.557270596786296,2.1883399470219937
A2780,135398516,-0.3122960179418635,1.8297395589946357
NCI-H292,23635314,4.8326715815763395,-1.7154080195958201
SNU-449,15547703,3.400796461378631,3.4337846433481407
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034,0.05630745943773757
LXF 289,46843906,2.101940493524925,3.14464499163347
DMS 273,46174525,4.164871991455526,3.285864237482753
NCI-H727,selumetinib-decitabine (4-1 mol-mol),-1.5172256962408457,3.1925937787379155
SNU-449,6917907,-5.317414756413243,-4.345997348793457
A2780,4705,2.567744201920244,3.079480953794079
KYSE-70,73707438,4.323396479680616,3.9079824311907565
NCI-H460,5329102,3.240160570329804,2.0470887087915846
NCI-H661,5282054,3.5253080606128133,3.502974813025874
NCI-H1623,119607,5.952206355872506,5.346427150171129
NCI-H522,64971,2.9291780846019413,2.42096230521813
CAL-51,11222830,1.6762547521470548,1.5250139810248442
A2780,vorinostat-carboplatin (1-1 mol-mol),2.197042842116113,2.6359581055607504
SCC-9,25062766,2.812414712404745,2.279912477261516
YAPC,31703,-0.7401868256368748,-0.3453666629871163
KYSE-70,2858523,3.054228167220651,2.9417449851226856
MDA-MB-453,1242560,3.902800159671119,3.652147879129271
MSTO-211H,71466380,4.302501611697816,4.4677782183358765
NCI-H2009,3689413,0.5343246791806224,0.22499805502576084
G-401,15547703,3.220896426279267,2.8329474758867166
NCI-H522,11719255,2.5592835843852337,2.671255393984603
LXF 289,46191454,2.351463869671111,1.9529832079538016
LoVo,71304818,2.0724805960279027,2.495342220955464
A-673,5311,0.6764453858481513,0.9151852037154232
KMRC-1,11175137,2.246406512349146,2.465246813053881
MDA-MB-157,568763,-0.4149964884485024,0.6561008107406403
LOU-NH91,11213558,0.661761515775888,1.9687008423435193
CAL-51,2733487,8.211583338705053,6.1042327713947815
LXF 289,16741245,5.010251526780332,4.110548108919309
SNU-61,24797083,1.0556452382424049,1.399496204874631
BT-549,44137675,4.586830027774197,3.6891097281889143
CAL-51,15547703,3.503799403292956,3.299474499787844
JM-1,3136844,3.4340507925237307,3.7954289246738857
NCI-H460,46191454,1.6495265120274705,1.708248236815559
CAL-51,16722836,0.8083581946159574,1.6163573908605335
FTC-133,25227462,2.318225674680384,0.54436527704345
A2780,51039095,0.059669762784491,2.3199934802948814
OPM-2,54613361,-1.307423897840743,-0.5972604694522586
LOU-NH91,5328940,1.6284519107294106,1.82313956470946
HSC-4,11640390,4.10313790521596,3.511107218578392
LoVo,11222830,1.6500045227885836,1.6019732844202763
NCI-H2171,53495165,-2.473385034422452,-1.4502342424292634
MDA-MB-453,5281321,-0.6344069396712416,-1.1372180794005677
FU-OV-1,9926054,2.079351745951841,1.6728188338027752
G-401,36462,-0.1566510321668276,1.085091413492794
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987,1.3570911218311505
NCI-H1623,11427553,2.6307082318350132,2.8257197333066926
A-673,6918638,-0.1443248090306654,0.25965803821237726
OPM-2,54596490,4.128803973627264,4.389318885112121
G-401,24753719,3.1602445998928186,3.7306701542005505
FTC-133,selumetinib-MK-2206 (8-1 mol-mol),6.933601402972985,2.276475133390713
DMS 273,637858,1.5802330029013405,1.182911533447542
OPM-2,72199292,0.0645754970830883,0.5302706994948929
SNU-449,5328940,1.97588831229785,1.7127815767752668
OVISE,49793307,0.0210083556696064,-2.785396896490372
A-673,11647372,1.3285775791052634,0.6159304667267167
OVISE,6918328,1.4244682512544402,0.24661251165459272
Panc 04.03,25154868,5.1819399857498025,4.5575671336315
EFO-27,17755052,1.748867275877649,2.0648148363309757
EFO-27,decitabine-navitoclax (2-1 mol-mol),3.595019869203868,2.3247126745971287
SBC-5,375860,-0.6399303579455221,-0.34670352874495947
HCC1143,selumetinib-piperlongumine (8-1 mol-mol),2.549848868109157,2.9507088395445793
MDA-MB-157,451668,4.959725465812671,3.812383501150294
YAPC,54619267,5.29132207947154,4.269189077550784
OPM-2,36462,1.377546018006998,-0.12898225907514546
BxPC-3,3081361,1.7902484572067556,2.279283074057305
SNU-449,11455910,0.8938620280411973,1.191309462184452
NCI-H1623,25022340,5.5347014016683875,3.225886138457919
NCI-H522,409805,3.737006742854017,4.4383398184065985
CAL-51,568763,0.0917223714484538,0.4584265822684436
HSC-4,12001922,2.169357927696289,1.8593002047897154
CA46,2742550,3.5037926309603944,3.237360339641862
LOU-NH91,11507802,2.1124947170440533,1.8547336874190758
LXF 289,6852167,2.2044562779321635,2.957235774072594
ONS-76,26596,0.1332187247782509,-1.0913018729716804
KYSE-70,9903786,2.353212274658888,2.7777491493122546
DMS 273,10385095,0.5027476993233067,0.9505309962681584
ONS-76,3025986,-0.4351415981508911,-0.6506796210911783
MDA-MB-453,89928392,1.7795585771799345,1.599253930235467
LXF 289,676352,2.537691956872654,2.1005551659348107
OPM-2,navitoclax-gemcitabine (1-1 mol-mol),-1.0437605792762972,-2.0410109218902917
HSC-4,135659046,3.804399419736421,3.6659610646744794
OVISE,alisertib-navitoclax (2-1 mol-mol),-0.6471026369576864,0.4237125515517564
SNU-81,6623618,-2.7236989498385733,2.309046351896473
HSC-4,5282054,3.7951129778884822,3.8545169273489184
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798,0.29982752321569694
A-673,16219061,2.4523595679466954,2.773929519592778
SCC-9,123631,1.8109604294388877,2.3014416078332487
A-673,11364421,-5.84995188170368,-3.536182341760015
A-673,216345,3.678855080389337,3.700237815618233
A-673,439501,-3.092013019617277,-2.6087046807521643
NCI-H460,1566236,4.3513012021592505,2.599573896198155
LOU-NH91,25195348,3.759766884877561,3.3397419758616427
DMS 273,23725625,4.676663171220921,4.068455084057295
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706,2.06086004751921
CAL-51,6852167,2.546662292056567,2.9252156624014822
OPM-2,5738263,2.0935625564909737,2.899716754623007
SCC-9,5311,1.75647433259966,1.7482158427082564
SNU-81,5291,3.232691727920098,3.6069469963934075
FU-OV-1,262093,2.4810055989466018,2.829969155240269
LoVo,56949517,2.258326270055845,4.434824784467742
A4/Fukuda,9825149,-2.050748608979426,1.9173987009016351
CAL-51,53392493,1.8808489153668793,2.49642083492285
NCI-H522,4521392,3.962796694444569,3.9830764813065453
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518,-0.061439913074142115
NCI-H2009,11612883,2.3268324416241777,2.888025375539785
NCI-H292,65064,3.148033598452649,5.199381011594461
NCI-H292,44589607,3.354505508461316,3.0114450027070916
KMRC-1,462382,0.2791911345900462,0.640598692975165
A4/Fukuda,5291,3.6218734753047226,3.3900844574120974
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.7104447209033448
A-673,135440466,1.1776565801361647,2.0719784366769067
Panc 04.03,60700,0.3719609401953118,-0.30823508470474775
LOU-NH91,66577038,3.4622279905398052,3.137201388883181
A2780,24856436,-0.502193855863573,0.40384128207011677
CAL-51,6852167,2.546662292056567,2.9252156624014822
JM-1,5311037,4.072371281952103,2.78899170399152
NCI-H460,374536,2.933441634270558,2.339142483157687
NCI-H460,216468,4.763843832635099,3.199025959855309
SW1463,421610,3.2195561799423804,2.996753487806729
NCI-H460,439501,-2.362377537788676,-1.984724862445802
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393,-0.9620015282798885
MDA-MB-157,24978538,3.306703195844951,1.0842719787989838
MDA-MB-453,54618795,1.052632381834858,0.8985461328601306
EFO-27,6914657,-5.685084863882177,-4.100863480054726
NCI-H661,9866186,1.9017456959186525,0.9357429420185751
CAL-51,6623618,2.223133904662847,2.3917482242761903
OPM-2,5281672,3.1701528707347015,4.099116403480751
CAL-51,1716436,3.275997904874087,3.137104419148608
NOMO-1,25183872,-0.6960845434284378,-1.9679278046703774
EFO-27,216239,3.3875560857040887,2.355345983728119
NOMO-1,54619267,3.207870909981956,3.7041152528627426
NCI-H460,400769,-0.4007490431715684,-0.5365172798333921
SNU-61,6610355,3.885584601382451,4.24523554619477
BT-549,vorinostat-carboplatin (1-1 mol-mol),4.114114464716558,3.1712378564523256
JM-1,10077130,2.0136903876831993,2.285216648658858
NCI-H661,81146,4.823771143587,4.7184040061940085
LoVo,56946209,-4.467950537911531,-4.085651927703204
NCI-H522,5460769,0.5614535105182378,2.503850912543765
CA46,9927531,3.0223750820915978,3.946332252260374
CAL-51,11612883,1.9359641259018452,2.992459405464823
CAL-51,11427553,2.069280384014222,2.9214000015587684
NCI-H727,5746,2.1304383256196293,1.0421069644722731
MDA-MB-453,16219061,1.5030881414961583,3.256502893039607
MDA-MB-453,68056272,3.261695748545246,3.0054153650757702
A4/Fukuda,6610216,3.4719570509087445,4.031955768879801
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.713755369178617
SCC-9,107985,-2.37702169012632,-3.4777160264350617
MDA-MB-157,23939,3.513284021833553,3.781270172809136
OPM-2,262093,0.5720462757198622,1.569296768947832
NCI-H661,5351362,2.412641003608378,1.6552729456520603
BT-549,53495165,-2.465962418573161,0.40689997539594924
A-673,decitabine-carboplatin (1-1 mol-mol),2.7905557903359246,2.196537603063716
HSC-4,1716436,3.018983829466311,3.1448679407281035
A4/Fukuda,10231331,-0.0070700765814584,1.0405863074338535
OPM-2,25105715,2.7306053213312027,3.1315193072511183
CAL-51,3384730,2.4775948365465905,2.927229979132588
DMS 273,vorinostat-navitoclax (4-1 mol-mol),0.8220813286666946,0.5469677061018181
KMRC-1,262093,3.6313310555506817,2.843803246379656
KYSE-70,5311281,3.780874632943925,2.295645244304768
Panc 04.03,135659046,3.760242578723066,3.7414224834534746
NCI-H460,46199207,3.5033257005335163,3.047963663467417
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062,-0.3510323569782667
NCI-H522,285033,-5.015646919007219,-2.2357532830763804
NCI-H1623,31703,-1.093718795909536,-0.5267543294302302
CA46,8515,3.648186715161825,3.185418696240173
A-673,54618164,3.9765209939943857,3.873075844781484
MDA-MB-453,71304818,1.4463301677266325,2.149164763040022
SNU-81,656346,0.6811147423088999,0.9229494471418078
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376,-0.17811168394871182
SCC-9,alisertib-navitoclax (2-1 mol-mol),1.3350821103573205,0.7001252389654705
OVISE,71680916,3.981894618274443,4.883926913312119
LOU-NH91,56963564,0.9665729866263152,0.30630994577148096
NCI-H661,23635314,-2.0342629068452056,-1.625831736516646
LOU-NH91,12001922,2.55699926148122,1.8865898778602475
JM-1,31703,-4.919166892515249,-2.4301477409799843
EFO-27,16065773,2.8503557299543063,2.5198448054616684
DMS 273,107970,2.226748766743483,2.1054957787307504
MDA-MB-157,67156097,-2.087594374926874,-0.6575619343340737
BxPC-3,JQ-1-UNC0638 (2-1 mol-mol),0.9591872546469856,1.588776960841495
LOU-NH91,46199207,3.3608515659177147,3.2786557347657355
DMS 273,JQ-1-vorinostat (2-1 mol-mol),0.2212996861992737,0.34886939645740983
BT-549,2871966,1.6191257261573118,0.7930057612410006
BT-549,46926350,-4.493585638609818,-3.854071781985785
OVISE,54626689,4.712933516379989,4.5833834738629085
NCI-H460,119182,0.2489341964189734,-0.5931872737672363
MDA-MB-453,7251185,1.8406187352582624,2.493943876881567
JM-1,4521392,4.181937683636394,3.9857457869197632
LoVo,44589607,1.625549992230134,3.069895223317064
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393,1.4673549296481014
A-673,24951314,0.6400096482448101,0.6870173026939453
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525,1.110528803464311
A2780,11152667,-1.0749204847082217,-0.8233550924352163
BT-549,5329102,2.9790267437316285,2.218833184209485
G-401,17755052,0.028133790527295,1.39856140664764
CAL-51,11238147,2.100409816322544,3.0272786675148904
FTC-133,16725315,5.918216987208106,4.126281039722195
HSC-4,10127622,4.548794444843462,3.5541450887414756
NCI-H2009,JQ-1-MK-0752 (1-1 mol-mol),0.489585373897599,2.1369153065455224
HSC-4,72376,-2.108784759313747,-1.826192247122283
HCC1143,11455910,1.411815978618001,1.348596079294427
G-401,6610216,3.9425308150709,4.045241516967797
OPM-2,73707398,-1.391957592490296,0.38897115799639725
Panc 04.03,crizotinib-PLX-4032 (2-1 mol-mol),2.2047528734152655,2.159282765814018
MSTO-211H,11396600,3.2938939565791765,3.616811910307584
NCI-H2171,15983966,-6.379176066325201,-2.3587559978075316
HCC1143,9903786,3.3387804215378885,2.854812030402036
JM-1,3385,1.6679469335870958,2.455369752803471
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.4284877108347667
JM-1,44487872,4.651129481786086,4.259110533204816
NOMO-1,439501,-2.35226533453039,-2.7321045143764504
Panc 04.03,568763,0.8595160951448656,0.7192467078081787
A-673,15953870,2.6171812575314757,3.2486695305290785
CA46,6917907,-5.812984110767001,-5.282131834508288
A4/Fukuda,11404337,-2.650657466190433,-1.0701218312681555
MDA-MB-157,6184667,1.80494393962058,2.8999690274835577
NCI-H2009,JQ-1-vorinostat (2-1 mol-mol),0.1591835457896471,1.303948006831947
NCI-H522,25102847,2.0692872541383784,2.1178781586573447
EFO-27,2113511,5.820212709586459,5.523407785386795
Panc 04.03,2729026,3.1546590032208948,2.775291374001083
MDA-MB-453,9866186,-0.0857862406385878,1.2511718557375842
CA46,44491742,3.801952242992866,3.803455429875488
MDA-MB-157,16720766,-3.610201854539628,0.6266868684738626
NCI-H522,168313016,4.366007701234683,4.156032534868913
JM-1,53232,3.389128909220105,2.3963483368986203
ONS-76,24901704,3.4855009095109435,3.2017922881537846
FTC-133,3136844,4.271719807093853,4.203528474779321
CAL-51,54619267,4.1828818787298765,4.049343404319918
NCI-H146,17755052,1.2442303799433287,1.4560252489285785
FU-OV-1,2858523,3.1344850445874752,3.0476990053324506
NCI-H292,5280436,4.014624366310106,3.6015926144752517
BT-549,15547703,2.0718927663287703,3.337017548815499
A2780,25126798,3.236047242798602,3.761686508203639
Panc 04.03,2945648,3.066534391812563,3.035793676639077
SCC-9,56963564,0.633234370730304,0.3439915633316007
A4/Fukuda,11507802,0.3746235533355334,0.7724222263819143
Panc 04.03,3025944,4.694936485248253,4.32596237520793
SBC-5,46398810,3.6562963267762183,2.5445733683312675
JM-1,49793307,-5.3555461291239075,-4.187595775193342
SNU-81,67156097,-1.5845934662844448,-1.3128479415190204
A2780,72376,-3.651935268939024,-2.585213539502099
CAL-51,25195348,5.6667768045179905,3.407651104188434
NOMO-1,10074640,3.0496099519927435,2.7132117182968085
FTC-133,46174525,5.692041239325808,4.544462876123909
YAPC,409805,4.253424942012428,5.010524336913331
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276,1.9951821146046882
SNU-61,11626560,1.823906724750755,1.5031284311308726
A-498,16736978,3.6467697702535182,1.9325320392997458
JM-1,9967941,2.969647244173239,3.0511004688637295
MSTO-211H,3815108,2.5678993468563913,2.9399305196026404
KYSE-70,637858,2.812350468450961,2.0297887480881407
A-673,16013152,4.069813049540754,3.91535944342579
A2780,4521392,3.924686212385386,4.265324643214964
A2780,23635314,-2.3171748001501635,-2.4936935030341427
JM-1,3689413,-3.612287026066889,-1.27688674056345
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057,0.3841812967287808
OPM-2,64971,2.0053510879561296,2.407560000287114
LXF 289,9935249,3.315625346230847,3.205242507672606
Panc 04.03,984333,1.398892433045171,1.1002930570942895
DMS 273,676352,1.7083859345894283,2.008383692954212
MDA-MB-453,4096211,1.6956492567589403,2.163114526452164
DMS 273,9903786,1.811418424711566,2.72356241575555
BxPC-3,3634881,3.024771766376516,3.5834472932921075
ONS-76,54618305,5.4771970245541866,4.564609103789666
Panc 04.03,44491742,4.30815140156182,4.1924395155911265
A-673,tretinoin-carboplatin (2-1 mol-mol),4.33843308891482,4.126423799949695
MDA-MB-453,123631,2.1950816453081545,2.2851302981560537
A4/Fukuda,426756,4.168045276817785,3.7561451383038746
CA46,252682,5.8821335535914905,6.304116655254771
Panc 04.03,2828334,6.268769524950107,6.203842938968558
EFO-27,135411,0.9008731550993504,0.8923983884968096
LXF 289,15983966,-1.3187435990338214,-0.9269857082298967
A4/Fukuda,3384730,1.825152720179272,1.5656254364691171
SCC-9,11404337,-1.771041191231111,-0.3281743056146207
SNU-61,6610216,4.086517799339023,4.045949965908397
LOU-NH91,446155,1.33101507486467,2.814541404813318
KMRC-1,71466380,4.698779777562497,4.339967553575784
SNU-61,46398810,2.7474251169458346,2.3186172085653407
NCI-H2009,9826308,-0.026532071259288,0.9498727400986899
NCI-H2009,56946209,-2.630012103472263,-3.8352480705730123
HCC1143,46843906,3.1964507186723305,3.005670381336076
A-673,2742550,4.033526638201744,3.5496808870473884
SNU-81,11507802,0.99367607100598,1.4418093240107874
KMRC-1,11485656,3.5314695534539045,2.1153971724830836
SBC-5,57330099,2.8388792643726295,4.062105167017179
LXF 289,219104,4.555444774518925,3.9500546965657746
Panc 04.03,9907093,4.451330392346362,4.27567124019284
DMS 273,19582717,4.273838780275844,3.2247445093971425
SBC-5,3815108,2.9831729144642956,2.8727716444278593
OPM-2,168313016,3.5498730155612863,3.8256339725222133
ONS-76,10427712,4.642311539672088,4.156952856199981
NCI-H522,54765302,4.051221649365855,3.878577649727283
JM-1,44620216,4.114569245447781,3.358162028193375
MDA-MB-453,9887053,5.45770037243801,3.3623177388400887
A4/Fukuda,72193861,-0.8043632874402014,0.4753350790403782
G-401,25102847,1.393287045797279,2.074487417974982
SBC-5,11507802,0.0977610232609949,1.7959149154699257
JM-1,168313200,1.89690041567587,2.5145403605319516
FTC-133,3634881,3.4388146515237468,3.144611147827482
NOMO-1,10427712,4.067466468396052,3.6180023122084166
SNU-61,6918328,0.4046547109968232,0.04216818006008435
NCI-H2171,23635314,-3.6505205606038382,-2.360326320953332
SNU-449,6438330,2.777557669825017,2.378408656875941
JM-1,25161177,3.865095276574429,3.1578208618455816
LOU-NH91,3025986,-0.3413799803632848,-0.6672653118552228
HCC1143,53232,5.137172207040132,2.931227205852034
LOU-NH91,53232,2.5403477328432933,2.7210114175998465
NCI-H1623,24797083,2.165751455730843,1.44929442493598
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651,3.181263558300296
LOU-NH91,crizotinib-PLX-4032 (2-1 mol-mol),1.9615360492611609,2.0230454365507984
SNU-449,3025986,4.266276949739511,-0.9204894053643788
NOMO-1,2858523,2.9127751570608136,2.8620670165930955
A-673,6918736,-0.9753951922870552,-1.945125354365865
A2780,44202524,1.0300821380640774,1.8274208837957389
DMS 273,25154868,4.488535380180048,4.278204152439241
NCI-H146,navitoclax-gemcitabine (1-1 mol-mol),-4.8472150579078646,-1.3621888260286688
BT-549,100016,6.139281322747303,6.1641560004478535
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006,2.8314776728785147
SCC-9,148124,-0.9222891029936632,-1.7756332579104837
DMS 273,11494412,0.2734180035919979,0.7293648087516478
A-673,ISOX-bortezomib (250-1 mol-mol),0.1019689677537875,0.2661691528943756
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355,1.5956383037577735
EFO-27,16725315,5.151426492732951,4.26780175188332
KYSE-70,3689413,0.9447440025313596,0.03659846479539996
A2780,navitoclax-MST-312 (1-1 mol-mol),0.9234968671687596,0.6754786604987273
NCI-H460,285033,-0.7054560098467199,-1.779944841616494
KMRC-1,5311,2.4483949186029794,1.5451616826614925
Panc 04.03,54618164,4.2869772681873695,4.184027806024571
NCI-H727,676352,2.629502567411482,2.0532963910541557
HSC-4,24779724,5.454925638847944,4.422495075154264
A2780,23725625,2.4195603562256873,4.3223789677967
CA46,56946209,-5.9555571874685755,-5.042400483976982
NCI-H146,6252,-1.7817409080320272,0.4093339926274941
SNU-449,44589607,3.7188226068257872,3.1809451007249
LoVo,969516,2.402995535890804,2.7925560817501855
KMRC-1,carboplatin-etoposide (40-17 mol-mol),4.177751638329711,2.627647644804855
CAL-51,9935249,3.84795648434564,3.155916600554625
NCI-H1623,53392493,3.831222645051568,2.6604149376081483
MDA-MB-453,54596490,5.641262539800198,4.383294901904034
A-498,42642645,1.5845020846141176,1.0259764749689717
FU-OV-1,4788,6.1006518616017615,5.650067260347673
DMS 273,6852167,2.1769146352356707,2.0184373551501515
LoVo,11612883,2.4190290931093954,2.65721382525977
A4/Fukuda,54618305,3.964460418875751,4.102961733615648
NCI-H2009,17755052,1.0629457660851225,2.1926931571880526
EFO-27,5113032,5.5462842201226925,4.874755934164381
LoVo,9907093,0.4604974674369004,4.083758331400293
SCC-9,44491742,4.764074483400304,4.380669600765478
NOMO-1,53392493,1.775943290565707,1.6725558890877616
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924,2.493320245928347
SNU-449,16725315,5.255161508937853,4.3130799538802
SNU-81,9825149,1.815233140933264,1.9615991772343273
NCI-H522,60700,-0.5552110519793028,-0.647043777409311
NCI-H2009,375860,-0.9754800160336818,-0.13258531443753033
OPM-2,44607530,0.8834373674969361,1.4430253316460266
MSTO-211H,2708,3.2234156242084073,4.786047212738351
OPM-2,15953870,2.653227585048534,3.1341596042764577
DMS 273,11238147,3.12717198165546,2.1701213187050943
OVISE,3062316,1.3579552700407893,0.918430197442974
NCI-H522,11955716,-2.355417617820864,-1.45677744777447
LXF 289,44486219,3.8558224358877298,4.294731425009782
NCI-H522,4261,1.255814980012561,1.4372616916836158
SBC-5,11396600,3.6683316442381617,3.7948740965900525
NCI-H727,448949,2.521247711014773,2.1379147454758747
CAL-51,126941,-2.448006630223804,-2.64845392262571
MDA-MB-157,156414,1.5733069512528617,1.5104573728798842
Panc 04.03,selumetinib-BRD-A02303741 (4-1 mol-mol),4.320411537707366,3.63375811648113
A2780,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4355880611725125,4.252260998387504
FTC-133,2871966,2.512715884905784,0.646311895111198
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.9567096019988512
KYSE-70,168313047,2.1859183661660624,2.2507637426729024
OVISE,serdemetan-SCH-529074 (1-1 mol-mol),2.136633519186749,2.114657657670938
LoVo,54454,2.7172548619434025,2.4715356108731705
SNU-61,73707398,0.7144154314829279,1.432981666939631
MSTO-211H,9866186,-1.5986440722967756,0.858116861658558
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416,1.0503962942675082
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909,2.6693724389206146
NCI-H2171,57519531,1.5586354952126105,1.8044214856609984
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.0264947141904193
NOMO-1,451668,-1.632426084818391,-0.7749109157161643
CA46,5282054,2.3254868404716755,2.7974955180905687
MDA-MB-157,54618795,2.0481333451118204,1.2035691087792315
OPM-2,11707110,-2.1571352516283113,0.3680577797091146
CA46,3136844,3.7113001526336338,3.6950551038615145
NCI-H2171,984333,-0.9596445260901963,0.07518077373421889
NCI-H1623,11507802,3.5238050648518136,2.166772972188212
NCI-H460,46191454,1.6495265120274705,1.708248236815559
EFO-27,BRD-A02303741-navitoclax (2-1 mol-mol),3.819919815231351,2.8659993670260064
MDA-MB-157,7326481,2.299098205794017,3.115493316121625
EFO-27,1239801,4.748117996702423,4.25513296521619
NCI-H460,969516,4.1763077592827225,3.100656920857618
G-401,44202524,1.447982360696086,1.6853506321041243
A-673,JQ-1-MK-0752 (1-1 mol-mol),1.0252952721702926,1.1024831924216323
NCI-H460,2749,2.5004778765083695,2.0971765256263626
DMS 273,119607,5.531574360726778,4.839344079654555
FU-OV-1,10074640,3.835416148861087,3.1348879575247253
DMS 273,navitoclax-MST-312 (1-1 mol-mol),0.9055949261710712,0.4181019833240452
MSTO-211H,9911830,2.3480580098381747,2.61334933527917
SBC-5,135411,0.301348299555382,0.844353576419737
MDA-MB-453,6610216,3.7821562137745217,4.102878610300191
SBC-5,2708,2.061546130614232,4.857427452523671
KYSE-70,11396600,3.829938839575827,3.5182289905121853
OPM-2,vorinostat-navitoclax (4-1 mol-mol),0.1768151572883334,-0.11236638012259118
A4/Fukuda,11152667,-2.4230854517211977,-1.6589732649061883
SBC-5,36314,-4.885811702708602,-1.9460369952248382
DMS 273,9884685,-1.1971048738595964,0.117422255162243
SNU-61,vorinostat-navitoclax (4-1 mol-mol),2.3944367596721547,0.7016466576251595
NCI-H2009,439501,-2.087429471182781,-2.2517029580098415
MDA-MB-157,1716436,1.1718034720311097,2.9724880111538328
ONS-76,216239,1.6729885995968985,2.2887978169156877
NCI-H460,9911830,3.1326305509826824,2.621530945551009
A-498,2858523,3.0988346297597293,3.033571872605296
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205,2.8994977424258734
OVISE,969516,2.883429877122848,2.867276634888289
SBC-5,3825829,3.3495967392740953,3.9263392956125274
LOU-NH91,5278396,3.7974378044691495,3.638049897164348
MSTO-211H,9935249,0.534197831206919,3.375455160156014
JM-1,9911463,2.675259516581914,3.0652478353111423
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477,3.1925125573429676
SCC-9,60750,4.9910553033212866,-1.706489472815469
SCC-9,387447,-4.584813930042193,-4.003257846291017
SNU-81,25062766,1.4859068805404914,2.0613442719462283
NCI-H661,2708,6.321788786635088,4.7797998509876045
NCI-H460,57519531,1.7606196796007008,2.666942343231388
KMRC-1,613753,3.207263348750723,3.0096017170684486
KYSE-70,67156097,-2.3379446798215127,0.1193742045732673
OPM-2,10127622,2.4771662101119194,2.9557354738616315
LOU-NH91,5291,3.971687681340124,3.75254393334007
DMS 273,6918638,-0.6329393875591668,0.20044442067279453
A4/Fukuda,16722836,0.6102638619225811,1.0648698857120134
NCI-H1623,11175137,3.026300100874371,2.6150706494962237
SCC-9,122327,5.629849115039079,4.683919040190059
CA46,11625818,3.63093624941088,2.978113187856351
FTC-133,navitoclax-piperlongumine (1-1 mol-mol),0.208088727166438,1.6673350411097059
Panc 04.03,156422,4.828457411788627,4.109256640287649
DMS 273,5278396,3.2906012116635694,3.399535217129103
HCC1143,53495165,-2.177337144630303,0.5331061763528475
OPM-2,1641662,3.0681099569104653,2.770117288557476
A2780,BRD-K27188169-navitoclax (2-1 mol-mol),1.5548908643939203,1.3401011342424602
NCI-H1623,doxorubicin-navitoclax (2-1 mol-mol),-1.3303127155633732,-1.0235956652885947
FU-OV-1,navitoclax-MST-312 (1-1 mol-mol),2.560090479517714,0.8689497415764206
A-498,6917907,2.9475757171512575,-3.6492159308825047
G-401,10385095,0.8697787767816428,1.0557265356720649
MDA-MB-453,702558,3.1332940697725435,5.174955439494262
BxPC-3,15547703,0.9056764589340796,3.1907082330488556
A-673,44632017,0.706241354368095,1.0969558629103333
FTC-133,JQ-1-navitoclax (2-1 mol-mol),0.6314108059190333,0.9817305318545726
NCI-H661,11626560,1.806538061239003,1.946291337905756
SBC-5,9840324,4.760330511699364,5.591845692348942
NCI-H727,46398810,3.032466795061864,2.4956976061094585
HSC-4,654092,0.2566378579351391,0.06972505202842251
G-401,5978,-3.1887203575088727,-2.7472161618303166
A4/Fukuda,11238147,1.0973923844128086,2.1964436076778435
MDA-MB-157,JQ-1-navitoclax (2-1 mol-mol),-0.7190689296194697,0.9197654839999925
NOMO-1,54678924,1.1055951494804663,1.2038760110231919
JM-1,135421197,0.410328587733175,1.4111213616569895
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774,-1.7753871992061356
BT-549,216468,4.5222519285579885,3.263654505471351
NCI-H2009,136227924,2.9896301065010933,3.0986506833933305
SCC-9,2828334,6.128266495621781,6.240837981949784
LOU-NH91,3025944,4.356407657994756,4.371514847808585
ONS-76,5329102,2.3644433253395545,1.7933178400753302
DMS 273,53495165,-0.9870251488119351,-1.3220266939726641
NCI-H1623,3634881,3.389178636612412,3.3083974710989907
NCI-H1623,446155,4.270765867841268,2.785326392435209
ONS-76,984333,0.6472143254241693,0.7081150366880149
SBC-5,3081361,3.306292226806483,2.2722541728351744
NCI-H2009,11625818,4.7000574258268255,4.435452494532189
CA46,24775005,3.732581966598925,3.3081390659369094
SCC-9,11222830,1.8600220042192213,1.6480128278494233
KMRC-1,12003241,-1.418239320082467,-1.078689008819719
SNU-61,613753,3.0121134483838037,2.907445790886207
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433,0.5899369822588814
SBC-5,4261,2.0931810634834105,1.5121181207599634
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505,1.9648740737452894
JM-1,445091,4.048660068158945,3.868109216642196
NCI-H292,44185566,2.325959343920572,2.6409704013540933
SNU-81,6918328,0.0758058419703895,0.09495923829038828
A-498,16659841,6.0591016575330325,4.138764349640364
NCI-H460,51037431,2.104101453867928,3.300801537880431
MSTO-211H,5978,-2.861470631068365,-1.7369813573833464
SBC-5,6918736,-1.7962623830849138,-1.3924169749620594
NCI-H2171,11178236,-6.134942659978268,-3.0313512045975033
ONS-76,11427553,2.8550216000544695,2.4489988040003405
JM-1,11234052,3.3092904099829115,2.8405142193887167
NCI-H661,ISOX-bortezomib (250-1 mol-mol),0.8750807194042233,0.7616482636864198
MDA-MB-453,11719255,3.0016884563631057,3.628915925327149
HSC-4,241158,3.797905223062241,4.105208381343157
SNU-61,49766530,-2.178873950286192,-1.259544350404596
ONS-76,54454,1.5364254879481318,2.4309493732512224
NCI-H2009,54618164,4.160237516111787,4.154657841410229
CAL-51,3136844,4.799885860604426,4.410804480800866
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096,0.840158861368075
SCC-9,46926350,-4.135183666473923,-4.136638433809827
YAPC,5460769,2.316930709954587,2.695679699304406
YAPC,135411,0.9254838530178896,1.3287066195924337
A-673,11228183,1.918128583172148,1.0981775735184836
MSTO-211H,24856436,-1.8779899697418416,0.8600046799845491
LXF 289,44185566,2.4809324153017265,2.732330189888036
OVISE,654092,-1.3076939787912127,-0.06288130706888954
A2780,6918328,-1.1386748973241003,-0.1583157506008826
FU-OV-1,44819697,-2.23904448126328,-0.7880963487699524
BT-549,42642645,1.6219324424635808,0.952208153084608
JM-1,216345,2.231105973795255,2.8536597715313574
G-401,73707398,0.5507155331982622,0.853622727392401
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.7733717644924347
KMRC-1,16722836,1.9243244677044424,1.5762257729702334
NCI-H1623,135875424,3.67415188779786,4.1031063323759565
NCI-H2009,638278,3.464543124143687,3.2423766173109714
NCI-H727,168313047,2.9561297907786717,2.4991879254183305
SNU-81,439501,-1.707157001292212,-2.0962125214649956
MDA-MB-157,11234052,1.0821323764870938,4.276535645620779
NCI-H727,11364421,1.2179988120980565,-1.5760763180252457
BxPC-3,2729026,2.140647578797141,2.744541647935352
NCI-H292,46224516,2.488403107417036,2.55919013758506
MSTO-211H,5746,0.1838030897357816,1.0475362172391074
NCI-H727,5280436,4.172163827724594,3.3635023822844112
NCI-H727,9911463,4.409308573364914,3.6889952048151633
LOU-NH91,9907093,4.908801109640004,4.324038252092629
HSC-4,24772860,-3.179601965562413,-1.6731197124810535
MDA-MB-453,10302451,3.3014196832790628,3.077671810347821
A-673,2945648,0.1856393110329161,2.5512815827474196
G-401,56946209,-5.714614119541748,-4.470007495095945
MSTO-211H,452548,-2.0931551112296742,0.23569364413623725
NCI-H2009,5280436,3.59103147994178,3.6679013978408572
CAL-51,241158,3.781489879449518,3.862856649159556
FU-OV-1,24772860,-2.86759244210788,-1.5533090450489622
DMS 273,54596558,4.317274835352231,4.391313528908664
DMS 273,71466380,4.5698020131067745,4.263857204288553
ONS-76,11175137,2.2807611594224975,2.4515751249575426
NCI-H522,136227331,5.948504593030567,3.5519181954598067
KYSE-70,262093,3.701785722517592,2.747667221159887
KMRC-1,119607,5.885636542486439,4.973797270521659
CA46,16722836,1.2778374610309875,0.8074677442431372
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874,2.9209394160837348
SNU-61,24772860,-2.9174361907600592,-2.1354972265025403
LoVo,322968,3.2361743048313536,3.9948195850430492
NCI-H460,168313047,3.736921155938788,2.455198153527667
LOU-NH91,123631,3.064358892537756,2.451033370823239
NCI-H146,10410894,2.10877812565835,3.1752456573797025
OPM-2,107985,-4.911691484457119,-3.774513267676316
HSC-4,4917,3.66079963002401,3.011920501210258
SBC-5,72376,-1.1693945126287038,-1.821899828168256
KYSE-70,11238147,3.36128873589197,3.0522355080606873
CA46,9935249,0.2545497442771542,1.2635805998050784
SCC-9,135421197,2.7056920215811293,2.1185853401684303
FU-OV-1,123631,2.446979601054181,2.3353988456922905
MSTO-211H,12001922,2.4775669078904397,2.0290819849208344
NCI-H661,3543504,4.269759852401949,4.628597849066245
FU-OV-1,53495165,2.0201630022514263,0.6437366570619666
NCI-H2009,448949,2.535639173937985,2.1000132043362925
EFO-27,285033,-1.172211692399995,-1.4987558208837302
YAPC,5978,3.3733616775717716,-1.503280855074563
BT-549,9911463,4.268645247281358,4.003133477853954
NCI-H522,2113511,5.298827483301359,5.217932490024128
SNU-61,1242560,3.7603648536411622,3.27703398374136
A2780,3503,2.123197367997407,2.06768919307273
JM-1,262093,0.3077511100871351,1.548056765833465
DMS 273,11612883,3.047294051558191,2.2295781465514066
A-673,156414,1.4246196000990916,0.9593687937098087
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223,1.513140122378901
SNU-81,3385,3.194341332216005,3.5321660073670187
SNU-449,44486219,4.185988120780244,4.43900648733207
SCC-9,25262965,-0.8228501050995407,-1.5908333922411027
NCI-H146,9967941,1.5373910611842192,3.4592117640883377
HCC1143,969516,2.4763079586135546,2.766791362562166
ONS-76,12003241,-1.3579895274230906,-0.8152076883909638
SNU-61,selumetinib-tretinoin (2-1 mol-mol),0.2011452068154318,2.3217719533678274
OPM-2,26596,-3.75281027154887,-2.561140230970298
KMRC-1,11955716,1.3700469468180672,-1.5647921361044603
ONS-76,445091,4.207927105180806,4.202640736841416
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.5808934132682841
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.8372000622449685
JM-1,11964036,0.6346833811859819,0.3638177078372336
MDA-MB-453,24180719,3.640576555720147,3.3176830296206488
NCI-H146,3689413,0.5626872136369616,-0.40766797530832904
A-673,5335621,4.03269099593382,4.289315183410111
FTC-133,44491742,4.538470926749077,4.301721031882525
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712,1.2982114164542833
LXF 289,23725625,4.938564251049365,5.271967812672363
OPM-2,11612883,1.2708799210561326,1.9856186207576052
CA46,11485656,1.2289823963881294,1.6958338153238395
SNU-61,227681,2.9666568152307993,2.865673102923049
NOMO-1,135421197,1.2386186938920458,1.2596957310183863
NCI-H1623,vorinostat-carboplatin (1-1 mol-mol),3.549282836614641,3.232085839634966
BxPC-3,135421197,1.4419000032460958,1.8513089853395652
CAL-51,66577038,4.134711160885491,3.1577646362410703
BxPC-3,11485656,2.0481416814216375,2.347499844869787
LOU-NH91,3689413,0.742189593443008,-0.262347649399824
OVISE,crizotinib-PLX-4032 (2-1 mol-mol),2.5474980530955844,2.080890461383393
JM-1,49766530,-3.0151701370453794,-1.8835599434991375
NOMO-1,15983966,-5.011559396504552,-3.884919157398444
HSC-4,24856436,1.7831446753384608,0.6430339065917705
OPM-2,387447,-6.258797979541162,-4.783883160340938
A-673,54765302,3.022220101838166,3.831616726995124
A-673,5479543,3.2499245267113928,3.203142179244689
SBC-5,docetaxel-tanespimycin (2-1 mol-mol),-4.858337371172803,-3.1898471428956174
A2780,441298,1.2276441630256645,2.4349639817940973
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923,0.17195842245163107
HSC-4,65064,5.180183799352401,5.070814501387735
OPM-2,3384730,1.6721258053175836,1.4661997846833446
NCI-H522,387447,-5.403881314975521,-4.195985933390441
MDA-MB-157,11640390,1.4666591993417384,3.6823624363873737
CA46,9911463,2.565133854881976,3.139163075452296
FTC-133,227681,2.0408407851095416,3.3198523520409076
JM-1,285033,-4.464347137363986,-3.6352245195107575
KYSE-70,16736978,1.1213704825993671,1.789271422920389
MSTO-211H,2729026,1.9618514095460544,2.7797922542997435
NCI-H661,24180719,3.917772031076744,3.5088009554617456
NCI-H1623,400769,-1.0076663191396935,-0.5671113566264964
YAPC,9840324,5.782457936566159,5.75228621458461
Panc 04.03,57330099,4.388225142481581,4.448674892773023
G-401,135659046,3.5574575455214608,3.334895277171553
A4/Fukuda,148198,-4.99238512913244,-3.6680374930764787
CA46,126941,-4.174426911659592,-2.9399645973835185
SCC-9,6610355,5.330005746360321,4.612725765875197
KYSE-70,44185566,2.2395157674699875,2.3955416257625073
NCI-H1623,462382,1.1150663609789129,0.5633360031594538
CAL-51,6914657,-5.067352950634086,-4.517346516737985
A-673,selumetinib-BRD-A02303741 (4-1 mol-mol),7.378712483637354,4.336321920734536
EFO-27,54618164,4.628305371415217,4.093291869666606
JM-1,23582824,0.2805180690676545,0.7569059706830878
NCI-H460,44185566,3.2105564381381035,2.745645438608012
CA46,52912189,-0.9978651387823436,0.3492067356162458
NCI-H2009,9935249,4.414461781647313,3.4128068437653227
NCI-H2009,135928012,4.098076343567735,4.263282455719657
CAL-51,60750,-3.4379358682898973,-2.0397766425904855
MSTO-211H,8515,1.6806311840995682,3.9288985221147885
ONS-76,15983966,-3.1712265481751243,-0.9817649119942018
NOMO-1,56946209,-4.862706213909506,-4.661840521244465
NOMO-1,24772860,-3.4546209155075687,-2.8587811777815517
FU-OV-1,44185566,3.182046500186311,2.6159047890381264
NCI-H2171,11977753,0.3036523614034643,-1.8720907625641012
FTC-133,31703,-0.768913830642622,-0.769588234494902
EFO-27,984333,0.9554706085777084,0.6473238827803591
NCI-H292,5329102,1.7855476735914897,2.1141276611606186
CA46,409805,3.3808362620175187,3.9186508268435385
MSTO-211H,25183872,0.3972499543283658,-1.0657134404276143
LOU-NH91,24180719,4.451607655435679,3.6080757895636246
A2780,44185566,1.1999498835751436,2.081034798557568
JM-1,piperlongumine-MST-312 (1-1 mol-mol),0.8602384647056689,0.9898818805285639
NCI-H2171,6505803,-0.0596794204500112,-0.5366625695528695
CA46,66577038,2.896384523521911,2.457100611252957
NCI-H2009,navitoclax-PLX-4032 (1-1 mol-mol),4.434532653738059,2.215025400490837
CA46,12003241,-2.799565618947511,-1.8521386376671944
NCI-H661,10427712,3.832896992750264,4.555504002890319
SNU-449,107970,2.557902386411369,2.405285677708169
Panc 04.03,2874250,5.078270927101478,4.720641800795703
NCI-H292,54626689,4.661071465435288,4.738974714144317
NCI-H460,23725625,5.666756485817308,5.099207537934323
CAL-51,53232,2.8018516258833395,2.825336234151342
FTC-133,decitabine-navitoclax (2-1 mol-mol),1.1951853583551142,1.8067943639261361
EFO-27,53495165,0.9078503906950024,0.9572281842306696
SNU-81,65064,4.179756271690876,4.420538919943595
BT-549,3689413,-0.9397914335397376,-0.1327716218771955
NCI-H2009,66577038,3.427367822074961,3.2253488060569055
LOU-NH91,10302451,4.426232341068122,3.251871253705941
CAL-51,168313047,1.9592520089902103,2.4021562151836546
NCI-H292,135411,0.5538002090667975,0.9067404422436338
LXF 289,2874250,5.409057432200043,4.5233763441663175
EFO-27,4261,1.4655103146060633,1.8352887964117734
ONS-76,25150857,2.480326692853007,2.4415402836612854
G-401,11175137,1.9335599830838224,2.1465020651494693
OPM-2,5460769,4.223891374112808,2.1886362826585475
NOMO-1,10385095,1.0593467546243338,1.0495821356377941
LOU-NH91,2126,5.273491801207327,4.7767335637611215
MDA-MB-453,11625818,5.002273286989784,4.171644273946867
OPM-2,44632017,0.7121474472673729,0.6901964472404337
LoVo,135411,-0.4629764704945864,0.7008756068607146
EFO-27,16722836,2.503686118945589,1.6789948260003356
LOU-NH91,10074640,3.3386477352477715,3.2649022623229143
DMS 273,11719255,4.586791904076426,2.4841067860761674
OPM-2,136227924,1.7425170628423947,2.3108889039161453
YAPC,vorinostat-navitoclax (4-1 mol-mol),1.7986594173334518,1.2940463731066216
KMRC-1,vorinostat-carboplatin (1-1 mol-mol),4.1908249815251075,3.03879506531882
NCI-H522,2828334,6.021027928266713,5.829848208354372
KYSE-70,72193861,1.5917149982909504,1.6695536925003374
MSTO-211H,9911463,2.6842905920893108,3.927713568594776
MDA-MB-453,969516,2.9001694226946153,3.094068792884949
CAL-51,44632017,0.9975947899898204,1.3376135047206419
LXF 289,10231331,2.4249622135671824,1.9116383048932277
A2780,25195348,2.1109786238814943,3.054959399888365
NCI-H2171,44202524,1.9759332673432517,1.7238339204584059
Panc 04.03,1641662,4.251343925322988,3.6581171903988503
NCI-H292,54686904,5.52345614596139,3.7141031357310754
DMS 273,7251185,2.13119393000196,1.8929224998102245
LoVo,9956119,3.291456775833892,3.678967967167036
BxPC-3,11404337,-0.6361724208993981,-0.3525716330911052
NCI-H2009,119182,-1.1305543955582442,-0.47985354080071857
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206,1.326733927774282
NCI-H2009,5278396,3.446569775137936,3.744669290028781
SNU-61,327653,2.3439595497702985,2.9938118094028523
Panc 04.03,11238147,2.6863632300229936,3.0133434297207837
LOU-NH91,9926054,3.1176474597994908,2.1784390096825863
NCI-H727,5566,3.3170373665309416,3.0359301322137555
SBC-5,25150857,3.1636616713903893,2.4242060770979905
A4/Fukuda,11719255,2.014724282446697,2.466001063457707
NCI-H460,374536,2.933441634270558,2.339142483157687
Panc 04.03,135875424,4.739147054003967,4.222932142592442
NCI-H522,9825149,2.538976142931882,2.112988750350468
NCI-H522,11964036,1.1738559849313974,0.970925436463708
NCI-H727,docetaxel-tanespimycin (2-1 mol-mol),-0.2306371483754844,-3.133175112714272
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.6910629789941651
SCC-9,5566,3.224791432055543,3.218783084320338
NCI-H460,9936388,2.3098343611543415,-0.8907536708626577
A-673,salermide-PLX-4032 (12-1 mol-mol),5.197476716146756,4.559307463073552
NCI-H460,16720766,0.8258921674033131,0.7743314788171005
FTC-133,54618164,4.149608396421597,4.078671724038174
NCI-H727,5281321,2.7498034475542803,-1.219120274542489
BT-549,31703,-0.610163723442028,-0.7759693900616305
JM-1,11609586,0.7887510712984062,1.526743742583516
MSTO-211H,65628,3.7458295220001,4.411719294096059
NCI-H661,9887053,5.171148908960024,3.8846706504016386
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053,3.2902128906249626
G-401,9887053,1.7608751069117703,3.1471849059875074
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126,0.8482831038023094
A-673,7251185,1.3487938120123666,2.0186964987856446
ONS-76,4259181,0.68334491499701,0.15388791971218116
NCI-H292,613753,2.7114183475644857,3.422528298425162
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647,0.8261489333249291
JM-1,25126798,3.029145333632086,3.2734497028672864
CAL-51,3815108,3.0623029951861396,3.249415196527276
SCC-9,16725315,5.212889946477865,4.354134786229352
NCI-H661,alisertib-navitoclax (2-1 mol-mol),3.068945671773435,0.3206540023103215
NCI-H522,serdemetan-SCH-529074 (1-1 mol-mol),2.019053107898385,1.686268998013588
LoVo,16722836,0.1488668556579147,1.7963114646130436
A4/Fukuda,25262965,-4.823082336145625,-1.8587456953495223
OPM-2,53392493,1.6243275023991692,1.82244934787003
HSC-4,9926054,2.0278633205902468,1.9447860068008402
SNU-81,9936388,-6.314751034125396,-3.591859201847524
G-401,9823820,1.4384887897470693,3.450609043340457
YAPC,24753719,5.0641073859888,4.5060705085699375
OPM-2,24772860,-2.8738620885527153,-2.558065987283494
MDA-MB-157,10427712,3.542893078297904,4.400746095766863
A-498,4259181,1.547873530266754,0.3835268842584904
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196,-0.1761376745536549
SBC-5,9927531,4.452264212548339,4.667701965697184
LXF 289,119607,4.549732560104057,5.264395420091883
MDA-MB-453,piperlongumine-MST-312 (1-1 mol-mol),1.140334319354309,1.8662704097407654
NCI-H2009,11396600,4.054693544346837,3.8381001689432916
SNU-81,15983966,-3.5187473914136738,-2.229193956651239
Panc 04.03,11494412,3.764008563191269,2.4203518866604337
OPM-2,216345,2.3930113976289364,3.2033476216175347
JM-1,66577038,2.266129645862272,2.6014317319716644
SNU-449,15953870,3.8419288275174326,3.5109295228272765
BT-549,9903786,2.513972936103366,3.1283303535267364
OPM-2,44202524,1.1830318509158162,1.392428168999906
OVISE,6623618,2.0550481440983153,2.3977627431870263
SNU-449,11657048,5.413893492178721,3.8403061558848766
NCI-H2171,67291369,-0.2342814323553679,0.9684827566156379
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767,0.9688561859148607
NCI-H522,11238147,3.4337502548923404,2.488052282268991
MDA-MB-453,16065773,1.7584918793826552,2.537919946206577
LoVo,136227924,4.6796674015936075,3.0533851225592623
LXF 289,3854666,2.0847029854583377,2.306108810832561
OVISE,984333,-1.5189255907846522,0.7086431664690467
A2780,159324,-2.166969557176003,2.168009686741665
SCC-9,17755052,1.3521912896367647,2.0145231391932112
OPM-2,9823820,1.0965123517529505,2.5093170078047864
DMS 273,12001922,1.9670879212293255,1.654195800208289
KMRC-1,24180719,3.956198558970242,3.3785997941049963
KMRC-1,637858,3.0556928718558707,1.9608771892177312
NCI-H2009,6917907,-5.363195379340594,-5.041553546193868
SBC-5,24748573,1.8248605513332548,2.208375736338564
CAL-51,452548,-0.9080095532304931,0.5733615601450832
BT-549,2858523,3.192172893232417,2.9851519631447148
KMRC-1,219104,4.439460794922528,3.7497893985329314
LXF 289,2858523,3.038787864461457,3.084439649909891
NCI-H1623,9907093,3.838952634819664,4.158739845870673
NCI-H460,168313047,3.736921155938788,2.455198153527667
JM-1,5287969,-2.2665073107333997,-2.1311804324990122
NCI-H1623,2828334,5.745033734102683,6.219793432141438
NCI-H522,53232,3.4340993190045763,2.492354276814769
MDA-MB-157,24180719,1.846017762198611,3.4316033765298757
NCI-H727,2858523,2.9690043699309094,2.983117329591013
HSC-4,3384730,1.6775009570022803,3.2292472706662156
MDA-MB-453,66577038,2.2210808109899687,2.9647971780961604
CA46,54619267,3.4754479185856604,3.5583739363263596
BxPC-3,selumetinib-decitabine (4-1 mol-mol),1.0861669276123684,3.4233937267713617
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147,4.431070701543301
DMS 273,89183176,4.012998903778193,3.2388149198133207
LXF 289,89183176,5.264029999533809,4.829855819500168
HCC1143,25154868,3.6479876335061863,4.263025571334508
NCI-H460,5566,3.3663694984335533,3.0876625942736164
EFO-27,3384730,3.632582575012134,3.0133607421985347
YAPC,3854666,3.60977300269674,2.3990340098900806
CAL-51,11960529,3.662834723962616,3.889260813414178
NCI-H522,4096211,1.7167000910654833,1.3846810969865053
LXF 289,46199207,3.0446562724495676,3.2426894116616647
MSTO-211H,44507138,3.561974329612715,2.5612050116620977
BxPC-3,10127622,0.1850831315580212,3.5987922455243804
SNU-81,57519531,3.6375637578947098,2.0899723768085887
NCI-H522,46926350,-4.757002390021422,-4.0035712119315825
LXF 289,675434,4.434927450149955,4.6659236350762185
SBC-5,2858523,3.0625939376722147,2.980183204429204
YAPC,3025986,-1.0818355674515514,-1.1880996538861417
G-401,753704,3.840031862409327,4.337267292445564
NCI-H2171,9933475,1.8341202855706125,1.9428869135516416
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609,2.9515619669577973
BT-549,5746,2.744550621458616,1.5857176798469148
MSTO-211H,2733487,6.00734552009151,5.942699570529072
LoVo,9908783,4.437010992006648,4.8411709217217895
NCI-H2009,46398810,2.5614683956162554,2.6852494207010476
NCI-H292,15983966,2.054572304908195,-0.321482233637606
G-401,46943432,1.6295589064479152,1.6842547271517585
LXF 289,54618771,-0.5375230222620658,1.5578573219201652
NCI-H2009,4261,0.1994590765469732,1.8158689882937553
NCI-H292,119182,-1.3574963176080912,-0.6840865488509921
LoVo,675434,4.114717976727459,4.5323444703832765
CAL-51,613753,3.3238399640193177,3.201709455171779
OVISE,tanespimycin-gemcitabine (1-1 mol-mol),2.9974689860461785,-0.588895215753715
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125,3.7073825418024593
MDA-MB-157,7251185,1.2275966709755557,2.662207990239545
LOU-NH91,168313047,3.5347026371928565,2.4369939856200404
Panc 04.03,11175137,3.811547013287204,2.674854160245975
YAPC,46191454,1.528991916080322,1.7624843336921001
Panc 04.03,246676,4.5210437514033615,4.513873277907814
LOU-NH91,107985,-2.204555775629559,-3.464457308481142
JM-1,9884685,0.5602575931973728,-0.49680893842636187
KYSE-70,26596,-1.4453873864890578,-0.9124461573856819
SBC-5,11238147,3.923057921789592,2.7925684261239536
CAL-51,5351362,1.1872361858703535,1.4360377456966307
CAL-51,148198,-3.728190383000159,-3.691139199473469
MSTO-211H,10074640,2.8901374693183848,3.1107301772048253
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576,-2.253561145545454
Panc 04.03,54618305,4.994656380487723,4.409442056637384
HSC-4,9444,4.231424733159592,4.171862013535946
ONS-76,136227924,2.542073211711186,2.85434838453817
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176,-0.07548051883045466
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066,0.7621528723144562
A-498,4705,4.1964696083385595,3.293333701817094
NCI-H292,4788,6.000922818610643,5.735999155385062
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293,1.8145815038512125
A4/Fukuda,168312962,0.589698091471745,0.6173460013715207
MSTO-211H,135421197,0.8053711662366769,1.8984459770515603
G-401,9826308,0.736562536874994,0.11376219935230412
JM-1,44202524,1.2333959484520816,1.3129995482443144
SNU-449,135984461,4.468051833024593,3.8759863921735893
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854,2.0538832884573797
HSC-4,135999136,1.7584955345229645,4.283712652979136
HCC1143,6918328,-0.4969866258783406,-0.05075456031352235
A4/Fukuda,2871966,-1.2628046939905593,-0.16706484117994924
HSC-4,89928392,1.9678897287961257,1.7377487485236176
CA46,7251185,0.9564015595877396,1.6639572432298742
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632,1.5912626444331377
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907,3.309279520292236
LOU-NH91,navitoclax-pluripotin (1-1 mol-mol),-2.6950691306043297,-0.4344505686574633
YAPC,9967941,3.379913520192136,3.8087392349225246
Panc 04.03,119607,5.706581209982884,5.5043521891049245
KMRC-1,46926350,-4.153095302049271,-4.136282447349967
OPM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5972514317296775,0.11498708438506493
OVISE,5287620,-0.8119274098935182,-1.8471444381066922
NOMO-1,135440466,1.6123042261647436,1.333663679400991
A-673,11507802,0.3878845266361032,1.0069917821734307
G-401,tanespimycin-gemcitabine (1-1 mol-mol),-2.3448363007854325,-1.56641923070442
NCI-H2009,3854666,0.912328636385412,2.260852767980412
SNU-81,2749,0.983670801340458,1.637894450446164
A4/Fukuda,25105715,3.290295740743095,3.1963212419265714
OVISE,erlotinib-PLX-4032 (2-1 mol-mol),3.714460286615586,2.7965854969737824
ONS-76,salermide-PLX-4032 (12-1 mol-mol),5.250502452848782,4.709305313908034
CAL-51,9903786,2.1849161121493847,2.7296906526614966
LXF 289,5113032,5.558232749512156,4.925680522791332
NCI-H522,46224516,2.9506377913569244,2.4594383766550716
FU-OV-1,56649450,4.970206677695459,3.093813099298311
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033,2.8256567293138035
MSTO-211H,9887053,4.1066593545259975,4.028811694082867
CA46,6610355,3.575030613446337,3.793861234633486
NCI-H522,445643,3.9693726836499863,3.8486131358491535
A-673,46224516,0.8314688808424526,2.3184323600730314
NCI-H661,6918736,-3.5059805921507823,-1.0820719981186542
NCI-H522,selumetinib-PLX-4032 (8-1 mol-mol),4.633194208623746,3.4257994488265275
A-673,3825829,3.830298825271896,3.3812816070005
ONS-76,11396600,3.887590392789339,3.368148936042624
LXF 289,5282054,3.512278681739004,3.8586578413852606
A-673,54618771,0.7910545462175201,0.7645382361834291
KMRC-1,25062766,1.7411663615582824,2.0211209978977642
EFO-27,71751553,4.378478985868248,4.578198306407029
EFO-27,10074640,3.872803440374816,3.232830883969625
ONS-76,24964624,2.710261416606334,2.115926971814015
LOU-NH91,53392493,2.3846272258457737,2.715112728215949
CAL-51,46199207,3.548155956826357,3.287680920369429
DMS 273,227681,4.814934070367145,2.762920270409865
HSC-4,9908783,6.127900398037499,4.906272393921301
HSC-4,10184653,-0.7296444895073179,0.8300873586328477
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546,2.4964024273458776
NCI-H1623,44185566,3.0587688781610667,2.5948959688944484
KYSE-70,6918328,0.2213620303324437,0.18298682985918
MDA-MB-453,327653,2.9444810987281533,2.9184523307260184
FTC-133,4259181,2.1331002918337925,0.47804278900750774
NCI-H292,60750,-3.187051343712646,-1.8200870917771
KYSE-70,60700,2.818490002790748,0.2040385346533924
MDA-MB-453,24821094,0.7464785951288041,2.639513094795837
NCI-H2009,656346,1.3969032628362248,0.941349020602419
SNU-61,24964624,2.494415785344137,2.1200990470252323
NCI-H661,4261,1.9569329914003135,1.5093352486103302
SNU-449,54618305,4.668068655096509,4.407470194403112
LoVo,135875424,3.182508442374063,3.820216170315234
LoVo,6623618,1.7195113979524326,2.320103565023684
A-498,135398516,3.177268179593805,2.4900887211940725
BxPC-3,26596,-1.629746525957504,-0.5148397097534583
NCI-H460,2749,2.5004778765083695,2.0971765256263626
KMRC-1,46398810,3.012918063271682,2.474705069882628
NCI-H522,5291,3.860595721411624,3.230371355703663
SNU-449,36462,4.301758862194218,2.588172999756689
SNU-449,6918837,-1.494845192804234,-2.0313231772048352
CA46,11955716,-2.7152267118714204,-2.3941027521643434
NCI-H1623,168313200,4.911870039242249,2.9500426189717253
NCI-H2171,10427712,3.6918148562663937,3.9062520953525315
NCI-H522,262093,3.0660845932794656,2.5578950574904185
BT-549,168312962,3.315695506914068,2.118006807666224
MDA-MB-157,15953870,0.7968689532543627,3.510109347728949
BxPC-3,carboplatin-etoposide (40-17 mol-mol),4.727119373262846,2.9263365586226935
SNU-61,11364421,-2.983927558247801,-1.7756656214502928
SNU-61,3101542,4.3555934573063695,2.437611841391807
NCI-H460,52947716,-4.997624319891589,-0.542933799399524
CAL-51,44543605,3.919885801001582,4.095626795873898
NCI-H292,12003241,-1.027467238096921,-0.8694555132934993
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957,0.9423247716589986
Panc 04.03,navitoclax-sorafenib (1-1 mol-mol),3.337045495454646,2.2618814476055804
NCI-H292,25154868,5.001413217408079,4.480335717971685
NCI-H292,36462,2.4286801987130486,2.5346730220563174
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746,-0.7839142662204627
NCI-H292,159324,3.210621191245253,3.3341197425608824
SNU-81,24978538,1.1236702452048486,0.8982947626745008
A2780,9929138,3.988043631552867,5.518759806467221
HSC-4,16065773,3.311693132411482,2.6496177365368077
A4/Fukuda,400769,-1.555916482707746,-1.2344658645984754
A2780,11977753,-3.718954593203518,-1.6319160893294762
FU-OV-1,60700,0.8482129777629449,-0.2590417834934109
DMS 273,168312962,2.633531304827929,1.2900917621522408
SCC-9,8515,4.77911141452934,3.9858278635417594
A2780,71680916,3.658218554445846,4.157740332747562
FU-OV-1,5328940,2.1307155577669143,1.8701493146809705
NCI-H661,42642645,1.2812432760018797,0.38944143231682815
A4/Fukuda,2113511,3.845432548996496,4.9478739787423205
SBC-5,19582717,5.27972019168548,4.229437968400351
HSC-4,11222830,1.068056053085511,1.76029568371734
CAL-51,10427712,4.2973287072996085,4.3857122882409065
A4/Fukuda,44185566,1.3030950937163224,1.8445227512390396
ONS-76,5278396,3.742938248744769,3.4349171157730614
MDA-MB-453,46943432,1.9398007817238585,2.824379725521778
NCI-H727,984333,1.9308701128060968,0.826029670321552
MDA-MB-157,24889392,2.1225906954298535,3.8978486827531573
FU-OV-1,ISOX-bortezomib (250-1 mol-mol),0.954548859556388,0.6784848651667705
A4/Fukuda,46843906,1.071626560517578,1.5444555708484622
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.388929550180623
HCC1143,44241473,5.874360916813842,4.725434950559145
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.3844191054413684
EFO-27,6918878,4.955152670116511,3.0921358477300758
CAL-51,5281672,3.9430830045045857,4.390079811433713
NCI-H146,9915743,-0.2957101551438801,0.8731315222762237
G-401,89928392,0.7343580800154272,1.010572553635504
SCC-9,navitoclax-piperlongumine (1-1 mol-mol),2.9839395541067515,1.7830782854127702
EFO-27,6184667,5.467001643500489,3.2040244184694817
NCI-H727,3854666,3.6466691501950512,1.835454429394683
LOU-NH91,9825149,6.244850491409518,2.3088902543331455
NCI-H146,11178236,-6.140205122942071,-3.4865610079051947
HCC1143,navitoclax-birinapant (1-1 mol-mol),-1.1255303234100646,1.0832661886031476
ONS-76,448949,2.486443038536461,2.0231850100984996
BT-549,57330099,4.335540938726609,4.059406391914938
CAL-51,44819697,-1.9765663783606575,-0.9660288996919966
SNU-449,5278396,3.499051739077657,3.5662990606807874
LXF 289,9956119,3.057634534881657,3.680214820635872
A-498,9933475,2.3013420942123655,2.030427258905037
DMS 273,10074640,2.948045052381196,3.0741010690755446
LOU-NH91,25102847,2.3579155704363206,2.4361618168597876
G-401,5311281,1.6046025374895514,2.1329498152082924
A-673,219104,2.2996165619151507,2.867724246720468
FU-OV-1,42642645,1.0692746742635495,0.7888797101156351
NCI-H460,135411,0.3374737909082799,0.6939523056069592
CAL-51,6252,-0.2076922850947726,0.8685898523612033
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903,1.8502012317921128
LXF 289,10296883,3.609856485747645,4.064120688141179
KMRC-1,54626689,4.972873475873264,4.501550047202117
A-673,JQ-1-UNC0638 (2-1 mol-mol),0.3202130450215845,1.0634507162725724
HCC1143,1750826,-1.2654463091368686,-0.8659220079668782
SNU-449,24785538,2.8069089427026346,2.1300500380113614
LOU-NH91,53495165,1.612116489462364,0.8458304227072593
EFO-27,11609586,3.640431752283184,3.117724422915842
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083,-1.108579676492036
Panc 04.03,104842,-1.0125052126256155,-2.452890898821485
NCI-H522,6610355,5.34603712705315,4.329298215329641
NCI-H661,11656518,2.215339329496845,1.9684750471207304
NCI-H661,6505803,-0.5859050253944337,-0.13576698536842915
NCI-H292,5351362,1.0382380370911135,1.6279243674892265
EFO-27,11612883,3.4595212211892377,2.944564310976805
FU-OV-1,vorinostat-carboplatin (1-1 mol-mol),2.1636839207385914,3.071714938427221
HSC-4,10302451,2.384078053411002,2.7368046172927594
NCI-H292,46199207,3.366381535989616,3.3142041128541924
LoVo,262093,2.370412929490009,3.0326718028309334
BxPC-3,445643,4.432772060189362,3.985421784976781
A-673,carboplatin-UNC0638 (2-1 mol-mol),1.4546927004142935,3.1688436086174483
A4/Fukuda,46224516,1.3171235816864948,2.3654357719429298
JM-1,3854666,0.4999957819555636,0.6073201278253336
NCI-H292,124202324,2.857386903129287,2.671475686559948
BT-549,1566236,1.7296376770428397,2.3745028771120125
LXF 289,11364421,-2.6687395721676577,-1.2830614156713398
NCI-H146,navitoclax-sorafenib (1-1 mol-mol),-1.8992247000680913,0.8538283647300454
FTC-133,148198,-1.6568063805549866,-3.2290416975523573
LXF 289,11640390,5.398484732926136,3.7242871942226703
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944,1.5807653188180575
LXF 289,2749,2.818144236178911,2.0463235352297384
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522,-0.20574127662911595
JM-1,135875424,2.019666731209586,3.3886263757084065
SCC-9,4705,2.492131143046821,3.1156198346549178
NCI-H2171,151289,1.4157771037164255,0.8837706094492916
NCI-H522,644241,2.1349742590503427,1.025230533050885
A-673,445643,4.040507929851862,3.8870784245791454
JM-1,6252,-5.0324479776154885,-1.6828613439383475
NCI-H292,208908,4.322795663590344,1.912872553899892
A-498,2871966,1.0686849145956876,0.9114194364358452
G-401,12001922,1.3873374697674952,1.7121346787606893
DMS 273,44491742,3.7307306463602545,4.134169704152883
A4/Fukuda,11396600,-8.215434514364686,2.790068082539516
HSC-4,3689413,2.5472025828962055,-0.3583405429028842
MDA-MB-453,4378219,1.7417226469020404,2.208678462650782
ONS-76,387447,-4.115404850127739,-3.696933523990986
LOU-NH91,656346,1.0077735762311986,0.937124372107673
A4/Fukuda,3081361,1.810117399969756,1.7240146151955176
NCI-H460,6505803,-0.4074860596498978,-0.8580604477010086
NCI-H146,45279963,2.8359939324557706,3.3911873298748696
OPM-2,6184667,1.6391974127027074,2.495650528767686
HCC1143,148198,-3.881060339055355,-3.4523091258278282
A-673,421610,1.6759942643549426,2.8438186768300584
SNU-61,4259181,0.2985440005718957,0.04380097252217993
LXF 289,44819697,0.5606163889857397,-0.4535085553601997
KYSE-70,168312962,-0.2970816131627225,1.181415398877597
NCI-H146,11494412,-1.136229477240518,1.1815182924611893
OPM-2,2746,0.9082445461467812,2.059425504169438
MDA-MB-157,6918736,-2.3678025624565175,-1.2782977844158636
DMS 273,135659046,3.477426326571923,3.4784656494097277
HSC-4,126941,-2.3076253927529127,-2.2058037772390704
CAL-51,57519531,1.893237876741888,2.421297558184181
MDA-MB-157,3038522,4.043799431595376,3.0175984312954762
ONS-76,SNX-2112-bortezomib (250-1 mol-mol),-0.0712128201037348,-1.3725060220473284
BxPC-3,54613361,-0.6294380958983512,0.05966618683383138
CA46,25102847,1.8345278315547784,1.8433800676099656
FTC-133,5746,0.3858378554684238,1.4942788036764143
BT-549,10113978,3.95693770646699,3.58932972629743
A2780,54618771,-0.248592168161829,1.015570655603629
SNU-61,6917907,-7.995083965311066,-5.3703766697678
ONS-76,3384730,2.185678697527176,3.0898426799052787
LOU-NH91,11228183,0.5456186750940368,2.5488034120942045
MDA-MB-157,25227462,1.286146426910961,0.22463893523906348
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286,1.278078745933609
BT-549,439501,-3.1266914034371567,-2.1883676550247824
LXF 289,409805,5.2068809837223435,5.031289510174538
OVISE,148198,-3.4121309130102055,-3.3080417993554363
YAPC,262093,3.6115167721531343,3.0019621998197037
NCI-H727,5738263,3.354715168796171,3.4478499580191504
A-673,6918328,-0.9424380212903694,-0.48570914509755186
MSTO-211H,navitoclax-piperlongumine (1-1 mol-mol),-1.4716070020924246,1.9265456486940713
JM-1,445643,3.755930816022248,3.3167468983471027
A2780,25154868,3.617715738937927,4.281367460785387
Panc 04.03,81146,4.4293645850092735,4.727951900295307
MDA-MB-453,4521392,4.261545411784443,4.005973748407549
CAL-51,5460769,1.3780575552768597,2.417653411301277
SNU-81,9926054,1.3093723678717843,1.7112994021708787
CAL-51,2113511,6.39897875596168,5.449724757055208
NCI-H460,136227924,3.925006850615035,3.075706201310735
NCI-H522,24856436,0.0798065953372803,0.3773720466564076
SBC-5,9967941,3.629642521259923,3.3938862450373266
A4/Fukuda,462382,-0.2406989279082468,0.6317376130881162
OVISE,11640390,4.491956307789174,3.756744951332184
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843,1.7815945743595023
CAL-51,24180125,2.8082301472193203,3.1406580295884563
LXF 289,25262965,-2.558275633709226,-1.2329571978441298
NCI-H2009,9903786,1.8298580590992315,3.220860452966183
SNU-61,54678924,1.5881868934361725,1.794691845494049
YAPC,24785538,1.575520805381804,1.7359616851391926
NCI-H2171,676352,1.591250217642193,2.0520337235248243
SCC-9,carboplatin-UNC0638 (2-1 mol-mol),3.5571818540455413,3.4290327611877958
ONS-76,BRD-K27188169-navitoclax (2-1 mol-mol),3.629677877626108,2.4077723572854426
NOMO-1,3689413,-2.5325178418163174,-1.7610573618451404
OPM-2,5284373,2.335601496737994,2.0446283961622544
NCI-H661,10127622,4.958480333722226,3.8790995262329977
ONS-76,44185566,2.3053400119978735,2.7176925632721436
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053,3.091320226841678
HCC1143,11485656,1.8564802256291268,2.3401828912820535
G-401,613753,2.8041503953296187,3.010959026907965
MDA-MB-157,11657048,4.26764748298064,4.189547624925307
ONS-76,24951314,1.2212354664419371,1.2094763469128187
A2780,36462,-2.0824592368546893,1.3536645258636861
FTC-133,vorinostat-carboplatin (1-1 mol-mol),4.046796900888368,3.15871961027511
OPM-2,72376,-3.1510357921092376,-3.2120989428266897
OPM-2,6918328,-2.875264730320658,-1.4798294036568271
NCI-H522,decitabine-navitoclax (2-1 mol-mol),4.970964992537572,1.0030610265766526
EFO-27,168312962,3.0506772104926343,2.2895598417386633
NCI-H1623,107985,-2.7226564689550488,-3.4372599647507043
MDA-MB-453,46398810,2.51328952557295,2.6148769767201787
SNU-449,49766530,-0.9876450445747244,-0.5878196974863461
OPM-2,25102847,1.4573873057147737,1.9248425908845448
G-401,3081361,2.1638535645332664,2.1758106124646552
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866,3.8910349029680873
A2780,24951314,0.3580646626980762,0.67020893357286
SCC-9,2871966,2.1501352130214695,0.9544960826735535
EFO-27,53232,3.845715413797161,2.7668841718940813
A2780,5460769,-5.6757466443406575,2.5898014253196306
Panc 04.03,10322450,4.721553837851545,4.0621397140925835
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783,1.6767649425073428
SNU-449,23582824,0.6769149785817056,0.8082796104161311
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531,2.984512437186236
ONS-76,3854666,0.984876663182433,2.051020990451205
MDA-MB-453,71466578,1.854784458712459,4.420516432251673
BT-549,piperlongumine-MST-312 (1-1 mol-mol),1.4526674208496635,1.890948192563574
MDA-MB-453,15547703,3.861172408325267,3.0668509223821685
MDA-MB-157,252682,6.150103454129247,6.473828433386775
G-401,46398810,1.5664917458517695,1.9814438301245811
NCI-H1623,327653,3.600793829240414,3.1556583395196713
SBC-5,6610355,5.221010400785003,4.4640378529224884
A4/Fukuda,6918878,-0.3411937140873722,0.5584716610972285
SNU-81,3062316,2.330723232319837,1.2650145463863545
OPM-2,9903786,2.6412283094975657,1.8601599263022903
HSC-4,15953870,4.269670192757531,3.4617299287727006
JM-1,984333,-1.6115401451915106,-0.33037096830425045
Panc 04.03,46174525,5.826098059849913,4.578399398139881
NCI-H292,5460769,0.0770188109309223,2.7092235537926026
FTC-133,216345,4.490711794352075,3.964258877134666
BT-549,alisertib-navitoclax (2-1 mol-mol),-0.0458580768045358,0.6123783262268454
FU-OV-1,5311,1.028726852721831,1.681652078474337
LoVo,9911830,1.9062113768292104,2.561218548181204
CA46,23582824,0.075225101675958,0.7733230547533106
JM-1,alisertib-navitoclax (2-1 mol-mol),-3.873969254990661,-1.3194279270838536
EFO-27,24797083,1.960036113572856,1.4057903671308876
NCI-H1623,5460769,3.63452416726077,2.9141068488974096
NCI-H661,5311,1.0541651051557333,1.8138871151152074
G-401,119182,-0.7625552993148171,-1.8214482505599014
KMRC-1,navitoclax-MST-312 (1-1 mol-mol),0.8819471903820566,0.9886553699546806
ONS-76,11507802,1.2556507557201144,1.7754238186716003
KYSE-70,6918736,-3.61435843984592,-0.9666534633198277
NCI-H2009,4788,5.716428228211685,5.730228658866492
ONS-76,54686904,4.527599605979478,3.548815519774625
CAL-51,2729026,2.5757432896171517,2.732605420468896
ONS-76,3689413,-0.2845128895134612,-0.5596578829780491
JM-1,676352,1.381688063426603,1.8131004380526254
NCI-H2171,11238147,2.9150011478889795,2.328151831803784
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715,2.5774239361535565
Panc 04.03,5738263,4.451939152518209,3.8407205833821596
HCC1143,71304818,2.928848735179534,2.608137361424022
OPM-2,9826308,-1.153894104617258,-0.24380927500958577
OVISE,73707438,4.551111956107329,4.02302712517665
KMRC-1,448949,2.0346247593103257,2.039159177285724
NCI-H661,44589607,2.97822499860898,2.9279032649734056
YAPC,3503,2.818608145608573,2.4559106322238478
NCI-H522,3825829,3.960912701697082,3.469703962982887
NCI-H661,5738263,2.7657344337958687,3.4167683248712812
CAL-51,168312962,1.4117577594763937,1.6878304735575134
CA46,4261,-0.8863355705331979,0.42894937246298687
CAL-51,241158,3.781489879449518,3.862856649159556
A-673,2874250,4.616954738528679,4.368908320421918
BT-549,46191454,1.72486803708685,1.8343705195238642
JM-1,6918878,0.0294179493888284,0.2589842916879607
CAL-51,4521392,4.667802355757324,4.346082461762578
CAL-51,9915743,1.1260994347217144,1.3547321022289815
NCI-H146,46943432,1.2283557348915184,2.1151442242516865
YAPC,168312962,3.6522382892319185,1.9072036094695688
NCI-H522,44493528,4.173254194812623,4.334935485205249
BT-549,10296883,4.161421407524775,4.044671841491301
OVISE,11152667,1.81896217810704,-0.39706834407002917
G-401,6852167,1.9492633511801831,2.2109538446667885
NCI-H292,168313047,2.7678931286458974,2.3694358394553485
A-673,5329102,0.93841525470917,1.4476352685842915
A-673,11404337,-2.7698937773977033,-0.7415995733370547
BxPC-3,11222830,1.6538054387944447,1.7165616145575664
KMRC-1,25102847,3.2500467863275735,2.410918268859404
MDA-MB-453,400769,-1.402270827463697,-0.6524288783279935
OVISE,89928392,2.0483381338479907,1.6499085299800516
MDA-MB-157,136227924,3.402219650297347,3.0820379553753967
SNU-449,JQ-1-UNC0638 (2-1 mol-mol),5.2681139205860354,1.7551840522177853
BxPC-3,5738263,3.0337675506106576,3.6916191853536544
NCI-H292,16741245,5.797273118380107,4.056609965053328
Panc 04.03,11404337,1.3784278741672673,-0.14496945377002304
HSC-4,2130404,3.512147769522711,3.2616032844948655
SBC-5,5329102,3.79532117952851,1.8373732857116745
SNU-449,57519531,5.8010509150022145,2.649022031433672
KMRC-1,1750826,-1.909836969824086,-1.8104524573139198
DMS 273,53245473,3.723579099176344,3.0859000082850376
A4/Fukuda,44137675,1.307300702935143,2.97020533456339
LoVo,72734382,4.052668353480041,4.571343354222227
SW1463,57519531,1.6287135351441295,2.1688779862562013
SNU-61,16038120,1.3103584397228891,0.5332197424435485
CAL-51,9926054,2.2227862000004577,1.9601731445579986
KMRC-1,15953870,4.40931040558564,3.5946745927091603
A4/Fukuda,46191454,-2.2780561859524457,0.3367830009897088
EFO-27,6505803,0.9411407576336728,-0.7829884913770045
A4/Fukuda,24951314,0.2081517019188384,0.3934112707974938
A-498,10184653,1.9377607214538883,1.4142854441105173
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932,-0.8981955313462683
NCI-H522,9911830,2.121034111225194,2.3502861801077954
YAPC,53392493,3.0834263437199705,2.6895789063793014
FU-OV-1,JQ-1-MK-0752 (1-1 mol-mol),1.194664031604259,1.6505759699256866
FTC-133,15547703,3.427766539334031,3.2472843595006275
SBC-5,11404337,1.1992857421773124,-0.39272478094951196
NOMO-1,654092,-2.6158486127541343,-0.9377483680094144
JM-1,navitoclax-sorafenib (1-1 mol-mol),0.8658356793776997,0.1047180035643821
OPM-2,49793307,-4.879066461483742,-4.119260087841106
JM-1,11717001,4.327873015149225,3.6126866765971553
MSTO-211H,969516,2.440842922513423,2.7576146090872795
NCI-H460,9926054,2.081701465030928,2.0746399756780236
LXF 289,9936388,-5.793518221083613,-0.560257716482922
LoVo,10184653,-0.0525672628767589,1.2528270601084168
G-401,9866186,0.2347893748246883,0.5401726774442379
ONS-76,BRD-K99584050,5.369990310930208,2.148195641034561
KMRC-1,168312962,3.867746451267385,1.8065062995336822
YAPC,452548,0.3485834104810916,0.6164349701272248
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597,2.045393230735454
FU-OV-1,6450551,4.626381712180732,2.8762975107426922
EFO-27,carboplatin-etoposide (40-17 mol-mol),3.749556119159122,2.9533399673021212
SNU-449,5978,1.8233754703073703,-1.1462950974217028
LOU-NH91,44589607,2.878199319266369,3.129771873185544
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,5.073538758870023
A4/Fukuda,65628,3.8428022223998366,3.496033626377517
A2780,42611257,2.862805810765337,3.5646428749541017
FTC-133,49867930,5.271360985380777,4.653869819123283
SNU-61,56946209,-2.5026309203687314,-3.9911124848155164
FU-OV-1,3062316,-5.013660753129892,0.809691588932165
KMRC-1,vorinostat-navitoclax (4-1 mol-mol),1.4468975732833491,1.0534799893450257
NCI-H522,123631,2.114949756755372,2.213640283665346
NOMO-1,52912189,-0.5265680930430634,0.5822722677314048
HCC1143,selumetinib-tretinoin (2-1 mol-mol),4.123174212921891,3.4770564085039513
CA46,2733526,4.193969711090682,3.4531050401921495
G-401,44819697,-1.6952135460319926,-1.2739662399747274
MDA-MB-453,44507138,1.496822662467132,2.141415538592541
NCI-H2171,9825149,1.181898582623386,2.138213791734998
OPM-2,8515,3.0418796641091226,3.2442974579284227
Panc 04.03,4096211,3.5665133346619684,2.372316430711682
KMRC-1,6610216,4.1544949822147,4.276702660039388
NCI-H460,25150857,3.536831166282903,2.4734589496008828
OPM-2,11977753,-4.6820583055789,-2.0539369697865113
G-401,49793307,-5.199300209786212,-3.6752372809507823
A2780,1239801,3.465676691044825,3.7350789759021144
Panc 04.03,46398810,3.688960594211219,2.738838070288944
G-401,65628,4.0909837295628275,3.69713423244874
BT-549,53232,2.511840395622571,2.5542647499517632
NCI-H727,104842,-0.3454800108905812,-2.7355790806886593
NCI-H292,6852167,2.409220580223775,3.0790257490228385
KMRC-1,15547703,4.785371110425684,3.2449533542033695
SCC-9,vorinostat-carboplatin (1-1 mol-mol),4.0549639225779615,3.0645837245631085
BxPC-3,16722836,0.8866010617403134,1.6820275215048182
OPM-2,BRD-A02303741-navitoclax (2-1 mol-mol),2.1588596939971625,0.5060853079270023
LXF 289,168312962,1.364587801939814,2.108007261445505
G-401,11626560,1.1843690178322546,1.2382152838462297
YAPC,3825829,4.484241364021175,4.243446395707539
NCI-H2009,46943432,2.8478796444115835,2.781079862347117
SNU-449,16038120,1.104181711259477,1.2768151963489889
MDA-MB-157,72193861,0.2105280638919307,1.6215688559289194
ONS-76,46191454,1.5088295462826262,1.6418028173533765
LXF 289,439501,-1.653941874457911,-2.1946204673123284
MDA-MB-453,54649381,4.094182376460235,3.7479793437339226
EFO-27,11507802,4.116687062031661,1.8021776126206204
ONS-76,crizotinib-PLX-4032 (2-1 mol-mol),2.136807968488312,1.5784930832912543
SNU-81,11427553,2.1196099795437733,2.1293507819287525
SNU-61,54143018,-0.3273600933762652,0.43818517757889835
HSC-4,17755052,1.8179922614483863,1.5951791657328034
EFO-27,2130404,3.4270754566369748,3.3689555379060363
FTC-133,24821094,3.776872089794721,3.1254854055240577
SNU-449,44607531,1.5485785292308227,1.5122478203616774
KYSE-70,24772860,-1.2328668610311222,-1.4498942029494413
NCI-H522,11214940,1.077396173859641,1.8354904664598795
SNU-449,1474550,4.524224948734458,3.522446020678536
LXF 289,44589607,3.4320685896186585,2.8827175793690474
OPM-2,31703,-1.5109362720248076,-2.4720337916429695
A4/Fukuda,445455,4.756694709293823,3.928184684419545
LoVo,71680916,4.224958300762603,4.7990063979192605
KMRC-1,25262965,-3.4791684180939,-1.4910254160686096
NCI-H1623,54613361,0.8976129642368637,0.06820334824995045
DMS 273,15547703,2.68216153568037,2.6156848033706153
HCC1143,5311,1.090656828429124,1.679889584221323
SNU-81,JQ-1-navitoclax (2-1 mol-mol),0.6755199584386623,0.418044588187476
MSTO-211H,11977753,-3.756718801235006,-1.5832967516341012
NCI-H661,51037431,4.262261435001038,3.196393876527684
EFO-27,25183872,0.6822597295955183,-0.7512011436494167
BT-549,docetaxel-tanespimycin (2-1 mol-mol),-6.584782072874471,-2.886463313959268
MDA-MB-453,16659841,4.43927192393091,3.620038535722531
SNU-449,3854666,3.254678167809475,2.1039653001803806
JM-1,selumetinib-navitoclax (8-1 mol-mol),1.96596855152698,0.6824372802472156
HSC-4,46174525,4.818915916273074,4.450361725106905
NCI-H727,25062766,3.0095924827905813,2.401386450198122
EFO-27,9823820,4.474335567240953,4.328751036863972
CAL-51,4917,3.122174268556499,3.066750050308745
SCC-9,676352,2.0394457592349093,2.1081760529665403
MSTO-211H,4259181,-0.7585521679245923,0.4041256414060893
Panc 04.03,3854666,3.6180263181428622,2.499938259055286
A2780,11214940,1.8716907673631955,1.5463493868842386
Panc 04.03,445455,5.108054343544362,4.708477580705228
SCC-9,SNX-2112-bortezomib (250-1 mol-mol),-2.0018823279326776,-1.1305930151062162
DMS 273,3081361,3.0365977955778805,2.2715435597659823
BxPC-3,126941,-2.8667568441276083,-2.425215474121434
EFO-27,6918837,-4.778560341054376,-2.3755733137939625
JM-1,9956119,1.3894298966841814,2.8284815528711547
CAL-51,60750,-3.4379358682898973,-2.0397766425904855
SNU-449,12001922,2.031450773900583,2.1506459860920253
SNU-81,119182,-3.3799134284972614,-1.3713413229897775
CAL-51,6918878,3.0110486558166274,2.8027907357683675
CA46,44819697,-3.819793103454841,-1.8063231129788104
OPM-2,46199207,2.048842595102616,2.5843981524270703
JM-1,11977753,-2.0561747941195674,-1.9705933015849326
MDA-MB-453,16038120,1.4822204990084098,0.8497817812200562
BT-549,selumetinib-tretinoin (2-1 mol-mol),5.357160165486871,4.213792016035071
G-401,135928012,4.758772301459146,3.9792332312142276
LoVo,445455,4.556737788306169,4.592352761987666
FU-OV-1,11964036,-0.3048537688067435,1.484682281974176
CAL-51,3825829,3.9510679995615257,3.9906537817350864
NOMO-1,66577038,2.985459327680272,2.569177451080914
YAPC,4259181,0.8211273757017798,0.3845667876636274
BT-549,2708,5.415828272287544,4.832075705770469
OPM-2,4477,0.1075725295912922,0.4635849625966375
ONS-76,23635314,-1.3572631369234491,-1.9619320263307458
Panc 04.03,168313200,2.993774278353398,3.117083711269237
A2780,25262965,-4.532154518345387,-2.2599786268998905
LoVo,24951314,0.8531724175888866,1.4355640917309274
SNU-61,6918837,-2.02709157063253,-3.104398156283293
LOU-NH91,6918878,5.623996708869271,2.9557934377420345
LOU-NH91,16725315,5.120050781978422,4.339253133703496
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376,0.7644193938129521
NCI-H661,16722836,1.177222753188902,1.613161572407104
A-498,9935249,3.347418171794467,3.696359941985878
NCI-H2009,44185566,3.0429431135599607,2.585959546594994
Panc 04.03,25126798,3.7756614801897377,3.9210754994256685
LOU-NH91,24771867,3.0978851297923895,2.938599186226566
Panc 04.03,10231331,4.944041434313903,2.4701282293541977
Panc 04.03,9967941,5.787601223768576,3.882396905899641
HCC1143,11497983,5.345504804401821,3.666916712847941
MDA-MB-453,6505803,-3.8322805026755806,-1.1145455279234746
LXF 289,285033,-1.4335563326434544,-1.631104939049855
NCI-H292,3689413,1.7536313837601494,-0.1596908776569284
OVISE,54618771,1.319775250733869,1.2903552597315133
SNU-81,135411,1.0381613293566891,0.4179291551663961
NCI-H2009,451668,5.323035746604961,4.08298132051078
SNU-81,3689413,1.1974270464491454,-0.3429425446777181
FTC-133,5738263,4.07617232189308,3.5294586092370555
NCI-H1623,5291,3.880629558524794,3.6999109059578212
NCI-H727,51039095,2.7124063556691267,2.8517703922166073
DMS 273,262093,2.141936221481062,1.8743195239184425
CAL-51,6918328,0.3807555589851347,0.1956222362179533
A-498,24951314,2.536702379510054,1.6400758343181556
OVISE,135440466,-0.9475229728449716,2.315037110314098
A2780,11404337,-0.8981705286722745,-0.6049060043161183
OVISE,selumetinib-navitoclax (8-1 mol-mol),1.5927997425042688,1.8171742476427186
Panc 04.03,24951314,1.470760951451068,1.7014198590452896
NOMO-1,4705,2.5023829157060926,2.8280164319087704
BxPC-3,176870,2.768163283404042,3.0201839044429506
G-401,11609586,0.8694160359503889,2.113755757850266
EFO-27,doxorubicin-navitoclax (2-1 mol-mol),0.6327917719948324,-1.0270103597408116
NCI-H2009,tanespimycin-gemcitabine (1-1 mol-mol),0.2582692893190324,-0.8035574559038007
NCI-H2009,15983966,-3.9047819028388178,-0.5365492098921392
JM-1,16659841,2.088291676862089,2.412737111461382
NCI-H146,5311,-0.0389435386139853,1.2046003328153536
A2780,72734382,3.371521062177298,3.9460364568776685
A-673,2708,2.956024737310482,3.9695799604426556
NCI-H460,11152667,1.2005763717636435,-0.33960830555425614
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945,3.469377673088145
G-401,60700,-0.931594906554522,-0.9765337692514012
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633,-1.3502678284167922
NCI-H146,31703,-2.278385754586821,-1.4367591447523766
KMRC-1,445643,4.4248475697731005,3.9055879218291385
SNU-61,tanespimycin-gemcitabine (1-1 mol-mol),-0.5770554338848054,-1.2602709696491552
KYSE-70,54613361,0.0645626216296427,0.2037565299876366
CAL-51,444795,5.053001195278548,4.568589717673257
KYSE-70,54619267,5.587983352589812,4.045607025182444
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506,2.3594013103379226
NCI-H522,135984461,5.248212763135773,3.2901200394593593
CA46,10385095,0.6992054873225039,1.0287354037018965
G-401,16038120,0.8239725572719159,0.5265321803030221
A2780,selumetinib-tretinoin (2-1 mol-mol),2.739843613325444,3.650130195085452
NCI-H1623,6918328,0.1782181011891448,0.05416422908013809
G-401,31703,-2.7567506026552904,-1.701992982377076
OPM-2,11497983,4.2316824511311,-0.009968004435064699
NCI-H522,46215462,1.6065433434555243,1.59830800352995
JM-1,selumetinib-UNC0638 (4-1 mol-mol),2.9715297614660474,2.0135899962050847
A-498,selumetinib-BRD-A02303741 (4-1 mol-mol),2.466660305447313,3.5794769159761706
A-673,16741245,3.6856166817392393,3.7699844674205694
DMS 273,44486219,3.889102530118227,4.18114811334444
ONS-76,3062316,0.3527292351029743,0.8883782183787129
NCI-H1623,4521392,4.396491619301915,4.226468567104946
SBC-5,3062316,3.347274022566764,0.7803663450326305
OPM-2,374536,1.7033153768622478,1.0343873508918786
NCI-H292,5291,3.74340966649761,3.6826355759079883
G-401,123631,2.330078370852269,2.1831502080292924
HSC-4,135423438,1.814117839489682,2.5936308221252915
CAL-51,25126798,3.926975819986009,3.8653002122471865
NCI-H727,409805,5.9670224431598875,4.953356750321184
A-673,4917,1.8117239982797952,2.931644295070053
DMS 273,57519531,1.9430749026869305,1.7936591108713187
MSTO-211H,vorinostat-carboplatin (1-1 mol-mol),3.1229894172951043,3.182948946885276
HSC-4,25262965,-0.4495508061813805,-1.2451925680409155
OVISE,327653,2.506626214633075,3.201161287440089
A4/Fukuda,71680916,4.641498651595925,4.045551691050056
EFO-27,104842,-1.4311942194738418,-2.7038890085704543
A-673,11626560,-0.097195247735582,1.3025083156275374
NCI-H146,3384730,2.6214971804948908,2.4048320402608807
MSTO-211H,26596,-0.5653018529577997,-0.947245116413724
JM-1,445455,3.9843646189648863,3.8033579297775066
CAL-51,11427553,2.069280384014222,2.9214000015587684
SNU-61,20959075,-3.60077638491687,-2.648671466986581
LXF 289,25062766,1.8533275351899623,2.067167155816995
LOU-NH91,24797083,1.602297413523094,1.453619414690288
CAL-51,24771867,-0.5018492111736887,2.8635940465078096
NOMO-1,44632017,0.9405041708842384,0.8304855113415897
NCI-H146,25195348,0.0229507172684141,3.148066562998979
A-673,151289,0.5990139557366498,0.874661032044347
JM-1,72376,-3.929922218649067,-3.45112147177314
NCI-H727,12003241,-0.657143782776601,-1.1689046776463583
JM-1,24180125,1.1035620934920058,2.1990591605949334
LoVo,24964624,-0.96112559187181,2.4620415858878775
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224,0.7175733860022325
OVISE,6610216,4.867128617935935,4.224022073697162
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466,4.881636290948796
CAL-51,11507802,1.2528060552922216,1.3522741246962937
A4/Fukuda,25227462,-5.883792654516593,-1.6057840671865664
BxPC-3,5566,2.8001360517565628,3.1817574665675203
DMS 273,119182,1.6620070398785467,-1.552889037752106
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465,1.2398977962367448
NOMO-1,168313200,3.152434526133537,2.775621452749978
A-673,navitoclax-PLX-4032 (1-1 mol-mol),0.8994506626912233,0.9904971171316553
NCI-H727,24856436,1.7647429516878397,0.6230251569572947
KMRC-1,72734382,5.690666345136703,4.268955753549679
A-673,56949517,4.212065281653062,4.529769286091757
BT-549,135421197,3.4062158650675265,2.2078503590820726
DMS 273,vorinostat-carboplatin (1-1 mol-mol),2.6049111550172506,2.232758003677361
NCI-H1623,10074640,3.727129107489099,3.108423494531164
YAPC,5329102,2.676937714502371,2.0818391156740117
YAPC,docetaxel-tanespimycin (2-1 mol-mol),2.5986620559096902,-2.7856111767775302
NCI-H2009,4917,2.9963488408029417,3.122632438570209
NCI-H727,44589607,2.894616632949603,2.9838307880197577
G-401,5328940,1.7098947779411977,1.4392397072405185
FTC-133,10410894,5.920528547603018,3.3248837874523773
CAL-51,216468,1.370586512271769,3.1154463670146915
MDA-MB-453,227681,3.97271964535407,3.207135154865132
A4/Fukuda,5284616,3.229953451024844,0.5925228508517931
NCI-H460,753704,5.635234970240753,4.901058010722653
NCI-H2009,vorinostat-carboplatin (1-1 mol-mol),1.7172571438659243,3.284827349332374
SBC-5,crizotinib-PLX-4032 (2-1 mol-mol),2.792734881189652,1.8817891204852557
NCI-H1623,25150857,2.7146098705885127,2.663350884048354
YAPC,JQ-1-vorinostat (2-1 mol-mol),2.9118979144458548,1.1356517074651884
LOU-NH91,2729026,2.877851429076431,2.899707505218073
CA46,46191454,-0.333651418813281,0.17018094482276738
FTC-133,65628,4.302527639906617,4.470046739029498
A2780,72193861,-0.1120033238626439,0.8947753162025465
SCC-9,49793307,-2.052824266331224,-2.2116949939522725
BxPC-3,135440466,1.2091890795281053,2.2664834876643387
NCI-H146,11455910,-0.4209962248823531,1.0759518663150052
A-673,46398810,1.6125076634642133,2.106597409676054
SNU-81,11626927,-0.7774954189098839,2.6599009413245667
JM-1,45279963,2.536030346276664,2.8058180780858435
MDA-MB-157,5746,1.4435337882328911,1.022703618874127
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684,4.632222537660828
ONS-76,2874250,6.058821088556036,4.2492089923360234
A2780,5284329,2.502098244540034,3.036521182264351
LoVo,53232,3.084407514553567,2.782747567793485
ONS-76,navitoclax-PLX-4032 (1-1 mol-mol),4.335120397658034,1.9871985181269267
OPM-2,9927531,3.0625153090482757,4.239706443467019
SNU-449,44202524,4.173676721592596,2.3427135852320067
SNU-61,124202324,2.5924607447988643,1.9506049709829503
JM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.853804462612268,-2.6729420764231913
CAL-51,44819697,-1.9765663783606575,-0.9660288996919966
FU-OV-1,2708,5.501261259949465,4.724217689225902
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408,2.0690880171306323
SNU-81,16722836,0.5712028725805488,1.475869630914154
SNU-61,1716436,2.6740680266491763,2.8416904544695307
OPM-2,3854666,0.6659331794855328,0.836347962244849
DMS 273,71304818,2.423766397759693,2.087871692656892
OPM-2,44185566,1.967847411757682,1.6257167040164677
SNU-449,25154868,5.089625763576692,4.5073420210138675
JM-1,serdemetan-SCH-529074 (1-1 mol-mol),0.850280297026697,1.5122514810348824
NCI-H661,5281321,0.7671093512543088,-0.4850593940861637
SCC-9,44185566,3.0958673753547785,2.7011716826821366
MDA-MB-453,16736978,1.2653262263884038,1.1530466771403056
KYSE-70,9935249,3.427959003246725,3.163507498401432
MDA-MB-453,11178236,-5.341922221503707,-2.9239784544256238
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496,4.820319993007924
EFO-27,24180719,4.15462806748021,3.563016024843479
NCI-H727,44607531,2.33451518290986,1.648192872475785
NCI-H292,10410894,3.620691172443616,3.350322956882554
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943,-2.790680431812579
MDA-MB-453,10184653,1.4947310227918462,0.5565105209057932
MDA-MB-453,11228183,3.436796326739784,2.2702916061839162
DMS 273,67291369,1.8884432049214537,1.1413925823623337
NCI-H2171,54619267,3.4799425585632204,3.5170757226117297
MDA-MB-453,448949,2.258073743229602,2.2561489389685727
A2780,135440466,1.248320725279374,2.237011655189646
NCI-H146,9866186,0.8123633746782326,0.8583859410818768
CAL-51,JQ-1-UNC0638 (2-1 mol-mol),2.957186158032418,1.8871020902034905
A4/Fukuda,10074640,2.009206402328629,2.7940679678967
KYSE-70,31703,-0.0860185315527888,-0.4458772214727474
A-673,11497983,-0.3979292238924095,0.9497597559434331
A2780,12003241,-2.743381978251489,-0.9694211359039034
A4/Fukuda,25102847,0.4372365282678318,2.191041186773213
KMRC-1,11717001,4.773123606238519,3.8292522622792795
FTC-133,36462,0.6793689394766376,2.4054949018077996
SCC-9,23582824,0.351039434592286,0.8739387614452664
BT-549,2729026,3.014205222238777,2.652097950961553
EFO-27,selumetinib-piperlongumine (8-1 mol-mol),4.5130277383980015,3.458741467812723
LXF 289,46943432,1.4312531154305732,2.8597857139114193
NCI-H727,11625818,5.425399240643101,4.413670133457738
HSC-4,44507138,3.308450875381542,2.3377956384907588
A-673,969516,1.3043572294505754,2.467626807036417
FTC-133,969516,2.842702479050133,2.880305123315173
HCC1143,11609586,3.6708937391840206,2.758561581497869
DMS 273,2733487,6.43119993607997,5.351071217537857
LoVo,10302451,1.0215583424111876,2.975311060445264
KYSE-70,46174525,4.613744209458669,4.173862384918637
SBC-5,65628,3.417870630997437,4.328370684267009
DMS 273,24180125,3.0640550148835812,2.5670496734732375
OVISE,452548,1.282500130328104,0.5698181927399372
BxPC-3,71304818,2.4465042326182247,2.6544592902557493
ONS-76,54143018,0.4309751541382265,0.6209093470191785
OVISE,24856436,2.006053298804951,0.5482471514019303
MDA-MB-453,71729975,-0.0804754192781109,1.85781417851935
NCI-H1623,65628,4.265717950525356,4.559154465258868
DMS 273,9927531,4.953960158421894,4.402489072275911
BxPC-3,426756,6.38858222821808,4.3253596664728065
NCI-H2009,49766530,0.9767616789625324,0.0067712394632452886
JM-1,2858523,2.95851246958296,2.777014884354738
YAPC,9935249,3.6850704434892823,3.1725510243914727
A2780,654092,-1.3080416104753447,-0.5002345700340749
OPM-2,6918638,-1.573449675489913,-0.21312320363136825
NCI-H2009,alisertib-navitoclax (2-1 mol-mol),-2.130413891599744,0.4266568611331437
SBC-5,25105715,3.9151038194938352,3.364823548325603
SNU-61,168313047,1.9617236271133212,2.1992231807559888
A4/Fukuda,11317348,1.1392337694005448,1.3680189609187599
NCI-H522,25262965,-1.3157493467877637,-1.309028869203515
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021,1.158229436295541
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567,-2.548010591252827
MSTO-211H,44607530,1.4093785076150551,1.754754965362288
HSC-4,984333,1.2474358256824072,0.826362442516555
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.08090900748620251
ONS-76,9967941,2.912852232249919,3.6549416087484756
DMS 273,24753719,4.257561408038297,3.6430918537345707
CAL-51,24772860,-2.425084956958233,-2.082736412225212
MSTO-211H,44632017,1.2059374560785627,1.6383712357049125
NCI-H146,5978,-4.422435519224839,-2.5462088129074063
G-401,2746,2.560873344661061,2.619291966731648
A-498,navitoclax-sorafenib (1-1 mol-mol),1.1504287043269172,2.1671757255710205
NCI-H2009,11152667,-0.3244172236423036,-0.2584229831461349
BxPC-3,erlotinib-PLX-4032 (2-1 mol-mol),3.269235353902274,2.6930124349593534
MDA-MB-453,219104,3.605347452429255,3.605142339772819
KMRC-1,5280436,0.1724698964633139,3.356360146263411
A-673,25154868,2.9619598302203176,4.192835829599542
A-673,135999136,4.231524255529223,3.1018940023950083
FU-OV-1,9884685,-0.2158788705773567,0.8360367571398786
NCI-H727,11626560,1.656358651993978,1.6874027820108646
CAL-51,9866186,1.45916914556855,0.4791716190987599
HCC1143,44507138,1.5952303095871043,2.5311197548774884
CA46,9823820,1.6053302041689723,2.3113802637641907
NCI-H522,docetaxel-tanespimycin (2-1 mol-mol),-6.262465399444894,-3.868669944239909
CAL-51,12001922,2.008779489179369,1.8724848222932615
FTC-133,selumetinib-PLX-4032 (8-1 mol-mol),5.295700336992507,3.217081405570444
NCI-H292,19582717,5.466560288208149,4.4430122018321505
A4/Fukuda,374536,-1.0311095755670416,0.9670407480426045
OPM-2,10113978,1.3298356496360293,2.313555506243945
SNU-449,9903786,3.696408358539977,3.049620824862418
JM-1,25195348,3.46638875562813,2.5530495859201565
NCI-H1623,5746,-0.5390712999232294,1.0715352251888575
KYSE-70,71466445,4.079477869375345,3.995112131468902
NCI-H460,44185566,3.2105564381381035,2.745645438608012
MSTO-211H,6918837,-2.204195063499652,-2.54971241091841
CAL-51,54613361,0.2180057854442524,0.14380530149512208
A2780,216345,1.0708930445758365,3.390021330380145
HCC1143,100016,7.122041956726765,6.084660421410365
NCI-H522,5278396,4.518604091155278,3.3780472072178993
SNU-61,54619267,4.677926252875765,4.01048271768403
OPM-2,135421197,1.341685947169011,1.1718259503767272
G-401,72193861,1.057396802085585,0.6738309597482532
NCI-H727,15547703,3.504014494953252,3.117706772712376
NCI-H292,11178236,-4.939590057195551,-3.1482838035167764
MDA-MB-453,44241473,4.685974466458818,4.0994830440872425
MSTO-211H,60700,-2.4521642225491065,-0.3293250249754754
BxPC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.5266408566121297,-1.2007942006053087
NCI-H2171,4096211,1.8093642806404184,1.2765318793782472
NCI-H146,68056272,3.3997347898500063,3.11128645325153
A2780,984333,-1.5561630492039429,0.5053734979992137
NCI-H2171,5479543,3.509510962528721,2.9163595335724106
ONS-76,6610355,5.379398654611739,4.437041876504323
G-401,2742550,4.179048555325354,3.1855323426568076
OPM-2,44137675,3.238695939616315,3.071255463615215
NCI-H661,selumetinib-navitoclax (8-1 mol-mol),5.100563052002661,2.187426036346365
FU-OV-1,387447,-1.63105242136749,-4.025062679971777
LoVo,3825829,3.571391318080427,4.044723695152344
JM-1,11404337,-2.1014875230304315,-1.3848494802908993
FU-OV-1,9929138,5.415072941349914,5.738437992975435
SBC-5,5738263,3.46908634421933,3.512783646185132
KMRC-1,navitoclax-piperlongumine (1-1 mol-mol),1.9271011950938683,1.392258207380802
G-401,4917,3.172752348635073,2.8632891248995374
A-673,44589607,3.5509265356046305,2.146454136043186
A-673,selumetinib-navitoclax (8-1 mol-mol),2.703259710676399,1.3107884663090528
CAL-51,2828334,6.190580852669228,6.097447586988747
MDA-MB-453,BRD-A02303741-navitoclax (2-1 mol-mol),4.399808633782925,2.1123468190109858
SNU-61,67156097,-2.2274361546113854,-1.1248763002040902
OPM-2,65628,4.597670741376445,3.1062288642524347
MDA-MB-453,3038522,2.334816038150176,2.850997760870395
HSC-4,2708,2.9878251305615477,5.03327226189178
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472,1.6644800132931488
CA46,54678924,0.940253932332064,1.2908266471685537
SNU-449,11964036,1.3997299371502423,1.5039914723113952
DMS 273,54613361,-0.0987092047967699,-0.30578862420472624
SW1463,2749,1.5016847157281326,1.6852193111503857
A2780,4477,0.2147996237825641,0.7042527838359987
NOMO-1,9907093,3.6530797436282434,3.534807790366793
A-673,54618305,4.212251300263772,4.272343479832739
LOU-NH91,65064,5.187256751294022,5.111187498319789
NCI-H2171,72376,-3.3432588050758296,-2.6034393318044313
MDA-MB-453,72199292,1.3092335372039157,0.4449973126523936
NCI-H522,107970,1.611650854248594,2.2327438512268665
A-673,444795,4.685959151928419,3.9934620637203726
HSC-4,6505803,0.688410933428746,-0.6037388480932325
CA46,11455910,-0.2967360934235351,0.6003903978842792
NCI-H460,6252,1.4342703041264255,0.9401687463658157
BT-549,49793307,-0.000238716840207,-2.0801861976755727
CAL-51,68056272,3.9955701948507247,3.5777424610942092
A-498,vorinostat-navitoclax (4-1 mol-mol),0.5641326032533043,1.196727151408709
A-673,227681,3.19347186106623,2.899779212433125
BxPC-3,54618771,0.182098153600537,1.126761393700411
A4/Fukuda,3385,2.3595203579832553,3.1327436101085406
LoVo,36314,1.7018910931264415,-1.877484478272323
BxPC-3,11152667,-1.4400195695513092,-0.7812106877161772
SCC-9,3025986,-0.0492814979551807,-0.989525441663437
MDA-MB-453,4259181,0.7923345004369465,0.5250607882056648
Panc 04.03,9927531,5.313421559596226,5.00696616888426
LoVo,448949,1.89047161937067,2.123513687316992
KMRC-1,5978,0.0310598033875183,-1.498300675506706
NCI-H292,262093,2.9868554632365556,2.9799482918960023
CAL-51,9884685,-0.2528326244590672,0.4284582330734948
KMRC-1,135421197,2.781168744821282,2.2535566292166256
A2780,56973724,1.317874340119369,2.3752328094540167
A4/Fukuda,46943432,-0.0927442133672991,1.132086849329845
HSC-4,50905018,4.462883747891921,4.34758707619427
JM-1,448949,0.7740790697885386,1.1292208740989214
EFO-27,11964036,1.3211691780165964,1.279406064445071
A4/Fukuda,637858,0.8198578842358093,1.3103748102322808
OPM-2,5282054,2.4375164125334217,2.808514888338517
ONS-76,637858,2.646425044184718,1.9193815227263078
HSC-4,439501,-1.7709622187792924,-2.0357826569789923
KYSE-70,24964624,1.4483005111507754,2.3591095842921503
LOU-NH91,5282054,3.3765969574471315,3.9219529337041465
A-498,selumetinib-UNC0638 (4-1 mol-mol),2.905526592026194,3.3743468620752357
SNU-81,5281321,-4.892530389502709,-1.61668603335396
HCC1143,168312962,3.1559735288767468,2.3392490618369366
JM-1,126941,-4.3883192692313955,-3.0411105101263836
SCC-9,54143018,0.8755026739061308,0.7798744305825999
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798,2.5525774444178455
SNU-449,1641662,3.672188762237013,3.558056330550075
NCI-H146,54765302,2.77091239654666,3.8649360947670397
NCI-H146,11427553,2.364557310661393,2.3428977357461687
CAL-51,159324,3.1794720270506307,3.155916600554625
YAPC,71466445,6.285156806731666,4.274963484458844
ONS-76,5351362,1.281569720069414,1.6003563272619465
NCI-H292,doxorubicin-navitoclax (2-1 mol-mol),-1.8265545031559949,-0.9157776398548791
BxPC-3,6505803,-3.0514917868960767,-1.0614265185659342
A-673,45279963,3.7593508340409287,3.0673787276064974
CA46,3465537,3.345448990020783,2.128760115259326
HCC1143,168313016,5.718985268806146,4.774054475121676
A-498,400769,-1.6101267353788036,-0.13259343849370153
NCI-H2009,10184653,1.0890186290305244,1.3694450248207042
NCI-H522,426756,6.015863149473534,3.9180131646771175
NCI-H2171,44819697,-4.1780638649943675,-1.0984904057948903
DMS 273,24785538,0.640909019865508,0.7772294519012506
NCI-H146,6918638,-1.4860665745363582,0.31229947414748044
NOMO-1,3543504,4.095340640265792,3.8003514704006496
NCI-H661,151289,0.3755226510544496,1.19108268929339
G-401,53495165,-2.4189675718778516,-0.8965928918579219
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136,2.1482908870213144
YAPC,6918837,-0.3723714565085887,-2.4281870942750614
BT-549,219104,4.096633484715141,3.9704714988655154
LXF 289,24753719,4.56569970094865,4.448086276077777
CAL-51,25102847,1.94226811064499,2.1410557251739006
A2780,doxorubicin-navitoclax (2-1 mol-mol),-3.696476342878232,-2.018062224059263
OPM-2,54618164,3.637238343412542,3.361003971594503
MDA-MB-157,2733526,3.146610844933737,3.719272813966624
KMRC-1,54618164,3.981312375484732,4.180640097239965
CA46,375860,-0.5712781411665353,-0.5119949892230173
G-401,24772860,-1.622851891505981,-2.4339015632814274
NCI-H1623,119182,-1.1196330586869003,-0.5761169924053173
A-673,984333,-2.7710011035310074,0.10990718526669124
KMRC-1,49793307,-2.5218593870176793,-2.7024028073429167
ONS-76,alisertib-navitoclax (2-1 mol-mol),2.05248890000496,0.6318566772821547
DMS 273,11152667,-1.0918930552191226,-1.0671373986297268
NCI-H460,44620216,3.8133491956675902,3.740966160695281
MDA-MB-453,19582717,2.5916230237173696,4.222606732091812
SNU-61,53495165,-0.6572534585269733,-0.6467854079664646
JM-1,6505803,0.12933264701109,-0.6193710296562344
SNU-449,60700,1.1315850608054705,0.09898741278626247
CAL-51,676352,2.3367523995253454,2.030183443415146
LXF 289,89928392,2.4967474535679623,1.673466042171901
LOU-NH91,11625818,5.704636625331963,4.4856007784126515
MDA-MB-453,156414,0.9469838239648454,1.0220308090194208
OPM-2,462382,-0.5185214646773461,0.5619044312492352
A2780,53392493,1.4842280461046395,2.2522070089926647
DMS 273,9823820,3.9764583445605006,3.2011041259558293
ONS-76,24772860,-0.9083480450936676,-1.5935260265768616
KYSE-70,11612883,2.3570058511886396,2.6387931689556763
SCC-9,3854666,1.6335835525169635,2.1661807948132044
KMRC-1,375860,0.0373834100132385,-0.14076192581445848
SBC-5,9866186,-0.1944977114504531,0.9190339869461082
NOMO-1,11719255,2.6566855899212944,2.286090074125883
CAL-51,702558,3.5144984342436563,5.340265650740536
ONS-76,51039095,3.253449307143194,2.8441566979056314
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.4497794285021033
BT-549,carboplatin-etoposide (40-17 mol-mol),3.0956073566699147,2.9269354528244413
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355,2.540557656484941
BxPC-3,216468,3.632186197150132,3.3231478979731848
SBC-5,2742550,4.323082293816951,3.635218197522379
HSC-4,24797083,0.9836127584085878,1.4576539661111494
OVISE,4788,6.030976207458705,5.759605524485246
LXF 289,11455910,1.909862916296106,1.3470284998573956
SCC-9,16659841,4.917362195715636,4.031267838555003
G-401,49766530,-2.7444300270308113,-1.4150773039081614
HSC-4,6450551,4.030000721690881,2.907854421440559
CAL-51,6918736,-2.0480142356294637,-1.5309398741535574
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208,-0.7462422523747757
SCC-9,4096211,2.914802879806832,2.277811302324503
EFO-27,168313200,3.5651936579716277,3.0375018715172697
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573,6.243402106229166
SCC-9,448949,2.996737074861378,2.2196863144275976
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338,4.629593538289761
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.8372000622449685
NCI-H661,15953870,2.9876041506010003,3.549855853700665
KMRC-1,6918638,1.621172594092556,0.4372808134669478
Panc 04.03,44489675,4.301555650291772,3.98601695644699
HSC-4,54143018,5.46718478704898,0.569400447968622
NCI-H661,11175137,2.5272908163527745,2.6516027424984916
OVISE,piperlongumine-MST-312 (1-1 mol-mol),1.6778401901556628,2.108321947950292
NCI-H292,24753719,4.2962074219620225,4.432250888966612
NCI-H146,11228183,-2.941805953111262,1.5647279093972464
MDA-MB-157,65064,3.084719541991811,4.832771248033726
HSC-4,44491742,4.173988284907792,4.432299319682658
CA46,9933475,1.582522184359856,1.5014600585685525
JM-1,53245473,3.7598021769733414,2.8420670910034636
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.2259241530814122
KMRC-1,702558,5.7321455674333475,4.9568357573692055
EFO-27,262093,3.0007323703470896,3.079876776065288
A4/Fukuda,72734382,2.815137004147321,3.6922807056853406
NCI-H727,44185566,2.6786881549102626,2.6429900612274952
OVISE,25062766,3.2029018764111896,2.274789683381771
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226,2.6747514676936532
CA46,3825829,3.8503527939376583,3.3668722634694457
EFO-27,JQ-1-navitoclax (2-1 mol-mol),3.2464971768878086,1.0604464573100867
BxPC-3,60750,-2.6920891843690273,-2.001036750458321
EFO-27,1566236,1.9834366009012432,2.759410252568003
LXF 289,53392493,2.5437082258312804,2.9591118312422258
NCI-H460,135421197,3.2510260026522233,2.1162718986934563
JM-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.316937276009384,-2.5473298336032384
Panc 04.03,44607531,1.8924568500741572,1.5790475956274808
ONS-76,15547703,3.220128707821482,3.14704347784021
BxPC-3,123631,1.9141625570683185,2.2016792598298984
NCI-H2009,24180125,3.399696031265864,3.07387954894578
A-673,19582717,3.777631654850071,3.545111739852414
FU-OV-1,12003241,-1.039273875540509,-0.9306400805390556
SNU-61,409805,4.743067556302579,4.781679792633415
DMS 273,11364421,-1.741561290091182,-3.6941761635378305
Panc 04.03,11214940,1.7867172186781857,2.2651766274476977
NCI-H522,31703,-1.0005486569838078,-1.264398158895364
KYSE-70,5287620,-1.7159794680358271,-1.6203527241839533
A2780,11507802,0.380240885087182,1.135463436074995
ONS-76,54613361,0.8570205233962582,0.12056401594048244
KMRC-1,2729026,3.101959850286169,2.6837892556214102
NCI-H522,136227924,2.2034936459857506,2.738933410332599
NCI-H661,52912189,3.763222756257729,2.483302806989813
ONS-76,262093,3.354802573562099,2.95266015927851
A2780,675434,3.840840752716624,4.3262105578666175
EFO-27,24771867,3.839082818590537,2.894566868648064
BT-549,44185566,3.1570730526396407,2.827106859227738
NCI-H2009,89183176,3.352860584382055,4.74052432294808
A2780,2949965,2.158264003903123,2.5409275886784446
MDA-MB-157,119182,-3.4496410534325093,-0.4537980986818002
MDA-MB-453,2949965,2.588847266095094,2.87890414514159
MDA-MB-453,71576739,4.365206221166654,3.5880815108358
A-498,11455910,2.747308138802023,1.6053133265114945
A4/Fukuda,448949,1.1686862984883333,1.5205105916364323
OPM-2,10385095,0.6586756349946576,0.9483935312617041
BxPC-3,52912189,1.4214477046132656,2.225462962774365
JM-1,46907787,-1.9243382261841309,-0.27740477947517717
G-401,3385,1.38862488630676,3.1308554113769254
LOU-NH91,24978538,-2.307670841327046,1.5201765007969903
BxPC-3,25262965,-1.1326145626109247,-1.2050668676879936
KYSE-70,9915743,1.2522553618909642,0.6659241995303247
A4/Fukuda,42642645,-1.373677794386147,0.18551589150510575
A-673,44202524,1.1944686936342714,1.6394229204922854
FU-OV-1,66577038,3.5319441468561648,3.0167349540135837
SBC-5,BRD-K99584050,5.772271611565925,2.339908453391555
MSTO-211H,2749,1.2029234831790616,1.9676311486371205
EFO-27,2858523,3.4178086224101527,3.1019727637149686
NCI-H2009,54613361,-1.6701870677586086,0.35112396708132965
CAL-51,11626560,0.7349282975065881,2.076845256873993
YAPC,446155,3.8433351119798695,2.8211878680580145
KYSE-70,3854666,1.6457032232411275,2.419919228767302
MDA-MB-157,49836020,-4.4611089332084335,3.1967184528696397
Panc 04.03,10385095,1.3607276101908192,1.5247518684241128
NCI-H522,piperlongumine-MST-312 (1-1 mol-mol),1.211540874463276,1.556168676948991
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.485491324431175
NCI-H460,31703,-0.6563705559837907,-0.8031969559119514
HSC-4,135421197,2.1482643592466495,2.1488634565366325
KYSE-70,216345,3.953496119268799,3.9557601383744427
NCI-H2009,44259,0.1981246725332563,1.18607426691128
NCI-H661,24771867,2.8989054210712784,2.3980738499059338
LOU-NH91,89928392,1.577129115434841,1.874610810749996
SBC-5,44819697,-0.6119786373907494,-0.41517456824888405
CAL-51,135398738,4.757337519270393,4.475166130548332
A2780,11234052,1.762226904306368,3.5725769592732894
EFO-27,5287969,-2.249416082595734,-1.6818637951294184
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167,1.128965598644823
EFO-27,72734382,4.838814549837177,4.758817463120913
A2780,2126,3.67742533530732,4.2146694689343
NOMO-1,656346,0.9377734591624955,0.24434893960552187
NCI-H522,439501,-5.784929410118117,-2.167395348951652
NOMO-1,4521392,4.093982124965485,3.872352988441847
NCI-H2009,452548,-0.9979896146805513,0.32930296387323293
NOMO-1,327653,2.81345515165661,2.6111895955474864
A-673,46191454,-1.7005324627981964,0.6536931946259423
A2780,168312962,0.1167104942518841,1.1026238115740217
HSC-4,11214940,4.953530718305131,2.0622767662618773
KYSE-70,44507138,1.8487883665285316,2.552680081120046
MDA-MB-453,5566,2.956907653722259,2.9173570036130076
SNU-81,selumetinib-PLX-4032 (8-1 mol-mol),-1.7498226144583562,3.509161176517548
SNU-449,24753719,4.452712705797618,4.372472413318305
HSC-4,6184667,2.683776581109496,3.149557327931584
Panc 04.03,4477,1.027037586587599,0.7663427389358914
CA46,24951314,-0.0442972386064399,0.3764924091042798
MDA-MB-453,JQ-1-vorinostat (2-1 mol-mol),-0.5883390027404639,0.8574502535223264
NCI-H460,637858,3.384702960830197,2.179531870534301
MSTO-211H,54618164,3.0389284404004795,4.093351499408774
BxPC-3,135875424,4.118804534986376,3.935329040244771
LoVo,374536,3.1459286411718055,2.4253153069421014
SBC-5,65064,5.87027592575748,4.905687816283457
A2780,2708,1.6817262399506028,4.05004384671544
NCI-H292,11427553,2.7677841547579347,3.034269404202602
EFO-27,10184653,2.474041422726229,1.52648327356608
LXF 289,16038120,0.5250135720403194,1.3665267591988737
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717,1.930507788340098
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823,1.7935931578689892
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893,1.6018317002985267
BxPC-3,10184653,-0.596247884950306,1.092428865455701
KMRC-1,54618771,0.2036698487849761,1.3184413044319447
FTC-133,4705,5.547028107549284,3.3391663905940736
A2780,107970,2.1177540249197246,2.170577754299206
DMS 273,15983966,-4.308041598319055,-3.18772960466398
DMS 273,JQ-1-UNC0638 (2-1 mol-mol),0.3284926048856003,0.9601984230090026
HCC1143,637858,1.5767538824178036,1.961138165330282
OVISE,753704,5.218614122812972,4.990803026239319
NCI-H1623,148124,4.04127286799143,-1.8050884539007794
NCI-H661,1716436,2.7606212382296205,2.8749185662971595
A2780,5328940,1.6938804432156576,1.5178185842661
Panc 04.03,doxorubicin-navitoclax (2-1 mol-mol),0.7758881761631229,-0.697227455070853
A-673,52947716,2.7267743407084333,-1.1424678781651514
LXF 289,51039095,1.6878089310027404,2.7359616754639804
LoVo,24753719,4.853832341629896,4.2937263371992564
FU-OV-1,16065773,3.3464590574422424,2.716362426114857
Panc 04.03,439501,0.3022334331499904,-1.9200136432284682
NCI-H2009,44137675,2.9238442509206606,3.8427214270722567
SCC-9,24964624,2.350052808289582,2.7977421230867403
BT-549,56946209,-4.178729112607428,-3.794123638233903
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038,2.9400797623492547
NCI-H460,1716436,4.318712917611328,3.1318871729789497
MSTO-211H,4917,2.9904400598930088,3.090094938634299
NCI-H2009,5282054,3.436101167626708,3.92724047309476
FU-OV-1,53232,3.5510277872612903,2.70281053972542
NCI-H460,3503,2.4668231300278154,2.382701451988935
CAL-51,6252,-0.2076922850947726,0.8685898523612033
CA46,44607531,1.0933116261411373,1.0880021964722202
NCI-H2171,44589607,1.1207968177639505,1.923332131390808
ONS-76,selumetinib-PLX-4032 (8-1 mol-mol),-0.2158611974685485,3.0836702508024985
BT-549,5311,2.3943998607281314,1.788209595086793
SNU-61,44491742,3.859456688826312,4.0689027579547545
JM-1,46943432,-0.1491870155181681,1.0454947066578248
HSC-4,156414,0.4374127066870092,1.4743331792810652
EFO-27,tretinoin-navitoclax (4-1 mol-mol),4.088217515777896,2.885641929905014
OPM-2,42611257,3.2957467857000404,2.9337984205602687
A2780,136227331,3.7351205807719863,3.3018676231518516
MDA-MB-157,71751553,2.589623955944651,4.5417931971185075
HCC1143,262093,2.740628946324062,3.0183427307451653
NCI-H522,56946209,-5.885513086137786,-4.128475293921335
A2780,67156097,-2.4563073864206633,-1.6633432213317934
FU-OV-1,136227924,3.2834953568281597,3.0724403501919646
NCI-H1623,241158,4.3681147628536445,3.983598425515173
ONS-76,2828334,6.172523844471339,6.05200849045207
BxPC-3,11625818,4.084435736278963,4.643267509901944
DMS 273,5281321,-3.764975659067455,-2.1004972043357073
KMRC-1,3825829,4.43742858244417,3.8554094802185954
JM-1,5280436,0.8051765864900793,2.404848848858942
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846,2.5561222424054106
MDA-MB-157,9927531,5.35009923211275,4.696454166626842
OPM-2,56963564,0.1507827744052812,-0.20526516188449861
JM-1,9825149,1.1101255190052433,1.6968757623258985
A4/Fukuda,136227924,1.9204852137512072,2.5550231601627855
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266,1.2032250207065378
Panc 04.03,16065773,3.1082338307326687,2.575165553012452
KMRC-1,148198,-3.0121915653316953,-3.3775203374124403
NCI-H727,11612883,2.6691234813665226,2.9167321249991893
A-673,25183872,-1.50300168442849,-1.3593892675809043
NCI-H292,5470400,0.7410873105484811,-0.307258682552631
SNU-61,24771867,2.3194270269791772,0.11373942360735415
ONS-76,2729026,2.9392891978845626,2.7910928762700893
NCI-H522,54618305,4.230012053256092,4.289108010554641
MDA-MB-157,6918328,-1.4439105140240134,0.09891255245304509
SCC-9,11609586,3.4579622750703902,2.7517249020581267
NCI-H2009,73707398,1.4628489872410333,1.5267197473537675
BT-549,613753,3.1113642662223913,3.156487225127252
NCI-H522,11396600,3.374818989992459,3.2986312864135066
A2780,227681,3.163289337051595,2.867537262315752
SNU-61,42642645,0.1547953205487765,0.42256076124751873
EFO-27,24753719,4.6250624916483405,4.2934343309870275
NCI-H522,1750826,-4.884358581349171,-1.8885879191552508
NCI-H460,3854666,3.1385110084048065,2.207544147423278
Panc 04.03,16736978,2.069266987472695,1.7505254525719798
KYSE-70,135875424,3.720063911223788,4.182202845635108
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981,-0.45512013704420434
NCI-H727,4369359,4.470803757423574,3.502994446867881
SNU-61,10296883,3.559313583941647,3.297226295658862
MSTO-211H,24748573,5.719931334372704,2.1297598550977
SNU-81,5479543,2.97701110816304,2.941882525291263
BT-549,2733526,4.582584043539932,3.8494584111575394
A2780,135423438,1.4521240670524396,1.7520933718982328
A-673,24772860,-3.1744597884682997,-2.1811459641373556
G-401,15953870,2.2768915791068483,3.1978067176075604
DMS 273,5738263,3.533950076223639,2.8968613369703924
BT-549,SNX-2112-bortezomib (250-1 mol-mol),0.8532729508269209,-1.4470205715288142
MSTO-211H,10385095,1.0224754227931234,1.3323885620948457
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616,2.0705025020543952
EFO-27,25062766,1.510659268863457,2.1786699300220937
FTC-133,11612883,4.310092339589411,2.7040822674063714
MDA-MB-453,11455910,-0.0078824359576409,1.334292619471186
FTC-133,23582824,1.291713189645836,0.7649122073114445
MSTO-211H,6918289,3.158366552983379,2.4167953553936052
CAL-51,9826308,0.5677925602140103,0.9368123287918217
OPM-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5033566295439995,-2.4522746537662607
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428,1.5290553103501971
NCI-H292,25195348,2.925898223014509,3.3428428148593428
NCI-H661,71466380,4.502023854991524,4.6104892720445125
SNU-449,17755052,1.8812917370069304,2.270030407566227
SCC-9,11977753,0.680369597029185,-1.1167250720687967
DMS 273,selumetinib-PLX-4032 (8-1 mol-mol),5.046947236193085,3.24351389699781
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116,3.9181010698611245
JM-1,carboplatin-UNC0638 (2-1 mol-mol),2.589326672729891,2.5126336028376257
OPM-2,56973724,2.552424788495835,1.4466433121540903
ONS-76,24785538,3.425081329750359,1.656319952697554
OVISE,6914657,-4.467384055269322,-3.716700109399917
CA46,7326481,2.91557869092902,2.5415366275490534
SNU-61,445091,3.84586130327939,4.092848317286099
SNU-81,387447,-4.728664972971387,-4.125880374158294
A4/Fukuda,613000,-0.1954730319333323,2.7389981943766704
JM-1,54143018,0.7319009489566454,-0.5453112379740491
FU-OV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2027157770718528,-0.8392010473550413
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911,-0.22693222378942937
NCI-H2009,11222830,1.732127254120576,1.800675355889805
Panc 04.03,25105715,3.6014191473601236,3.550197171368786
BxPC-3,3038522,3.5132521338876352,3.1134195475586255
SBC-5,2945648,3.183732803518487,2.85238348263508
SNU-449,6450551,3.816508101047544,2.681112546477121
A2780,4261,0.5678575604143293,1.3735144334662672
JM-1,54639665,5.005029028557516,3.026478419809284
MDA-MB-453,55508,3.100658329893645,3.307035645077651
FU-OV-1,vorinostat-navitoclax (4-1 mol-mol),1.2627597867759035,1.3330082067932967
OPM-2,71466578,1.093801721105574,2.4832315783463836
DMS 273,219104,2.8685320291275276,2.8489182599048206
MSTO-211H,36314,2.7056254754018,-1.6543942236642712
NCI-H661,135999136,1.375733620998009,3.751591003975621
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011,3.5387269483552033
A4/Fukuda,387447,-5.631039688913266,-4.801884104205875
ONS-76,65064,5.2757302482281005,4.986902841104105
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606,1.9030133288854385
LXF 289,613753,3.241655631161551,2.909044203160103
NCI-H661,25262965,-2.0298208680132253,-0.6625666767493382
LXF 289,6438330,5.338014468481796,2.4918956476709204
HSC-4,51037431,1.5211622982639597,3.14449272338381
HCC1143,ISOX-bortezomib (250-1 mol-mol),0.6900085602161256,0.5970592008016861
A-673,613000,2.3658771635142877,2.2588950051456864
A4/Fukuda,135421197,1.440002399326734,1.4995881848928962
G-401,tretinoin-carboplatin (2-1 mol-mol),5.235487615212222,3.726031297113942
NCI-H522,322968,2.453472191773609,2.6206228619891503
JM-1,702558,3.1195416036187646,3.899339467195846
NCI-H1623,60700,-0.6326390393669364,-0.2837053925493219
KYSE-70,71466578,3.801340757329347,4.508125307833801
OPM-2,969516,1.7213945625906069,2.3269721512501573
FTC-133,71751553,4.47121108066688,4.548455571202421
HSC-4,4261,2.7283942469645424,1.4923408679772234
DMS 273,60750,-2.8080851182888096,-3.054046724207796
BT-549,11955716,4.243153956403502,-1.7030311662855917
ONS-76,104842,-3.1760610756826826,-2.533476294261326
JM-1,54619267,3.2762986321752656,3.4370623228232065
NCI-H460,11427553,3.3912724357702873,2.8094778768823976
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037,1.6127908879963289
KYSE-70,3503,4.330341802091645,2.3423892792065013
LoVo,6505803,-0.2027234925460443,-0.941056478696461
A2780,123631,2.055120977987268,2.238705630074337
CA46,216345,3.098455032375494,2.86158764996401
SBC-5,216345,4.3270666561224935,4.030016280290049
SBC-5,104842,-4.617883126488141,-2.795358753735783
KYSE-70,3025944,3.9400169946897226,4.337831934342624
JM-1,16725315,3.055633956084052,3.338806846790409
KYSE-70,3385,2.7043091028991175,4.050462847502594
SNU-61,241158,3.885428513145571,3.544897128286719
Panc 04.03,44819697,-0.3269217472163675,0.23920916188071323
LOU-NH91,151289,1.7382502757713727,1.1533906441437458
SW1463,72193861,2.3780707386668563,0.8590308749528637
FU-OV-1,3081361,1.2672435670761582,2.4543336762350116
NCI-H2171,5311,-0.0981787470707459,0.7573435523880273
OVISE,15983966,2.4746719809654474,-0.024196368160309917
CA46,56649450,3.397645307363617,2.7895571601236258
G-401,135398516,1.567409789625541,1.6481125814745496
A4/Fukuda,285033,-4.063528792592557,-3.075337704075381
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546,-0.613006647598222
SNU-81,2113511,5.998073078967423,5.4849262513435635
SBC-5,984333,1.1242620116457585,0.2774592879777808
DMS 273,31703,-1.0453531837534489,-1.4375953925447291
SNU-449,11955716,-1.9372940063200903,-1.014092779945221
JM-1,156414,0.9517000986854224,0.5252136476807211
A-498,5746,0.9967598286589636,1.643813300635223
CAL-51,168313016,5.819136604546001,4.838330188630019
SNU-61,doxorubicin-navitoclax (2-1 mol-mol),0.8790870297518688,-0.6278591119110349
SNU-449,selumetinib-PLX-4032 (8-1 mol-mol),4.586042131351809,3.388655828338601
DMS 273,285033,-4.2902604104934685,-2.643785307052657
NCI-H1623,25227462,1.3835292391956049,0.6595208734128625
SNU-449,46199207,3.2102080061749665,3.1886461738083343
NCI-H727,54619267,4.766187279700058,3.9296125554395527
KYSE-70,2729026,2.877153539650856,2.701092791072049
JM-1,9866186,-1.392842627261666,-0.07080705706225332
CA46,9956119,2.2503821303322864,2.982956621951565
NCI-H1623,10302451,3.5735543079001553,2.8715297860868123
NCI-H460,119607,4.735621464768821,5.050381388374807
LXF 289,36462,2.912637639845359,2.589687147519856
HCC1143,208908,2.564266394778906,1.7788722608946026
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936,-2.771556810521901
HSC-4,10296883,4.12801319058873,4.126619793744269
NCI-H460,44819697,0.8384181776379687,-0.10376032004751051
A-673,644241,3.265724898737132,0.9678024818453477
SBC-5,55283,1.6476943611515316,2.9003594365242726
CAL-51,60700,-0.6497243984818711,-0.3439241557681669
NCI-H460,44819697,0.8384181776379687,-0.10376032004751051
NCI-H460,2113511,6.407699041859446,5.331511628328701
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.515412170291972
NCI-H146,44819697,-3.0409273944044672,-0.9457237132044285
CAL-51,2729026,2.5757432896171517,2.732605420468896
OPM-2,25262965,-5.528707504919602,-1.8255649007549624
BxPC-3,67156097,-2.0030489961064664,0.09480426871210262
SNU-61,11455910,1.387165489844305,0.905117054662638
MDA-MB-157,6252,-1.2956844965038024,1.4138960233221138
BxPC-3,decitabine-navitoclax (2-1 mol-mol),-0.3566314519475204,2.0525677393211885
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777,1.8684581676323833
MSTO-211H,5284616,-7.533473618112548,2.4317837135547253
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.5808934132682841
NCI-H146,11609586,1.562173805318663,2.5637694075909843
A2780,tretinoin-navitoclax (4-1 mol-mol),1.5980580193271057,2.179188829901288
KMRC-1,9908783,5.060189279561186,4.7857327673158645
OPM-2,3825829,3.9075204590636226,3.3056451300911585
FTC-133,439501,-1.0725688155870328,-1.9173954090253695
MDA-MB-157,73707398,-0.5856522541525173,1.4421404679147392
YAPC,71466380,5.668462841036745,4.7220520131302575
YAPC,81146,5.922853011724604,4.734652895241535
SNU-61,9935249,2.942554259952632,2.0749882417120964
FTC-133,72193861,2.4976681850124516,1.8981718728723813
NCI-H2171,3025944,4.816182739912449,4.123697155004041
BT-549,6918638,1.3825585614023566,0.6993619282999254
A-673,24180125,1.1732098097274752,2.443409492809619
KYSE-70,46907787,2.9670215892594793,2.1102050994074903
NCI-H2171,54678924,2.405018759443171,1.6879778140596755
FU-OV-1,15547703,4.297867355017808,3.2810908424953293
EFO-27,49846579,4.098108273885428,1.308997626975214
HSC-4,24748573,1.230311327364621,2.30610492933354
BT-549,10427712,4.3521452258648505,4.619103753444067
EFO-27,126941,-4.256911665013358,-2.4260787112366207
NCI-H2009,4096211,1.934112859371262,2.220115577205007
MDA-MB-157,salermide-PLX-4032 (12-1 mol-mol),3.2199843556039593,4.720620259120239
NCI-H146,135999136,1.6477982136645704,3.4041103612720156
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932,3.1770968570813993
SNU-449,2746,3.928036011173348,3.254323272054076
CAL-51,11228183,3.6770505489909007,2.4676606194452777
Panc 04.03,123631,3.678186856777378,2.423448346481991
MDA-MB-453,6184667,2.451074325070958,2.9978848019597386
EFO-27,6438330,1.8682975687900552,2.3955547700713766
NCI-H661,11497983,4.324872079299071,3.726591043550601
Panc 04.03,637858,2.9634699724220783,2.223055917627518
SNU-61,168312962,1.49910092402229,1.5693069077760393
NCI-H522,25183872,-1.6150957585419312,-0.981727008507495
A2780,6252,0.4918472463671758,-0.9368444301960343
A-673,15547703,3.0802315016781843,2.7082499113269374
NCI-H1623,36462,0.862958596391428,2.1656029603433353
MSTO-211H,44819697,0.327886174428457,-0.22898572566599995
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-0.9718406532556326
SNU-81,19582717,3.466001022974326,3.4312005593698642
A2780,6610355,3.3735704633901973,4.2234422600563155
SCC-9,119607,6.006958395758143,5.184871256453555
NCI-H146,11625818,3.4222174762792843,3.529897261757725
CAL-51,11178236,-3.674192911743539,-3.2803038010052585
NCI-H460,168312962,-1.8333752522095308,1.8719892537761536
NCI-H661,4788,4.879892558412017,5.4781456111524305
JM-1,4705,3.374089362448498,2.7403486486195514
LoVo,3634881,2.800959668083557,3.2092602179772927
OPM-2,11178236,-3.008129792299995,-3.4912268900419416
CA46,9884685,-1.0270691788705264,-0.17613036404166188
MDA-MB-453,44589607,2.562256212112598,2.9151508051479857
SBC-5,54454,2.279469523172582,2.588652833953798
LoVo,5311,0.3380696500116906,1.4227601134495833
NOMO-1,100016,4.546215242968586,4.901424275116938
CAL-51,71304818,3.0248956992793565,2.448167782874118
HCC1143,216345,3.8986832350959792,3.8494157984810125
CAL-51,54618164,4.021329289838694,4.110709694928535
NCI-H292,135398516,1.6270415918019412,2.2895831063543275
HSC-4,71466445,6.061667629347064,4.109732726502863
BT-549,51039095,3.595187367514741,2.7026001220946467
MDA-MB-453,26596,-1.0726693130426117,-0.42664766183909947
CA46,4259181,0.0375174782651609,-0.5602459253853969
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345,1.0111599225232688
SBC-5,9887053,2.384081187432928,4.001455686437998
FTC-133,25154868,4.81278236826852,4.554262862189425
SNU-61,44202524,1.623676041505741,2.0584498055269385
Panc 04.03,6914657,-3.724597953552904,-3.472917463747158
EFO-27,445091,4.884678811382666,4.456733677611011
SCC-9,54619267,4.260733417129102,4.209771182142777
LOU-NH91,3815108,3.3787088400125422,3.284735563361837
NCI-H2171,135875424,2.950178944342904,3.4527795622383675
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381,2.99735941376756
LOU-NH91,11404337,-0.9599092047687252,0.13073115834627302
SBC-5,5746,-1.5208844717109098,0.9655666220897988
NCI-H460,135440466,3.295247648571462,2.185396740452174
OPM-2,1242560,2.912152501304371,3.0541775304592806
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,3.215546029636707
BxPC-3,11364421,-1.186359589843585,-1.2834686846373682
NOMO-1,11626560,1.0628914473501356,0.5949349904145231
MDA-MB-157,5311281,2.9465431337253065,2.4836172404054078
LoVo,753704,4.37626239298451,5.061432983292727
LoVo,1317464,3.6287749925486743,3.096814685725207
LoVo,11626560,0.8234069861143318,1.929490203860425
SCC-9,60700,0.6764265945588348,-0.5154055403973303
YAPC,5351362,2.7486257978183812,1.5708076101175792
KYSE-70,24797083,1.8843278101436565,1.2372667637679229
LXF 289,65064,4.964411921317377,5.073523537733527
SNU-449,16736978,1.6431800441666105,1.6227308859747749
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289,4.231551295433129
CAL-51,3062316,-2.5625958708444205,1.6133825845338314
Panc 04.03,49793307,-2.352687994078586,-2.30882091717129
MSTO-211H,10302451,2.2723798321327826,3.099410528606091
A-673,54619267,3.9525164677601015,3.8338638312174256
G-401,448949,1.8289326894340776,1.8165863669916407
SCC-9,15983966,-4.042628093805887,-0.30318211407004614
CA46,3854666,0.2733202158609283,0.5559828107794254
SBC-5,42642645,2.1700569257248734,0.7151604421092189
FTC-133,6184667,4.171777093513536,3.1838468830574977
A-673,3543504,4.433549859321033,4.064374678074566
CAL-51,409805,3.8515087112009656,5.135481377890895
SNU-61,5287620,-1.5621550618200195,-1.8965277568833776
BT-549,6610216,4.341228931549091,4.3285328616601655
MDA-MB-453,44566777,-0.164341777615228,0.779240104958526
CAL-51,219104,3.260140555917495,3.8677984530141614
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187,-1.7594344582239867
A2780,65064,4.350950935999884,4.466403910598188
G-401,9803433,5.696660690430479,4.648096687256243
BT-549,11626560,2.6049019780447473,1.8941034911783174
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214,4.284829064193642
A-673,107970,1.5652885370840817,2.065715709835284
A-498,46199207,3.6222117747737057,3.2856597955692366
OPM-2,navitoclax-pluripotin (1-1 mol-mol),-2.4334437397089053,-1.8877860767885748
BT-549,11364421,-5.683704390961643,-1.2318719645014855
G-401,25195348,3.8836243061511215,2.938085068312142
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003,2.7277933954438947
LoVo,24901704,1.9806347162028537,3.339077624907576
NCI-H2009,11485656,2.228831542035607,2.478349877813171
NCI-H2171,1750826,-2.946975931831454,-2.625824675247458
MSTO-211H,5738263,2.0448017247583996,3.6399145860170194
SBC-5,2729026,3.0750341046070933,2.7271047095218512
A-673,60700,-2.9578260017137437,-1.1642761586279666
KMRC-1,216239,3.2937854483312172,2.311830776511212
G-401,7251185,1.5631627066286176,1.7765447565982038
NCI-H522,568763,-0.6787143148403639,0.07826130129884828
MDA-MB-453,52912189,0.0253127265648339,2.4754562508292386
NCI-H1623,637858,3.185553411157662,2.300180151303098
BxPC-3,65064,4.239552039257921,5.044792069530146
BxPC-3,44202524,1.2355479078044973,2.1280202168084155
HCC1143,10231331,3.1675049490504943,1.8484694040511886
NCI-H727,4917,3.0740580007272125,3.036522021384426
NCI-H522,46907787,0.5375692456309028,1.456006643708248
G-401,4261,0.8301994759372666,1.3170792995603748
HSC-4,46398810,3.0881815243810897,2.6521740800424336
NCI-H460,16722836,2.818869820371906,1.9004657953831108
CAL-51,107985,-4.126908547019261,-3.615512752860047
EFO-27,445643,4.157223404562412,3.9688143769653443
NCI-H661,327653,3.5614910429728295,3.1750198233404587
A2780,15547703,2.917961616739491,2.9466339221877846
Panc 04.03,11222830,1.7267772277517466,1.8370689829453042
NCI-H727,445455,6.030056890362138,4.536695232562405
A-673,72199292,0.9360047714765588,0.21778391468977493
DMS 273,2945648,3.171749675698132,2.403233232159056
SCC-9,6917907,-5.592045136043938,-4.647897577137841
CAL-51,72193861,0.6423702350358801,1.5705410825137494
SBC-5,5281321,2.671163534426493,-0.7241197451692039
NCI-H2009,10231331,-1.9302715463885551,2.3350618062813004
SCC-9,3825829,4.24505295528646,4.052198962910453
NCI-H661,702558,4.861012061293982,5.030783826413842
SCC-9,piperlongumine-MST-312 (1-1 mol-mol),2.236566574852554,2.0237428094944563
MSTO-211H,451668,4.9569649646478515,4.0427590014624055
A2780,9908783,4.382006664554736,4.303874846806022
EFO-27,44566777,0.6667958565864378,0.6572819990347099
SNU-449,11228183,3.721594588319689,2.3310881708103617
MSTO-211H,322968,3.0218271531726897,4.05003018990094
NCI-H522,135999136,4.552466214525868,2.8221337084953095
BxPC-3,375860,-1.018881063070817,-0.12268455790848452
FTC-133,46398810,3.783858454202458,2.4882968136453205
LXF 289,446155,3.7142968943868073,2.5194358838120157
NCI-H146,54619267,2.4574193717136663,3.8548929930139177
JM-1,400769,-1.2746733592438322,-1.4081037289986622
BT-549,5328940,1.7912058861852873,1.8348270330421792
NCI-H460,15547703,4.965379127843483,3.185471333336167
JM-1,10026128,4.426440879951995,3.4007568974132907
LoVo,327653,2.9108064375514604,3.314930749323853
HSC-4,5329102,2.7247882686097458,2.0442058403173067
BxPC-3,5460769,-0.1362128387149436,2.6366689246211927
SNU-449,148124,1.515559327544478,-1.206650077145471
KYSE-70,24951314,1.3178292218062186,1.5050940807443538
BT-549,11485656,2.9441987555380855,2.654415738303834
CAL-51,9866186,1.45916914556855,0.4791716190987599
NOMO-1,5278396,3.0205756000124775,3.0474197786336368
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257,1.2405599646083763
KMRC-1,42642645,1.142476115564406,1.1387210936040149
NCI-H460,100016,5.855223104671776,6.03480098653766
MDA-MB-157,25062766,0.4624374403471977,2.0201115223391097
MDA-MB-453,107970,2.0242856345207834,2.3854745506536528
DMS 273,16741245,5.579276049340643,3.601912248725345
BxPC-3,3689413,-0.056748072256038,0.3500755770316148
KYSE-70,25126798,3.963979956832577,3.7364695909245182
A-673,54678924,2.025744293137832,1.7437626005488738
HCC1143,25062766,2.2830484377909492,2.325621682085238
NCI-H2171,11625818,4.794880990749841,3.458306988466968
MDA-MB-453,2729026,2.974469204821206,2.7240420342568736
G-401,9933475,0.0956350981602405,1.519435061089935
NCI-H460,51039095,3.9314979002332535,2.7907489213823875
NCI-H522,219104,3.343081396349963,3.0189417408621013
NCI-H661,56946209,-3.6194559692185018,-3.623316791482651
SNU-81,568763,0.5116878508289208,0.0868075835718706
A-673,67291369,2.4007963238191854,1.9764413811576547
LoVo,3854666,1.417426416420887,2.2364916583619845
MSTO-211H,439501,-1.1644309958543906,-2.3268385884141485
SNU-449,285033,1.5882926770841097,-1.2697727373888759
CA46,6918878,-0.7300256707111569,0.6634417154599531
NCI-H146,71466445,0.6815814889300492,3.3592034022058215
SBC-5,10385095,2.1758850118167077,1.257767102756391
A-498,637858,3.4757595298108974,2.3083177810355546
ONS-76,11964036,2.0748582848578865,0.8527714990605115
NCI-H727,16725315,4.353817237787042,4.276211313005515
G-401,10427712,4.653472001336551,3.885413806594437
CA46,10127622,5.462644164632326,3.1176506540307782
SNU-449,25161177,4.378304661297746,4.2388980954330115
MDA-MB-157,49766530,-2.405889714389838,-0.1519061936299518
FU-OV-1,23582824,0.4003812349581704,0.7996154608776045
FTC-133,24180719,5.041424864241871,3.257641282864823
CA46,3689413,-3.563387503989764,-1.3751311567535769
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012,2.021411188699591
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-0.9718406532556326
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947,3.840010072573242
NCI-H522,6918638,0.2628749411775776,0.4786745174020308
EFO-27,10127622,7.049186817655218,4.528900636659977
MDA-MB-157,400769,-0.9429856644264992,-0.4461055667839516
CAL-51,54618164,4.021329289838694,4.110709694928535
LOU-NH91,9935249,4.429052878520747,3.3658367500837882
NCI-H727,49766530,1.5110740555461553,-0.123753412516177
A-673,9926054,1.7717409858597033,1.8249753784208393
HCC1143,5351362,1.6023771560954885,1.518389465946704
NOMO-1,54613361,-1.5441782746277026,-0.8855612651664767
JM-1,613000,2.2697515166000355,2.4940379446193455
CAL-51,49793307,-3.2015156477281193,-2.647697647931364
NCI-H1623,1750826,-0.130863987039663,-0.9707788386960127
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516,-0.0661211084087073
NCI-H460,107970,2.752075604137296,2.3498635795111715
SNU-81,JQ-1-vorinostat (2-1 mol-mol),0.90621526316067,0.6700664842017586
CAL-51,46199207,3.548155956826357,3.287680920369429
NCI-H2171,10074640,2.5219754676966435,3.029774958869025
A2780,selumetinib-navitoclax (8-1 mol-mol),1.1083480952702989,1.6035459178592317
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225,2.6935202886028513
JM-1,11238147,1.2374439058156688,2.0821230002675084
SNU-449,54678924,2.162306121493456,2.3212859355672957
NCI-H522,3854666,0.0482767863302698,1.5406835879526009
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561,1.4687207805414084
HSC-4,10427712,3.709601221495256,4.306436425031331
KMRC-1,10296883,4.079927671527966,3.8305987693201184
A-673,46907787,1.1836850249017303,1.3097866841983685
NCI-H460,67156097,3.7191617083219097,0.1318347329057082
Panc 04.03,11364421,2.200002813497647,-0.5946307764786735
A2780,57330099,3.934423580004946,4.082226183931312
KMRC-1,400769,0.144742351180573,-0.4351905141110992
LOU-NH91,25062766,1.8056251936091945,1.9085054355061204
NCI-H460,11175137,3.7005840280640374,2.694045135835053
HSC-4,124202324,2.961748327308983,2.592840377304524
DMS 273,46191454,0.2871755056280096,0.9237391884869486
LoVo,23582824,-0.7966748622900964,0.5955235405639385
FU-OV-1,24785538,3.56375796516153,1.7641904095287269
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883,2.631986588555368
CAL-51,216345,2.9520334452605637,4.05355683752008
KYSE-70,11427553,3.0124804015996185,2.9026368665463265
NCI-H2009,decitabine-navitoclax (2-1 mol-mol),4.93341873674704,2.1930816830931747
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898,2.0422515945018334
A2780,54618164,3.641335469190071,3.820602836714236
SNU-61,2708,5.501133929338057,4.162875481667205
CAL-51,702558,3.5144984342436563,5.340265650740536
CAL-51,11175137,1.2330676481368064,2.5366403526854517
OPM-2,119607,4.667002181538018,4.534400513630314
BxPC-3,4096211,0.9773140949236826,2.1497618739750353
NCI-H146,2749,0.7789788955457625,1.6347003927998451
LXF 289,16725315,3.2486511295045677,4.088860603829702
HCC1143,4261,1.976797651434544,2.0221773968679075
SNU-449,11152667,1.3844218204303944,-0.4727889357308361
CAL-51,52947716,-4.729660133739893,0.22460479819061585
SBC-5,4477,-0.6853772163114386,0.5534054144758772
A4/Fukuda,44819697,-1.7397384839387715,-1.2265630678180321
NCI-H2009,54618771,-0.2233577251443086,1.431656334909589
LOU-NH91,2733487,6.3296049393179485,6.068319694566143
G-401,erlotinib-PLX-4032 (2-1 mol-mol),3.757739778609172,2.9371930240324264
NCI-H146,89928392,0.6603214053079605,1.2385082553152535
SW1463,10231331,-1.1566445252598772,1.5877441121049989
MDA-MB-453,11977753,-1.828846421242697,-0.5803044526472669
HSC-4,445643,4.123722857917103,4.074852169184883
EFO-27,42642645,1.7670896576814532,0.949992312231386
EFO-27,crizotinib-PLX-4032 (2-1 mol-mol),3.36614562688719,2.1976231956903676
BxPC-3,5311281,3.739267965753581,2.3806998401521056
SBC-5,44185566,3.097813648169307,2.518426193588825
LOU-NH91,5351362,1.6461408289790205,1.4865245058578054
EFO-27,50905018,5.404252445104634,4.514184766299119
MDA-MB-453,374536,3.68630764751743,1.6182403933425398
G-401,25262965,-3.9564581939856582,-2.099413051303603
CA46,2749,1.009648399882346,0.7491604654175609
SW1463,387447,-4.88012723681038,-4.00182679106771
A4/Fukuda,8515,2.244185004641864,3.3020680677915664
NCI-H1623,24901704,3.7829050158791064,3.302652388365225
HCC1143,71680916,4.5741598898507565,4.778658259369628
YAPC,54143018,2.4773688492488892,0.8380930001283577
FU-OV-1,49793307,-0.2872221589202163,-2.524646800358066
Panc 04.03,168312962,4.832441653848414,2.2591698463241023
NCI-H292,11609586,2.9930145326420146,3.007136701090764
NCI-H727,25150857,2.574637897952517,2.343011809209142
NCI-H292,6438330,2.681078996624105,2.5168360833508974
OPM-2,12003241,-2.9738714531294232,-1.490075886608261
MSTO-211H,BRD-A02303741-navitoclax (2-1 mol-mol),0.3230364092955163,2.496746118409082
NCI-H522,151289,0.0217168787144745,0.7697298101904363
NCI-H146,docetaxel-tanespimycin (2-1 mol-mol),-0.2232334336717333,-3.4333253328740483
BT-549,11238147,3.2866911979765803,2.9582055033767514
OVISE,9866186,0.5630702781820192,1.0559308269479217
HSC-4,6918328,0.4827098957230251,0.15721194974334465
NCI-H2009,135411,0.2253946709705592,0.7911115904716738
JM-1,10385095,0.4126425157623973,0.7960071674393313
CA46,45279963,3.66447519946476,2.7118749209555673
A-673,44197249,4.247235211402652,3.245251465616753
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069,1.458401207925401
NCI-H661,135440466,2.665416885593315,2.373101806148656
G-401,168313016,4.483065775660181,4.286388933283695
BxPC-3,168313047,2.402437406788064,2.427059861128947
NCI-H661,2746,2.7828270451310786,3.234995004709534
FU-OV-1,11612883,1.8669069183790803,2.997291737841373
DMS 273,53232,2.0931635545137266,2.5425204461060567
BxPC-3,9903786,2.126136875029704,2.882845239516567
NCI-H661,11625818,4.41260734243293,4.339685192721972
NCI-H522,16659841,2.9113601324358287,3.1145864818232933
OVISE,53232,2.4849914286727426,2.996467562696446
EFO-27,135440466,3.806006891786582,2.315957350550252
SNU-449,5746,3.348109332475853,1.69761579776291
CAL-51,969516,2.948027689121256,2.7804330713134933
FTC-133,11238147,4.273178384451577,3.067927588918408
NCI-H522,24748573,1.6076101041751254,1.8506597948308143
MDA-MB-453,46224516,2.0758190952131215,2.3185629985565788
LXF 289,6918878,2.1668969721619833,3.033767768371042
OPM-2,451668,-1.14063259637223,-0.2454946778346811
HCC1143,3689413,0.0716522323698814,-0.07162468133492869
SBC-5,135398744,6.447254342428179,6.289242531287532
CAL-51,227681,3.694103991631346,3.511040523212251
CAL-51,5287620,-2.338247824560234,-1.9804267323332343
A2780,3062316,2.0817886994426704,1.239442886390136
SNU-61,2858523,2.9582475566417195,2.994460435654977
SNU-61,54649381,3.9147762798202863,3.5590393856364604
A2780,10385095,0.5603604864283975,1.0496771672270837
MDA-MB-157,11152667,0.7570225590856333,-0.35021550015843145
ONS-76,400769,-0.3525004301248006,-0.3639420944164232
A-673,409805,3.491559756034339,4.283707652102121
SBC-5,10184653,2.5351322042771356,1.2392223655968027
NCI-H727,66577038,2.8647542032772604,2.98877426761594
A-498,6505803,4.020571046679738,-0.10167203745994449
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045,-2.874475667616638
NCI-H522,2708,5.085998334781725,4.105315060047615
BT-549,45279963,4.047021813577569,3.912255951494337
LOU-NH91,25183872,2.2713164299079627,-0.602394193977617
FU-OV-1,24797083,1.8707999880079529,1.3383673405047196
SNU-449,44607530,1.456313243054954,1.6364124757047598
MSTO-211H,1566236,2.167071233614174,2.726978593323553
JM-1,24951314,0.1302219808330525,0.17547137380667416
EFO-27,53392493,1.9151019076026368,2.907424278252861
FU-OV-1,16725315,4.930691545287574,4.389711599374194
NCI-H1623,12003241,-0.4868602659209724,-0.5197724839260559
SBC-5,148198,-1.371938553790338,-3.713904452013184
BxPC-3,17755052,0.5794893802598977,1.7885883705900882
SNU-61,11485656,2.115016827038527,1.949384644479825
LXF 289,2729026,2.289348740995074,2.904023830676055
MSTO-211H,654092,-1.1984807631004837,-0.21385330844887396
A-673,5291,3.269854942504113,3.2900027901386903
LOU-NH91,4705,2.8449970854381945,3.3486461787205264
SBC-5,24753719,5.823724927288436,4.204294621342308
SNU-61,675434,4.254516948181055,4.33133740118693
A2780,5278396,2.562980728115376,3.2929423230298274
DMS 273,122327,5.509571347430681,4.024445926915582
A-673,9884685,0.1604809562987641,0.1205020238510354
NCI-H1623,16722836,1.0817030477122866,1.6864369548492966
NCI-H661,67291369,1.7470049727917394,2.999049547493789
A4/Fukuda,135398516,0.099848878431286,1.5054554447870112
A-673,568763,-0.0608974572236531,0.05752897193248032
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115,3.542382747747613
SNU-81,11178236,-8.196337700198193,-2.50465010878473
OVISE,navitoclax-PLX-4032 (1-1 mol-mol),-1.1204888715090109,1.802817478072852
A4/Fukuda,46215462,1.453707580765341,1.3084311168968858
HSC-4,6252,1.1187983220422375,1.660606300474901
HSC-4,3062316,-0.6194675763886993,1.0265710114401903
NCI-H1623,57330099,4.486652982197453,4.2887293546880185
BxPC-3,23635314,-1.513116034089344,-1.029595046228444
OPM-2,46943432,-1.735277326796896,1.1252087205349186
FTC-133,11175137,3.295108533345337,2.640751592762375
SNU-61,100016,6.106397388471953,5.660762710595133
MDA-MB-453,446155,5.408001660467943,2.5592068875611718
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194,2.3898079811731194
MSTO-211H,168313200,3.954855187852925,2.71031008760595
LoVo,2729026,2.166128688763036,2.6994655531410574
FU-OV-1,73707398,1.0047751906041116,1.4786450817268884
LOU-NH91,44241473,5.33179348194517,4.878302369799301
YAPC,135440466,2.1529261418392807,2.297488934527059
KMRC-1,568763,1.1483170277588293,0.5180304273499688
CAL-51,656346,0.8466306406200714,0.9244660344204507
MDA-MB-157,327653,1.3811083957143218,3.060829450839776
NCI-H460,107985,-2.632533954936978,-3.23715139958537
NCI-H460,135875424,3.211754300989152,3.943284421130436
BT-549,119607,5.663531776682701,5.418245472930574
KYSE-70,4261,1.9447398866595849,1.7075455834412505
CAL-51,44543605,3.919885801001582,4.095626795873898
SCC-9,44566777,0.4714703461280546,1.1223509031737835
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783,1.8353857432914669
EFO-27,10322450,4.618987367546035,3.9109793633004752
LoVo,452548,-1.7762082467733018,0.3476365613532779
G-401,24821094,2.5559581237528097,2.951706847645066
Panc 04.03,docetaxel-tanespimycin (2-1 mol-mol),-0.4013709222669032,-2.4546262423458565
KYSE-70,135999136,5.194226724950964,3.5082431410920436
NCI-H146,6438330,-0.4558524131736901,1.7183047448355788
BxPC-3,31703,-0.5929664629875476,-0.7796150283927765
Panc 04.03,5470400,0.9135030177256964,-0.07147045582760318
KYSE-70,25150857,2.5963104301055258,2.575872421121635
OVISE,selumetinib-piperlongumine (8-1 mol-mol),3.917327807535022,3.148001058801621
A4/Fukuda,439501,-3.252400391503616,-2.222380588969267
SBC-5,107985,-2.339881885950972,-3.6307526335814653
NCI-H146,25227462,0.2247724046939956,-0.4090620533609834
JM-1,44491742,3.590859136704876,3.778206383661892
YAPC,6505803,-0.1975849276423945,-0.8689033045774047
MDA-MB-453,10113978,3.193218839681212,2.926656581986768
A-673,16038120,-1.140194872712738,0.5638541633214325
FTC-133,675434,4.640800834602054,4.542603529432773
MDA-MB-157,439501,-3.062684000428755,-2.037475294816103
SBC-5,10074640,3.660613951501144,3.021220696656221
DMS 273,3689413,-1.7704206659692223,-1.3454467177414688
SCC-9,36462,2.4622585602605493,2.444133881181599
NCI-H1623,46843906,3.212648418277938,3.340736527841151
NCI-H2009,676352,1.803439035619831,2.3103257481717354
CAL-51,387447,-3.720200693098244,-4.403045035439966
SNU-61,navitoclax-pluripotin (1-1 mol-mol),0.1014096267424324,-0.8392897679359389
CAL-51,44632017,0.9975947899898204,1.3376135047206419
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122,-0.5812528052867257
DMS 273,9936388,3.4086707637717883,-4.535145572190025
NCI-H1623,24180125,3.727544824819635,3.089033510826062
NOMO-1,969516,2.327280884248625,2.1773273994144837
A4/Fukuda,1750826,-3.1003590099134284,-2.8899424378063934
Panc 04.03,5281321,2.674318568781228,-0.8638578801894288
FTC-133,176870,5.80195413779655,3.74811688155132
CAL-51,10113978,3.4506321601115397,3.280064140401177
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193,2.495909291736288
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566,-0.1307527649966883
A2780,3385,2.4446535707127537,3.1944713063561316
DMS 273,45279963,3.8289869697511527,3.1113642590345294
OPM-2,11609586,2.7966274513563496,1.805872736887841
NCI-H1623,26596,-1.1542368606327895,-0.9480989930778593
SW1463,5479543,1.0422897086412093,2.9041242045206492
SNU-449,53392493,3.0071956547718113,2.742944557892522
Panc 04.03,11178236,-2.395899374087587,-3.217173190834149
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344,1.197480143120077
OVISE,BRD-A02303741-navitoclax (2-1 mol-mol),0.9537570528694392,2.4456166669432364
NCI-H460,9866186,0.4176494313944011,1.1146032743061982
FTC-133,53232,1.7186310962422595,2.710447478650498
BxPC-3,216345,4.279216843902863,4.261315613473715
A-673,10296883,3.758044639987347,3.4657824613666683
ONS-76,11178236,-3.26201925681368,-3.057358311424908
CAL-51,25062766,1.9168321284868295,1.882188496033239
NCI-H522,6852167,2.4506568165817777,2.2301846191023698
SNU-61,72193861,1.1230875557226898,0.9254267395107988
ONS-76,vorinostat-navitoclax (4-1 mol-mol),1.54700333580169,0.9028666005251408
BxPC-3,3543504,4.240175882152398,4.510672429983207
NCI-H661,73707438,4.487630336801632,4.03196722416497
OVISE,638278,1.1296919637825429,3.272465953290222
A4/Fukuda,36314,4.126705075384559,-1.8085893715482486
SBC-5,10127622,7.037598772691409,3.544850495276492
MDA-MB-157,selumetinib-decitabine (4-1 mol-mol),4.44139235410904,3.840678569759378
BxPC-3,49766530,0.5943123243750338,-0.5206558905273413
LoVo,54143018,-0.354466194309244,0.38881220430524804
BT-549,44589607,2.161067974853105,3.070154968042685
LOU-NH91,3136844,4.41334270983783,4.528244471242581
OPM-2,5311,-0.071810443528602,0.46239509258245043
G-401,JQ-1-MK-0752 (1-1 mol-mol),0.1350272017197765,1.2187944908869002
HCC1143,676352,2.389016147507623,2.106283548764887
Panc 04.03,11657048,4.4356176445581,4.214682289945247
NCI-H661,navitoclax-piperlongumine (1-1 mol-mol),2.7076431504633676,1.9296216508613102
DMS 273,doxorubicin-navitoclax (2-1 mol-mol),-0.5717172949913683,-1.6290599445262053
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807,1.725988244100829
NCI-H1623,374536,0.6337427379168257,2.1865438271969326
SNU-61,3825829,4.102120147241808,3.7098775307711214
DMS 273,56649450,3.5073695444545288,3.0379632311057985
CAL-51,24785538,0.7720267524795773,1.7843345171589005
OVISE,16038120,2.1825815777023965,1.184356221173938
EFO-27,6918328,-0.3264411901724555,0.35141144087222165
FTC-133,3025944,4.352563236352026,4.366010303913462
A-673,89183176,3.363943107585485,3.610005943423528
KYSE-70,123631,1.697265417228948,2.3771667104858736
MDA-MB-157,441298,1.9245422363016824,2.451371541975442
A-673,156422,4.078876073319714,3.498989226309557
BxPC-3,676352,2.25430531813019,2.011134553400558
HSC-4,25150857,3.233332545340528,2.709086109669025
G-401,24856436,-0.0141865957174665,0.25971073722862276
MSTO-211H,49793307,-4.316049670445352,-2.1407330632270583
OPM-2,11485656,1.3184852346481954,1.5866868068741775
HSC-4,208908,1.4999275809756432,1.7143592892058988
MDA-MB-453,54613361,-2.035930507333412,0.45306944080369627
G-401,serdemetan-SCH-529074 (1-1 mol-mol),0.8425945982642317,1.787666508833421
EFO-27,44589607,3.0601109795549295,3.0729267489901413
SNU-61,44493528,4.287806417412906,4.267508330819049
G-401,11152667,0.9519757620011424,-0.9555729754301493
NCI-H2009,5287620,-2.745575302534365,-1.8726359726728041
ONS-76,23725625,4.840348822045759,4.863376552615075
CAL-51,44620216,5.469091994130916,3.9254830854438745
NCI-H460,9903786,4.057661845653794,2.77699668186589
A-673,11214940,1.1675505170406824,1.465767955006722
A-673,24964624,2.426022149354347,1.807490289411855
BxPC-3,9866186,0.8001699279354296,0.9146025956432423
FTC-133,25062766,3.8237771334178903,2.0734192965118217
HSC-4,42642645,1.8060847122685193,1.0005223820752531
HSC-4,11178236,-3.2670379451965164,-3.1571386642268378
HCC1143,JQ-1-vorinostat (2-1 mol-mol),1.5570491988867368,1.1449540884489202
NCI-H2009,selumetinib-UNC0638 (4-1 mol-mol),-1.7113919065901229,3.1953431298788306
MDA-MB-157,selumetinib-MK-2206 (8-1 mol-mol),3.246099259686085,2.072674722289401
NOMO-1,46843906,1.7610241193794407,1.352166527360278
NCI-H2171,6917907,-6.363958938419671,-5.329929135444981
DMS 273,11707110,5.189560989731051,1.2367574990714403
LoVo,6918328,-0.3156299102516719,0.19672569442056712
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717,3.1451620813490497
NCI-H2009,44632017,1.0717713653211387,1.5936007479135426
DMS 273,11626560,1.283315066012986,1.326003562017311
MDA-MB-157,11317348,1.0421206228140214,2.81973831904577
A2780,5311281,0.918852428114819,2.3587518459172427
DMS 273,2113511,5.781557942421417,5.36168232510151
LOU-NH91,10184653,1.5324310696398793,1.6447523781439157
BT-549,selumetinib-navitoclax (8-1 mol-mol),4.705621989339038,2.085577528231794
Panc 04.03,73707398,1.757833710000806,1.6320496548155572
JM-1,JQ-1-navitoclax (2-1 mol-mol),-2.0715419523140883,-0.3621549446611992
BxPC-3,11455910,2.77826122800999,1.4845829339079535
MDA-MB-453,11955716,-2.2213534191245303,-0.9805831510718839
A-673,navitoclax-MST-312 (1-1 mol-mol),0.824497586093143,0.38014465779508405
NCI-H661,3634881,2.923822089210327,3.3159458300390683
NCI-H460,5281672,4.99885948312363,4.751264311402818
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808,1.521774906038643
KYSE-70,4259181,-4.187670573846372,0.29653965005328603
BxPC-3,2756,5.8394588105914105,3.6353701190332925
HCC1143,24901704,3.259585605807663,3.2854201620601953
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374,2.246124120773736
CAL-51,5470400,4.528848471588079,-0.360995261173483
JM-1,10296883,2.092198976716966,2.7234121455244673
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176,-0.5974252581455444
NCI-H146,46199207,1.7925573568525552,2.8065106100407866
OPM-2,448949,1.278414281383,1.2940029038851808
NCI-H146,216239,1.510222966819436,2.1507658596183097
HSC-4,9903786,4.262681016067309,2.8412785087648924
ONS-76,57330099,4.261013423315652,4.1398012556861525
NCI-H522,148124,-6.241132033807486,-2.5775155947144293
SNU-449,156414,1.8120811787876097,1.8657360884635248
NCI-H2171,2746,1.1013983502046127,2.2179832364347973
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268,-0.2824706540812413
LXF 289,135398744,6.087135496005038,6.4594104931500205
SNU-449,3689413,-2.168376107627999,-0.28553596966846934
A4/Fukuda,5351362,0.320845740356061,1.0490606302165022
A4/Fukuda,446155,1.0805751863544764,2.4912842048910395
CA46,151289,0.6780663351050565,0.6694049626332768
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984,1.138295634124352
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525,1.8602352196300445
NCI-H460,11625818,5.428588497019925,4.197951065734793
A2780,119182,-2.871948238792312,-1.963555230501196
ONS-76,10385095,1.1655527010487017,1.3024209084330016
EFO-27,51037431,5.317639691280149,2.976012307491394
A-673,72376,-3.645473298633041,-2.770607935814033
MDA-MB-157,24748573,1.7707431454067368,2.1478685724746476
JM-1,6610355,3.6312795132079136,3.928677378820048
EFO-27,44819697,-1.290536172530674,-0.5970295445554746
A2780,5702613,3.197014181878355,2.5501404539608323
A-498,25102847,3.3376740856950335,2.6130930495560993
KMRC-1,3634881,3.321374403116886,3.1621930998054757
OPM-2,3081361,1.5210485339307265,1.417576250501124
LOU-NH91,3038522,4.554088179549466,3.331323864478631
SNU-61,216239,1.9834133881004128,2.052186074227248
FU-OV-1,124202324,1.4335087059128786,2.7726334595377637
NCI-H292,72193861,2.2952018559260363,1.9983611200938685
MDA-MB-453,53495165,1.832682106227088,0.37963209336968035
NCI-H2171,31703,-2.460746582121975,-1.100604053051687
NCI-H460,2729026,3.0609463870825926,2.6488688645324006
SBC-5,9868037,1.591902673624677,3.257640528694538
LoVo,44632017,0.6073588127957028,1.3305649068218002
JM-1,25262965,-2.478831797463893,-2.460626222899229
SCC-9,148198,-2.735497552895971,-3.4013674381504653
CA46,89928392,0.0283947615438792,0.3784123829076481
OVISE,5566,3.518034595538079,3.12923549089022
HSC-4,5278396,3.3910828172613128,3.7085979639906412
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388,0.6885296245836088
KYSE-70,4788,5.890959200463747,5.568073246949586
SNU-61,serdemetan-SCH-529074 (1-1 mol-mol),2.1746130433144386,1.6551760346302444
Panc 04.03,374536,2.376032280196277,2.674045686336843
NCI-H661,20959075,-3.3600823520668306,-2.5310568211837206
LXF 289,3543504,4.042070583449167,4.456611328576251
SNU-449,5287620,0.008240040829162,-1.7618376324345337
HCC1143,11719255,3.553533872223464,3.5345627479682014
NOMO-1,54618164,3.731990472759892,3.7142837091577237
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889,1.2770697116186855
NCI-H1623,5311,1.5946462199665867,1.6170871480986946
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.4077885273394284
LOU-NH91,216468,5.562373540734892,3.6219676291864324
JM-1,9915743,0.8499678141273637,-0.025723079649509675
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426,1.8715941678205446
NOMO-1,107985,-4.118574275669005,-3.93509056369157
JM-1,135423438,1.5495237102322077,1.005593504940254
A-673,24856436,-1.1403661815810562,0.10685462599385433
CAL-51,5282054,3.552468823116285,3.8402080126257796
CAL-51,11178236,-3.674192911743539,-3.2803038010052585
G-401,6252,-0.6004387834343344,-0.4948756392184992
KMRC-1,4261,3.216149224144429,1.5689242162430208
MSTO-211H,54454,-0.190602208325988,2.501439756414484
CAL-51,4917,3.122174268556499,3.066750050308745
HCC1143,54649381,3.828405406955801,3.9067608783666965
EFO-27,25262965,-3.442895730672298,-1.656217615114612
NCI-H522,54626689,4.6269731577498066,4.527888735941118
KMRC-1,123631,2.4243478642730634,2.030453780166976
JM-1,JQ-1-vorinostat (2-1 mol-mol),-2.067527251050835,-0.4640472631565307
MSTO-211H,6438330,1.6419113469823416,2.1915203228561166
CAL-51,446155,1.9002286289262065,2.7977793055577367
MSTO-211H,25126798,3.885175037199499,3.960277524209462
KYSE-70,54626689,6.762622459467938,4.48077036115582
FTC-133,navitoclax-pluripotin (1-1 mol-mol),-1.324010652875928,-0.7017594224492378
CA46,4705,3.1649236354970154,2.8694739494418644
LOU-NH91,36314,-6.12634068503974,-1.2661083542731526
OPM-2,49766530,-3.767684481967312,-2.2016836672798425
NCI-H460,135411,0.3374737909082799,0.6939523056069592
NCI-H2009,6623618,3.0922058987418315,2.391725480575125
KMRC-1,44185566,3.110367208302614,2.446743168658877
Panc 04.03,9933475,2.3468691227324965,2.043053575466018
NCI-H146,25105715,3.2144396386290617,3.169242943458311
SBC-5,25062766,3.305997596539037,1.989183252358597
G-401,11364421,-5.069536717957333,-3.192980873894141
OPM-2,1285940,4.143301448340403,2.917731063543152
NCI-H661,46843906,3.609730466041,3.053303637007838
JM-1,selumetinib-piperlongumine (8-1 mol-mol),2.3811879474866093,1.9327390092407706
NCI-H292,selumetinib-MK-2206 (8-1 mol-mol),0.2769010439937888,2.635983647653283
ONS-76,656346,2.4725060186946974,0.8288703034895423
A-498,135421197,2.4500558267656873,2.329209482821501
YAPC,5280436,4.973863444979394,3.520360938400478
NCI-H522,53481919,3.906372094667401,3.6516606145909933
CAL-51,448949,2.479839067238928,2.0564200204496546
MSTO-211H,JQ-1-navitoclax (2-1 mol-mol),-0.1744059770900167,0.9112428022397557
NCI-H727,15953870,3.6175866373148713,3.1493724806485925
A4/Fukuda,4378219,1.9024946719152895,2.0271843349686005
ONS-76,374536,5.32668572402577,2.002183771421876
HCC1143,387447,-2.8902460626215216,-3.7462094642878587
A2780,navitoclax-piperlongumine (1-1 mol-mol),1.0612869409921282,1.3815833318847397
OPM-2,3543504,2.699241331915609,3.736570350706121
G-401,54618305,4.431468655886698,3.9828024310050627
A2780,54649381,3.634529154077109,3.5290088578430674
LXF 289,5287620,-2.3080718171081385,-1.8834530139445598
YAPC,637858,2.16601707981449,2.099210964191041
NCI-H522,9915743,1.083108246388964,0.9155664310460943
KYSE-70,25183872,-0.2407157689495178,-0.5672621577263427
NCI-H522,56649450,4.1349782138767655,3.202914697978161
OPM-2,52947716,0.8847701060718332,-3.250839877183756
SBC-5,124202324,2.6085939591802307,2.728901395772846
DMS 273,2742550,3.72774264414297,3.2221827445899422
NCI-H522,BRD-A02303741-navitoclax (2-1 mol-mol),5.562601250875811,1.6916645058804776
NCI-H522,44491742,4.766943404170333,4.185965920560104
MSTO-211H,3503,2.7854032891391163,2.4135552477563653
FTC-133,10427712,4.710340548147587,4.321715268596275
SW1463,56946209,-2.6004240108086187,-3.9639524706558196
KMRC-1,11178236,-3.5821993315226175,-3.2419721436768265
NCI-H146,5281672,3.80713040102785,4.254715633234927
SBC-5,16038120,3.1431644252796835,0.9388129194187402
NCI-H522,421610,1.9391714098470076,2.743167619318372
DMS 273,9866186,1.1265446059819233,0.5972119990777935
SNU-61,11717001,3.914635952460324,3.9382035375285023
NCI-H522,JQ-1-MK-0752 (1-1 mol-mol),0.1872499419058635,1.4202017385204786
LOU-NH91,44137675,3.1585262513685612,3.764616226917812
JM-1,5335621,3.4974928376934766,4.021735549129781
CAL-51,444795,5.053001195278548,4.568589717673257
SNU-81,68056272,2.81466177200511,3.301658064139628
MDA-MB-157,23582824,1.002360199735323,0.6018470819651381
CAL-51,44185566,1.8630594392382311,2.6035079419804132
MDA-MB-453,54618771,-0.4179555738274852,0.8985461328601306
MDA-MB-157,16038120,1.7351596622267822,1.0324710059037536
OVISE,44589607,3.8530354372246394,2.9338465637079825
LOU-NH91,navitoclax-MST-312 (1-1 mol-mol),-1.3828767553270485,0.9913139359010793
NCI-H460,400769,-0.4007490431715684,-0.5365172798333921
SCC-9,5460769,4.655053652221148,2.6828165997893594
MDA-MB-453,135398516,1.6443590350340722,1.9338612631202643
OPM-2,444795,4.04932788863876,3.3544543413788115
MDA-MB-157,navitoclax-birinapant (1-1 mol-mol),-3.5674569438027977,1.4045133846756934
OVISE,navitoclax-MST-312 (1-1 mol-mol),0.1298249702458385,1.0936928131263906
HSC-4,11656518,1.5757846986297326,1.9120817258396425
MDA-MB-453,navitoclax-pluripotin (1-1 mol-mol),-0.3400363144819007,-0.7453295367230582
G-401,3062316,1.3877203939609295,1.3131084589211302
SNU-61,16013152,3.3306050431250056,3.7269625459146734
NCI-H292,4259181,-0.3596950747779806,0.32190365867776277
G-401,6918638,0.0373379560261908,0.171571748891307
NCI-H460,53232,3.485336782178725,2.776235944284636
NCI-H292,navitoclax-pluripotin (1-1 mol-mol),-0.7245377190748261,-0.7337307509534251
HSC-4,262093,2.780665409693215,2.980556750553205
LoVo,100016,6.001395250082881,6.183815850999005
OVISE,2729026,3.0624747536258843,2.7119941785798902
SNU-449,46174525,4.694645250518289,4.288215032477902
MDA-MB-453,25102847,3.185871702253412,2.2698973973445398
NCI-H661,selumetinib-piperlongumine (8-1 mol-mol),4.143402820216487,3.269632710483358
LoVo,208908,1.8298234127328137,1.9998167114505083
DMS 273,36462,2.158918041886743,1.4763921590388713
SCC-9,252682,6.244434841835944,6.427306550065842
CAL-51,3689413,0.5709426612715743,-0.01466212853259396
ONS-76,5328940,1.5304760606777814,1.528201528989153
KYSE-70,46199207,3.0458734214111436,3.051175631221132
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225,1.1840456210463595
NCI-H727,16720766,2.0944103672723577,0.7559247858163605
CAL-51,16741245,4.222373420591208,4.206463052882181
HSC-4,23939,4.494005895197972,3.9288282453544183
LoVo,60700,-0.3967380120150421,-0.47806222447544927
MDA-MB-453,25262965,-0.03783703480807,-1.2698618183621324
A-498,374536,-1.3715174839162405,2.6227672451987143
SNU-61,107970,2.0644711824277757,2.143199089432786
G-401,702558,4.958816468985481,4.499264547773466
MDA-MB-157,tanespimycin-gemcitabine (1-1 mol-mol),-1.0230607950179071,-0.49468015873703886
NOMO-1,16038120,-0.1786929053902652,0.1910932506283055
HSC-4,3543504,3.922868331711394,4.174034382623206
NCI-H460,vorinostat-carboplatin (1-1 mol-mol),4.479996249659036,3.244409051762004
SNU-61,10410894,3.2150759349666176,2.916189493048659
JM-1,2746,0.8560843341026924,1.8662946856889968
NCI-H2009,15547703,2.9018345982556935,3.0689022554593293
A2780,246676,4.314588687253318,4.092847825940943
CA46,135398738,2.145043320547598,2.32512174785468
MDA-MB-157,55508,0.9028127001821934,3.440549388633942
Panc 04.03,71304818,2.709197405012258,2.6012017443420272
MDA-MB-453,53301938,4.664434739240087,2.785909770020353
A-673,46843906,1.5511639515888018,2.0437570144934125
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384,-0.30009769650115325
MDA-MB-453,3543504,4.170014094465671,4.131767050542817
NCI-H2171,5470400,-1.4637445210918176,0.14399702453879906
NCI-H292,25062766,1.6798511870535655,2.089277885907324
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.642270346910352
A4/Fukuda,16736978,-0.5754825114210159,1.18419772164495
JM-1,2749,0.0460059123026362,0.8445593492835534
SCC-9,46215462,2.815249887965138,2.1918645136559105
SNU-61,24821094,2.5022209832597757,2.893859675314817
LXF 289,44493528,4.295099384269069,4.488452707755935
KYSE-70,54649381,4.140433754758901,3.919988224314725
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603,-0.3931265482563318
SNU-61,9826308,1.2155896819085543,0.12846665734067972
NCI-H522,49766530,-2.92412408259348,-0.9665517029907689
HCC1143,44493528,4.485488370266477,4.380443894241437
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555,0.1385250982935661
CAL-51,3081361,1.780158758130264,2.2200530050744836
DMS 273,2746,1.8465116882146249,2.233607591936253
HCC1143,5282054,3.2164949694146237,3.731391418748891
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594,-0.7672780745918266
SBC-5,644241,3.9213876276885458,2.2627948165497003
DMS 273,702558,5.649496210085508,4.223597515942786
NCI-H661,25183872,-0.013752841490686,-0.7359680883466431
NCI-H1623,71751553,5.091527890142487,4.512321637131656
SNU-61,10322450,3.828611192492266,3.434043474287891
YAPC,44589607,1.444383642816813,2.9910521720258747
FTC-133,426756,4.37678677221598,4.323507375176502
DMS 273,25062766,2.819032107658894,1.7292880949238174
KYSE-70,375860,-0.042936769343065,0.1570429688283296
NCI-H292,6623618,2.2662127680014708,2.341390374379559
A2780,3634881,2.2771511965432767,2.92288078047381
FTC-133,11427553,5.52425857278767,2.9872171268067316
FTC-133,613753,3.41594619216373,3.2789883807448423
DMS 273,5978,-4.4169630962529896,-2.903342576018994
MDA-MB-453,135398738,3.241714649843938,4.215385104234607
G-401,252682,7.482268639703102,6.385671524598918
CAL-51,126941,-2.448006630223804,-2.64845392262571
KMRC-1,1716436,3.642710819139985,3.168138936701392
KMRC-1,9967941,4.338887861114791,3.565072595182871
ONS-76,serdemetan-SCH-529074 (1-1 mol-mol),2.2978761416603812,2.0496138242550117
A-673,16725315,4.562355532440761,3.7590446125249066
NCI-H661,54613361,-0.43407763491745,0.05923095774978715
NCI-H727,17755052,2.165535951118127,1.916027490587163
LOU-NH91,4521392,4.279385220000522,4.35848890047201
NCI-H661,448949,1.832526735111792,2.040701357863726
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881,5.772864082292415
JM-1,24753719,1.6485500810507543,2.990862224304506
CA46,42642645,0.1424242949920916,0.0663440324015646
A2780,122327,3.970459431332868,4.271469286193446
LoVo,11609586,1.9215259939554383,2.8874120879741514
NCI-H292,piperlongumine-MST-312 (1-1 mol-mol),3.188802005351175,2.0040440185964985
Panc 04.03,6918328,0.7116207668770654,0.29749471039363196
YAPC,10302451,3.503177254309001,2.9330373143444963
Panc 04.03,262093,3.918875507815306,3.083432356893499
Panc 04.03,4261,1.8035720705799856,1.7538723055401064
HCC1143,11238147,3.6259374679037943,3.055573003898287
FU-OV-1,24951314,0.7779749033617789,1.5033628525425602
CA46,135440466,2.9995621349054007,1.4416268332595388
SNU-449,675434,6.334911868299287,4.608064942446342
G-401,568763,-0.8413074079434755,0.02255969368619837
A4/Fukuda,421610,2.9916322722523425,2.829339367624182
NCI-H727,11964036,1.415853516680377,1.3823785736696519
SBC-5,53232,3.018737473370281,2.699994414688457
NCI-H1623,2746,3.1722069840164533,3.1813064768829906
A-673,25102847,1.6240664882379,2.2379737314205888
NCI-H146,71680916,3.9962882248297182,4.473540059024148
CA46,702558,3.0016875761250383,4.197141616161324
HSC-4,3465537,2.7025414883497443,2.5166188568186323
SBC-5,15983966,-3.760719305706525,-1.226066127960418
NCI-H661,10184653,-0.0970326303224196,1.3491537477601048
KMRC-1,docetaxel-tanespimycin (2-1 mol-mol),-1.2179749713416546,-2.1897073689564976
MDA-MB-453,3634881,3.217596499324366,3.180162495333166
KMRC-1,54596558,4.448003654736506,4.423986917135113
SBC-5,6438330,2.801398037891768,2.278490115247787
DMS 273,11317348,1.436395200538785,1.382146489860784
MDA-MB-453,241158,3.8848602363142697,3.7454753056075605
CA46,72376,-3.3789820311778764,-3.477358364171266
EFO-27,1242560,3.615097330539702,3.688586251201237
BxPC-3,51039095,2.7952547650191297,2.5298453812870245
BxPC-3,71466380,5.524538311672043,4.686160372710978
A2780,49850262,3.28716577139928,3.211954255735726
EFO-27,148124,2.931737870457193,-1.9363689684423533
DMS 273,65064,5.260786534928717,4.505394186630774
NCI-H727,5328940,1.5210077536616875,1.8021628355898982
SBC-5,20959075,-3.707780876124786,-2.6127308044828705
LOU-NH91,5281321,-2.3527775967876097,-1.1704336541954574
OVISE,123631,2.580734449711204,2.328534374286756
BT-549,navitoclax-piperlongumine (1-1 mol-mol),2.0033323756459325,1.6710701210475107
OVISE,56946209,-1.506774361262591,-3.7620249894290447
DMS 273,5282054,2.793045570742954,2.885709764949001
SNU-449,11626560,2.613161578711923,2.1054847186662933
HCC1143,vorinostat-carboplatin (1-1 mol-mol),2.950179443799285,3.1454414464163585
KYSE-70,11214940,1.7563649507227177,2.778050370684258
Panc 04.03,15953870,4.151399322633975,3.7147798722542036
LXF 289,16736978,1.6084503302226174,1.8318721487647576
MDA-MB-157,60700,-3.9633933148193066,-0.06954142228206638
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544,2.379008090470771
NCI-H522,11152667,0.761836671652074,-0.7564142292415563
SCC-9,1750826,-1.358939777918893,-1.107032521956189
CAL-51,3854666,1.1494535123186709,1.924080184478348
CA46,11656518,1.817934601803022,0.40284539008124765
CA46,46843906,1.200591966763502,1.5455579597220277
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864,0.1392145244837943
CA46,24772860,-2.6679944090404035,-2.9394162931088976
G-401,24771867,0.701574094296253,0.1650090808849714
SBC-5,44202524,1.3408029920565403,2.1753083603814645
NCI-H2009,44507138,1.543580962147717,2.570791357200134
OPM-2,24748573,1.2641689672749945,1.553391448967182
NCI-H661,3025986,-0.862198206140106,-0.8402691914311735
ONS-76,107970,2.339276188405755,2.253351903454787
BxPC-3,54619267,3.7277591748612866,4.345411874001564
ONS-76,4917,3.1821597264511863,3.0871676405505464
NOMO-1,44493528,4.211717002525977,4.164212508708105
SNU-449,421610,4.477929285236737,3.083367522880341
NCI-H460,4259181,-0.2054535095090753,0.28551161081215454
G-401,327653,2.827166761380022,2.953824683871225
SNU-449,10302451,2.626140201612578,3.016691718580146
OPM-2,24964624,1.0133948666397414,1.3510801214010402
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,3.8270386364686266
SBC-5,441298,0.8643210359830038,2.455382750018977
NCI-H727,44489367,5.9503570299169875,4.681311339724515
HSC-4,123631,0.7882754974693414,2.236439049097181
ONS-76,24753719,3.8801096922841656,4.291212234565171
A2780,53495165,-2.5208465146636008,-0.9973433304970307
SCC-9,135411,1.0456929507985402,0.9850542451892571
A2780,6918878,0.724096247903148,1.779619225125767
A-498,45279963,3.865048616527305,3.6263736669716202
NCI-H522,51039095,-2.208127710853326,2.373645308301336
LoVo,5335621,4.644708398315867,4.3359303283726724
HSC-4,46199207,3.2853086951025197,3.21593257056828
KMRC-1,45279963,3.811973271229391,3.4131671043849554
LXF 289,56946209,-4.292268406284497,-3.8136561684984014
OPM-2,24775005,3.1759511003243532,3.2551516138364467
MDA-MB-453,11609586,2.797782394552202,3.0687650946503107
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175,2.60454348960289
A2780,53481919,3.3933560170788355,3.594843142932246
G-401,25150857,1.6513368879801875,1.9923491718689246
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.642270346910352
G-401,126941,-1.029913917257394,-2.6541093240415905
FTC-133,JQ-1-MK-0752 (1-1 mol-mol),4.281585420865333,1.9743327329589286
MDA-MB-453,BRD-K55473186,2.6877336742225424,3.8636926542730485
MSTO-211H,5311281,0.6318902138586533,2.23636432605704
CAL-51,44589607,2.4963130908502107,3.1656271124556947
KMRC-1,11234052,5.10610802043039,3.6608912549706605
OPM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.4874212858880314,2.8721822004495947
HSC-4,5291,4.568554891244716,3.7041837682127348
KYSE-70,3543504,4.273044270546896,4.424610301969428
NCI-H522,54618164,3.979913879048498,3.911507929909253
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581,3.239846310134722
DMS 273,439501,-3.5888564067388633,-2.277151770661332
MDA-MB-453,122327,4.8881767020652775,4.453612105195179
A2780,6918837,-3.827695834319955,-3.605907221462391
A4/Fukuda,44489675,3.3968348796203003,3.736944081749426
NCI-H522,25195348,4.252884841670477,3.0569303663399126
SNU-449,11404337,-0.5921655065432572,-0.13210118839014615
MSTO-211H,12003241,-2.79016034960529,-1.5407799810293563
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287,2.8372915910366423
SNU-61,654092,-1.5451038120184588,-0.08231037831452341
NCI-H1623,4705,0.0935418442786881,2.9876361595370433
NCI-H460,3543504,4.388423548450019,4.307837804961424
NCI-H522,23635314,-4.582316729083318,-1.5606488604446964
LXF 289,6918837,-2.0130943060067454,-2.195756516114321
LoVo,31703,-2.470313869470646,-0.7312309890058855
MSTO-211H,ISOX-bortezomib (250-1 mol-mol),-0.1802030513255949,0.5655808378112795
FU-OV-1,654092,-1.6613932676517214,-0.250357205492176
OPM-2,60750,-2.943046758118922,-2.8222718128006794
Panc 04.03,serdemetan-SCH-529074 (1-1 mol-mol),2.4838177280551057,2.097007256982138
A4/Fukuda,445643,2.2110077600401996,3.74666906839316
JM-1,25105715,3.1433974364296526,2.769375455832685
KYSE-70,9967941,5.193135802047497,3.742209142621846
Panc 04.03,24748573,2.946919213932378,2.3329032040693725
MDA-MB-453,6918878,0.409116855324534,2.8921122937511177
Panc 04.03,24901704,4.022965674422846,3.5504517947254772
CAL-51,16736978,0.375988055286384,1.6601424446249862
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885,0.5685553982982716
NCI-H727,carboplatin-etoposide (40-17 mol-mol),5.344630715975986,2.5832885897280233
Panc 04.03,462382,1.207122186011881,0.5532837136247974
BxPC-3,568763,0.1839879990612418,0.6669124045136934
A4/Fukuda,11640390,-1.5428779369431247,2.773289767093737
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102,3.0186946898129703
NCI-H522,216239,1.926799438191183,1.7623154576227942
G-401,53392493,1.8463111416757765,1.8651165684055746
KMRC-1,241158,4.823138037217212,3.6306224876320914
A-498,5566,2.910612965628124,3.161932971845688
SNU-61,17755052,2.932810476371255,1.3241750389105533
HSC-4,49793307,-1.7279713732228117,-2.4835104012487093
SW1463,49793307,-1.9541064611693424,-3.1405022250015695
LXF 289,11964036,0.5627528071719251,1.5486343390953528
FU-OV-1,11228183,2.3859582400300683,2.578024020739309
EFO-27,5311,0.9089041307391243,1.7103996560867794
SNU-449,44819697,-1.6819344520854818,-0.33197193230653077
G-401,JQ-1-UNC0638 (2-1 mol-mol),-0.8221581174940659,1.1392661558974084
A-498,168313307,4.423397924448837,2.8660625565418
NCI-H522,19582717,4.722348713472889,3.358684426169155
FU-OV-1,9903786,2.8592788804010936,2.881382470740442
DMS 273,444795,4.3404236236698495,3.623485768440651
A2780,56946209,-4.674045280410088,-4.436701141780851
A-498,tretinoin-navitoclax (4-1 mol-mol),1.5109888268131983,2.5059938610429544
A4/Fukuda,3503,1.0521499831923595,2.0517630011380352
SBC-5,6918837,-2.402107568310104,-2.702115345968707
YAPC,23582824,3.2647123156294855,0.806129054854368
HSC-4,159324,3.192829599869501,3.0722923681706735
ONS-76,54619238,4.4304444652836805,4.704323436858976
G-401,11228183,5.702662541402335,0.811994799841465
JM-1,44819697,-3.7816867530650535,-1.8894950827627084
SBC-5,54143018,-0.8844414516239579,0.8567583536229474
A4/Fukuda,44589607,1.1710928843495056,1.889753659127936
ONS-76,44543605,3.8219566402137457,4.123676292293971
YAPC,15983966,2.0827072702810847,-0.9696734394985004
SBC-5,2749,1.818007095297154,2.077671193971204
FU-OV-1,44487872,4.488734888040304,4.433908842352174
EFO-27,44197249,3.884486906001317,4.139886046270065
NCI-H2171,10385095,0.5588950968794439,1.0168899392523527
LXF 289,5351362,2.37199640031851,1.7452912614874954
OPM-2,54618305,3.930022905522119,2.961595657012009
NCI-H146,327653,2.704686127708374,2.8440535787135097
OVISE,11497983,4.4381003844097595,3.6968707816578643
NCI-H522,11977753,-0.2877362686640902,-1.5052535278535506
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.1383088037209668
NCI-H522,11707110,3.8955176091352857,1.3757858780171113
HSC-4,3676137,3.997252050059137,4.6336305078102225
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095,0.6988095097981618
A2780,9840324,5.381878860524984,5.609680121457761
BT-549,crizotinib-PLX-4032 (2-1 mol-mol),2.4648473849576384,1.9253349531448785
FU-OV-1,6917907,-4.405886494893828,-4.7143880722087665
CAL-51,71304818,3.0248956992793565,2.448167782874118
FU-OV-1,51039095,3.5191953123451096,2.8553909933059485
SNU-449,5470400,0.6313893315276518,-0.0584359989073106
MDA-MB-157,6438330,1.1379279588809148,2.330990404103177
NCI-H727,969516,3.103754409621015,2.939299426518461
LOU-NH91,439501,-1.197324809082114,-2.0488053544929916
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977,0.745671628192883
FTC-133,148124,-3.926787463073679,-1.9173000485962133
NCI-H146,24901704,3.4954665576646216,2.9892845272793016
NCI-H146,6505803,-0.3489025917214021,-0.9824655284692922
BT-549,44819697,3.658602858416661,-0.33488563937676363
Panc 04.03,5278396,4.260606427966062,3.728177909936187
G-401,11647372,0.0479330615057392,0.9096797411647952
EFO-27,71466445,6.412452895571818,4.123892163354546
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993,1.35306240002718
SNU-61,selumetinib-UNC0638 (4-1 mol-mol),1.9080621375720417,2.9023507677559737
NOMO-1,1716436,2.6410194121109773,2.4071669176299504
JM-1,navitoclax-pluripotin (1-1 mol-mol),-1.136595381126137,-1.9512028583027519
SNU-61,46199207,3.1956978461436014,3.095995997443493
LXF 289,4261,1.4002862892534345,1.8364723661332547
DMS 273,46843906,2.9019571008738763,1.8023058186120529
SCC-9,25150857,2.532575506870741,2.5454577271840435
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,0.9078721497613829
NCI-H727,24785538,-1.326987163467981,1.925917234340037
NCI-H661,11404337,-0.0954545894437525,-0.293232549784503
MSTO-211H,66577038,3.302731292752764,2.8724113041453188
OVISE,126941,-1.5326684035544371,-2.263437059650793
BT-549,44566777,1.3521548270810906,0.7085735079364031
A2780,3025986,-2.2950808421603983,-0.947128754963537
NCI-H727,16736978,4.598640955798025,1.6516539861629422
JM-1,6610216,3.7780643735318615,3.7911625806354348
MDA-MB-453,168312962,-1.3854623993271444,1.0962520416994175
LoVo,2749,2.494181165729376,1.8172342662199106
OVISE,15547703,4.212246909591729,3.184180381699511
ONS-76,16736978,2.0849164003870877,1.7277439940559065
MDA-MB-453,1714884,2.9618056579194585,3.255116864518243
DMS 273,327653,3.1988672985426847,2.7348076248624213
YAPC,2828334,6.193046978626199,6.34590633271902
CAL-51,10184653,1.4453250777347395,1.302853487769578
Panc 04.03,9936388,2.385451093408398,-0.1943999388287149
NCI-H2009,4477,0.2115452666376647,0.43924626824373225
A2780,322968,2.566344426002007,2.7979330281400157
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596,2.3797243676805184
EFO-27,216345,4.384346641524126,4.07092804635011
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194,1.9197761935470512
LOU-NH91,9956119,4.571782850484356,3.7675148652809387
NCI-H661,1641662,2.9325574972427813,3.387435523375457
CA46,44493528,3.81061502276679,4.091496416073678
OPM-2,navitoclax-PLX-4032 (1-1 mol-mol),2.9114134564638037,0.28331620425247134
A2780,11647372,-1.4335547211387447,0.7236670023687212
SCC-9,176870,2.779248818408345,3.0311302017652735
NCI-H2171,JQ-1-vorinostat (2-1 mol-mol),-0.591426926021434,0.5699856095216935
SCC-9,ISOX-bortezomib (250-1 mol-mol),0.3127664498221564,0.7550751876498617
NCI-H2009,25183872,2.394233803753281,-0.7373423041044925
BxPC-3,selumetinib-piperlongumine (8-1 mol-mol),1.5279722865269718,2.878614717679773
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789,1.436645764219368
NCI-H727,11222830,1.7878002384813196,1.6870862083455032
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319,-0.7227742647181938
SCC-9,9823820,5.247901285797655,3.941712135519234
FTC-133,44462760,4.267925011817446,3.368335289688901
EFO-27,salermide-PLX-4032 (12-1 mol-mol),5.523351402733512,5.04845434973043
DMS 273,54618164,3.989243888703328,3.9036786069629135
A-673,5470400,-1.9410984929514092,-0.0378996032434178
A4/Fukuda,56973724,1.7857996527787343,1.7648939097200247
NOMO-1,5311281,1.2143454060885572,1.6545867785166184
CA46,135423438,1.6657304721140649,1.3692490713701904
HCC1143,5287620,-1.5012475814925117,-1.8811599993286436
EFO-27,107970,2.9901836608736883,2.4563641925205077
EFO-27,7251185,1.6138148752584345,2.8879140538501105
LoVo,11214940,1.900565531770479,1.9007961609875168
NCI-H2009,6450551,1.0382100121131883,2.906425960285466
LoVo,3081361,0.9226789940369008,2.1239663735556893
SBC-5,BRD-A02303741-carboplatin (1-1 mol-mol),4.575375432825298,4.288178335893517
Panc 04.03,2113511,7.412620584739622,5.762865010482707
G-401,crizotinib-PLX-4032 (2-1 mol-mol),1.2254709557426715,1.2027356914010345
A2780,42642645,-1.071178701221225,0.333032801221621
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051,1.9105604307258406
G-401,72376,-2.6056367900842745,-2.658405648429939
NCI-H460,54618771,1.6853262233131374,1.271345892016082
BT-549,selumetinib-piperlongumine (8-1 mol-mol),4.450190552332179,3.5579537762693034
NCI-H1623,60750,-5.650217340343659,-1.4797633851338967
BT-549,49766530,-1.005486623843658,-0.47040707913159757
NCI-H292,10184653,1.6188231902933972,1.5173561083638853
NCI-H727,5282054,3.939726324876112,3.744165386946374
Panc 04.03,11485656,3.4698409381110435,2.5518847703070846
NCI-H522,24772860,-1.6489481573528793,-1.5125477432333654
NOMO-1,136227331,3.913043208951298,3.1669570758298415
FU-OV-1,984333,0.3323688812243723,0.3518972230185377
LoVo,9911463,2.8816718818913176,3.8974733945000555
NCI-H661,6917907,-5.078778116905793,-4.683353273781092
SNU-81,25102847,1.5499571993593506,2.223092775926919
CAL-51,159324,3.1794720270506307,3.155916600554625
A-673,122327,3.9666709409894527,4.0871821595049775
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911,4.615100887108927
KMRC-1,2858523,3.233729541186922,2.9139739410241394
LOU-NH91,9823820,5.384931157369051,4.3398615989869525
NCI-H2171,5287969,-2.1635291246577286,-1.9783083305513371
A-673,426756,2.5032328390514365,4.092266429316562
HSC-4,24964624,2.5086826728272538,2.663785576833622
NCI-H1623,176870,0.1873243677029567,3.048466524993753
KMRC-1,7251185,3.109058235493882,2.5158215329230713
NCI-H727,6610216,4.563405769903236,4.3711185781799005
BxPC-3,15983966,-3.8778410742282694,-0.023535883349047174
G-401,46843906,1.9398273455018735,2.186680716354684
NCI-H661,126941,-5.16742432120375,-2.446750259873809
FU-OV-1,5746,2.910322472492285,1.2106670633230907
CAL-51,11609586,1.5077859423552509,2.9941061616471325
NCI-H292,navitoclax-birinapant (1-1 mol-mol),3.1013974556417825,1.7927758442310753
NCI-H1623,23582824,0.0165284592292431,0.7475061688884155
SNU-449,31703,3.0847938162993707,-0.8967111360875561
A2780,4788,4.492604658524488,5.214609807642744
Panc 04.03,25102847,3.783052108341051,2.5680168009819577
FTC-133,selumetinib-decitabine (4-1 mol-mol),6.596226241094775,3.2811400246439733
NCI-H522,5113032,5.82110442960573,4.783120688326739
KYSE-70,16038120,2.0286855638164054,0.9359827780265715
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544,2.937641775373884
JM-1,2828334,5.9839290329767945,5.598566933428356
G-401,16736978,0.7492323653316314,1.5228439852780398
CAL-51,107970,2.299284460939792,2.219160711494936
NCI-H522,carboplatin-etoposide (40-17 mol-mol),3.969229835066765,1.6558892614110114
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007,2.791596435557232
NCI-H460,51039095,3.9314979002332535,2.7907489213823875
MDA-MB-157,9903786,1.458865596348786,2.9995706001131874
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127,2.712535785888704
Panc 04.03,54678924,3.3151598744761626,2.295028374027458
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012,-0.6932052210846887
ONS-76,25195348,3.7356955751438754,3.0818353049973264
MSTO-211H,71466578,5.31450298723974,4.685215582725439
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203,0.8360039656222551
LOU-NH91,10385095,0.9698085069900604,1.3330907890984187
FTC-133,24856436,2.183528137346661,0.6660118989274659
A2780,54613361,-2.0737031658574043,0.03305584195662728
CAL-51,5311,1.4183219405835503,1.372214032085589
NCI-H522,51037431,4.989409718658752,3.029771976977188
Panc 04.03,11647372,2.0191280123179824,1.2218963638627194
NCI-H727,327653,3.8552398443183193,3.2458577000807325
OPM-2,9884685,-0.7869928949425254,-0.2935461551840273
BT-549,676352,1.8104954024890367,2.200369687113909
CAL-51,46907787,3.297361866649883,2.22409641899103
EFO-27,11494412,4.723849828867172,1.9742062071126034
A2780,60700,-2.20534635529039,-0.964212544762193
A-673,5281321,-1.2857978730590742,-1.7879710546474985
NCI-H522,navitoclax-birinapant (1-1 mol-mol),2.79987001717094,1.3567099714141166
NCI-H661,6610216,4.875851858170822,4.244245793646695
NCI-H460,6917907,-4.956095121428261,-4.543525426602117
A4/Fukuda,5460769,3.0365194168079572,2.362722754468994
BxPC-3,3025944,3.477531707151509,4.2874441596179445
CAL-51,16065773,2.8749329306977853,2.6545533915983293
SBC-5,navitoclax-piperlongumine (1-1 mol-mol),3.0140004933884796,1.7316325224229567
EFO-27,2874250,5.869363689503336,4.85561403656635
A-673,702558,2.7000584853196936,4.5814025781651235
HCC1143,107985,-3.4652614368177432,-3.47660536753762
SNU-81,navitoclax-piperlongumine (1-1 mol-mol),0.0853232254018234,1.1040835943349292
NCI-H522,3025986,-1.0139106356663683,-1.3456430190899915
NCI-H2171,439501,-3.0635131055453924,-2.304968882745053
NCI-H522,444795,5.191031194563041,4.143626474389164
NCI-H661,53392493,2.28152765608909,2.5472535423145932
Panc 04.03,445643,3.9306423242452673,4.0699805919129055
NCI-H727,selumetinib-piperlongumine (8-1 mol-mol),-1.6426158910123243,3.0297494733007055
NCI-H292,25150857,2.3048085705836563,2.6644450191686007
NCI-H727,25126798,3.836281743476004,3.7466873528433866
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416,5.09661278380561
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187,-0.4147304853421814
ONS-76,9887053,4.335145594020597,3.619936610343731
OPM-2,675434,4.053836549963459,3.88414576388168
KMRC-1,16725315,5.238650021868635,3.805101555120106
SNU-449,piperlongumine-MST-312 (1-1 mol-mol),1.362794205944183,1.9719939449026345
A4/Fukuda,151289,0.1986917338936865,0.8072758379208598
SNU-449,ISOX-bortezomib (250-1 mol-mol),2.1712489431250437,0.9093226057535252
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291,0.8351373519668648
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698,2.407524724088013
MDA-MB-453,56963564,1.2952259038449256,0.786126007041819
NCI-H522,65064,5.303150406450188,4.450952844382863
NCI-H2171,24772860,-3.209318985857815,-2.3740261031941885
KMRC-1,104842,1.0931359128213904,-2.6230834882554133
NCI-H460,16741245,2.175171044948558,3.647119174733295
OVISE,4259181,0.909929291036465,0.22928593380665557
HSC-4,46191454,1.405754738797376,1.6003282900583065
KYSE-70,2749,2.2442090130660577,2.093118999107027
SNU-81,400769,-1.1944669265215293,-0.6049008634352446
NCI-H2009,6852167,1.9075911063810396,3.08193698889535
SBC-5,241158,4.402731015442316,4.004694693980029
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236,1.0901387389623165
HSC-4,44185566,3.0805483382503844,2.563895129907647
FU-OV-1,17755052,0.0450390211671309,2.2640847428001165
KMRC-1,53495165,5.726132279462146,0.03783743958711663
NCI-H146,6184667,1.5836777358218528,3.030885885945305
NCI-H1623,selumetinib-MK-2206 (8-1 mol-mol),1.9939850846524236,1.8100338085571448
HCC1143,55283,3.9101720152241226,2.8332160424258372
OPM-2,71466445,2.165442844786418,2.315530129469013
A2780,49867926,3.0666746223408157,3.5144287658933364
LOU-NH91,17755052,2.4120102833965844,2.0537826514320012
MDA-MB-453,49867926,4.180155964726801,4.042839056447418
Panc 04.03,25183872,0.1973991794911014,-0.6864088629719977
CAL-51,9967941,3.511576456928413,3.4368584939405373
SBC-5,6852167,3.965917526242172,2.921255513514816
NCI-H292,navitoclax-gemcitabine (1-1 mol-mol),-2.2738254252186314,-0.43805522620008364
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294,2.9159989859798445
NCI-H522,54596558,4.342696772784201,4.176083267821152
HSC-4,2733526,3.5101027459294425,3.757167922081594
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981,5.120263241044206
OVISE,decitabine-navitoclax (2-1 mol-mol),0.3462958100091469,1.587225848830362
MDA-MB-453,4477,-0.2020943624975227,0.5794677574910223
NCI-H2171,72193861,0.5955631718249997,0.8057531199194243
NCI-H292,2828334,6.458495810735601,6.297386765734165
ONS-76,7326481,1.79748139254514,2.959322391426618
A-673,44607531,1.457749077960986,1.3069454710173134
NOMO-1,73707438,4.2876330596581305,4.275235763240752
NCI-H460,60750,-0.8382921927225392,-2.096160229957378
NCI-H522,4259181,-0.2456063667287351,-0.06277163839886515
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366,1.3230915975876791
ONS-76,969516,2.910086136195903,2.7261435190719094
YAPC,49850262,3.6789282041181095,3.5773021290411884
SNU-449,44491742,3.9284370838515903,4.378815767497728
MDA-MB-453,11485656,1.765591398344026,2.59821950224756
NCI-H460,44607530,3.4043015144880444,1.7831180062500016
OPM-2,56949517,5.349058842742104,4.169158486282914
SBC-5,216239,1.5582588949606833,2.3641009775830892
NCI-H661,219104,3.9372744940630646,3.6804809848316906
NCI-H460,44484440,3.757520830720006,3.0270029716443974
MDA-MB-453,44462760,5.00879187339522,3.8077636010491975
ONS-76,5281321,-1.2480266745690851,-1.3865615148316008
LOU-NH91,5566,3.288881685822646,3.0769108020949556
MSTO-211H,72193861,1.6065459514404858,1.7524792467911752
NCI-H1623,16038120,-0.158474112921266,0.9135440995049616
BxPC-3,11238147,1.751681691561693,2.9684082619401955
YAPC,3025944,4.720838189364642,4.367077378204457
SNU-61,1239801,4.195034605110225,3.761600311927355
NCI-H522,11640390,4.472705990017258,3.0370134505371174
OPM-2,11238147,3.2386204402735874,2.2097315875712518
YAPC,16722836,1.8948218470527252,1.8406868364736324
MSTO-211H,4261,1.9115438043118669,1.7856250056265432
BxPC-3,24901704,3.2492386456059266,3.295059578203484
A2780,2742550,2.799223861459344,3.3784816758652467
LoVo,6918736,-4.296362304597629,-1.7774506333939155
NCI-H292,3854666,3.3764205876154074,2.1655268754920307
G-401,11222830,1.5347756238466792,1.4560538411224975
CAL-51,44620216,5.469091994130916,3.9254830854438745
NCI-H146,6918328,-4.616864565737749,-0.6438419881478569
SNU-449,100016,6.350050439021361,6.44086040525138
CAL-51,6438330,3.884194225982375,2.3254899494760624
A4/Fukuda,451668,-0.3897468918932548,0.5847340939750495
NOMO-1,135875424,3.068632733482165,3.209077435938893
OPM-2,selumetinib-UNC0638 (4-1 mol-mol),2.327180479574148,2.312257038179254
MDA-MB-453,9907093,5.353373126975176,3.8568872207311156
SNU-81,11404337,-1.7380856142345846,-0.3710057369609967
BT-549,3634881,2.142843752657143,3.3535252354124223
SW1463,6918837,-3.406571913442127,-3.0681426405224177
HSC-4,6610216,4.241818899552939,4.271925188770556
G-401,135421197,1.4306754302223277,1.6280093640379687
MSTO-211H,400769,-2.118881346037636,-0.5707472673092591
OPM-2,56946209,-6.715247823396851,-4.755280467305343
OPM-2,156414,0.898749748032719,0.3788434755328219
SCC-9,2708,5.420316309291021,4.934306535422511
BxPC-3,72376,-2.7426383250741786,-1.843521137330918
LXF 289,44607530,1.309750089611443,1.808723457834875
A4/Fukuda,216468,0.7779788317268376,1.2643779085994196
ONS-76,9936388,2.029236983033262,-1.173328670302454
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383,0.292654328870775
A4/Fukuda,15953870,2.701018205920996,3.1276086785370234
A4/Fukuda,3825829,2.918538307685252,3.5891236056502596
NCI-H522,1716436,2.601362471636894,2.85797420443566
NCI-H460,16725315,5.407057101640495,4.394570852156005
NCI-H661,969516,2.7370069869182996,2.836256088723095
SNU-449,9915743,1.6643053553641087,1.5841415021420175
NCI-H522,16219061,2.1788816492377054,2.7626042965903603
NCI-H1623,25126798,4.062693377799547,3.723703705056929
LoVo,46199207,2.62459096292295,3.2437161835778228
Panc 04.03,2126,5.406308275886939,4.730712096872219
NCI-H522,702558,5.065903257418961,4.411927873147256
NCI-H661,44489675,4.0470438340050086,4.091302553741195
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975,4.9987540579906415
CAL-51,11175137,1.2330676481368064,2.5366403526854517
EFO-27,tanespimycin-gemcitabine (1-1 mol-mol),1.7387659506719169,-0.9233135916364854
A-498,119607,5.756544485429512,5.241918273299428
CAL-51,89183176,3.8950338695454088,4.647814117063317
FTC-133,2828334,5.859070513237425,6.255469957905138
KMRC-1,135440466,2.425894917183188,2.105997330583558
NCI-H2009,36314,-5.253596358515139,-1.5658123936144335
G-401,11238147,2.0802759078276853,2.5568401462621484
NCI-H661,452548,0.003417557634082,0.15812378444645275
NCI-H292,5282054,4.085287507740134,3.8954709446548264
HCC1143,10385095,1.0799280769088206,1.464675634924533
A4/Fukuda,11626560,-1.03034976821798,0.7935910836446294
FTC-133,65064,5.375666939367713,4.9511567487806385
BT-549,753704,4.958873098850826,5.148416061029497
KYSE-70,46224516,2.993089177283032,2.425224356268849
CA46,11707110,2.876405562319207,0.5430797063380376
LXF 289,11609586,2.9430338892136354,3.066994405827543
KYSE-70,10296883,3.691258417269261,3.6941894161173114
A2780,tanespimycin-gemcitabine (1-1 mol-mol),-1.0115297721833665,-1.7787075296312367
DMS 273,67156097,-2.1294955352549,-2.0154763726072282
NCI-H2171,11955716,-2.5749004703466976,-1.7366289885131316
LOU-NH91,124202324,3.0671378719618283,2.69198212653987
A2780,135659046,3.385733838662662,3.4236924174118735
OPM-2,11427553,0.184758700497643,1.206765872926042
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377,3.2310756131584877
OVISE,11427553,3.886061021243629,3.0188522429540114
A2780,24821094,2.7975033336102095,2.928980544872199
LoVo,10410894,2.092646303934145,3.2453774915177926
CA46,327653,2.398308016277815,2.4504355441001575
NCI-H522,135440466,2.851321997265629,2.088201941656102
NCI-H661,9903786,4.646166413465223,2.7378065008609247
ONS-76,docetaxel-tanespimycin (2-1 mol-mol),-1.0307664921769042,-2.595753338456197
CA46,11427553,1.0834968953052575,1.3449670152577522
Panc 04.03,6450551,3.8538949310121353,3.0267204038435285
A2780,644241,1.9281614760038184,1.1781433754819057
A2780,3815108,2.053113262637462,2.5057447925348395
NOMO-1,71466380,3.4384411266907295,4.026790536282519
EFO-27,serdemetan-SCH-529074 (1-1 mol-mol),3.002804413616897,2.208277250112805
A4/Fukuda,24821094,2.016569070962388,2.519719282329655
LoVo,3503,2.2987332704820016,2.4166571321288384
LXF 289,46398810,1.8383298322371264,2.674666621665922
NCI-H146,42642645,1.3339409860624971,0.6187614112092316
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408,-1.8039819247329703
HCC1143,135984461,4.873829103860087,4.005097258633796
LoVo,23725625,5.102020281972671,5.186375924354677
NCI-H2171,4477,0.0540600744484099,0.6597425222025612
Panc 04.03,24964624,3.127575767188385,2.704212209864723
CA46,676352,1.5563040092860552,1.7608044294592708
ONS-76,135440466,2.234484066901876,2.0081722040528134
EFO-27,31703,1.037291503873681,-0.6834642586578993
MDA-MB-157,208908,2.741119640746793,2.1727104974206726
G-401,46191454,0.141864729037356,1.1885186908862955
LoVo,439501,-1.7683171506776545,-2.0318974780843266
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813,3.153108190375708
A-498,36314,4.095863504824457,-0.595617498860339
G-401,ISOX-bortezomib (250-1 mol-mol),0.1394395041296586,0.33182778681983466
NCI-H727,9935249,3.73205967923935,3.0902123485648976
KYSE-70,53392493,3.454381994737171,2.5985879167658896
HCC1143,11234052,5.229903952882612,3.910371195837064
CAL-51,4705,2.903463840875761,3.2514604577951918
MDA-MB-157,56946209,-3.6171244608990905,-3.768414308839854
LoVo,3689413,-0.0015328635235731,-0.11104105467447939
NCI-H460,46199207,3.5033257005335163,3.047963663467417
BxPC-3,135411,0.8341107494370649,0.8671419664913678
NCI-H727,46191454,2.1799448668848105,1.906441916286865
OPM-2,25195348,0.9238255530721258,2.5184936086932197
SNU-61,JQ-1-UNC0638 (2-1 mol-mol),2.3060253857026343,1.0488838365032598
SNU-61,656346,0.8749051442535513,0.758009645363112
JM-1,136227924,1.2038413750130548,2.252167021634136
SNU-449,49867930,4.864159132996777,4.625881642905599
A2780,2733526,2.8794725769531997,3.691811379463634
OVISE,23725625,5.908959950408421,5.114571727418163
BxPC-3,60700,-0.122761385712052,-0.16601606813369826
OPM-2,53495165,-4.146839218250571,-1.643455420411694
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497,0.9888330779365461
A-673,25227462,-5.829932006274449,-0.38012202795320876
KMRC-1,6918328,0.9635513821249304,0.052968751205445655
JM-1,89183176,3.1890961462334335,3.166814139267946
MSTO-211H,16038120,0.2471942161915729,0.8194457854429013
JM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.175928698896838,3.1969033109882705
ONS-76,6918878,5.0214366982824306,2.653499086964048
CA46,60750,-0.9269398092944348,-3.8401041514797045
HCC1143,42642645,1.0566197638440329,0.8342103738450839
OPM-2,3503,1.0860674816661569,1.6923300751531223
BxPC-3,11612883,2.2063280154469993,2.8667236585158964
NCI-H522,16065773,1.5488087432962436,2.174099200606052
A-673,3634881,3.109333818891092,2.988422291170496
NCI-H2171,71466445,1.378191899492029,2.7334963434347603
SNU-81,JQ-1-UNC0638 (2-1 mol-mol),0.4433096898383019,1.3675043900534671
NCI-H292,17755052,1.3393568867062529,1.8561431545835638
NCI-H522,11427553,1.733163384028149,1.8691821905284085
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819,0.9355571603392617
BT-549,24797083,1.6394182791354686,1.6025420507841286
OVISE,6438330,2.2515103089504818,2.5361366190934125
LXF 289,10410894,3.939992216810496,3.342776973649125
EFO-27,60750,5.390319994108079,-2.0316752402355864
BT-549,400769,-1.1296625579443007,-0.447304044497263
SCC-9,2742550,4.1692460597635135,3.8842088536053008
JM-1,5281321,-3.43257780081901,-2.578070864329518
OVISE,24771867,1.656692666128474,2.747798190458281
SBC-5,3384730,0.0954837515635063,2.9092094614241573
BT-549,navitoclax-sorafenib (1-1 mol-mol),3.9279804703061703,1.8763624881318024
A4/Fukuda,2749,1.141581020051295,1.230016260568041
G-401,1716436,2.4290804430946547,2.864281367245521
NCI-H2009,23635314,-2.363129056883172,-1.541566034837117
SNU-449,3081361,2.056588488576824,2.583434975048237
NCI-H522,969516,2.4900188230240485,2.398635010073854
MDA-MB-157,11626560,3.460415978238755,1.744393922552311
NCI-H292,selumetinib-UNC0638 (4-1 mol-mol),2.5678319047053244,3.31692013905714
HSC-4,11719255,4.924721636143113,3.4132812168211277
KYSE-70,17755052,0.9465092626724514,1.8162010348087758
G-401,25062766,0.8725390828623283,1.9513791560743325
KMRC-1,4477,0.198014478122684,0.4713128034483461
SNU-81,44197249,-2.185783961489413,3.3728925877975784
A-673,10410894,2.502904420433103,3.071321867752066
ONS-76,6914657,-4.101072641720643,-3.280479597166709
MDA-MB-157,53495165,-1.8622859982145463,0.6038711716869565
Panc 04.03,72734382,5.165438336919353,4.790912211289912
FU-OV-1,navitoclax-pluripotin (1-1 mol-mol),-0.2689466648852067,-0.5148313203108646
CA46,613000,1.1767209163070167,2.5370589789355726
EFO-27,3503,2.721888959468924,2.445621323688878
SNU-81,decitabine-navitoclax (2-1 mol-mol),0.903824446896739,0.7141965991109752
MSTO-211H,6917907,-6.416473568686441,-4.6767271893477735
CAL-51,675434,4.354107922133551,4.416893103279984
CA46,5278396,3.312720557512005,2.9687959150683816
FU-OV-1,9911463,4.1305925074662575,3.9714460079989284
DMS 273,5328940,1.9629216769229116,1.5154719334792501
LXF 289,54454,1.7599180903835134,2.5766451684629095
A2780,446155,3.1527811730433366,2.5100717609450847
CA46,11222830,0.90552754986452,1.2202541802518794
MDA-MB-157,15547703,2.7177027433879912,3.212978606949637
A-673,9915743,0.6829950735134661,0.9810520689954191
Panc 04.03,50905018,4.96616490546014,4.270380342842282
NCI-H146,50905018,3.857703749758686,3.7373300698991385
OPM-2,carboplatin-etoposide (40-17 mol-mol),2.4358856749484596,0.3863994822760983
CA46,148198,-5.7845042531785,-4.276714421465648
BxPC-3,11427553,2.964396595429347,2.8375590466784786
JM-1,17755052,1.8568486472237824,0.7122636332312331
MDA-MB-453,135875424,2.7753375231350104,3.829883885526053
LoVo,52947716,-5.666189039665748,0.008091847214893578
SNU-81,3543504,4.205084802754879,4.084256262333791
CAL-51,9887053,4.486783389261201,3.8446916456123295
YAPC,SNX-2112-bortezomib (250-1 mol-mol),0.1222425985645655,-1.1825486644805325
FTC-133,6852167,4.78859095347106,2.9075392795825366
SBC-5,46907787,3.799315463541784,2.131760509618725
SNU-449,6918638,1.2557717528626495,0.7053301667806836
NCI-H2171,6438330,1.125878118169246,1.4780378370963336
ONS-76,15953870,3.841628876209717,3.705496944794943
KYSE-70,44493528,4.735176242945038,4.4047481375713025
BT-549,71751553,4.2471267374516435,4.647273108236217
NCI-H2171,46943432,3.4065574915710735,1.2783185227597007
SNU-61,carboplatin-UNC0638 (2-1 mol-mol),3.8198655410363287,3.4862721150037164
A4/Fukuda,135875424,2.943838777845953,3.3412469453554507
SCC-9,25154868,5.2906536290113975,4.4872429308421715
A4/Fukuda,11964036,-0.0142982917472374,0.7148637222074395
NCI-H292,10302451,3.577296661602114,3.19697437699954
A2780,135999136,1.5930192405329104,3.0372413991042526
NCI-H292,54618164,4.184972812062346,4.186127638682703
LXF 289,107985,-2.691798131563437,-3.2557354581741498
NCI-H522,44137675,3.8599044567005434,3.628203172197855
CAL-51,3503,3.2899889427654245,2.2262384032733467
A2780,409805,4.989244714218352,4.370122298265178
HSC-4,71466380,3.6804948915169784,4.486786422822315
JM-1,6918638,-1.945896791217812,-0.7158702667311663
SNU-449,44566777,0.6479277578392284,0.6495237180932036
MSTO-211H,387447,-3.4382078488280063,-4.124283918226839
DMS 273,9915743,1.912374780622189,1.0163171010903662
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022,1.02744796696721
NCI-H661,16736978,1.5408428303752983,1.9062542320168354
MSTO-211H,44241473,3.911097970359605,4.810371263848671
NCI-H460,60700,-0.2314807684970784,-0.3383497715339645
A2780,serdemetan-SCH-529074 (1-1 mol-mol),0.9740349619499052,1.8062171376888188
JM-1,227681,1.6891640861629382,2.6656175403925912
G-401,JQ-1-navitoclax (2-1 mol-mol),-0.4060053682032895,0.16796610686605615
NCI-H661,656346,0.6919490200967222,0.8943693108332763
SW1463,5311,0.7635678260369684,1.1387865757342417
NCI-H460,387447,-2.436463262555682,-3.7608454221855463
MSTO-211H,navitoclax-MST-312 (1-1 mol-mol),-0.7166631771213113,0.7286180087999273
HSC-4,9825149,2.985341504866837,2.140229655789498
NCI-H727,25262965,0.7692581364380534,-1.2791441122399179
A2780,10077130,2.5506457702723786,2.795495617447761
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617,2.1239242343982494
NCI-H661,136227924,2.7818959309662183,2.990805759074328
SCC-9,446155,1.3937663931747788,2.8300600167982317
BT-549,73707398,1.468839183930599,1.3626563021869382
A-498,navitoclax-PLX-4032 (1-1 mol-mol),0.6341402769109122,2.170036749378234
CAL-51,6623618,2.223133904662847,2.3917482242761903
LOU-NH91,327653,3.620861790086289,3.3063964607320866
BT-549,67291369,4.3793706620025095,3.24715059359288
MSTO-211H,docetaxel-tanespimycin (2-1 mol-mol),-6.863228932141716,-3.173619691464093
NCI-H460,3025986,0.3909368316008428,-0.9208577226688266
Panc 04.03,11228183,3.2874901590346934,2.5934430883578488
LoVo,25262965,-3.8912736240644694,-1.6348486463333556
SBC-5,73707398,1.6541333685248465,1.3090881392826543
NCI-H661,89183176,4.289155461605826,4.411238136751532
G-401,44241473,4.28251451131172,4.279884192633774
BT-549,2746,3.8188337512891137,3.57661504791217
YAPC,25062766,2.237282024435701,2.214160232412478
LXF 289,20959075,-2.4089188058085,-2.5168728895247083
SCC-9,53232,2.1606412524830017,2.900315097335518
G-401,56649450,1.8227428945555348,3.235097998435256
MSTO-211H,11222830,1.162959487763126,1.7861293002143912
JM-1,15953870,2.1778700018066144,2.8931626069911687
LoVo,15953870,2.9352023189332703,3.459996392468997
DMS 273,15953870,3.8128904638275216,3.3264711690032396
G-401,JQ-1-vorinostat (2-1 mol-mol),-0.8769966942019048,0.6237095929734908
CAL-51,1750826,-0.4147302595408071,-1.2128915167718555
NCI-H522,9884685,0.1045560296672991,0.09413374206990252
HSC-4,327653,3.5197711195347434,3.0712709966474474
BxPC-3,6918328,-0.2318480121478282,0.13377714602684476
NCI-H661,10074640,2.974634579766932,2.999484962905187
FTC-133,11178236,-4.398882676695501,-3.320414101052663
CAL-51,6450551,1.9748462748620472,2.932732882917173
NCI-H522,SNX-2112-bortezomib (250-1 mol-mol),-2.0311318982301665,-1.3226698894773399
SCC-9,5978,-3.875351555062552,-1.4765283441286974
LOU-NH91,5311,1.697115177859265,1.7435310799606907
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876,3.7816300079097296
A4/Fukuda,49766530,-0.1813275565198268,-1.5915928929286807
CA46,5978,-7.34958411963843,-3.529846000408241
JM-1,15547703,2.5122126082355227,2.4799506560790867
HSC-4,3038522,3.958216901800584,3.1429978901420332
MDA-MB-453,24901704,3.2296574944609735,3.37440468514364
SCC-9,23635314,-1.650613607792241,-1.0741794845906634
KMRC-1,11612883,3.608500084904783,2.6139725000149845
OVISE,24772860,-1.0102375693918164,-1.5271235771030536
A2780,11626560,0.43489025720173,1.5250426249428954
MDA-MB-453,51037431,1.3361098813185686,3.1806905556892713
HSC-4,4705,3.95336427523857,2.981714073012284
A4/Fukuda,24748573,1.3032837048402657,1.635654021558629
OPM-2,51039095,-2.6866952618976434,1.814505569277169
KMRC-1,11609586,2.4412406506497155,2.6587956012487193
ONS-76,11609586,3.485979398565755,2.922838692317802
LoVo,12003241,-2.8621949377385465,-0.8932812633686197
DMS 273,241158,3.177272786345067,2.778014213990375
KYSE-70,20959075,-2.927604227069557,-2.5916304097098166
SNU-61,16722836,1.3959733890222568,1.3002381035604833
SBC-5,89928392,2.3719311856170537,1.688978741902135
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,2.1513533306041808
A-498,4261,1.667462132250413,1.9894720584935643
SNU-449,23725625,6.429990861305722,5.087813691642151
A2780,4259181,-1.27299012623329,0.06817038790886155
ONS-76,10127622,-2.1347139098699706,3.154930263853691
A2780,1641662,2.3828094640764412,3.181218802373792
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891,1.9052250829603767
Panc 04.03,9549297,5.2530677537073975,2.704718027660485
MDA-MB-453,53481919,3.1180191774885735,3.7235341609820183
JM-1,56963564,0.0249959117693502,-0.5084131362106001
HSC-4,11234052,4.4583786214563865,4.181549792966812
A-498,SNX-2112-bortezomib (250-1 mol-mol),0.1538165542627618,-0.6928763435527311
BxPC-3,119607,5.22613990212802,5.410260449110343
BxPC-3,5278396,2.866816315326302,3.61625637199559
LOU-NH91,400769,-0.4518117512524929,-0.31716828213816456
A-673,doxorubicin-navitoclax (2-1 mol-mol),-4.20921708976932,-1.9522002865513313
FU-OV-1,16722836,-0.0099462763207794,1.7855448825537792
SNU-449,46907787,4.480861537403045,2.7150203486287667
NCI-H292,24748573,1.9235457900331792,2.361758505176619
NCI-H460,2113511,6.407699041859446,5.331511628328701
HCC1143,selumetinib-UNC0638 (4-1 mol-mol),1.3639730576271398,3.185435938447767
NCI-H1623,46174525,4.205988468269685,4.653236125332601
NCI-H1623,6917907,-5.728045829659389,-4.398633278448497
MDA-MB-453,1641662,3.085427143962118,3.60377702157121
NOMO-1,3854666,1.0231806307237967,0.7575925723740969
SNU-449,24821094,1.9429996101140543,2.978618523031512
SNU-449,crizotinib-PLX-4032 (2-1 mol-mol),2.114422576149497,2.1545938157693785
Panc 04.03,216345,4.594435961426402,4.087610913534311
DMS 273,2708,4.711982190259564,3.559180123666638
NCI-H2009,navitoclax-MST-312 (1-1 mol-mol),0.6133760469311309,1.0705209257386776
A-673,11222830,1.3107049031534492,1.433144143842828
SCC-9,219104,4.323236898621614,4.002804429406122
KYSE-70,11455910,0.6771697782379181,1.5570778189956027
MSTO-211H,9915743,-1.0722844498490078,1.603208155936526
HCC1143,3062316,0.306898118520016,0.48931491146603123
NCI-H460,11427553,3.3912724357702873,2.8094778768823976
NCI-H1623,675434,4.403585448845777,4.517164283111003
NCI-H1623,135928012,3.849713333151309,4.222671219715182
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473,1.664479718653835
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785,2.051047345432049
KMRC-1,11222830,1.6210071273597368,1.668263993759794
NCI-H661,44607530,1.6067743901515843,1.7236264298602024
HSC-4,24753719,5.996217074466553,4.4483993081152695
NCI-H1623,44607530,0.6082825778474802,1.7206325132251112
G-401,409805,3.720272745750916,4.20540428996988
MSTO-211H,24771867,-1.256499005348058,2.9404332311564385
LOU-NH91,100016,8.416108067142021,6.397949010588628
LOU-NH91,navitoclax-gemcitabine (1-1 mol-mol),-1.5749911209291652,-1.01257982540748
MDA-MB-453,9911830,2.483477791354312,2.649452263823974
MSTO-211H,216345,2.6222222224733702,3.8759282860728312
A-673,5738263,2.33182798743241,2.9196054194445185
NCI-H292,navitoclax-MST-312 (1-1 mol-mol),1.1730740558558932,1.1780994307671218
CAL-51,16038120,-0.248771562775031,1.113947108999001
SNU-449,11222830,1.6348775900621026,1.7682803442623476
SBC-5,11656518,1.8588197700646856,1.632411979386251
LoVo,637858,1.5179613366947162,1.7873230673039198
OPM-2,16065773,1.0643824527623371,1.9928567892504234
LoVo,17759555,2.3197484044750905,3.424458569023149
LoVo,23635314,-2.3980395881052723,-1.5410131800174063
OVISE,241158,2.9923875981017134,4.026802404443369
LXF 289,6918736,-2.4177135652368476,-1.4505124299210457
NCI-H727,24180125,3.0565666249941015,2.996717280240281
HCC1143,72193861,2.4539335535877607,1.7724276327637256
LXF 289,17755052,1.3903450452706496,1.9708610297570157
SNU-449,24797083,1.6612369643963127,1.589435697615375
A-673,9903786,1.5948741514342302,2.7719890074210696
FU-OV-1,docetaxel-tanespimycin (2-1 mol-mol),1.25716738994227,-2.9345985343643846
SCC-9,3552672,2.2159119862051355,2.691872078179957
G-401,9903786,2.8038927126182327,2.48211947601523
CAL-51,36314,1.3238047725901672,-2.368566717837414
A2780,4917,2.608891014350475,2.8349852950266072
BT-549,446155,2.043062772915461,2.7470106844473987
LOU-NH91,2828334,6.123728588021327,6.184345126421248
SCC-9,89928392,1.8759175792930969,1.918013624233629
LXF 289,54613361,1.2100808209747431,0.29430641651036576
BT-549,navitoclax-pluripotin (1-1 mol-mol),-0.784652451279203,-0.6206980920341296
YAPC,4788,5.944205132488497,5.703422678070719
NCI-H661,11485656,2.0326011859644075,2.542413566464161
A4/Fukuda,56649450,0.8497740308893211,2.9404134709721346
JM-1,151289,0.6364544108799082,0.6248366214698226
SNU-449,1566236,1.8764566240908545,2.044639496094116
NCI-H522,11234052,4.642717967560772,3.452566091214053
MDA-MB-453,262093,2.6969191096415113,2.7465556956847785
SNU-449,36314,1.881882754123643,-0.7041970935152677
FTC-133,3552672,1.929463221662531,2.7363667825840245
DMS 273,44202524,0.9824733163321672,1.8559803172232678
CAL-51,2708,4.939881356462198,4.899152525554427
NCI-H661,doxorubicin-navitoclax (2-1 mol-mol),-1.1391297012173984,-1.1903837991135993
LOU-NH91,44507138,2.849532358816909,2.7006701718866397
A4/Fukuda,24856436,-2.105951383298443,-0.2483666540204764
EFO-27,9967941,3.205966960393555,3.640805961071731
NCI-H460,24964624,3.5490884182562565,2.4633403750508935
A2780,71304818,1.3100858151797232,2.186045355843984
LoVo,16065773,3.0239362353443195,2.4940529510833294
MDA-MB-157,19582717,3.2682056974125744,4.496733341532359
G-401,44607531,1.4405644617048554,1.5287720585602884
DMS 273,426756,5.171527401006451,4.199639823062352
A-673,selumetinib-MK-2206 (8-1 mol-mol),2.344238409661225,1.8848933031275754
A-673,3465537,3.0102553460613626,2.077345552450217
KYSE-70,135398744,6.338938630156892,6.405486355065108
NCI-H727,439501,-2.2848783314382133,-1.9083688994681327
EFO-27,1750826,-2.462449966677767,-1.2271598422360996
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236,0.9344035898104576
NCI-H2171,15547703,3.4091207334536717,2.8393866176333575
BxPC-3,24753719,4.274594841538204,4.55110851225048
A2780,49846579,2.326369228321655,0.8232960503620054
KMRC-1,135398516,2.513650186922018,1.890800988668425
LXF 289,12001922,1.5738020993239468,1.9673516614873148
OVISE,107985,-3.603598955800668,-3.5242162582778467
FTC-133,crizotinib-PLX-4032 (2-1 mol-mol),3.9800326864083506,1.6460986560336843
MSTO-211H,51039095,-0.728954813106199,2.7669269710294158
MDA-MB-453,24856436,0.153871218683687,0.639899960328992
OVISE,12003241,-0.8183931153803442,-1.0564297027744471
JM-1,219104,1.4868441806857289,2.299915738616227
KMRC-1,24901704,3.4724240700357414,3.1217191583794874
CAL-51,25105715,4.077363851334658,3.4250895289582273
Panc 04.03,5284616,3.514498334257777,2.832286254712723
NCI-H2009,446155,3.3217785993510884,2.846008796081772
NCI-H1623,66577038,3.365380490578284,3.034139044940792
NCI-H460,72193861,2.1658883750752844,1.8080016467896594
NCI-H522,17755052,3.243909986839396,1.7280854061402153
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655,4.60076214738969
LoVo,9936388,-7.372990206557469,-1.7131582590963885
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742,1.2393291358267753
A2780,46907787,0.387414270491788,1.1060163899951427
A-673,25150857,0.7583223763798244,1.9965991950427011
KYSE-70,11175137,2.267736133904179,2.7046268958526514
KYSE-70,6852167,2.2981101713941814,2.9591044708655665
SNU-61,3081361,2.723820700669796,1.9025379575195038
NCI-H661,6252,2.9131036022991728,1.532513171294729
NCI-H1623,9903786,3.0418604220511436,3.0985790128306205
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.5529079271037503
NCI-H2009,JQ-1-navitoclax (2-1 mol-mol),-0.3100400196592782,1.0547962980052288
SNU-449,10322450,2.7236273289045942,3.9204111176888365
LXF 289,4096211,2.4023988219433337,2.1516513896439546
SNU-81,10026128,-0.7780702377310673,3.3628777711914193
KYSE-70,6610216,4.087252338732691,4.156644517450873
MDA-MB-453,44607530,0.880863900568506,1.5143081403825505
NCI-H522,24978538,3.1859390482195216,0.9230552761201908
SBC-5,107970,3.247043743319875,2.340476527770461
DMS 273,969516,2.584462316279732,2.31586176458056
MDA-MB-453,5284616,0.7898078062241378,0.8902412394606033
A2780,16720766,0.7344228111589829,0.16993016331918462
OPM-2,25154868,3.783948059993976,4.1437335710698155
DMS 273,44493528,4.2569430545307725,4.332493642987814
MDA-MB-157,25022340,3.479219964634342,2.7402290781802594
LOU-NH91,15547703,3.808438680736899,3.3028172360234054
CA46,426756,4.77193452473935,3.6321644518779124
DMS 273,2858523,3.0502279484440233,2.9923721262241623
EFO-27,3676137,4.310046032716647,4.77180524415883
MDA-MB-157,3025986,-1.856662168016076,-1.1191388411690317
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705,-0.20971335730465904
LOU-NH91,44607531,1.3180545967249335,1.6599066588253553
G-401,46215462,1.5390133747858452,1.5757983830613358
OPM-2,7251185,0.5721351512480617,1.5591475088352789
CAL-51,15953870,3.220977372988981,3.5018506971465895
YAPC,11964036,3.221056153642411,1.3555781079679636
BxPC-3,208908,2.4547812946400502,1.6708235535821685
MDA-MB-157,44589607,1.2787513073565453,3.041764375513334
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868,-0.6254774360504376
NCI-H727,72193861,2.684204612264405,1.6789983968533955
MDA-MB-453,5287969,-1.436813958809434,-1.6228597363917698
NCI-H727,15983966,2.109759483394555,-1.113371786201814
KMRC-1,216468,4.973373200756221,2.938114412799887
SNU-449,52912189,4.380826008996873,2.3822637998360885
SCC-9,46174525,4.3512864598075645,4.60602737873592
A2780,3011155,5.55303778809739,2.636460660291648
SBC-5,135999136,5.333154079184271,3.735451531793377
YAPC,322968,3.8135092450764656,3.6971527834979714
SNU-449,vorinostat-navitoclax (4-1 mol-mol),2.197410731070427,1.4124961235868765
NCI-H146,5328940,1.6811042727449883,1.6769275772435197
CAL-51,168313200,3.900876548563449,2.7313292732708074
DMS 273,1750826,-1.913269562568005,-2.5411711576592855
A2780,54618305,3.781380565087532,4.454294003045509
NOMO-1,9936388,-6.523282887173488,-5.27499006791499
NCI-H460,5282054,4.802373462225767,3.974667205772205
SBC-5,82146,3.3774942308101785,3.718317538338131
NCI-H727,56946209,-2.7175198163763232,-3.8797469635338255
FTC-133,3062316,3.806169585149848,0.7338233833010775
A2780,9967941,1.4564169862408056,3.378335225817303
DMS 273,5351362,1.0025978169272032,1.047438641507492
SCC-9,16038120,1.877705535955449,1.174551278692454
NCI-H522,6917907,-6.015261010654924,-5.130830686031398
CA46,4477,-0.2706834990523855,0.6388988361899609
NCI-H661,erlotinib-PLX-4032 (2-1 mol-mol),2.455448460706525,3.00540850228015
SNU-449,11178236,-2.056078636199096,-3.4353244494701958
SBC-5,5278396,3.3013936373431996,3.389979419281168
NCI-H1623,44493528,4.638812765070766,4.377874535705782
NOMO-1,16720766,-1.891739380903732,-0.7497031993598587
G-401,2729026,2.5705443446476828,2.373447328928341
G-401,6917907,-5.905222634362146,-5.51450446836384
MDA-MB-453,2858523,2.664825786894245,2.8857359810886916
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.5583108057373318
LoVo,11427553,2.604805449600099,2.935237102089868
G-401,11234052,3.7167035951130423,3.480354008332959
FU-OV-1,168312962,3.576057642182836,2.2325908887159143
JM-1,11228183,-0.9199972643114134,0.25591093970648987
ONS-76,65628,4.406189432641036,4.265539415709708
Panc 04.03,11964036,1.4501208375942458,1.4405163930059917
YAPC,17759555,4.434513834785858,3.6316293415094445
Panc 04.03,5311,1.931700632460216,1.7321828968127522
NCI-H522,tretinoin-carboplatin (2-1 mol-mol),5.2025586729101185,4.160273547399461
NOMO-1,49793307,-3.1091933140229,-4.220230506140236
MDA-MB-453,46174525,3.691895458218128,4.451962773201846
G-401,11977753,-3.640604480016117,-1.7509049468964886
A-673,16722836,0.9037523157925,1.4571474741417287
MDA-MB-453,5494449,3.8003034085581993,2.79193316491314
NCI-H522,25150857,1.47132219158847,2.298720027147345
OPM-2,5311037,3.4844810711382936,2.771325136531118
LXF 289,11152667,-0.4789950074309144,-0.16025623848757792
CAL-51,9911830,2.6702149728757343,2.3835961531329484
KMRC-1,4378219,2.060133570967863,2.642351814257714
SNU-61,navitoclax-sorafenib (1-1 mol-mol),1.8672566595023088,1.046047076788577
CAL-51,156414,1.13799157004995,1.4645388731848612
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173,1.2395926121269434
NCI-H727,89928392,1.7873251449620886,1.740587363855993
KYSE-70,6918837,-2.6267197721971582,-2.738414349650707
JM-1,135928012,4.176764785732949,3.6856790503938845
NCI-H522,10427712,4.202859541756615,3.9754569443163406
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.7733717644924347
CA46,5470400,3.727677755196873,0.676299252150113
KMRC-1,navitoclax-pluripotin (1-1 mol-mol),-0.6870292633838142,-0.9869984036418221
EFO-27,9936388,3.039710224097925,0.10454783152281269
NCI-H292,54618771,0.019803014891406,1.3525169568538078
KYSE-70,25262965,-2.1035778811550836,-1.0426780233847548
ONS-76,selumetinib-piperlongumine (8-1 mol-mol),-1.0642702210035522,2.6645621606742247
MDA-MB-453,11656518,1.9818038641727111,1.3958400808862705
YAPC,5282054,4.005772938817316,3.9664197448496528
SNU-449,24180719,3.8016565421464072,3.437847443328274
FU-OV-1,15983966,2.2280291717608947,-0.523061174671618
SBC-5,11485656,2.2866280503579812,2.43195649810593
ONS-76,702558,5.821489397293988,5.047959213823719
SCC-9,9911463,4.4493328300482995,3.7307803993004063
HSC-4,72193861,2.788231918333871,1.7501618099994463
DMS 273,2126,4.20633218634453,3.9883969843512053
OVISE,46199207,4.361349086507746,3.202158999774026
Panc 04.03,241158,4.444137488799797,4.134825837457395
NCI-H460,654092,0.4612941847378306,-0.20917501711625203
A4/Fukuda,45279963,1.9027034071047564,3.0806854181329326
NCI-H292,44259,1.4427392496176257,1.0792413536673293
FU-OV-1,17759555,4.190415677120393,3.7878859788272097
SNU-81,3634881,2.620060882721275,2.9364004051875074
NCI-H2009,107970,2.2954238398166344,2.452519235943784
LoVo,5278396,2.046108484267772,3.511346193195321
NCI-H146,vorinostat-navitoclax (4-1 mol-mol),-3.3112811386444525,0.2994828540016914
HCC1143,12003241,-0.0421467164139253,-1.2155928551622692
Panc 04.03,46926350,-3.8788763459733473,-3.926362743753283
A4/Fukuda,4578,3.815086457915261,3.863156732615971
CAL-51,9929138,6.421072450841616,5.733165325741574
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383,-0.5724726676586163
SNU-81,4259181,-0.3131255720640173,-0.04457218577206093
KYSE-70,675434,4.695192974207532,4.416743890747911
A2780,selumetinib-MK-2206 (8-1 mol-mol),0.1736531975308503,2.2603424927552793
A-673,135659046,3.595490040408381,3.401954837890678
NCI-H522,4578,4.727447650100284,4.104449500263112
DMS 273,54765302,4.301325739041371,3.8577003271775805
A4/Fukuda,135440466,-0.9873079875011114,1.9356125442579684
LXF 289,24821094,2.4128137194258215,2.917535820653265
NCI-H460,5746,0.0249012606464236,1.1707867895799726
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195,1.1439076989485777
A-498,25062766,2.0793230877467166,2.235683204733026
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058,2.943466258505296
Panc 04.03,10127622,4.886231353649791,3.8413626785881836
G-401,57330099,4.350194890812272,4.142973002622635
NCI-H1623,168312962,4.13769742192025,1.906816092941753
SBC-5,5566,3.1825236444892124,2.8026805020152326
Panc 04.03,9825149,3.055289787116955,2.5444204823420478
BT-549,11507802,2.533090965918468,1.7920598830411685
OPM-2,5951923,4.162321290800766,3.7559698070938508
MDA-MB-453,salermide-PLX-4032 (12-1 mol-mol),3.8592412133005265,4.496286329664937
NOMO-1,9935249,2.770043096032674,1.1731230163584412
LOU-NH91,11640390,4.567382593568383,3.7676036048687056
MDA-MB-453,135440466,2.739035638886915,2.0452677376006
HSC-4,644241,2.6183127396598262,2.227448088916846
MSTO-211H,17755052,-0.0733710656781619,1.8568157411452932
A-498,crizotinib-PLX-4032 (2-1 mol-mol),2.697469324317316,2.222046793061248
BxPC-3,5281321,-1.5422365883768068,-0.6848295383718017
MSTO-211H,9444,4.1850544738080915,4.273856844920799
LoVo,17755052,-0.1303127354802701,1.5102200420805771
KMRC-1,44137675,2.117874577310701,3.887868240474875
A4/Fukuda,9911463,2.417745886609146,3.328058721508343
MSTO-211H,3101542,4.302130070317232,2.850821185732455
NCI-H146,426756,4.36191990335561,4.303837620660032
Panc 04.03,44589607,3.8783822611027454,3.176430673389751
G-401,24901704,2.2796887972749307,2.425875993817469
MSTO-211H,285033,-3.2380358495287695,-1.7327512893810484
BxPC-3,452548,1.628130986083035,0.7032832832464655
SCC-9,9926054,1.898935947612019,2.0106995877363065
MSTO-211H,1750826,-4.930051018535606,-1.6922214884647246
NCI-H2171,navitoclax-sorafenib (1-1 mol-mol),0.0359030592746101,0.7465883572957034
HSC-4,216345,4.5807127841732775,4.026042064029807
LOU-NH91,168312962,3.892175490150028,2.7080336565596155
MSTO-211H,53232,-0.5437095856797647,2.5891076764577807
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576,0.161745231609871
EFO-27,5335621,6.264647611417884,4.849336643049748
CAL-51,1716436,3.275997904874087,3.137104419148608
NCI-H460,53232,3.485336782178725,2.776235944284636
MDA-MB-157,54454,1.950382699789776,2.5944303610005095
NCI-H292,44489367,4.492014578968512,4.735632927664664
KMRC-1,4521392,4.136909747869898,4.199315974343899
HCC1143,selumetinib-PLX-4032 (8-1 mol-mol),-0.2774552513051289,3.151251123560509
HSC-4,56649450,2.6853332826773144,3.251957060452211
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.630341885481472
BT-549,9926054,1.9687680834705423,2.0301628753378016
SCC-9,9911830,2.3699428367857145,2.4721356007645063
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,4.212905111578933
FU-OV-1,409805,4.026686349090877,4.9182415841986895
BxPC-3,387447,-4.571753731996322,-3.8270517466199028
CA46,44486219,3.6158388001945463,3.9005841678773736
EFO-27,135659046,3.7618075322397297,3.708224384931512
NCI-H661,104842,-3.978937701952532,-2.7892692789256217
SBC-5,16741245,1.694771238369721,3.6524765238554893
FU-OV-1,676352,2.7826635655764473,2.0168363040870863
CA46,969516,2.1845952347247306,2.2037115977154462
ONS-76,decitabine-navitoclax (2-1 mol-mol),2.571137533276933,1.8037288624412056
HCC1143,9825149,3.0211594258387486,2.3890794782941027
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785,-0.4328605609744459
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935,1.5198711183764044
MDA-MB-453,selumetinib-UNC0638 (4-1 mol-mol),4.2655945403569815,2.507170234807026
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272,2.0713406258818834
MDA-MB-453,676352,1.703646310562033,2.0955287346932163
CAL-51,46191454,0.2698308836515951,1.5237743884406358
Panc 04.03,9823820,5.907522872650916,4.262663030375678
SNU-81,44259,0.6272555485824429,0.8006516007615306
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325,2.629239899212573
EFO-27,445455,4.405247459654703,4.835025491092043
BT-549,11152667,-0.4620191787747055,-0.14513289286581943
HSC-4,23725625,4.12890848458229,5.169900967005892
BxPC-3,11640390,3.353927872983648,3.7296895075722314
HCC1143,216468,1.9778651637296407,3.12021485858404
Panc 04.03,49766530,1.2448845141630578,-0.21108756797821657
SCC-9,10427712,3.976850957625781,4.411294166496454
HCC1143,36462,4.303888689757339,2.046765507277005
NCI-H460,262093,3.3627537421549314,3.115952897906179
SNU-61,56963564,0.6866306287041547,0.010271990250815427
SNU-449,2858523,3.0307383113048676,2.9765972024665706
KMRC-1,11214940,1.677559369833433,2.125498867875264
A2780,216239,1.3949646663017006,2.027424650216643
MDA-MB-157,89183176,3.472749903375588,4.533884784791223
NCI-H146,11152667,-0.8780602169524299,-0.56023386234499
NCI-H460,9956119,4.485375019847723,3.6712830941430843
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.0734156996597246
A2780,BRD-A02303741-carboplatin (1-1 mol-mol),3.111500594060002,4.258829862553913
DMS 273,6450551,2.589238729256945,1.678468787491582
NCI-H2171,5311281,0.8399284053106422,2.281608090244981
SNU-81,23635314,-3.737654632526069,-1.9032310453376093
FTC-133,119182,-0.5312905210850081,-0.7633354864265468
A2780,656346,0.4231070640442763,0.7357402037850467
HSC-4,441298,2.8371907900438535,2.6002514666671415
MDA-MB-157,285033,-2.194765851649468,-1.4705221262307895
JM-1,73707398,-0.8556338999048841,0.231959852335471
JM-1,6852167,1.3157742507093588,1.5066543061907527
A2780,11364421,-5.7057574677584295,-3.040392479234431
NCI-H522,54596490,4.410611853984333,4.183700908145303
NOMO-1,159324,1.6027654254866297,1.1731230163584412
A-673,107985,-4.827881226135439,-3.826522949990119
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.874549072416564
NCI-H661,5287620,-2.104840782561513,-1.7054117941288727
LOU-NH91,119182,4.180997641513534,-0.7295845772663738
SBC-5,10113978,4.162999994539472,3.1278860622532
A-673,252682,5.861850244558702,6.413005616337649
NCI-H2171,5281321,-4.274427204887198,-2.3184611138161384
EFO-27,3854666,3.6632128701571194,2.4054899556586102
A-498,25154868,5.700321852894753,4.355991848875634
LOU-NH91,JQ-1-vorinostat (2-1 mol-mol),0.7101877793592652,1.3910653047911112
CAL-51,31703,-2.726607914110417,-1.156254292542859
KMRC-1,9840324,5.892638074147807,5.785593768605628
BxPC-3,49850262,4.227475038244019,3.661127628909768
JM-1,6450551,1.340572992486765,1.0991491625119705
KMRC-1,148124,2.1112012667960656,-0.719803978750283
MDA-MB-453,navitoclax-gemcitabine (1-1 mol-mol),-2.0425828682575684,-0.6887530828496322
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528,-0.2856767438250423
NCI-H522,7326481,4.603358487226629,2.876452006880013
KMRC-1,3025944,4.220614757043024,4.272419804193723
EFO-27,9935249,3.352272124535396,3.2009569996301535
SNU-449,10296883,3.939630786750968,3.8821258504297815
A-673,42611257,3.360985567795572,3.248926003836333
MDA-MB-453,156422,3.699160121301749,3.8660484950802902
A4/Fukuda,89928392,-0.3543848103605003,0.41970658272774886
SNU-449,10385095,1.0986031812390589,1.631029840353529
HCC1143,6438330,1.6030228226948184,2.275379744627625
MDA-MB-453,3854666,1.8999840682298523,2.1742755922687422
SCC-9,46191454,1.8170261878735936,1.5716747521229038
OPM-2,9825149,0.9763440152106764,1.7755876277332812
NCI-H661,vorinostat-carboplatin (1-1 mol-mol),2.835829919183064,3.058767173550399
BxPC-3,25150857,2.298115585090939,2.7077720616261827
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033,2.534497662543307
NCI-H2171,25227462,0.3993487036849301,-0.2226250032879842
JM-1,24748573,1.2692721555493711,1.505551959702154
EFO-27,selumetinib-navitoclax (8-1 mol-mol),4.865349283387626,2.4509610403797204
JM-1,doxorubicin-navitoclax (2-1 mol-mol),-4.099692246271054,-2.5627717928832827
KYSE-70,5281321,-0.9979352327108848,-1.0789226585339748
NCI-H460,11507802,2.848054270429628,1.9569048895273864
SCC-9,4259181,1.940043087837339,0.4257140132426509
ONS-76,135421197,2.4329108516652775,1.9906357301133364
CAL-51,52947716,-4.729660133739893,0.22460479819061585
JM-1,123631,2.636256127990424,1.8886104963222314
HCC1143,1641662,3.4150871228937563,3.656217360869418
NCI-H292,8515,4.694095877434875,4.035774588647994
SNU-449,71304818,1.9790204353457292,2.7600656418638647
A2780,5566,2.7251077604344696,2.946934946978849
EFO-27,82146,5.16738023752069,3.872414999334666
NCI-H727,107985,-2.9799734550318204,-3.120582680057816
CAL-51,446155,1.9002286289262065,2.7977793055577367
SNU-61,4378219,2.193359587578685,2.435293689093824
NCI-H522,1641662,3.4912081270508293,3.108530124040229
FTC-133,44607530,3.0000417574370157,1.733503663178287
A-673,448949,0.8158812974066569,1.6896131785860602
LOU-NH91,20959075,-3.4746906487579494,-2.4619429787772336
SNU-449,5113032,5.017862259712187,4.904299755256641
NCI-H522,6450551,3.1458433056927295,1.8358508739280242
SNU-449,16659841,4.200866251374559,3.893568510164631
NCI-H460,409805,5.4278006548731295,5.217925226647188
MSTO-211H,46943432,4.749068259324704,2.963967749762179
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425,0.5655165339715906
ONS-76,navitoclax-MST-312 (1-1 mol-mol),0.8596431807362984,0.879635736148485
SCC-9,11455910,1.869884665357408,1.4405374796868935
Panc 04.03,613753,3.3040029053289772,3.345001262777265
OPM-2,6918736,-1.006954953557461,-2.115049487939422
A2780,3854666,-0.0414990172822217,1.1923578973760582
FTC-133,25183872,2.254027462535002,-0.6125964861396669
MDA-MB-157,387447,-4.079240132125457,-3.8198238741517074
SNU-449,54618771,0.9697829427454708,1.4101164478437533
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866,1.3276101756510363
MDA-MB-157,72376,-2.1484578807410553,-1.7927253367890428
SBC-5,5287620,-1.4097460130546278,-1.8752630454919474
FU-OV-1,54649381,4.3760479468817675,3.9828567059839384
NCI-H2009,26596,-1.5885219134108934,-0.964358410467151
A-673,66577038,2.223533674143975,2.821808613909692
SBC-5,6918878,2.928817535111611,2.827062694181336
OPM-2,11640390,0.8264429779628358,2.392945498986629
NCI-H460,3503,2.4668231300278154,2.382701451988935
SBC-5,156422,4.2102641448485345,4.205309826092238
ONS-76,216345,3.2166812322741043,3.761482304398748
BT-549,15983966,-4.218963036377602,-0.9412412079838838
A4/Fukuda,3038522,1.5780319148667876,2.940170044635285
BT-549,23582824,0.5256314804740283,0.7534952474762412
NCI-H146,2871966,-2.058689249756004,0.07100520354567638
OVISE,17755052,3.2346427318945263,1.8245631009296124
OVISE,44819697,-1.8576377458936848,-0.03532636589685924
SNU-449,46398810,3.267032406348896,2.8402253369822343
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727,3.0994501778631736
A2780,11228183,2.2113347222865123,0.8621474896629415
NCI-H1623,piperlongumine-MST-312 (1-1 mol-mol),2.715053183810439,2.060373331880494
NCI-H661,tanespimycin-gemcitabine (1-1 mol-mol),-0.3480588357963589,-0.46334956144781636
SNU-81,46398810,0.3023493978041217,2.2022313553216875
KYSE-70,11152667,0.5949086715112851,-0.44515447490837445
LoVo,73707386,4.416344333605744,3.0309677713062513
NCI-H522,5746,0.3558137383480795,0.5012984839639378
NCI-H460,135421197,3.2510260026522233,2.1162718986934563
MDA-MB-453,11507802,1.551744908234443,1.6208883999286425
A-673,4096211,1.8222389073608836,1.447292270378051
NCI-H727,136227924,3.2179651731130585,3.025873003577841
NCI-H460,16065773,2.454458456288103,2.5015379980872954
SNU-61,24901704,3.3171528895384115,2.84634223471073
NCI-H292,11612883,2.84187428422206,2.7991784838198224
NCI-H2171,9907093,4.086146580877247,3.525303728080269
NCI-H522,3634881,3.092168984490579,2.965431876678826
G-401,9915743,0.7240748800691799,1.2168900172383648
SNU-61,46843906,2.645147040347038,2.312599876997354
SNU-81,73707386,1.6277005390789234,2.868539909370183
NCI-H1623,4261,0.4244365105903193,1.665608968263424
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687,2.322059962119079
OVISE,1750826,-3.1689535405206715,-1.2247809389144084
OVISE,25183872,-0.2641805795712313,-0.5731597481985417
MDA-MB-157,753704,5.007751734334353,5.089232209132734
CAL-51,54618771,0.0049145289548569,1.4934921198206808
NCI-H661,25195348,2.4001868352132445,3.0987301393017996
KMRC-1,3689413,-1.8207429228817171,-0.848234631502076
HSC-4,650361,3.951915492066197,3.666763579666445
KYSE-70,10427712,2.9549225300897977,4.264255860441222
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842,0.9792933384173531
OPM-2,11717001,3.8340096164502135,3.821110314411494
NCI-H727,11214940,2.165075102098245,2.1374262755151
KMRC-1,11404337,1.3121470144090095,-0.3105028545166308
MDA-MB-453,24951314,-0.4314694021522904,1.3448751383257167
SCC-9,135398516,3.38372398158662,2.2247713568646716
KMRC-1,11977753,-0.1874629547163491,-1.5721938820107284
NCI-H2009,25062766,1.439977805675878,2.059140514776066
NCI-H2171,6918638,-1.5146784294865197,0.009482462901763133
Panc 04.03,3081361,3.5741960453568464,2.515296542797011
BxPC-3,73707398,1.0061551215696194,1.556914288339978
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361,-0.9538615825002436
BT-549,11404337,-0.1293922368150601,-0.3637624103205447
SCC-9,5281321,1.285660121438517,-0.48428090882609287
SNU-81,104842,-4.044454085478647,-2.4724535018232894
CAL-51,6610216,4.7761200098267365,4.245190787412404
JM-1,9933475,1.5625695981291614,1.065514238320854
NCI-H727,11485656,2.2939690780404423,2.265450656948828
A2780,426756,4.623757394028108,4.082405133703848
A2780,5311,0.5155233924036543,1.0670169313479223
NCI-H146,11707110,3.3128142773805176,-0.32171865154015195
MDA-MB-157,11977753,-1.6055696025393866,-1.1306330751915725
A4/Fukuda,11494412,-1.359408079628026,0.47536874202425766
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097,1.5380953494059233
LoVo,11977753,-2.85765012298846,-0.8256557867904047
FU-OV-1,56963564,3.5833852081145836,0.6663694757758007
NOMO-1,375860,-0.5184264862355304,-0.3788010154435903
EFO-27,3136844,4.472321824110979,4.402838744430768
MDA-MB-157,selumetinib-BRD-A02303741 (4-1 mol-mol),5.186273377251054,4.040704879552519
NCI-H292,168312962,3.5892294654935726,2.3662832422017597
CAL-51,44607530,2.3415901962162855,1.8541060505469316
EFO-27,2949965,3.1309950522818277,2.7804729496125766
DMS 273,carboplatin-UNC0638 (2-1 mol-mol),3.439220302346012,3.2517107081301915
A4/Fukuda,12001922,1.2276815023009988,1.6450762608062026
CAL-51,24951314,1.3730048574034712,1.2693087655870006
A4/Fukuda,135928012,2.23734461349398,4.009440337382142
SNU-81,10127622,-3.2164123245129095,3.2177658339853816
MDA-MB-157,navitoclax-PLX-4032 (1-1 mol-mol),-2.380477221349832,2.231541097259975
NCI-H2171,decitabine-navitoclax (2-1 mol-mol),-1.124671467486642,0.20226105884644288
OPM-2,122327,3.690232587907526,3.774463478058487
NCI-H522,5329102,1.9502496806074603,1.9111033661085923
NCI-H2171,9903786,1.7901794952315444,2.746214372497862
HCC1143,SNX-2112-bortezomib (250-1 mol-mol),-0.3762551319629964,-1.0358894442284794
YAPC,676352,2.46422610000008,2.117469734654196
NCI-H292,44507138,1.692325111571909,2.5757128029677574
SNU-449,2945648,2.540265867455936,2.980089556551556
MDA-MB-157,navitoclax-gemcitabine (1-1 mol-mol),-2.3120540291625766,-1.2579483811995669
A-673,3136844,3.9161258830055736,3.799274636636693
OPM-2,151289,0.8971834485048114,0.5873626775630701
LoVo,219104,3.1119995266948237,3.8095827762577796
NCI-H1623,9936388,-4.968103162812744,-0.41324859152087595
DMS 273,11485656,2.8704893197930272,1.9728213451885253
LoVo,73707398,0.5951327141059009,1.3908190085182814
NCI-H2009,135421197,1.5480281661357902,2.172595496737936
NCI-H1623,409805,3.8984511674912943,5.043803361373401
CAL-51,1750826,-0.4147302595408071,-1.2128915167718555
MDA-MB-453,54143018,-0.7571444922765344,1.1270464323893123
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203,-0.8795207102711337
HSC-4,54619267,4.093335991980471,4.21443502470159
BxPC-3,4378219,2.0321108717651426,2.359625985646745
NCI-H292,5978,-1.7096488796134024,-1.645949026764091
A2780,71466380,3.7792629508428783,4.286921066649531
MSTO-211H,44589607,1.2735087838172758,3.1692633917420867
NOMO-1,54143018,-1.1216489579847602,-0.515276815633695
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857,-1.3577090987142761
A-673,46174525,2.7075701285598375,3.461830952231078
NCI-H661,3854666,2.0669995151297633,1.8978787365220333
NCI-H1623,322968,2.7878661836218863,3.948045383561573
Panc 04.03,52947716,3.0713971775620448,0.4702552860315742
DMS 273,9840324,6.645778367521572,5.379525894494022
NCI-H460,15547703,4.965379127843483,3.185471333336167
FTC-133,11228183,0.2445093238012437,2.435317971532277
NCI-H522,9935249,3.002706281912375,1.8244779676466067
NOMO-1,6610216,4.0700997553747325,3.9781359757863894
A4/Fukuda,46199207,1.9027513858957976,2.8155699999654575
EFO-27,16659841,4.389988364450653,4.124609643108134
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278,2.4441074265608727
CA46,11977753,-4.21997551918338,-2.57947812646036
OPM-2,tretinoin-navitoclax (4-1 mol-mol),3.1299009016579253,0.7068681902910504
SBC-5,54613361,-1.7173374464522142,0.15495256074827998
MDA-MB-157,16065773,0.9216763205067852,2.627562332681559
NCI-H1623,selumetinib-BRD-A02303741 (4-1 mol-mol),6.385895152539582,3.400948920207118
SNU-81,44137675,1.234825635215107,3.406069430787498
OVISE,9929138,5.66720682434708,5.2911251744182834
Panc 04.03,16725315,5.278537246983346,4.652311369519199
A4/Fukuda,6438330,0.8804707138455458,1.533865833968146
NCI-H292,984333,1.6058463338689488,0.9112057672683617
NOMO-1,11396600,3.3888037624860674,2.653799455264429
SNU-81,24964624,0.6434241987426411,2.007760465501344
BT-549,11964036,1.9997330886235436,1.7579228561019975
A-673,135411,0.3370419809316401,0.4067544474207234
NCI-H1623,10296883,4.489600285768525,4.035199353498093
NCI-H292,2733526,4.552154891253422,3.8859136945482255
YAPC,6914657,-3.2827547721856423,-3.839726685243659
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459,1.7362151228818765
NCI-H2009,327653,3.1880644035572825,3.4084503776385366
CAL-51,3384730,2.4775948365465905,2.927229979132588
FTC-133,3689413,-0.3036251064519336,-0.16156476720889848
MDA-MB-453,11964036,0.3676608059270313,1.1984339854249377
NCI-H2009,5281321,-2.3281539094269843,-1.1096120570818502
FU-OV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.708642246881296,2.1016401280531447
LoVo,654092,0.3814222362545946,-0.15161402243819785
MDA-MB-453,50905018,4.488581944485688,4.261952318103073
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736,3.0934863971561812
OPM-2,46215462,1.142494911690201,1.0391528636805856
SCC-9,navitoclax-PLX-4032 (1-1 mol-mol),4.098864709147574,1.8962336844862142
A4/Fukuda,5329102,0.822909221294871,1.356486738211436
A4/Fukuda,11228183,1.827405863351363,0.8215533929503992
Panc 04.03,5460769,2.0457621674825224,2.564771091513094
MDA-MB-157,9933475,1.5029335433067268,2.026999664011637
A-673,12003241,-2.2168793422392103,-1.387911733698707
NCI-H460,54618164,4.49670945938676,4.052139408921185
NCI-H292,11656518,2.099021496243428,1.9930940556435797
SCC-9,51039095,3.242385267473305,2.99913759450389
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685,4.381985049895488
SBC-5,3634881,3.763213110876527,3.321068177656643
SCC-9,984333,1.3591962563360305,0.9673331788244682
CAL-51,72193861,0.6423702350358801,1.5705410825137494
SNU-449,6610216,3.892858260461962,4.246585311320098
HCC1143,6918837,-2.8885170378203995,-2.599328083949415
DMS 273,10427712,3.7833762157010655,3.7304405280502926
SBC-5,ISOX-bortezomib (250-1 mol-mol),0.5037473854516791,0.6736630931191442
LoVo,8515,2.0502092932288543,3.8831916172014376
ONS-76,5311281,3.0534152046102507,2.461828942210663
EFO-27,100016,6.711163327148508,6.293837722546321
A-498,6610216,4.284288503720797,4.373244247205641
SNU-449,docetaxel-tanespimycin (2-1 mol-mol),0.921733403174168,-2.2494118459214594
G-401,71466578,3.958692091033976,3.599175185820909
A2780,2749,1.2168739363641357,1.3589315830550686
LXF 289,23635314,-2.0420734326640253,-1.737363517542508
LXF 289,24901704,2.332916050939017,3.2410035517738898
LoVo,9887053,2.8676927346989265,3.8975586483310183
OPM-2,6918837,-6.102124609605729,-4.58922092052255
NOMO-1,72734382,3.160209893803666,3.595060383367427
A2780,44507138,1.3155442648841038,2.2433298128652184
NCI-H661,9915743,-0.8538809858854721,0.973770849712166
SW1463,168313047,-3.1836020137929246,2.3860306724678466
SNU-81,55283,4.080745185244615,2.5625632487765655
YAPC,159324,3.323857793241652,3.1725510243914727
HCC1143,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9300366262923152,3.7220606788800983
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194,2.6420695843514794
A-673,31703,-3.778183583095139,-1.612028967337028
OPM-2,439501,-4.648238189793765,-2.115208738789276
A2780,452548,-4.864509732913544,-0.9111432986731974
CA46,71304818,1.9606514180280712,1.8278605821493354
LoVo,25150857,3.1045912764862056,2.4476968026389287
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915,2.1907101958419526
OVISE,446155,3.256033609420766,2.600447080650004
SBC-5,54626689,4.608121703383126,4.459337532885617
DMS 273,11497983,-3.3171386440582467,0.7546462180210274
BT-549,46398810,3.037551805065761,2.6815909889124323
KYSE-70,44819697,2.67312291481412,0.31319482269140764
DMS 273,10113978,3.3411401717417135,2.8839888658626087
YAPC,11178236,-2.1853000629740342,-3.085707641856366
EFO-27,89928392,2.3405290602814586,1.7379247773744015
NCI-H727,3062316,3.1124899612632135,1.2722118113801784
MSTO-211H,9825149,1.7087798179810727,2.3153045567326287
OPM-2,25062766,1.526966504091227,1.6949551403219243
LoVo,24797083,1.0858534416002044,1.3885877610964998
MDA-MB-157,11612883,1.9249665557248452,2.8069645055773393
MDA-MB-453,24978538,2.762094535978925,1.1067912035453702
A-673,55283,2.8138583621562288,2.469186447353861
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781,3.7612533224127684
OPM-2,11228183,2.227238978219669,0.32281319114288587
SNU-449,11640390,3.8548607423510384,3.5862658502174027
NCI-H522,5281321,-1.0736628447197911,-1.35144684132508
NCI-H460,25126798,4.092385726400508,3.783593214419332
JM-1,9887053,1.8224498727300744,2.4225650748484004
MDA-MB-453,3689413,0.605092083526794,-0.038528246143502295
BT-549,322968,4.038930181616003,3.938763527036688
G-401,969516,2.4612878169829067,2.4112966745216293
FU-OV-1,10127622,2.361983631252389,3.6498693542225684
G-401,5738263,2.503403034491448,2.8043183971908503
MDA-MB-453,5328940,1.6011356292327752,1.7357145841004669
HSC-4,25105715,3.6888708464756337,3.356169288304744
G-401,5291,3.6897209629580616,3.4423412026102698
SNU-81,148198,-1.0516438667772403,-3.5295879920228104
FU-OV-1,25183872,1.8271723160300688,-0.5464079851899889
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.906422364460267
JM-1,9935249,0.9666917954448688,0.6953936765766402
JM-1,44607531,1.0390724505323097,1.0730657878314287
BT-549,5566,3.2694223641451887,2.8542131765058487
LXF 289,637858,2.285720521187594,2.088595716223057
SNU-81,56946209,-4.781557694686043,-4.146259705705879
FU-OV-1,89928392,1.4286122200262183,1.7573832508683183
MSTO-211H,doxorubicin-navitoclax (2-1 mol-mol),-1.8407653022035375,-1.2065108036551653
CAL-51,54618359,4.544084907505638,1.7013059311423921
LoVo,15983966,-3.091518031584947,-1.1889102105393041
CA46,5746,0.6077367646083516,-0.8843333840294848
CAL-51,2733487,8.211583338705053,6.1042327713947815
NCI-H522,4705,3.8595388748644375,3.104122698009806
A4/Fukuda,5284329,2.3119801528783244,2.8496574072506706
DMS 273,ISOX-bortezomib (250-1 mol-mol),0.050266361305609,0.3000612363625209
OPM-2,6505803,-0.5489645461029444,-1.058724707171025
NCI-H146,11955716,-2.61946993472624,-1.5104143394126013
Panc 04.03,19582717,5.125237161512837,4.5101474926311855
LXF 289,9926054,2.043368643335034,1.9601339813116452
BT-549,136227924,3.266068806496957,3.1155473486292067
LOU-NH91,24901704,2.9181520482303585,3.4052113546972786
A2780,11167602,1.1290528312474395,2.005286164494115
HCC1143,15983966,0.2074313732487278,-1.5701185196621075
G-401,piperlongumine-MST-312 (1-1 mol-mol),1.0766364038162666,1.4007778885182827
JM-1,2871966,-2.1290689366468354,-0.4815113447615864
FU-OV-1,6852167,2.292876265150526,2.6505182504777496
MSTO-211H,31703,-2.679199045886266,-0.8863802720092147
BxPC-3,5335621,4.830409945539455,4.378438871876807
SNU-81,6438330,3.0600940001891863,2.0633628514710463
CAL-51,6918878,3.0110486558166274,2.8027907357683675
LXF 289,6610355,4.558728947318035,4.662857788527589
KYSE-70,12001922,1.7900886800743383,1.9596010313167904
BxPC-3,60168763,4.708123265391542,3.19009385353616
CAL-51,44137675,3.485867182081199,3.227108455436554
SBC-5,carboplatin-UNC0638 (2-1 mol-mol),4.8107215741986105,3.1934870052680306
NCI-H460,216345,3.827300936034388,4.075262535339399
NCI-H522,15953870,3.615553645162116,3.3232797356087707
A-673,46199207,3.2534509529249176,3.1352797407986164
SCC-9,10127622,7.404435857651999,3.552120361808252
Panc 04.03,11977753,1.829262770264154,-0.894350974617832
HCC1143,168313047,3.0210205197435935,2.471612101295289
EFO-27,3465537,3.52414234339403,2.4843075355663347
A-498,462382,4.566729065673536,0.4487059298465882
FTC-133,45279963,4.126382655862848,3.776200452561855
G-401,71751553,4.092007605377758,4.172114215150923
MDA-MB-453,119607,3.891659451485504,5.005103743660296
MDA-MB-453,3384730,-0.7236289420344145,2.9682035157640136
SNU-61,6184667,2.8549853776409937,2.6723003232492157
NOMO-1,23635314,-2.3321691272104697,-3.1331136527921144
SNU-81,54618164,-0.3986435357924686,3.793144809941936
NCI-H727,65064,3.1010913931031867,4.6838799137564635
CAL-51,44607531,1.640429423812436,1.4980942075472836
CAL-51,72376,-2.938334648898351,-1.7238021737529277
NCI-H522,126941,-2.655181013676553,-2.472955558582325
ONS-76,3025944,4.431691617199171,4.227833587580159
NCI-H460,25154868,3.4600493825904564,4.323912535398794
FTC-133,71304818,3.18789827914798,2.530243804493154
CAL-51,151289,0.6583498849401344,1.100730161785548
LXF 289,11238147,3.4273419568352006,3.0700535340535042
BT-549,BRD-A02303741-carboplatin (1-1 mol-mol),5.675509495895237,4.684126303742769
KYSE-70,702558,6.39879445367054,5.140883645343738
CAL-51,124202324,2.033990287468598,2.5088995918763723
MSTO-211H,46907787,2.574686905184434,2.502010570796635
MSTO-211H,4521392,4.029667841571139,4.271095821171836
EFO-27,ISOX-bortezomib (250-1 mol-mol),0.3269008359156463,0.6773761679914003
A2780,9549297,1.1491610880845489,2.005051709040274
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277,-0.2411514460130466
NCI-H2009,2729026,1.97459320968498,2.7442999116485605
HSC-4,5311,1.8002123285320597,1.5726003909737047
YAPC,135398738,5.4751822545753415,4.373574581729536
Panc 04.03,285033,-1.1400173305697017,-1.4975961278824224
OPM-2,decitabine-carboplatin (1-1 mol-mol),3.56587263318402,0.48999624193971153
A4/Fukuda,71466578,0.6387062903604859,2.6066543943050204
CAL-51,135398738,4.757337519270393,4.475166130548332
A2780,selumetinib-PLX-4032 (8-1 mol-mol),1.6060841409900903,3.8634696961809247
A-498,24785538,3.3641680302296564,1.835482154315843
HSC-4,452548,-1.2537746146037845,0.2941736017242442
NOMO-1,6918837,-4.687337521865761,-4.354832872298725
A2780,6505803,-1.803583295606165,-0.5871383767724685
YAPC,387447,-2.999100837413036,-4.098091547197067
NCI-H292,25183872,-0.4983801682636667,-0.5976205209442939
NCI-H1623,44137675,2.921297693984664,3.5356772500191895
LoVo,46843906,2.381362357237743,2.871675297479931
MDA-MB-157,5281321,-2.46264909171439,-0.6900915363627554
NCI-H292,44137675,3.1459685562862707,3.7122002539019237
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106,1.0697119581222363
JM-1,5470400,3.917661049847631,0.09854315535811553
NCI-H522,52912189,0.1662181985496506,1.7077610638002496
MDA-MB-157,15983966,-4.787780953616188,-1.2150354059637463
CAL-51,10322450,3.881825194853649,3.9684901387647504
CAL-51,6918837,-3.0563476396929703,-2.474520246935824
NCI-H661,54639126,4.507619035006863,3.5667231105472457
NCI-H661,5311281,4.526772174839299,2.38508397011628
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.1823273100460088
LXF 289,3025986,-0.453776319374568,-0.5533676405253088
Panc 04.03,25262965,-1.014076783670677,-1.284354067893654
MDA-MB-453,5746,3.800897853250581,0.5411864888312222
SBC-5,15953870,3.487984127844562,3.377739024804331
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557,2.0357408968919812
OVISE,3025986,-0.0395702470459638,-0.8094020664121468
FTC-133,5311,2.4215013743463647,1.5398957076441706
NCI-H2171,11485656,1.3701169509015756,1.9581827057078809
A4/Fukuda,5282054,2.418862118344995,2.8844245749308555
NCI-H1623,25102847,3.8675819706398418,2.3847933973510784
OPM-2,984333,-0.0237710386013994,-0.21823131384021083
FTC-133,387447,-3.6414317999651336,-3.948384893843404
BT-549,5311281,2.333978253730499,2.615096244275698
OVISE,16720766,3.986904391501256,0.9522507753264204
NOMO-1,11612883,1.4996443311921075,1.7838208183222386
NCI-H146,5282054,2.6062567229872924,3.1655785716607023
SBC-5,6917907,0.6114763356012877,-4.944189989531118
NCI-H727,24951314,2.050368453430269,1.2329686626062626
MDA-MB-157,613753,2.6621381248494456,3.2104934480908476
JM-1,44486219,4.06629583721778,3.5870424601703497
CA46,285033,-4.358161131916293,-3.5791332944290044
A-673,9952709,2.6406542482442545,2.5424055032563158
BxPC-3,124202324,2.2278087185314694,2.4602600834806347
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.5529079271037503
A-673,6852167,1.8255345198368305,2.1776486164007873
NCI-H146,6610355,3.561762383324193,4.248273255738352
NOMO-1,46215462,1.6253213091786816,1.1909040329647038
CA46,439501,-3.521132637790176,-2.322960044051956
KMRC-1,5329102,1.6227643750477536,1.7299622534371597
MDA-MB-453,568763,0.1355288059345826,0.6598267288083849
NCI-H2009,15953870,4.632669867834425,3.674279461835506
G-401,16725315,3.2068580834321048,3.7380335035022405
SNU-81,25154868,4.054299809836995,4.127131235261195
SNU-61,2742550,3.576212598776706,3.433712682896479
BxPC-3,44589607,1.722183316619471,2.978445751729241
SNU-61,3025986,-0.1307165413786875,-0.9493044058020237
NCI-H1623,3062316,1.6941172744123574,0.7733576796713894
ONS-76,16115403,-5.005393778847352,-3.597857950681255
LXF 289,12003241,-2.348837864712453,-1.0342730589709206
DMS 273,168313016,5.378851860414917,3.9263000936720793
CA46,54765302,3.694944477545822,3.296784254994104
MDA-MB-453,vorinostat-navitoclax (4-1 mol-mol),-0.1886705997266854,0.8927026015253045
A2780,10113978,1.7525717433500034,3.0115055256753083
OVISE,9911463,4.4041109725525525,3.773076636913851
ONS-76,44589607,2.6985455021272573,2.877783336147491
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965,3.8847734819417443
FU-OV-1,JQ-1-vorinostat (2-1 mol-mol),0.8626774662663057,1.1826210389509635
NCI-H522,JQ-1-UNC0638 (2-1 mol-mol),-1.3225503189993402,1.258527501390799
A2780,26596,-4.32263985415392,-1.7965006902339042
SNU-449,53481919,3.639889931386733,3.870532451035473
A-673,135875424,2.9734448822107886,3.511855726010189
A-673,49867926,4.049605811998934,3.3331088871931325
MSTO-211H,16720766,-0.9979081980160748,0.4112844834905902
MDA-MB-157,24785538,1.324170410962965,1.7165089329842187
CAL-51,107970,2.299284460939792,2.219160711494936
OVISE,11178236,-4.082767785475175,-2.8525676735411065
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941,2.1369806908069062
A4/Fukuda,25154868,2.544294393199085,4.120568735879754
CAL-51,46191454,0.2698308836515951,1.5237743884406358
NOMO-1,136227924,2.5449106490851263,2.409519169574971
KMRC-1,24821094,3.705597482955712,2.633338462817852
A2780,5282054,2.567919090275208,3.0798541179550405
NCI-H2009,11404337,-0.0657811746758558,-0.04001745178036054
HSC-4,409805,5.399675964474335,5.13616093277947
LoVo,24772860,-3.380615847351667,-1.883321000967922
MDA-MB-453,54626689,4.438407624810902,4.630139577286767
G-401,104842,-3.837747012299513,-3.8723471356454375
BT-549,135440466,3.2033555971359267,2.4167833095900333
MDA-MB-157,docetaxel-tanespimycin (2-1 mol-mol),-4.4000012039018594,-2.667300607585339
NCI-H460,5280436,4.847067650781305,3.476062910364028
NCI-H727,10385095,1.3903964913374658,1.269295049719628
NCI-H727,262093,2.950291125725139,2.889749242336313
CA46,25227462,-5.088225796968986,-1.7741828311606564
HCC1143,439501,-0.7374061663212956,-2.090460332783185
MSTO-211H,10113978,1.403014421240365,3.6205707214550777
SNU-449,72734382,5.7131640484247805,4.853439596354031
MSTO-211H,tanespimycin-gemcitabine (1-1 mol-mol),-0.5272277437526489,-0.5424553856207568
MSTO-211H,selumetinib-decitabine (4-1 mol-mol),3.004409574636068,3.5029961945198353
BxPC-3,24772860,-3.1359973170310993,-1.4640797937212127
LoVo,5281321,-2.272723057934536,-1.353732610053479
FU-OV-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9353082171221765,2.2265501688386844
MDA-MB-453,10427712,3.2513664008238874,4.076024355370363
Panc 04.03,53495165,2.8699642151767746,0.6988823388963139
FU-OV-1,54619267,4.302850520300199,4.165212554624136
MSTO-211H,24964624,0.1425074184859401,2.540332065137498
G-401,135875424,3.147536590476696,3.3842975920237945
ONS-76,selumetinib-tretinoin (2-1 mol-mol),-0.7324247564116871,2.6788320318645265
A-673,selumetinib-UNC0638 (4-1 mol-mol),2.386430695912322,3.09850127643069
MDA-MB-157,9967941,1.858403940770751,3.578313410951611
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368,0.6980504486587553
NCI-H292,11497983,4.544493181272098,4.516005538638338
HSC-4,3011155,4.427149856421904,4.040252497165507
NCI-H1623,17755052,0.7357373094762232,1.7994749945760555
SNU-61,navitoclax-piperlongumine (1-1 mol-mol),1.6755715296131175,0.9500331086768634
BxPC-3,5746,0.9856415477525818,1.3262059438439444
OPM-2,24901704,1.9220236520558196,2.58793291199195
MSTO-211H,2858523,3.0747353868294627,3.025256035610717
BT-549,107970,2.9169966931039113,2.3200650276610073
NCI-H292,135875424,4.14052752249008,4.215096903876297
LOU-NH91,107970,2.5070848864255093,2.3878995217146284
MDA-MB-453,6918328,-2.060631340343386,-0.3997322798463253
KMRC-1,44566777,-0.0538941449270197,0.6912984969170622
HCC1143,17755052,1.15684078766818,2.016300740410256
Panc 04.03,9956119,4.202347043107845,3.7975805158953193
G-401,54613361,-0.5160099475891917,-0.38479743046555526
NCI-H460,6918837,-0.9355989207233988,-2.2371109814914187
SCC-9,10302451,2.205114392498864,2.9289357795274746
BT-549,24856436,0.2415814283223239,0.6854934097711011
Panc 04.03,25150857,3.139734816867742,2.57861786836351
A-498,9866186,-1.262750837313692,1.14056301552947
SW1463,11497983,4.077621288565615,1.1448047389840132
LoVo,124202324,1.6089295836770297,2.3896602890808505
JM-1,46215462,1.389060279673689,0.9677803140111572
A-673,2729026,1.806074207860909,2.3495145228668775
MSTO-211H,241158,2.290519528489604,3.87080816538286
A4/Fukuda,6917907,-6.123586781218294,-5.596503213344156
NCI-H460,11485656,2.6212830818798065,2.5777793650220207
A2780,135875424,2.703796648613349,3.5357539050412474
NCI-H292,10127622,7.746640801358069,3.9758221319050695
DMS 273,9887053,1.8082863610482875,2.784356421677454
EFO-27,426756,4.432789586131128,4.453018037131797
MDA-MB-453,2749,0.298775024907787,1.8663973535741036
NCI-H460,11222830,2.8861636193629323,1.7342167646600135
NCI-H460,119182,0.2489341964189734,-0.5931872737672363
MSTO-211H,676352,2.2606828184976955,2.1301384487081925
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816,1.4015919899424971
SNU-81,16736978,0.587276282018702,1.631287433987961
BxPC-3,10113978,2.7603674185652536,3.5132337666437063
SCC-9,6505803,-0.8932206272709824,-0.43294343305294825
HSC-4,122327,4.034102983304833,4.698145740539448
MDA-MB-157,107985,-3.8805729202788304,-3.393798155975461
HCC1143,5566,3.096162587379626,2.8688865821875096
BT-549,5738263,2.4683192628765753,3.458385053727319
A-498,3854666,2.914304878080617,2.6100463112709575
SNU-449,navitoclax-pluripotin (1-1 mol-mol),0.5416887924611083,-0.5117008572278555
ONS-76,73707398,1.7098056225756528,1.2700186677818186
A2780,10322450,2.9165978660974545,3.415405822852859
CA46,3062316,1.4079672687586804,0.3556661108561282
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664,2.058971666377167
BT-549,71466380,5.5332032048485065,4.514328374766326
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198,1.2128992730100974
KYSE-70,24180719,3.52071426185984,3.1520579602370744
BT-549,10385095,1.777553004720717,1.2711320421646617
JM-1,4259181,-0.0762731042787348,-0.7092182139627468
BxPC-3,12003241,-1.7282705692868598,-0.8073170890656323
LXF 289,9840324,4.681234496405457,5.808944936311848
KYSE-70,17759555,3.816264723168541,3.3504886119486628
NCI-H292,9911830,2.887423578139022,2.609081974159174
HSC-4,9840324,5.223554072523372,5.71893793180769
G-401,selumetinib-UNC0638 (4-1 mol-mol),3.413545127228383,3.0422072003960956
A2780,9915743,1.3754925129164983,1.1832821970304415
NCI-H2009,10302451,1.2105403110698565,3.07599825638653
JM-1,tretinoin-navitoclax (4-1 mol-mol),0.3453404774126501,0.2941720528048931
ONS-76,9935249,3.5330143946083874,3.0113789993395743
BT-549,11427553,2.4752578658091524,2.9304077916758677
G-401,148198,-4.717755806624399,-3.9859062838114085
NCI-H661,JQ-1-UNC0638 (2-1 mol-mol),3.1332466289853884,1.6676151749172465
NCI-H460,5351362,3.0809857123464037,1.7536508855878568
BxPC-3,5978,-3.126756112961715,-1.237632923447917
OPM-2,11396600,1.8817984525619431,2.457003128300107
A-673,5328940,0.9058407904985936,1.595676539091925
LoVo,16720766,-0.1141862087465287,0.5526546461508225
LoVo,11404337,-0.8407014552816361,-0.42935301421524774
JM-1,11455910,-0.0097968256607179,0.3822155777059655
A2780,54686904,3.0280150906907206,3.2236861246814112
G-401,selumetinib-decitabine (4-1 mol-mol),1.9675825066475652,2.304178307642714
SNU-449,9956119,3.198924280342594,3.689976855589867
OPM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.9902018365290752,-2.5741488535862853
SNU-81,60700,-1.0304958014583914,-0.6668637162119824
SBC-5,navitoclax-PLX-4032 (1-1 mol-mol),2.6386672409141756,2.065287078080683
Panc 04.03,216468,3.559067681626077,3.6303328562268846
OVISE,46398810,3.0089868889673426,2.631173928853566
MDA-MB-453,11494412,1.83607541398336,1.4673789689606156
NOMO-1,409805,3.6617718212828874,3.7485464748572195
BT-549,25062766,0.9643791751629904,2.300860799349765
FTC-133,446155,0.3759987857405991,2.6906407164635864
KMRC-1,23635314,0.7760380281113136,-1.3941166268661798
SW1463,15953870,3.283482316204368,3.59885629670077
LoVo,46943432,3.050109964187685,2.7202397841779793
HSC-4,46907787,5.727789952108257,1.9750468032888508
BT-549,navitoclax-MST-312 (1-1 mol-mol),1.130665765716481,0.9279893451771842
FTC-133,135440466,5.15132472260749,2.322385999794791
SW1463,568763,0.7789022422759734,0.021565791203272653
JM-1,25150857,0.7748927856999902,1.6507291431439575
A4/Fukuda,71304818,1.5363144884487692,1.9714318083987594
HCC1143,tanespimycin-gemcitabine (1-1 mol-mol),0.1249858816054574,-0.5579534409455317
NCI-H661,24785538,4.2805678056942,1.8210660012144597
FTC-133,5282054,4.434007222498336,3.806898626711387
A2780,613000,1.210736664046428,2.3608763017813557
SNU-449,6852167,2.6501635563943977,2.8818014071315408
NCI-H1623,5280436,2.3425513929901043,3.511784075819665
SNU-61,11625818,5.738401007397874,3.8613789211971783
NCI-H146,selumetinib-tretinoin (2-1 mol-mol),5.090146461709555,3.394650349766079
G-401,selumetinib-BRD-A02303741 (4-1 mol-mol),3.259716171612134,4.181439038357262
G-401,11396600,3.403558125152034,3.4205173109813902
LoVo,11396600,2.965288622606591,3.826689337245217
YAPC,5311,2.641039705119952,1.5796152594190733
HSC-4,168313047,3.0036663016787015,2.3305503587409624
LXF 289,135440466,1.0541158239349229,2.1128135096874066
FTC-133,navitoclax-PLX-4032 (1-1 mol-mol),5.2980010762745415,1.6255867562276847
SW1463,16720766,2.9834843450585193,0.6033459250315124
Panc 04.03,2708,5.3340089352485816,5.088083796519142
MSTO-211H,11612883,1.8196539401694043,2.975508941811425
G-401,219104,1.9483296496250493,3.108100089046134
OVISE,3854666,4.260793298508907,2.470873490960464
JM-1,327653,2.4402793258430786,2.5305332965896916
SNU-449,984333,0.3609894515007521,0.9316601303844082
NCI-H146,40482356,6.02837292181762,3.648604476406703
NCI-H2009,selumetinib-navitoclax (8-1 mol-mol),-2.134794996272836,2.3213443433032936
HSC-4,9952709,2.643320259436509,3.0038098460665914
CA46,71680916,4.255070441315874,3.7440846951939584
MSTO-211H,119182,-3.3068023354733156,-0.6401425910497461
HSC-4,4788,5.270141450772874,5.636466088707823
MDA-MB-453,11612883,2.003650622053601,2.8537155411499917
A-498,2729026,3.0720683032694827,2.823563673323618
CAL-51,135659046,3.6035863494873137,3.494189424112375
A-673,16736978,0.9204710311128564,1.3470251914388627
SNU-61,selumetinib-navitoclax (8-1 mol-mol),-0.634937533687344,1.7439249686774738
G-401,5335621,4.041162639386401,4.101676185114593
NCI-H292,11647372,0.0082735983152987,1.5365368732035907
NCI-H661,46191454,1.844409109204796,1.9013494822129573
NCI-H460,439501,-2.362377537788676,-1.984724862445802
NCI-H146,BRD-A02303741-navitoclax (2-1 mol-mol),-1.9757799692204725,1.294840745819153
JM-1,navitoclax-birinapant (1-1 mol-mol),0.1360362208330573,-0.01684021337127257
A4/Fukuda,5328940,-0.5379688872377596,1.3005789766390508
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125,4.654258430466674
LOU-NH91,25126798,3.943021506059378,3.955352379353441
CAL-51,56963564,0.4281851677964957,0.47519450666332314
Panc 04.03,24785538,2.964340727211602,2.0333194249951783
SNU-449,56963564,1.9660320048352,0.4490172584613132
SBC-5,156414,2.5142262290401516,1.198529502435667
FU-OV-1,46398810,1.7086224401878771,2.5834242848355813
MDA-MB-157,426756,4.156862898324412,4.407367588872931
G-401,4521392,4.161493335374481,4.03756079869325
OVISE,36462,4.611657944155446,1.9327290338783474
SCC-9,serdemetan-SCH-529074 (1-1 mol-mol),2.940999186382139,2.120122684186084
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918,-1.5681606571824735
CAL-51,5351362,1.1872361858703535,1.4360377456966307
CAL-51,119182,-1.323881847361974,-0.8089971627141775
NCI-H522,24753719,5.009376195679754,3.7876940856462107
JM-1,tretinoin-carboplatin (2-1 mol-mol),2.443432654603248,3.189252769931839
HCC1143,9915743,0.7364353129897024,0.6465640846686231
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.906422364460267
NCI-H522,24889392,3.251100273050004,3.7806888346695797
LoVo,11178236,-1.6059359070935737,-3.1150956771016935
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212,3.9550648189712816
CA46,23725625,5.582899861703026,3.3614145160556133
NCI-H460,25154868,3.4600493825904564,4.323912535398794
CAL-51,36462,0.7338920585832341,1.9892794746961158
EFO-27,5281321,-1.9543223460886947,-0.9998897818427277
LXF 289,11612883,1.9814919247106189,2.929025769023758
HCC1143,2828334,6.454192166435682,6.265043810300394
A4/Fukuda,3854666,-0.0838776105349313,0.8207037962198992
CA46,10322450,2.6264913036213606,3.065494189800177
NCI-H2009,51039095,1.8360035457780568,2.8798652376555482
BxPC-3,10231331,0.6961573218104748,2.054972708881218
LOU-NH91,56649450,2.5557041031897705,3.711465404406573
G-401,216239,1.6826916037000108,2.1119984578555675
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.3151522255566954
HCC1143,5281321,0.7613054606946723,-1.0048763703206225
EFO-27,72376,-1.8608022629783372,-1.3367001936428904
NCI-H2171,19582717,3.772812394316534,3.307219406507275
MDA-MB-453,10074640,2.421510718072182,2.9026411355149566
G-401,11317348,2.32763680059041,1.9851604709939221
FU-OV-1,selumetinib-tretinoin (2-1 mol-mol),-1.802800887870168,4.011707282038947
NCI-H146,2729026,1.2131739481587438,2.5241233896805166
OPM-2,46907787,-3.368300500627006,-0.4532909115243287
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154,1.9146341566456335
KYSE-70,15547703,3.259406085484829,3.3909039760623214
NCI-H522,107985,-4.282222583037789,-3.6307760027851415
A4/Fukuda,9933475,1.717973727652582,1.6426630440452548
CAL-51,6505803,-1.1525670311484852,-0.5573769427671885
HCC1143,5329102,2.41968992927328,2.0208869627369346
MDA-MB-453,46215462,2.7539180673476986,2.022705228858735
LoVo,151289,0.7390860710542093,1.0288156301866977
SCC-9,10296883,4.238304408621306,3.811000345978793
LOU-NH91,54454,2.054793401572522,2.4988991213310063
A4/Fukuda,9884685,-2.10728676228506,-0.18771362606395392
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156,-3.573989288125779
JM-1,11317348,1.0457451678280252,1.0390210372637596
MDA-MB-157,5287620,-1.8230093056434509,-1.6887563360356124
FU-OV-1,24821094,1.823018038350918,2.835831237151142
Panc 04.03,15547703,3.067090198790942,3.420123562198246
DMS 273,568763,0.8680081273298318,-0.09481390544044363
KMRC-1,16038120,1.697027615564608,0.826538141452025
A4/Fukuda,11214940,3.3298423014633585,1.507907087716864
LoVo,168313016,4.599216339831628,4.621423540981162
JM-1,3011155,4.445867330482826,1.8292182403314061
NOMO-1,135411,-0.3073928829727976,-0.3273878952755264
A2780,24772860,-3.463956246093966,-2.3950116257750955
MSTO-211H,11625818,2.0984197145893853,4.313317432244526
FU-OV-1,219104,2.911303350256359,3.90158463187939
SBC-5,JQ-1-navitoclax (2-1 mol-mol),3.919217693519999,0.7886163882737357
SBC-5,49793307,2.0795512515040144,-2.604747981226305
CA46,53232,2.437328600755792,2.3594448514377144
EFO-27,24901704,4.244323432217726,3.5525661651569163
CA46,2746,0.9501634288999758,1.811142453473812
Panc 04.03,selumetinib-navitoclax (8-1 mol-mol),2.4072445179954665,2.080951208779001
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842,0.6546549006482119
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768,0.7863834764377109
NCI-H661,9956119,3.313685900900753,3.800355977386151
SW1463,44185566,1.4171512734588314,1.9231498175052997
FU-OV-1,3384730,4.633609637548597,2.82015675086505
SW1463,3384730,2.9539510373394458,2.260007052907594
MDA-MB-453,3825829,3.844348445708714,3.579700872572031
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937,0.9838472014585126
Panc 04.03,400769,-0.067858138339059,-0.42605004220476156
CAL-51,445643,4.334473435217703,4.043992124214366
EFO-27,156414,2.3785601677308215,1.7251087677465688
NCI-H2009,4259181,1.0344432117954978,0.29162467306264583
MSTO-211H,16722836,0.7655247341289007,1.6361570004827113
SNU-81,11364421,-4.012430935720713,-2.7035802338869495
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.252198614746458
A-673,2746,1.857945511282164,2.554275262111255
OVISE,navitoclax-sorafenib (1-1 mol-mol),0.9257424766739848,1.6780031256470918
NCI-H460,135398516,4.13019906717736,1.9465161651476939
BT-549,25183872,-0.4430920052505824,-0.641155242905632
JM-1,49846579,-3.8749150343559498,-0.9187044085159524
NCI-H522,10127622,6.598645867237379,3.7124067000818597
OPM-2,446155,0.7744505725193765,2.086172849410253
G-401,10296883,3.7583450228982342,3.380365345465403
DMS 273,1716436,3.74376938939547,2.8618249227904755
SNU-449,serdemetan-SCH-529074 (1-1 mol-mol),2.2114452533334212,2.0944319888873992
NCI-H522,44566777,-0.9754694174653856,0.7421092125132239
MDA-MB-453,53393127,2.113910519669698,4.095246026657757
FTC-133,49793307,1.1308238833509443,-2.0566707176870698
OPM-2,carboplatin-UNC0638 (2-1 mol-mol),3.55532531474596,2.867345357120352
A-673,135928012,2.926877088120134,4.09687638245189
NCI-H661,5280436,4.871704282803626,3.1476691630745695
NCI-H661,docetaxel-tanespimycin (2-1 mol-mol),-5.324368950628822,-3.097025266518454
JM-1,5282054,2.3244175489984573,2.716462652628133
JM-1,9549297,1.5955396397117223,1.575657430617152
NCI-H460,11507802,2.848054270429628,1.9569048895273864
A-673,387447,-4.940230504934896,-4.659240892353625
LoVo,89928392,0.5944678691764933,1.3928841638494254
SNU-449,navitoclax-MST-312 (1-1 mol-mol),1.1854227296029016,1.1445058605187184
BxPC-3,doxorubicin-navitoclax (2-1 mol-mol),-1.6348135682657186,-0.6706419310835134
NCI-H2171,67156097,-2.093355563734418,-1.8868733472009211
CAL-51,9929138,6.421072450841616,5.733165325741574
NCI-H522,11609586,2.3447481698139545,2.387217385078751
JM-1,56946209,-6.537344033049601,-5.041504438899772
MSTO-211H,54649381,3.373909346349482,4.055390825396184
A-673,4261,1.089626824326701,1.0602459430978792
SNU-61,56649450,4.501229591303133,3.00258277175855
EFO-27,5738263,4.449588569174732,3.7630248799364314
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515,-1.7988931298322848
EFO-27,462382,1.6036436678954449,0.5903302751748966
BT-549,24180719,4.750015939259711,3.6834849962275915
HSC-4,73707398,0.9895931551524366,1.5466586002705318
LXF 289,52912189,-0.1394416798850269,2.5364891210576825
DMS 273,BRD-A02303741-navitoclax (2-1 mol-mol),4.151780169779293,1.5795412208729989
NCI-H2009,31703,-0.97323545782719,-0.583302307462463
NCI-H2009,219104,3.953506929532588,4.018334827575254
A2780,11626927,5.568414170846121,2.712186081788559
NCI-H1623,navitoclax-pluripotin (1-1 mol-mol),-0.2970825131911801,-0.5752773347482977
Panc 04.03,4788,6.095957987809042,5.754407368637934
OPM-2,4259181,-0.0185783035827133,-0.4619175971564983
LOU-NH91,9915743,1.51930479588737,1.4343959160720854
G-401,2828334,5.836351566381613,5.864456807293445
LXF 289,3689413,0.4542816941401804,0.1518323326007163
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467,1.3397721427538638
SBC-5,119182,0.2964340092945935,-0.7892160574543194
JM-1,2729026,2.071801783442454,1.8986222479808421
SNU-81,11214940,1.7135053171337324,1.798403328900895
SBC-5,439501,-2.4874901722547977,-2.1996043651400767
OPM-2,46174525,3.627220507837432,3.047015497118717
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402,0.030547048013487732
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765,2.381179935418536
NCI-H2009,3062316,-2.678423554108453,1.1063342597369137
HSC-4,6438330,1.0116267584860468,2.314653263089981
A2780,1317464,4.304763369285543,3.0977113325996957
G-401,3025944,3.816605103301755,4.077426687051766
NOMO-1,9915743,0.4758643096003905,0.31352511414879575
CAL-51,9877608,5.917079709597661,3.105477523105076
LoVo,71466380,3.017013363980257,4.485231600945503
HCC1143,53392493,2.60613854373917,2.6351657232339027
A-673,6918837,-5.129930095166698,-3.813060442738796
SNU-61,60700,1.2670278964841577,-0.6064148077573664
OVISE,6918837,-1.5846953199834826,-2.7503754510572014
NCI-H727,11609586,3.3120945172723917,2.605934715241507
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415,3.0615707587145895
NCI-H1623,5281672,4.562545083615407,4.758826000390992
NCI-H2009,6918328,-0.9509353973047906,0.23718369023547614
LOU-NH91,vorinostat-carboplatin (1-1 mol-mol),3.369896826709664,3.36554467665202
OVISE,16722836,2.434488476233433,1.7858801207710986
JM-1,10127622,5.153041805169496,2.921968098891704
NCI-H1623,252682,6.46254793762087,6.626806608698488
JM-1,53392493,1.8440760854554048,1.8364792790865772
MDA-MB-157,168312962,1.1798186112423137,1.8410013124842655
YAPC,44819697,-1.3460219164430964,-0.4697665016939245
KMRC-1,44607531,1.585622780528836,1.5831598771072124
NCI-H2171,6918878,0.0284372668850805,1.0641237448468401
MDA-MB-453,44607531,1.359301388322155,1.2508606812658933
ONS-76,11485656,2.5953354109263262,2.2268711943505783
MDA-MB-157,135398516,1.565807276365399,2.229521017544539
A2780,24753719,3.5545225878481745,3.742860627510046
NCI-H661,6918328,-0.1140400883450083,-0.013853435017728215
JM-1,4578,4.1991230056704785,3.8276302887257487
A4/Fukuda,9903786,0.7546004224414102,2.207322807599244
CAL-51,11485656,2.6541256228973773,2.2965850226170055
NCI-H292,24964624,2.911439833663599,2.718841005474351
NCI-H661,6918837,-3.3797686305940156,-2.7515734406139583
EFO-27,71304818,3.2919872626583486,2.672905511524965
MSTO-211H,4705,2.457156821386339,3.1235393052352354
DMS 273,107985,-4.548014092027974,-3.684115695168651
SNU-61,2729026,2.4451253635155106,2.4572991598902947
JM-1,60700,-2.9904484465209036,-2.0510605501367998
SNU-449,JQ-1-MK-0752 (1-1 mol-mol),5.5892167281424285,2.046042434187093
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257,3.7281311347208828
SNU-449,24856436,4.072390930567189,0.3838081403408568
NCI-H460,159324,4.0462841352482855,3.073419817592809
NCI-H2009,11175137,2.49599907102206,2.6618041907177683
A-673,208908,1.851861192467165,1.996297039145722
BxPC-3,25183872,-1.12027566647844,-0.6326462886712061
EFO-27,5328940,2.731901822530229,1.8595620841492226
HSC-4,135398516,2.2759469773851224,2.1125620308114064
HSC-4,11647372,1.1815136799972823,1.1563941071672723
CA46,16038120,1.1324791438314847,0.23876520587723807
MDA-MB-453,9868037,1.568237926564538,3.4833830647922794
A-673,446155,1.1478268834845686,2.6818090454419234
A2780,5479543,3.565203320915574,3.0657359553772907
MDA-MB-157,10322450,5.067042624032479,3.8470343698295206
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236,1.078509998473047
MDA-MB-157,9915743,0.9957990206413116,0.9295317734807271
A4/Fukuda,219104,2.2512696330904447,2.609405278064898
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723,3.157070364771292
SBC-5,12001922,2.404615034975172,1.9975130291588943
A-673,51037431,1.861905373589415,3.0916270744824565
A2780,637858,1.382423379201008,1.3762341062234933
NCI-H2171,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1592201049133759,1.091095696862198
A2780,9884685,-1.5939943621043984,0.19051835598204495
JM-1,5311,-0.0672732572458771,0.41075145345012254
CA46,15547703,2.518572103836232,2.458255492683343
BxPC-3,54618164,4.016743819691475,4.337220676422657
BT-549,2749,3.5786970568950913,1.950803971066455
SNU-81,73707398,1.1294477244846828,1.0662141024186682
SNU-61,docetaxel-tanespimycin (2-1 mol-mol),-4.617294417621486,-2.793693808573715
A-673,55508,3.3138750706926157,3.0294428050482525
SNU-449,carboplatin-etoposide (40-17 mol-mol),5.135900435909966,3.200262735597113
MDA-MB-453,23725625,4.029710365908802,4.79436827212913
A4/Fukuda,4261,-0.9007526332595048,0.6695177236025295
NCI-H727,446155,4.65589483782911,2.8362749834309495
NCI-H1623,44486219,4.206804435599472,4.317436343631669
MDA-MB-453,441298,1.8295928982069447,2.524708686649019
SNU-449,54454,2.520106415523585,2.4764243202980962
A2780,387447,-4.368237522415053,-4.716057820351937
MSTO-211H,11152667,-3.5300772231011703,-0.5162552859455202
SNU-449,25195348,3.622170031481097,3.3897813915203416
MDA-MB-157,322968,2.1225136411127545,3.937906457972424
A2780,168313200,1.7543183926879495,3.063718927066985
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625,1.5178633273948865
SNU-449,5329102,2.0099859216843075,1.9644554458504597
NCI-H2009,322968,4.70725114827159,4.068111831636196
KYSE-70,16722836,1.4327625680833322,1.764964490712931
MDA-MB-157,11609586,1.0926317538630208,2.9180706260990097
FU-OV-1,10231331,3.398558944555642,2.3373317666419418
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172,2.9328196548987573
NCI-H292,docetaxel-tanespimycin (2-1 mol-mol),-3.440758677710888,-2.4949687339465
LOU-NH91,11238147,4.007302405058718,2.918705000805761
LOU-NH91,49766530,0.361985362717411,-0.6932538687679177
YAPC,9444,4.346283036692295,4.1855703697351725
NCI-H522,15547703,3.471643136947843,2.700376420425508
NCI-H522,375860,-0.630771500248647,-0.10143986525223453
CA46,119182,-4.388833865288787,-2.5423596047036026
OPM-2,10410894,2.9147321100270593,2.7611832730990113
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,3.215546029636707
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803,1.2115684143805376
OPM-2,docetaxel-tanespimycin (2-1 mol-mol),-6.145766231617617,-4.182144921052036
NCI-H2171,4261,0.9024779156039784,1.0295128420528847
NCI-H1623,25262965,-3.228781743363827,-1.470093490125937
NCI-H2171,navitoclax-gemcitabine (1-1 mol-mol),-4.23755685830139,-1.5966936945529295
MSTO-211H,10427712,4.183883954719584,4.436023269465066
EFO-27,navitoclax-birinapant (1-1 mol-mol),3.2392186746278244,1.5772143254824644
A-498,9967941,4.3277437867326025,3.4975153884064674
HCC1143,25183872,-1.001460572121427,-0.5469701750152085
NCI-H522,crizotinib-PLX-4032 (2-1 mol-mol),2.133335771815486,1.2229368907434708
CAL-51,17755052,0.5283491907817935,1.7351749900750415
SW1463,44137675,3.7114847318755806,3.4405496621030527
BT-549,5278396,3.375604766419473,3.657261451635257
NCI-H292,3025986,-0.8794264876923694,-0.8365458511706355
NCI-H2171,3825829,3.727904622873516,3.368085545387338
EFO-27,327653,2.4330037956805133,3.213630789079793
NCI-H460,637858,3.384702960830197,2.179531870534301
G-401,5746,-1.2143401521495898,0.39134575897170004
A2780,5281321,-0.7497434400684011,-1.971318437132922
NCI-H460,409805,5.4278006548731295,5.217925226647188
MSTO-211H,alisertib-navitoclax (2-1 mol-mol),-1.8568151112874771,0.39108315719716663
SNU-81,11964036,-0.3940350311201446,0.9007133306799082
OPM-2,53232,1.210133300080481,2.5146011490410745
A-498,216468,3.41587450505901,3.6312801830624877
LoVo,6852167,1.8421975016001388,3.045292267583969
SNU-449,53325874,4.456238471946744,4.481855627548636
FU-OV-1,10296883,4.259179003182187,3.9728388520107982
LoVo,3136844,3.7568853791466608,4.389078873999159
HSC-4,637858,2.398043952194309,2.049200698224963
NCI-H522,9927531,4.749051096908956,4.291751115895774
MSTO-211H,53392493,1.8202473930982712,2.8311771218989237
Panc 04.03,11626560,2.20525660125161,2.111761849617865
EFO-27,11178236,-5.208504296414087,-3.207231822672692
SBC-5,3503,1.24841833111282,2.1488231992487115
G-401,11640390,2.8162749001609417,2.9638212706579092
NCI-H727,selumetinib-UNC0638 (4-1 mol-mol),-1.3488333019368446,2.940998209584763
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158,3.190460375389329
FTC-133,54454,1.7579296666098376,2.607050439092341
MSTO-211H,54613361,-0.4311183648022992,0.22130282938609094
G-401,5282054,2.6200467258422235,2.8900877221421046
NCI-H727,135440466,0.3181577925646752,2.1388279593778847
SCC-9,6852167,2.7106856908699255,3.0619651569777404
NCI-H2009,124202324,1.390796248932456,2.6283792566087625
SCC-9,54618771,0.4910288003516506,1.3102868043217493
A-673,9826308,0.1905391916215918,0.3205910923752796
KYSE-70,446155,3.830415114438346,2.5715674547847076
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.2020864122166244
CA46,10296883,3.259152671675197,3.114371565682691
NCI-H661,159324,2.633762936698375,3.071884266127335
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827,1.793475190561887
LXF 289,5328940,2.0490491787199687,1.849851468314532
KYSE-70,400769,-0.6610715268602807,-0.2974619924564781
BxPC-3,9911463,3.950256717526944,3.9315366072209965
MDA-MB-157,119607,5.813382396653367,5.198096842940697
NCI-H727,168312962,2.354698653601169,1.9788385228662353
G-401,67156097,-1.3508759360204068,-1.6961715730762186
HSC-4,53232,3.536415160688875,2.871749103821814
BT-549,9866186,1.9395157417186848,1.0000485785872322
A2780,46174525,3.809782337657401,3.649824827857826
NCI-H661,24797083,0.8737198077858661,1.5314237178338437
OPM-2,107970,1.3408908225452507,1.9513704444320825
HCC1143,3038522,3.729990546362485,3.151592582510091
JM-1,5746,-1.3315669786621744,-0.7644305087440604
OPM-2,9935249,1.874633336412032,1.0725961470010061
A4/Fukuda,10302451,3.353566161735505,3.0603488509545618
SBC-5,1641662,2.7360117188732684,3.471656840209344
CAL-51,25183872,-0.1080661998677032,-0.7846609326652235
HCC1143,72734382,3.642829686089203,4.691357425913097
SCC-9,67156097,-0.5297515363076177,0.36097479940103633
LOU-NH91,17759555,3.0310153631552295,3.6222784264226053
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249,1.3814065699036595
FTC-133,6252,3.0791801983523297,1.2603638992917778
NCI-H146,10026128,3.971012402354388,3.612962495579843
HCC1143,327653,2.9245812810780745,3.221596031583865
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335,1.72239383322144
BxPC-3,docetaxel-tanespimycin (2-1 mol-mol),-4.5492420076102045,-2.940644050180137
SNU-449,SNX-2112-bortezomib (250-1 mol-mol),0.2827290486356496,-0.945494985684952
A2780,71466445,2.121500658196736,3.1537093835423335
FTC-133,11640390,4.129780643497309,3.7272945358766885
NCI-H661,66577038,3.3791675548307225,3.117501370420974
A4/Fukuda,89183176,1.286008536767452,3.0322989826621605
KYSE-70,49793307,-3.275020883815728,-2.872915529425398
NCI-H2171,36314,-6.271125424872196,-2.4024324015456164
G-401,5351362,1.1066788885055705,1.3396255533548962
NOMO-1,44507138,0.557170216692965,1.983123525150815
CAL-51,56649450,1.7310987503885624,3.190396350115466
MDA-MB-453,100016,6.0730906594859215,5.9779189370646915
NCI-H1623,6852167,1.7873387390250663,2.9238524476532417
A-673,16659841,2.6132078541729404,3.1012149905367425
OPM-2,67291369,1.773293288142809,1.083380022651907
OVISE,374536,3.768512931442208,1.9143876631722285
CAL-51,11238147,2.100409816322544,3.0272786675148904
YAPC,11175137,3.2313352651289327,2.734263178491977
NCI-H522,ISOX-bortezomib (250-1 mol-mol),0.0474854277983787,0.49029595208751703
OVISE,10427712,4.5158462716299415,4.502421351604352
EFO-27,5351362,1.1790960486008195,1.5979366732879692
NCI-H292,6505803,0.1482155149138876,-0.862302996723276
SNU-61,vorinostat-carboplatin (1-1 mol-mol),3.629887150631109,2.5476591277619227
DMS 273,71680916,4.789726238699708,4.152323742943185
CA46,10184653,1.13668363671425,0.43029677501489993
SBC-5,49867926,4.30527508614513,3.973309747387593
LoVo,11238147,1.4038592423826672,2.885682022155458
MDA-MB-157,11427553,2.127814795485051,2.683779098064127
SNU-61,11178236,-3.475859478717308,-2.6742039999961342
SBC-5,piperlongumine-MST-312 (1-1 mol-mol),2.5701291604117045,1.7113849415037727
FU-OV-1,11214940,1.6800576649286882,2.142928174292587
LoVo,9903786,0.6551100591729495,2.6534858180129772
NCI-H1623,135411,0.3784026464220375,0.7945941548455234
LoVo,3062316,-2.119304437973892,1.2436096331429853
NCI-H661,46174525,4.042428757819544,4.552434564727468
SBC-5,51037431,0.5420283127367359,2.9835627351206737
A-498,3689413,-0.327867250415736,-0.19067636365950968
DMS 273,selumetinib-UNC0638 (4-1 mol-mol),4.157627757757485,2.782372311838609
CAL-51,54649381,3.902782783768603,4.042539487846979
A4/Fukuda,16038120,-3.113498344638628,0.4735284958174217
A-673,135398516,1.4288802928040978,1.7295843213728068
NOMO-1,135398744,6.340708200805823,4.502314384184917
KYSE-70,216468,2.031191966418552,3.166457726321697
A2780,67291369,1.1130592599106983,1.7345520144994004
NCI-H2009,654092,0.0283248260105453,-0.28314594293048995
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535,1.7037518013040718
NCI-H146,navitoclax-PLX-4032 (1-1 mol-mol),-2.8852479543284617,0.8943565977127164
SNU-61,11612883,3.050953505253589,2.112028892324889
SNU-61,5746,1.3298489283886064,0.9147583670938026
KYSE-70,124202324,2.186627813347476,2.8225239671461058
SNU-449,carboplatin-UNC0638 (2-1 mol-mol),4.161475175536438,3.493608285732054
BxPC-3,409805,3.7922849099240734,4.910973395581869
A4/Fukuda,3552672,1.9607713184754867,2.463773591284463
KYSE-70,9907093,3.6347338213446454,4.36802279359463
SNU-61,12003241,0.1572719330395487,-0.8426723694510929
HSC-4,322968,4.636798889333657,3.9849751760642325
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673,2.358909350836792
CAL-51,16115403,-4.643171700082743,-4.196812755117472
LOU-NH91,2746,5.002248002286792,3.537528891798202
A2780,3543504,4.147653095225295,3.960191026736058
NCI-H661,25126798,3.9237728184770946,3.704131903027479
DMS 273,4521392,4.235410021964807,3.9461559186187545
BxPC-3,49836020,-2.380895293574403,2.766434348108031
NCI-H146,JQ-1-vorinostat (2-1 mol-mol),-0.8208901447975969,0.6620070370911912
OPM-2,3689413,-4.501811354570108,-1.0512320224470406
Panc 04.03,selumetinib-piperlongumine (8-1 mol-mol),4.132461761791421,3.456492662514295
NCI-H727,navitoclax-gemcitabine (1-1 mol-mol),1.335724896470854,-1.089245963722157
NCI-H460,5328940,3.322075361136407,1.7451529748512595
ONS-76,25126798,4.148768722347094,3.785481713217599
OPM-2,57519531,1.419627244644159,1.6512594945754164
BxPC-3,20959075,-3.864209289368053,-2.7329691596267742
OVISE,54618164,4.29678583267412,4.241532312899113
YAPC,10074640,3.068654585130056,3.139682744828106
BxPC-3,5287620,-2.837282092833542,-1.6703291887995346
SNU-81,24785538,-0.3807988804027284,1.1087652521805198
NCI-H292,5287620,-2.1513248285430997,-2.0204266400632567
NCI-H146,104842,-5.965892600420639,-3.4309456222881063
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236,2.4479348937844896
KMRC-1,17755052,1.9475900469511016,1.6100839592966552
NCI-H2171,24856436,-0.4096039036242957,0.24870507423851593
NCI-H2009,11364421,-4.013811791110126,-1.7442666876834187
MDA-MB-157,5470400,0.4579153499304774,0.41547396242299633
HCC1143,51039095,3.6749130279746938,2.531020008822983
G-401,11964036,0.0453230579510409,0.9804055833111153
NOMO-1,1641662,3.174576963224712,2.7356212436053187
MSTO-211H,25102847,1.842661618149511,2.4855957642727633
A-673,9908783,4.713034696547774,4.513758991662038
BT-549,71680916,6.0821013857398745,4.824405676872279
JM-1,11719255,1.4438675590466743,2.04159229854355
HSC-4,2874250,5.810325396532396,4.677457097029599
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553,0.629769801245642
NCI-H460,654092,0.4612941847378306,-0.20917501711625203
OPM-2,5328940,0.8145180628284293,0.951721725170027
A4/Fukuda,44202524,1.0259860145116777,1.598860999235181
G-401,11213558,0.7886605378704363,1.4804738546495044
OVISE,135984461,1.6429740508824469,3.9209184602972584
NOMO-1,11964036,-1.1045639043109698,0.3171407601490406
CA46,6184667,1.8666466805539537,2.293909090804303
NCI-H460,9903786,4.057661845653794,2.77699668186589
BxPC-3,25102847,2.0998558206838913,2.579563880196367
SCC-9,5470400,0.9401931564199802,-0.19536279066258044
ONS-76,5284329,2.36276815665719,3.1718187563111764
DMS 273,25227462,-3.883072621079263,-0.11989328518995712
A-673,42642645,-0.8052568071576633,0.16240141866927893
A4/Fukuda,9549297,1.6255879909683784,1.952797199100472
FU-OV-1,11427553,3.01783779671809,2.9651633526827084
SNU-61,5328940,1.147707594205283,1.5795270603026572
HSC-4,5281321,1.7816899121848235,-0.7334073826126627
KYSE-70,656346,0.9492660515895844,1.144155920830373
NCI-H1623,72734382,4.853935764849827,4.696900747532454
MSTO-211H,67156097,-3.635314822435898,-0.6163812583347196
MDA-MB-453,637858,1.2138352699902215,1.8452834962091598
CAL-51,56963564,0.4281851677964957,0.47519450666332314
A-673,10113978,2.507382463710335,2.607117771196623
YAPC,2946601,6.339465197306548,2.9198692882005592
NCI-H2171,ISOX-bortezomib (250-1 mol-mol),-0.1667670458768617,0.1981121651884886
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872,3.104880135131216
HSC-4,65628,3.12205826618997,4.503519755160086
HCC1143,227681,3.1373347590378335,3.3742849957497305
A-673,53301938,4.3782771731899555,1.0356998486823676
G-401,66577038,2.320880294749871,2.943747783773592
NCI-H661,9884685,0.1767392095869446,0.892440806080288
SNU-449,6184667,3.7989058233577566,3.179485613265222
OPM-2,24951314,0.2222837933942169,0.3713358959008833
LXF 289,56963564,0.2991276479966406,0.3245357049492691
HCC1143,11364421,-2.85203888888326,-2.044218583695687
NCI-H292,9936388,-1.1579069678838152,-0.08379514567090396
G-401,10231331,2.894718734978725,1.4362658585745824
CAL-51,89928392,1.068329558331595,1.232793040346623
NCI-H2171,53392493,1.8740494203136608,2.1008551794424415
A-673,136227331,4.241984110268528,3.601691631050519
NCI-H727,11717001,2.7053596974758594,4.0461463621882565
A2780,16219061,2.814782356526162,2.708984799955943
SCC-9,54454,3.1137155512464596,2.8213696753806268
YAPC,12003241,-0.7644111057992425,-0.9477111878274762
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.630341885481472
SNU-81,5335621,4.181800470543683,4.27309332056948
CAL-51,5329102,2.0492492410301484,2.1558934181605043
NCI-H146,10385095,0.6869778017915235,1.143325038397098
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165,2.806606190815901
SCC-9,2113511,6.3303497429476625,5.645472171415933
ONS-76,2708,5.792421817961339,4.591201875530029
SNU-449,11485656,3.58452534173841,2.585518438929382
A-673,46215462,1.2771489946566346,1.4352960397468282
FTC-133,285033,-1.2963608176743802,-1.6613749707298766
SCC-9,6184667,3.279451062583292,3.2147749841100626
NCI-H146,16722836,0.0677462505380894,1.4356737994027293
NCI-H661,44137675,3.7576040576240257,3.6462196492196557
NCI-H1623,11612883,1.5649574760969076,2.7422560918366514
LOU-NH91,3825829,4.327670981782257,4.036006546418178
SCC-9,5287969,-2.1272191034883874,-1.7479618024586587
Panc 04.03,10410894,3.886544188244091,3.4128240282285716
NCI-H146,135398516,1.5035346569298091,1.717984252275369
A-498,4096211,4.004902569915099,2.422589168865403
OVISE,104842,-0.680714151991963,-1.9828715800035528
SCC-9,135440466,2.439160969941936,2.2925595847405265
ONS-76,10322450,3.321198163736043,4.115625801727365
SNU-449,81146,6.119223793669881,4.803344694191631
JM-1,148124,-7.840698833354439,-4.5410289791439995
BT-549,5460769,6.35928800843138,2.968923283019709
MDA-MB-157,969516,1.7670354115722269,2.8460661843579853
LXF 289,5278396,2.6487510770020104,3.6829617094082296
ONS-76,100016,6.019166856387977,5.881899536653986
A4/Fukuda,11707110,-3.666992219196893,0.8734307990982466
JM-1,6438330,0.1685207017328377,1.0738316838066941
SBC-5,navitoclax-sorafenib (1-1 mol-mol),1.4051935643931297,1.7427931848755898
BT-549,10074640,3.6929061121608577,3.1477898324070064
A4/Fukuda,46926350,-6.021657358635238,-3.9584544605142473
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384,0.8258317620614752
SNU-81,4917,2.3748179961814375,2.9468068427446594
A4/Fukuda,119607,3.918640768426122,4.607646473174529
HSC-4,613753,3.3632883902358715,3.1277345018082077
DMS 273,135411,0.7219297948054574,0.2997130701275727
KMRC-1,46907787,3.729545872280723,1.6791288024565443
LXF 289,44489675,4.904101073680104,3.9809585058058135
BxPC-3,6918736,-1.9181543280529496,-1.4284717013958856
KYSE-70,65064,5.1318583658275205,4.886321541915823
HSC-4,25062766,1.8609848482730849,2.1072744037353597
SW1463,15983966,1.3055923116721375,-2.2263959716743065
HCC1143,11396600,3.529486359294858,3.769987066488611
SCC-9,45279963,4.124125049817703,3.687316159048466
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289,-1.906671061123677
NCI-H661,5113032,4.99918939361245,4.878953416953747
LXF 289,17759555,2.434653643868842,3.6720863873610643
DMS 273,46926350,-4.333780789364997,-4.485249208518403
OPM-2,46224516,2.1207785622277373,2.0495247257660547
A4/Fukuda,9908783,4.281950187885367,4.738348620595254
A4/Fukuda,1716436,2.785785051354721,2.5539810170162416
KMRC-1,54454,2.958009627513852,2.428635792644734
HSC-4,73707371,4.771220465805862,4.8909551274233065
KYSE-70,9911830,3.1951659700149886,2.4151733853072517
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346,-0.4799311674481275
HSC-4,16720766,-1.6245250648624636,0.6943686461463188
OPM-2,11964036,0.2409704368173301,0.7098681186259057
LXF 289,3038522,4.104388560491244,3.262867648034038
A2780,49793307,-3.5064247630527494,-3.465701492318207
MDA-MB-157,12003241,-1.4339892472843776,-0.9796228444780675
MSTO-211H,53495165,-2.281905985837366,0.8172659712978688
MDA-MB-453,24797083,1.319210590833939,1.2191253126331945
HSC-4,25126798,3.2488654911973196,3.8032739946206338
BxPC-3,3854666,3.4835595653471167,2.3177057419279303
HSC-4,176870,2.813832788377266,3.0327247530888997
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128,-0.4255782040161491
MDA-MB-157,alisertib-navitoclax (2-1 mol-mol),-2.615500389933575,0.34604130161168994
YAPC,135398744,6.484368053683043,6.468969127822451
MDA-MB-453,51039095,2.709903892694302,2.7484288118283926
CAL-51,24821094,3.2618915388877023,3.2151347473066942
NCI-H522,1239801,3.903810420887451,3.4083695538287277
KYSE-70,7251185,4.369311092923008,2.4563424278645036
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.4143399707846047
G-401,60750,-4.380742093252711,-2.9202471508291143
YAPC,11404337,0.4717703732171429,-0.06465366751443613
MDA-MB-157,9826308,-1.0851482905673768,1.1142908837642367
MDA-MB-157,25262965,0.470934001928582,-0.46945901873288426
FU-OV-1,10427712,2.3896052276409887,4.489219185642903
CAL-51,285033,-2.914004430070481,-1.98843842047579
CA46,246676,4.699933053014099,3.663767481994234
A-498,9926054,1.5026788619071982,2.070357544542073
LXF 289,44632017,2.313535350982782,1.2953823097504746
NCI-H727,3689413,0.3749801507161196,-0.09610856053591008
SNU-449,1716436,3.0856052265463023,3.1901653926441456
LOU-NH91,24951314,1.380037957351277,1.7739158345182582
SNU-81,46191454,-1.5874627182763832,1.317795296311178
KMRC-1,119182,-0.1449504353389931,-0.7009890680110832
NCI-H522,9823820,3.261618834820585,3.2060574949737664
NCI-H460,11178236,-2.300904923417752,-3.370231458129547
A2780,5738263,3.096886997462696,2.9593196520823737
NCI-H661,carboplatin-etoposide (40-17 mol-mol),2.8210696568936786,2.4373776577328177
BT-549,5287969,-2.055370090828861,-1.8722383039780168
BT-549,11609586,2.735581966533724,3.1702689030439264
OPM-2,1317464,3.5924971065959244,2.7004740596738737
NCI-H146,54639701,4.038686865533554,2.6895504367716745
LOU-NH91,3384730,3.7773271912609623,3.1507140743990414
YAPC,11152667,0.3482753398657929,-0.27960088866211213
SNU-449,702558,5.257858019653286,5.303427835702628
MDA-MB-157,selumetinib-tretinoin (2-1 mol-mol),1.8981533797930392,3.340547132571722
FTC-133,6438330,2.249518605035186,2.469711612299671
NCI-H727,12001922,1.7281936629666887,1.8947188341191878
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685,2.6866610984726793
HSC-4,60750,-5.118377280037083,-2.085819985171246
SNU-61,1566236,1.9599867850180668,2.164924833890819
NCI-H460,5282054,4.802373462225767,3.974667205772205
DMS 273,6610216,4.172124776089646,3.9486469589938817
NCI-H727,6852167,3.356078560596427,2.9188612549727098
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.3712238596799438
SNU-61,445455,4.539446073708065,4.163299735822859
DMS 273,3062316,3.60345807305724,1.0238822316103273
MDA-MB-157,9956119,2.310937024804907,3.5417685883486247
OPM-2,135423438,0.9866001177758746,1.0118237971986848
Panc 04.03,16722836,2.845252730089092,1.741031584370859
MDA-MB-453,9936388,0.6028011486270662,-1.4686893362897797
A-673,68056272,3.7833857366006094,3.1179006898673958
HCC1143,16722836,1.2433455264432278,1.5861023395958307
DMS 273,72193861,0.4647891664131632,0.7218556312336735
DMS 273,navitoclax-birinapant (1-1 mol-mol),3.616691876772055,0.9462859220215337
Panc 04.03,11396600,3.73844061007523,3.8792401113439285
NCI-H522,6505803,-3.5272214952237344,-0.25524797259040444
CA46,56963564,-0.0544830399645368,-0.1703870085580315
A-673,9825149,0.7138432506885886,1.8516492534380442
NCI-H1623,2871966,1.4286416314522286,0.49497022571370186
SNU-449,4096211,1.9400565485658428,2.1495709650377934
CAL-51,44137675,3.485867182081199,3.227108455436554
MDA-MB-157,375860,0.0174110406826079,-0.021462153094597494
MSTO-211H,327653,2.467891014920142,3.234950413469038
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371,0.2945373351746855
CA46,11178236,-6.883102305003874,-3.4091338921874548
NCI-H661,5291,3.8370923902638063,3.5152015899922655
FTC-133,25262965,1.6757685209235111,-1.298856464694762
SNU-449,24771867,3.0453458349703793,3.136788956415838
HCC1143,9911830,2.6182666070844447,2.456357326333372
SNU-61,44185566,2.430559307269213,1.9849963756540387
SNU-449,445091,4.4459202939225815,4.374092513860777
LXF 289,123631,1.612545473594554,2.5104319414180374
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453,4.3935630571705815
SNU-61,637858,1.6436621136217924,1.7581527370871166
MSTO-211H,3025944,3.596075182431598,4.331890715903558
SNU-81,11612883,1.8877401103471,2.186262112234253
A-673,52912189,-0.9448854486243604,1.2121543952148999
NCI-H727,613753,3.184500780825273,3.149346996304168
BxPC-3,24856436,-0.8809901773698104,0.7222371281585037
SNU-61,3038522,3.6960216122526943,3.1930773107277957
KMRC-1,374536,2.325099751463231,2.630256782113034
CAL-51,54613361,0.2180057854442524,0.14380530149512208
CAL-51,10385095,1.0305027810027567,1.143283356037432
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945,4.2498132868153045
LXF 289,5281321,-2.4870532876216487,-0.9550559762310171
SNU-449,10184653,1.7910926490151993,1.4530734226336515
SNU-81,9887053,2.281153151762533,3.18458914788057
KYSE-70,11485656,2.2230455690794404,2.272618902618413
CAL-51,439501,-2.444412450902406,-2.027341025710113
A4/Fukuda,72967,3.695839205584607,2.5280342079891978
NCI-H1623,navitoclax-MST-312 (1-1 mol-mol),2.6356568038196175,0.9822505107350876
BT-549,57519531,1.7866000969199525,2.5578331737662463
YAPC,9911830,4.0093640169179325,2.4795223135765734
KYSE-70,54143018,-0.2928055682999507,0.960871836882089
ONS-76,6852167,3.4771955261396252,2.4437901377183073
CA46,216468,1.7849524837603168,1.0992645417560327
KYSE-70,71304818,1.8226881659751617,2.4680959201992234
SNU-449,10427712,4.716616821408685,4.576921679225379
KYSE-70,11364421,-0.2598881855214042,-1.0623376778556328
SCC-9,46199207,3.715699147831311,3.2677896254720786
OVISE,tretinoin-navitoclax (4-1 mol-mol),1.2267801901076945,2.59347402171217
SNU-81,selumetinib-navitoclax (8-1 mol-mol),-4.808792251277437,1.4186168457864088
NCI-H522,45279963,2.975445810656792,3.3616196513597982
NCI-H727,44137675,3.902640688581202,3.6387703988677087
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.3077664161930427
CAL-51,3854666,1.1494535123186709,1.924080184478348
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446,2.7295513542325858
NCI-H2009,81146,6.16166931928307,4.63065048464371
LoVo,135440466,2.5900307411888357,2.2659489240886184
G-401,445455,4.8654155018395535,4.154946445482399
NCI-H1623,15547703,3.108106821400364,3.313164800724006
SCC-9,322968,4.6886309532040435,3.979636639132078
MDA-MB-157,23635314,-3.347178711973772,-1.0162235107841644
CA46,49793307,-4.01311922110524,-4.405904846370659
CAL-51,53495165,0.3298774405260949,0.7226432744083184
SNU-449,54618164,4.194291334344069,4.126738202979107
LOU-NH91,11178236,-2.353397629942184,-3.1018514907536456
A2780,5284616,-6.357248921927095,2.070062063772092
OVISE,11404337,1.793635825025173,-0.29884511886643866
HSC-4,216239,1.6239220207771676,2.358261100456872
NCI-H1623,208908,0.8939149685214822,1.8669400137908776
NCI-H146,25161177,3.485806465133522,3.7883909965537153
YAPC,6918328,1.93910137978286,0.30507512095000017
EFO-27,3038522,3.6669358154068097,3.207178839973186
DMS 273,25262965,-3.6359475061731534,-1.7430817741925595
SNU-81,9803433,4.184314019267332,4.710944383885927
SBC-5,5351362,3.2358684618056164,1.706606753653438
NCI-H661,9826308,-0.3578866099027624,0.7603299179232833
CA46,462382,0.6475442737717811,0.42054813508615424
SNU-449,168313200,1.9091128501610053,3.107353441854209
SBC-5,613753,3.3291324843640497,3.2757007107876968
HCC1143,24797083,1.671403596818138,1.6316874971094497
NCI-H522,11625818,5.118334572164132,4.000869465611965
Panc 04.03,446155,2.4976903608369994,3.050151482872191
NOMO-1,2733487,3.664178503465112,5.194649071327161
CA46,11494412,-0.1540181126177876,0.19738835231429103
KMRC-1,168313200,3.9547474801247455,2.84867145203142
BT-549,12003241,-0.9663956127583828,-0.9151100694335106
MDA-MB-453,53232,4.528141583720988,2.858509714744423
Panc 04.03,BRD-A02303741-carboplatin (1-1 mol-mol),4.551523048928573,4.222538382717012
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604,2.2282424799205582
BT-549,7251185,2.7032329014559555,2.800052658497378
YAPC,72734382,4.459010686131963,4.838301751169978
NCI-H2171,navitoclax-birinapant (1-1 mol-mol),-1.0975266283205345,0.6373729163980363
LoVo,10113978,1.9718639606113115,3.3139471401226523
G-401,9884685,-1.463173781220529,0.03191110194886469
NCI-H460,969516,4.1763077592827225,3.100656920857618
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.58698731840708
NCI-H522,10302451,3.5044820085806645,2.682090212726302
SNU-61,10127622,0.6703048084308344,2.5949553046185265
DMS 273,216239,1.7826696655906364,1.8113391139779231
NCI-H2171,24785538,-0.9958553447114444,0.17143386630844615
OPM-2,2945648,2.5610378238786367,2.3954028221198818
JM-1,5278396,3.0111139094733987,2.8417652154478095
A-673,11625818,4.166556040788123,3.843809032196736
MSTO-211H,23582824,0.616921606097025,0.6457264208449726
CAL-51,11977753,-3.094424679361229,-0.9813205368722905
OPM-2,55283,2.954343465689474,2.102914709813335
SCC-9,445091,4.9115801471194365,4.396822761446509
FTC-133,11609586,3.5175505098064113,3.0603969798763146
DMS 273,16065773,2.5819171284899873,1.9213711894877563
NCI-H661,16725315,3.2574493912109315,4.1141593389958055
ONS-76,3825829,4.014711164490238,3.9827850472477837
NCI-H2009,613753,3.3208706433892483,3.3609380846007584
OVISE,72376,-0.0680425204905225,-1.8111058631207293
Panc 04.03,1566236,3.6247050899799698,2.3150332467126673
KMRC-1,10385095,1.0697515150450725,1.3585009079984338
MDA-MB-157,6918638,0.523436976846598,0.7440689773097887
SNU-61,10231331,-0.1396530061474971,1.3398570407334232
SBC-5,67156097,-2.1260485275267684,-0.1327672876138061
HCC1143,16720766,1.508740109375584,0.7246891450676624
SNU-449,5311281,1.2425771495660034,2.581773844605432
EFO-27,15547703,3.36481674718985,3.3061038841876007
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683,4.333551375175851
HCC1143,71466445,2.406598865609875,4.007625636063573
HCC1143,11625818,4.1599423197543395,4.266526881470457
LoVo,67156097,-2.753278115102512,-0.739140798372733
NOMO-1,3385,1.8227638422939128,2.6621437172047258
JM-1,11494412,0.2153546786296628,0.15861606588221755
SNU-449,3384730,4.130527031297823,2.8077945659541155
KMRC-1,2871966,0.6996568641549454,0.7936792714344493
MDA-MB-157,2126,3.382661447598077,4.662380230321644
SBC-5,444795,4.741830288065925,4.890876881800564
CAL-51,135398516,1.449392214756173,2.2798832210255755
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.3431438807461045
FTC-133,11626560,4.477282693511418,1.817044424754141
NCI-H2171,135411,0.036573209368321,0.21989032013880383
NCI-H522,5479543,3.719555600198391,3.0771128277454007
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547,1.7022445647527724
SNU-81,44494148,1.061827805146114,3.044062036392376
OVISE,119607,5.735286818250817,5.195719809840181
CA46,4578,4.451375135730711,3.692627094081792
FU-OV-1,navitoclax-piperlongumine (1-1 mol-mol),2.023653307095543,1.8182666176667663
MDA-MB-453,148198,-6.384072425395857,-3.51336119701501
CAL-51,44491742,5.152478206660974,4.27012023376853
G-401,6438330,1.230579919692557,1.521224842417183
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266,2.09055590541975
KMRC-1,2746,4.901784458568857,3.0386997831942946
SW1463,3025986,0.7137013515595916,-0.900038940679051
NCI-H727,54618164,4.079418853402711,4.0394846078426205
CA46,9907093,3.753589195065423,3.383904362832362
CA46,1750826,-4.755590130007624,-2.9161672290332756
G-401,135411,0.5966957307940325,0.16943499828590738
NCI-H727,9825149,0.533141934304371,2.4022566628027526
NCI-H2009,168312962,3.455210391348572,2.3143127104371986
NCI-H522,25154868,4.970187113391964,4.233743840499197
HSC-4,3503,2.6271988960037502,2.416281427973209
SNU-449,54619267,4.584813130836932,4.1181266313349285
CAL-51,44507138,2.6477043136390637,2.185548077557803
CAL-51,24753719,3.9981702522006257,4.203164254387426
SBC-5,16725315,4.9617798252058165,4.192509427986485
CAL-51,123631,2.4616591372530605,2.6752896450107397
A2780,56963564,-1.0587892817911606,0.061753434161317323
LoVo,119182,-3.2827225124554804,-1.087769811925554
A-498,3503,2.8872062971439436,2.693858634781396
ONS-76,navitoclax-sorafenib (1-1 mol-mol),1.6529923050445217,1.6158488905887176
FU-OV-1,9915743,0.5010130642537969,1.2251342979319053
LOU-NH91,6917907,-5.4115573726076125,-5.078209958480505
A4/Fukuda,322968,1.909418940393303,2.2257710803444364
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936,2.2571272571179013
HSC-4,54618164,4.183236352259565,4.2260190937960935
SNU-81,navitoclax-MST-312 (1-1 mol-mol),0.1255158725803597,0.608478228381743
MSTO-211H,89928392,0.2675284607275224,1.7363532871530958
MSTO-211H,16741245,3.31564558456852,3.8647009171530096
FU-OV-1,969516,2.7898134338200093,2.988597135530563
FTC-133,9840324,5.72186430729165,5.8361608338954465
FU-OV-1,2828334,6.23308188240882,6.157835764141645
JM-1,docetaxel-tanespimycin (2-1 mol-mol),-7.819980451052631,-5.138212989018863
NCI-H146,25062766,0.9164062509537028,1.843810866992253
MDA-MB-453,44197249,5.538441394278097,3.87709685269052
NCI-H292,25126798,3.8121795120859865,3.8366144654463947
NCI-H2009,49793307,-2.1832388254663746,-2.1169945262800103
ONS-76,446155,1.9434822335598465,2.579844112887755
NCI-H460,613753,5.368273372553464,3.2115652690583363
NCI-H1623,375860,-0.2497324332058591,-0.19409712531546522
NCI-H292,135440466,1.1809367948500966,2.2185740059408463
DMS 273,24821094,3.2786522000090974,2.985440989386871
CA46,1566236,0.9666867201201066,1.5814060357038189
LXF 289,6914657,-2.1957863105134474,-3.89452647185637
BxPC-3,68056272,4.30573170491611,3.3916367852559324
CA46,24856436,-0.7056093623802927,-0.4569814116698744
SCC-9,136227924,3.721677265331546,2.901647960173481
BT-549,5281672,6.431065394953252,4.71189252517049
KMRC-1,136227924,2.9529226708788734,2.8593133312778827
A2780,46224516,3.0956757820489966,2.4046125329311927
OPM-2,2871966,-0.6940984937409527,0.008423458136542512
NCI-H522,44607530,1.256897748575463,1.7268554960116247
YAPC,135421197,1.6415717791988456,1.981154209677262
Panc 04.03,11609586,3.1950022878003375,3.044278409773103
YAPC,285033,-1.734058118132599,-1.5893057810785185
EFO-27,25161177,4.775691091389994,4.062348390446989
MDA-MB-453,285033,-3.584093663874095,-2.1906648382278893
YAPC,135398516,2.168624804585352,2.415144887340854
BT-549,10184653,2.4120945582019098,1.4790209537116894
SNU-61,322968,3.1681402320576924,3.25092112083936
CAL-51,9911463,4.251278022142156,3.9302355020552677
NCI-H661,119607,4.8407678671423975,5.073777168428766
Panc 04.03,navitoclax-pluripotin (1-1 mol-mol),0.6568791219760653,-0.5741319841515852
CA46,16720766,0.453567173389679,-0.3941590057621993
CAL-51,11404337,-1.4033364127444676,-0.252991256381949
SBC-5,9911463,4.310936662946409,3.8937726756730284
NCI-H727,2828334,5.890997909388885,6.341074400038589
JM-1,104842,-7.303088314363844,-4.48277345522023
NCI-H460,5335621,5.645903220513178,4.699147396038891
MDA-MB-157,ISOX-bortezomib (250-1 mol-mol),0.8277419655011916,0.7243556089742075
HSC-4,12003241,-0.0373048915881231,-1.0878069720418477
MDA-MB-157,53301938,4.15898814375023,2.6882700692599393
MDA-MB-453,25150857,2.1104930677980964,2.4316115790714843
HSC-4,25183872,-0.8460464512297751,-0.6706383518711138
CA46,46907787,-0.8110179268567884,-0.6176154062104883
LXF 289,5311,1.216776445363927,1.6513786584152086
NOMO-1,6610355,3.932739350210071,4.024605954739617
CAL-51,11222830,1.6762547521470548,1.5250139810248442
HSC-4,9915743,0.765957034876682,0.7514793568202545
SBC-5,72193861,-0.1091418694351138,1.6478703728855926
NCI-H460,60700,-0.2314807684970784,-0.3383497715339645
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585,-0.30880669088533386
SNU-449,2729026,2.998695944617882,2.7140756335473957
A-673,6914657,-9.096845778146204,-4.769310498592374
EFO-27,64971,3.389505323176025,2.7662682128392775
MDA-MB-157,44137675,2.4962707088889524,3.3939472411881364
A-673,374536,-2.1767869041067462,1.593076393499489
NCI-H522,24951314,1.0216385721244754,0.7721970977429519
JM-1,16038120,-0.8379540118722992,0.15017925990108874
SNU-449,25126798,3.9846076439311258,3.805637273639
JM-1,9444,3.0857992205099616,3.4916890081304364
NCI-H2009,selumetinib-MK-2206 (8-1 mol-mol),-2.109665042041408,2.518935161945878
A-673,327653,2.521292352419487,2.966575991479402
MDA-MB-453,5470400,0.9814504444661803,-0.6247805497272948
KMRC-1,71751553,4.436686890494674,4.44851099320606
FU-OV-1,52947716,3.0881190342895626,0.5014912287167094
A2780,selumetinib-piperlongumine (8-1 mol-mol),1.4682842142884078,2.5370157126149078
JM-1,3825829,3.3725964609251005,3.3421691822772948
G-401,6918328,-1.3062418496747916,-0.18743789258888563
OPM-2,136227331,3.7431952210756014,2.8099738015010707
OVISE,5281321,-1.443802792924895,-1.2381312625663263
CAL-51,6450551,1.9748462748620472,2.932732882917173
DMS 273,387447,-5.016212668564022,-4.441060764322818
OPM-2,5278396,3.463635489570463,3.0157452883116944
ONS-76,445643,3.769289821936489,3.9736438029638905
OVISE,676352,3.019558255819343,2.1113574953168475
OPM-2,126941,-4.73900193491969,-2.6276661086565576
MDA-MB-453,11404337,-0.3002498088297632,-0.19319153384827537
NOMO-1,24797083,1.0415171353084307,1.0317410074382642
NCI-H522,374536,3.894183139895475,1.3391698712360238
A-673,6252,-1.7615808961584718,-0.7539384396062023
LXF 289,9915743,1.5678711489122208,1.5603090176144019
DMS 273,72734382,4.203397510599988,3.7779884722957062
NCI-H522,selumetinib-tretinoin (2-1 mol-mol),5.363366003063694,3.367649728809354
A4/Fukuda,BRD-K55473186,4.020373973875239,3.9139411741339614
FU-OV-1,6505803,0.8019489696335256,-0.5920153737659445
NCI-H292,10074640,3.1247192788252134,3.239712469762839
A-673,3854666,0.8608139997201792,1.382963063281843
EFO-27,637858,1.802850970746332,2.051706666983539
MSTO-211H,123631,1.7071024302486195,2.2715250521391446
OPM-2,54619267,3.38914180731132,3.3576907037058827
SCC-9,11612883,3.4111633177056992,2.8416126160412425
MSTO-211H,BRD-K55473186,4.0690738661382175,4.341415997480554
CA46,25154868,4.248651634430963,3.900889358603989
LOU-NH91,6918837,-1.6936529516603684,-2.1652616960276907
OPM-2,9911830,2.101419447334853,1.6386232929785733
BT-549,6438330,1.5528656655176645,2.4599914037006507
EFO-27,11647372,2.575313315468432,1.3315689419548877
SNU-61,568763,-0.2886838000487807,0.13873500959550442
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462,2.860245781954694
Panc 04.03,5282054,4.5317440773242925,4.028220938391382
YAPC,53232,3.166937959197618,3.180135463791767
SCC-9,44486219,3.972056382599232,4.330489951329246
NCI-H460,104842,-2.7771726159534773,-2.4355694396469527
BxPC-3,4788,5.831531206482249,5.771950631058665
KMRC-1,753704,4.9867166993089365,4.658015956813343
MDA-MB-157,71729975,1.9097389430207852,2.0535895900488095
MDA-MB-157,46398810,3.5828771462995666,2.4757472093688015
ONS-76,42642645,1.3507577274785498,0.7956981562966077
EFO-27,9956119,4.364890218263242,3.7593945234420465
SNU-61,49850262,3.504538311157692,3.3812874883501713
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322,4.4188625521888865
MDA-MB-453,9967941,2.180105496017499,2.9264795052471198
OPM-2,409805,3.1459770002319023,4.092616415062304
BxPC-3,11214940,1.4945762019529478,2.2967126835483973
CAL-51,71466445,4.7818956768695715,4.2507420846295085
YAPC,44137675,4.160217990140765,3.5532925835429516
A2780,3465537,2.6217509140821247,2.3112689982114953
SNU-449,135398744,6.632733291537939,6.47457927714339
A4/Fukuda,676352,1.592410759121419,1.991049260972934
NCI-H522,5566,3.055916396278747,2.7717572941321897
SBC-5,6252,1.1660150864515155,1.1830438535756853
NCI-H460,65064,5.803776096144955,4.89808964934621
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678,0.7774043320250159
KMRC-1,60700,1.5998244644110848,-0.09762226226616284
MDA-MB-453,72734382,3.580352840578633,4.272097515298456
FTC-133,BRD-K55473186,4.331616686106064,4.101146896086499
NCI-H661,3062316,-1.6378145648450078,1.0632854815170858
NCI-H661,11977753,-1.2976183269776842,-1.0995622902140485
KYSE-70,4477,1.3887255745641551,0.45146315631090544
A2780,15953870,2.2934332620703457,3.3571086806771246
SBC-5,44589607,3.2873586375678627,2.736524045786828
NCI-H2009,3634881,3.6058977960867233,3.5940966401006404
A2780,5951923,4.306994873236267,3.7568857518361267
HSC-4,11152667,-1.532358108136572,-0.6542447936655278
OVISE,3543504,4.513312782724499,4.386348432491192
CAL-51,676352,2.3367523995253454,2.030183443415146
LXF 289,100016,7.121965810949268,6.432973099218867
OVISE,JQ-1-vorinostat (2-1 mol-mol),2.753881285057562,1.156620243403497
KMRC-1,4096211,2.4789291220770053,2.0273306739135193
NCI-H522,2949965,1.5154466163896825,2.7421719367734774
G-401,613000,2.0341288465268397,2.3978661106080836
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745,3.4623525753542284
FU-OV-1,46907787,-0.0188806347407138,2.511663561524859
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331,1.5401607659997327
NCI-H522,9926054,1.815484319665427,1.901911025399522
EFO-27,9866186,1.214213380462077,1.2837296244300627
DMS 273,446155,1.3230843960440628,2.606721557629443
EFO-27,136227924,3.515702384882397,3.276953597512622
NCI-H522,25161177,5.347457629837048,3.4416543408591713
BT-549,107985,-4.157404914346088,-3.2248355887825046
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344,1.72600833104695
CAL-51,984333,0.1261860025273146,0.5649101074279358
NCI-H2009,60700,0.1880080174398503,-0.43246256570321484
CAL-51,135421197,1.6266864976107616,1.8565825016184152
MDA-MB-453,54619267,4.30313846005301,3.871289395160174
NCI-H727,72376,-1.9917966726836325,-1.9054665108353526
A4/Fukuda,54618771,0.259551202975953,0.5765179457238652
HCC1143,5280436,2.2824596389444567,3.3543524872427883
FTC-133,168313200,3.883948141330694,3.1024597821914273
LOU-NH91,11427553,1.5999683226177923,2.965275235720905
LoVo,5287620,-2.196691557023958,-2.355553073835517
LOU-NH91,11222830,1.619786635706389,1.6998472358741565
SNU-81,ISOX-bortezomib (250-1 mol-mol),0.4477556870323437,0.22215545003373044
ONS-76,44507138,2.3475098717107685,2.4818402213420754
EFO-27,12001922,2.6878207164132517,2.0348312313700943
HSC-4,25102847,2.881629074853979,2.6579513009399665
A-673,4477,0.9527863024115504,0.4552696397526099
YAPC,119607,5.457421403002251,5.314127178829306
SNU-449,11364421,1.172419453845969,-1.3093190597138993
FTC-133,1566236,2.958331107997485,2.6378452966230337
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068,2.8378467247019774
A2780,9956119,3.341179703016576,3.2777621343782823
A2780,421610,3.3194399172740296,2.9584467102548433
MSTO-211H,11656518,-2.9147381038014095,1.7201985073169122
YAPC,carboplatin-etoposide (40-17 mol-mol),3.290819811015708,3.0761996297444125
ONS-76,5282054,3.726244399490591,3.5337117074837177
BT-549,JQ-1-vorinostat (2-1 mol-mol),2.606631722875188,1.370071188493191
SNU-449,1750826,-2.5268598200751504,-1.3034006712865875
HSC-4,56949517,4.34052816497715,4.373954826343037
BxPC-3,alisertib-navitoclax (2-1 mol-mol),-2.4786410081497223,0.6675996833844061
LXF 289,11175137,1.607203821415342,2.8444414387030745
LoVo,400769,-0.9988261077541156,-0.7069533275050582
SNU-449,9823820,4.446865909721317,4.31700895421023
A2780,23582824,-1.3073183780043152,0.7836566816676698
LOU-NH91,24821094,3.1074025746804854,3.177473776816224
NCI-H2171,1566236,1.862945078393334,2.129568773781115
SBC-5,alisertib-navitoclax (2-1 mol-mol),-0.5027212648938616,0.17581860020051313
SNU-81,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.6771468011681286,2.8702568397555597
LXF 289,3815108,3.5075214319549683,2.933865926299782
SCC-9,6918638,0.4192666549800527,0.7787434805316751
LoVo,54626689,4.759845357486115,4.602766677443444
HSC-4,9956119,3.775946121479013,3.6834514432841825
Panc 04.03,carboplatin-UNC0638 (2-1 mol-mol),4.7376936577432405,3.5955621464435366
JM-1,2708,2.6994993672471774,3.1147825853396283
A2780,151289,-0.0035192392559562,0.8986270256701886
JM-1,135440466,2.1821804764998785,1.9347548234894945
SNU-449,JQ-1-vorinostat (2-1 mol-mol),1.642225062280099,1.1662706645122558
SCC-9,100016,6.423023301160456,6.285594001290307
MDA-MB-453,24180125,2.9500133631526477,3.008477096172696
MDA-MB-157,6610216,4.481014218943506,4.386262435801359
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758,-0.4206752053615045
MDA-MB-157,216239,2.048111671637324,2.421809042048335
ONS-76,72376,-2.745447792813742,-1.5755210978859768
YAPC,56946209,-4.683971162846982,-3.978955831769011
LXF 289,11977753,-2.1467130480879217,-1.0045265583654697
A-673,46926350,-6.171938943197618,-4.013586706548722
SNU-81,44490293,1.2258782245734428,3.089759364732608
A-673,3384730,1.4382839107098095,2.172473164705883
HSC-4,5328940,0.4436918358674775,1.5838219714869248
MDA-MB-453,15953870,2.92470748098227,3.4694057688861566
ONS-76,44487061,4.494085272908884,3.184454557160151
MSTO-211H,656346,1.1626228980727835,1.1226485975508624
NCI-H522,72376,-2.490005030905514,-2.6330630987890755
A2780,2945648,2.954770875487345,2.422078806141726
OPM-2,49867926,3.883283056469906,3.1812350121972113
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078,-1.4436110715131971
FU-OV-1,2729026,1.7636424043101242,2.7246710656346234
A-673,5351362,0.6290025594893434,1.2125599106087657
NCI-H727,crizotinib-PLX-4032 (2-1 mol-mol),1.979940863489789,1.7725772138301208
NOMO-1,3384730,0.781590014898287,1.4123192974725924
A2780,753704,5.064252843259393,4.378639441223508
LOU-NH91,104842,-1.007764649763801,-2.6396915862507444
SCC-9,selumetinib-PLX-4032 (8-1 mol-mol),4.645114234652884,3.3118235342403755
NCI-H661,135398738,5.197398941249139,4.590689557344319
OPM-2,11213558,0.5330056992590615,1.0563569730115043
SCC-9,216345,4.596520649168519,4.024479515708286
LXF 289,73707398,1.5723760999376108,1.5539119065311169
KYSE-70,148198,-2.193158047226166,-3.213230143784009
LoVo,5281672,4.34355838965171,4.693498083185714
NCI-H292,3081361,1.6323755734101046,2.5037347637350376
NCI-H292,969516,2.7034021602074207,2.841665064029752
BxPC-3,carboplatin-UNC0638 (2-1 mol-mol),3.4079462645676815,3.4867449671264152
DMS 273,56963564,0.2331753873879126,-0.12505578488760657
CAL-51,168313047,1.9592520089902103,2.4021562151836546
CA46,2949965,2.263314804434843,2.3167388555628383
G-401,135423438,1.541142645334712,1.3776643249855693
OVISE,16741245,2.37455837119256,4.0337831674789495
CA46,3634881,2.7183374991781903,2.5213153455034596
HSC-4,11427553,3.1625220487182193,2.9159221794186987
BT-549,selumetinib-UNC0638 (4-1 mol-mol),5.0457009484631365,3.419723754131086
G-401,168313200,3.793890782777564,2.754572090848289
A-673,3689413,-2.493408888485536,-0.7966301892432816
OVISE,JQ-1-navitoclax (2-1 mol-mol),0.6695486858757606,0.5311085936210629
A-673,3062316,1.882423163055416,1.2083884264435802
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045,2.5092751561559523
FU-OV-1,49766530,-1.0180111021842635,-0.4442340346968401
NCI-H1623,4259181,0.7011384719609343,0.4233375332689508
NOMO-1,11427553,1.1686106553832942,1.1185349174379113
JM-1,25102847,1.7356230100982195,1.6793742681520871
A2780,219104,2.8403974518726938,2.977705044001066
SBC-5,2113511,4.3346082595960045,5.26634468668585
BxPC-3,navitoclax-birinapant (1-1 mol-mol),-2.5138239615221907,1.771006109305174
A-498,JQ-1-vorinostat (2-1 mol-mol),1.7562292819472516,1.088413657910515
BT-549,44607530,1.0072782741331217,1.8851931961309683
FTC-133,56946209,-2.082875590070058,-3.7489899526515678
SBC-5,49766530,2.674414744921775,-0.43091975748908373
NCI-H727,1750826,-0.0055354600789778,-1.3016555287413691
SNU-449,2749,2.680740017346485,2.1219984842782513
YAPC,46843906,3.8406256643083214,3.429579169480411
OVISE,3503,3.051689922997692,2.435826061418385
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903,-0.8574796923637584
A4/Fukuda,24901704,2.035809268681581,2.433253513809662
SNU-449,2949965,2.551789087127138,3.076130940542908
MSTO-211H,65064,5.509158922836103,4.806790150126075
NCI-H460,753704,5.635234970240753,4.901058010722653
BT-549,9907093,5.687861442777729,4.2231118784218555
SNU-449,89928392,1.7008506784074908,1.6919379964628662
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506,1.9455340682635396
LOU-NH91,675434,4.5447066201437325,4.661601426787906
CA46,5351362,0.7524287969492447,0.6431499051666582
BT-549,3025944,4.080638158593822,4.304111064311567
SW1463,57330099,3.693611547578868,4.0349450650033525
HSC-4,16722836,1.7684769334825834,1.8111225356829466
G-401,4096211,1.4243357241965535,1.4691238122557362
Panc 04.03,6610216,4.328711123736605,4.322294558401843
KMRC-1,5287620,-2.779883294896464,-1.835567851829293
BxPC-3,119182,-1.1309049402050737,-0.6115946809749084
G-401,135999136,2.1711954992798987,2.8864798322743237
KYSE-70,285033,-2.195981319752621,-1.9390153431939046
NCI-H1623,selumetinib-decitabine (4-1 mol-mol),5.307511276565798,3.470807460430737
KYSE-70,44607531,3.0404164934883733,1.348253217440134
SCC-9,6918878,3.402250236896725,2.8130669818100444
MDA-MB-453,5282054,2.7696083041072237,3.514441112276539
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563,2.652716667884054
BxPC-3,57519531,2.3630144255947045,2.6958351774632967
NCI-H2171,56949517,4.289308734480345,4.201118796439698
Panc 04.03,54619267,4.1321899610425215,4.190717700740592
G-401,11485656,1.708547873036538,1.9368768394524656
A-673,6917907,-5.646852280462545,-5.378078916246027
NOMO-1,71304818,2.372593058500035,1.9426423150388814
MSTO-211H,11214940,0.3292815706978371,2.273657051322512
HSC-4,1750826,0.4564084690350189,-1.3272457049711324
HSC-4,426756,6.131320111521982,4.182067482495657
SCC-9,12001922,2.463166865850559,2.109191612556603
CAL-51,656346,0.8466306406200714,0.9244660344204507
NCI-H661,49793307,-1.6947898398784864,-2.6417354142291822
MSTO-211H,6450551,1.5186693992042568,2.945521709818534
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005,1.9131398563410582
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277,0.8893334791961811
NCI-H460,73707398,3.251551904382877,1.4706085779460125
CAL-51,168313016,5.819136604546001,4.838330188630019
NCI-H292,119607,5.8072644572840915,5.456468842880646
SNU-81,31703,-2.2099083949209715,-1.0954038127931103
A-673,11719255,3.0296971336672627,2.7923092397109794
HSC-4,9911830,2.7717739782698563,2.69687999212962
CAL-51,44589607,2.4963130908502107,3.1656271124556947
FU-OV-1,24180125,2.037807307003979,3.1420083893718163
EFO-27,3634881,3.530057446917586,3.4268633674566003
MSTO-211H,25262965,-3.426128826799908,-1.536233806899981
LOU-NH91,3543504,4.266458043071255,4.517466459658629
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961,0.3937769813385808
NCI-H2171,23582824,0.048802245172864,0.815640203753835
SCC-9,11507802,1.3688807961315366,1.917939655831154
MDA-MB-453,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9656310639147305,3.372720712910336
CAL-51,65628,4.560195683913681,4.393695315404077
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256,3.1772333081717794
CA46,6505803,0.7805822725654986,-0.6202852277731868
KYSE-70,327653,3.7336437717951103,3.0530699114805975
NCI-H2171,11494412,-0.1110474347644453,0.791130597666792
LXF 289,6918328,-0.239589445073231,0.5503449510551632
CAL-51,24951314,1.3730048574034712,1.2693087655870006
OPM-2,tretinoin-carboplatin (2-1 mol-mol),4.37691141446878,3.0882492374536126
A4/Fukuda,2858523,2.415383768636832,2.9006014244454392
NCI-H522,753704,4.098243268802601,4.459713293973988
A4/Fukuda,11625818,2.700159842549232,3.5089951053569597
MDA-MB-157,2949965,2.5406478696331587,2.906992682191712
ONS-76,409805,3.962852167855045,4.808220893515319
NCI-H146,439501,-3.5641402563292393,-2.6093514217656018
CAL-51,24856436,-0.3083697359271743,0.39375921930090546
SBC-5,31703,-1.5086983052531706,-1.163273546080066
NCI-H522,10184653,0.5663226513641079,0.7110910912190943
NCI-H522,135421197,1.9700795220087195,1.7100492645201912
A-673,alisertib-navitoclax (2-1 mol-mol),-1.8576644604152912,-0.62031515502512
NCI-H1623,46398810,3.5623335184860196,2.5933892746422216
A-673,216468,-1.1121166448103192,1.4511355056715118
BxPC-3,2708,4.650566781622339,4.98709180289058
SNU-81,6184667,-0.6614889419446587,2.702028612620062
NOMO-1,168312962,2.6221164331885003,0.5912191167545477
MDA-MB-453,16720766,-0.5495005772629474,0.6565306346303298
NCI-H522,9956119,4.024745164263863,3.2297029396960646
NCI-H1623,135440466,0.8012621152288821,2.255465933636678
CA46,3025944,4.264528242833472,3.830989598183006
CAL-51,71466380,3.802692276073616,4.464732018556075
Panc 04.03,11656518,3.295682085422899,2.0299856897644433
SNU-61,JQ-1-MK-0752 (1-1 mol-mol),2.077081766151821,0.7302405812307023
LOU-NH91,16720766,0.888730139062919,0.7077700574158372
HCC1143,selumetinib-MK-2206 (8-1 mol-mol),0.0669797287296957,2.2376656971484463
JM-1,57519531,1.1574190263295916,1.3740170479798945
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.2020864122166244
MSTO-211H,148198,-2.180219295506665,-3.021903852387295
SCC-9,4521392,4.43257578464979,4.343006061300738
FTC-133,2746,3.487652314498242,3.297738687453456
LoVo,44819697,3.398153390084315,-0.262759609381112
Panc 04.03,122327,5.490637645011104,4.75948860126256
BxPC-3,25154868,5.007679584209566,4.224388406046729
NCI-H661,3503,2.324538290067321,2.1121839324218636
NCI-H727,54618771,2.7901712320729333,1.2293088119734816
A2780,10302451,4.067201499125142,2.9615763567403532
A4/Fukuda,5281321,-4.090150251628595,-2.0021559090581644
Panc 04.03,24771867,4.398084543376112,2.8690697369604434
CA46,241158,1.6221144264981358,2.494542024383589
SBC-5,26596,-2.1907470722084414,-1.0425569676384487
A-498,11625818,3.6553151033235904,4.461016662296653
G-401,9911830,0.6760173642929876,2.286852547614371
CA46,123631,1.9024335998312112,2.069205521142356
LoVo,104842,-3.39586805089817,-2.7961250122487153
OPM-2,5479543,3.226492982806864,2.7639189463328684
HCC1143,6623618,3.4930934009716226,2.4226724862374764
NCI-H2009,46199207,3.041674504763304,3.2189881774649014
NCI-H661,49766530,1.1318827683023138,-0.2553825846355125
CAL-51,1641662,3.5457804017420744,3.571589745372645
ONS-76,44819697,-0.7397391051726983,-0.40744377519039837
BxPC-3,57330099,4.21152658046839,4.368740600674344
MSTO-211H,3038522,3.865174160499475,3.0396542678672382
LXF 289,71466380,3.888647536265504,4.60469576192623
CA46,5479543,2.004846411807367,2.5460951664585947
OPM-2,9907093,3.786753386665246,3.504182179820648
NCI-H522,54613361,-1.014694822148615,-0.20933937836357766
NCI-H2171,25195348,2.4042641753284872,2.9916993798105245
LOU-NH91,9911463,4.226439837654448,4.118661766755858
JM-1,6918736,-2.112176013423493,-2.2069798065338166
OPM-2,89183176,2.1177805080987633,2.8485247155109494
OPM-2,135875424,2.796643273298537,3.2927519115486232
HCC1143,24964624,2.836653438175677,2.3402459175167154
DMS 273,44566777,1.254196350489733,0.47907588282782215
NCI-H522,49867926,4.17523654199276,3.457928750421599
LoVo,72193861,-0.0557430791680942,1.6269095294576223
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856,1.3868336334379334
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008,1.5433527299140979
SNU-61,374536,-1.8297483787291275,1.1666264940574753
CA46,44566777,-1.0409480025289963,-0.2574354127398698
JM-1,54613361,-0.7111924625528845,-0.5980046007723457
LoVo,25154868,3.829103546750207,4.345787859999854
A4/Fukuda,15547703,2.4441609561923547,2.468933050383725
KMRC-1,10074640,3.6694615069556886,3.1056670262268757
NCI-H2171,2729026,2.1337054337121466,2.5084583793443627
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768,-0.6880585125375344
HCC1143,68056272,4.744387863321378,3.621885230758187
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,0.7969234105149292
NCI-H2009,44607531,0.9822487023795796,1.4534335143596593
KYSE-70,89183176,4.766828638924323,4.469549523336554
SBC-5,25154868,3.0138435145006155,4.327856608017006
A-498,11719255,3.5352993104723245,3.6458129396034296
SCC-9,208908,2.838235608451249,1.8054897248993351
SW1463,2126,3.781949624288532,4.348221947759773
SBC-5,5311,0.7694897344457827,1.5049682354662273
BxPC-3,11609586,2.766108761160721,3.105499833759761
CA46,71466380,3.212448709653588,3.7963057068353097
FTC-133,25126798,4.495223588633032,3.7913420384964693
JM-1,44632017,0.8586744690995054,0.7447327298594202
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598,0.8259212030701185
SNU-449,4917,3.4001304631059965,3.013888010149898
JM-1,135984461,1.552881480804892,2.3668734157037825
NCI-H2009,969516,2.7623608328977314,3.0029882703155892
SCC-9,104842,-1.437225086828998,-2.532160449666943
CAL-51,73707398,0.7053044464230985,1.0464112165387973
KMRC-1,67156097,2.0694443843024173,-0.8612157029711078
SNU-449,135411,1.1071215925884743,0.9596989566868598
A4/Fukuda,72376,-3.4342601152101473,-3.077738339497418
CAL-51,54619238,5.308906879487735,4.57736525323651
SBC-5,5282054,4.370273963099393,3.4776276094674556
SNU-81,vorinostat-carboplatin (1-1 mol-mol),3.3031492334396977,2.5114922715685504
OVISE,5328940,2.3935755372069676,1.6633889895594889
SNU-449,BRD-A02303741-carboplatin (1-1 mol-mol),6.10453045453208,4.162464934696624
A2780,24779724,4.3340331177123765,3.460700577861473
A-673,400769,-0.9976419565742564,-0.7475979182158181
MDA-MB-453,3081361,2.1431734647577496,2.0577920502180045
A4/Fukuda,123631,1.573225246333458,2.304201032093197
A-498,46224516,5.193995490382977,2.7339292103443666
CA46,5738263,2.2696720462337456,2.6686330302194823
DMS 273,16722836,2.1308156944151833,1.3240453920909285
KYSE-70,119607,5.065055719995064,5.141134943207126
MDA-MB-157,637858,0.0650158223638603,2.0179700802017995
KMRC-1,24180125,3.3952911821821052,2.8611922474552434
A4/Fukuda,9935249,-4.132944592984893,1.145558046436548
A4/Fukuda,9915743,-0.3554458205966057,0.6297160477481321
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143,-3.8534122458744924
FU-OV-1,11222830,1.8946229471337992,1.5339714647983345
SNU-81,BRD-K27188169-navitoclax (2-1 mol-mol),2.560233422856499,1.536706064736228
NCI-H522,24775005,3.057250054087749,3.5221157762314785
NCI-H522,15983966,4.053677978120726,-1.7246183034255873
DMS 273,25102847,1.54508352242066,2.021099321242824
A4/Fukuda,44543605,3.1271044447490235,3.9720980957202987
CAL-51,44507138,2.6477043136390637,2.185548077557803
SNU-61,16725315,5.215969195263621,4.1859138487083625
EFO-27,448949,1.7491267397814168,2.024066978691922
A-673,5280436,1.8974559090481808,3.1414560620934213
MDA-MB-453,24779724,5.606505141806212,3.9196180601006
SCC-9,carboplatin-etoposide (40-17 mol-mol),3.166154009244092,3.1286621843381943
G-401,alisertib-navitoclax (2-1 mol-mol),-1.5256164798687666,-0.8213184124247285
NCI-H522,216345,3.499198551341706,3.479007920378324
BT-549,25022340,3.398199457605664,3.1986103353328126
SCC-9,23725625,6.300420686237622,5.2104226541249306
MSTO-211H,54619267,2.133098694540018,3.930454509170192
NCI-H146,JQ-1-UNC0638 (2-1 mol-mol),-1.369706115362065,0.9724393530616531
A-498,148198,-1.0809020747576437,-2.8904505742585913
SNU-449,10127622,5.039458046327855,3.8847733302136698
CAL-51,1641662,3.5457804017420744,3.571589745372645
MDA-MB-453,5291,3.622613892398656,3.266838226970137
A-673,168312962,-0.712468254461992,1.505265756875876
SNU-61,52912189,0.4386789975034979,1.3803597640365413
LXF 289,2828334,5.402872149224608,6.252749598580972
BxPC-3,374536,3.0351492595764347,2.5836826001924815
EFO-27,9825149,3.71226874457915,2.567878657318114
NCI-H727,216345,4.166745514794161,4.055385404728506
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.485491324431175
A2780,156414,1.0391092981452308,1.3801977995279067
BxPC-3,11647372,-0.5523773269560157,1.1353900287504808
NOMO-1,10296883,3.647443685498321,2.9876432767980816
LOU-NH91,60750,2.5426597160889823,-1.9451023970701544
NCI-H460,16038120,2.547350732010626,1.1776030888223221
ONS-76,123631,2.7486777230854176,2.373238514562352
OVISE,9903786,4.69480560533159,2.7612771345319502
HSC-4,168312962,-1.5337410071263893,1.950631136087609
NOMO-1,421610,4.35383474826381,2.3624839915896256
NCI-H661,4917,2.840246866325883,3.0516131994442204
LXF 289,3634881,3.11935208210029,3.276426417910577
EFO-27,9911830,3.273850069923984,2.6987560742755763
A2780,46215462,1.4920420325768875,1.510161612433588
MSTO-211H,11234052,3.0252233847843515,4.092051510091966
NCI-H522,2842253,4.095670069869479,4.2824877247248505
A-673,3385,3.2869772752619033,3.171707497456903
MSTO-211H,46398810,1.7478948810000858,2.4419200893373216
ONS-76,49850262,3.849158291733923,3.1866095499770335
MDA-MB-157,11507802,-0.5781039838427031,1.7559196911978177
A2780,24978538,0.9309197302054482,1.0200622265460215
BxPC-3,24180719,3.164671730334926,3.516533934332173
NCI-H146,676352,1.7139908333138,1.906611579395421
A-673,82146,3.820966427179324,3.2684533737750723
NCI-H2009,46174525,3.5250507211438107,4.497581110258004
EFO-27,10302451,6.465018307145316,3.1759134337908184
A-673,135984461,3.9402009784769745,3.136433172138263
HCC1143,4521392,4.180219407268625,4.403032843232989
A2780,5351362,1.3372825777001471,1.3107073928233393
EFO-27,10296883,4.235346466258499,3.9860004507394096
SNU-61,25150857,2.1451887473522295,2.0841525405952996
LXF 289,25150857,2.4132050810476,2.59604113301805
KYSE-70,135440466,2.892957215680813,2.1653420179422116
MDA-MB-453,11222830,1.1155100991132725,1.5032018702404606
A2780,6918289,-5.622064624678881,2.335606224967657
OPM-2,445455,3.93427157933256,3.8912959102476434
EFO-27,15953870,3.8448280803188233,3.4950801647527374
A4/Fukuda,4917,1.915641979161103,2.7349327144737146
YAPC,44185566,2.6271326170179248,2.655260185569895
SNU-449,3634881,3.3285371967859128,3.3692989886571554
OPM-2,44566777,-0.9514063433103236,0.1772356220804256
NCI-H2171,docetaxel-tanespimycin (2-1 mol-mol),-7.650275881256593,-3.801537794027855
MDA-MB-157,4259181,-0.4671059045276012,0.38749546318480077
SNU-81,11656518,-0.0512259493867009,1.3028918427043785
NCI-H522,11494412,-0.7022253688217924,1.0781944203060718
A2780,selumetinib-decitabine (4-1 mol-mol),1.5025491201295178,2.163238812651813
CA46,24180719,4.114109141176105,3.0655618670713807
MDA-MB-157,82146,3.0360891700929984,3.7298329827487855
G-401,23635314,-3.865618451368766,-2.5064255914317126
LoVo,42642645,0.0146125142547242,0.8689095118641752
HSC-4,9826308,3.3704185574061456,0.7166937429814317
NCI-H292,176870,4.643600229240446,3.151017393176177
ONS-76,44202524,1.6130278410730936,2.2379955389521182
KYSE-70,9911463,3.4914249269651307,3.9015519326228025
NCI-H146,24779724,4.32606530761132,3.372763649197932
LoVo,44493528,4.114958638118981,4.332897076414492
CAL-51,44486219,4.943814728636009,4.259606985440432
HCC1143,serdemetan-SCH-529074 (1-1 mol-mol),1.8750312876622353,2.0866163263291635
MDA-MB-453,8515,4.14044832994183,3.5378540000206185
A-498,tanespimycin-gemcitabine (1-1 mol-mol),3.605685519475067,-0.1905522573244977
FTC-133,56963564,0.7376209226585526,0.6291964722351964
MDA-MB-157,11494412,-1.4760508995443156,1.728921655723614
SNU-449,4261,2.5462586921108197,1.8894309315245246
MSTO-211H,984333,0.926178476056404,0.8633167011534182
SCC-9,1641662,3.777884166860496,3.453129153758292
HSC-4,2949965,3.8536489984175097,2.991598990216336
NCI-H2009,5566,2.98031688083636,3.1538815804816718
HCC1143,16741245,3.781249389530293,3.9421675051222356
CA46,67156097,-2.616833441535583,-2.307608690376058
SNU-449,vorinostat-carboplatin (1-1 mol-mol),4.005391500954191,3.226987150690291
G-401,55283,4.120501166008349,2.449951162855234
A-673,11977753,-4.8378783477247875,-1.7417610062069548
BT-549,637858,2.0216713295762614,1.9693413372202304
MDA-MB-453,5287620,-1.4808110009700917,-2.23027944024504
BxPC-3,46907787,0.03250860780982,2.0377991736575436
NCI-H661,44819697,-3.610310878099198,-0.762133918742905
Panc 04.03,vorinostat-carboplatin (1-1 mol-mol),3.8664916709741792,3.249561915018295
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492,2.362062822657105
BxPC-3,46191454,0.7426288337003383,1.6053398371853245
MDA-MB-453,322968,3.088283756332906,3.355890092091004
NCI-H1623,16736978,1.234327001570643,1.7515208391358297
KYSE-70,1641662,3.490090790744947,3.337107547138188
A2780,5470400,5.365026906170319,0.1131999010741877
NCI-H522,23582824,0.9084599252004664,0.758076330382274
OPM-2,BRD-A02303741-carboplatin (1-1 mol-mol),5.621987253531824,3.757971291065881
MDA-MB-157,23725625,0.2462467633250468,5.162169943488466
SNU-61,44632017,1.0979359106396418,1.3575527540931431
ONS-76,8515,4.109060881613791,3.8159560977776525
BT-549,erlotinib-PLX-4032 (2-1 mol-mol),4.9890831311831665,3.173045179969812
HSC-4,54626689,4.284935050666877,4.566582272260538
SCC-9,42642645,1.380036396261508,1.0881776090079065
LOU-NH91,9866186,2.5706791809917258,0.8346014141164292
MDA-MB-453,3552672,1.8646445353613752,2.7443797284191915
LXF 289,11507802,1.7765111516543377,2.0972215607886033
KYSE-70,107985,-3.298359335305578,-3.4216372712803933
G-401,53325874,4.831157164763357,3.783434294369582
NCI-H460,5746,0.0249012606464236,1.1707867895799726
MSTO-211H,11213558,-0.8326933060339966,2.0153101865498773
KYSE-70,56963564,0.3897414986371327,0.6067621949353899
FU-OV-1,11485656,3.4521578130267336,2.4932535916518
A4/Fukuda,56963564,-0.5107551488404702,-0.25310617688645953
A-498,51039095,3.6847311434926535,3.0700059244238127
BxPC-3,44486219,3.8860987116797703,4.386234288098116
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696,0.3702704143709377
OPM-2,piperlongumine-MST-312 (1-1 mol-mol),0.9476168525414524,1.1651572315224021
HSC-4,44819697,-1.3561318696958864,-0.5924771588544813
LOU-NH91,selumetinib-PLX-4032 (8-1 mol-mol),3.969843428334973,3.7093580655657323
A2780,148198,-4.120801514793353,-3.9136912900135967
YAPC,36462,2.246335150310725,2.390257249502927
NCI-H460,10184653,3.574651577310896,1.3419132601331425
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.2259241530814122
LOU-NH91,54678924,3.1162234647683205,2.313888974007368
ONS-76,11214940,1.2536021206371053,1.8009994900096116
SCC-9,9907093,4.490912734248418,4.254034629190568
NCI-H661,11964036,1.3116184134954847,1.73044572857082
CAL-51,135411,0.595745817277345,0.48766673296465707
EFO-27,613753,3.260816470325069,3.286373606904405
A-673,73707398,-0.4228078892765429,0.9348982653828998
YAPC,25262965,-0.9761970914901598,-1.035412773151344
LXF 289,31703,0.1888440469000175,-0.5540456921091831
A-673,44486219,3.969252294689724,4.132230848128178
HCC1143,135875424,3.1375636080090925,3.963262647050168
NCI-H661,241158,4.406370209729512,3.6737890868943652
A-673,17755052,1.3895683648511998,1.5539849131291157
LXF 289,4788,5.213081732847737,5.682705037356121
NCI-H522,5738263,2.340773324031017,2.7212381595102095
SCC-9,4788,5.928282303581182,5.731264939337198
JM-1,46843906,0.1108259550663182,1.3299335589036718
CAL-51,9967941,3.511576456928413,3.4368584939405373
Panc 04.03,5746,1.7282227653726634,1.2596941429621962
JM-1,444795,2.4559914793227597,3.116885421532341
A2780,25183872,-0.9660294253312856,-1.2927655988928775
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.7104447209033448
A-498,12001922,2.3665933531109564,2.1759499343936732
NCI-H522,selumetinib-decitabine (4-1 mol-mol),5.680021227414058,2.589420091367117
NCI-H460,3384730,3.247736649900264,3.163640665695291
NCI-H292,9884685,1.805947993429832,0.8446899455214409
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456,3.757753919914604
NCI-H2009,25126798,3.423512143516965,3.9312412238055945
A-673,67156097,-2.6530750558799268,-1.3504892639709942
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538,1.3284118803594793
NCI-H1623,11364421,1.5638784569997608,-0.6363410016649267
OVISE,65064,5.3042455172619345,4.9883989439875025
CAL-51,11485656,2.6541256228973773,2.2965850226170055
EFO-27,navitoclax-MST-312 (1-1 mol-mol),1.1101378003165483,1.061077186551291
G-401,135984461,4.271777659576195,3.3912350681659755
A2780,11960529,3.87105656281655,3.6260789246678184
OVISE,168312962,-1.1497759256084987,1.9484788585785884
SNU-449,25062766,2.0173338536366776,2.046653205928293
CA46,44462760,4.878030903037556,3.012972627566664
SNU-449,126941,-4.267074342641938,-2.4233727879780087
BxPC-3,55283,0.3092833280624811,2.859358643397211
MDA-MB-453,2708,5.180783048838842,5.047904430607071
EFO-27,441298,3.357031616162376,2.6646171445260514
A-673,25195348,4.457358631051988,2.9941456825282473
OPM-2,285033,-4.309653599496783,-3.546000755668362
FTC-133,156414,2.701071854154092,1.370013101560544
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065,0.2200418736770118
A-673,vorinostat-navitoclax (4-1 mol-mol),0.758498532756487,0.4366447750076028
SNU-449,219104,4.193064059209751,3.9143003887103447
SNU-61,387447,-3.847354855280633,-4.373729212380378
ONS-76,89928392,2.125505613903981,1.6370832763322454
DMS 273,10296883,4.130929131041443,3.4695410259340895
SCC-9,71466380,4.753733846444339,4.6742660918354195
CAL-51,11234052,5.18044926966805,4.133857917812538
FTC-133,135875424,4.265925786122884,4.088750214886105
NCI-H292,135398738,5.91070825601545,4.765009728793508
NCI-H2009,24785538,-2.0037312151285462,2.0618263772448326
KMRC-1,5281321,-2.040334048066586,-1.3797018346060401
OPM-2,9926054,1.8132463747821628,1.4666153303839524
NOMO-1,44607530,2.1799605259844914,1.3888689576278648
BxPC-3,104842,-2.6661298782325265,-3.0125365660719847
JM-1,decitabine-carboplatin (1-1 mol-mol),-2.2469818975584004,-0.4486870246608238
A-498,1716436,3.6890609174990057,2.983607203726562
NCI-H522,252682,6.061888172888063,6.441118410372093
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908,3.824919986521233
CAL-51,409805,3.8515087112009656,5.135481377890895
SNU-449,676352,1.7938896042567478,2.238404410600952
NOMO-1,72193861,0.7304873005319745,0.15423711878279747
FU-OV-1,5566,3.32118213388136,3.07816623467959
YAPC,piperlongumine-MST-312 (1-1 mol-mol),2.5050103055031356,1.9528065043814116
CAL-51,5291,4.8235616489491635,3.64208640278259
NCI-H1623,73707398,1.8898657972875643,1.5989374405827403
G-401,navitoclax-PLX-4032 (1-1 mol-mol),3.453832495837289,1.4257525956759798
A2780,54619267,2.083839750794981,3.741059671572886
A4/Fukuda,25150857,1.0832866246256998,1.8955366607768689
SCC-9,25195348,3.9019221273063858,3.2868793032499983
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705,4.305840085142475
NCI-H2009,20959075,-3.4439076637996076,-2.767794041413986
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907,1.811139683670587
YAPC,135875424,4.215334227700636,3.93262697283358
NCI-H522,vorinostat-carboplatin (1-1 mol-mol),3.5371010286521827,2.406084801914051
LOU-NH91,2708,7.798658787946165,5.0702637836558075
MDA-MB-157,54613361,-1.9100924648361528,0.27117183798723543
YAPC,613753,3.436227254149273,3.333878450797704
G-401,26596,-1.5666727843222663,-1.9708976866873755
A2780,124202324,1.685811695923782,1.9350378265324457
BT-549,52912189,4.655826026030035,2.388421247208725
OPM-2,6438330,0.5735051923287856,1.1574719273407228
ONS-76,49766530,-0.8397126534273769,-0.7414240951751873
A-673,24180719,3.918829940752815,3.4415359717018545
A-673,72734382,3.862779655203366,3.927023970233583
JM-1,46926350,-6.131969810114727,-4.23415938867387
A-498,216239,2.9738940537308203,2.493898348891188
NOMO-1,54618771,-0.7336388686704796,0.4584254088875717
A4/Fukuda,25126798,3.529395374343333,3.4746660894477657
NCI-H522,16013152,4.870026952980287,3.501139323103175
NCI-H1623,JQ-1-vorinostat (2-1 mol-mol),1.274501215342979,1.062956983396787
ONS-76,6918328,0.1573953751573411,0.04051384485483319
LOU-NH91,1566236,3.241690914019502,2.525772546908534
HCC1143,2858523,3.0390361797055276,2.9484864968353097
BT-549,71304818,3.5849392152335713,2.6912551787971557
MDA-MB-453,49867930,4.991198207309722,4.635213953106202
LOU-NH91,4261,2.7247094190978007,1.9140153582689912
NCI-H522,52947716,2.6251827866590385,-1.5760269295991762
NCI-H661,6852167,3.3441449371697205,2.912521760877268
NCI-H292,16736978,2.16203795839555,1.87264198273222
SNU-449,637858,2.172600125936458,2.118905251889866
SBC-5,16720766,-1.9276845300945755,0.6977160789948006
ONS-76,piperlongumine-MST-312 (1-1 mol-mol),1.8657254357935973,1.8894238847773657
NCI-H661,2828334,5.966055284777512,6.2537771564009255
EFO-27,9884685,1.4230112837032636,0.8069793230675001
OPM-2,25227462,-6.0467342682230445,-2.051025267981123
A-673,3038522,2.0400506341720237,2.8663642911886917
HSC-4,54686904,4.85379149564711,3.463151094788931
A4/Fukuda,969516,2.117405484631732,2.161027059475383
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573,1.7030251810559434
LOU-NH91,6610216,4.701575628194421,4.312858107929215
NCI-H661,24856436,-1.6135015308236011,0.7714914894934138
LoVo,6252,1.008875569338637,1.1259882477490282
CAL-51,5281672,3.9430830045045857,4.390079811433713
YAPC,25183872,-0.4840811687838853,-0.13663959845521478
NCI-H2171,11222830,1.3474519729527985,1.278662762745193
SBC-5,16722836,3.112579400078665,1.6686326240938751
FU-OV-1,3689413,-2.180005064661593,-0.1932447336026713
JM-1,6914657,-7.803103466538306,-5.390889770355998
A4/Fukuda,11222830,1.361211164053787,1.2168464600933604
OPM-2,24180719,3.7347961717129383,3.2335338379148038
A2780,50905018,3.503420862443992,3.816342646860134
LXF 289,168313016,5.746715572468322,4.788240125997003
MDA-MB-453,2874250,4.390759253530558,4.157704702320425
NCI-H146,3543504,3.2112662755133616,3.89288714851293
MSTO-211H,9956119,3.2798548332341246,3.8393994246624046
NOMO-1,11152667,-1.8753376491976492,-2.138115582789616
NCI-H292,241158,3.585722962787503,4.0354307593828045
SCC-9,52912189,3.371588298050412,2.230749153479313
A-673,15983966,-8.138595470092604,-2.5746921863537113
OPM-2,JQ-1-navitoclax (2-1 mol-mol),-3.008224254673695,-0.3343548629883544
NCI-H146,5287969,-2.632266530811145,-1.872017148038058
A4/Fukuda,44632017,0.3391160528514481,1.011348473429602
CA46,1242560,2.637858421223904,2.891491329790099
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.10561661456686
NCI-H727,10184653,0.8809089143232124,1.2615934601611898
MSTO-211H,6918736,-4.031815262851263,-1.501254958000063
Panc 04.03,54454,4.748257983656133,2.6781397764431154
BxPC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.8536024337573052,-1.2553206438062283
SNU-449,6918328,2.053547134624907,0.2528033266187717
A4/Fukuda,262093,3.0357368226896178,1.6295536812210871
ONS-76,6918837,-2.636307015456442,-2.4621545136564458
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525,-2.6001801638291284
ONS-76,107985,-3.307412021608342,-3.4668628326611595
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383,2.861099311081847
OPM-2,42642645,-0.4905470491794313,0.06770378967157631
FTC-133,16722836,3.262117509304611,1.9232870701058795
SNU-449,123631,2.9179285945779183,2.40642171360794
OPM-2,644241,1.6900050339542656,0.23859209375644372
HSC-4,1242560,3.572222416741055,3.5933496116206465
NCI-H292,123631,3.5457837677726833,2.48732392618905
HSC-4,2842253,4.76622062087716,5.48621885995284
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908,3.518080746323176
Panc 04.03,3689413,0.3957464459941977,0.14129078452798013
NCI-H460,135398516,4.13019906717736,1.9465161651476939
NCI-H460,5311,2.161812802665503,1.762412122115434
SNU-61,11238147,3.2212717665721375,2.7901679327242666
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242,0.6367720481486722
HCC1143,44607531,1.4024247683472026,1.540090050001006
NCI-H727,5351362,1.1476230363651536,1.4075380648670484
KMRC-1,6852167,3.0099217565414693,2.7000148679801494
MDA-MB-157,5311,0.9088479539093504,1.5836102775267868
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117,4.21713845440707
HCC1143,crizotinib-PLX-4032 (2-1 mol-mol),1.506008388614785,2.0539447394431685
SNU-449,3025944,4.153676005178765,4.364935678946753
A-673,23635314,-4.460908555858267,-2.120144573809097
JM-1,5351362,0.3312371174067021,0.7911643753867577
DMS 273,24901704,3.9468378622372264,2.632436352672607
MDA-MB-453,9911463,3.8683390626627454,3.8471547589744843
OVISE,60700,1.357326318980797,0.0205199081329031
FTC-133,448949,3.317946341403347,2.0326543024911525
LoVo,5566,2.507145044552918,2.9890282165261852
DMS 273,9967941,3.979035067958665,3.3711932510413107
LOU-NH91,16038120,-0.2213795856096394,1.165467361825073
NCI-H1623,11977753,-1.4500330036408269,-0.9539121619904221
NCI-H522,JQ-1-navitoclax (2-1 mol-mol),0.228465095222191,0.519134979638386
NCI-H460,31703,-0.6563705559837907,-0.8031969559119514
A-673,9866186,-0.4052980916556575,0.44344780709171366
OVISE,31703,0.0982732174518241,-0.5014658061859469
HCC1143,124202324,1.6321362493528402,2.487739365040751
G-401,4705,3.1032512954578415,3.2429166669017606
NOMO-1,3025986,-1.4139862297409005,-1.6426725871305485
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.6805565842272989
NOMO-1,148198,-5.33573798573566,-3.9411256100506535
A2780,9907093,2.8643649893432106,3.7942373506215996
HSC-4,44607531,1.5153971496977892,1.409680344286822
LXF 289,2746,3.190299829163617,3.4142763520490975
MDA-MB-453,4261,0.3032353935433951,1.309668810723212
BxPC-3,656346,-0.1234429100103727,0.7104443355528319
Panc 04.03,BRD-K55473186,5.259619810258457,4.1794352430084665
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966,0.8539456261791907
CAL-51,3385,3.064238699960593,4.359404803950294
BT-549,675434,4.287026263227802,4.687610427925049
LOU-NH91,9868037,3.6278868560603574,3.6040264846826715
G-401,400769,-0.955062013548762,-0.9338407521337669
SNU-449,44185566,2.80206906512974,2.8009444013194753
DMS 273,613753,3.2268993277161524,2.94587636027901
FTC-133,9911830,2.8814152307979946,2.5703607060431612
KMRC-1,selumetinib-navitoclax (8-1 mol-mol),3.760872598946533,2.3527831400027033
FTC-133,462382,1.2436445575195818,0.32404817693333987
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276,2.5629973125738847
NOMO-1,9884685,0.4754269892492985,-0.4154086868497341
FU-OV-1,44589607,2.6910555486326397,3.122898150538944
CA46,11228183,3.2150932794291975,0.5117377110890966
G-401,24797083,1.4378353960151609,1.2416935524355908
OPM-2,4705,3.10353547990691,2.973923606196662
SCC-9,49766530,0.4117706354329887,-0.7393236582964481
DMS 273,44819697,-0.9932488797546292,-1.187914907001149
NCI-H661,56963564,-1.1338494929069671,0.587535600012369
NCI-H727,25154868,4.680199730171404,4.166220161495189
MDA-MB-453,56649450,1.3470223737131497,3.0374701574491887
CAL-51,54678924,3.225490994604415,2.0829202573626158
NCI-H292,vorinostat-navitoclax (4-1 mol-mol),3.14329221790471,1.2604908740596863
NCI-H522,56963564,-0.3134921987801757,0.3520678699014411
JM-1,10322450,2.576608882705072,3.151917306397503
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433,0.7209243623561994
A-673,24748573,1.962021648564739,1.8145586745618685
LoVo,24785538,0.3940436885335026,1.7944867607616644
NCI-H292,135421197,1.1571557888211337,2.076936350620835
SCC-9,19582717,4.601399638975327,4.284297025726067
NCI-H2009,5311281,-0.1357038590739554,2.6497520041535783
BT-549,24951314,1.7605147679012945,1.6368796637892251
CAL-51,10302451,1.350542324147247,3.109192109813114
HCC1143,10127622,3.54698748679943,3.870979198430727
NCI-H460,44589607,4.73035444754351,3.1765512778797795
LXF 289,10113978,1.6721223719755247,3.439243107240938
YAPC,5566,3.1204203259985044,3.0553278645769364
NCI-H522,135423438,2.202740699610144,1.6325766908471804
MDA-MB-453,5280436,1.8692407341233208,3.1930419215476236
BxPC-3,400769,-1.094495387384235,-0.6626840763649345
MDA-MB-453,57330099,4.336922942952946,4.207193332504925
DMS 273,24964624,-0.4885915334424611,1.7089619572832608
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546,1.794230371619377
A2780,11964036,-0.2399638951327319,1.0769153124176285
BxPC-3,56963564,-0.5407215297938537,0.4576733234425403
A-673,9907093,4.212541297476806,3.8361880215647846
EFO-27,11427553,3.591439679350591,3.0694788268202338
MDA-MB-453,439501,-3.002845657836036,-2.2369979903205057
LOU-NH91,11485656,3.2972382499502935,2.4814465309900675
MDA-MB-453,25161177,4.057301598200359,4.025962673327538
NCI-H460,54143018,2.5592633032091956,0.5959246849151637
MDA-MB-453,53325874,4.468628295310174,4.545491190702469
CAL-51,71466380,3.802692276073616,4.464732018556075
NCI-H1623,4788,5.98570816019398,5.661373866935971
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446,2.1005484537765002
Panc 04.03,11707110,4.882480457753906,-0.6808117073927867
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181,2.6594975309221485
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196,1.9846789002413967
SNU-61,285033,-2.2323165928541746,-1.6346405809217897
A2780,25150857,2.724824774969284,2.1403159013966353
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825,-0.4600885971814745
SW1463,36314,3.0951531870893523,-0.9257250153800392
A2780,2858523,2.134868506415456,2.944044213616997
NCI-H460,3825829,4.446795399525052,3.960281532724538
A2780,1750826,-0.9954774428329844,-2.2235096466887447
NCI-H661,carboplatin-UNC0638 (2-1 mol-mol),4.544203960519617,3.2488984359344557
MSTO-211H,selumetinib-MK-2206 (8-1 mol-mol),1.2523786732506748,2.02242170318736
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606,1.2680783458483422
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552,0.1472605705407101
MSTO-211H,107985,-3.699787970340743,-3.2785958247321174
SNU-81,navitoclax-birinapant (1-1 mol-mol),-3.02925999333472,0.748420260095754
DMS 273,10302451,4.121656528900648,3.277120118580786
CAL-51,262093,2.862241975448649,3.1053600091899587
DMS 273,4261,-0.2104746005525494,1.0457976304556187
MDA-MB-453,148124,-4.8335014079709975,-1.6549420001788533
G-401,11178236,-6.653209761704985,-3.384914951678779
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312,2.4579912086861326
MDA-MB-157,262093,2.565616950913742,2.820986721874516
MSTO-211H,9868037,1.9157833543052896,3.2910271165166773
HSC-4,5280436,3.1415705358429884,3.409711784838748
MSTO-211H,10231331,1.7809441814393978,2.2181616779635522
NCI-H2171,969516,2.758162928931276,2.4336548497477524
HCC1143,10184653,0.277782870066905,1.1458614329962378
A-673,4788,5.851137286094999,5.257761024024584
OVISE,11364421,1.999223974612241,-0.8545946597408611
NCI-H661,44202524,1.2385989199848235,2.3814713830295196
NCI-H460,3062316,3.704520183651484,0.7681165848246109
NCI-H1623,44607531,0.8047036576600745,1.368877680969882
OPM-2,9956119,3.674575368535915,2.9363306608247086
OVISE,carboplatin-UNC0638 (2-1 mol-mol),3.0965224412296743,3.3955179081095848
NCI-H146,54618305,4.054654997899016,4.345923266889852
OPM-2,11507802,0.0988268127526858,0.7525988492928184
CAL-51,10385095,1.0305027810027567,1.143283356037432
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.760542611954146
A-673,71466380,3.8107210551169577,4.294598110224443
A-673,10427712,3.6867963290416346,4.076945875034329
DMS 273,56946209,-5.704769625352934,-4.359288286928856
A2780,53301938,-5.924783673466769,1.2520968144537798
MDA-MB-453,3025944,3.940846865776467,4.1358774249376
NCI-H146,9840324,5.546223512080725,5.630580049460491
HCC1143,3815108,2.289037887638348,3.0518904651320597
NCI-H460,11625818,5.428588497019925,4.197951065734793
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886,4.8747274659426685
SNU-61,123631,1.7897165257078365,2.1704408042392127
HCC1143,73707398,0.6963565440176983,1.3582118706785085
FU-OV-1,24964624,0.6948307959675745,2.4665668061830095
BxPC-3,89928392,1.339609071089843,1.7185670579037446
MSTO-211H,carboplatin-etoposide (40-17 mol-mol),1.373265530821681,2.770251120407417
NCI-H661,46398810,2.545394900571619,2.476753688290577
NCI-H661,17755052,1.4228000150725233,1.9443122393121937
CAL-51,10427712,4.2973287072996085,4.3857122882409065
NCI-H661,208908,1.9265593878348335,1.9163312914347919
LXF 289,71466578,4.726723075051965,4.778724498717991
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549,1.9418330836589173
KMRC-1,46224516,3.1277122869876064,2.4846226323405385
JM-1,2113511,3.632981632735763,4.478123022002874
LOU-NH91,2113511,6.175446639496144,5.722023817203191
A4/Fukuda,6918837,-6.1208599704470865,-3.9712387204501347
FU-OV-1,11640390,5.4167064390474335,3.5533948712478476
SBC-5,44607531,2.697205944866836,1.471525215562858
OVISE,71304818,3.3064642565645572,2.4509646413926913
OPM-2,11152667,-1.3080541002664456,-1.8281677177941955
NCI-H146,3552672,1.604439194031644,2.748723086491273
CAL-51,12001922,2.008779489179369,1.8724848222932615
SBC-5,969516,3.68635139774897,2.9012206515689924
KMRC-1,alisertib-navitoclax (2-1 mol-mol),1.4545717666785216,0.6450819159827591
CA46,53495165,-3.0280125025934495,-1.7886854384801685
SW1463,60750,0.1610513612263897,-1.8818784871902752
FU-OV-1,46215462,1.830231092617303,2.0696990862890825
ONS-76,49793307,-2.5280436252167733,-2.5027292825047738
NOMO-1,11404337,-0.1001889231988697,-1.1716297365099668
SW1463,123631,0.5150504925697384,2.286170649445087
A2780,44819697,-3.3662473846109333,-1.1375337935179024
A-673,44491742,3.844993574977925,4.217728189142751
NOMO-1,5280436,3.413613220161409,2.7681636179718163
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034,3.747543108162705
BxPC-3,2858523,2.8297817429760945,2.9722679730894863
A2780,445091,3.798794327077476,4.008809023082698
OPM-2,11647372,1.2733466761832082,0.14887659627712155
CA46,71751553,4.222934016329145,3.7491686416272905
G-401,44486219,4.1772416968228505,4.08399668827264
NCI-H522,9826308,0.3930789830124517,0.3389961232043759
CAL-51,5566,3.271951139375183,3.0771143497127604
G-401,89183176,4.003742825914683,3.795158777574137
NOMO-1,12003241,-0.5951695723430065,-1.6813131156468375
MDA-MB-157,2708,2.34132544783096,4.747521742897219
YAPC,10410894,3.466680540940763,3.1858887030088625
HCC1143,65064,3.71051637258464,4.6250311026300785
EFO-27,2746,3.149760082978987,3.340446150184696
LoVo,216468,2.992200557668688,2.8335850141991363
DMS 273,3025944,4.590997145359233,4.241536998369566
NCI-H661,15983966,-5.492856258402122,-1.3534419732347676
BxPC-3,selumetinib-tretinoin (2-1 mol-mol),-1.7965498046170116,3.104207265171647
CAL-51,2708,4.939881356462198,4.899152525554427
HCC1143,11175137,3.393081010308343,2.516594224292292
CA46,42611257,2.680269393096826,2.9291674104993706
ONS-76,68056272,2.9147642388168675,3.2201052710684506
Panc 04.03,2871966,2.8539977368648275,0.7924879273454484
CAL-51,25062766,1.9168321284868295,1.882188496033239
FU-OV-1,52912189,0.1271866873311006,2.5134959850494254
EFO-27,73707371,4.965139584704115,4.934213873010915
SNU-449,24951314,2.758293516562198,1.5038694294984187
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691,0.3001849714828499
A4/Fukuda,135999136,4.178898868342667,2.8208011342159143
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716,1.077079400819941
HSC-4,119182,0.0150561689419209,-0.8189452665505789
LXF 289,68056272,4.660756431297166,3.2684941305065167
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265,1.9063082985127275
SNU-61,31703,0.3335579072308824,-0.606149346740488
SCC-9,9915743,1.0040050158500469,0.9635055130751313
NCI-H460,446155,3.79922347841428,2.768442104361936
MSTO-211H,51037431,1.7350128995421004,2.8155915957145
OPM-2,73707438,4.146852269482474,4.192299271129727
MDA-MB-453,9926054,1.6596725660557576,2.111205415536392
FU-OV-1,selumetinib-decitabine (4-1 mol-mol),7.280025082931535,3.5550036134726226
MDA-MB-157,126941,-4.13859012935224,-2.7387184913556064
NCI-H522,doxorubicin-navitoclax (2-1 mol-mol),-0.6296252861358815,-1.5788920429052538
MDA-MB-453,24785538,3.5897722779252383,1.66300115691572
JM-1,24978538,0.0218307924501431,-0.4606949874097267
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434,3.4244319333017894
DMS 273,3503,1.4004718919159695,1.9883558052840413
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.1383088037209668
NCI-H2009,9926054,2.181635437582939,2.1334992807386426
KYSE-70,23725625,6.518030965677853,5.126037758071562
CA46,2729026,2.6315261399645755,2.0167779495523828
OPM-2,135398516,1.2750707316498222,1.2491156354407174
SNU-449,42642645,1.3579889941817174,1.1089331838778553
HCC1143,25126798,4.15297730422149,3.8785257151519743
KMRC-1,9933475,1.7755712843428362,1.7481480916045502
G-401,12003241,-2.103305079214356,-1.2438156047781952
A-498,5113032,5.384850868352965,5.1170457956981865
NCI-H2009,6918736,-2.2815319513344896,-1.2955457200449383
NCI-H292,11455910,1.285235050416197,1.2324782697774197
NOMO-1,24889392,4.281820029392572,3.6489430169406853
HSC-4,4259181,1.301377168384764,0.23309355556902367
NCI-H2171,73707371,5.940029655461802,3.834803629370605
A-498,5329102,2.2449182254359843,2.3122223496319
JM-1,51037431,4.238886241129638,2.825596207515349
A-673,56973724,1.675633920325915,2.2203475312208183
MDA-MB-157,BRD9876-MK-1775 (4-1 mol-mol),0.1874852527806031,0.8226741446165385
MDA-MB-157,136227331,3.870321503168366,4.033039828723138
A-673,navitoclax-gemcitabine (1-1 mol-mol),-4.77481524796036,-1.6507733983775796
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128,1.5268021633445898
OPM-2,7326481,2.643641332780412,2.790865565038638
NCI-H146,135423438,2.8528911509997137,1.8864444560856992
BT-549,36314,1.6954100357352504,-1.3282392356337493
A2780,11717001,3.193837101204412,4.159090314888752
NCI-H2171,136227924,2.167829841056951,2.5230133252875806
NCI-H292,selumetinib-navitoclax (8-1 mol-mol),1.0361315723218127,2.354140777226481
NCI-H460,11152667,1.2005763717636435,-0.33960830555425614
JM-1,462382,-0.3688196944858197,0.6575152676126587
SNU-61,262093,2.836545473910542,2.421517516788997
FU-OV-1,10385095,1.480245925499038,1.3650482664386032
SCC-9,72193861,2.3270498811162508,1.8445720137006143
NCI-H661,1242560,4.217168015363727,3.6484491345137764
CAL-51,984333,0.1261860025273146,0.5649101074279358
NCI-H522,navitoclax-pluripotin (1-1 mol-mol),-0.4896519907045426,-0.8422343081680966
MDA-MB-157,SNX-2112-bortezomib (250-1 mol-mol),-2.8250293733048615,-0.9492249976520626
BT-549,374536,3.1184462544943363,2.467285230194248
NCI-H1623,11640390,0.1271923003977441,3.5685991411102664
HSC-4,387447,-4.060952426407354,-3.9765313063862986
MDA-MB-157,5311037,2.9595373739718087,3.7457928726453025
MDA-MB-453,navitoclax-sorafenib (1-1 mol-mol),1.523284542572191,1.4533064794054391
YAPC,3543504,4.3832051547821855,4.487950016996233
SNU-449,tanespimycin-gemcitabine (1-1 mol-mol),2.625273627898756,-0.11897844431562885
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006,1.7113931360477637
NCI-H1623,9866186,-0.0100221274837169,1.4132138625480852
SNU-449,4788,5.842775682236554,5.778059826696196
Panc 04.03,5287620,-2.39349186702993,-1.9163701289073274
MDA-MB-157,11717001,3.389932991765854,4.20220126343381
NCI-H2009,216468,1.7077485468094884,3.6556787184048045
HSC-4,24821094,3.2038955653523713,2.670206623743251
A-673,4578,4.214026417190043,4.072504826208228
KMRC-1,135875424,5.075329697898493,4.1605065053251
G-401,11612883,1.6387860096052431,2.1665837264794283
HSC-4,156422,5.249929789072156,3.9302452264787298
NCI-H522,2742550,2.7952007563166203,3.209688576024681
NCI-H522,400769,-0.9806645547005408,-0.7160151255253818
NCI-H2009,selumetinib-PLX-4032 (8-1 mol-mol),-1.4525193887521055,3.6283517413769784
NCI-H661,46199207,2.8133245189521054,3.166994848919054
A2780,10184653,1.3482388837291208,1.3566467227089434
SCC-9,24856436,1.519847806890015,0.7329016905707948
NCI-H460,2729026,3.0609463870825926,2.6488688645324006
LXF 289,11222830,2.2114905387790755,1.7423959516775134
KMRC-1,46215462,1.6205494448376236,1.9004259311488292
SCC-9,tanespimycin-gemcitabine (1-1 mol-mol),-0.581626900680549,-0.7900486787443692
OPM-2,421610,2.2409150931042072,2.377853824660046
KMRC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.70640431324625,1.880285240330218
CAL-51,119607,5.291790266428237,5.320528494166266
CAL-51,24753719,3.9981702522006257,4.203164254387426
KMRC-1,25154868,5.3943697684741805,4.4576441415419215
Panc 04.03,89928392,1.6805018731496522,1.851582256917505
SNU-61,25126798,4.129245799651812,3.60909730630656
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854,1.4449746183599146
HSC-4,11977753,4.574500022269399,-1.074718699316045
NCI-H727,4477,0.5438785176620984,0.5248541560129211
CA46,5335621,3.676802077981384,4.0708626472388305
JM-1,322968,1.8634300837521185,2.089403822431751
CAL-51,46907787,3.297361866649883,2.22409641899103
OVISE,doxorubicin-navitoclax (2-1 mol-mol),-1.2556065332393784,-0.804242782823024
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629,4.893098960898056
NCI-H522,53495165,-1.820766752755188,-0.8581248659377185
MSTO-211H,11626560,1.3885064506517848,1.8308831030642587
SBC-5,262093,2.1741934315953726,2.827656148591012
MSTO-211H,52912189,3.1066961080068123,2.4619882390653465
HSC-4,568763,1.3764913265299208,0.8468073895252446
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626,0.7457859581298153
DMS 273,25195348,3.734209419300899,2.9257204628477944
Panc 04.03,5951923,4.37213064077745,4.624654275098116
FU-OV-1,439501,-0.5556149973103641,-2.2525955199655767
A2780,BRD-A02303741-navitoclax (2-1 mol-mol),1.977156193717172,2.0402033013794982
LXF 289,168313047,4.113002678801054,2.3474594201770027
SCC-9,67291369,5.015060977849177,3.146252469851137
OPM-2,5351362,0.2459388559982981,0.9156383673599755
FTC-133,11485656,4.087051585535102,2.4324764698802968
HSC-4,46843906,4.814917111969106,3.157175560843847
CA46,51039095,1.651262767418978,2.134585337500939
NCI-H522,2945648,3.0823392214986343,2.5405782045219794
MDA-MB-453,selumetinib-piperlongumine (8-1 mol-mol),3.1080333616625713,3.3000557875370067
YAPC,9911463,3.901904463732921,4.001099954129282
DMS 273,11977753,-2.475673354763999,-1.7585766664078226
SNU-449,46191454,5.774811831739998,1.9064271807758644
NCI-H661,25062766,2.1967321973268294,2.207391673453669
A-498,53301938,4.241910990361246,2.868378596244582
Panc 04.03,10302451,3.874200048588579,3.210697014430638
A-673,16065773,1.4559751864460968,1.9225097666354887
NCI-H1623,135398516,1.607867961646436,2.2998174693753564
FTC-133,60700,-2.7194012548196,-0.09250990199877147
NCI-H661,3384730,1.2254103498827775,2.8373475724527673
SCC-9,168313200,4.072126418899639,2.902359480303248
OPM-2,25150857,1.3601106429565517,1.8440962291183995
NCI-H292,3385,4.509781783210997,4.42202351360575
NOMO-1,227681,3.177880686522457,2.7613871705149826
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947,2.831234170779146
OPM-2,46191454,-0.9534482392265864,-0.1470056806118884
NCI-H522,3081361,1.6470006965888542,2.0710259124689445
CA46,374536,0.6029387131655304,0.9823794895258798
SCC-9,selumetinib-UNC0638 (4-1 mol-mol),3.717663096766538,3.169215236459979
DMS 273,4705,3.496116762813734,2.931045032781849
A4/Fukuda,17755052,-0.6813796549781841,1.0985595637558112
SNU-81,24180125,-1.7131691030529954,2.4149177748029316
Panc 04.03,969516,3.706271998961216,3.0339157964438765
CAL-51,15547703,3.503799403292956,3.299474499787844
NCI-H460,24951314,1.96669984187411,1.719579318620598
SBC-5,446155,1.3486611419477716,2.516100458596599
Panc 04.03,6184667,3.768891848670565,3.3132745529769236
MDA-MB-157,4096211,2.1957324566584715,2.2864933147577378
CAL-51,15983966,-4.387912760170627,-1.8111064635618237
NCI-H2171,49793307,-5.547674326636965,-3.9745334997147723
MDA-MB-453,31703,-1.1483878700266144,-0.8515708266712971
KMRC-1,24785538,2.687509195601708,1.5152885567141714
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615,0.9760049060511142
FU-OV-1,54618164,4.603510021761196,4.171485321008067
YAPC,5287620,-1.8729921135671632,-1.8439729717078799
NCI-H661,16065773,2.6852778174065435,2.6018311098613043
CA46,5329102,1.3169898780971163,1.227356842078223
OVISE,66577038,3.7859124338920065,2.9701885816924674
LOU-NH91,57519531,4.764819520424852,2.7480454213334946
LOU-NH91,448949,2.461672905148464,2.2691810196786704
LXF 289,10427712,4.0701965709145504,4.597666233168341
CAL-51,9915743,1.1260994347217144,1.3547321022289815
NCI-H2009,11609586,4.059888202416809,3.050179351278511
SBC-5,60700,-1.8327808511007615,0.05323408539780907
NCI-H2009,SNX-2112-bortezomib (250-1 mol-mol),-2.754596306388576,-1.1631062819007811
OVISE,24951314,2.5954730551837386,1.5745914958646567
KMRC-1,66577038,2.9827052655036206,2.9309033701570435
LXF 289,36314,1.2391029615263165,-1.1401782636432334
NCI-H292,44607531,0.4181911293940362,1.3901615788261135
KYSE-70,219104,3.9271840577372705,3.6999685727635345
NCI-H460,71304818,2.359856693071434,2.4478471327011375
SNU-81,4477,1.0310003158688126,0.5513579251320122
A2780,1716436,1.933630716197044,2.8286807681890047
LOU-NH91,11964036,1.2476019563081622,1.7766263274745415
SBC-5,9936388,-5.234314033557506,-0.9152732546613652
KMRC-1,24964624,2.351358467802262,2.5585507730109738
MSTO-211H,73707438,4.334782721865043,4.057255972087165
MDA-MB-453,73707438,3.778137609083601,3.9608684252348723
EFO-27,49793307,-1.9052761294403429,-2.5263779689614765
G-401,71680916,4.434691555895244,4.348297816624921
MSTO-211H,3634881,2.531877742135044,3.3500792679940004
NCI-H292,42642645,0.8145779285410705,1.1014585391745197
OPM-2,168313200,1.8002020874491595,2.6392899279057773
NCI-H2009,53232,2.115043522086945,2.9105839698370644
SNU-449,9825149,2.659052538489635,2.4054340489036083
CAL-51,25105715,4.077363851334658,3.4250895289582273
MDA-MB-157,53232,1.9030895496471385,2.957881894138783
NCI-H727,2708,6.607150814967448,4.962806323130758
A-673,carboplatin-etoposide (40-17 mol-mol),0.9497431982903584,1.6099601369237633
NCI-H1623,44632017,1.5464636141196502,1.5110618187400104
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478,0.9161533990541503
FTC-133,selumetinib-tretinoin (2-1 mol-mol),5.415389433541197,3.158147124416711
SCC-9,3689413,-0.5284639903905319,0.13053928290392428
NCI-H460,23725625,5.666756485817308,5.099207537934323
NCI-H460,100016,5.855223104671776,6.03480098653766
NCI-H2009,24771867,-1.6305331500245923,2.735369922233558
SBC-5,9952709,3.0525329755213466,3.0824464732846155
SNU-449,5566,3.0151612646695822,3.0666880261724936
NOMO-1,9926054,1.6113291347040215,1.553670315968066
EFO-27,11404337,1.0583908830182924,-0.2738075791974156
A2780,54626689,3.943205764450006,4.31853827546725
A4/Fukuda,168313200,2.9572494196719723,2.748021239512793
LoVo,5460769,-2.1468642890382412,2.383771164708247
NCI-H661,25102847,2.378632231655901,2.3146173959345284
A4/Fukuda,9866186,-0.2462641713744652,0.35205776144460293
MSTO-211H,selumetinib-piperlongumine (8-1 mol-mol),2.1949656994292455,3.429686099735535
KYSE-70,36314,1.2189527676950276,-0.2590300341355531
BT-549,2828334,6.061535937537666,6.195912720757884
NOMO-1,25262965,-2.043358942198166,-2.4686556268832716
LXF 289,25195348,5.284501520866742,3.382100421258976
CA46,451668,2.285623139838705,-1.2205179155006838
SNU-61,24856436,-0.371488374536367,0.5267652491032803
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,2.0396567757018627
SCC-9,44137675,3.491154886377157,3.6419004560106982
BT-549,151289,0.9825598768305964,1.3826449397215799
JM-1,49836020,4.6064946369246025,2.544129270715295
YAPC,54618771,0.5686030675412354,1.3087284710644687
SCC-9,24772860,-2.0717241396099473,-1.2497685987453198
A-673,10385095,1.0544598585596625,0.9567913631339541
SNU-449,216468,4.54901774756382,3.4073651709114627
SNU-61,67291369,4.2845115751683736,1.7475004415654305
FU-OV-1,5291,4.051520848138153,3.6448318655695475
LoVo,12001922,1.64420677630862,1.9992229058619355
NCI-H661,3815108,3.885074716587427,2.7905698769322806
JM-1,374536,-1.2279479926310035,1.0288134860331204
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119,4.974424593546861
NOMO-1,4788,5.067002306940809,5.154041570796681
SNU-61,24748573,1.6967337473161408,1.766655941639297
BxPC-3,16720766,0.4925277259578197,0.8557399234260304
EFO-27,46215462,2.714023108610326,2.0396720556518977
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564,0.6206939195382514
SCC-9,31703,-1.2436349312067534,-0.630182313124127
A2780,5335621,4.014990109441054,4.155964679985176
EFO-27,4917,3.7917867214450096,3.0710773525273374
A2780,9926054,1.5482217772077662,1.747859483865519
A4/Fukuda,3689413,-1.7998697854540155,-1.292168657828511
OPM-2,6610216,3.8953919440086575,3.982728376419397
NCI-H522,6918328,0.2751454024017333,-0.2241485011012016
LoVo,60750,-4.161283305326802,-2.2278507254907534
LXF 289,15547703,4.3915240757493565,3.2954780523852856
HSC-4,55283,3.529343210540244,2.744317959362825
MDA-MB-453,6436223,-6.0469700747965325,-3.8115342799603953
OVISE,54619267,4.300185321056238,4.178762519283392
CA46,12001922,1.4868064190708767,1.5766064273364677
SNU-61,53392493,2.2959575452819543,2.111408192170322
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632,-1.657719214153554
G-401,44137675,2.141460704144857,3.1763058298323914
NOMO-1,9825149,1.4944850939332062,1.8228424635590728
CAL-51,4788,6.061217822513647,5.592329283539857
HSC-4,119607,3.948608575005578,5.151301150941542
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645,0.07398583507115959
LXF 289,4477,1.125394938272502,0.5095804562865867
JM-1,11657048,4.676495506604394,3.1016902858561286
G-401,10302451,3.1015289114526774,3.0178705555137726
HCC1143,31703,-0.2055424786168501,-0.644713857828828
HCC1143,374536,1.384467639208202,2.2047526009931118
Panc 04.03,10184653,2.983159460505767,1.4247731436800841
NCI-H2009,crizotinib-PLX-4032 (2-1 mol-mol),1.3104929839779844,1.9143425258018503
MDA-MB-453,9915743,0.2126089191242519,0.1832398093641896
HCC1143,4477,1.746819852748151,0.6357858123913144
LoVo,44486219,3.9526381308541025,4.229918983976623
ONS-76,135875424,3.856833286433643,3.7927638739524614
SCC-9,24797083,1.144476664186746,1.4615627511062539
OPM-2,4096211,1.0315429789467454,0.8073744393552069
OPM-2,selumetinib-piperlongumine (8-1 mol-mol),2.005304394078306,1.7870048767745883
SNU-81,25262965,-1.8265758424412304,-1.2611339957053849
KYSE-70,44137675,3.4677446622108925,3.608666294164759
NCI-H1623,3854666,1.505587442259218,2.2739765796475484
HSC-4,10385095,0.4573663196580717,1.4087320949376185
EFO-27,107985,-2.474640150808475,-3.4431245804063537
NCI-H2009,6610216,3.953101400309774,4.3190169409640635
SNU-61,135421197,1.1046098427392648,1.6273161500863202
HCC1143,4259181,-0.4991941409006941,0.21443608553385574
BxPC-3,16038120,0.5924635925282854,1.2162616177821608
NCI-H661,135875424,2.4725937826628006,3.8349989531697792
SCC-9,9866186,1.319539660579235,1.2107287904340938
LXF 289,24964624,1.3940062455599875,2.625886463927497
HCC1143,vorinostat-navitoclax (4-1 mol-mol),1.2828606463085703,1.3511627437000429
HCC1143,6610216,3.638345017281011,3.9636758115400017
G-401,2949965,1.5385484234582818,2.438217621400399
BxPC-3,49793307,-3.2953922214008697,-2.6526434936477945
A4/Fukuda,5287969,-2.571307610380136,-2.1481460764364644
A-673,6184667,1.935989865778159,2.629797104955819
NCI-H2171,24821094,2.9775477594317743,2.7423846659011373
NCI-H2009,67156097,-1.7347724318553324,-0.34854109776998227
A4/Fukuda,409805,3.596796639089143,4.077480953645592
JM-1,5738263,2.278112606764228,2.4725193544136124
SBC-5,2828334,5.980106592077389,6.07688778799013
BxPC-3,107985,-2.51349631829315,-3.8299516709844017
G-401,11427553,1.555705840809683,1.7868893275117068
G-401,10113978,1.710663554595952,2.577953392607214
NCI-H661,16013152,4.678017706607999,3.9983379596257675
A4/Fukuda,11497983,-1.0595923666648657,1.072692645665843
NCI-H522,10296883,3.751667506317718,3.2939601906159677
HCC1143,6610355,4.569348514461763,4.6900624163855
SCC-9,56946209,-4.978704692275232,-3.8594907530752733
LOU-NH91,54613361,0.2217026048603205,0.2041929696547859
Panc 04.03,ISOX-bortezomib (250-1 mol-mol),0.266400908707645,0.7170116445508309
G-401,42642645,-0.5846467586678221,0.12669174539966865
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289,1.61564130778865
NCI-H727,5287620,-1.579053209750056,-1.7614028879910029
FTC-133,16038120,2.9212616737408896,1.2685299664345124
SCC-9,11626560,2.4253223939520976,1.750776678531672
Panc 04.03,2742550,4.347188786942969,3.988788090732022
OPM-2,15547703,2.634316496996711,2.7547687229284543
NCI-H522,10074640,3.1231046963753686,2.7865146621899
HSC-4,2945648,2.59041604505869,2.9826193444846636
NCI-H661,vorinostat-navitoclax (4-1 mol-mol),1.2789358142207048,1.2308321186025835
MSTO-211H,10127622,2.776094640706434,3.4444002939059506
FTC-133,serdemetan-SCH-529074 (1-1 mol-mol),3.1500157786176777,2.0371107289644828
NCI-H661,2858523,3.1395656938248124,2.8727217268170535
A-673,56946209,-5.889509916794497,-4.792338052798236
CAL-51,44185566,1.8630594392382311,2.6035079419804132
YAPC,51039095,2.046611375354791,2.8416788243594926
OPM-2,4261,-0.9911458583810344,0.7288482876335831
BT-549,969516,2.601131538014171,2.8694961796464815
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637,2.5867403405499503
A-498,55508,4.21947279006693,3.448195167278389
SNU-449,71466380,4.63195087543953,4.518458929638682
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363,3.9922252142625734
A-673,11707110,3.906892758790242,0.7244859199905609
NCI-H460,54649381,4.173104904963283,3.859825437088546
KYSE-70,5282054,4.279196842795529,3.528568978126844
G-401,119607,4.5837417334889885,4.793038690290675
YAPC,24856436,1.898811352025064,0.714550100094186
CAL-51,5460769,1.3780575552768597,2.417653411301277
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787,-2.277371362074652
CA46,400769,-1.5476292313826252,-1.3215542849118898
SNU-449,19582717,4.423938746946012,4.408280694676475
KMRC-1,46191454,1.86757619496812,1.4674867503148954
MDA-MB-453,45279963,3.011106079512325,3.4524439693762528
BT-549,25150857,2.011062957026122,2.5888793917849746
BxPC-3,navitoclax-pluripotin (1-1 mol-mol),-1.3920803089523777,-0.790423041264482
NCI-H2009,135999136,4.285465393980956,4.2574636819992415
LXF 289,984333,0.880488465949386,1.1032163401724295
NCI-H146,11238147,0.964491846183422,2.6523840446016083
Panc 04.03,5287969,-1.8253556910298991,-1.6149892997558484
NCI-H292,654092,0.1209701484650686,-0.17936768596045063
MDA-MB-453,9927531,3.885109165752666,4.649278403036078
NCI-H522,44819697,-2.38793523497331,-0.9574431182103328
LOU-NH91,11364421,-1.522672653311712,-1.3682099890337611
NOMO-1,4477,1.0767445259598296,0.45629437430848424
LoVo,148198,-1.1147075342847712,-3.3268035997342853
SBC-5,54619267,3.782844847718682,4.219984040113314
BxPC-3,vorinostat-carboplatin (1-1 mol-mol),1.8300641490410745,3.2380264734156334
NCI-H2171,46224516,1.006764214935909,2.3250178200598146
SNU-61,55283,2.411692675664504,2.3394222128244326
ONS-76,navitoclax-birinapant (1-1 mol-mol),1.131765862858429,1.5221045720290158
BxPC-3,vorinostat-navitoclax (4-1 mol-mol),1.2956332154746788,1.132039975580307
G-401,135398738,4.751845538055463,3.1713466610621732
A2780,24889392,2.5877097444926265,3.7843801553022716
CAL-51,3081361,1.780158758130264,2.2200530050744836
MSTO-211H,3025986,-0.6925850648320051,-0.8921337874701366
NCI-H1623,10231331,4.737119210946733,2.0151300657277633
LXF 289,60750,-4.482846219959503,-1.6122777902765006
JM-1,19582717,1.6871405928140415,2.8345370246782244
MDA-MB-453,24775005,1.4926368241852035,3.5670920730482565
JM-1,10074640,2.5195149680920657,2.5664717553704777
A-673,2749,0.4791921848862392,1.609336482833159
ONS-76,9911463,3.87028315643254,3.7757370204199265
A2780,3136844,3.626688956130205,3.8309225732371646
LOU-NH91,2945648,3.130856585594597,2.965889796217511
NCI-H146,52912189,0.5266703058361273,1.8891785563488528
A2780,156422,3.602973007130472,3.4712365891551578
LXF 289,969516,2.6399649875984355,3.0830437694959563
NCI-H146,25154868,-1.0719819424572428,3.963734522389331
YAPC,1641662,3.645861677961698,3.7300334311992156
LOU-NH91,136227331,3.865245001267085,4.102662115203227
YAPC,46224516,2.408657893134071,2.6706020978421363
JM-1,46199207,1.915427322474508,2.7300467735176364
G-401,54618164,3.8592700204433807,3.8732772193046414
A-673,53232,1.7702469915903785,2.86648094525877
SBC-5,6918289,2.991753308414544,1.969801137958083
MDA-MB-453,selumetinib-MK-2206 (8-1 mol-mol),2.1996282854374303,2.1140322621623393
NCI-H522,24797083,1.396487413816628,1.4811854450038344
YAPC,11238147,2.574935183805209,2.9941202673986136
BT-549,9444,3.939814284899288,4.260628744047078
NCI-H460,11364421,0.3566052665939138,-1.9617802095818087
LXF 289,23582824,0.8647594683412683,0.9545115595667311
FTC-133,89928392,1.8077600838169707,1.7093131412548725
NCI-H661,15547703,3.600649740500543,3.1899582964339794
JM-1,8515,3.19981027650634,3.2776807337683778
LXF 289,25102847,1.656353256373218,2.5238725746195447
NCI-H1623,11626560,2.1087636260711333,2.01744458838468
NOMO-1,2729026,1.9247353379999697,2.3243281807835623
A2780,carboplatin-etoposide (40-17 mol-mol),-0.855870041276873,1.992820678270973
OPM-2,60700,-1.448416790812607,-1.7005234549944441
NCI-H292,9825149,1.7347241761388297,2.3615706187777836
KMRC-1,6918878,5.2070030404450485,2.4002797233808555
SBC-5,4259181,0.3536055110585087,0.26435542837355297
KMRC-1,71466578,5.804397104747809,3.6228961626453087
JM-1,selumetinib-MK-2206 (8-1 mol-mol),3.384959636780238,1.3258111727099067
SCC-9,54596490,5.620994411748341,4.504371927733967
MSTO-211H,42642645,-0.4763575861779333,0.7202221433339671
DMS 273,4378219,3.0463884183789336,2.3926912160668956
FTC-133,SNX-2112-bortezomib (250-1 mol-mol),2.186622613691835,-0.9116494101059979
MDA-MB-453,11626560,2.2881538301476696,1.9149274173169721
BT-549,46215462,1.7261150757919093,2.023261524725711
SNU-449,45279963,4.011305658965759,3.7117342316819135
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935,3.981115436340492
MSTO-211H,serdemetan-SCH-529074 (1-1 mol-mol),1.7679544322052605,1.9589688336090736
A-673,10302451,3.0176041071951345,3.167701933867111
CAL-51,5280436,3.749440064194485,3.3699255900025604
OPM-2,23582824,0.3145394278485406,0.6140483660450514
JM-1,5287620,-0.1298713463901946,-2.3348752506347283
MDA-MB-157,3503,1.1658051797362206,2.201311982728914
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757,1.9980049623100982
SNU-61,16741245,4.568608723382813,3.9413803659492186
SNU-449,54626689,4.585589968636992,4.535767676191153
G-401,49867930,6.047675909857249,3.8866864993350885
HCC1143,46199207,3.122692827276537,3.041360087595499
OPM-2,445643,3.4082912819673536,3.5220471807419873
DMS 273,54618771,0.8675837195237585,0.7875901849089356
NCI-H1623,71304818,2.8160491805212615,2.514624226393985
MDA-MB-157,16659841,3.727147143419768,3.8391258843700258
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146,0.6951046360229641
MDA-MB-453,1750826,0.6003684780059517,-0.8584960255905826
NCI-H1623,5281321,-0.5392861044239732,-1.2772899216582367
MDA-MB-453,613753,2.5060803116052357,3.175305524188149
MDA-MB-453,2871966,-0.7610622755396385,0.6164091359595044
MSTO-211H,5281321,-2.386258436411726,-1.0648796777055778
KMRC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.854846859119752,3.423708422902962
FU-OV-1,44137675,3.1043101525841377,3.628250382320914
NCI-H2171,285033,-3.2427052076981693,-3.0096503186164
FTC-133,alisertib-navitoclax (2-1 mol-mol),-1.780189218062184,0.46758313361743986
NCI-H727,5311,2.2708816030438816,1.5027388974173832
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859,-0.9291096437005149
A2780,5746,0.8697095475366516,0.6515163613435714
NCI-H2171,53232,2.7429596689347875,2.9019535221246415
EFO-27,5291,4.106816055599409,3.7191528998984054
MDA-MB-453,9933475,1.6213532539721074,1.807575628670562
OPM-2,5281321,-3.721370442971226,-1.8275737336881903
SBC-5,25183872,-1.21590268467039,-1.0828824978242109
SBC-5,452548,-1.978558467437607,0.6143399182446566
NCI-H522,5351362,1.1598735323390523,1.3407809912542599
MSTO-211H,3552672,1.7334798735784387,2.8285495867024046
A2780,10427712,3.0744297357135557,3.994611061175126
LOU-NH91,409805,5.248055334811583,5.295641165841358
JM-1,5460769,0.6255065324989537,1.6503154971881164
NCI-H292,9967941,4.033073764451828,3.7694698281390377
NCI-H727,16038120,-0.1646423801756905,1.142860024990162
NCI-H460,16038120,2.547350732010626,1.1776030888223221
LXF 289,241158,4.717778097263283,3.9961552375467484
OPM-2,46398810,1.9487214127979129,1.7788653050611705
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038,0.8019935863650496
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738,2.2735176941016215
CAL-51,9884685,-0.2528326244590672,0.4284582330734948
LoVo,44607531,1.302221694572025,1.3497853311159074
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.6910629789941651
MSTO-211H,56963564,1.234327129960966,0.5034133719113065
MDA-MB-453,73707398,1.1537227860078607,1.2816099357505077
BxPC-3,5329102,1.9407746673909456,2.1006843115060208
HSC-4,5287620,-1.917371788332746,-1.9029052703258267
FTC-133,11152667,-0.4786534736280033,-0.29716893662299215
NCI-H146,9935249,1.0600603569941576,2.450921829694738
YAPC,2729026,2.7496252904978293,2.6632350516666183
SNU-449,71751553,4.402646349497825,4.550071321301615
HCC1143,9926054,1.808099247882512,2.079540125988062
Panc 04.03,448949,2.534760210414342,2.1404603605658705
NCI-H661,5566,3.151274839096282,2.9834082875710277
FTC-133,6610355,5.440540243356366,4.520248825889849
JM-1,16741245,4.187666128361383,3.365801858717021
SBC-5,navitoclax-birinapant (1-1 mol-mol),2.2573957245834246,1.3600164078176138
LXF 289,107970,2.2922723928752307,2.3931598117054564
Panc 04.03,54626689,4.659724899973851,4.620098045150072
MSTO-211H,16736978,0.1439838744803616,2.153624555614624
MDA-MB-453,151289,1.613318506724072,1.2199805481428947
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.760542611954146
CA46,6918638,-2.155597959241919,-0.5699173589179872
ONS-76,selumetinib-UNC0638 (4-1 mol-mol),0.4414887098860544,3.3011684796356486
A4/Fukuda,53495165,-3.058270414187161,-1.5314837842173068
DMS 273,135984461,4.327877942465965,3.1977198025159663
OPM-2,89928392,0.3187576395153793,0.5794255281900327
NCI-H1623,10385095,1.1256497169747182,1.57772190161805
ONS-76,11717001,3.327449083785458,3.697448539644837
LoVo,6610216,4.332472846182503,4.3180676667653355
NCI-H292,16722836,1.3558361632896196,1.7906666141105136
MSTO-211H,135440466,1.110539790918092,2.061211473598867
BxPC-3,9868037,2.7194108471732243,3.50437791903037
CA46,2874250,4.668483912698598,3.724708299623698
MSTO-211H,11238147,2.1702387480753393,3.1251899796854428
JM-1,44607530,1.0639194271383936,1.1862025237916145
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.7665940812125964
ONS-76,2749,5.1102698724547375,2.024629798541954
CAL-51,36462,0.7338920585832341,1.9892794746961158
CAL-51,6610216,4.7761200098267365,4.245190787412404
KYSE-70,3062316,0.8461927752800795,0.4514564595917584
LOU-NH91,285033,0.7293222441785373,-1.610359304602949
A2780,11485656,1.5628347007454235,1.8416014020827447
A-673,26596,-3.820628112159822,-1.394092558935163
KYSE-70,44632017,1.4611535882953923,0.9942854811049487
NCI-H2171,702558,3.801125308495619,4.321245609917202
MSTO-211H,23635314,-1.96294908215212,-1.5848681100673923
SNU-81,5746,1.2061469752663514,0.9225730604002542
KMRC-1,4788,5.9167994505540475,5.611265384471519
CAL-51,15983966,-4.387912760170627,-1.8111064635618237
CA46,49867930,4.292641096024632,3.4237412677041887
HSC-4,11455910,0.337268703123225,1.3297990932146104
YAPC,5281672,4.680001258160183,4.413833157313858
SBC-5,5978,-3.632907311761228,-1.983878927989
NCI-H460,3825829,4.446795399525052,3.960281532724538
MDA-MB-157,9444,2.0478202605503206,3.827951237808008
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207,0.011572915548707095
SBC-5,46191454,2.9096163569547,1.673542791517411
CA46,644241,2.374325583681648,0.12409114985612352
EFO-27,erlotinib-PLX-4032 (2-1 mol-mol),3.67875442693599,2.944223862432569
FTC-133,252682,6.679184103041344,6.543853660533668
SCC-9,56649450,2.7319907342568275,3.3502986890457724
CA46,5311,-0.1889513685103653,0.4993537989297612
OVISE,9967941,3.747669270164806,3.595084244146609
KMRC-1,5328940,2.3844062156656256,1.5218106577553905
NCI-H146,9825149,1.1795040286889695,2.231422717313051
SNU-81,445091,-0.9408785363266468,3.783054492257349
FU-OV-1,6610216,4.742914927321441,4.412357731055644
A2780,56949517,4.37203598237815,4.381419631736801
EFO-27,119607,5.664089470896734,5.385675925766171
ONS-76,57519531,2.0495811593793105,2.5860163414383766
MDA-MB-157,42642645,0.4106458170856017,0.9057402450747196
CA46,135421197,1.13174100448049,1.124054222283626
LOU-NH91,11719255,2.9529273796726394,3.499323518869863
A-673,9967941,2.0264988474191377,3.233283612579112
A-673,23582824,0.2073680927392712,0.6241834671002575
CAL-51,374536,3.1977545561189347,2.512818275497109
SNU-449,5311,2.373513113952619,1.705687120056544
SCC-9,11178236,-3.8920346249942264,-3.3363612370428597
SNU-61,71680916,4.248107596602719,4.138503182018539
BT-549,4578,4.840393866327907,4.635389620417771
JM-1,56973724,1.572059771180543,1.5061886589439641
BT-549,6184667,4.320802676068414,3.305404171856093
OPM-2,6918878,0.2719026340750923,0.7232912664140878
HSC-4,9967941,3.0274642479334215,3.598161833118307
G-401,6610355,3.5029306645068696,4.148310774303705
Panc 04.03,1750826,0.308709425359425,-0.5752590762068354
KYSE-70,6610355,4.961596413135767,4.618874695905014
A-673,24775005,3.310963685757038,3.688086857537769
SNU-81,208908,2.232815974371363,1.7040993791975527
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772,0.9510357362654497
NCI-H727,3543504,4.299187359877464,4.4690497469365615
SCC-9,11152667,-0.1233430086603879,-0.23687260582977604
A2780,208908,2.5004436475537974,1.9064768655854265
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678,-0.46852086786703057
A4/Fukuda,44607531,1.1783204907000706,1.2521256980796036
ONS-76,54649381,4.0197495944656465,3.8523641054122875
A4/Fukuda,31703,-2.1013190360416147,-2.2061310334568476
EFO-27,46398810,2.9967281863964867,2.6391812412337834
JM-1,119182,-5.01139227406357,-3.2325145170928082
NCI-H2171,25183872,-2.065345244597309,-0.9921224844413643
SCC-9,53392493,3.3396857977581917,2.8614919560699734
ONS-76,44259,0.6373390659589321,0.976924554338597
NCI-H661,72376,-3.040643961037913,-1.947462769681286
KYSE-70,11609586,2.827625452517046,2.6926055066700054
NCI-H727,3025944,4.64192894764355,4.275183009499989
NCI-H460,262093,3.3627537421549314,3.115952897906179
MDA-MB-157,tretinoin-navitoclax (4-1 mol-mol),4.215736518135254,2.5093551719124987
NCI-H292,11396600,3.7365966834404225,3.80434034175485
OPM-2,11626560,0.8852338363333486,0.8523371058034533
MDA-MB-453,24772860,-3.354356853525474,-1.3396696218471178
BxPC-3,168312962,2.7485538585474547,1.72284972009532
KMRC-1,46199207,3.449143967158838,3.0443298572709234
MDA-MB-157,2729026,3.2437974205657816,2.8445149048718252
LoVo,4259181,0.2045859597859785,0.13205074968938088
KYSE-70,5329102,1.9375891375175784,2.0797989302297104
EFO-27,3025944,4.337116030950391,4.23186057108129
EFO-27,2742550,4.50908635993052,3.9463182413512965
A2780,6610216,3.3472253004646593,4.0106958455735295
LOU-NH91,docetaxel-tanespimycin (2-1 mol-mol),-3.5084138300894625,-3.1128123909643297
EFO-27,24856436,4.205894943099943,0.4460868868143267
Panc 04.03,9444,4.565679465533194,4.274957696495894
ONS-76,72193861,2.0006819721723197,1.778052814062559
MSTO-211H,445643,1.8400808237063873,3.885312387720216
CAL-51,8515,3.5852991976047863,4.131953909587546
OVISE,25150857,3.4132003431569524,2.527095097476905
KMRC-1,tanespimycin-gemcitabine (1-1 mol-mol),2.381825597611343,-0.8087108948907512
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442,-0.23899469106764612
OVISE,5746,2.6308159153246047,1.2365723746654351
A4/Fukuda,168313016,2.0147776130358253,4.092823917792901
LOU-NH91,54686904,4.160622905506427,3.8935427052279525
LOU-NH91,8515,5.2113767400480775,4.1589393209888526
NCI-H727,73707398,1.5620380856857303,1.573900439199493
OPM-2,16722836,0.349034656527362,0.8921650017268994
NCI-H2009,119607,5.663513162505294,5.2501071108043424
G-401,11707110,-1.5866495763270043,1.2697945525801568
SCC-9,439501,-2.6581193485563737,-2.012386713365414
NCI-H2171,4259181,0.2390230285316857,-0.1430615236570296
MDA-MB-157,45279963,1.9862312593637983,3.63008275604104
LXF 289,6610216,3.700752852024682,4.1296657510979
NCI-H2009,9936388,-6.076047204085024,-0.5226950652913172
ONS-76,11612883,3.1090836160489417,2.8736705681334547
SNU-61,969516,2.346236032939849,2.472830746040616
HCC1143,3025986,-1.3091092061734078,-0.9475371194572587
NCI-H146,46398810,1.4219775291726766,2.285348667521875
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953,2.711295061370891
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336,-1.5861879515129576
HSC-4,9887053,4.087399127765092,3.997702751350041
JM-1,11178236,-8.647638887964375,-4.197654190493484
LOU-NH91,24856436,2.045063798311017,0.709351333135123
JM-1,4477,0.6485766089343484,0.4649908186524144
MDA-MB-157,31703,-2.5361356877609142,-0.808800239628638
NCI-H1623,carboplatin-UNC0638 (2-1 mol-mol),3.4805064241678627,3.3412102752003703
NCI-H661,54619267,3.8937949591354486,4.183240174317377
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452,1.0711260043492843
CAL-51,135398516,1.449392214756173,2.2798832210255755
CA46,4917,3.2539126844885757,2.512647813230823
A-673,4705,3.2416788332737454,3.086047838451254
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746,2.832959633149483
NCI-H661,107985,-3.0533673433660393,-3.553831030742449
G-401,navitoclax-gemcitabine (1-1 mol-mol),-3.419368467159671,-1.7705632932160165
NCI-H727,322968,3.201201930682186,3.6763104378268645
MDA-MB-453,9823820,3.844639760703811,3.7381966103054847
CAL-51,44202524,1.5528850010053556,1.9732873237664352
MDA-MB-157,BRD-A02303741-navitoclax (2-1 mol-mol),-1.256832531766744,2.6265484564072263
NCI-H522,216468,3.814024876197808,1.7048861795259216
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244,1.5359241808556228
FTC-133,46191454,4.521976640758756,1.8821932429712198
A-673,tanespimycin-gemcitabine (1-1 mol-mol),-3.600781620367816,-1.5108161618699425
NCI-H460,3385,3.2657114863965573,3.930136193394881
SBC-5,4917,3.6947166304022465,2.933696234754632
SNU-449,241158,4.010766929552104,3.8954896201277847
SBC-5,676352,1.191452976157089,2.034896410737375
FU-OV-1,11626560,1.6217924510760422,2.0130906752290434
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608,1.9413982851557912
JM-1,23635314,-4.012358401321602,-3.309970897666302
MSTO-211H,24978538,-1.489482683206989,1.4145983914531555
A-673,6438330,1.8412388803722883,1.5227014761988733
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088,2.8589244698475484
SNU-449,11719255,4.899085715446655,3.5414553710114136
SBC-5,3025986,0.415316224839701,-1.1949790235663835
YAPC,439501,-1.3344819600707327,-1.9175717967851136
NCI-H292,25262965,-1.3774761624707286,-1.620485206916446
OVISE,4261,2.633875372862392,1.65435168003697
SCC-9,24951314,2.365472705935838,1.5767917822614277
CAL-51,57519531,1.893237876741888,2.421297558184181
SNU-449,4521392,4.287622659497221,4.2612817623948755
SNU-61,136227924,2.341371828887226,2.71785269758162
HCC1143,24772860,-1.4749293698634824,-1.4229346965892091
BT-549,11178236,-2.7962989267365828,-3.1525240855951786
G-401,322968,2.2957138552590264,2.903647706029328
DMS 273,322968,3.714238246037839,2.422774827267919
NCI-H460,135875424,3.211754300989152,3.943284421130436
SNU-449,8515,3.796953450261519,3.9696045918055005
EFO-27,3689413,-2.375877948841856,-0.365057375562791
SBC-5,46224516,4.445568719663603,2.5161005633706224
SCC-9,285033,-1.0227924755741569,-1.798995244001909
MDA-MB-157,vorinostat-navitoclax (4-1 mol-mol),-2.302516692171374,1.1080391628091604
YAPC,6610216,4.2275333940091215,4.312487363773653
DMS 273,26596,-2.1961333269229173,-1.9601461617662364
NCI-H460,15953870,5.00315267734786,3.5526561266541523
JM-1,16065773,2.0826903108024646,1.8454785132711444
CA46,5280436,1.6785665289286047,2.620672924336213
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884,0.5709148660068588
JM-1,navitoclax-piperlongumine (1-1 mol-mol),-0.2702753374722612,-0.046934222749011295
NCI-H522,40482356,5.076444098213918,3.5023747453478022
SNU-449,72193861,2.670314458690751,1.9382230780671952
A-673,44185566,1.862123250313604,1.6719725729279995
MSTO-211H,6623618,1.8328237574963773,2.2760113761132046
NCI-H661,9868037,2.6835007144938032,3.5374999187885705
NCI-H522,9903786,3.9217135447784783,2.51732414529025
A2780,2828334,5.5086207374667175,5.853514717567142
FTC-133,9887053,4.335569761437092,4.131211233364878
Panc 04.03,3503,2.292907505320521,2.577182714835223
A-498,126941,-2.1438583463370495,-1.9624471000628525
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268,0.14147664717576822
OPM-2,2130404,2.9720984033823896,2.179214491877792
HCC1143,10427712,3.6655746579836497,4.376787927561417
EFO-27,148198,-4.612142049540045,-3.3795567852212804
MSTO-211H,25195348,2.7607409792089186,3.1869857174167864
NCI-H460,11455910,1.4134750909778395,1.221949503110057
LOU-NH91,selumetinib-piperlongumine (8-1 mol-mol),4.488619060244233,4.0011499970432185
NCI-H727,11640390,0.8742840152576016,3.1929747537072433
EFO-27,51039095,3.8168650627357903,2.9110186486208
OPM-2,148198,-4.827513159673032,-4.028615832383413
CAL-51,10113978,3.4506321601115397,3.280064140401177
NCI-H2009,71304818,2.93523377765095,2.522480977321438
A4/Fukuda,24772860,-3.4983689572797307,-2.6411475902845627
NCI-H460,6918837,-0.9355989207233988,-2.2371109814914187
MDA-MB-453,3503,1.4691071846699333,1.9606327264248333
EFO-27,135398516,1.6834680726831996,2.369049174342797
A2780,19582717,2.5113952618702102,3.292533325181619
SNU-61,6918289,4.130324820008196,2.406300812753166
SNU-81,navitoclax-pluripotin (1-1 mol-mol),-1.399520137964588,-1.0171393904175066
MDA-MB-157,448949,1.9498713128669924,1.9405552570787246
NCI-H727,675434,4.719754403481023,4.580555405768709
KMRC-1,11152667,-0.0604913513883814,-0.6899374983930846
ONS-76,9926054,2.5108803232151304,2.0690098610258945
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566,-0.3535680414912761
CAL-51,44491742,5.152478206660974,4.27012023376853
NCI-H1623,5278396,3.5068270087169022,3.623349978837621
DMS 273,3634881,3.2856933751991844,2.8186528989104485
NCI-H146,23582824,-0.1302486758765051,0.9435863418634746
NCI-H522,salermide-PLX-4032 (12-1 mol-mol),5.39637133830604,4.488283584001815
A-673,11175137,1.5552265537901524,2.075559624742263
A-673,4378219,1.9880690032317576,2.2919609467010584
NCI-H661,5460769,1.0320957244219937,2.728047262520733
NCI-H522,selumetinib-BRD-A02303741 (4-1 mol-mol),6.687730464329683,3.728261900945393
NCI-H146,2746,0.8652413173737366,2.6496112912464387
NCI-H1623,11955716,5.690110889982477,-1.300826611861107
JM-1,46224516,0.3128269384104456,1.7857082124023915
NCI-H2009,docetaxel-tanespimycin (2-1 mol-mol),-5.612671071914989,-3.2815871243718435
A2780,11317348,0.9115498056774632,1.9210219306122156
NCI-H661,9911830,2.711917815790479,2.1595330047673214
CAL-51,44202524,1.5528850010053556,1.9732873237664352
BT-549,4096211,1.216432091282546,2.2604155148182716
FTC-133,6918328,0.7944971797491694,0.35464823961628694
CAL-51,9911830,2.6702149728757343,2.3835961531329484
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482,1.321770274847299
NCI-H146,BRD-K55473186,3.591565624419444,3.785426481086126
ONS-76,doxorubicin-navitoclax (2-1 mol-mol),-1.5086467428383314,-0.9906012233418064
SNU-81,16720766,0.0913844680975832,0.29807332192495706
LOU-NH91,46215462,2.06389335978863,2.0956273761842423
MDA-MB-453,navitoclax-PLX-4032 (1-1 mol-mol),2.982075726164247,1.7755221619058694
CAL-51,5978,-2.6819752982341463,-2.515505828964661
CAL-51,5278396,3.885366261927898,3.6219885519865893
HSC-4,4477,1.1301199037714704,0.5492585869332626
HSC-4,25195348,4.125902627491381,3.294337369760579
NCI-H661,227681,4.255095664751994,3.217646162155161
NCI-H292,24951314,1.8411912809473163,1.7480958804907916
NCI-H522,3543504,4.389197316233122,3.898091739972854
NCI-H460,452548,0.6919333948360032,0.4907494707733464
SNU-61,25105715,3.603411279706935,3.3802066715442236
NCI-H727,navitoclax-pluripotin (1-1 mol-mol),-0.0549082702470221,-0.6104634064179489
SW1463,11175137,3.4916395483032256,2.469660741013726
SBC-5,6914657,-3.351925471283153,-4.159297045043544
JM-1,65064,5.210865559450395,3.8397126143508182
OPM-2,9967941,3.958466181768741,3.283853947740829
KMRC-1,969516,2.336566526495707,2.635760221753662
MSTO-211H,15983966,-3.5322347663594016,-1.3570019795598887
OPM-2,9952709,2.422518614873216,2.246522071798486
NOMO-1,16741245,4.369418152152245,3.497769895002304
DMS 273,16659841,4.479005871158747,2.982318282652929
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,4.113008775855528
JM-1,46398810,2.06860116520361,1.7050920075232587
NCI-H661,12003241,-1.8871798966926587,-0.9999683501999769
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748,-5.046109673632952
FU-OV-1,10184653,3.943218547538411,1.461854594312845
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402,3.786297062728887
OPM-2,156422,3.8836640353636382,2.947204121481789
BxPC-3,JQ-1-vorinostat (2-1 mol-mol),0.8253599744929256,0.9601951719080667
SNU-449,56649450,3.812927022122559,3.349471059131298
CAL-51,119607,5.291790266428237,5.320528494166266
LOU-NH91,selumetinib-UNC0638 (4-1 mol-mol),4.70852852885549,3.7047772341727687
BT-549,148124,3.591112191677911,-1.9953437072485007
A2780,216468,0.3493873836888674,1.8657683395656637
MDA-MB-453,176870,4.531738011413092,3.2844028101936287
FTC-133,docetaxel-tanespimycin (2-1 mol-mol),-1.4229742664151317,-2.5452342909323864
LXF 289,24180125,2.8590757937383517,3.214537185997761
G-401,4259181,0.5796012369716917,-0.4016682102390108
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044,4.473523012124947
SNU-81,alisertib-navitoclax (2-1 mol-mol),-2.6757706059542445,-0.48057506258145805
JM-1,54618305,4.117087010604098,3.5921707975093256
NCI-H522,16736978,1.523319728114192,1.2860575193092754
NCI-H522,36462,3.1215227661343925,1.2874159309068873
HSC-4,400769,-0.948607557046086,-0.5169787144844786
FU-OV-1,piperlongumine-MST-312 (1-1 mol-mol),2.3913949476666243,1.9374925494536357
YAPC,20959075,1.1991758721406616,-2.735323704560119
A-498,5328940,1.8314953095149151,1.8362744735019687
YAPC,9915743,1.8269757962027744,1.1035795546299476
SNU-81,54613361,-2.01246069716893,-0.1325326724283911
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224,-2.4134338226394783
OPM-2,1716436,2.6292767753294437,2.736557596851944
Panc 04.03,3025986,-1.5275729109481309,-0.8686908860913941
NCI-H661,25150857,2.764254958619497,2.5098232996950305
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544,2.3751012630441757
LOU-NH91,5746,1.403252091596802,1.6394170634046623
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391,1.700874611552571
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698,2.6958016510024594
NCI-H146,135398738,5.0513404057578155,3.9556499621690135
MDA-MB-453,25227462,0.3575965628816619,-0.27737571196370703
NCI-H460,2858523,3.1665522277325575,2.8438105244922425
SNU-449,9866186,1.4050575476777012,1.2319624430906655
CAL-51,54686904,4.850424917483252,3.4851816167004377
LoVo,53392493,2.4765619401689154,2.619717529011938
LXF 289,24951314,1.0119406639366386,1.6119410490051873
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992,2.8926816536984905
NCI-H1623,5329102,1.790138577011996,2.1586415912476378
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017,2.6858617949965184
NCI-H292,3815108,3.432884993584308,3.0947796446525615
OPM-2,400769,-3.2268127368380215,-1.1024229266109244
MDA-MB-157,9823820,1.002295209558588,3.9870776658149936
MDA-MB-453,vorinostat-carboplatin (1-1 mol-mol),1.132828187068375,3.1170045991224664
YAPC,135999136,4.461108174764027,3.971881233108488
A-498,71680916,6.416494665581045,4.809658994053908
BT-549,252682,5.865498031558929,6.73167748442007
NCI-H522,2130404,2.4549438882602463,2.318750667216899
BT-549,60750,3.345812478570961,-2.1454214879498488
A2780,55508,1.942124594025635,3.0856351050600237
BT-549,3136844,5.53345832245052,4.441636237719856
A-673,SNX-2112-bortezomib (250-1 mol-mol),-3.639662214518592,-1.7904549124054767
NCI-H522,135398516,2.766899162932887,1.8589878389267542
Panc 04.03,45279963,4.427260741974604,3.9293998770169862
MDA-MB-157,107970,2.1200224507121868,2.4705734037757523
DMS 273,24180719,3.915275581303962,3.4519398090405518
Panc 04.03,71680916,5.172010716636655,4.843089178226205
DMS 273,44632017,0.8019003224742934,0.8873905752103736
NCI-H292,5311281,4.174884455345005,2.508036015312611
NCI-H2171,9549297,1.2348443580878434,1.9666813823842164
NCI-H661,135398516,2.0112722508641525,2.1579218140229224
A4/Fukuda,6918328,-3.9252329494253586,-1.2721070730347468
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603,2.448101205844274
A-673,5284616,-2.8220877865693996,1.4642290178854942
A-498,11222830,1.898532346529896,1.9680665618039737
SNU-81,44589607,-1.0723208776906596,2.0717960934882815
SCC-9,54596558,4.378159430294897,4.543479914242778
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617,0.044525736179707474
OPM-2,56649450,1.6365959554779024,2.625926815536875
JM-1,2945648,1.8231052373320176,2.094758022157383
Panc 04.03,6852167,3.6951209581653743,3.067348153016573
OPM-2,5311281,1.024044758253736,1.787129589553353
SCC-9,9967941,4.677287493278682,3.631346608821551
CAL-51,11609586,1.5077859423552509,2.9941061616471325
SNU-61,9911463,3.407728451470452,3.5210018910693264
LOU-NH91,BRD-A02303741-navitoclax (2-1 mol-mol),0.4254312881757893,2.6720888788245225
KMRC-1,72193861,2.923138623905541,1.781431937612393
SCC-9,168313016,4.940700460648117,4.748895475799899
NCI-H1623,46215462,1.70222177248337,1.977443817631156
MDA-MB-157,6505803,-0.678815881739905,-0.22432398615738294
A-673,25062766,1.5933001652207863,1.9215255379131693
NCI-H522,148198,-5.538025476960186,-3.507475227160889
KMRC-1,11625818,4.222506706272698,4.370634498467811
LoVo,10074640,2.9851259451828476,3.105030345135394
NCI-H1623,12001922,2.89915315578861,1.9980064925740584
NCI-H460,107970,2.752075604137296,2.3498635795111715
HSC-4,10322450,4.749470049467763,3.9717763111255526
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982,-0.12905746911685267
CAL-51,65628,4.560195683913681,4.393695315404077
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797,2.7106819685895975
SCC-9,2746,3.644005246156997,3.3126153583503184
JM-1,107985,-4.195149425063274,-4.009331439064834
NCI-H146,119607,3.9951566487227823,5.03149549718062
JM-1,44566777,-1.1129943275867182,-0.17929746643990532
SBC-5,11167602,1.6319389998554443,2.4797541159921064
LOU-NH91,9936388,-6.294191236399446,-0.25072249269586583
SNU-61,135875424,3.609444893060012,3.4933999938441764
NCI-H292,6917907,-6.008612763335491,-5.41263520634553
G-401,19582717,3.4233639988307623,3.4349212398573963
LXF 289,46174525,4.3838011857350585,4.534730036464254
SW1463,10184653,-0.9517511422842978,1.0412067568635581
SCC-9,7251185,3.4755501931610486,2.7629186339763225
OPM-2,4788,3.799883557086963,5.079780701829395
MSTO-211H,selumetinib-UNC0638 (4-1 mol-mol),2.638630251212758,3.159838753405849
OPM-2,selumetinib-navitoclax (8-1 mol-mol),2.2674041559669917,0.6391493869260916
DMS 273,JQ-1-navitoclax (2-1 mol-mol),1.419130204387569,0.21212334118936924
NCI-H460,387447,-2.436463262555682,-3.7608454221855463
NCI-H522,3465537,1.2201304719285595,2.323319492418638
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637,2.4594839739270116
OVISE,11228183,1.089434907795814,2.3370653854064978
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958,0.9431607337220891
NOMO-1,10410894,2.884775843935945,2.669670436504921
NCI-H522,3062316,1.3416096793720445,0.9540369119690844
NCI-H522,5328940,1.3898569828081493,1.6939379144270728
OVISE,6917907,-2.8614664806523975,-4.263045065536307
DMS 273,53392493,1.951320459884087,1.9680607437008029
BxPC-3,44259,0.1590720374324279,1.2635209229377915
CAL-51,17755052,0.5283491907817935,1.7351749900750415
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112,2.547781127557077
NCI-H661,676352,2.2217693895783115,2.0388491594766616
LXF 289,452548,0.2436004430663324,0.25047058273419653
LoVo,6438330,1.2087527750724023,2.542050131599834
OPM-2,16736978,1.1906517256258733,0.6917486797022847
DMS 273,89928392,1.202164769006387,0.9663055788722639
CA46,3543504,2.8823298921776717,3.4865909803832307
SBC-5,11427553,4.187017651849035,2.5023358449858137
CAL-51,67156097,-2.385254348530768,-1.1344918125193404
FTC-133,23725625,5.526585624025884,5.22209166496084
BT-549,25227462,1.1552638438270102,0.9968172445620884
SNU-81,374536,-2.2172994025671877,1.4464602463693215
MSTO-211H,navitoclax-pluripotin (1-1 mol-mol),-2.948162650279317,-0.8223111470040719
BT-549,65064,5.372588334008338,4.910607519142871
NOMO-1,135398738,0.7085728369009435,2.54955683761818
A-673,44566777,0.6818018070798556,0.4109495345561885
OVISE,42642645,1.7980918591344808,0.935517572248119
CA46,637858,0.8997823848237061,0.8106032902504837
NCI-H292,9877608,5.923265260718527,3.4939727240971847
DMS 273,11964036,0.5570994002779035,0.8530102892650744
FTC-133,44137675,6.176024086140045,3.6540716213610147
BxPC-3,9926054,1.7603137158224154,2.014906197214825
DMS 273,5311,0.3077166337368,0.8209125667480518
SNU-61,36314,2.631499046696298,-1.4634171389578878
EFO-27,6917907,-5.745836009999857,-5.267621625045703
OPM-2,11455910,0.7503761469114726,0.5325449732416994
NCI-H1623,24785538,-1.341558176424811,1.7856173824324315
SNU-449,462382,1.3667681892704822,0.524617453326891
G-401,8515,3.316277000480566,3.33366542765716
SNU-449,25102847,2.813788740655036,2.4135659517611083
BT-549,JQ-1-UNC0638 (2-1 mol-mol),2.8120688111855845,1.9262992472192266
ONS-76,11404337,-0.4259392266769182,-0.19524145631202894
KMRC-1,49766530,-0.1675164065777726,-0.9840545107547719
HSC-4,24785538,3.772420906085344,1.4397601997419276
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447,5.2909914374492875
KYSE-70,73707398,2.029692143461395,1.544250134066932
NCI-H1623,2729026,3.210868522276231,2.804020861436042
ONS-76,selumetinib-MK-2206 (8-1 mol-mol),-0.5692436577416031,1.8841300779197923
FTC-133,56649450,4.4227260509908275,3.331098087541042
NCI-H727,3815108,3.498449156165097,2.870778641889469
FU-OV-1,448949,2.8154029654914137,1.9672816086244418
FU-OV-1,168313200,1.721890351327649,2.915603601273466
HSC-4,107985,-2.2656284906222144,-3.4917214033820487
NCI-H2009,44241473,6.22803294537171,4.7386817885782015
CAL-51,46843906,2.776329873296567,3.0001807492811947
NCI-H1623,56946209,-3.1229213094171895,-4.09270401051988
FU-OV-1,3825829,3.720797122696784,4.0420743095907055
LXF 289,10385095,0.5776298837700374,1.4900751095922076
KMRC-1,4259181,1.968851453570829,0.015506319275967012
G-401,11494412,0.2825252149996007,0.5953520510542883
KYSE-70,6918878,2.8589087884624673,2.8511279013503863
CA46,44185566,1.786162700750641,1.5687699662651589
LoVo,54618164,3.038824107117225,4.0943708772367
NOMO-1,16722836,0.125485002235246,0.8129743163659328
A4/Fukuda,44486219,1.5854911698245977,3.968241466570596
LOU-NH91,10127622,4.686411868973226,4.48959909559873
KMRC-1,387447,-4.945508167403058,-4.073665477285031
NCI-H146,54618164,3.6762408834701423,3.9371705392162353
KMRC-1,5351362,3.133883590343709,1.645806742095234
NCI-H2171,54765302,2.983840848305476,3.6881676210370067
KMRC-1,16013152,4.7431155582488325,3.6758141551112073
SNU-61,71304818,2.3861681407496125,2.2621900700965885
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046,1.543096384865983
SW1463,2708,3.597321448088185,4.226152055101433
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546,-0.18743702339955573
FTC-133,piperlongumine-MST-312 (1-1 mol-mol),3.9575841468826383,1.9538592968574944
SBC-5,445643,4.051401497201939,3.913203357755851
A4/Fukuda,241158,1.407426277414268,2.480193796883053
NOMO-1,6852167,1.234836949550939,1.4005140533128289
A-673,9887053,2.3565868011684956,3.003916152783829
SNU-61,6450551,3.0035817833604783,2.1539467689713665
OPM-2,24771867,-0.0082042750480303,-1.3071530679890144
NOMO-1,11507802,1.1250810428603863,0.947911630335635
CAL-51,2828334,6.190580852669228,6.097447586988747
OPM-2,selumetinib-PLX-4032 (8-1 mol-mol),2.3146569091496847,3.1855854359693017
KMRC-1,44489675,3.6404436921550607,3.954381484334242
FU-OV-1,23725625,5.156277829802871,5.083482231310699
NCI-H1623,navitoclax-gemcitabine (1-1 mol-mol),-5.01790230865627,-0.722986799931315
OVISE,439501,-2.343202219776273,-1.779976160072963
CAL-51,5281321,-0.4656602142962174,-1.2177221930587205
DMS 273,151289,0.7083247440682101,0.6389100518277462
MSTO-211H,9903786,1.212702371904443,2.9690617899035576
LXF 289,135421197,2.6553019911408056,2.094482077914535
NCI-H146,24771867,1.252264036368602,1.7332571981366192
CAL-51,136227924,2.079284078064279,3.092930467594591
NCI-H522,3689413,-4.273368850016072,-0.5140366944541606
NCI-H460,46907787,4.3372157131836255,2.54252701204051
NCI-H146,25183872,-1.3449770735764903,-1.1711095029082308
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.388929550180623
CAL-51,9887053,4.486783389261201,3.8446916456123295
NCI-H460,107985,-2.632533954936978,-3.23715139958537
YAPC,65064,4.247853222703643,4.932692607550811
SCC-9,9884685,0.522968392230544,1.1005211806022208
SNU-61,6852167,3.859693430343892,2.531335827760767
NCI-H292,400769,-0.4441855968341354,-0.4689048185078154
EFO-27,24748573,3.2354879524418347,2.493093664318194
CA46,65628,4.372814936384242,3.0563913818721846
NOMO-1,1750826,-5.797741098147838,-2.8834671634218307
LOU-NH91,135440466,0.9387697781897782,2.4569222408102567
MSTO-211H,11427553,1.7459714847796464,3.0448308869205136
SNU-61,9903786,2.1391845181717373,2.742199074144669
JM-1,9952709,2.333856130884211,2.0855646663217744
YAPC,44507138,4.423761616669373,2.510804743245563
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152,1.8187361045982888
NCI-H727,10231331,-2.105430518957453,1.6946935664531142
NCI-H661,navitoclax-gemcitabine (1-1 mol-mol),-0.9367360763965996,-0.872352144626896
LoVo,6610355,3.962139785065475,4.452928391433664
LOU-NH91,16065773,1.5129164046929433,2.67485452447803
NCI-H292,51039095,2.62578521626359,3.148728574041735
NCI-H2009,135398516,3.792403018557381,2.2688143368595606
Panc 04.03,44566777,0.5187219827219705,0.814872558814011
NOMO-1,285033,-2.4289999699368923,-3.003274539391853
LOU-NH91,doxorubicin-navitoclax (2-1 mol-mol),-1.426641258307621,-0.795471044790513
KYSE-70,51039095,3.5490987853947247,2.6647455510702915
NCI-H460,36462,3.103581216464206,2.0671324690509754
MDA-MB-157,216345,3.882260039310166,3.764883605730454
NCI-H522,104842,-1.8805759610000512,-3.476393311334312
FU-OV-1,72376,-3.2802123060842283,-1.5298489947653022
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302,1.7936240994645767
NCI-H661,5978,-4.21717720873681,-2.2735645055649414
A-498,54619267,3.764771843303345,4.159617421055241
SCC-9,53495165,0.7472636588137463,0.4094805325555605
MSTO-211H,9823820,1.3460489687603958,4.3415536043603185
EFO-27,11222830,1.8018026478898377,1.6954406298813662
JM-1,11612883,1.345048153552996,1.8542583526888123
NCI-H146,carboplatin-etoposide (40-17 mol-mol),0.3222331814864832,2.07786469134353
EFO-27,12003241,-1.7336155023360622,-1.033705839737995
SNU-449,969516,2.7263398794742972,2.9413315665888695
NCI-H146,4259181,0.4591034911128469,0.06010158518487515
NOMO-1,24901704,1.738276567126731,2.124971331597226
BxPC-3,54619238,5.160880582862859,4.893670141790507
SBC-5,654092,0.9915803206550192,-0.4046021607277288
MDA-MB-453,71751553,4.5545018888168185,4.273742547127647
MDA-MB-157,5978,-4.802538048228265,-1.0422778610907137
CAL-51,24964624,1.6704816041215405,2.641758388607209
LOU-NH91,5280436,5.173335280456015,3.532616808072457
EFO-27,53481919,4.175905541374054,3.98932319831438
ONS-76,6610216,4.821554065133985,4.29576068223829
JM-1,53495165,-3.850144918627292,-1.7101389407022005
YAPC,16065773,2.864044457230109,2.6214658243385998
SNU-449,51039095,3.650396552732121,2.835218150935455
NCI-H661,71466445,2.1620252686029646,4.2070269577804575
A4/Fukuda,984333,-0.4165614363108865,-0.059329816262981165
JM-1,4096211,0.9764948319580444,1.1321207893933944
SNU-449,44197249,4.950419501644914,3.968150015319881
NCI-H460,11178236,-2.300904923417752,-3.370231458129547
MDA-MB-453,12001922,1.470906003655458,1.8981953699995902
NCI-H460,44620216,3.8133491956675902,3.740966160695281
A-673,119182,-1.0392852637873304,-1.7719829159695997
NCI-H727,11178236,-2.542459533585497,-2.9751981006345045
NCI-H1623,erlotinib-PLX-4032 (2-1 mol-mol),-0.1422885712238643,2.849570473558241
A4/Fukuda,753704,3.7176461109746897,4.136533898618785
SW1463,168312962,2.678519281942756,1.5607484238327682
KMRC-1,SNX-2112-bortezomib (250-1 mol-mol),0.0767950067042666,-1.2545452535478572
OPM-2,227681,1.827584998281281,2.799854957585211
HCC1143,3081361,2.3254724072420316,2.304202925386652
CAL-51,44607531,1.640429423812436,1.4980942075472836
HCC1143,322968,3.187805633465504,3.7380769091110686
FTC-133,9911463,4.36756965003986,3.9968925770828485
SNU-61,159324,1.5880493113453718,2.0749882417120964
NCI-H2171,5738263,2.6832104272478188,2.8381394061532803
CA46,49867926,4.142181337076857,2.805164009440731
SNU-81,BRD-A02303741-navitoclax (2-1 mol-mol),0.8522567387086551,1.8824729473061501
HSC-4,44589607,3.345116081225748,2.9258221984287487
EFO-27,11485656,3.240498776862908,2.469415478447439
SNU-81,23725625,1.2739024793065858,4.370961613397939
A4/Fukuda,9911830,0.8865121451383732,2.1471427380657353
NCI-H1623,JQ-1-UNC0638 (2-1 mol-mol),2.6843347454635604,1.7204706534139325
NCI-H292,9866186,0.3072921576740348,0.9817710219870464
NCI-H460,54143018,2.5592633032091956,0.5959246849151637
A2780,4378219,4.7769256594107254,2.2324323833060307
NCI-H1623,44566777,3.7111231324950102,0.8924458910508355
CAL-51,10074640,3.192334769578339,3.1768596217845144
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452,4.607953242903622
CAL-51,60700,-0.6497243984818711,-0.3439241557681669
HCC1143,12001922,1.8011931254041345,1.994594520158207
NCI-H727,638278,3.5555642892396744,2.9669895017910077
LOU-NH91,72376,-0.6247816475402558,-1.3663443597208984
EFO-27,4578,4.426476303141277,4.563418165958111
HCC1143,119607,4.074424413991316,5.2728207340476
JM-1,selumetinib-decitabine (4-1 mol-mol),-2.432451496880968,0.475899993158501
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878,0.32768372609174895
NCI-H727,159324,3.364651085509472,3.0902123485648976
NCI-H1623,5287620,-2.020641279124402,-1.9877574198303338
CAL-51,4261,2.4552246887350417,1.8852728091325432
JM-1,3543504,2.821603823672808,3.61063519457898
SNU-81,11497983,2.4691665919847514,1.1218071792541773
G-401,5113032,4.898905985161468,4.656068221834251
MDA-MB-157,52912189,4.238554807379722,2.0789169707917234
G-401,selumetinib-navitoclax (8-1 mol-mol),2.1097176548583407,1.4476523149752105
KYSE-70,10410894,6.372300696648814,3.3615166995480723
LXF 289,54618164,3.0378434141224617,4.127711075988509
SNU-61,11214940,-0.337645985307237,1.8576495489675022
ONS-76,11364421,-0.3098764345335473,-1.992572858150478
KYSE-70,5978,-0.772629381148284,-0.9426430726726093
Panc 04.03,53232,3.444660782403792,2.611051200682106
FTC-133,46926350,-4.117104249862265,-3.9568511118301783
